PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Viskin, S; Fish, R; Roth, A; Schwartz, PJ; Belhassen, B				Viskin, S; Fish, R; Roth, A; Schwartz, PJ; Belhassen, B			QT or not QT?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TORSADE-DE-POINTES; AFTERDEPOLARIZATIONS		Sourasky Tel Aviv Med Ctr, Dept Cardiol, IL-64239 Tel Aviv, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Univ Pavia, Dept Cardiol, I-27100 Pavia, Italy; Policlin San Matteo, Ist Ricovero & Cura Carattere Sci, I-27100 Pavia, Italy	Tel Aviv University; Sackler Faculty of Medicine; University of Pavia; IRCCS Fondazione San Matteo	Viskin, S (corresponding author), Sourasky Tel Aviv Med Ctr, Dept Cardiol, Weizman 6, IL-64239 Tel Aviv, Israel.		Schwartz, Peter J/J-4267-2016	Schwartz, Peter J/0000-0003-0367-1048				BENDAVID J, 1990, CIRCULATION, V82, P225, DOI 10.1161/01.CIR.82.1.225; JERVELL A, 1957, AM HEART J, V54, P59, DOI 10.1016/0002-8703(57)90079-0; KASSIRER JP, 1978, ANN INTERN MED, V89, P245, DOI 10.7326/0003-4819-89-2-245; Kihara H, 1997, J Cardiol, V30, P37; LEE JH, 1994, J CARDIOVASC ELECTR, V5, P232, DOI 10.1111/j.1540-8167.1994.tb01160.x; Priori SG, 1997, PACE, V20, P2052, DOI 10.1111/j.1540-8159.1997.tb03626.x; PRIORI SG, 1990, AM J PHYSIOL, V258, pH1796, DOI 10.1152/ajpheart.1990.258.6.H1796; ROMANO C, 1963, Clin Pediatr (Bologna), V45, P656; SCHWARTZ PJ, 1993, CIRCULATION, V88, P782, DOI 10.1161/01.CIR.88.2.782; SHIMIZU K, 1992, AM HEART J, V124, P235, DOI 10.1016/0002-8703(92)90954-T; STENSTROM G, 1988, ACTA MED SCAND, V224, P231; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; VINCENT G, 1999, CARDIAC ELECTROPHYSI, V3, P207; Viskin S, 1999, LANCET, V354, P1625, DOI 10.1016/S0140-6736(99)02107-8; WARD O. C., 1966, IRISH J MED SCI, V491, P553; WARD O C, 1964, J Ir Med Assoc, V54, P103; YOUNG JB, 1998, WILLIAMS TXB ENDOCRI, P665	17	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2000	343	5					352	356		10.1056/NEJM200008033430508	http://dx.doi.org/10.1056/NEJM200008033430508			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340GR	10922426				2022-12-28	WOS:000088525200008
J	Heim, C; Newport, DJ; Heit, S; Graham, YP; Wilcox, M; Bonsall, R; Miller, AH; Nemeroff, CB				Heim, C; Newport, DJ; Heit, S; Graham, YP; Wilcox, M; Bonsall, R; Miller, AH; Nemeroff, CB			Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORTICOTROPIN-RELEASING-FACTOR; FACTOR-LIKE IMMUNOREACTIVITY; EARLY PARENTAL SEPARATION; MAJOR DEPRESSION; PARAVENTRICULAR NUCLEUS; CEREBROSPINAL-FLUID; ANXIETY DISORDERS; BIPOLAR DISORDER; MESSENGER-RNA; COMMUNITY	Context Evidence suggests that early adverse experiences play a preeminent role in development of mood and anxiety disorders and that corticotropin-releasing factor (CRF) systems may mediate this association. Objective To determine whether early-life stress results in a persistent sensitization of the hypothalamic-pituitary-adrenal axis to mild stress in adulthood, thereby contributing to vulnerability to psychopathological conditions, Design and Setting Prospective controlled study conducted from May 1997 to July 1999 at the General Clinical Research Center of Emery University Hospital, Atlanta, Ga. Participants Forty-nine healthy women aged 18 to 45 years with regular menses, with no history of mania or psychosis, with no active substance abuse or eating disorder within 6 months, and who were free of hormonal and psychotropic medications were recruited into 4 study groups (n = 12 with no history of childhood abuse or psychiatric disorder [controls]; n =13 with diagnosis of current major depression who were sexually or physically abused as children; n = 14 without current major depression who were sexually or physically abused as children; and n = 10 with diagnosis of current major depression and no history of childhood abuse). Main Outcome Measures Adrenocorticotropic hormone (ACTH) and cortisol levels and heart rate responses to a standardized psychosocial laboratory stressor compared among the 4 study groups. Results Women with a history of childhood abuse exhibited increased pituitary-adrenal and autonomic responses to stress compared with controls. This effect was particularly robust in women with current symptoms of depression and anxiety. Women with a history of childhood abuse and a current major depression diagnosis exhibited a more than 6-fold greater ACTH response to stress than age-matched controls (net peak of 9.0 pmol/L [41.0 pg/ml]; 95% confidence interval [CI], 4.7-13.3 pmol/L [21.6-60.4 pg/mL]; vs net peak of 1.4 pmol/L [6.19 pg/ml]; 95% CI, 0.2-2.5 pmol/L [1.0-11.4 pg/mL]; difference, 8.6 pmol/L [38.9 pg/ml]; 95% CI, 4.6-12.6 pmol/L [20.8-57.1 pg/mL]; P < .001). Conclusions Our findings suggest that hypothalamic-pituitary-adrenal axis and autonomic nervous system hyperreactivity, presumably due to CRF hypersecretion, is a persistent consequence of childhood abuse that may contribute to the diathesis for adulthood psychopathological conditions. Furthermore, these results imply a role for CRF receptor antagonists in the prevention and treatment of psychopathological conditions related to early-life stress.	Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; Univ Trier, Ctr Psychobiol & Psychosomat Res, Trier, Germany	Emory University; Universitat Trier	Nemeroff, CB (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, 1639 Pierce Dr,WMRB,Suite 4000, Atlanta, GA 30322 USA.	cnemero@emory.edu	Newport, D. Jeffrey/AAN-5036-2020; Heim, Christine/J-4693-2014; Heim, Christine/A-1183-2009; Newport, Donald Jeffrey/H-9846-2013	Newport, D. Jeffrey/0000-0003-1695-9710; Heim, Christine/0000-0002-6580-6326; Nemeroff, Charles/0000-0001-7867-1160	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Agid O, 1999, MOL PSYCHIATR, V4, P163, DOI 10.1038/sj.mp.4000473; ALTEMUS M, 1992, ARCH GEN PSYCHIAT, V49, P9; [Anonymous], 1994, SEMIN NEUROSCI; Baker DG, 1999, AM J PSYCHIAT, V156, P585; BANKI CM, 1987, AM J PSYCHIAT, V144, P873; BREMNER JD, 1993, AM J PSYCHIAT, V150, P235; Bremner JD, 1997, AM J PSYCHIAT, V154, P624; BREMNER JD, IN PRESS J TRAUMA ST; BRITTON DR, 1982, LIFE SCI, V31, P363, DOI 10.1016/0024-3205(82)90416-7; BROWNE MAO, 1995, AUST NZ J PSYCHIAT, V29, P437; BUTLER PD, 1990, COMORBIDITY OF MOOD AND ANXIETY DISORDERS, P413; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Coplan JD, 1996, P NATL ACAD SCI USA, V93, P1619, DOI 10.1073/pnas.93.4.1619; DUNN AJ, 1990, BRAIN RES REV, V15, P71, DOI 10.1016/0165-0173(90)90012-D; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; FARAVELLI C, 1986, BRIT J PSYCHIAT, V148, P288, DOI 10.1192/bjp.148.3.288; FRIST MB, 1997, STRUCTURED CLIN INTE, V4; Furukawa TA, 1999, J AFFECT DISORDERS, V52, P85, DOI 10.1016/S0165-0327(98)00054-8; GULLEY LR, 1993, J CLIN PSYCHIAT, V54, P16; HALLSTROM T, 1987, ACTA PSYCHIAT SCAND, V75, P212, DOI 10.1111/j.1600-0447.1987.tb02777.x; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hartline KM, 1996, ANN NY ACAD SCI, V780, P96, DOI 10.1111/j.1749-6632.1996.tb15114.x; Holsboer F, 1999, J PSYCHIATR RES, V33, P181, DOI 10.1016/S0022-3956(98)90056-5; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P109; KENDLER KS, 1993, AM J PSYCHIAT, V150, P1139; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Ladd CO, 1996, ENDOCRINOLOGY, V137, P1212, DOI 10.1210/en.137.4.1212; Levene H, 1960, CONTRIBUTIONS PROBAB; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mullen PE, 1996, CHILD ABUSE NEGLECT, V20, P7, DOI 10.1016/0145-2134(95)00112-3; Nemeroff CB, 1999, MOL PSYCHIATR, V4, P106, DOI 10.1038/sj.mp.4000512; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; OWENS MJ, 1991, PHARMACOL REV, V43, P425; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Portegijs PJM, 1996, FAM PRACT, V13, P1, DOI 10.1093/fampra/13.1.1; RAADSHEER FC, 1995, AM J PSYCHIAT, V152, P1372; RAADSHEER FC, 1994, NEUROENDOCRINOLOGY, V60, P436, DOI 10.1159/000126778; ROSENBLUM LA, 1984, CHILD DEV, V55, P305, DOI 10.1111/j.1467-8624.1984.tb00293.x; ROY A, 1985, ARCH GEN PSYCHIAT, V42, P987; SAUNDERS BE, 1992, J INTERPERS VIOLENCE, V7, P189, DOI 10.1177/088626092007002005; SIRINATHSINGHJI DJS, 1983, NATURE, V305, P232, DOI 10.1038/305232a0; Stein MB, 1996, AM J PSYCHIAT, V153, P275; SUTTON RE, 1982, NATURE, V297, P331, DOI 10.1038/297331a0; WIDERLOV E, 1988, J AFFECT DISORDERS, V14, P99, DOI 10.1016/0165-0327(88)90051-1; Zobel AW, 2000, J PSYCHIATR RES, V34, P171, DOI 10.1016/S0022-3956(00)00016-9	46	1372	1396	0	168	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2000	284	5					592	597		10.1001/jama.284.5.592	http://dx.doi.org/10.1001/jama.284.5.592			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	337WG	10918705	Bronze			2022-12-28	WOS:000088385400028
J	Burris, S; Lurie, P; Abrahamson, D; Rich, JD				Burris, S; Lurie, P; Abrahamson, D; Rich, JD			Physician prescribing of sterile injection equipment to prevent HIV infection: Time for action	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS INFECTION; SYRINGE-EXCHANGE PROGRAMS; UNITED-STATES; DRUG-USERS; CARE	Injection drug users, their sex partners, and their children are at high risk for acquiring HIV infection and other bloodborne diseases. The risk for disease transmission in the United States is partly the result of restricted access to sterile injection equipment. Physicians and pharmacists can play an important role in providing syringe access by prescribing and dispensing syringes to patients who use injection drugs and cannot or will not enter drug treatment. Prescribing and dispensing injection equipment are ethical, clinically appropriate, and fully consistent with current public health guidelines on disease prevention. An analysis of the laws of the 50 U.S. states, the District of Columbia, and Puerto Rico finds that physicians in nearly all these jurisdictions may legally prescribe sterile injection equipment to prevent disease transmission among drug-using patients and that pharmacists in most states have a clear or reasonable legal basis for filling the prescriptions. Given these medical and legal findings, physicians may wish to take a larger role in improving access to sterile injection equipment by prescribing this equipment for their patients where this practice is legal, and by joining efforts to change the law where it poses a barrier.	Temple Univ, Sch Law, Philadelphia, PA 19122 USA; Publ Citizens Hlth Res Grp, Washington, DC USA; Lindsmith Ctr W, San Francisco, CA USA; Brown Univ, Miriam Hosp, Sch Med, Providence, RI USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Brown University; Lifespan Health Rhode Island; Miriam Hospital	Burris, S (corresponding author), Temple Univ, Sch Law, 1719 N Broad St, Philadelphia, PA 19122 USA.	burris@vm.temple.edu		Burris, Scott/0000-0002-6013-5842	NIDA NIH HHS [K20 DA00268, DA 09712] Funding Source: Medline; CSAT SAMHSA HHS [KD1 TI12037-01] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009712, K20DA000268] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); CSAT SAMHSA HHS; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alter MJ, 1998, J ACQ IMMUN DEF SYND, V18, pS6, DOI 10.1097/00042560-199802001-00003; Beauchamp TL, 2009, PRINCIPLES BIOMEDICA; BRIDGES FS, 1998, FLORIDA J PHARM, V1, P12; Brooner R, 1998, Public Health Rep, V113 Suppl 1, P129; Burris S, 1996, AM J PUBLIC HEALTH, V86, P1161, DOI 10.2105/AJPH.86.8_Pt_1.1161; Case P, 1998, J ACQ IMMUN DEF SYND, V18, pS94, DOI 10.1097/00042560-199802001-00017; COMPTON WM, 1992, AM J PUBLIC HEALTH, V82, P595, DOI 10.2105/AJPH.82.4.595; Costarides AH, 1998, TOP LANG DISORD, V18, P1, DOI 10.1097/00011363-199805000-00004; FERGUSON LK, 1998, TEMPLE POLITICAL CIV, V8, P41; FRIEDLAND GH, 1998, HARRISONS PRINCIPLES, P831; FURROW BR, 1995, HLTH LAW, P139; Garfein RS, 1998, J ACQ IMMUN DEF SYND, V18, pS11, DOI 10.1097/00042560-199802001-00004; Gleghorn AA, 1998, J ACQ IMMUN DEF SYND, V18, pS89, DOI 10.1097/00042560-199802001-00016; Gostin L O, 1997, Emory Law J, V46, P587; Heimer R, 1996, AIDS PUBLIC POLICY J, V11, P169; Holmberg SD, 1996, AM J PUBLIC HEALTH, V86, P642, DOI 10.2105/AJPH.86.5.642; Hurley SF, 1997, LANCET, V349, P1797, DOI 10.1016/S0140-6736(96)11380-5; JARLAIS DCD, 1988, AM PSYCHOL, V43, P865, DOI 10.1037/0003-066X.43.11.865; Jarlais DCD, 1996, LANCET, V348, P987, DOI 10.1016/S0140-6736(96)02536-6; JONES TS, 1999, J AM PHARM ASSOC, V39, P1; Kapp M B, 1997, Univ Toledo Law Rev, V28, P521; KOESTER SK, 1994, HUM ORGAN, V53, P286; Lazzarini Z, 1998, J ACQ IMMUN DEF SYND, V18, pS141, DOI 10.1097/00042560-199802001-00025; LIURIE P, 1993, PUBLIC HLTH IMPACT N; Loue S, 1995, J LAW MED ETHICS, V23, P382, DOI 10.1111/j.1748-720X.1995.tb01383.x; Lurie P, 1998, J ACQ IMMUN DEF SYND, V18, pS45, DOI 10.1097/00042560-199802001-00009; Macalino GE, 1998, J ACQ IMMUN DEF SYND, V18, pS111, DOI 10.1097/00042560-199802001-00019; MCCLELLAN FM, 1994, MED MALPRACTICE LAW; NELSON KE, 1991, JAMA-J AM MED ASSOC, V266, P2259, DOI 10.1001/jama.266.16.2259; NORMAND J, 1995, PREVENTING HIV TRANS; Novick A, 1996, AIDS PUBLIC POLICY J, V11, P63; OCONNOR PG, 1994, NEW ENGL J MED, V331, P450, DOI 10.1056/NEJM199408183310707; Osterholm MT, 2000, PRINCIPLES PRACTICE, V5th, P156; RENO J, 1998, COMMUNICATION   0605; Satterfield D, 1991, Diabetes Educ, V17, P321, DOI 10.1177/014572179101700412; Singer M, 1998, Public Health Rep, V113 Suppl 1, P81; Stolberg Sheryl Gay, 1998, N Y Times Web, pA21; STONE SE, 1983, DRUG ENFORCEMENT, V21, P23; STRAUSS S, 1980, PHARM LAW, P29; TOEWS DW, 1995, AM J PUBLIC HEALTH, V85, P1447; *US PHS, 1997, HIV PREV B MED ADV P; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; VAETH C, 1994, AM LAW REPORTS, V13, P1; Vlahov D, 1997, J ACQ IMMUN DEF SYND, V16, P400, DOI 10.1097/00042560-199712150-00014; WEILER PC, 1991, MEASURE MALPRACTICE; Wortley PM, 1997, JAMA-J AM MED ASSOC, V278, P911, DOI 10.1001/jama.278.11.911; 1998, MMWR MORB MORTAL WKL, V47, P652	47	31	31	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2000	133	3					218	226		10.7326/0003-4819-133-3-200008010-00015	http://dx.doi.org/10.7326/0003-4819-133-3-200008010-00015			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	338XW	10906838				2022-12-28	WOS:000088449400008
J	Singer, PA				Singer, PA			Recent advances - Medical ethics	BRITISH MEDICAL JOURNAL			English	Review							PHYSICIAN-ASSISTED SUICIDE; HEALTH-CARE; UNITED-STATES; EUTHANASIA; PRIORITIES		Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5G 1L4, Canada	University of Toronto	Singer, PA (corresponding author), Univ Toronto, Joint Ctr Bioeth, 88 Coll St, Toronto, ON M5G 1L4, Canada.							*AM MED ASS, 2000, EPEC PART HDB; BIOETHICS CLIN, 2000, CAN MED ASS J; *BROWN U CTR GER H, 2000, TOOLK INSTR MEAS END; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; Coulter A., 2000, GLOBAL CHALLENGE HLT; Daniels N, 1997, PHILOS PUBLIC AFF, V26, P303, DOI 10.1111/j.1088-4963.1997.tb00082.x; Daniels N, 1998, HEALTH AFFAIR, V17, P50, DOI 10.1377/hlthaff.17.5.50; Emanuel EJ, 1998, JAMA-J AM MED ASSOC, V280, P507, DOI 10.1001/jama.280.6.507; Feachem RGA, 2000, B WORLD HEALTH ORGAN, V78, P1; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; HAFFERTY FW, 1994, ACAD MED, V69, P861, DOI 10.1097/00001888-199411000-00001; Ham C, 1999, BMJ-BRIT MED J, V319, P1258, DOI 10.1136/bmj.319.7219.1258; Holm S, 1998, BRIT MED J, V317, P1000, DOI 10.1136/bmj.317.7164.1000; Hope T, 1998, BRIT MED J, V317, P1067; HUGO Ethics Committee, 2000, EUBIOS J ASIAN INT B, V10, P70; *I HEALTHC IMPR, 2000, COLL; *INT HLTH COAL, 2000, E HLTH ETH IN; Klein R, 1998, BMJ-BRIT MED J, V317, P959, DOI 10.1136/bmj.317.7164.959; KOHN LT, 1990, ERR HUMAN BUILDING S; Kung Hans., 1998, GLOBAL ETHIC GLOBAL; Leape LL, 2000, BMJ-BRIT MED J, V320, P725, DOI 10.1136/bmj.320.7237.725; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; *NUFF COUNC BIOTH, 2000, STEM CELL THER ETH I; Olsen JA, 1998, SOC SCI MED, V46, P1, DOI 10.1016/S0277-9536(97)00129-9; Perry D, 2000, SCIENCE, V287, P1423, DOI 10.1126/science.287.5457.1423; Potter V. R., 1988, GLOBAL BIOETHICS; Reinertsen JL, 2000, BRIT MED J, V320, P730, DOI 10.1136/bmj.320.7237.730; *ROYAL COLLPHYS SU, 2000, BIOETH CURR; Sen Amartya, 1995, INEQUALITY REEXAMINE; Shapiro HT, 1999, SCIENCE, V285, P2065, DOI 10.1126/science.285.5436.2065; Siegler M, 1990, J Clin Ethics, V1, P5; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Smith R, 1999, BRIT MED J, V318, P248; *U TOR JOINT CTR B, 2000, DISC BOARD GLOB BIOE; *U TOR JOINT CTR B, 2000, BIOETH RES; Vogel G, 2000, SCIENCE, V287, P1418, DOI 10.1126/science.287.5457.1418; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; *WHO, 1999, NATURE, V398, P175; Wu AW, 2000, BRIT MED J, V320, P726, DOI 10.1136/bmj.320.7237.726; Young FE, 2000, SCIENCE, V287, P1424, DOI 10.1126/science.287.5457.1424; 1998, BMJ, V316	41	53	56	1	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					282	285		10.1136/bmj.321.7256.282	http://dx.doi.org/10.1136/bmj.321.7256.282			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	341ZA	10915134	Green Submitted, Green Published			2022-12-28	WOS:000088619800031
J	di Primio, R; Horsfield, B; Guzman-Vega, MA				di Primio, R; Horsfield, B; Guzman-Vega, MA			Determining the temperature of petroleum formation from the kinetic properties of petroleum asphaltenes	NATURE			English	Article							PYROLYSIS-GAS CHROMATOGRAPHY; ORGANIC GEOCHEMISTRY; CRUDE OILS; MATURITY; ORIGIN; MEXICO; DISTRIBUTIONS; GENERATION; CAMPECHE; GERMANY	Knowledge of the timing and location of petroleum formation is important in assessing the extent of available reserves in hydrocarbon-forming basins. This can be predicted from the thermal history of a basin and the kinetic parameters that characterize the thermal breakdown of kerogen in source rocks. At present, the kinetic parameters of kerogen breakdown are experimentally determined using immature rock samples from basin margins(1), but questions remain about the accuracy of this approach(2), especially when significant variability is observed within individual source units(3-5). Here we show that the kinetics of hydrocarbon generation from petroleum asphaltenes can be used to determine the temperature conditions of the actual source rock at the time of expulsion of the sampled petroleum. This relationship reflects the structural similarity of asphaltenes to the parent kerogen(6,7). We expect that our approach may be used as a comparatively simple alternative method for assessing the petroleum generation characteristics of a given basin, which will allow for better estimates of the available oil resources and the risks associated with their exploration.	Saga Petr ASA, N-1301 Sandvika, Norway; Forschungszentrum Julich, D-52425 Julich, Germany; Inst Mexicano Petr, Mexico City 07730, DF, Mexico	Helmholtz Association; Research Center Julich; Instituto Mexicano del Petroleo	di Primio, R (corresponding author), Norsk Hydro AS, Res Ctr, POB 7190, N-5020 Bergen, Norway.	rolando.di-primio@hydro.com		, Zeinab/0000-0001-7975-7943				BEHAR F, 1985, J ANAL APPL PYROL, V8, P173, DOI 10.1016/0165-2370(85)80024-3; CASSANI F, 1986, CHEM GEOL, V56, P167, DOI 10.1016/0009-2541(86)90001-X; diPrimio R, 1996, ORG GEOCHEM, V24, P999, DOI 10.1016/S0146-6380(96)00116-7; Guzman-Vega MA, 1999, AAPG BULL, V83, P1068; Horsfield B, 1998, NATURWISSENSCHAFTEN, V85, P233, DOI 10.1007/s001140050489; HORSFIELD B, 1991, MAR PETROL GEOL, V8, P198, DOI 10.1016/0264-8172(91)90007-N; HORSFIELD B, 1993, NORWEGIAN PETROLEUM, V3, P243; HORSTAD I, 1995, GEOLOGICAL SOC SPECI, V86, P159, DOI DOI 10.1144/GSL.SP.1995.086.01.12; JARVIE DM, 1991, CHEM GEOL, V93, P79, DOI 10.1016/0009-2541(91)90065-Y; JONES DM, 1988, ORG GEOCHEM, V13, P981, DOI 10.1016/0146-6380(88)90280-X; Louis M. C., 1967, 7 C MOND PETR MEX, V2, P47; MILLS N, 2000, NORWEGIAN PETROLEUM, V9; MUSCIO GPA, 1991, ORGANIC GEOCHEMISTRY, P447; Neumann H.-J., 1981, COMPOSITION PROPERTI; PELET R, 1986, ORG GEOCHEM, V10, P481, DOI 10.1016/0146-6380(86)90048-3; Santamaria-Orozco D, 1998, ORG GEOCHEM, V28, P423, DOI 10.1016/S0146-6380(98)00009-6; Schafer R.G., 1990, ADV ORG GEOCHEM, P115; SOLDAN AL, 1995, ORGANIC GEOCHEMISTRY, P128; SPEIGHT JG, 1985, REV I FR PETROL, V40, P51, DOI 10.2516/ogst:1985004; SUNDARARAMAN P, 1992, ENERG FUEL, V6, P793, DOI 10.1021/ef00036a015; TEGELAAR EW, 1994, ORG GEOCHEM, V22, P543, DOI 10.1016/0146-6380(94)90125-2; Tissot B.P, 1984, PETROLEUM FORMATION, P1, DOI DOI 10.1007/978-3-642-87813-8; UNGERER P, 1987, NATURE, V327, P52, DOI 10.1038/327052a0; WILHELMS A, 1994, MAR PETROL GEOL, V11, P418, DOI 10.1016/0264-8172(94)90077-9	24	50	51	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					173	176		10.1038/35018046	http://dx.doi.org/10.1038/35018046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910353				2022-12-28	WOS:000088221100043
J	Klein, JD; St Clair, S				Klein, JD; St Clair, S			Do candy cigarettes encourage young people to smoke?	BRITISH MEDICAL JOURNAL			English	Article									Univ Rochester, Sch Med, Div Adolescent Med, Rochester, NY 14642 USA	University of Rochester	Klein, JD (corresponding author), Univ Rochester, Sch Med, Div Adolescent Med, Rochester, NY 14642 USA.			Klein, Jonathan/0000-0003-4185-1998				BLUM A, 1980, NEW ENGL J MED, V302, P972; BOLAND M, 1999, EVENING POST    0611; Davis R M, 1996, Alaska Med, V38, P43; DAVIS RM, 1987, NEW ENGL J MED, V316, P725, DOI 10.1056/NEJM198703193161206; FISHEL DB, 1980, NEW ENGL J MED, V303, P589; GHOULISH DR, 1994, TOB CONTROL, V3, P372; KASSINOVE H, 1997, COMMUNICATION   1022; KASSINOVE H, 1991, UNPUB CANDY CIGARETT; KASSINOVE H, 1997, COMMUNICATION   0911; LIPMAN J, 1990, WASHINGTON POST 0709; MCNAMARA M, 1994, COMMUNICATION   0129; THOMAS P, 1996, WALL STREET J   0823; TRIGUEIRO D, 1994, CALGARY HERALD  0225; WALTERS D, 1992, SACRAMENTO BEE  0124; 1993, HARTFORD COURAN 1119	15	11	11	2	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					362	365		10.1136/bmj.321.7257.362	http://dx.doi.org/10.1136/bmj.321.7257.362			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QH	10926600	Green Published			2022-12-28	WOS:000088656300030
J	Angelucci, E; Brittenham, GM; McLaren, CE; Ripalti, M; Baronciani, D; Giardini, C; Galimberti, M; Polchi, P; Lucarelli, G				Angelucci, E; Brittenham, GM; McLaren, CE; Ripalti, M; Baronciani, D; Giardini, C; Galimberti, M; Polchi, P; Lucarelli, G			Hepatic iron concentration and total body iron stores in thalassemia major.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW TRANSPLANTATION; STORAGE IRON; OVERLOAD; SELECTION	Background and Methods: We tested the usefulness of measuring the hepatic iron concentration to evaluate total body iron stores in patients who had been cured of thalassemia major by bone marrow transplantation and who were undergoing phlebotomy treatment to remove excess iron. Results: We began treatment with phlebotomy a mean (+/-SD) of 4.3+/-2.7 years after transplantation in 48 patients without hepatic cirrhosis. In the group of 25 patients with liver-biopsy samples that were at least 1.0 mg in dry weight, there was a significant correlation between the decrease in the hepatic iron concentration and total body iron stores (r=0.98, P<0.001). Assuming that the hepatic iron concentration is reduced to zero with complete removal of body iron stores during phlebotomy, the amount of total body iron stores (in milligrams per kilogram of body weight) is equivalent to 10.6 times the hepatic iron concentration (in milligrams per gram of liver, dry weight). With the use of this equation, we could reliably estimate total body iron stores as high as 250 mg per kilogram of body weight, with a standard error of less than 7.9. Conclusions: The hepatic iron concentration is a reliable indicator of total body iron stores in patients with thalassemia major. In patients with transfusion-related iron overload, repeated determinations of the hepatic iron concentration can provide a quantitative means of measuring the long-term iron balance. (N Engl J Med 2000;343:327-31.) (C) 2000, Massachusetts Medical Society.	Azienda Osped Pesaro, Unita Operat Ematol, Pesaro, Italy; Azienda Osped Pesaro, Ctr Trapianto Midollo Osseo Muraglia, Pesaro, Italy; Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Univ Calif Irvine, Dept Med, Div Epidemiol, Irvine, CA 92717 USA	Columbia University; Columbia University; University of California System; University of California Irvine	Angelucci, E (corresponding author), Azienda Osped Pesaro, Unita Operat Ematol Muraglia, I-61100 Pesaro, Italy.		Angelucci, Emanuele/AAC-1855-2021	Baronciani, Donatella/0000-0001-6087-2431; Angelucci, Emanuele/0000-0002-6512-6080	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049108, R01DK049108] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL61219, HL62882] Funding Source: Medline; NIDDK NIH HHS [DK49108] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLEN DM, 1974, TECHNOMETRICS, V16, P125, DOI 10.2307/1267500; Angelucci E, 1997, BLOOD, V90, P4736, DOI 10.1182/blood.V90.12.4736.4736_4736_4742; Angelucci E, 1997, BLOOD, V90, P994, DOI 10.1182/blood.V90.3.994.994_994_998; ANGELUCCI E, 1995, BRIT J HAEMATOL, V89, P757; BARRY M, 1974, BMJ-BRIT MED J, V2, P16, DOI 10.1136/bmj.2.5909.16; BARRY M, 1974, GUT, V15, P411, DOI 10.1136/gut.15.5.411; Bonkovsky HL, 1999, RADIOLOGY, V212, P227, DOI 10.1148/radiology.212.1.r99jl35227; BOTHWELL T. H., 1964, S AFR J MED SCI, V29, P21; BRITTENHAM G, IN PRESS SEMIN HEMAT; Brittenham GM, 1998, BLOOD, V92, p38B; BRITTENHAM GM, 1982, NEW ENGL J MED, V307, P1671, DOI 10.1056/NEJM198212303072703; BRITTENHAM GM, 1994, NEW ENGL J MED, V331, P567, DOI 10.1056/NEJM199409013310902; Brittenham GM, 2000, HEMATOLOGY BASIC PRI, P397; Fischer R., 1998, MAGNETISM MED HDB, P286; GEISSER S, 1979, J AM STAT ASSOC, V74, P153, DOI 10.2307/2286745; HALLBERG L, 1966, ACTA OBSTET GYN SCAN, V45, P320, DOI 10.3109/00016346609158455; Jandl J.H., 1996, BLOOD TXB HEMATOLOGY; LUCARELLI G, 1993, LANCET, V342, P1388, DOI 10.1016/0140-6736(93)92753-G; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; MURETTO P, 1994, LIVER, V14, P14; Oelckers S, 1996, PHYS MED BIOL, V41, P1149, DOI 10.1088/0031-9155/41/7/006; Pippard M J, 1989, Prog Clin Biol Res, V309, P85; SMITH N, 1991, J APPL PHYS, V69, P5082, DOI 10.1063/1.348130; Soriano-Cubells MJ, 1984, ATOM SPECTROSC, V5, P217; VALBERG LS, 1975, J LAB CLIN MED, V86, P479; Wang ZYJ, 1999, J MAGN RESON, V140, P477, DOI 10.1006/jmre.1999.1873; Weisberg S., 1985, APPL LINEAR REGRESSI; Worwood M, 1994, IRON METABOLISM HLTH, P449	28	432	461	3	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2000	343	5					327	331		10.1056/NEJM200008033430503	http://dx.doi.org/10.1056/NEJM200008033430503			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340GR	10922422	Bronze			2022-12-28	WOS:000088525200003
J	Dumont, L; Mardirosoff, C; Tramer, MR				Dumont, L; Mardirosoff, C; Tramer, MR			Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review	BRITISH MEDICAL JOURNAL			English	Article							HIGH-ALTITUDE; DOUBLE-BLIND; DEXAMETHASONE; ACETAZOLAMIDE; PROPHYLAXIS; PERFORMANCE; VENTILATION; NIFEDIPINE; SYMPTOMS; EXPOSURE	Objective To quantify efficacy and harm of pharmacological prevention of acute mountain sickness. Data sources Systematic search (Medline, Embase, Cochrane Library, internet, bibliographies, authors) in any language, up to October 1999. Study selection Randomised placebo controlled trials. Data extraction Dichotomous data on efficacy and harm from 33 trials (523 subjects received 13 different interventions, 519 a placebo). Data synthesis At above 4000 m the mean incidence of acute mountain sickness with placebo was 67% (range 25% to 100%); incidence depended on the rate of ascent, but not on the altitude or the mode of ascent. Across all ascent rates, dexamethasone 8-16 mg prevented acute mountain sickness (relative risk 2.50 (95% confidence interval 1.71 to 3.66); number needed to treat (NNT) 2.8 (2.0 to 4.6)), without evidence or dose responsiveness. Acetazolamide 750 mg was also efficacious (2.18 (1.52 to 3.15); NNT 2.9 (2.0 to 5.2)), but 500 mg was not. In two trials, adverse reaction (including depression) occurred after dexamethasone was stopped abruptly (4.45 (1.08 to 18); NNT 3.7 (2.5 to 6.9)). With acetazolamide, paraesthesia (4.02 (1.71 to 9.43); NNT 3.0 (2.0 to 6.0)) and polyuria (4.24 (1.92 to 9.37); NNT 3.6 (2.5 to 6.2)) were reported. Data were sparse on nifedipine, frusemide (furosemide), dihydroxyaluminium-sodium, spironolactone, phenytoin, codeine, phenformin, antidiuretic hormone, and ginkgo biloba. Conclusions At above 4000 m, with a high ascent rate, fewer than three subjects need to be treated with prophylactic dexamethasone 8-16 mg or acetazolamide 750 mg for one subject not to experience acute mountain sickness who would have done so had they all received a placebo. Acetazolamide 500 mg does not work.	Univ Hosp Geneva, Dept APSIC, Div Anaesthesiol, CH-1211 Geneva 14, Switzerland; Hop Sud Leman Valserine, Dept Anesthesie Reanimat, F-74164 St Julien En Genevois, France	University of Geneva	Dumont, L (corresponding author), Univ Hosp Geneva, Dept APSIC, Div Anaesthesiol, CH-1211 Geneva 14, Switzerland.		Chahe, Mardirosoff/AAB-6330-2020					AOKI VS, 1971, J APPL PHYSIOL, V31, P363, DOI 10.1152/jappl.1971.31.3.363; BARTSCH P, 1991, NEW ENGL J MED, V325, P1284, DOI 10.1056/NEJM199110313251805; BERNHARD WN, 1994, J WILDERNESS MED, V5, P331, DOI 10.1580/0953-9859-5.3.331; Bernhard WN, 1998, AVIAT SPACE ENVIR MD, V69, P883; BRADWELL AR, 1987, POSTGRAD MED J, V63, P165, DOI 10.1136/pgmj.63.737.165; BRADWELL AR, 1986, LANCET, V1, P1001; Bradwell AR, 1981, LANCET, V1, P180; BROOKFIELD DSK, 1977, E AFR MED J, V54, P690; BURKI NK, 1992, CHEST, V101, P736, DOI 10.1378/chest.101.3.736; Burtscher M, 1998, BRIT MED J, V316, P1057; CAIN SM, 1966, J APPL PHYSIOL, V21, P1195, DOI 10.1152/jappl.1966.21.4.1195; CARSON RP, 1969, FED PROC, V28, P1085; CLARKE C, 1999, INT UNION ALPINE ASS; COATES G, 1979, J APPL PHYSIOL, V46, P752, DOI 10.1152/jappl.1979.46.4.752; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; ELLSWORTH AJ, 1987, AM J MED, V83, P1024, DOI 10.1016/0002-9343(87)90937-5; ELLSWORTH AJ, 1991, WESTERN J MED, V154, P289; *FDA, 1983, FDA DRUG B, V13, P27; FORWAND SA, 1968, NEW ENGL J MED, V279, P839, DOI 10.1056/NEJM196810172791601; GOERRE S, 1995, CIRCULATION, V91, P359; GREENE MK, 1981, BRIT MED J, V283, P811, DOI 10.1136/bmj.283.6295.811; HACKETT PH, 1979, AM J MED, V67, P214, DOI 10.1016/0002-9343(79)90393-0; HACKETT PH, 1976, LANCET, V2, P1149; HACKETT PH, 1988, AVIAT SPACE ENVIR MD, V59, P950; HOHENHAUS E, 1994, AM J RESP CRIT CARE, V150, P857, DOI 10.1164/ajrccm.150.3.8087361; HOUSTON CS, 1976, JAMA-J AM MED ASSOC, V236, P2193, DOI 10.1001/jama.236.19.2193; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JAIN SC, 1986, INT J BIOMETEOROL, V30, P293, DOI 10.1007/BF02189364; JOBE JB, 1991, AVIAT SPACE ENVIR MD, V62, P727; JOHNSON TS, 1984, NEW ENGL J MED, V310, P683, DOI 10.1056/NEJM198403153101103; Kronenberg R S, 1967, Tech Rep SAM-TR, P1; KRONENBERG RS, 1968, J APPL PHYSIOL, V24, P17, DOI 10.1152/jappl.1968.24.1.17; LARSON EB, 1982, JAMA-J AM MED ASSOC, V248, P328, DOI 10.1001/jama.248.3.328; MAGGIORINI M, 1990, BRIT MED J, V301, P853, DOI 10.1136/bmj.301.6756.853; McQuay HJ, 1997, ANN INTERN MED, V126, P712, DOI 10.7326/0003-4819-126-9-199705010-00007; MONTGOMERY AB, 1989, JAMA-J AM MED ASSOC, V261, P734, DOI 10.1001/jama.261.5.734; MORRIS JA, 1995, STAT CONFIDENCE; MORRISSEY SC, 1987, POSTGRAD MED J, V63, P189, DOI 10.1136/pgmj.63.737.189; MURDOCH DR, 1999, NEWSLETTER INT SOC M, V3, P3; NICHOLSON AN, 1988, SLEEP, V11, P354, DOI 10.1093/sleep/11.4.354; OELZ O, 1997, INT C MOUNT MED F XA, P23; RAMSAY LE, 1977, LANCET, V1, P540; RIED LD, 1994, J WILDERNESS MED, V5, P34; ROACH RC, 1983, AVIAT SPACE ENVIR MD, V54, P397; ROCK PB, 1987, AVIAT SPACE ENVIR MD, V58, P668; ROCK PB, 1989, CHEST, V95, P568, DOI 10.1378/chest.95.3.568; Roncin JP, 1996, AVIAT SPACE ENVIR MD, V67, P445; UTZ G, 1970, Muenchener Medizinische Wochenschrift, V112, P1122; WHONS RNW, 1986, AM J MED, V80, P32; WILSON I, 1985, POSTGRAD MED J, V61, P472, DOI 10.1136/pgmj.61.715.472; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; ZELL SC, 1988, WESTERN J MED, V148, P541	52	121	128	2	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					267	272		10.1136/bmj.321.7256.267	http://dx.doi.org/10.1136/bmj.321.7256.267			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915127	Green Published, Bronze			2022-12-28	WOS:000088619800024
J	Lieu, T; Ray, GT; Black, S; Shinefield, H; Butler, J; Miller, M				Lieu, T; Ray, GT; Black, S; Shinefield, H; Butler, J; Miller, M			Cost-effectiveness of pneumococcal vaccine - Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Harvard Pilgrim Hlth Care, Boston, MA USA; Kaiser Permanente, Oakland, CA USA; Ctr Dis Control & Prevent, Atlanta, GA USA; NIH, Bethesda, MD 20892 USA	Harvard Pilgrim Health Care; Kaiser Permanente; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA	Lieu, T (corresponding author), Harvard Pilgrim Hlth Care, Boston, MA USA.							Dagan R, 2000, PEDIATR RES, V47, p260A; Luce BR, 1996, COST EFFECTIVENESS H, P176	2	6	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					440	441						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904501				2022-12-28	WOS:000088254200023
J	Maritan, A; Micheletti, C; Trovato, A; Banavar, JR				Maritan, A; Micheletti, C; Trovato, A; Banavar, JR			Optimal shapes of compact strings	NATURE			English	Article							SECONDARY STRUCTURE; KNOTS; GEOMETRY	Optimal geometrical arrangements, such as the stacking of atoms, are of relevance in diverse disciplines(1-5). A classic problem is the determination of the optimal arrangement of spheres in three dimensions in order to achieve the highest packing fraction; only recently has it been proved(1,2) that the answer for infinite systems is a face-centred-cubic lattice. This simply stated problem has had a profound impact in many areas(3-5), ranging from the crystallization and melting of atomic systems, to optimal packing of objects and the sub-division of space. Here we study an analogous problem-that of determining the optimal shapes of closely packed compact strings. This problem is a mathematical idealization of situations commonly encountered in biology, chemistry and physics, involving the optimal structure of folded polymeric chains. We rnd that, in cases where boundary effects(6) are not dominant, helices with a particular pitch-radius ratio are selected. Interestingly, the same geometry is observed in helices in naturally occurring proteins.	Penn State Univ, Dept Phys, University Pk, PA 16802 USA; Penn State Univ, Ctr Phys Mat, Davey Lab 104, University Pk, PA 16802 USA; Scuola Int Super Studi Avanzati, I-34014 Trieste, Italy; Ist Nazl Fis Mat, Trieste, Italy; Abdus Salam Int Ctr Theoret Phys, Trieste, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; International School for Advanced Studies (SISSA); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Padua; Abdus Salam International Centre for Theoretical Physics (ICTP)	Banavar, JR (corresponding author), Penn State Univ, Dept Phys, University Pk, PA 16802 USA.	jayanth@phys.psu.edu	Trovato, Antonio/A-3471-2009	Trovato, Antonio/0000-0002-1596-9477; Micheletti, Cristian/0000-0002-1022-1638; Maritan, Amos/0000-0002-3535-7873				Buck G, 1998, NATURE, V392, P238, DOI 10.1038/32561; BUCK G, 1995, TOPOL APPL, V61, P205, DOI 10.1016/0166-8641(94)00024-W; Cantarella J, 1998, NATURE, V392, P237, DOI 10.1038/32558; Car R, 1997, NATURE, V385, P115, DOI 10.1038/385115a0; Cipra B, 1998, SCIENCE, V281, P1267, DOI 10.1126/science.281.5381.1267; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P182; Gonzalez O, 1999, P NATL ACAD SCI USA, V96, P4769, DOI 10.1073/pnas.96.9.4769; Katritch V, 1997, NATURE, V388, P148, DOI 10.1038/40582; Katritch V, 1996, NATURE, V384, P142, DOI 10.1038/384142a0; Mackenzie D, 1999, SCIENCE, V285, P1338, DOI 10.1126/science.285.5432.1338; Maritan A, 2000, PHYS REV LETT, V84, P3009, DOI 10.1103/PhysRevLett.84.3009; Micheletti C, 1999, PHYS REV LETT, V82, P3372, DOI 10.1103/PhysRevLett.82.3372; ROSE GD, 1977, J MOL BIOL, V113, P153, DOI 10.1016/0022-2836(77)90046-8; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; Sloane NJA, 1998, NATURE, V395, P435, DOI 10.1038/26609; SOCCI ND, 1994, PHYS REV E, V49, P3440, DOI 10.1103/PhysRevE.49.3440; Sokal AD, 1996, NUCL PHYS B, P172, DOI 10.1016/0920-5632(96)00042-4; STEWART I, 1998, SCI AM           FEB, P80; Woodcock LV, 1997, NATURE, V385, P141, DOI 10.1038/385141a0; YEE DP, 1994, J MOL BIOL, V241, P557, DOI 10.1006/jmbi.1994.1531	20	236	235	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					287	290		10.1038/35018538	http://dx.doi.org/10.1038/35018538			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917526	Green Submitted			2022-12-28	WOS:000088251900044
J	Margolis, KL; Ensrud, KE; Schreiner, PJ; Tabor, HK				Margolis, KL; Ensrud, KE; Schreiner, PJ; Tabor, HK		Study Osteoporotic Fractures Res	Body size and risk for clinical fractures in older women	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	21st Annual Meeting of the Society-of-General-Internal-Medicine	APR 23-25, 1998	CHICAGO, IL	Soc Gen Internal Med			HIP FRACTURE; ELDERLY WOMEN; OSTEOPOROTIC FRACTURES; BONE-DENSITY	Background: Small body size predicts hip fractures in older women. Objective: To test the hypothesis that small body size predicts the risk for other clinical fractures. Design: Prospective cohort study, Setting: Population-based listings in four areas of the United States. Patients: 8059 ambulatory nonblack women 65 years of age or older. Measurements: Weight, weight change since 25 years of age, body mass index, lean body mass and percent body fat, and nonspine fractures during 6.4 years of follow-up. Results: Compared with women in the highest quartile of weight, women in the lowest quartile had relative risks of 2.0 (95% CI, 1.5 to 2.8) for hip fractures, 2.3 (CI, 1.1 to 4.7) for pelvis fractures, and 2.4 (CI, 1.5 to 3.9) for rib fractures. Adjustment for total-hip bone mineral density eliminated the elevated risk. Results were similar for other body size measures. Smaller body size was not a risk factor for humerus, elbow, wrist, ankle, or foot fractures, Conclusions: Total body weight is useful in the prediction of hip, pelvis, and rib fractures when bone mineral density has not been measured.	Univ Minnesota, Hennepin Cty Med Ctr, Minneapolis Med Res Fdn, Vet Affairs Med Ctr, Minneapolis, MN 55415 USA; Univ Minnesota, Sch Publ Hlth, Minneapolis, MN 55415 USA	Hennepin County Medical Center; Minneapolis Medical Research Foundation; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Margolis, KL (corresponding author), Univ Minnesota, Hennepin Cty Med Ctr, Minneapolis Med Res Fdn, Vet Affairs Med Ctr, 701 Pk Ave, Minneapolis, MN 55415 USA.			Ensrud, Kristine/0000-0002-9069-3036; Margolis, Karen/0000-0003-1862-7402; Schreiner, Pamela/0000-0002-9920-6257	NIA NIH HHS [5-R01-AG-05395] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG005395] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Ensrud KE, 1997, ARCH INTERN MED, V157, P857, DOI 10.1001/archinte.157.8.857; Ensrud KE, 1997, AM J MED, V103, P274, DOI 10.1016/S0002-9343(97)00025-9; Ettinger B, 1998, J CLIN ENDOCR METAB, V83, P2239, DOI 10.1210/jc.83.7.2239; FARMER ME, 1989, J AM GERIATR SOC, V37, P9, DOI 10.1111/j.1532-5415.1989.tb01562.x; KIEL DP, 1987, NEW ENGL J MED, V317, P1169, DOI 10.1056/NEJM198711053171901; Lohman TG, 1988, ANTHROPOMETRIC STAND, P177, DOI DOI 10.1002/AJHB.1310040323; LOHMAN TG, 1992, ADV BODY COMPOSITION, P119; *NAT OST FDN, 1998, OSTEOPOROS INT S4, V8, pS3; NEVITT MC, 1992, AM J EPIDEMIOL, V135, P490, DOI 10.1093/oxfordjournals.aje.a116315; Paganini-Hill A, 1991, Epidemiology, V2, P16; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; SEELEY DG, 1991, ANN INTERN MED, V115, P837, DOI 10.7326/0003-4819-115-11-837; Seeley DG, 1996, J BONE MINER RES, V11, P1347; 1994, NIH TECHNOLOGY  1212, V1	16	72	74	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2000	133	2					123	127		10.7326/0003-4819-133-2-200007180-00011	http://dx.doi.org/10.7326/0003-4819-133-2-200007180-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	335RL	10896638				2022-12-28	WOS:000088258500005
J	Delaunay, F; Thisse, C; Marchand, O; Laudet, V; Thisse, B				Delaunay, F; Thisse, C; Marchand, O; Laudet, V; Thisse, B			An inherited functional circadian clock in zebrafish embryos	SCIENCE			English	Article							PERIOD HOMOLOGS; DROSOPHILA; GENE; EXPRESSION; RHYTHMS; TRANSCRIPTION; ENTRAINMENT; MOTHER; BRAIN; LOOP	Circadian clocks are time-keeping systems found in most organisms. In zebrafish, expression of the clock gene Period3 (Per3) oscillates throughout embryogenesis in the central nervous system and the retina. Per3 rhythmic expression was free-running and was reset by light but not by the developmental delays caused by Low temperature. The time of fertilization had no effect on Per3 expression. Per3 messenger RNA accumulates rhythmically in oocytes and persists in embryos. Our results establish that the circadian clock functions during early embryogenesis in zebrafish. Inheritance of maternal clock gene products suggests a mechanism of phase inheritance through ovogenesis.	Ecole Normale Super Lyon, CNRS, UMR 5665, F-69364 Lyon, France; Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, ULP, F-67404 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Laudet, V (corresponding author), Ecole Normale Super Lyon, CNRS, UMR 5665, 46 Allee Italie, F-69364 Lyon, France.		Weydahl, Andi/C-6391-2008	THISSE, Christine/0000-0002-8684-1681; Delaunay, Franck/0000-0003-4927-1701				Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; DAVIS FC, 1988, AM J PHYSIOL, V255, pR439, DOI 10.1152/ajpregu.1988.255.3.R439; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; KANE DA, 1993, DEVELOPMENT, V119, P447; Kazimi N, 1999, DEV BRAIN RES, V117, P47, DOI 10.1016/S0165-3806(99)00096-6; MIYAJIMA N, 1989, CELL, V57, P31, DOI 10.1016/0092-8674(89)90169-4; Pittendrigh C, 1993, ANNU REV PHYSIOL, V55, P17; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; REPPERT SM, 1995, CIBA F SYMP, V183, P198; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; SEHGAL A, 1992, P NATL ACAD SCI USA, V89, P1423, DOI 10.1073/pnas.89.4.1423; SERONFERRE M, 1993, ENDOCR REV, V14, P594, DOI 10.1210/er.14.5.594; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; THISSE C, 1993, DEVELOPMENT, V119, P1203; THISSE C, UNPUB; Westerfield M, 1995, ZEBRAFISH BOOK; WILSON SW, 1991, DEVELOPMENT, V112, P723; WILSON SW, 1990, DEVELOPMENT, V108, P121; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	27	95	101	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					297	300		10.1126/science.289.5477.297	http://dx.doi.org/10.1126/science.289.5477.297			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894777				2022-12-28	WOS:000088169400041
J	Gaensler, BM; Frail, DA				Gaensler, BM; Frail, DA			A large age for the pulsar B1757-24 from an upper limit on its proper motion	NATURE			English	Article							SUPERNOVA-REMNANTS; YOUNG PULSARS; NEUTRON-STARS; RADIO-SOURCES; WIND NEBULAE; VELOCITIES; G5.4-1.2; LIFETIME; DYNAMICS; FIELDS	The 'characteristic age'(1) of a pulsar is usually considered to approximate its true age, but this assumption has led to some puzzling results, including the fact that many pulsars with small characteristic ages have no associated supernova remnants(2,3). The pulsar B1757-24 is located just outside the edge of a supernova remnant(4-6); the properties of the system indicate that the pulsar was born at the centre of the remnant with a substantial velocity, and that it has subsequently overtaken the expanding blast wave(5-8). With a characteristic age of 16,000 yr, the pulsar is expected(8) to have a proper motion of 63-80 milliarcseconds (mas) per year. Here we report observations of the nebula surrounding the pulsar, which limit its proper motion to less than 25 mas yr(-1), implying a minimum age of 39,000 yr. A more detailed analysis argues that the true age may be as great as 170,000 yr, which is significantly larger than the characteristic age. We conclude from this result and other discrepancies associated with pulsars that characteristic ages greatly underestimate the true ages of pulsars.	MIT, Ctr Space Res, Cambridge, MA 02139 USA; Natl Radio Astron Observ, Socorro, NM 87801 USA	Massachusetts Institute of Technology (MIT); National Radio Astronomy Observatory (NRAO)	Gaensler, BM (corresponding author), MIT, Ctr Space Res, Cambridge, MA 02139 USA.		Gaensler, Bryan M/F-8655-2010	Gaensler, Bryan/0000-0002-3382-9558				BECKER RH, 1985, NATURE, V313, P115, DOI 10.1038/313115a0; BLANDFORD RD, 1988, MON NOT R ASTRON SOC, V234, pP57, DOI 10.1093/mnras/234.1.57P; BLANDFORD RD, 1983, MON NOT R ASTRON SOC, V204, P1025, DOI 10.1093/mnras/204.4.1025; BRAUN R, 1989, ASTROPHYS J, V340, P355, DOI 10.1086/167398; Brazier KTS, 1999, MON NOT R ASTRON SOC, V305, P671, DOI 10.1046/j.1365-8711.1999.02490.x; CASWELL JL, 1987, MON NOT R ASTRON SOC, V225, P329, DOI 10.1093/mnras/225.2.329; CIOFFI DF, 1988, ASTROPHYS J, V334, P252, DOI 10.1086/166834; Cordes JM, 1998, ASTROPHYS J, V505, P315, DOI 10.1086/306138; FRAIL DA, 1994, ASTRON J, V107, P1120, DOI 10.1086/116923; Frail DA, 1997, ASTROPHYS J, V480, P364, DOI 10.1086/303943; FRAIL DA, 1991, NATURE, V352, P785, DOI 10.1038/352785a0; FRAIL DA, 1994, ASTROPHYS J, V437, P781, DOI 10.1086/175038; Gaensler BM, 1995, MON NOT R ASTRON SOC, V277, P1243, DOI 10.1093/mnras/277.4.1243; KASPI VM, 1994, ASTROPHYS J, V422, pL83, DOI 10.1086/187218; KEYS RG, 1981, IEEE T ACOUSTIC SPEE, V29, P1151; Lyne AG, 1996, MON NOT R ASTRON SOC, V281, pL14, DOI 10.1093/mnras/281.2.L14; LYNE AG, 1988, MON NOT R ASTRON SOC, V233, P667, DOI 10.1093/mnras/233.3.667; LYNE AG, 1994, NATURE, V369, P127, DOI 10.1038/369127a0; Lyne AG, 1996, NATURE, V381, P497, DOI 10.1038/381497a0; MANCHESTER RN, 1985, MON NOT R ASTRON SOC, V212, P975, DOI 10.1093/mnras/212.4.975; MANCHESTER RN, 1991, MON NOT R ASTRON SOC, V253, pP7, DOI 10.1093/mnras/253.1.7P; POWELL MJD, 1964, COMPUT J, V7, P303; Sault R. J., 1998, MIRIAD USERS GUIDE; SEWARD FD, 1983, ASTROPHYS J, V267, P698, DOI 10.1086/160907; SHULL JM, 1989, ASTROPHYS J, V346, P860, DOI 10.1086/168067; Stappers BW, 1999, MON NOT R ASTRON SOC, V308, P609, DOI 10.1046/j.1365-8711.1999.02701.x; THOMPSON DJ, 1994, ASTROPHYS J, V436, P229, DOI 10.1086/174895; UMEDA H, 1993, ASTROPHYS J, V408, P186, DOI 10.1086/172579; VANBUREN D, 1988, ASTROPHYS J, V329, pL93, DOI 10.1086/185184	30	61	64	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					158	160		10.1038/35018010	http://dx.doi.org/10.1038/35018010			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910348	Green Submitted			2022-12-28	WOS:000088221100038
J	Gibbs, R				Gibbs, R			The search continues for Karman's St Christopher	NATURE			English	Letter									Univ Glasgow, Dept Hist Art, Glasgow G3 6UW, Lanark, Scotland	University of Glasgow	Gibbs, R (corresponding author), Univ Glasgow, Dept Hist Art, 3l Albany Mans,351 Renfrew St, Glasgow G3 6UW, Lanark, Scotland.							Arcangeli Francesco, 1978, PITTURA BOLOGNESE 30; DAMICO R, 1983, STRENNA STORICA BOLO, V33, P95; MIZOTA T, 2000, NATURE, V404, P226	3	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					122	122		10.1038/35018274	http://dx.doi.org/10.1038/35018274			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910331	Bronze			2022-12-28	WOS:000088221100016
J	Hardin, J				Hardin, J			Development - A degrading way to make an organ	SCIENCE			English	Editorial Material							CAENORHABDITIS-ELEGANS; CELL-MIGRATION		Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; Univ Wisconsin, Program Mol & Cellular Biol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hardin, J (corresponding author), Univ Wisconsin, Dept Zool, 1117 W Johnson St, Madison, WI 53706 USA.							Blelloch R, 1999, CURR OPIN CELL BIOL, V11, P608, DOI 10.1016/S0955-0674(99)00028-9; Blelloch R, 1999, DEV BIOL, V216, P382, DOI 10.1006/dbio.1999.9491; Blelloch R, 1999, NATURE, V399, P586, DOI 10.1038/21196; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Hardin J, 1996, CURR TOP DEV BIOL, V33, P159, DOI 10.1016/S0070-2153(08)60339-7; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Murphy G, 1999, CURR OPIN CELL BIOL, V11, P614, DOI 10.1016/S0955-0674(99)00022-8; Nishiwaki K, 2000, SCIENCE, V288, P2205, DOI 10.1126/science.288.5474.2205; Nishiwaki K, 1999, GENETICS, V152, P985; Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5	12	2	11	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2142	2143		10.1126/science.288.5474.2142	http://dx.doi.org/10.1126/science.288.5474.2142			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10896589				2022-12-28	WOS:000087782900026
J	Lundblad, V				Lundblad, V			Molecular biology - Telomeres keep on rappin'	SCIENCE			English	Editorial Material							LENGTH REGULATION; TRF1; END		Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine	Lundblad, V (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.							Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Cohn M, 1998, CURR GENET, V33, P83, DOI 10.1007/s002940050312; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Murti KG, 1999, P NATL ACAD SCI USA, V96, P14436, DOI 10.1073/pnas.96.25.14436; Shore D, 1997, BIOL CHEM, V378, P591; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0	11	6	7	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2141	2142		10.1126/science.288.5474.2141	http://dx.doi.org/10.1126/science.288.5474.2141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10896588				2022-12-28	WOS:000087782900025
J	Barber, PA; Demchuk, AM; Zhang, JJ; Buchan, AM				Barber, PA; Demchuk, AM; Zhang, JJ; Buchan, AM		ASPECTS Study Grp	Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy	LANCET			English	Article							ACUTE ISCHEMIC STROKE; TISSUE-PLASMINOGEN ACTIVATOR; CT; ECASS	Background Computed tomography (CT) must be done before thrombolytic treatment of hyperacute ischaemic stroke, but the significance of early ischaemic change on CT is unclear. We tested a quantitative CT score, the Alberta Stroke Programme Early CT Score (ASPECTS). Methods 203 consecutive patients with ischaemic stroke were treated with intravenous alteplase within 3 h of symptom onset in two North American teaching hospitals. All pretreatment CT scans were prospectively scored. The score divides the middle-cererbral-artery territory into ten regions of interest. Primary outcomes were symptomatic intracerebral haemorrhage and 3-month functional outcome. The sensitivity and specificity of ASPECTS for the primary outcomes were calculated. Logistic regression was used to test the association between the score on ASPECTS and the primary outcomes. Findings Ischaemic changes on the baseline CT were seen in 117 (75%) of 156 treated patients with anterior-circulation ischaemia included in the analysis (23 had ischaemia in the posterior circulation and 24 were treated outside the protocol). Baseline ASPECTS value correlated inversely with the severity of stroke on the National institutes of Health Stroke Scale (r=-0.56, p<0.001). Baseline ASPECTS value predicted functional outcome and symptomatic intracerebral haemorrhage (p<0.001, p=0.012, respectively). The sensitivity of ASPECTS for functional outcome was 0.78 and specificity 0.96; the values for symptomatic intracerebral haemorrhage were 0.90 and 0.62, Agreement between observers for ASPECTS, with knowledge of the affected hemisphere, was good (kappa statistic 0.71-0.89). Interpretation This CT score is simple and reliable and identifies stroke patients unlikely to make an independent recovery despite thrombolytic treatment.	Univ Calgary, Dept Clin Neurosci, Alberta Stroke Programme, Calgary, AB, Canada; Univ Texas, Stroke Program, Houston, TX USA	University of Calgary; University of Texas System	Buchan, AM (corresponding author), Foothills Hosp, Dept Clin Neurosci, Room 1162,1403 29th St NW, Calgary, AB T2N 2T9, Canada.		Barber, Philip A/C-7108-2016; Buchan, Alastair M/B-9095-2009; Demchuk, Andrew M/E-1103-2012; Hill, Michael D/C-9073-2012	Buchan, Alastair M/0000-0002-2918-5200; Demchuk, Andrew M/0000-0002-4930-7789; Hill, Michael D/0000-0002-6269-1543				Armitage P., 1987, STAT METHODS MED RES; Baird AE, 1998, J CEREBR BLOOD F MET, V18, P583, DOI 10.1097/00004647-199806000-00001; BARON JC, 1995, STROKE, V26, P2219, DOI 10.1161/01.STR.26.12.2219; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Buchan AM, 2000, NEUROLOGY, V54, P679, DOI 10.1212/WNL.54.3.679; del Zoppo GJ, 1998, J NEUROL NEUROSUR PS, V65, P1, DOI 10.1136/jnnp.65.1.1; Demchuk AM, 1999, STROKE, V30, P34, DOI 10.1161/01.STR.30.1.34; DIPPEL DWJ, 1997, CEREBROVASC DIS, V7, P15; Grotta JC, 1999, STROKE, V30, P1528, DOI 10.1161/01.STR.30.8.1528; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Kasner SE, 1999, STROKE, V30, P1534, DOI 10.1161/01.STR.30.8.1534; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Schriger DL, 1998, JAMA-J AM MED ASSOC, V279, P1293, DOI 10.1001/jama.279.16.1293; vonKummer R, 1997, RADIOLOGY, V205, P327, DOI 10.1148/radiology.205.2.9356611; Wardlaw JM, 1999, J NEUROL NEUROSUR PS, V67, P651, DOI 10.1136/jnnp.67.5.651; Wardlaw JM, 1999, COCHRANE LIB	17	1543	1620	3	68	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2000	355	9216					1670	1674		10.1016/S0140-6736(00)02237-6	http://dx.doi.org/10.1016/S0140-6736(00)02237-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905241				2022-12-28	WOS:000086983800008
J	Bartolazzi, A				Bartolazzi, A			Improving accuracy of cytology for nodular thyroid lesions	LANCET			English	Editorial Material							FINE-NEEDLE ASPIRATION; GALECTIN-3; EXPERIENCE; EXPRESSION; MARKER		Karolinska Hosp, Canc Ctr Karolinska, S-17176 Stockholm, Sweden; NCI Regina Elena, Dept Pathol, Rome, Italy	Karolinska Institutet; Karolinska University Hospital	Bartolazzi, A (corresponding author), Karolinska Hosp, Canc Ctr Karolinska, S-17176 Stockholm, Sweden.		Bartolazzi, Armando/K-9708-2016	Bartolazzi, Armando/0000-0001-7820-5127				Baloch ZW, 1998, THYROID, V8, P565, DOI 10.1089/thy.1998.8.565; CHIARIOTTI L, 1992, ONCOGENE, V7, P2507; ERMAK G, 1995, CANCER RES, V55, P4594; Gasbarri A, 1999, J CLIN ONCOL, V17, P3494, DOI 10.1200/JCO.1999.17.11.3494; Inohara H, 1999, CANCER, V85, P2475, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2475::AID-CNCR25>3.3.CO;2-T; Kini SR, 1987, GUIDE CLIN ASPIRATIO, V3; Lowhagen T, 1981, World J Surg, V5, P61; Orlandi F, 1998, CANCER RES, V58, P3015; Raber W, 1997, WIEN KLIN WOCHENSCHR, V109, P116; ROSAI J, 1992, ATLAS TUMOR PATHOL, P343; Schlinkert RT, 1997, MAYO CLIN PROC, V72, P913, DOI 10.1016/S0025-6196(11)63360-0; Tuttle RM, 1998, THYROID, V8, P377, DOI 10.1089/thy.1998.8.377	12	33	40	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2000	355	9216					1661	1662		10.1016/S0140-6736(00)02233-9	http://dx.doi.org/10.1016/S0140-6736(00)02233-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905237				2022-12-28	WOS:000086983800004
J	Akerman, F				Akerman, F			Is general practice being consigned to history?	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					391	391		10.1136/bmj.321.7257.391	http://dx.doi.org/10.1136/bmj.321.7257.391			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QH	10926610	Green Published			2022-12-28	WOS:000088656300073
J	Grime, JP; Brown, VK; Thompson, K; Masters, GJ; Hillier, SH; Clarke, IP; Askew, AP; Corker, D; Kielty, JP				Grime, JP; Brown, VK; Thompson, K; Masters, GJ; Hillier, SH; Clarke, IP; Askew, AP; Corker, D; Kielty, JP			The response of two contrasting limestone grasslands to simulated climate change	SCIENCE			English	Article							PLANT FUNCTIONAL TYPES; COMMUNITIES; STRATEGIES; RESILIENCE; STABILITY; DROUGHT; ENGLAND	Two different UK limestone grasslands were exposed to simulated climate change with the use of nonintrusive techniques to manipulate Local climate over 5 years. Resistance to climate change, defined as the ability of a community to maintain its composition and biomass in response to environmental stress, could be explained by reference to the functional composition and successional status of the grasslands. The more fertile, early-successional grassland was much more responsive to climate change. Resistance could not be explained by the particular climates experienced by the two grasslands. Productive, disturbed Landscapes created by modern human activity may prove more vulnerable to climate change than older, traditional Landscapes.	Univ Sheffield, Dept Anim & Plant Sci, Unit Comparat Plant Ecol, Sheffield S10 2TN, S Yorkshire, England; CABI Biosci Environm, Ascot SL5 7TA, Berks, England	University of Sheffield	Grime, JP (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Buxton Climate Change Impacts Lab, Sheffield S10 2TN, S Yorkshire, England.							Bekker RM, 1998, ACTA BOT NEERL, V47, P15; Buckland SM, 1997, J ECOL, V85, P875, DOI 10.2307/2960608; Diaz S, 1997, J VEG SCI, V8, P463, DOI 10.2307/3237198; FRANK DA, 1991, OIKOS, V62, P360, DOI 10.2307/3545501; Gauch Jr HG, 1982, MULTIVARIATE ANAL CO; GOODALL DW, 1952, AUST J SCI RES SER B, V5, P1, DOI 10.1071/BI9520001; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; GRIME JP, 1974, NATURE, V250, P26, DOI 10.1038/250026a0; HARTE J, 1995, SCIENCE, V267, P876, DOI 10.1126/science.267.5199.876; Hodgson JG, 1999, OIKOS, V85, P282, DOI 10.2307/3546494; Hossell JE, 1996, GEOFORUM, V27, P149, DOI 10.1016/0016-7185(96)00005-X; LEPS J, 1982, VEGETATIO, V50, P53, DOI 10.1007/BF00120678; Levitt J., 1980, RESPONSES PLANTS ENV, V1, DOI [10.1006/anbo.2000.1352, DOI 10.1006/ANBO.2000.1352]; MACGILLIVRAY CW, 1995, FUNCT ECOL, V9, P640, DOI 10.2307/2390156; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; PARRY ML, 1999, EC IMPLICATIONS CLIM; PERRING F, 1960, J ECOL, V48, P415, DOI 10.2307/2257526; POLLOCK CJ, 1990, J AGR SCI, V115, P1, DOI 10.1017/S0021859600073834; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; WESTMAN WE, 1978, BIOSCIENCE, V28, P705, DOI 10.2307/1307321; [No title captured]	21	290	307	16	219	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					762	765		10.1126/science.289.5480.762	http://dx.doi.org/10.1126/science.289.5480.762			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926535				2022-12-28	WOS:000088581500036
J	Schwartz, PJ; Priori, SG; Dumaine, R; Napolitano, C; Antzelevitch, C; Stramba-Badiale, M; Richard, TA; Berti, MR; Bloise, R				Schwartz, PJ; Priori, SG; Dumaine, R; Napolitano, C; Antzelevitch, C; Stramba-Badiale, M; Richard, TA; Berti, MR; Bloise, R			A molecular link between the sudden infant death syndrome and the long-QT syndrome.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SODIUM-CHANNEL; MULTIPLE MECHANISMS; CARDIAC-ARRHYTHMIAS; CLINICAL MANAGEMENT; IMPACT; MUTATIONS; PROGRESS; SCN5A; GENES; HERG		Policlin San Matteo, IRCCS, Dept Cardiol, I-27100 Pavia, Italy; Univ Pavia, Dept Cardiol, I-27100 Pavia, Italy; Fdn Salvatore Maugeri, IRCCS, Mol Crdiol & Eletrophysiol Lab, Pavia, Italy; Masonic Med Res Lab, Dept Mol Biol, Utica, NY USA; Univ Milan, IRCCS, Ctr Fisiol Clin & Ipertens, Milan, Italy; Osped San Luca, Ist Auxol, IRCCS, Milan, Italy; Osped S Chiara, Unite Operat Neonatol, Trento, Italy	IRCCS Fondazione San Matteo; University of Pavia; University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; Masonic Medical Research Laboratory; University of Milan; IRCCS Istituto Auxologico Italiano	Schwartz, PJ (corresponding author), Policlin San Matteo, IRCCS, Dept Cardiol, Viale Golgi 19, I-27100 Pavia, Italy.	pjqt@compuserve.com	bloise, raffaella/AAC-2922-2020; Napolitano, Carlo/K-4760-2016; Schwartz, Peter J/J-4267-2016; Priori, Silvia G/ABH-6894-2020; Priori, Silvia G G/A-6116-2014; Stramba-Badiale, Marco/AAA-6183-2020; napolitano, carlo/ABI-4608-2020	bloise, raffaella/0000-0003-3485-9596; Napolitano, Carlo/0000-0002-7643-4628; Schwartz, Peter J/0000-0003-0367-1048; Priori, Silvia G/0000-0001-6877-0288; Priori, Silvia G G/0000-0001-6877-0288; napolitano, carlo/0000-0002-7643-4628; Antzelevitch, Charles/0000-0001-7349-1582; Antzelevitch, Charles/0000-0001-5215-4667; Stramba-Badiale, Marco/0000-0001-5900-811X				Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Dumaine R, 1996, CIRC RES, V78, P916, DOI 10.1161/01.RES.78.5.916; DWYER T, 1995, JAMA-J AM MED ASSOC, V273, P783, DOI 10.1001/jama.273.10.783; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; Gorgels APM, 1998, J CARDIOVASC ELECTR, V9, P1225, DOI 10.1111/j.1540-8167.1998.tb00096.x; HARTMANN HA, 1994, CIRC RES, V75, P114, DOI 10.1161/01.RES.75.1.114; MARON BJ, 1986, AM J CARDIOL, V58, P1104, DOI 10.1016/0002-9149(86)90122-0; MYERBURG RJ, 1999, MIAMI HERALD    0317; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Priori SG, 1999, CIRCULATION, V99, P518, DOI 10.1161/01.CIR.99.4.518; Priori SG, 2000, LANCET, V355, P808, DOI 10.1016/S0140-6736(99)05277-0; Priori SG, 1999, CIRCULATION, V99, P529, DOI 10.1161/01.CIR.99.4.529; Priori SG, 1999, CIRCULATION, V99, P674, DOI 10.1161/01.CIR.99.5.674; Roden DM, 1996, CIRCULATION, V94, P1996, DOI 10.1161/01.CIR.94.8.1996; ROMANO C, 1963, Clin Pediatr (Bologna), V45, P656; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SCHWARTZ PJ, 1981, REV PERINATAL MED, V4, P475; SCHWARTZ PJ, 1987, CIRCULATION, V75, P677, DOI 10.1161/01.CIR.75.4.677; SCHWARTZ PJ, 1995, CIRCULATION, V92, P3381, DOI 10.1161/01.CIR.92.12.3381; Schwartz PJ, 1998, NEW ENGL J MED, V338, P1709, DOI 10.1056/NEJM199806113382401; SCHWARTZ PJ, 1985, AM HEART J, V109, P399, DOI 10.1016/0002-8703(85)90626-X; SCHWARTZ PJ, 1976, AM J MED, V60, P167, DOI 10.1016/0002-9343(76)90425-3; SCHWARTZ PJ, 2000, CARDIAC ELECTROPHYSI, P597; SCHWARTZ PJ, 1997, CIRCULATION S1, V96, P212; SCHWARTZ PJ, 1974, EXPT REPROD LONG QT; SCHWARTZ PJ, 1988, ANN NY ACAD SCI, V533, P1; Shimizu W, 1997, CIRCULATION, V96, P2038, DOI 10.1161/01.CIR.96.6.2038; Splawski I, 1998, GENOMICS, V51, P86, DOI 10.1006/geno.1998.5361; Stramba-Badiale M, 2000, Ital Heart J, V1, P323; VALDESDA.MA, 1973, NEW ENGL J MED, V289, P1195, DOI 10.1056/NEJM197311292892213; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; Zareba W, 1998, NEW ENGL J MED, V339, P960, DOI 10.1056/NEJM199810013391404	33	259	272	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2000	343	4					262	267		10.1056/NEJM200007273430405	http://dx.doi.org/10.1056/NEJM200007273430405			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	337QC	10911008	Bronze			2022-12-28	WOS:000088372300005
J	Garman, SC; Wurzburg, BA; Tarchevskaya, SS; Kinet, JP; Jardetzky, TS				Garman, SC; Wurzburg, BA; Tarchevskaya, SS; Kinet, JP; Jardetzky, TS			Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilon RI alpha	NATURE			English	Article							HUMAN-IMMUNOGLOBULIN-E; MEDIATED EFFECTOR FUNCTIONS; BINDING-SITE; CRYSTAL-STRUCTURE; GAMMA-RII; MONOCLONAL-ANTIBODY; IDENTIFICATION; SUBUNIT; COMPLEX; GLYCOSYLATION	The initiation of immunoglobulin-E (IgE)-mediated allergic responses requires the binding of IgE antibody to its high-affinity receptor, Fc epsilon RI. Crosslinking of Fc epsilon RI initiates an intracellular signal transduction cascade that triggers the release of mediators of the allergic response. The interaction of the crystallizable fragment (Fc) of IgE (IgE-Fc) with Fc epsilon RI is a key recognition event of this process and involves the extracellular domains of the Fc epsilon RI alpha-chain. To understand the structural basis for this interaction, we have solved the crystal structure of the human IgE-Fc-Fc epsilon RI alpha complex to 3.5-Angstrom resolution. The crystal structure reveals that one receptor binds one dimeric IgE-Fc molecule asymmetrically through interactions at two sites, each involving one C epsilon 3 domain of the IgE-Fc. The interaction of one receptor with the IgE-Fc blocks the binding of a second receptor, and features of this interaction are conserved in other members of the Fc receptor family. The structure suggests new approaches to inhibiting the binding of IgE to Fc epsilon RI for the treatment of allergy and asthma.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Beth Israel Deaconness Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Northwestern University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Jardetzky, TS (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	tedj@northwestern.edu						ANDERSON CL, 1987, J IMMUNOL, V138, P2254; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASU M, 1993, J BIOL CHEM, V268, P13118; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang TW, 2000, NAT BIOTECHNOL, V18, P157, DOI 10.1038/72601; CHAPPEL MS, 1991, P NATL ACAD SCI USA, V88, P9036, DOI 10.1073/pnas.88.20.9036; Cook JPD, 1997, BIOCHEMISTRY-US, V36, P15579, DOI 10.1021/bi9713005; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DEISENHOFER J, 1976, H-S Z PHYSIOL CHEM, V357, P1421, DOI 10.1515/bchm2.1976.357.2.1421; DORRINGTON KJ, 1978, IMMUNOL REV, V41, P3, DOI 10.1111/j.1600-065X.1978.tb01458.x; DUNCAN AR, 1988, NATURE, V332, P563, DOI 10.1038/332563a0; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; GRANATO DA, 1987, MOL IMMUNOL, V24, P849, DOI 10.1016/0161-5890(87)90187-8; Harris LJ, 1999, ADV IMMUNOL, V72, P191; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; Henry AJ, 1997, BIOCHEMISTRY-US, V36, P15568, DOI 10.1021/bi971299+; HULETT MD, 1995, J BIOL CHEM, V270, P21188, DOI 10.1074/jbc.270.36.21188; HULETT MD, 1993, EUR J IMMUNOL, V23, P640, DOI 10.1002/eji.1830230310; Hulett MD, 1999, J BIOL CHEM, V274, P13345, DOI 10.1074/jbc.274.19.13345; HULETT MD, 1994, J BIOL CHEM, V269, P15287; Jardieu PM, 1999, INT ARCH ALLERGY IMM, V118, P112, DOI 10.1159/000024043; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KANELLOPOULOS JM, 1980, J BIOL CHEM, V255, P9060; KEEGAN AD, 1991, MOL IMMUNOL, V28, P1149, DOI 10.1016/0161-5890(91)90030-N; Keown MB, 1997, EUR BIOPHYS J BIOPHY, V25, P471, DOI 10.1007/s002490050062; KEOWN MB, 1995, P NATL ACAD SCI USA, V92, P1841, DOI 10.1073/pnas.92.6.1841; Keown MB, 1998, BIOCHEMISTRY-US, V37, P8863, DOI 10.1021/bi972354h; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LETOURNEUR O, 1995, J BIOL CHEM, V270, P8249, DOI 10.1074/jbc.270.14.8249; MALLAMACI MA, 1993, J BIOL CHEM, V268, P22076; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; METZGER H, 1992, IMMUNOL REV, V125, P37, DOI 10.1111/j.1600-065X.1992.tb00624.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NISSIM A, 1991, EMBO J, V10, P101, DOI 10.1002/j.1460-2075.1991.tb07925.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRESTA L, 1994, J BIOL CHEM, V269, P26368; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; ROBERTSON MW, 1993, J BIOL CHEM, V268, P12736; Sanchez LM, 1999, BIOCHEMISTRY-US, V38, P9471, DOI 10.1021/bi9907330; Sayers I, 1998, BIOCHEMISTRY-US, V37, P16152, DOI 10.1021/bi981456k; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Shi JG, 1997, BIOCHEMISTRY-US, V36, P2112, DOI 10.1021/bi961231e; Sondermann P, 1999, BIOCHEMISTRY-US, V38, P8469, DOI 10.1021/bi982889q; Sondermann P, 1999, EMBO J, V18, P1095, DOI 10.1093/emboj/18.5.1095; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; ZHENG Y, 1992, BIOCHEMISTRY-US, V31, P7446, DOI 10.1021/bi00148a004	50	282	345	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					259	266		10.1038/35018500	http://dx.doi.org/10.1038/35018500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917520				2022-12-28	WOS:000088251900038
J	Avorn, J; Solomon, DH				Avorn, J; Solomon, DH			Cultural and economic factors that (Mis)Shape antibiotic use: The nonpharmacologic basis of therapeutics	ANNALS OF INTERNAL MEDICINE			English	Article							RESISTANT STREPTOCOCCUS-PNEUMONIAE; RANDOMIZED CONTROLLED TRIAL; DAY-CARE-CENTER; ACUTE BRONCHITIS; DECISION-SUPPORT; DRUG-RESISTANCE; VANCOMYCIN USE; ORDER FORM; PHYSICIANS; IMPACT	The use of antibiotics in both ambulatory and inpatient settings is heavily shaped by cultural and economic factors as well as by microbiological considerations. These nonpharmacologic factors are relevant to clinicians and policymakers because of the clinical and fiscal toll of inappropriate antibiotic prescribing, including excessive use, preventable adverse effects, and the increasing prevalence of resistant organisms. An understanding of the determinants of antibiotic consumption is critical to explain current patterns of use and to devise programs to reduce inappropriate use. Patient motivations include the desire for a tangible product of the clinical encounter coupled with incorrect perceptions of the effectiveness of antibiotics, particularly in viral infections. Physician behavior can be explained by such factors as lack of information, a desire to satisfy patient demand, and pressure from managed care organizations to speed throughput. Marketing campaigns directed at both physicians and patients further serve to increase demand, especially for newer, costlier products. Studies of antibiotic use patterns in inpatient and outpatient care consistently demonstrate considerable inappropriate prescribing, which is likely to exacerbate the emergence of resistant organisms. Several approaches have been shown to improve the rationality of antibiotic use. Computer-based algorithms or reminders can prompt physicians to improve antibiotic choices at the time of prescribing; paper-based order entry forms can achieve the same goal. Interactive educational outreach ("academic detailing") is a practical implementation of social marketing principles to improve antibiotic use. Public education programs directed at consumers can help to reduce the inappropriate patient demand that helps to drive much improper antibiotic prescribing.	Brigham & Womens Hosp, Div Pharmaco Epidemiol & Pharmacoeconom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Avorn, J (corresponding author), Brigham & Womens Hosp, Div Pharmaco Epidemiol & Pharmacoeconom, 221 Longwood Ave,BLI-341, Boston, MA 02115 USA.							Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; AVOM J, 1987, REV INFECT DIS, V9, pS286; AVORN J, 1988, ARCH INTERN MED, V148, P1720, DOI 10.1001/archinte.148.8.1720; AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; Bell RA, 1999, J GEN INTERN MED, V14, P651, DOI 10.1046/j.1525-1497.1999.01049.x; BRICKFIELD FX, 1986, J FAM PRACTICE, V23, P119; CLASSEN DC, 1991, JAMA-J AM MED ASSOC, V266, P2847, DOI 10.1001/jama.266.20.2847; COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Dowell SF, 1997, AM FAM PHYSICIAN, V55, P1647; DUCHIN JS, 1995, PEDIATR INFECT DIS J, V14, P745, DOI 10.1097/00006454-199509000-00004; ECHOLS RM, 1984, J INFECT DIS, V150, P803, DOI 10.1093/infdis/150.6.803; EVANS RS, 1994, ARCH INTERN MED, V154, P878, DOI 10.1001/archinte.154.8.878; EVERITT DE, 1990, INFECT CONT HOSP EP, V11, P578; Farmer P, 1997, SOC SCI MED, V44, P347, DOI 10.1016/S0277-9536(96)00143-8; FARYNA A, 1987, J GEN INTERN MED, V2, P102, DOI 10.1007/BF02596306; Freidson E., 1970, PROFESSION MED STUDY; Gonzales R, 1998, J GEN INTERN MED, V13, P541, DOI 10.1046/j.1525-1497.1998.00165.x; Gonzales R, 1999, JAMA-J AM MED ASSOC, V281, P1512, DOI 10.1001/jama.281.16.1512; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; HOWIE JGR, 1976, BRIT MED J, V2, P1061, DOI 10.1136/bmj.2.6043.1061; Jernigan DB, 1996, JAMA-J AM MED ASSOC, V275, P206, DOI 10.1001/jama.275.3.206; KATON W, 1980, RELEVANCE SOCIAL SCI, P253; Levy S.B., 1992, ANTIBIOTIC PARADOX H; Lipsky BA, 1999, AM J INFECT CONTROL, V27, P84, DOI 10.1016/S0196-6553(99)70086-6; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; MCGOWAN JE, 1983, REV INFECT DIS, V5, P1033; McIsaac WJ, 2000, MED DECIS MAKING, V20, P33, DOI 10.1177/0272989X0002000104; Metlay JP, 1998, ARCH INTERN MED, V158, P1813, DOI 10.1001/archinte.158.16.1813; *OFF TECHN ASS, 1995, IMP ANT RES BACT; OSLER W, 1920, AECQUANIMITAS, P254; Parsons T, 1951, SOCIAL SYSTEM, P428; Pestotnik SL, 1996, ANN INTERN MED, V124, P884, DOI 10.7326/0003-4819-124-10-199605150-00004; PESTOTNIK SL, 1990, AM J MED, V88, P43, DOI 10.1016/0002-9343(90)90126-X; PHELPS CE, 1989, MED CARE, V27, P194, DOI 10.1097/00005650-198902000-00009; RADETSKY MS, 1981, LANCET, V2, P771; RAY WA, 1985, JAMA-J AM MED ASSOC, V253, P1774, DOI 10.1001/jama.253.12.1774; REICHLER MR, 1992, J INFECT DIS, V166, P1346, DOI 10.1093/infdis/166.6.1346; ROBINSBROWNE RM, 1984, J HYG-CAMBRIDGE, V93, P9, DOI 10.1017/S0022172400060873; Shojania KG, 1998, J AM MED INFORM ASSN, V5, P554, DOI 10.1136/jamia.1998.0050554; SOUMERAI SB, 1986, MED CARE, V24, P313, DOI 10.1097/00005650-198604000-00003; Starr P, 1982, SOCIAL TRANSFORMATIO; STOTT NCH, 1976, BRIT MED J, V2, P556, DOI 10.1136/bmj.2.6035.556; UTTLEY AHC, 1988, LANCET, V1, P57; Watson RL, 1999, PEDIATRICS, V104, P1251, DOI 10.1542/peds.104.6.1251; Wilson AA, 1999, J GEN INTERN MED, V14, P658, DOI 10.1046/j.1525-1497.1999.08118.x; ZENNI MK, 1995, J PEDIATR-US, V127, P533, DOI 10.1016/S0022-3476(95)70108-7	47	195	196	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2000	133	2					128	135		10.7326/0003-4819-133-2-200007180-00012	http://dx.doi.org/10.7326/0003-4819-133-2-200007180-00012			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	335RL	10896639				2022-12-28	WOS:000088258500006
J	Vorosmarty, CJ; Green, P; Salisbury, J; Lammers, RB				Vorosmarty, CJ; Green, P; Salisbury, J; Lammers, RB			Global water resources: Vulnerability from climate change and population growth	SCIENCE			English	Article							SCALE	The future adequacy of freshwater resources is difficult to assess, owing to a complex and rapidly changing geography of water supply and use. Numerical experiments combining climate model outputs, water budgets, and socioeconomic information along digitized river networks demonstrate that (i) a large proportion of the world's population is currently experiencing water stress and (ii) rising water demands greatly outweigh greenhouse warming in defining the state of global water systems to 2025. Consideration of direct human impacts on global water supply remains a poorly articulated but potentially important facet of the larger global change question.	Univ New Hampshire, Water Syst Anal Grp, Durham, NH 03824 USA; Univ New Hampshire, Complex Syst Res Ctr, Durham, NH 03824 USA; Univ New Hampshire, Ocean Proc Analyt Lab, Durham, NH 03824 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire	Vorosmarty, CJ (corresponding author), Univ New Hampshire, Water Syst Anal Grp, Durham, NH 03824 USA.		Quinn, Patrick/B-5489-2010	Choudhury, Aloshree/0000-0002-8986-5881				ALCAMO J, 2000, WORLD WATER SCENARIO, P204; [Anonymous], 1990, EARTH TRANSFORMED HU; Arnell N, 1996, CLIMATE CHANGE 1995, P325; Bonell M, 1993, HYDROLOGY WATER MANA, V1993; Conway D, 1996, AMBIO, V25, P336; Doll P., 1999, A9901 U KASS; Elvidge CD, 1997, INT J REMOTE SENS, V18, P1373, DOI 10.1080/014311697218485; FALKENMARK M, 1993, AMBIO, V22, P427; FALKENMARK M, 1991, WATER INT, V16, P229, DOI 10.1080/02508069108686116; FEKETE B, 1999, 22 WORLD MET ORG GLO; Gleick P. H., 2000, WORLD WATER SCENARIO, P27; Gleick P.H., 1998, WORLDS WATER BIENNIA; HOMERDIXON TF, 1994, INT SECURITY, V19, P5, DOI 10.2307/2539147; Kaczmarek Z, 1996, CLIMATE CHANGE 1995, P469; Milliman J.D., 1995, CLIMATE CHANGE IMPAC, P57; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; POSTEL SL, 1985, INTERCIENCIA, V10, P290; RODDA JC, 1998, WATER LOOMING CRISIS; Shiklomanov, 1996, ASSESSMENT WATER RES; STRZEPEK KM, 2000, WORLD WATER SCENARIO, P120; TOBLER W, 1995, TR956 NAT CTR GEOGR; United Nations, 1997, COMPREHENSIVE ASSESS; van Dam J. C, 1999, IMPACTS CLIMATE CHAN; Vorosmarty CJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P599, DOI 10.1029/1999GB900092; Vorosmarty CJ, 1998, J HYDROL, V207, P147, DOI 10.1016/S0022-1694(98)00109-7; *WORLD RES I, 1998, WORLD RES GUID GLOB; World Resources Institute, 1996, WORLD RES GUID GLOB; 1995, GLOBAL BIOGEOCHEM CY, V9, P407	28	2939	3080	81	1760	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					284	288		10.1126/science.289.5477.284	http://dx.doi.org/10.1126/science.289.5477.284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894773				2022-12-28	WOS:000088169400037
J	Williams, TL; Baker, TA				Williams, TL; Baker, TA			Molecular biology - Transposase team puts a headlock on DNA	SCIENCE			English	Editorial Material							SARCOMA VIRUS INTEGRASE; ACTIVE-SITE; TRANSPOSITIONAL RECOMBINATION; CATALYTIC DOMAIN; DIVALENT-CATIONS; STRAND TRANSFER; MU TRANSPOSASE; RESOLUTION; RESIDUES; CLEAVAGE		MIT, Dept Chem, Off 68 517, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Williams, TL (corresponding author), MIT, Dept Chem, Off 68 517, Cambridge, MA 02139 USA.							Aldaz H, 1996, CELL, V85, P257, DOI 10.1016/S0092-8674(00)81102-2; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bhasin A, 1999, J BIOL CHEM, V274, P37021, DOI 10.1074/jbc.274.52.37021; Bujacz G, 1997, J BIOL CHEM, V272, P18161, DOI 10.1074/jbc.272.29.18161; Bujacz G, 1996, STRUCTURE, V4, P89, DOI 10.1016/S0969-2126(96)00012-3; CRAIG NL, 1995, SCIENCE, V270, P253, DOI 10.1126/science.270.5234.253; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Davies DR, 1999, J BIOL CHEM, V274, P11904, DOI 10.1074/jbc.274.17.11904; KATAYANAGI K, 1993, PROTEINS, V17, P337, DOI 10.1002/prot.340170402; Kennedy AK, 1998, CELL, V95, P125, DOI 10.1016/S0092-8674(00)81788-2; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; MIZUUCHI K, 1992, ANNU REV BIOCHEM, V61, P1011; Mizuuchi K, 1997, GENES CELLS, V2, P1, DOI 10.1046/j.1365-2443.1997.970297.x; Namgoong SY, 1998, EMBO J, V17, P3775, DOI 10.1093/emboj/17.13.3775; Rice P, 1996, CURR OPIN STRUC BIOL, V6, P76, DOI 10.1016/S0959-440X(96)80098-4; Savilahti H, 1996, CELL, V85, P271, DOI 10.1016/S0092-8674(00)81103-4; WANG Y, 1995, STRUCTURE, V3, P131; Williams TL, 1999, GENE DEV, V13, P2725, DOI 10.1101/gad.13.20.2725	19	4	4	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2000	289	5476					73	74		10.1126/science.289.5476.73	http://dx.doi.org/10.1126/science.289.5476.73			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332TW	10928934				2022-12-28	WOS:000088090400033
J	Aultman, KS; Walker, ED; Gifford, F; Severson, DW; Ben Beard, C; Scott, TW				Aultman, KS; Walker, ED; Gifford, F; Severson, DW; Ben Beard, C; Scott, TW			Research ethics - Managing risks of arthropod vector research	SCIENCE			English	Article							TRANSMISSION; DISEASE		NIAID, Parasitol & Int Programs Branch, Bethesda, MD 20892 USA; Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; Michigan State Univ, Dept Philosophy, E Lansing, MI 48824 USA; Univ Notre Dame, Dept Biol, Notre Dame, IN 46556 USA; Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; Ctr Dis Control & Prevent, Div Parasit Dis, Atlanta, GA 30341 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Michigan State University; Michigan State University; University of Notre Dame; University of California System; University of California Davis; Centers for Disease Control & Prevention - USA	Aultman, KS (corresponding author), NIAID, Parasitol & Int Programs Branch, 9000 Rockville Pike, Bethesda, MD 20892 USA.			Gifford, Fred/0000-0001-6066-4931				Beard CB, 1998, EMERG INFECT DIS, V4, P581, DOI 10.3201/eid0404.980408; CURTIS CF, 1978, NATURE, V273, P96, DOI 10.1038/273096a0; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; Hoy MA, 2000, INSECT TRANSGENESIS, P335; Kidwell MG, 1998, P NATL ACAD SCI USA, V95, P3349, DOI 10.1073/pnas.95.7.3349; RICHMOND JY, 1999, DHHS PUBL; SERVICE MW, 1993, MOSQUITO ECOLOGY FIE, P924	7	19	19	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 30	2000	288	5475					2321	2322		10.1126/science.288.5475.2321	http://dx.doi.org/10.1126/science.288.5475.2321			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329NP	10917830				2022-12-28	WOS:000087913400021
J	Halliday, HL				Halliday, HL			Towards earlier neonatal extubation	LANCET			English	Editorial Material									Queens Univ Belfast, Nuffield Dept Child Hlth, Belfast BT12 6BJ, Antrim, North Ireland	Queens University Belfast	Halliday, HL (corresponding author), Queens Univ Belfast, Nuffield Dept Child Hlth, Belfast BT12 6BJ, Antrim, North Ireland.			Halliday, Henry/0000-0001-7978-4992				Bancalari Eduardo, 1992, P200; DAVIES MW, 2000, COCHRANE LIB; DAVIS PG, 2000, COCHRANE LIB; Dimitriou G, 2000, BRIT J RADIOL, V73, P156, DOI 10.1259/bjr.73.866.10884728; FLENADY VJ, 2000, COCHRANE LIB; HENDERSONSMART DJ, 2000, COCHRANE LIB; SPENCE K, 2000, COCHRANE LIB; Verder H, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.2.e24	8	6	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2091	2092		10.1016/S0140-6736(00)02372-2	http://dx.doi.org/10.1016/S0140-6736(00)02372-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902619				2022-12-28	WOS:000087687100005
J	Richards, F; Hopkins, D; Cupp, E				Richards, F; Hopkins, D; Cupp, E			Programmatic goals and approaches to onchocerciasis	LANCET			English	Editorial Material							IVERMECTIN; VOLVULUS; TRANSMISSION		Carter Ctr, Atlanta, GA 30307 USA; Auburn Univ, Auburn, AL 36849 USA	Auburn University System; Auburn University	Richards, F (corresponding author), Carter Ctr, Atlanta, GA 30307 USA.							ABIOSE AO, 1995, WHO TECH REP SER, V852, P1; Burnham G, 1998, LANCET, V351, P1341, DOI 10.1016/S0140-6736(97)12450-3; CLINE BL, 1992, AM J TROP MED HYG, V47, P512, DOI 10.4269/ajtmh.1992.47.512; CUPP EW, 1986, SCIENCE, V231, P740, DOI 10.1126/science.3753801; CUPP EW, 1989, AM J TROP MED HYG, V40, P501, DOI 10.4269/ajtmh.1989.40.501; CUPP EW, 1992, AM J TROP MED HYG, V47, P170, DOI 10.4269/ajtmh.1992.47.170; Dean M, 2000, LANCET, V355, P385, DOI 10.1016/S0140-6736(05)74012-5; DUKE BOL, 1993, TROP MED PARASITOL, V44, P61; Dull HB, 1998, ANN TROP MED PARASIT, V92, pS69, DOI 10.1080/00034983.1998.11813368; Guderian RH, 1997, TROP MED INT HEALTH, V2, P982, DOI 10.1046/j.1365-3156.1997.d01-158.x; KHABIR A, 1999, LANCET, V354, P1455; REMME JHF, 1995, PARASITOL TODAY, V11, P403, DOI 10.1016/0169-4758(95)80017-4; Richards F O, 1998, Bull World Health Organ, V76 Suppl 2, P147; Stevenson P, 1999, LANCET, V354, P2143, DOI 10.1016/S0140-6736(05)77052-5; *WHO, 1999, WKLY EPIDEMIOL REC, V74, P12	15	45	45	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2000	355	9216					1663	1664		10.1016/S0140-6736(00)02235-2	http://dx.doi.org/10.1016/S0140-6736(00)02235-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905239				2022-12-28	WOS:000086983800006
J	Shretta, R; Brugha, R; Robb, A; Snow, RW				Shretta, R; Brugha, R; Robb, A; Snow, RW			Sustainability, affordability, and equity of corporate drug donations: the case of Malarone	LANCET			English	Editorial Material							PROGRAM; AFRICA		Kenya Govt Med Res Ctr, Wellcome Trust Collaborat Programme, Nairobi, Kenya; London Sch Hyg & Trop Med, Hlth Policy Unit, London WC1, England; WHO, Malaria Unit AFRO, Harare, Zimbabwe; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 9DU, England	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; University of Oxford	Shretta, R (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Collaborat Programme, POB 43460, Nairobi, Kenya.	rima@wtrl.or.ke	Snow, Robert William/AFR-1436-2022; Brugha, Ruairi/C-8420-2012	Snow, Robert William/0000-0003-3725-6088; Brugha, Ruairi/0000-0003-0729-0197				BATES JA, 1998, OPTIONS PROMOTING FI, P1; Bloland PB, 1997, LANCET, V350, P1624, DOI 10.1016/S0140-6736(97)06082-0; BRUNDTLAND GH, 1999, WHO WAY AHEAD; BUSE K, IN PRESS B WHO; Foege WH, 1997, LANCET, V350, P1628, DOI 10.1016/S0140-6736(05)64045-7; Nabarro DN, 1998, SCIENCE, V280, P2067, DOI 10.1126/science.280.5372.2067; Nzila AM, 2000, ANTIMICROB AGENTS CH, V44, P991, DOI 10.1128/AAC.44.4.991-996.2000; Radloff PD, 1996, LANCET, V347, P1511, DOI 10.1016/S0140-6736(96)90671-6; RAPUODA BA, 1998, MALARIA INFECT DIS A, V8, P25; RIDLEY R, 1999, 3 GLOB FOR HLTH RES; Ringwald P, 1998, LANCET, V351, P673, DOI 10.1016/S0140-6736(05)78458-0; SACHS J, 1999, ECONOMIST       0814, P17; Sharp D, 1996, LANCET, V348, P1575, DOI 10.1016/S0140-6736(05)66177-6; Snow RW, 1998, T ROY SOC TROP MED H, V92, P601, DOI 10.1016/S0035-9203(98)90781-7; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; W.H.O, 1999, GUID TREATM DENG FEV, P1	16	17	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2000	355	9216					1718	1720		10.1016/S0140-6736(00)02251-0	http://dx.doi.org/10.1016/S0140-6736(00)02251-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905260				2022-12-28	WOS:000086983800040
J	Farkas, AJ; Gilpin, EA; White, MM; Pierce, JP				Farkas, AJ; Gilpin, EA; White, MM; Pierce, JP			Association between household and workplace smoking restrictions and adolescent smoking	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; CIGARETTE-SMOKING; ANTISMOKING SOCIALIZATION; PARENTAL SMOKING; EMPLOYEE SMOKING; POLICY; WORK; INITIATION; ATTITUDES; BEHAVIOR	Context Recent marked increases in adolescent smoking indicate a need for new prevention approaches. Whether workplace and home smoking restrictions play a role in such prevention is unknown. Objective To assess the association between workplace and home smoking restrictions and adolescent smoking. Design, Setting, and Subjects Data were analyzed from 2 large national population-based surveys, the Current Population Surveys of 1992-1993 and 1995-1996, which included 17185 adolescents aged 15 to 17 years. Main Outcome Measures Smoking status of the adolescents surveyed, compared by presence of home and workplace smoking restrictions. Results After adjusting for demographics and other smokers in the household, adolescents who lived in smoke-free households were 74% (95% confidence interval [CI], 62%-88%) as likely to be smokers as adolescents who lived in households with no smoking restrictions. Similarly, adolescents who worked in smoke-free workplaces were 68% (95% CI, 51%-90%) as likely to be smokers as adolescents who worked in a workplace with no smoking restrictions. Adolescent smokers were 1.80 (95% CI, 1.23-2.65) times more likely to be former smokers if they lived in smoke-free homes. The most marked relationship of home smoking restrictions to current adolescent smoking occurred in households where all other members were never-smokers. Current smoking prevalence among adolescents in homes without smoking restrictions approached that among adolescents in homes with a current smoker but with smoking restrictions. Conclusions Parents with minor children should be encouraged to adopt smoke-free homes. Smoke-free workplaces can also augment smoking prevention. These findings emphasize the importance of tobacco control strategies aimed at the entire population rather than at youth alone.	Univ Calif San Diego, Ctr Canc, Canc Prevent & Control Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Farkas, AJ (corresponding author), Univ Calif San Diego, Ctr Canc, Canc Prevent & Control Program, 9500 Gilman Dr, La Jolla, CA 92093 USA.			Pierce, John/0000-0002-0075-7471	NATIONAL CANCER INSTITUTE [P01CA072092] Funding Source: NIH RePORTER; NCI NIH HHS [CA 72092] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARNEA Z, 1987, BRIT J ADDICT, V82, P891; BEINER L, 1997, TOB CONTROL, V6, P199; BIENER L, 1989, AM J PUBLIC HEALTH, V79, P192, DOI 10.2105/AJPH.79.2.192; BORLAND R, 1990, AM J PUBLIC HEALTH, V80, P178, DOI 10.2105/AJPH.80.2.178; BRENNER H, 1994, PREV MED, V23, P230, DOI 10.1006/pmed.1994.1031; BRIGHAM J, 1994, AM J PUBLIC HEALTH, V84, P773, DOI 10.2105/AJPH.84.5.773; *CDCP, 1995, MMWR-MORBID MORTAL W, V44, P521; CHALOUPKA FJ, 1996, 5740 NBER RES INC, P5740; CONRAD KM, 1992, BRIT J ADDICT, V87, P1711; CRUMP C, 1998, MMWR-MORBID MORTAL W, V47, P827; Distefan JM, 1998, J ADOLESCENT HEALTH, V22, P466, DOI 10.1016/S1054-139X(98)00013-5; Farkas AJ, 1999, PREV MED, V28, P213, DOI 10.1006/pmed.1998.0451; Farrelly MC, 1999, TOB CONTROL, V8, P272, DOI 10.1136/tc.8.3.272; FIORE MC, 1989, JAMA-J AM MED ASSOC, V261, P49, DOI 10.1001/jama.261.1.49; FLAY BR, 1994, J HEALTH SOC BEHAV, V35, P248, DOI 10.2307/2137279; Gilpin E A, 1997, Tob Control, V6, P122; GILPIN EA, 1994, AM J EPIDEMIOL, V140, P535, DOI 10.1093/oxfordjournals.aje.a117280; GOTTLIEB NH, 1990, J OCCUP ENVIRON MED, V32, P16, DOI 10.1097/00043764-199001000-00008; Henriksen L, 1998, HEALTH COMMUN, V10, P87, DOI 10.1207/s15327027hc1001_5; HILL D, 1991, PUBLIC HEALTH REP, V106, P181; Jackson C, 1997, ADDICT BEHAV, V22, P107, DOI 10.1016/0306-4603(95)00108-5; JOHNSTON LD, 1999, NIH PUBL, V1; KINNE S, 1993, AM J PUBLIC HEALTH, V83, P1031, DOI 10.2105/AJPH.83.7.1031; LEE L, 1993, CANCER EPIDEM BIOMAR, V2, P593; MCNEILL AD, 1988, J EPIDEMIOLOGY COMMU, V43, P72; PETERSEN LR, 1988, PUBLIC HEALTH REP, V103, P115; PIERCE JP, 1991, J NATL CANCER I, V83, P1009, DOI 10.1093/jnci/83.14.1009; Pierce JP, 1998, CANCER EPIDEM BIOMAR, V7, P459; PIERCE JP, 1989, JAMA-J AM MED ASSOC, V261, P61, DOI 10.1001/jama.261.1.61; ROSENSTOCK IM, 1986, AM J PUBLIC HEALTH, V76, P1014, DOI 10.2105/AJPH.76.8.1014; SORSENSEN G, 1991, AM J PUBLIC HEALTH, V81, P202, DOI 10.2105/AJPH.81.2.202; STAVE GM, 1991, J OCCUP ENVIRON MED, V33, P884, DOI 10.1097/00043764-199108000-00014; STILLMAN FA, 1990, JAMA-J AM MED ASSOC, V264, P1565, DOI 10.1001/jama.264.12.1565; *US BUR CENS, 1992, CURR POP SURV SEPT 1; *US DEP HHS, 1994, US DEP HHS PUBL; *US DEP HHS, 1964, US DEP HHS PHS PUBL, V1103; *US DEP HHS, 1989, DHHS PUBL CTR CHRON; WOODRUFF TJ, 1993, ARCH INTERN MED, V153, P1485, DOI 10.1001/archinte.153.12.1485	38	218	222	0	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					717	722		10.1001/jama.284.6.717	http://dx.doi.org/10.1001/jama.284.6.717			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	341JM	10927780	Bronze			2022-12-28	WOS:000088587300030
J	Wakefield, MA; Chaloupka, FJ; Kaufman, NJ; Orleans, CT; Barker, DC; Ruel, EE				Wakefield, MA; Chaloupka, FJ; Kaufman, NJ; Orleans, CT; Barker, DC; Ruel, EE			Effect of restrictions on smoking at home, at school, and in public places on teenage smoking: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; POLICY IMPLICATIONS; WORKPLACE SMOKING; UNITED-STATES; ADOLESCENTS; HOUSEHOLD; AUSTRALIA	Objective To determine the relation between extent of restrictions on smoking at home, at school, and in public places and smoking uptake and smoking prevalence among school students, Design Cross sectional survey with merged records of extent of restrictions on smoking in public places. Setting United States. Participants 17 287 high school students, Main outcome measures Five point scale of smoking uptake; 30 day smoking prevalence, Results More restrictive arrangements on smoking at home were associated with a greater likelihood of being in an earlier stage of smoking uptake (P < 0.05) and a lower 30 day prevalence (odds ratio 0.79 (95% confidence interval 0.67 to 0.91), P < 0.001). These findings applied even when parents were smokers. More pervasive restrictions on smoking in public places were associated with a higher probability of being in a earlier stage of smoking uptake (P < 0.05) and lower 30 day prevalence (0.91 (0.83 to 0.99), P = 0.03). School smoking bans were related to a greater likelihood of being in an earlier stage of smoking uptake (0.89 (0.85 to 0.99), P < 0.05) and lower prevalence (0.86 (0.77 to 0.91), P< 0.001) only when the ban was strongly enforced, as measured by instances when teenagers perceived that most or ail students obeyed the rule. Conclusions These findings suggest that restrictions on smoking at home, more extensive bans on smoking in public places, and enforced bans on smoking at school may reduce teenage smoking.	Univ Illinois, Hlth Res Ctr, Chicago, IL 60607 USA; Univ Illinois, Policy Ctr, Chicago, IL 60607 USA; Univ Illinois, Dept Econ, Chicago, IL 60680 USA; Robert Wood Johnson Fdn, Princeton, NJ 08543 USA; Barker Bi Coastal Hlth Consultants, Calabasas, CA 91302 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Robert Wood Johnson Foundation (RWJF)	Wakefield, MA (corresponding author), Univ Illinois, Hlth Res Ctr, 850 W Jackson Blvd, Chicago, IL 60607 USA.		Wakefield, Melanie/E-5019-2012					AARO LE, 1981, SCAND J PSYCHOL, V22, P297, DOI 10.1111/j.1467-9450.1981.tb00404.x; Biener L, 1997, PREV MED, V26, P358, DOI 10.1006/pmed.1997.0152; Borland R, 1999, TOB CONTROL, V8, P266, DOI 10.1136/tc.8.3.266; CHALOUPKA RJ, 1996, NATL BUR EC RES WORK, V5740; Chapman S, 1999, AM J PUBLIC HEALTH, V89, P1018, DOI 10.2105/AJPH.89.7.1018; CHARLTON A, 1994, HLTH ED J, V53, P191; EISER JR, 1989, BRIT J SOC PSYCHOL, V28, P193, DOI 10.1111/j.2044-8309.1989.tb00861.x; Emont SL., 1993, TOB CONTROL, V2, P13, DOI [10.1136/tc.2.1.13, DOI 10.1136/TC.2.1.13]; Farkas AJ, 1999, TOB CONTROL, V8, P261, DOI 10.1136/tc.8.3.261; FLAY BR, 1993, NICOTINE ADDICTION P, P365; Gilpin E A, 1999, Nicotine Tob Res, V1, P153, DOI 10.1080/14622299050011261; Hedeker D, 1998, MULTIVAR BEHAV RES, V33, P427, DOI 10.1207/s15327906mbr3304_1; HEDEKER D, 2000, MIXOR MIXREG PROGRAM; HOCKING B, 1991, J OCCUP ENVIRON MED, V33, P163; Hyland A, 1999, J Public Health Manag Pract, V5, P22; Jacobson PD, 1999, J HEALTH POLIT POLIC, V24, P567, DOI 10.1215/03616878-24-3-567; Mermelstein R, 1999, Nicotine Tob Res, V1 Suppl 1, pS91; *OFF SMOK HLTH, 2000, STAT TOB ACT TRACK E; PENTZ MA, 1989, JAMA-J AM MED ASSOC, V261, P3259, DOI 10.1001/jama.261.22.3259; Pentz MA, 1997, ADDICTION, V92, P1165; Pierce JP, 1996, HEALTH PSYCHOL, V15, P355, DOI 10.1037/0278-6133.15.5.355; Pierce JP., 1998, TOBACCO CONTROL CALI; Tauras JohnA, 1999, 6937 NAT BUR EC RES; Wakefield M, 1996, Tob Control, V5, P205, DOI 10.1136/tc.5.3.205; WAKEFIELD M, 2000, IMPACTEEN WORKING PA, V3; WASSERMAN J, 1991, J HEALTH ECON, V10, P43, DOI 10.1016/0167-6296(91)90016-G	26	373	381	0	20	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					333	337		10.1136/bmj.321.7257.333	http://dx.doi.org/10.1136/bmj.321.7257.333			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	342QH	10926588	Green Published, Bronze			2022-12-28	WOS:000088656300022
J	Palczewski, K; Kumasaka, T; Hori, T; Behnke, CA; Motoshima, H; Fox, BA; Le Trong, I; Teller, DC; Okada, T; Stenkamp, RE; Yamamoto, M; Miyano, M				Palczewski, K; Kumasaka, T; Hori, T; Behnke, CA; Motoshima, H; Fox, BA; Le Trong, I; Teller, DC; Okada, T; Stenkamp, RE; Yamamoto, M; Miyano, M			Crystal structure of rhodopsin: A G protein-coupled receptor	SCIENCE			English	Article							SCHIFF-BASE COUNTERION; BOVINE RHODOPSIN; VISUAL PIGMENTS; TRANSMEMBRANE HELICES; ANGSTROM RESOLUTION; RETINAL CHROMOPHORE; LIGHT ACTIVATION; AMINO-ACID; ROD; BACTERIORHODOPSIN	Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) respond to a variety of different external stimuli and activate G proteins. GPCRs share many structural features, including a bundle of seven transmembrane alpha helices connected by six Loops of varying Lengths. We determined the structure of rhodopsin from diffraction data extending to 2.8 angstroms resolution. The highly organized structure in the extracellular region, including a conserved disulfide bridge, forms a basis for the arrangement of the seven-helix transmembrane motif. The ground-state chromophore, Il-cis-retinal, holds the transmembrane region of the protein in the inactive conformation. Interactions of the chromophore with a cluster of key residues determine the wavelength of the maximum absorption. Changes in these interactions among rhodopsins facilitate color discrimination. Identification of a set of residues that mediate interactions between the transmembrane helices and the cytoplasmic surface, where C-protein activation occurs, also suggests a possible structural change upon photoactivation.	Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; Univ Washington, Biomol Struct Ctr, Seattle, WA 98195 USA; RIKEN, Harima Inst, Struct Biophys Lab, Mikazuki, Hyogo 6795148, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; RIKEN; Tokyo Institute of Technology	Palczewski, K (corresponding author), Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA.	palczews@u.washington.edu; stenkamp@u.washington.edu; miyano@spring8.or.jp	Martinez, Octavio/B-7375-2009; soler, martha maricel m gomez/L-6025-2014; Kumasaka, Takashi/D-7428-2018; Yamamoto, Masaki/B-7844-2015; Oka, Yoshitaka/C-9670-2010; Miyano, Masashi/R-2785-2016	soler, martha maricel m gomez/0000-0002-4412-8108; Kumasaka, Takashi/0000-0001-9289-1557; Yamamoto, Masaki/0000-0002-1311-1768; Oka, Yoshitaka/0000-0002-3482-3051; Miyano, Masashi/0000-0003-2253-6175; Behnke, Craig/0000-0001-6949-7957; Fox, Brian/0000-0001-6620-3853	NEI NIH HHS [EY09339] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009339] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; BROWN PK, 1956, J BIOL CHEM, V222, P865; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CALLENDER RH, 1976, BIOCHEMISTRY-US, V15, P1621, DOI 10.1021/bi00653a005; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Creemers AFL, 1999, BIOCHEMISTRY-US, V38, P7195, DOI 10.1021/bi9830157; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DOI T, 1990, P NATL ACAD SCI USA, V87, P4991, DOI 10.1073/pnas.87.13.4991; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; EBREY T, 1980, FEBS LETT, V116, P217, DOI 10.1016/0014-5793(80)80647-8; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P8812, DOI 10.1021/bi00027a033; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FUKUDA MN, 1979, J BIOL CHEM, V254, P8201; FUNG BKK, 1980, P NATL ACAD SCI-BIOL, V77, P2500, DOI 10.1073/pnas.77.5.2500; HARGRAVE PA, 1992, FASEB J, V6, P2323, DOI 10.1096/fasebj.6.6.1544542; HARGRAVE PA, 1983, BIOPHYS STRUCT MECH, V9, P235, DOI 10.1007/BF00535659; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Herzyk P, 1998, J MOL BIOL, V281, P741, DOI 10.1006/jmbi.1998.1981; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; Imai H, 1997, P NATL ACAD SCI USA, V94, P2322, DOI 10.1073/pnas.94.6.2322; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung H, 1996, BIOCHEMISTRY-US, V35, P6399, DOI 10.1021/bi952575s; Kim JM, 1997, P NATL ACAD SCI USA, V94, P14273, DOI 10.1073/pnas.94.26.14273; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; Meyer CK, 2000, J BIOL CHEM, V275, P19713, DOI 10.1074/jbc.M000603200; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; Okada T, 1998, PHOTOCHEM PHOTOBIOL, V67, P495, DOI 10.1111/j.1751-1097.1998.tb09445.x; Okada T, 2000, J STRUCT BIOL, V130, P73, DOI 10.1006/jsbi.1999.4209; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OVCHINNIKOV YA, 1982, FEBS LETT, V148, P179, DOI 10.1016/0014-5793(82)80805-3; OVCHINNIKOV YA, 1988, FEBS LETT, V230, P1, DOI 10.1016/0014-5793(88)80628-8; PALINGS I, 1987, BIOCHEMISTRY-US, V26, P2544, DOI 10.1021/bi00383a021; Pogozheva ID, 1997, BIOPHYS J, V72, P1963, DOI 10.1016/S0006-3495(97)78842-8; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Sakmar TP, 1998, PROG NUCLEIC ACID RE, V59, P1; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; Shieh T, 1997, J MOL BIOL, V269, P373, DOI 10.1006/jmbi.1997.1035; SMITH SO, 1987, BIOCHEMISTRY-US, V26, P1606, DOI 10.1021/bi00380a018; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMAS DD, 1982, J MOL BIOL, V154, P145, DOI 10.1016/0022-2836(82)90422-3; Unger VM, 1997, NATURE, V389, P203, DOI 10.1038/38316; WAKAMATSU K, 1992, BIOCHEMISTRY-US, V31, P5654, DOI 10.1021/bi00139a032; WANG ZY, 1993, BIOCHEMISTRY-US, V32, P2125, DOI 10.1021/bi00060a001; Yamamoto M, 1998, J SYNCHROTRON RADIAT, V5, P222, DOI 10.1107/S0909049597014738; YOSHIZAWA T, 1963, NATURE, V197, P1279, DOI 10.1038/1971279a0; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154	55	4747	4884	10	715	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2000	289	5480					739	745		10.1126/science.289.5480.739	http://dx.doi.org/10.1126/science.289.5480.739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926528				2022-12-28	WOS:000088581500029
J	Yamamoto, Y; Jeffery, WR				Yamamoto, Y; Jeffery, WR			Central role for the lens in cave fish eye degeneration	SCIENCE			English	Article							RETINAL DEVELOPMENT; ASTYANAX; CHARACIDAE; EVOLUTION; GENETICS; PAX-6	Astyanax mexicanus is a teleost with eyed surface-dwelling and eyeless cave-dwelling forms. Eye formation is initiated in cave fish embryos, but the eye subsequently arrests and degenerates. The surface fish lens stimulates growth and development after transplantation into the cave fish optic cup, restoring optic tissues lost during cave fish evolution. Conversely, eye growth and development are retarded following transplantation of a surface fish lens into a cave fish optic cup or lens extirpation. These results show that evolutionary changes in an inductive signal from the Lens are involved in cave fish eye degeneration.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Jeffery, WR (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	wj33@umail.umd.edu						AVISE JC, 1972, EVOLUTION, V26, P1, DOI 10.1111/j.1558-5646.1972.tb00170.x; CAHN PH, 1958, B AM MUS NAT HIST, V115, P75; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Hall B.K., 1998, EVOLUTIONARY DEV BIO; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.3.CO;2-V; Jeffery WR, 2000, DEV GENES EVOL, V210, P223, DOI 10.1007/s004270050308; Jeffery WR, 1998, AM ZOOL, V38, P685; LANGECKER TG, 1993, CELL TISSUE RES, V273, P183, DOI 10.1007/BF00304625; Macdonald R, 1997, DEV GENES EVOL, V206, P363, DOI 10.1007/s004270050065; MITCHELL RW, 1977, SPEC PUBL MUS TEXAS, V12, P1; NEGISHI K, 1990, DEV BRAIN RES, V55, P121, DOI 10.1016/0165-3806(90)90112-C; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; Raff R.A., 1996, SHAPE LIFE; WILKENS H, 1988, EVOL BIOL, V23, P271	14	188	191	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2000	289	5479					631	633		10.1126/science.289.5479.631	http://dx.doi.org/10.1126/science.289.5479.631			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915628				2022-12-28	WOS:000088447800057
J	Helft, PR; Siegler, M; Lantos, J				Helft, PR; Siegler, M; Lantos, J			The rise and fall of the futility movement.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PREVENTIVE ETHICS APPROACH; INTENSIVE-CARE UNIT; MEDICAL FUTILITY; CARDIOPULMONARY-RESUSCITATION; DEBATE; AUTONOMY; LIMITS; PHYSICIAN; SURVIVAL; REFUSAL		Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Helft, PR (corresponding author), Univ Chicago, Chicago, IL 60637 USA.							BEDELL SE, 1983, NEW ENGL J MED, V309, P569, DOI 10.1056/NEJM198309083091001; BRETT AS, 1986, NEW ENGL J MED, V315, P1347, DOI 10.1056/NEJM198611203152109; BRODY BA, 1995, J MED PHILOS, V20, P123, DOI 10.1093/jmp/20.2.123; BRODY H, 1994, J AM GERIATR SOC, V42, P875, DOI 10.1111/j.1532-5415.1994.tb06562.x; CALLAHAN D, 1994, J AM GERIATR SOC, V42, P866, DOI 10.1111/j.1532-5415.1994.tb06559.x; Cotler M P, 1993, Camb Q Healthc Ethics, V2, P219; CRANFORD RE, 1994, J AM GERIATR SOC, V42, P894, DOI 10.1111/j.1532-5415.1994.tb06567.x; CURTIS JR, 1995, JAMA-J AM MED ASSOC, V273, P124, DOI 10.1001/jama.273.2.124; DAAR JF, 1995, AM J LAW MED, V21, P221; Doukas DJ, 1996, ARCH FAM MED, V5, P589, DOI 10.1001/archfami.5.10.589; EMSON HE, 1995, CAMB Q HEALTHC ETHIC, V4, P7; FABERLANGENDOEN K, 1991, ARCH INTERN MED, V151, P235, DOI 10.1001/archinte.151.2.235; GATTER RA, 1995, J MED PHILOS, V20, P191, DOI 10.1093/jmp/20.2.191; Halevy A, 1996, JAMA-J AM MED ASSOC, V276, P571, DOI 10.1001/jama.276.7.571; JECKER NS, 1995, J CLIN ETHIC, V6, P133; JECKER NS, 1992, AM J MED, V92, P189, DOI 10.1016/0002-9343(92)90111-N; JECKER NS, 1995, CAMB Q HEALTHC ETHIC, V4, P23, DOI 10.1017/S0963180100005612; Johnson D H, 1993, Camb Q Healthc Ethics, V2, P161; KELLERMANN AL, 1988, ANN EMERG MED, V17, P589, DOI 10.1016/S0196-0644(88)80398-6; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LANTOS JD, 1989, AM J MED, V87, P81; Layson RT, 1996, ARCH INTERN MED, V156, P2617, DOI 10.1001/archinte.156.22.2617; MEADOW W, 1995, ACTA PAEDIATR, V84, P589, DOI 10.1111/j.1651-2227.1995.tb13704.x; Murphy D J, 1994, New Horiz, V2, P326; Paris J J, 1992, Camb Q Healthc Ethics, V1, P127; PARIS JJ, 1993, NEW ENGL J MED, V329, P354, DOI 10.1056/NEJM199307293290512; Plows CW, 1999, JAMA-J AM MED ASSOC, V281, P937; POSES RM, 1989, CRIT CARE MED, V17, P827, DOI 10.1097/00003246-198908000-00021; Prendergast T J, 1997, New Horiz, V5, P62; Rubenfeld GD, 1996, ANN INTERN MED, V125, P625, DOI 10.7326/0003-4819-125-8-199610150-00001; SCHNEIDERMAN LJ, 1990, ANN INTERN MED, V112, P949, DOI 10.7326/0003-4819-112-12-949; SCHNEIDERMAN LJ, 1993, ARCH INTERN MED, V153, P437, DOI 10.1001/archinte.153.4.437; SCHNEIDERMAN LJ, 1994, J AM GERIATR SOC, V42, P883, DOI 10.1111/j.1532-5415.1994.tb06564.x; SCHUSTER DP, 1983, AM J MED, V75, P402, DOI 10.1016/0002-9343(83)90340-6; SMITH GP, 1995, J PALLIATIVE CARE, V11, P9, DOI 10.1177/082585979501100303; SOLOMON MZ, 1991, LIFE DEATH DECISIONS; *SUPPORT PRINC INV, 1996, JAMA-J AM MED ASSOC, V275, P1232, DOI DOI 10.1001/JAMA.1995.03530200027032; Tilford JM, 1996, J PEDIATR-US, V128, P725; TOMLINSON T, 1990, JAMA-J AM MED ASSOC, V264, P1276, DOI 10.1001/jama.264.10.1276; TONG R, 1995, J MED PHILOS, V20, P165, DOI 10.1093/jmp/20.2.165; TRUOG RD, 1995, J CLIN ETHIC, V6, P128; TRUOG RD, 1992, NEW ENGL J MED, V326, P1560, DOI 10.1056/NEJM199206043262310; VANMCCRARY S, 1994, J CLIN ETHIC, V5, P100; VEATCH RM, 1992, AM J LAW MED, V18, P15; VEATCH RM, 1994, J AM GERIATR SOC, V42, P871, DOI 10.1111/j.1532-5415.1994.tb06561.x; VITELLI CE, 1991, J CLIN ONCOL, V9, P111, DOI 10.1200/JCO.1991.9.1.111; WEAR S, 1995, J CLIN ETHIC, V6, P138; YOUNGER SJ, 1988, JAMA-J AM MED ASSOC, V260, P2094, DOI 10.1001/jama.260.14.2094; Youngner SJ, 1996, CRIT CARE CLIN, V12, P165, DOI 10.1016/S0749-0704(05)70222-0; YOUNGNER SJ, 1994, J AM GERIATR SOC, V42, P887, DOI 10.1111/j.1532-5415.1994.tb06565.x; ZAWACKI BE, 1995, J CLIN ETHIC, V6, P112	52	234	238	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2000	343	4					293	296		10.1056/NEJM200007273430411	http://dx.doi.org/10.1056/NEJM200007273430411			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	337QC	10911014				2022-12-28	WOS:000088372300011
J	Giacomini, MK; Cook, DJ				Giacomini, MK; Cook, DJ		Evidence-Based Med Working Grp	Users' guides to the medical literature - XXIII. Qualitative research in health care B. What are the results and how do they help me care for my patients?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREDICTIONS	The second part of this a-part series on how to interpret qualitative research addresses, "what are the results," and, "how do they help me care for my patients?" Qualitative analysis is a process of summarizing and interpreting data to develop theoretical insights that describe and explain social phenomena such as interactions, experiences, roles, perspectives, symbols, and organizations. Key results are often illustrated with excerpts from interview transcripts, field notes, or documents. The results of a qualitative research report are best understood as an empirically based contribution to ongoing dialogue and exploration. Empirically based theory evolves from a process of exploration, discovery, analysis, and synthesis. Each concept should be defined carefully in a way that is meaningful to the reader. Concepts should be adequately developed and illustrated when theoretical conclusions are drawn. Arguments should be explained and justified. The qualitative research report ideally should address how the findings relate to other theories in the field. The qualitative study can provide a useful road map for understanding and navigating similar social settings interactions, or relationships.	McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Fac Hlth Sci, Ctr Hlth Econ & Policy Anal, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Fac Hlth Sci, Dept Med, Div Gen Med,Evidence Based Med Working Grp, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Fac Hlth Sci, Dept Med, Div Crit Care,Evidence Based Med Working Grp, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Giacomini, MK (corresponding author), McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Room 2C12,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.							Altheide David L., 1994, HDB QUALITATIVE RES, P485; [Anonymous], 1994, QUAL DATA ANAL; ELDER NC, 1995, J FAM PRACTICE, V41, P279; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Glaser B.G., 1967, DISCOVERY GROUNDED T, P101; HAMBERG K, 1994, FAM PRACT, V11, P176, DOI 10.1093/fampra/11.2.176; Lincoln Y., 1985, NATURALISTIC INQUIRY, P92; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; SCHATZMAN L, 1973, FIELD RES STRATEGIES, P108; SECKLER AB, 1991, ANN INTERN MED, V115, P92, DOI 10.7326/0003-4819-115-2-92; Strauss A., 1990, BASICS QUALITATIVE R; UHLMANN RF, 1988, J GERONTOL, V43, pM115, DOI 10.1093/geronj/43.5.M115; VENTRES W, 1993, J CLIN ETHIC, V4, P134	13	292	297	0	31	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					478	482		10.1001/jama.284.4.478	http://dx.doi.org/10.1001/jama.284.4.478			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	335QB	10904512				2022-12-28	WOS:000088254200035
J	Beattie, GC; Ravi, NR; Lewis, M; Williams, H; Blair, AW; Campbell, IW; Browning, GGP				Beattie, GC; Ravi, NR; Lewis, M; Williams, H; Blair, AW; Campbell, IW; Browning, GGP			Lesson of the week - Rare presentation of maternal primary hyperparathyroidism	BRITISH MEDICAL JOURNAL			English	Review							PREGNANCY		Victoria Hosp, Dept Surg, Kirkcaldy KY2 5AH, Scotland; Victoria Hosp, Dept Med, Kirkcaldy, Scotland; Victoria Hosp, Dept Paediat, Kirkcaldy, Scotland		Browning, GGP (corresponding author), Victoria Hosp, Dept Surg, Kirkcaldy KY2 5AH, Scotland.							Behrman R., 1992, NELSON TXB PEDIAT; BRISSE F, 1994, ARCH PEDIATR, V3, P225; CAMPBELL AGM, 1992, FORFAR ARNEILS TXB P; CUSHARD WG, 1972, J CLIN ENDOCR METAB, V34, P767, DOI 10.1210/jcem-34-5-767; DELMONICO FL, 1976, AM J SURG, V131, P328, DOI 10.1016/0002-9610(76)90127-6; HEATH H, 1980, NEW ENGL J MED, V302, P189, DOI 10.1056/NEJM198001243020402; JACOBSEN BB, 1978, ARCH DIS CHILD, V53, P308, DOI 10.1136/adc.53.4.308; KRISTOFFERSSON A, 1987, SURG GYNECOL OBSTET, V164, P119; Makhdoomi KR, 1996, J ROY COLL SURG EDIN, V41, P351; MITCHELL BK, 1995, J CLIN ENDOCR METAB, V80, P7, DOI 10.1210/jc.80.1.7; MONTORO MN, 1980, OBSTET GYNECOL, V55, P431; Shangold M M, 1982, Obstet Gynecol Surv, V37, P217, DOI 10.1097/00006254-198204000-00002	12	27	27	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 22	2000	321	7255					223	224		10.1136/bmj.321.7255.223	http://dx.doi.org/10.1136/bmj.321.7255.223			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903659	Green Published			2022-12-28	WOS:000088448100027
J	Schultes, EA; Bartel, DP				Schultes, EA; Bartel, DP			One sequence, two ribozymes: Implications for the emergence of new ribozyme folds	SCIENCE			English	Article							RNA SECONDARY STRUCTURES; GROUP-I INTRON; NEUTRAL NETWORKS; PROTEIN SPACE; EVOLUTION; LIGATION	We describe a single RNA sequence that can assume either of two ribozyme folds and catalyze the two respective reactions. The two ribozyme fords share no evolutionary history and are completely different, with no base pairs rand probably no hydrogen bonds) in common, Minor variants of this sequence are highly active for one or the other reaction, and can be accessed from prototype ribozymes through a series of neutral mutations. Thus, in the course of evolution, new RNA folds could arise from preexisting folds, without the need to carry inactive intermediate sequences. This raises the possibility that biological RNAs having no structural or functional similarity might share a common ancestry. Furthermore, functional and structural divergence might, in some cases, precede rather than follow gene duplication.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu	Schultes, Erik/B-6035-2012	Schultes, Erik/0000-0001-8888-635X				ARONSON HEG, 1994, PROTEIN SCI, V3, P1706, DOI 10.1002/pro.5560031009; Babajide A, 1997, FOLD DES, V2, P261, DOI 10.1016/S1359-0278(97)00037-0; Been MD, 1997, EUR J BIOCHEM, V247, P741, DOI 10.1111/j.1432-1033.1997.00741.x; Ciesiolka J, 1998, J MOL BIOL, V275, P211, DOI 10.1006/jmbi.1997.1462; Cohen FE, 1999, J MOL BIOL, V293, P313, DOI 10.1006/jmbi.1999.2990; Cordes MHJ, 1999, SCIENCE, V284, P325, DOI 10.1126/science.284.5412.325; Dalal S, 1997, FOLD DES, V2, pR71, DOI 10.1016/S1359-0278(97)00036-9; EKLAND EH, 1995, NUCLEIC ACIDS RES, V23, P3231, DOI 10.1093/nar/23.16.3231; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Flamm C, 2000, RNA, V6, P325, DOI 10.1017/S1355838200992161; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Li YF, 1999, J AM CHEM SOC, V121, P5364, DOI 10.1021/ja990592p; LISACEK F, 1994, J MOL BIOL, V235, P1206, DOI 10.1006/jmbi.1994.1074; Minor DL, 1996, NATURE, V380, P730, DOI 10.1038/380730a0; Ohno S., 1970, EVOLUTION GENE DUPLI; Perrotta AT, 1998, J MOL BIOL, V279, P361, DOI 10.1006/jmbi.1998.1798; Reidys C, 1997, B MATH BIOL, V59, P339, DOI 10.1016/S0092-8240(96)00089-4; Rohatgi R, 1996, J AM CHEM SOC, V118, P3340, DOI 10.1021/ja9537134; Rohatgi R, 1996, J AM CHEM SOC, V118, P3332, DOI 10.1021/ja953712b; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Tanner MA, 1996, RNA, V2, P74; Ye XM, 1999, CHEM BIOL, V6, P657, DOI 10.1016/S1074-5521(99)80117-3	25	257	268	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2000	289	5478					448	452		10.1126/science.289.5478.448	http://dx.doi.org/10.1126/science.289.5478.448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903205				2022-12-28	WOS:000088305500047
J	Temeles, EJ; Pan, IL; Brennan, JL; Horwitt, JN				Temeles, EJ; Pan, IL; Brennan, JL; Horwitt, JN			Evidence for ecological causation of sexual dimorphism in a hummingbird	SCIENCE			English	Article							EVOLUTION; TESTS	Unambiguous examples of ecological causes of animal sexual dimorphism are rare. Here we present evidence for ecological causation of sexual dimorphism in the bill morphology of a hummingbird, the purple-throated carib. This hummingbird is the sole pollinator of two Heliconia species whose flowers correspond to the bills of either males or females. Each sex feeds most quickly at the flower species approximating its bill dimensions, which supports the hypothesis that floral specialization has driven the evolution of bill dimorphism. Further evidence for ecological causation of sexual dimorphism was provided by a geographic replacement of one Heliconia species by the other and the subsequent development of a floral dimorphism, with one floral morph matching the bills of males and the other of females.	Amherst Coll, Dept Biol, Amherst, MA 01002 USA	Amherst College	Temeles, EJ (corresponding author), Amherst Coll, Dept Biol, Amherst, MA 01002 USA.		Temeles, Ethan J./AAD-7366-2021					Berry F., 1991, HELICONIA IDENTIFICA; Bleiweiss R, 1998, BIOL J LINN SOC, V65, P77, DOI 10.1111/j.1095-8312.1998.tb00352.x; COLWELL RK, 1989, IBIS, V131, P548, DOI 10.1111/j.1474-919X.1989.tb04790.x; Darwin C., 1871, P475; DIAMOND AW, 1973, IBIS, V115, P313, DOI 10.1111/j.1474-919X.1973.tb01973.x; HEDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136, DOI 10.1016/0169-5347(89)90212-7; KEITH AR, 1997, BIRDS ST LUCIA W IND; KRESS W, COMMUNICATION; PIMM SL, 1985, ECOLOGY, V66, P798, DOI 10.2307/1940541; Proctor M., 1996, NATURAL HIST POLLINA; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RIDGWAY R, 1911, B US NATL MUS 5, V50; SCHUCHMANN K-L, 1984, Bonner Zoologische Beitraege, V35, P327; Selander R.K., 1972, SEXUAL SELECTION DES, P180, DOI DOI 10.4324/9781315129266-8; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; TEMELES EJ, 1993, OECOLOGIA, V94, P87, DOI 10.1007/BF00317307; WETMORE A, 1968, SMITHSONIAN MISC C 2, V150; WHITTAM TS, 1981, ECOLOGY, V62, P1515, DOI 10.2307/1941508; WOLF LL, 1975, AUK, V92, P511, DOI 10.2307/4084604; WOLF LL, 1972, SCIENCE, V176, P1351, DOI 10.1126/science.176.4041.1351	20	173	185	1	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					441	443		10.1126/science.289.5478.441	http://dx.doi.org/10.1126/science.289.5478.441			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903203				2022-12-28	WOS:000088305500045
J	Gopalan, R; Cooke, CG				Gopalan, R; Cooke, CG			Boerhaave's syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Greater Baltimore Med Ctr, Baltimore, MD 21204 USA	Greater Baltimore Medical Center	Gopalan, R (corresponding author), Greater Baltimore Med Ctr, Baltimore, MD 21204 USA.								0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2000	343	3					190	190		10.1056/NEJM200007203430306	http://dx.doi.org/10.1056/NEJM200007203430306			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335HY	10900279				2022-12-28	WOS:000088239100006
J	Westerfeld, S				Westerfeld, S			All is not lost	NATURE			English	Article																			0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					241	241		10.1038/35018654	http://dx.doi.org/10.1038/35018654			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917508	Bronze			2022-12-28	WOS:000088251900026
J	DesMarteau, DD				DesMarteau, DD			Chemistry - Superacids - It's a lot about anions	SCIENCE			English	Editorial Material									Clemson Univ, Dept Chem, Clemson, SC 29634 USA	Clemson University	DesMarteau, DD (corresponding author), Clemson Univ, Dept Chem, Clemson, SC 29634 USA.							DESMARTEAU DD, 1995, J FLUORINE CHEM, V72, P203, DOI 10.1016/0022-1139(94)00408-8; GILLESPI.RJ, 1973, J AM CHEM SOC, V95, P5173, DOI 10.1021/ja00797a013; GILLESPIE RJ, 1988, J AM CHEM SOC, V110, P6053, DOI 10.1021/ja00226a020; Hall NF, 1927, J AM CHEM SOC, V49, P3047, DOI 10.1021/ja01411a010; KOPPEL IA, 1994, J AM CHEM SOC, V116, P3047, DOI 10.1021/ja00086a038; OLAH GA, 1973, ANGEW CHEM INT EDIT, V12, P173, DOI 10.1002/anie.197301731; OLAH GA, 1985, SUPERACIDS; Reed CA, 2000, SCIENCE, V289, P101, DOI 10.1126/science.289.5476.101; STRAUSS SH, 1993, CHEM REV, V93, P927, DOI 10.1021/cr00019a005	9	26	29	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2000	289	5476					72	73		10.1126/science.289.5476.72	http://dx.doi.org/10.1126/science.289.5476.72			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332TW	10928933				2022-12-28	WOS:000088090400032
J	Davis, R				Davis, R			Liz Hurley sucks to stop smoking	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					319	319						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QH	10926579				2022-12-28	WOS:000088656300013
J	Silove, D; Steel, Z; Watters, C				Silove, D; Steel, Z; Watters, C			Policies of deterrence and the mental health of asylum seekers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SOUTHEAST-ASIAN REFUGEES; POSTTRAUMATIC-STRESS-DISORDER; DOSE-EFFECT RELATIONSHIPS; VIETNAMESE REFUGEES; ORGANIZED VIOLENCE; HMONG REFUGEES; UNITED-STATES; OF-TORTURE; TRAUMA; DEPRESSION	In the past, most refugees who permanently resettled in the traditional recipient countries of North America, Europe, and Australasia were screened prior to arrival in a host country. In the last decade, increasing numbers of unauthorized refugees or asylum seekers, those who formally lodge application for refugee status in the country in which they are residing, have applied for protection after crossing the borders of these countries. Concerns about uncontrolled migration have encouraged host countries to adopt policies of deterrence in which increasingly restrictive measures are being imposed on persons seeking asylum. These measures include, variously, confinement in detention centers, enforced dispersal within the community, the implementation of more stringent refugee determination procedures, and temporary forms of asylum, In several countries, asylum seekers living in the community face restricted access to work, education, housing, welfare, and, in some situations, to basic health care services, Allegations of abuse, untreated medical and psychiatric illnesses, suicidal behavior, hunger strikes, and outbreaks of violence among asylum seekers in detention centers have been reported. Although systematic research into the mental health of asylum seekers is in its infancy, and methods are limited by sampling difficulties, there is growing evidence that salient postmigration stress facing asylum seekers adds to the effect of previous trauma in creating risk of ongoing posttraumatic stress disorder and other psychiatric symptoms. The medical profession has a role in educating governments and the public about the potential risks of imposing excessively harsh policies of deterrence on the mental health of asylum seekers.	Univ New S Wales, Sch Psychiat, Psychiat Res & Teaching Unit, Liverpool, NSW, Australia; Univ Kent, European Ctr Study Social Care Minor Grp & Refuge, Canterbury, Kent, England	University of New South Wales Sydney; University of Kent	Silove, D (corresponding author), Univ New S Wales, Liverpool Hosp, Level 4 Hlth Serv Bldg, Liverpool, NSW 2170, Australia.	D.Silove@unsw.edu.au		Watters, Charles/0000-0001-7911-9642; Steel, Zachary/0000-0002-5048-2920				ABE J, 1994, J COMMUNITY PSYCHOL, V22, P121, DOI 10.1002/1520-6629(199404)22:2<121::AID-JCOP2290220208>3.0.CO;2-D; *AMN INT, 2000, LOST LAB DET AS SEEK; *AMN INT UK, 1996, CELL CULT DET IMPR A; ARON A, 1992, APPL PSYCHOL-INT REV, V41, P77, DOI 10.1111/j.1464-0597.1992.tb00687.x; Baker R., 1992, TORTURE ITS CONSEQUE, P83; BASOGLU M, 1994, JAMA-J AM MED ASSOC, V272, P357, DOI 10.1001/jama.272.5.357; Becker R., 1993, PROTECTION PUNISHMEN; BEGLEY MG, 1999, ASYLUM IRELAND PUBLI; BEISER M, 1989, SOC SCI MED, V28, P183, DOI 10.1016/0277-9536(89)90261-X; BEISER M, 1988, AM J PSYCHIAT, V145, P46; Bracken P., 1991, PSYCHIAT B, V5, P657; Bunce C, 1997, BRIT MED J, V314, P393, DOI 10.1136/bmj.314.7078.393; Bunce C, 1997, BRIT MED J, V314, P535, DOI 10.1136/bmj.314.7080.535; Cheung P, 1994, Int J Soc Psychiatry, V40, P17, DOI 10.1177/002076409404000102; CHUNG RCY, 1993, SOC SCI MED, V36, P631, DOI 10.1016/0277-9536(93)90060-H; CUNNINGHAM M, 1993, INT HDB TRAUMATIC ST, P751; Delbecchi G, 1999, PRESSE MED, V28, P1075; *DEP FOR AFF INT T, 2000, CAN OFF SAF HAV KOS; *DEP IMM MULT AFF, 2000, OP SAF HAV KOS E TIM; *DEP JUST IMM NA S, 2000, ANN REP AS FISC YEAR; *DEP JUST IMM NAT, 2000, INS AD NEW LEG INT M; *DEP JUST IMM NAT, 2000, US EXP EXT TEMP PROT; DRASGOW F, 1987, REV INTERAM PSICOL, V21, P1; DROZDEK B, 2000, P 3 WORLD C INT SOC; George M, 1998, Nurs Stand, V13, P27; GIL K, 1998, CMAJ, V159, P1237; Gorst-Unsworth C, 1998, BRIT J PSYCHIAT, V172, P90, DOI 10.1192/bjp.172.1.90; GREEN BL, 1996, INT REV PSYCHIATR, P177; HARGREAVES S, 1999, BRIT MED J, V353, P1497; Harvey A., 1998, CURRENT ISSUES UK AS, P176; HAUFF E, 1994, J NERV MENT DIS, V182, P85, DOI 10.1097/00005053-199402000-00004; HINTON WL, 1993, J NERV MENT DIS, V181, P113, DOI 10.1097/00005053-199302000-00007; Hjern A, 1997, SCAND J SOC MED, V25, P207, DOI 10.1177/140349489702500310; Hogan H, 1999, BRIT MED J, V318, P671, DOI 10.1136/bmj.318.7184.671; Hosking P, 1997, ASYLUM SEEKERS AUSTR; *HUM RIGHTS EQ OPP, 1998, THOS WHOV COM ACR SE; *HUM RIGHTS WATCH, 2000, LOCK AW IMM DET JAIL; ICHIKAW AM, 1998, TRAUMA EXPOSURE POST; JENSEN SB, 1989, ACTA PSYCHIAT SCAND, V80, P125, DOI 10.1111/j.1600-0447.1989.tb01313.x; JOLY D, 1997, REFUGEES EUROPE HOST; JONES D, 1998, BRIT MED J, V317, P1144; Kahler L R, 1996, Health Care Women Int, V17, P15; KELSO P, 2000, GUARDIAN        0621, P1; KRUPINSKI J, 1986, PRICE FREEDOM YOUGN; KUMIN J, 2000, REFUGEES MAGAZINE, P13; Lawson M, 1999, Med Confl Surviv, V15, P255, DOI 10.1080/13623699908409462; Lawson MH, 1999, LANCET, V353, P1365, DOI 10.1016/S0140-6736(05)74367-1; LLORENTE E, 2000, RECORD          0411; MCGORRY P, 1995, AUST NZ J PSYCHIAT, V29, P463, DOI 10.3109/00048679509064955; MILLBANK A, 2000, BOAT PEOPL ILL MIGR; Mirzaei S, 1998, LANCET, V352, P949, DOI 10.1016/S0140-6736(98)05049-1; Mollica RF, 1998, J NERV MENT DIS, V186, P543, DOI 10.1097/00005053-199809000-00005; Mollica RF, 1998, BRIT J PSYCHIAT, V173, P482, DOI 10.1192/bjp.173.6.482; Mollica RF, 1999, JAMA-J AM MED ASSOC, V282, P433, DOI 10.1001/jama.282.5.433; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; *PHYS HUM RIGHTS, 1999, MED TEST VICT TORT P; PIROUET L, 1991, SUICIDE ATTEMPTED SU; POURGOURIDES CK, 1995, 2 EXILE MENTAL HLTH; REID J, 1990, AUST NZ J PSYCHIAT, V24, P486, DOI 10.3109/00048679009062904; REID J, 1987, TORTURE TRAUMA HLTH; Rodenburg JJ, 1997, BRIT J PSYCHIAT, V171, P394; Rogler LH, 1999, AM PSYCHOL, V54, P424, DOI 10.1037/0003-066X.54.6.424; Rumbaut R. G., 1991, REFUGEE CHILDREN THE; RUMBAUT RD, 1989, SE ASIAN MENTAL HLTH; SACHS S, 2000, NY TIMES        0730; SACHS S, 2000, NY TIMES        0721; Salinsky M, 1997, BRIT MED J, V314, P456, DOI 10.1136/bmj.314.7079.456; Shrestha NM, 1998, JAMA-J AM MED ASSOC, V280, P443, DOI 10.1001/jama.280.5.443; SIEGAL N, 2000, NY TIMES        0131; Silove D, 1997, BRIT J PSYCHIAT, V170, P351, DOI 10.1192/bjp.170.4.351; SILOVE D, 1993, AUST NZ J PSYCHIAT, V27, P606, DOI 10.3109/00048679309075823; Silove D, 1998, ACTA PSYCHIAT SCAND, V97, P175, DOI 10.1111/j.1600-0447.1998.tb09984.x; Silove D, 1999, J NERV MENT DIS, V187, P200, DOI 10.1097/00005053-199904000-00002; Silove D, 1999, SOC SCI MED, V49, P951, DOI 10.1016/S0277-9536(99)00188-4; Silove D, 2000, CURR OPIN PSYCHIATR, V13, P231, DOI 10.1097/00001504-200003000-00016; Silove D, 1996, JAMA-J AM MED ASSOC, V276, P410; Sinnerbrink I, 1996, MED J AUSTRALIA, V165, P634, DOI 10.5694/j.1326-5377.1996.tb138671.x; Sourander A, 1998, CHILD ABUSE NEGLECT, V22, P719, DOI 10.1016/S0145-2134(98)00053-2; Steel Z, 1999, J TRAUMA STRESS, V12, P421, DOI 10.1023/A:1024710902534; STEEL Z, 2000, PL S STRESS, P421; Summer field D., 1999, REFUGEES PERSPECTIVE, P111; SUMMERFIELD D, 1991, LANCET, V338, P58, DOI 10.1016/0140-6736(91)90051-P; THOMPSON M, 1988, MENTAL HLTH WELL BEI, P27; THONNEAU P, 1990, CAN J PUBLIC HEALTH, V81, P182; *UN, 2000, CONV REL STAT REF; *UN HIGH COMM REF, 2000, UNHCRS GUID APPL CRI; *UN HIGH COMM REF, 2000, 2000 STAT TABL V2 RE; *UN HIGH COMM REF, 2000, 2000 STAT TABL, V1; United Nations High Commission for Refugees, 1997, STAT WORLDS REF HUM; VANDEVIJVER FJR, 1982, J CROSS CULT PSYCHOL, V13, P387, DOI 10.1177/0022002182013004001; *VICT FDN SURV TOR, 1996, CLIN SOC ASS E TIM P; Watters C., 1998, CURRENT ISSUES UK AS, P282; WESTERMEYER J, 1989, J NERV MENT DIS, V177, P132, DOI 10.1097/00005053-198903000-00002; WESTERMEYER J, 1988, AM J PSYCHIAT, V145, P197; WILKINSON R, 2000, REFUGEES MAGAZINE, P113; *WOM COMM REF WOM, 1998, FORG PRIS FOLL REP R; YOUNG WA, 2000, US DETENTION WOMEN A; 1999, AMN INT REP 1999	98	172	175	0	50	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2000	284	5					604	611		10.1001/jama.284.5.604	http://dx.doi.org/10.1001/jama.284.5.604			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	337WG	10918707				2022-12-28	WOS:000088385400030
J	Chalmers, I; Trohler, U				Chalmers, I; Trohler, U			Helping physicians to keep abreast of the medical literature: Medical and Philosophical Commentaries, 1773-1795	ANNALS OF INTERNAL MEDICINE			English	Article							CONTROLLED TRIALS; METAANALYSES; JOURNALS; ARTICLES; REVIEWS		UK Cochrane Ctr, NHS Res & Dev Programme, Oxford OX2 7LG, England; Univ Freiburg, D-79104 Freiburg, Germany	Cochrane Centre; University of Freiburg	Chalmers, I (corresponding author), UK Cochrane Ctr, NHS Res & Dev Programme, Summertown Pavil,Middle Way, Oxford OX2 7LG, England.	ichalmers@cochrane.co.uk						ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Black W., 1781, OBSERVATIONS MED POL; Blane G, 1785, OBSERVATIONS DIS INC; Clark J., 1773, OBSERVATIONS DIS LON; Clarke M, 1998, JAMA-J AM MED ASSOC, V280, P280, DOI 10.1001/jama.280.3.280; Cochrane AL, 2000, MED YEAR 2000, V1979, P1; Colman E, 1999, LANCET, V354, P324, DOI 10.1016/S0140-6736(98)11102-9; Dobson M, 1779, MED COMMENTARY FIXED; EGGER M, 2000, IN PRESS SYSTEMATIC; Fowler T, 1786, MED REPORTS EFFECTS; Fowler T, 1795, MED REPORTS EFFECTS; Fowler Thomas, 1785, MED REPORTS EFFECTS; GUYAT GH, 1993, JAMA-J AM MED ASSOC, V270, P2096, DOI 10.1001/jama.270.17.2096; HAYNES RB, 1990, ANN INTERN MED, V113, P69, DOI 10.7326/0003-4819-113-1-69; HUIE R, 1829, HARVEIAN ORATION 182, P3; HUTH EJ, 1987, ANN INTERN MED, V106, P470, DOI 10.7326/0003-4819-106-3-470_2; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; Johnstone RW, 1954, EDINBURGH MED J, V61, P389; Lettsom J. C., 1774, MED MEMOIRS GEN DISP; Lind J., 1772, TREATISE SCURVY, V3rd; Lock Stephen P., 1991, FUTURE MED J, P127; Maehle Andreas-Holger, 1999, DRUGS TRIAL EXPT PHA; Millar J, 1778, OBSERVATIONS MANAGEM; Millar J, 1777, OBSERVATIONS PRACTIC, P4; MULROW CD, 1987, ANN INTERN MED, V106, P485, DOI 10.7326/0003-4819-106-3-485; MUNDIE G, 1786, MED COMMENTARIES DEC, V1, pR6; MUNDIE G, 1788, MED COMMENTARIES DEC, V2, pR6; MUNDIE G, 1779, MED PHILOS COMMENT 1, P5; MUNDIE G, 1786, MED COMMENTARIES, P123; MURRAY J, 1973, SOC EDINBURGH MED 1; MURRAY J, 1773, MED PHILOS COMMENT 1, P5; OXMAN AD, 1988, CAN MED ASSOC J, V138, P697; OXMAN AD, 2000, IN RPESS SYSTEMATIC; Percival T, 1767, ESSAYS MED EXPT; ROLLO J, 1801, SHORT ACCOUNT ROYAL, P80; ROSNER LM, 1981, SCOTTISH MEN MED A D; SACKETT DL, 1981, CAN MED ASSOC J, V124, P555; Sackett DL, 2000, EVIDENCE BASED MED; Sackett DL, 1985, CLIN EPIDEMIOLOGY BA; Trohler U, 1988, Hist Philos Life Sci, V10 Suppl, P31; Trohler U, 1987, Schweiz Rundsch Med Prax, V76, P958; TROHLER U, 2000, IN PRESS IMPROVE EVI; Trolher U., 1999, HIST PENSEE MED OCCI, V3; Withering W, 1785, ACCOUNT FOXGLOVE SOM; Zachs W, 1998, 1 J MURRAY LATE 18 C, P179; ZACHS W, 1998, 1 J MURRAY LATE 18 C, P190	47	11	12	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2000	133	3					238	243		10.7326/0003-4819-133-3-200008010-00024	http://dx.doi.org/10.7326/0003-4819-133-3-200008010-00024			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XW	10906847				2022-12-28	WOS:000088449400015
J	Avery, AJ; Rodgers, S; Heron, T; Crombie, R; Whynes, D; Pringle, M; Baines, D; Petchey, R				Avery, AJ; Rodgers, S; Heron, T; Crombie, R; Whynes, D; Pringle, M; Baines, D; Petchey, R			A prescription for improvement? An observational study to identify how general practices vary in their growth in prescribing costs	BRITISH MEDICAL JOURNAL			English	Article							DISPENSING PRACTICES; PRACTITIONERS; FUNDHOLDERS; ENGLAND	Objective To identify how some general practices have low growth in prescribing costs relative to other practices. Design Observational study. Setting Trent region of England. Participants 162 general practices: 54 with low growth in prescribing costs, 54 with average increases in costs, and 54 with large increases in costs. Main outcome measures Changes in prescribing costs in therapeutic categories in which it has been suggested that savings can be made. Results There were significant differences between the three groups of practices in terms of their changes in prescribing costs for almost all the variables studied. For the group of practices with lowest growth in costs the most important factors were reducing numbers of prescription items and costs per item; relatively low growth in the costs of "new and expensive" drugs; increasing generic prescribing; and reducing costs for modified release products. This group of practices did not increase costs as much the others for lipid lowering drugs (P = 0.012) a hormone replacement therapy (P = 0.007). The practices with the greatest increases in costs had particularly large increases for proton pump inhibitors, selective serotonin reuptake inhibitors, and modified release products. Compared with the other groups these practices had larger increases in costs for "expensive hospital initiated drugs" (P = 0.009). Conclusion General practices vary in their growth in prescribing costs in many ways, with growth in costs for "new and expensive" drugs being particularly important.	Univ Nottingham Hosp, Sch Community Hlth Sci, Div Gen Practice, Nottingham NG7 2UH, England; Enigma Med Syst, Cleethorpes DN35 0HF, North East Linc, England; Univ Nottingham, Sch Econ, Nottingham NG7 2RD, England; Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England; City Univ London, Sch Humanities & Social Sci, Hlth Management Grp, London EC1V 0HB, England	University of Nottingham; University of Nottingham; University of Birmingham; City University London	Avery, AJ (corresponding author), Univ Nottingham Hosp, Sch Community Hlth Sci, Div Gen Practice, Nottingham NG7 2UH, England.		Baines, Darrin/ABI-5893-2020	Baines, Darrin/0000-0001-9502-4678; Rodgers, Sarah/0000-0003-1676-1982; Avery, Anthony/0000-0001-7591-4438				*AUD COMM, 1994, PRESCR IMPR RAT PRES; AVERY AJ, 1999, PRESCRIBER, V10, P109; BAINES D, 1997, PRESCRIBING BUDGETS; Baines DL, 1996, J CLIN PHARM THER, V21, P343, DOI 10.1111/j.1365-2710.1996.tb00029.x; Baines DL, 1997, PHARMACOECONOMICS, V11, P350, DOI 10.2165/00019053-199711040-00006; BRADLOW J, 1993, BRIT MED J, V307, P1186, DOI 10.1136/bmj.307.6913.1186; *BRIT MED ASS ROYA, 1996, BRIT NAT MUL; *DEP HLTH, 1994, GEN MED STAT ENGL WA; DOWELL JS, 1995, BRIT MED J, V310, P505, DOI 10.1136/bmj.310.6978.505; Harris CM, 1996, BRIT MED J, V313, P1531, DOI 10.1136/bmj.313.7071.1531; MAXWELL M, 1993, BRIT MED J, V307, P1190, DOI 10.1136/bmj.307.6913.1190; MORTONJONES TJ, 1993, BRIT MED J, V306, P1244, DOI 10.1136/bmj.306.6887.1244; RICE N, 1999, DERIVATION NEEDS BAS; ROBERTS SJ, 1993, BRIT MED J, V307, P485, DOI 10.1136/bmj.307.6902.485; SIBBALD B, 1992, BRIT MED J, V304, P31, DOI 10.1136/bmj.304.6818.31; STEWARTBROWN S, 1995, BRIT MED J, V311, P1543, DOI 10.1136/bmj.311.7019.1543; WILSON RPH, 1995, BRIT MED J, V311, P1347, DOI 10.1136/bmj.311.7016.1347	17	15	15	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					276	281		10.1136/bmj.321.7256.276	http://dx.doi.org/10.1136/bmj.321.7256.276			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915132	Green Published, Bronze			2022-12-28	WOS:000088619800029
J	Takahashi, T; Hori, T; Kajikawa, Y; Tsujimoto, T				Takahashi, T; Hori, T; Kajikawa, Y; Tsujimoto, T			The role of GTP-binding protein activity in fast central synaptic transmission	SCIENCE			English	Article							FROG NEUROMUSCULAR-JUNCTION; PRESYNAPTIC CALCIUM CURRENT; READILY RELEASABLE POOL; CA2+-DEPENDENT EXOCYTOSIS; REGULATED EXOCYTOSIS; TRANSMITTER RELEASE; CHROMAFFIN CELLS; CALYX SYNAPSE; DEPRESSION; VESICLES	Guanosine 5'-triphosphate (GTP)-binding proteins (G proteins) are involved in exocytosis, endocytosis, and recycling of vesicles in yeast and mammalian secretory cells. However, little is known about their contribution to fast synaptic transmission. We Loaded guanine nucleotide analogs directly into a giant nerve terminal in rat brainstem slices. Inhibition of G-protein activity had no effect on basal synaptic transmission, but augmented synaptic depression and significantly slowed recovery from depression. A nonhydrolyzable GTP analog blocked recovery of transmission from activity-dependent depression. Neither effect was accompanied by a change in presynaptic calcium currents. Thus, G proteins contribute to fast synaptic transmission by refitting synaptic vesicles depleted after massive exocytosis.	Univ Tokyo, Fac Med, Dept Neurophysiol, Tokyo 1130033, Japan	University of Tokyo	Takahashi, T (corresponding author), Univ Tokyo, Fac Med, Dept Neurophysiol, Tokyo 1130033, Japan.		Takahashi, Tomoyuki/G-5951-2015	Takahashi, Tomoyuki/0000-0002-8771-7666; Hori, Tetsuya/0000-0002-0823-3306				Ashery U, 1999, P NATL ACAD SCI USA, V96, P1094, DOI 10.1073/pnas.96.3.1094; Augustine GJ, 1999, J PHYSIOL-LONDON, V520, P33, DOI 10.1111/j.1469-7793.1999.00033.x; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Burns ME, 1998, J GEN PHYSIOL, V111, P243, DOI 10.1085/jgp.111.2.243; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; Dittman JS, 1998, J NEUROSCI, V18, P6147; FERRONOVICK S, 1993, ANNU REV CELL BIOL, V9, P575; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; HAROOTUNIAN AT, 1991, CELL CALCIUM, V12, P153, DOI 10.1016/0143-4160(91)90017-9; HESS SD, 1993, SCIENCE, V259, P1169, DOI 10.1126/science.8438167; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; HOLZ RW, 1994, J BIOL CHEM, V269, P10229; Hori T, 1999, J NEUROSCI, V19, P7262, DOI 10.1523/JNEUROSCI.19-17-07262.1999; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; Katz B., 1969, RELEASE NEURAL TRANS; Nagao M, 1999, ONCOGENE, V18, P4425, DOI 10.1038/sj.onc.1202832; NUOFFER C, 1994, ANNU REV BIOCHEM, V63, P949, DOI 10.1146/annurev.bi.63.070194.004505; Oishi H, 1998, J BIOL CHEM, V273, P34580, DOI 10.1074/jbc.273.51.34580; Otis T, 1996, J NEUROSCI, V16, P7496; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; RUPNIK M, 1995, NEUROREPORT, V6, P853, DOI 10.1097/00001756-199504190-00007; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Takahashi T, 1998, J NEUROSCI, V18, P3138; Takahashi T, UNPUB; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8	33	39	39	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					460	463		10.1126/science.289.5478.460	http://dx.doi.org/10.1126/science.289.5478.460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903208				2022-12-28	WOS:000088305500050
J	Huang, SA; Tu, HM; Harney, JW; Venihaki, M; Butte, AJ; Kozakewich, HPW; Fishman, SJ; Larsen, PR				Huang, SA; Tu, HM; Harney, JW; Venihaki, M; Butte, AJ; Kozakewich, HPW; Fishman, SJ; Larsen, PR			Brief report: Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RAT BROWN ADIPOCYTES; CONGENITAL HYPOTHYROIDISM; SPASTIC DIPLEGIA; GROWTH-FACTORS; THYROID-DISEASE; INFANCY; INTERFERON; THERAPY; TRIIODOTHYRONINE; COMPLICATION		Harvard Univ, Sch Med, Harvard Inst Med, Div Thyroid, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; Childrens Hosp, Dept Surg, Boston, MA 02115 USA; Childrens Hosp, Vascular Anomalies Ctr, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Thyroid, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital	Larsen, PR (corresponding author), Harvard Univ, Sch Med, Harvard Inst Med, Div Thyroid, Rm 560,77 Ave Louis Pasteur, Boston, MA 02115 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044128, T32DK007529] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK07529, DK44128, DK07699] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALDUCCI G, 1991, PEDIATR CARDIOL, V12, P28, DOI 10.1007/BF02238495; Barlow CF, 1998, J PEDIATR-US, V132, P527, DOI 10.1016/S0022-3476(98)70034-4; CHOPRA IJ, 1975, J CLIN INVEST, V55, P1137, DOI 10.1172/JCI108030; COURTIN F, 1991, J NEUROCHEM, V56, P1107, DOI 10.1111/j.1471-4159.1991.tb11399.x; Deb G, 1999, J PEDIATR-US, V134, P382, DOI 10.1016/S0022-3476(99)70474-9; Drolet BA, 1999, NEW ENGL J MED, V341, P173, DOI 10.1056/NEJM199907153410307; FISHER DA, 1991, J CLIN ENDOCR METAB, V72, P523, DOI 10.1210/jcem-72-3-523; FISHMAN SJ, 1993, PEDIATR CLIN N AM, V40, P1177; GERMAK JA, 1990, J PEDIATR-US, V117, P211, DOI 10.1016/S0022-3476(05)80532-3; HERNANDEZ A, 1995, ENDOCRINOLOGY, V136, P4543, DOI 10.1210/en.136.10.4543; Hernandez A, 1998, ENDOCRINOLOGY, V139, P634, DOI 10.1210/en.139.2.634; KET JL, 1981, J CLIN ENDOCR METAB, V53, P1301, DOI 10.1210/jcem-53-6-1301; Koh LKH, 1997, THYROID, V7, P891, DOI 10.1089/thy.1997.7.891; LADENSON PW, 1983, J CLIN ENDOCR METAB, V56, P1252, DOI 10.1210/jcem-56-6-1252; LaFranchi S, 1999, THYROID, V9, P735, DOI 10.1089/thy.1999.9.735; Larsen PR, 1998, WILLIAMS TXB ENDOCRI, P389; MANDEL SJ, 1993, ANN INTERN MED, V119, P492, DOI 10.7326/0003-4819-119-6-199309150-00009; MYRUP B, 1995, J INTERN MED, V238, P59, DOI 10.1111/j.1365-2796.1995.tb00899.x; OSTERGAARD GZ, 1989, HORM RES, V31, P190, DOI 10.1159/000181114; Pallud S, 1999, ENDOCRINOLOGY, V140, P2917, DOI 10.1210/en.140.6.2917; SALVATORE D, 1995, J CLIN INVEST, V96, P2421, DOI 10.1172/JCI118299; TAKAHASHI K, 1994, J CLIN INVEST, V93, P2357, DOI 10.1172/JCI117241; Worle H, 1999, EUR J PEDIATR, V158, P344, DOI 10.1007/s004310051089; Zurakowski D, 1999, CLIN CHEM, V45, P1087	24	320	340	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2000	343	3					185	189		10.1056/NEJM200007203430305	http://dx.doi.org/10.1056/NEJM200007203430305			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335HY	10900278				2022-12-28	WOS:000088239100005
J	Lucky, R				Lucky, R			The quickening of science communication	SCIENCE			English	Article									Telcordia Technol Inc, Appl Res, Morristown, NJ 07960 USA	Ericsson; Telcordia Technologies	Lucky, R (corresponding author), Telcordia Technol Inc, Appl Res, Morristown, NJ 07960 USA.							BERNERSLEE T, 1999, M DERTOUZOS WEAVING; Brooks John, 1976, TELEPHONE 1 100 YEAR; DYSON GB, 1998, DARWIN MACHINES EVOL; [No title captured]	4	14	14	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					259	264		10.1126/science.289.5477.259	http://dx.doi.org/10.1126/science.289.5477.259			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10917852				2022-12-28	WOS:000088169400032
J	Bolliger, CT; Zellweger, JP; Danielsson, T; van Biljon, X; Robidou, A; Westin, A; Perruchoud, AP; Sawe, U				Bolliger, CT; Zellweger, JP; Danielsson, T; van Biljon, X; Robidou, A; Westin, A; Perruchoud, AP; Sawe, U			Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CESSATION; REPLACEMENT; HARM	Objectives To determine whether use of an oral nicotine inhaler can result in long term reduction in smoking and whether concomitant use of nicotine replacement and smoking is safe, Design Double blind, randomised, placebo controlled trial. Four month trial with a two year follow up. Setting Two university hospital pulmonary clinics in Switzerland. Participants 100 healthy volunteers, recruited through newspaper advertisements, willing to reduce their smoking but unable or unwilling to stop smoking immediately. Intervention Active or placebo inhaler as needed for up to 18 months, with participants encouraged to limit their smoking as much as possible. Main outcome measures Number of cigarettes smoked per day from week six to end point Decrease verified by a measurement of exhaled carbon monoxide at each time point compared with measurement at baseline, Results At four months sustained reduction of smoking was achieved in 52 (26%) participants in the active group and 18 (9%) in the placebo group (P < 0.001; Fisher's test). Corresponding figures after two years were 19 (9.5%) and 6 (3.0%) (P = 0.012), Conclusion Nicotine inhalers effectively and safely achieved sustained reduction in smoking over 24 months. Reduction with or without nicotine substitution may be a feasible first step towards smoking cessation in people not able or not willing to stop abruptly.	Univ Basel Hosp, Dept Internal Med, Div Resp, CH-4031 Basel, Switzerland; CHU Vaudois, Univ Med Policlin, CH-1000 Lausanne, Switzerland; Pharmacia & Upjohn Inc, Biostat, S-25109 Helsingborg, Sweden	University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Pfizer; Pharmacia Corporation	Bolliger, CT (corresponding author), Univ Basel Hosp, Dept Internal Med, Div Resp, CH-4031 Basel, Switzerland.	ctb@gerga.sun.ac.za						Benowitz NL, 1996, ANNU REV PHARMACOL, V36, P597, DOI 10.1146/annurev.pa.36.040196.003121; Bolliger CT, 2000, ADDICTION, V95, pS19; DICLEMENTE CC, 1991, J CONSULT CLIN PSYCH, V59, P295, DOI 10.1037/0022-006X.59.2.295; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Fagerstrom K O, 1997, Tob Control, V6, P311; Fiore MC, 1996, JAMA-J AM MED ASSOC, V275, P1270, DOI 10.1001/jama.1996.03530400058039; GLASGOW RE, 1985, BEHAV THER, V16, P303, DOI 10.1016/S0005-7894(85)80018-6; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hjalmarson A, 1997, ARCH INTERN MED, V157, P1721, DOI 10.1001/archinte.157.15.1721; Hughes JR, 1999, ADDICTION, V94, P109, DOI 10.1046/j.1360-0443.1999.9411097.x; Jimenez-Ruiz C, 1998, EUR RESPIR J, V11, P473, DOI 10.1183/09031936.98.11020473; Kunze M, 1997, PROG RESPIR RES, V28, P190; Murray RP, 1996, CHEST, V109, P438, DOI 10.1378/chest.109.2.438; Paoletti P, 1996, EUR RESPIR J, V9, P643, DOI 10.1183/09031936.96.09040643; SILAGY C, 1999, COCHRANE LIB; TONNESEN P, 1993, JAMA-J AM MED ASSOC, V269, P1268, DOI 10.1001/jama.269.10.1268	17	164	165	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2000	321	7257					329	333		10.1136/bmj.321.7257.329	http://dx.doi.org/10.1136/bmj.321.7257.329			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	342QH	10926587	Bronze, Green Published			2022-12-28	WOS:000088656300021
J	Sessions, A; Yanofsky, MF; Weigel, D				Sessions, A; Yanofsky, MF; Weigel, D			Cell-cell signaling and movement by the floral transcription factors LEAFY and APETALA1	SCIENCE			English	Article							HOMEOTIC GENES; FLOWER DEVELOPMENT; MERISTEM IDENTITY; ARABIDOPSIS; ANTIRRHINUM; PLASMODESMATA; TRAFFICKING; ACTIVATION; FLORICAULA; EXPRESSION	LEAFY (LFY) and APETALA1 (AP1) encode unrelated transcription factors that activate overlapping sets of homeotic genes in Arabidopsis flowers. Sector analysis and targeted expression in transgenic plants were used to study whether LFY and AP1 can participate in cell-cell signaling between and within different layers of the floral meristem. LFY signaled equally well from all Layers and had substantial Long-range action within layers. Nonautonomous action of LFY was accompanied by movement of the protein to adjacent cells, where it directly activated homeotic target genes. In contrast, AP1 had only Limited nonautonomous effects, apparently mediated by downstream genes because activation of early target genes by AP1 was cell-autonomous.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Salk Institute	Yanofsky, MF (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.		Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/C-1418-2008	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963				Bouhidel K, 1996, DEV BIOL, V174, P22, DOI 10.1006/dbio.1996.0048; Bradley D, 1996, NATURE, V379, P791, DOI 10.1038/379791a0; Busch MA, 1999, SCIENCE, V285, P585, DOI 10.1126/science.285.5427.585; CARPENTER R, 1995, DEVELOPMENT, V121, P19; CARPENTER R, 1990, GENE DEV, V4, P1483, DOI 10.1101/gad.4.9.1483; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; HANTKE SS, 1995, DEVELOPMENT, V121, P27; Hill TA, 1998, DEVELOPMENT, V125, P1711; HUALA E, 1992, PLANT CELL, V4, P901, DOI 10.1105/tpc.4.8.901; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; JACKSON D, 1994, DEVELOPMENT, V120, P405; KILBY NJ, 1995, PLANT J, V8, P637, DOI 10.1046/j.1365-313X.1995.08050637.x; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; LUCAS WJ, 1995, CURR OPIN CELL BIOL, V7, P673, DOI 10.1016/0955-0674(95)80109-X; Perbal MC, 1996, DEVELOPMENT, V122, P3433; Sieburth LE, 1998, DEVELOPMENT, V125, P4303; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; WEIGEL D, 1993, SCIENCE, V261, P1723, DOI 10.1126/science.261.5129.1723; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WEIGEL D, 1995, NATURE, V377, P4950	20	241	265	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					779	781		10.1126/science.289.5480.779	http://dx.doi.org/10.1126/science.289.5480.779			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926540				2022-12-28	WOS:000088581500041
J	Willis, BM; Levy, BS				Willis, BM; Levy, BS			Recognizing the public health impact of genocide	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS; WAR		Ctr Dis Control & Prevent, Portland, OR USA; Tufts Univ, Sch Med, Dept Family Med & Community Hlth, Boston, MA USA	Centers for Disease Control & Prevention - USA; Tufts University	Levy, BS (corresponding author), POB 1230, Sherborn, MA 01770 USA.	blevy@igc.org						*AMN INT, 2000, FORS CRIES; *AMN INT, 2000, FORG SREBR AN SNUB J; Carnegie Commission on Preventing Deadly Conflict, 1997, PREV DEADL CONFL; *CDCP, 1993, MMWR-MORBID MORTAL W, V42, P973; *CDCP, 1993, MMWR-MORBID MORTAL W, V42, P979; FEIL SR, 1998, PREVENTING GENOCIDE; GEIGER HJ, 1993, JAMA-J AM MED ASSOC, V270, P616; Hunter E, 1996, AUST NZ J PUBL HEAL, V20, P565, DOI 10.1111/j.1467-842X.1996.tb01066.x; Iacopino V, 1999, JAMA-J AM MED ASSOC, V282, P479, DOI 10.1001/jama.282.5.479; Levy Barry S, 1997, WAR PUBLIC HLTH; LOVGREN S, 2000, MSNBC; LOWN B, 1986, NEW ENGL J MED, V314, P985, DOI 10.1056/NEJM198604103141509; Mann Jonathan M, 1994, Health Hum Rights, V1, P6; Rosenberg Mark L., 1991, VIOLENCE AM PUBLIC H; TOOLE MJ, 1995, LANCET, V345, P339, DOI 10.1016/S0140-6736(95)90338-0; TOOLE MJ, 1993, JAMA-J AM MED ASSOC, V270, P600, DOI 10.1001/jama.270.5.600; *UN, 1999, UN PUBL; *UN, 1998, PREV PUN GEN DUT ALL; VanRooyen MJ, 1999, JAMA-J AM MED ASSOC, V282, P428, DOI 10.1001/jama.282.5.428-a; Waldman R, 1999, AM J PUBLIC HEALTH, V89, P1483, DOI 10.2105/AJPH.89.10.1483; *WHO, 1998, VIOL PREV PUBL HLTH; *WHO, 1997, WHO INF CONS HLTH HU; WILLIAMS J, 1999, WALK FEAR GLOBAL MOV; Winett LB, 1998, PUBLIC HEALTH REP, V113, P498; YIP R, 1993, JAMA-J AM MED ASSOC, V270, P587, DOI 10.1001/jama.270.5.587; 2000, CONV PREV PUN CRIM G	26	12	12	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2000	284	5					612	614		10.1001/jama.284.5.612	http://dx.doi.org/10.1001/jama.284.5.612			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	337WG	10918708				2022-12-28	WOS:000088385400031
J	Brand, U; Fletcher, JC; Hobe, M; Meyerowitz, EM; Simon, R				Brand, U; Fletcher, JC; Hobe, M; Meyerowitz, EM; Simon, R			Dependence of stem cell fate in Arabidopsis an a feedback loop regulated by CLV3 activity	SCIENCE			English	Article							SHOOT APICAL MERISTEM; RECEPTOR-LIKE KINASE; GENE ENCODES; CLAVATA1; PROTEIN; THALIANA; WUSCHEL; PLANTS	The fate of stem cells in plant meristems is governed by directional signaling systems that are regulated by negative feedback. In Arabidopsis thaliana, the CLAVATA (CLV) genes encode the essential components of a negative, stem cell-restricting pathway. We used transgenic plants overexpressing CLV3 to show that meristem cell accumulation and fate depends directly on the Level of CLV3 activity and that CLV3 signaling occurs exclusively through a CLV1/ CLV2 receptor kinase complex. We also demonstrate that the CLV pathway acts by repressing the activity of the transcription factor WUSCHEL, an element of the positive, stem cell-promoting pathway.	Univ Cologne, Inst Entwicklungsbiol, D-50923 Cologne, Germany; CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	University of Cologne; California Institute of Technology	Simon, R (corresponding author), Univ Cologne, Inst Entwicklungsbiol, Gyrhofstr 17, D-50923 Cologne, Germany.	ruediger.simon@uni-koeln.de	Meyerowitz, Elliot M/A-7118-2009; Simon, Rudiger/T-6755-2018	Simon, Rudiger/0000-0002-1317-7716				BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BRAND U, UNPUB; CLARK SE, 1993, DEVELOPMENT, V119, P397; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Fletcher JC, 2000, CURR OPIN PLANT BIOL, V3, P23, DOI 10.1016/S1369-5266(99)00033-3; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Kayes JM, 1998, DEVELOPMENT, V125, P3843; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; Laux T, 1996, DEVELOPMENT, V122, P87; Lee I, 1997, CURR BIOL, V7, P95, DOI 10.1016/S0960-9822(06)00053-4; LEYSER HMO, 1992, DEVELOPMENT, V116, P397; Long JA, 1998, DEVELOPMENT, V125, P3027; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Meyerowitz EM, 1997, CELL, V88, P299, DOI 10.1016/S0092-8674(00)81868-1; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; Williams RW, 1997, P NATL ACAD SCI USA, V94, P10467, DOI 10.1073/pnas.94.19.10467; Yu LP, 2000, DEVELOPMENT, V127, P1661	21	796	855	52	509	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2000	289	5479					617	619		10.1126/science.289.5479.617	http://dx.doi.org/10.1126/science.289.5479.617			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915624				2022-12-28	WOS:000088447800053
J	Jubelt, B; Agre, JC				Jubelt, B; Agre, JC			Characteristics and management of postpolio syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PARALYTIC POLIOMYELITIS; LATE POLIO; SEQUELAE; INDIVIDUALS; SYMPTOMS; STRENGTH; POPULATION; ENDURANCE; EXERCISE; RECOVERY		SUNY Upstate Med Ctr, Dept Neurol, Syracuse, NY 13210 USA; Howard Young Med Ctr, Dept Physiatry, Woodruff, WI USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Jubelt, B (corresponding author), SUNY Upstate Med Ctr, Dept Neurol, 750 E Adams St, Syracuse, NY 13210 USA.	jubeltb@mail.upstate.edu						AGRE JC, 1995, SCAND J REHABIL MED, V27, P183; AGRE JC, 1989, ARCH PHYS MED REHAB, V70, P367; Agre JC, 1997, NEUROREHABILITATION, V8, P107, DOI 10.3233/NRE-1997-8205; Agre JC, 1997, ARCH PHYS MED REHAB, V78, P681, DOI 10.1016/S0003-9993(97)90073-3; AGRE JC, 1991, ARCH PHYS MED REHAB, V72, P971; Agre JC, 1998, AM J PHYS MED REHAB, V77, P140, DOI 10.1097/00002060-199803000-00009; BACH JR, 1995, ANN NY ACAD SCI, V753, P96, DOI 10.1111/j.1749-6632.1995.tb27535.x; BRUNO RL, 1998, AM J MED, V105, P665; CASHMAN NR, 1987, NEW ENGL J MED, V317, P7, DOI 10.1056/NEJM198707023170102; Dalakas MC, 1999, NEUROLOGY, V53, P1166, DOI 10.1212/WNL.53.6.1166; DALAKAS MC, 1986, NEW ENGL J MED, V314, P959, DOI 10.1056/NEJM198604103141505; Dean AC, 1998, ANN NEUROL, V43, P661, DOI 10.1002/ana.410430516; Ernstoff B, 1996, ARCH PHYS MED REHAB, V77, P843, DOI 10.1016/S0003-9993(96)90268-3; Grimby G, 1998, MUSCLE NERVE, V21, P1428, DOI 10.1002/(SICI)1097-4598(199811)21:11<1428::AID-MUS10>3.3.CO;2-D; Halstead L S, 1987, Birth Defects Orig Artic Ser, V23, P13; Hsu AA, 1998, MAYO CLIN PROC, V73, P216, DOI 10.4065/73.3.216; Ivanyi B, 1999, ARCH PHYS MED REHAB, V80, P687, DOI 10.1016/S0003-9993(99)90173-9; JUBELT B, 1995, ANN NY ACAD SCI, V753, P201, DOI 10.1111/j.1749-6632.1995.tb27546.x; Jubelt BB, 1999, LINCOLNSHIRE POSTPOL; Julien J, 1999, J NEUROL, V246, P472, DOI 10.1007/s004150050386; KLINGMAN J, 1988, ARCH NEUROL-CHICAGO, V45, P645, DOI 10.1001/archneur.1988.00520300065020; KRIZ JL, 1992, ARCH PHYS MED REHAB, V73, P49; McComas AJ, 1997, BRAIN, V120, P1415, DOI 10.1093/brain/120.8.1415; MULDER DW, 1972, MAYO CLIN PROC, V47, P756; PEACH PE, 1991, ORTHOPEDICS, V14, P1199; PERRY J, 1988, CLIN ORTHOP RELAT R, V233, P145; Prins JH, 1994, SPORTS MED TRAINING, V5, P29, DOI DOI 10.1080/15438629409511999; RAMLOW J, 1992, AM J EPIDEMIOL, V136, P769, DOI 10.1093/aje/136.7.769; Sharma N, 1998, J DENT RES, V77, P649; SILBERGLEIT AK, 1991, OTOLARYNG HEAD NECK, V104, P333, DOI 10.1177/019459989110400308; Trojan DA, 1999, NEUROLOGY, V53, P1225, DOI 10.1212/WNL.53.6.1225; WARING WP, 1989, ARCH PHYS MED REHAB, V70, P371; Willen C, 1998, ARCH PHYS MED REHAB, V79, P915, DOI 10.1016/S0003-9993(98)90087-9; WILLEN C, 1999, THESIS GOTEBORG U SW; WINDEBANK AJ, 1991, NEUROLOGY, V41, P501, DOI 10.1212/WNL.41.4.501	35	90	95	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					412	414		10.1001/jama.284.4.412	http://dx.doi.org/10.1001/jama.284.4.412			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904484				2022-12-28	WOS:000088254200002
J	Ahissar, E; Sosnik, R; Haidarliu, S				Ahissar, E; Sosnik, R; Haidarliu, S			Transformation from temporal to rate coding in a somatosensory thalamocortical pathway	NATURE			English	Article							POSTERIOR MEDIAL NUCLEUS; SOMATIC SENSORY RESPONSES; BARREL CORTEX; ANTEROGRADE TRACER; ROSTRAL SECTOR; GROUP POM; THALAMUS; NEURONS; ORGANIZATION; FIELD	The anatomical connections from the whiskers to the rodent somatosensory (barrel) cortex form two parallel (lemniscal and paralemniscal) pathways(1,2). It is unclear whether the paralemniscal pathway is directly involved in tactile processing, because paralemniscal neuronal responses show poor spatial resolution, labile latencies and strong dependence on cortical feedback(3-5). Here we show that the paralemniscal system can transform temporally encoded vibrissal information into a rate code. We recorded the representations of the frequency of whisker movement along the two pathways in anaesthetized rats. In response to varying stimulus frequencies, the lemniscal neurons exhibited amplitude modulations and constant latencies. In contrast, paralemniscal neurons in both thalamus and cortex coded the input frequency as changes in latency. Because the onset latencies increased and the offset latencies remained constant, the latency increments were translated into a rate code: increasing onset latencies led to lower spike counts. A thalamocortical loop that includes cortical oscillations and thalamic gating can account for these results. Thus, variable latencies and effective cortical feedback in the paralemniscal system can serve the processing of temporal sensory cues, such as those that encode object location during whisking. In contrast, fixed time locking in the lemniscal system is crucial for reliable spatial processing.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Ahissar, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	Ehud.Ahissar@weizmann.ac.il						Ahissar E, 1998, NEURAL COMPUT, V10, P597, DOI 10.1162/089976698300017683; Ahissar E, 1997, P NATL ACAD SCI USA, V94, P11633, DOI 10.1073/pnas.94.21.11633; BOURASSA J, 1995, EUR J NEUROSCI, V7, P19, DOI 10.1111/j.1460-9568.1995.tb01016.x; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; CARVELL GE, 1990, J NEUROSCI, V10, P2638; CHIAIA NL, 1991, J COMP NEUROL, V314, P217, DOI 10.1002/cne.903140203; CHMIELOWSKA J, 1989, J COMP NEUROL, V285, P325, DOI 10.1002/cne.902850304; Crabtree JW, 1998, NAT NEUROSCI, V1, P389, DOI 10.1038/1603; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; DIAMOND ME, 1992, J COMP NEUROL, V318, P462, DOI 10.1002/cne.903180410; DIAMOND ME, 1992, CONCEPT NEUROSCI, V3, P55; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Haidarliu S, 1999, J NEUROSCI METH, V94, P27, DOI 10.1016/S0165-0270(99)00123-5; Hartings JA, 1998, J NEUROPHYSIOL, V80, P1016, DOI 10.1152/jn.1998.80.2.1016; HOOGLAND PV, 1988, CELLULAR THALAMIC ME, P152; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; NICOLELIS MAL, 1994, J NEUROSCI, V14, P3511; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; SIMONS DJ, 1992, EXP BRAIN RES, V91, P259; SWADLOW HA, 1995, J NEUROPHYSIOL, V73, P1584, DOI 10.1152/jn.1995.73.4.1584; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; WHITE EL, 1987, J COMP NEUROL, V262, P13, DOI 10.1002/cne.902620103; WILLIAMS MN, 1994, EUR J NEUROSCI, V6, P429, DOI 10.1111/j.1460-9568.1994.tb00286.x; WOOLSEY TA, 1997, ENCY NEUROSCIENCE, P195; ZUCKER E, 1969, BRAIN RES, V12, P138, DOI 10.1016/0006-8993(69)90061-4	30	283	286	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					302	306		10.1038/35018568	http://dx.doi.org/10.1038/35018568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917531				2022-12-28	WOS:000088251900049
J	Smil, V				Smil, V			Jumbo	NATURE			English	Editorial Material									Univ Manitoba, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Smil, V (corresponding author), Univ Manitoba, Winnipeg, MB R3T 2N2, Canada.								0	3	3	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					239	239		10.1038/35018651	http://dx.doi.org/10.1038/35018651			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917507	Bronze			2022-12-28	WOS:000088251900025
J	Wang, LJ; Kuzmich, A; Dogariu, A				Wang, LJ; Kuzmich, A; Dogariu, A			Gain-assisted superluminal light propagation	NATURE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; PULSE-PROPAGATION; GROUP-VELOCITY; ATOMIC GAS; VAPOR; LASER	Einstein's theory of special relativity and the principle of causality(1-4) imply that the speed of any moving object cannot exceed that of light in a vacuum (c). Nevertheless, there exist various proposals(5-18) for observing faster-than-c propagation of light pulses, using anomalous dispersion near an absorption line(4,6-8), nonlinear(9) and linear gain lines(10-18), or tunnelling barriers(19). However, in all previous experimental demonstrations, the light pulses experienced either very large absorption(7) or severe reshaping(9,19), resulting in controversies over the interpretation. Here we use gain-assisted linear anomalous dispersion to demonstrate superluminal light propagation in atomic caesium gas. The group velocity of a laser pulse in this region exceeds c and can even become negative(16,17), while the shape of the pulse is preserved. We measure a group-velocity index of n(g) = -310(+/-5); in practice, this means that a light pulse propagating through the atomic vapour cell appears at the exit side so much earlier than if it had propagated the same distance in a vacuum that the peak of the pulse appears to leave the cell before entering it. The observed superluminal light pulse propagation is not at odds with causality, being a direct consequence of classical interference between its different frequency components in an anomalous dispersion region.	NEC Res Inst, Princeton, NJ 08540 USA	NEC Corporation	Wang, LJ (corresponding author), NEC Res Inst, 4 Independence Way, Princeton, NJ 08540 USA.							Akulshin AM, 1999, PHYS REV LETT, V83, P4277, DOI 10.1103/PhysRevLett.83.4277; BASOV NG, 1966, SOV PHYS JETP-USSR, V23, P16; BOLDA EL, 1994, PHYS REV A, V49, P2938, DOI 10.1103/PhysRevA.49.2938; BOLDA EL, 1993, PHYS REV A, V48, P3890, DOI 10.1103/PhysRevA.48.3890; Born M., 1997, PRINCIPLE OPTICS, VVolume 7, P360; Brillouin L., 1960, WAVE PROPAGATION GRO; Budker D, 1999, PHYS REV LETT, V83, P1767, DOI 10.1103/PhysRevLett.83.1767; CASPERSO.L, 1971, PHYS REV LETT, V26, P293, DOI 10.1103/PhysRevLett.26.293; CHIAO RY, 1996, AMAZING LIGHT VOLUME, P91; CHIAO RY, 1993, PHYS REV A, V48, P34; CHU S, 1982, PHYS REV LETT, V48, P738, DOI 10.1103/PhysRevLett.48.738; Einstein A., 1952, PRINCIPLE RELATIVITY; FISHER DL, 1993, PHYS REV LETT, V71, P4338, DOI 10.1103/PhysRevLett.71.4338; GARRETT CGB, 1970, PHYS REV A, V1, P305, DOI 10.1103/PhysRevA.1.305; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; ICSEVGI A, 1969, PHYS REV, V185, P517, DOI 10.1103/PhysRev.185.517; Kash MM, 1999, PHYS REV LETT, V82, P5229, DOI 10.1103/PhysRevLett.82.5229; Landau LD., 1984, ELECTRODYNAMICS CONT; Mitchell MW, 1998, AM J PHYS, V66, P14, DOI 10.1119/1.18813; PICHOLLE E, 1991, PHYS REV LETT, V66, P1454, DOI 10.1103/PhysRevLett.66.1454; Scully M.O., 1997, QUANTUM OPT; STEINBERG AM, 1994, PHYS REV A, V49, P2071, DOI 10.1103/PhysRevA.49.2071; STEINBERG AM, 1993, PHYS REV LETT, V71, P708, DOI 10.1103/PhysRevLett.71.708; XIAO M, 1995, PHYS REV LETT, V74, P666, DOI 10.1103/PhysRevLett.74.666	25	1157	1225	5	109	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					277	279		10.1038/35018520	http://dx.doi.org/10.1038/35018520			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917523				2022-12-28	WOS:000088251900041
J	Feng, DL; Lu, DH; Shen, KM; Kim, C; Eisaki, H; Damascelli, A; Yoshizaki, R; Shimoyama, J; Kishio, K; Gu, GD; Oh, S; Andrus, A; O'Donnell, J; Eckstein, JN; Shen, ZX				Feng, DL; Lu, DH; Shen, KM; Kim, C; Eisaki, H; Damascelli, A; Yoshizaki, R; Shimoyama, J; Kishio, K; Gu, GD; Oh, S; Andrus, A; O'Donnell, J; Eckstein, JN; Shen, ZX			Signature of superfluid density in the single-particle excitation spectrum of Bi2Sr2CaCu2O8+delta	SCIENCE			English	Article							T-C SUPERCONDUCTORS; ELECTRONIC-STRUCTURE; PENETRATION-DEPTH; DOPING DEPENDENCE; TEMPERATURE; PHASE; STATE; YBA2CU3O6.95; FLUCTUATIONS; SUPPRESSION	We report that the doping and temperature dependence of photoemission spectra near the Brillouin zone boundary of Bi2Sr2CaCu2O8+delta exhibit unexpected sensitivity to the superfluid density. In the superconducting state, the photoemission peak intensity as a function of doping scales with the superfluid density and the condensation energy. As a function of temperature, the peak intensity shows an abrupt behavior near the superconducting phase transition temperature where phase coherence sets in, rather than near the temperature where the gap opens. This anomalous manifestation of collective effects in single-particle spectroscopy raises important questions concerning the mechanism of high-temperature superconductivity.	Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Stanford Synchrotron Radiat Lab, Stanford, CA 94305 USA; Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 305, Japan; Univ Tokyo, Dept Appl Chem, Tokyo 1138656, Japan; Univ New S Wales, Sch Phys, Kensington, NSW 2033, Australia; Univ Illinois, Dept Phys, Urbana, IL 61801 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Tsukuba; University of Tokyo; University of New South Wales Sydney; University of Illinois System; University of Illinois Urbana-Champaign	Feng, DL (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.		Feng, Donglai/R-1615-2018; damascelli, andrea/P-6329-2014; Shen, Kyle/B-3693-2008; Eisaki, Hiroshi/F-6317-2018; Kishio, Kohji/AAL-2904-2020	Feng, Donglai/0000-0001-9370-5357; damascelli, andrea/0000-0001-9895-2226; Eisaki, Hiroshi/0000-0002-8299-6416; Kishio, Kohji/0000-0002-2759-8618				Abanov A, 1999, PHYS REV LETT, V83, P1652, DOI 10.1103/PhysRevLett.83.1652; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; BONN DA, 1994, PHYS REV B, V50, P4051, DOI 10.1103/PhysRevB.50.4051; Campuzano JC, 1999, PHYS REV LETT, V83, P3709, DOI 10.1103/PhysRevLett.83.3709; Corson J, 1999, NATURE, V398, P221, DOI 10.1038/18402; DESSAU DS, 1991, PHYS REV LETT, V66, P2160, DOI 10.1103/PhysRevLett.66.2160; Fedorov AV, 1999, PHYS REV LETT, V82, P2179, DOI 10.1103/PhysRevLett.82.2179; Franz M, 1998, PHYS REV B, V58, P14572, DOI 10.1103/PhysRevB.58.14572; Harris JM, 1997, PHYS REV LETT, V79, P143, DOI 10.1103/PhysRevLett.79.143; Hudson EW, 1999, SCIENCE, V285, P88, DOI 10.1126/science.285.5424.88; IOFFE LB, 1989, PHYS REV B, V39, P8988, DOI 10.1103/PhysRevB.39.8988; JACOBS T, 1995, PHYS REV LETT, V75, P4516, DOI 10.1103/PhysRevLett.75.4516; KIVELSON SA, 1987, PHYS REV B, V35, P8865, DOI 10.1103/PhysRevB.35.8865; KOTLIAR G, 1988, PHYS REV B, V38, P5142, DOI 10.1103/PhysRevB.38.5142; Lee DH, 2000, PHYS REV LETT, V84, P2694, DOI 10.1103/PhysRevLett.84.2694; Loeser AG, 1997, PHYS REV B, V56, P14185, DOI 10.1103/PhysRevB.56.14185; Marshall DS, 1996, PHYS REV LETT, V76, P4841, DOI 10.1103/PhysRevLett.76.4841; Millis AJ, 1999, NATURE, V398, P193, DOI 10.1038/18311; Norman MR, 1997, PHYS REV LETT, V79, P3506, DOI 10.1103/PhysRevLett.79.3506; PRESLAND MR, 1991, PHYSICA C, V176, P95, DOI 10.1016/0921-4534(91)90700-9; Sachdev S, 2000, SCIENCE, V288, P475, DOI 10.1126/science.288.5465.475; Salkola MI, 1996, PHYS REV LETT, V77, P155, DOI 10.1103/PhysRevLett.77.155; Shen ZX, 1997, PHYS REV LETT, V78, P1771, DOI 10.1103/PhysRevLett.78.1771; Sonier JE, 1999, PHYS REV LETT, V83, P4156, DOI 10.1103/PhysRevLett.83.4156; Tallon JL, 1999, PHYS STATUS SOLIDI B, V215, P531, DOI 10.1002/(SICI)1521-3951(199909)215:1<531::AID-PSSB531>3.0.CO;2-W; TANAMOTO T, 1992, J PHYS SOC JPN, V61, P1886, DOI 10.1143/JPSJ.61.1886; UEMURA YJ, 1991, PHYS REV LETT, V66, P2665, DOI 10.1103/PhysRevLett.66.2665; UEMURA YJ, 1995, P CCAST S HIGH TC SU, P113; Wen XG, 1996, PHYS REV LETT, V76, P503, DOI 10.1103/PhysRevLett.76.503; White PJ, 1996, PHYS REV B, V54, P15669, DOI 10.1103/PhysRevB.54.R15669; Zaanen J, 1999, SCIENCE, V286, P251, DOI 10.1126/science.286.5438.251; Zhou XJ, 1999, SCIENCE, V286, P268, DOI 10.1126/science.286.5438.268	33	227	229	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					277	281		10.1126/science.289.5477.277	http://dx.doi.org/10.1126/science.289.5477.277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894771	Green Submitted			2022-12-28	WOS:000088169400035
J	van der Fits, L; Memelink, J				van der Fits, L; Memelink, J			ORCA3, a jasmonate-responsive transcriptional regulator of plant primary and secondary metabolism	SCIENCE			English	Article							CATHARANTHUS-ROSEUS; ALKALOID BIOSYNTHESIS; GENE; ELEMENT; FAMILY; TISSUE; CELLS	Biosynthesis of many classes of secondary metabolites in plants is induced by the stress hormone jasmonate. The gene for ORCA3, a jasmonate-responsive APETALA2 (AP2)-domain transcription factor from Catharanthus roseus, was isolated by transferred DNA activation tagging. Orca3 overexpression resulted in enhanced expression of several metabolite biosynthetic genes and, consequently, in increased accumulation of terpenoid indole alkaloids, Regulation of metabolite biosynthetic genes by jasmonate-responsive AP2-domain transcription factors may link plant stress responses to changes in metabolism.	Leiden State Univ, Inst Mol Plant Sci, Clusius Lab, NL-2333 AL Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Memelink, J (corresponding author), Leiden State Univ, Inst Mol Plant Sci, Clusius Lab, Wassenaarseweg 64, NL-2333 AL Leiden, Netherlands.			Memelink, Johan/0000-0002-4767-506X				AERTS RJ, 1994, PLANT J, V5, P635, DOI 10.1111/j.1365-313X.1994.00635.x; Furini A, 1997, EMBO J, V16, P3599, DOI 10.1093/emboj/16.12.3599; GODDIJN OJM, 1993, PLANT MOL BIOL, V22, P907, DOI 10.1007/BF00027376; Kakimoto T, 1996, SCIENCE, V274, P982, DOI 10.1126/science.274.5289.982; KUTCHAN TM, 1995, PLANT CELL, V7, P1059, DOI 10.2307/3870057; Menke FLH, 1999, EMBO J, V18, P4455, DOI 10.1093/emboj/18.16.4455; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; NEUTEBOOM STC, 1993, PLANT J, V4, P525, DOI 10.1046/j.1365-313X.1993.04030525.x; Riechmann JL, 1998, BIOL CHEM, V379, P633; St-Pierre B, 1999, PLANT CELL, V11, P887, DOI 10.1105/tpc.11.5.887; vanderFits L, 1997, PLANT MOL BIOL, V33, P943, DOI 10.1023/A:1005763605355; Whitmer S, 1998, PLANT PHYSIOL, V116, P853, DOI 10.1104/pp.116.2.853; Zhao JM, 1996, PLANT CELL, V8, P2235, DOI 10.1105/tpc.8.12.2235	13	654	701	7	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					295	297		10.1126/science.289.5477.295	http://dx.doi.org/10.1126/science.289.5477.295			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894776				2022-12-28	WOS:000088169400040
J	Heath, RJ; Rock, CO				Heath, RJ; Rock, CO			Microbiology - A triclosan-resistant bacterial enzyme	NATURE			English	Article							ACYL CARRIER PROTEIN; FATTY-ACID ELONGATION; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; REDUCTASE FABI; TARGET; BIOSYNTHESIS		St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; Univ Tennessee, Dept Biochem, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Heath, RJ (corresponding author), St Jude Childrens Res Hosp, Dept Biochem, 332 N Lauderdale St, Memphis, TN 38105 USA.			Heath, Richard/0000-0002-1795-1254				Bhargava HN, 1996, AM J INFECT CONTROL, V24, P209, DOI 10.1016/S0196-6553(96)90017-6; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; Heath RJ, 1998, J BIOL CHEM, V273, P30316, DOI 10.1074/jbc.273.46.30316; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Hoang TT, 1999, J BACTERIOL, V181, P5489, DOI 10.1128/JB.181.17.5489-5497.1999; Levy CW, 1999, NATURE, V398, P383, DOI 10.1038/18803; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; ROCK CO, 1986, BIOCHIM BIOPHYS ACTA, V1302, P1; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Schweizer HP, 1998, ANTIMICROB AGENTS CH, V42, P394	12	247	275	2	41	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					145	146		10.1038/35018162	http://dx.doi.org/10.1038/35018162			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910344				2022-12-28	WOS:000088221100034
J	Rigotti, NA				Rigotti, NA			A 36-year-old woman who smokes cigarettes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUSTAINED-RELEASE BUPROPION; RANDOMIZED CONTROLLED TRIAL; NICOTINE NASAL SPRAY; DOUBLE-BLIND TRIAL; SMOKING CESSATION; COST-EFFECTIVENESS; HEART-DISEASE; WEIGHT-GAIN; RISK FACTOR; PATCH		Harvard Univ, Sch Med, Boston, MA USA; Massachusetts Gen Hosp, Dept Med, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Rigotti, NA (corresponding author), Care of Hartman EE, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave,LY318, Boston, MA 02215 USA.							[Anonymous], 1999, CURBING EPIDEMIC GOV; Ayanian JZ, 1999, JAMA-J AM MED ASSOC, V281, P1019, DOI 10.1001/jama.281.11.1019; Benowitz NL, 1997, J AM COLL CARDIOL, V29, P1422, DOI 10.1016/S0735-1097(97)00079-X; BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318; Blondal T, 1999, BRIT MED J, V318, P285, DOI 10.1136/bmj.318.7179.285; *CDCP, 1996, MMWR-MORBID MORTAL W, V45, P971; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P986; Centers for Disease Control and Prevention (CDC), 1999, MMWR-MORBID MORTAL W, V48, P993; CHRISTEN WG, 1992, JAMA-J AM MED ASSOC, V268, P989; COHEN S, 1993, AM J PUBLIC HEALTH, V83, P1277, DOI 10.2105/AJPH.83.9.1277; Colby SM, 1998, J CONSULT CLIN PSYCH, V66, P574, DOI 10.1037/0022-006X.66.3.574; Connolly G, 1998, CANCER, V83, P2722, DOI 10.1002/(SICI)1097-0142(19981215)83:12A+<2722::AID-CNCR12>3.0.CO;2-O; Covey LS, 2000, DRUGS, V59, P17, DOI 10.2165/00003495-200059010-00003; Cromwell J, 1997, JAMA-J AM MED ASSOC, V278, P1759, DOI 10.1001/jama.278.21.1759; Cruickshanks KJ, 1998, JAMA-J AM MED ASSOC, V279, P1715, DOI 10.1001/jama.279.21.1715; *CTR TOB PREV CONT, 2000, PHARM TREATM NIC DEP; CURRY SJ, 1997, ADDICT BEHAV, V22, P7727; Emery S, 2000, AM J PUBLIC HEALTH, V90, P387, DOI 10.2105/AJPH.90.3.387; Fiore MC, 1996, JAMA-J AM MED ASSOC, V275, P1270, DOI 10.1001/jama.1996.03530400058039; Fiore MC, 2000, JAMA-J AM MED ASSOC, V283, P3244; FIORE MC, 1994, JAMA-J AM MED ASSOC, V271, P1940, DOI 10.1001/jama.271.24.1940; FIORE MC, 2000, PHS DHHS AHRQ PUB; GLASSMAN AH, 1990, JAMA-J AM MED ASSOC, V264, P1546, DOI 10.1001/jama.264.12.1546; Haire-Joshu D, 1999, DIABETES CARE, V22, P1887, DOI 10.2337/diacare.22.11.1887; Hajek P, 1999, ARCH INTERN MED, V159, P2033, DOI 10.1001/archinte.159.17.2033; Hall SM, 1998, ARCH GEN PSYCHIAT, V55, P683, DOI 10.1001/archpsyc.55.8.683; HANKINSON SE, 1992, JAMA-J AM MED ASSOC, V268, P994, DOI 10.1001/jama.268.8.994; Hughes JR, 1999, JAMA-J AM MED ASSOC, V281, P72, DOI 10.1001/jama.281.1.72; Hurt RD, 2000, ARCH PEDIAT ADOL MED, V154, P31; Hurt RD, 1997, NEW ENGL J MED, V337, P1195, DOI 10.1056/NEJM199710233371703; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; JOSEPH A, 1996, NEW ENGL J MED, V335, P1790; KARK JD, 1982, NEW ENGL J MED, V307, P1042, DOI 10.1056/NEJM198210213071702; KAWACHI I, 1993, ANN INTERN MED, V119, P992, DOI 10.7326/0003-4819-119-10-199311150-00005; Kawachi I, 1996, AM J PUBLIC HEALTH, V86, P999, DOI 10.2105/AJPH.86.7.999; KORNITZER M, 1995, PREV MED, V24, P41, DOI 10.1006/pmed.1995.1006; LACROIX AZ, 1991, NEW ENGL J MED, V324, P1619, DOI 10.1056/NEJM199106063242303; LAM W, 1987, LANCET, V2, P27; Leischow SJ, 1996, AM J HEALTH BEHAV, V20, P364; Marcus BH, 1999, ARCH INTERN MED, V159, P1229, DOI 10.1001/archinte.159.11.1229; MATTSON ME, 1987, AM J PUBLIC HEALTH, V77, P425, DOI 10.2105/AJPH.77.4.425; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; Miller W, 2002, MOTIVATIONAL INTERVI, V2nd; PERKINS KA, 1997, J SUBST ABUSE TREAT, V14, P1; *PHS CDCP, 1994, PREV TOB US AYOUNG P; *PHS DHHS, 1989, PHS DHHS PUBL CDC; PROCHASKA JO, 1991, CLIN CHEST MED, V12, P727; Prochazka AV, 1998, ARCH INTERN MED, V158, P2035, DOI 10.1001/archinte.158.18.2035; PROCHAZKA AV, 1992, ARCH INTERN MED, V152, P2065, DOI 10.1001/archinte.152.10.2065; Rigotti NA, 1999, ARCH INTERN MED, V159, P1169, DOI 10.1001/archinte.159.11.1169; SCHNEIDER NG, 1995, ADDICTION, V90, P1671, DOI 10.1046/j.1360-0443.1995.901216719.x; Schneider NG, 1996, ADDICTION, V91, P1293; Smith TA, 1996, PEDIATRICS, V98, P659; SUTHERLAND G, 1992, LANCET, V340, P324, DOI 10.1016/0140-6736(92)91403-U; TONNESEN P, 1993, JAMA-J AM MED ASSOC, V269, P1268, DOI 10.1001/jama.269.10.1268; Tsoh JY, 2000, AM J PSYCHIAT, V157, P368, DOI 10.1176/appi.ajp.157.3.368; *US DEP HHS, 1990, US DEP HHS PUBL CDC; WAGNER EH, 1995, ARCH INTERN MED, V155, P1789, DOI 10.1001/archinte.155.16.1789; WARNER KE, 1987, JAMA-J AM MED ASSOC, V258, P2080, DOI 10.1001/jama.258.15.2080; Warner KE, 1997, PHARMACOECONOMICS, V11, P538, DOI 10.2165/00019053-199711060-00003; *WHO, 1999, MAK DIFF WORLD HLTH; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; Wilson K, 2000, ARCH INTERN MED, V160, P939, DOI 10.1001/archinte.160.7.939; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	64	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					741	749		10.1001/jama.284.6.741	http://dx.doi.org/10.1001/jama.284.6.741			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	341JM	10927784				2022-12-28	WOS:000088587300034
J	Hawkey, CJ				Hawkey, CJ			Outcomes studies of drug induced ulcer complications: do we need them and how should they be done?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PLACEBO-CONTROLLED TRIAL; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; GASTRIC-ULCER; MISOPROSTOL; CYCLOOXYGENASE-2; OSTEOARTHRITIS; PREVENTION; INHIBITOR		Univ Nottingham Hosp, Queens Med Ctr, Div Gastroenterol, Nottingham NG7 2UH, England	University of Nottingham	Hawkey, CJ (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Div Gastroenterol, Nottingham NG7 2UH, England.	cj.hawkey@nottingham.ac.uk						[Anonymous], 1986, LANCET, V2, P57; Boyce EG, 1999, FORMULARY, V34, P405; Chan FKL, 1998, GASTROENTEROLOGY, V114, pA87, DOI 10.1016/S0016-5085(98)80353-3; ELLIOTT SL, 1994, SCAND J RHEUMATOL, V23, P171, DOI 10.3109/03009749409103056; Emery P, 1999, LANCET, V354, P2106, DOI 10.1016/S0140-6736(99)02332-6; GOLDSTEIN JL, 1999, GASTROENTEROLOGY, V116, pA17; GRAHAM DY, 1988, LANCET, V2, P1277; GRAHAM DY, 1993, ANN INTERN MED, V119, P257, DOI 10.7326/0003-4819-119-4-199308150-00001; *GROUP ISIS 4, 1994, LANCET, V343, P115; Hawkey C, 1998, BRIT J RHEUMATOL, V37, P937; Hawkey C, 2000, ARTHRITIS RHEUM-US, V43, P370, DOI 10.1002/1529-0131(200002)43:2<370::AID-ANR17>3.0.CO;2-D; Hawkey CJ, 1998, NEW ENGL J MED, V338, P727, DOI 10.1056/NEJM199803123381105; HAWKEY CJ, 1990, BMJ-BRIT MED J, V300, P278, DOI 10.1136/bmj.300.6720.278; Hawkey CJ, 1997, ALIMENT PHARM THERAP, V11, P293, DOI 10.1046/j.1365-2036.1997.150326000.x; Hawkey CJ, 1999, LANCET, V353, P307, DOI 10.1016/S0140-6736(98)12154-2; KOCH M, 1995, DIGEST DIS, V13, P62, DOI 10.1159/000171527; Laine L, 1999, GASTROENTEROLOGY, V117, P776, DOI 10.1016/S0016-5085(99)70334-3; Langman MJ, 1999, JAMA-J AM MED ASSOC, V282, P1929, DOI 10.1001/jama.282.20.1929; Lanza FL, 1999, ALIMENT PHARM THERAP, V13, P761, DOI 10.1046/j.1365-2036.1999.00529.x; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Raskin JB, 1996, AM J GASTROENTEROL, V91, P223; Scott LJ, 1999, DRUGS, V58, P499, DOI 10.2165/00003495-199958030-00016; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Simon LS, 1998, ARTHRITIS RHEUM-US, V41, P1591, DOI 10.1002/1529-0131(199809)41:9<1591::AID-ART9>3.0.CO;2-J; Tramer MR, 2000, PAIN, V85, P169, DOI 10.1016/S0304-3959(99)00267-5; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; WIGHT NJ, 1999, GUT, V45, P30; Yeomans ND, 1998, NEW ENGL J MED, V338, P719, DOI 10.1056/NEJM199803123381104	28	13	13	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2000	321	7256					291	293		10.1136/bmj.321.7256.291	http://dx.doi.org/10.1136/bmj.321.7256.291			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915140	Green Published			2022-12-28	WOS:000088619800034
J	MacQueen, G; Santa-Barbara, J				MacQueen, G; Santa-Barbara, J			Conflict and health - Peace building through health initiatives	BRITISH MEDICAL JOURNAL			English	Article									McMaster Univ, Ctr Peace Studies, Dept Psychiat & Behav Neurosci, Hamilton, ON L8S 4K1, Canada; McMaster Univ, Ctr Peace Studies, Dept Religious Studies, Hamilton, ON L8S 4K1, Canada	McMaster University; McMaster University	Santa-Barbara, J (corresponding author), McMaster Univ, Ctr Peace Studies, Dept Psychiat & Behav Neurosci, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.							[Anonymous], 1976, EPIDEMICS; BEECHAM L, 2000, BRIT MED J, V320, P653; Bloom S., 1994, HIDDEN CASUALTIES EN; Bollet AJ, 1987, PLAGUES POXES RISE F; Bush K., 1998, 1 INT DEV RES CTR PE; CARTWIRGHT F, 1972, DIS HIST; Coupland Robin, 1997, SIRUS PROJECT DETERM; *CROAT MIN ED SPOR, 1998, SCH BAS HLTH PEAC IN; CULHANE C, 1972, WASTED NATIONS REPOR; Culhane Claire, 1972, WHY IS CANADA VIETNA; Elliot G., 1972, 20 CENTURY BOOK DEAD; Gallup G, 1997, GALLUP POLL PUBLIC O; Gutlove P., 1998, MED CONFLICT SURVIVA, V14, P6; HART B, TRAUMA HEALING RECON; HESS G, 1999, EURICPCORD030501 WHO; *INT STUD TEAM, 1991, HLTH WELF IR GULF CR; KAVOLIS V, 1993, MORALIZING CULTURES, pR8; LAPRISE AM, 1998, PROGRAMMING RESULTS; Lasswell H., 1927, PROPAGANDA TECHNIQUE; Levy Barry S, 1997, WAR PUBLIC HLTH; LIFTON R, 1986, NAZI DOCTROS MED KIL; LOWN B, 1995, JAMA-J AM MED ASSOC, V274, P418; MacQueen G., 1997, PEACE CHANGE, V22, P175, DOI [10.1111/0149-0508.451997011, DOI 10.1111/0149-0508.451997011]; MACRAE J, 1995, HLTH PEACE REHABILIT; Marmon L., 1994, MED GLOBAL SURVIVAL, V1, P234; McNeill William H, 1984, PLAGUES AND PEOPLE; PETERS M, 1997, HLTH PECE HDB; Rosenberg CE., 1992, EXPLAINING EPIDEMICS; SHARP G, 1973, POWER STRUGGLE POL 1, P68; Thornton R., 1987, AM INDIAN HOLOCAUST; WALKER J, 1993, ORPHANS STORM PEACEB; Woodside D, 1999, Med Confl Surviv, V15, P355, DOI 10.1080/13623699908409477; ZAROULIS N, 1984, WHO SPOKE UP AM PROT; Zinsser H, 1934, RATS LICE HIST; 1996, GALLUP POLL, V56, P26	35	60	60	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					293	296		10.1136/bmj.321.7256.293	http://dx.doi.org/10.1136/bmj.321.7256.293			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915141	Green Published			2022-12-28	WOS:000088619800035
J	Epstein, SS				Epstein, SS			The politics of cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Univ Illinois, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Epstein, SS (corresponding author), Univ Illinois, Chicago, IL 60680 USA.							Epstein Samuel, 1998, POLITICS CANC REVISI; EPSTEIN SS, 1993, AM J IND MED, V24, P109, DOI 10.1002/ajim.4700240111; Epstein SS, 1999, INT J HEALTH SERV, V29, P565, DOI 10.2190/LRDF-UX2C-WVAV-VPC6; FELLERS L, 1998, WASHINGTON POST 0531, P10; HALL H, 1992, CHRONICLE PHILA 0128, P26; MEYER RL, 2000, JAMA-J AM MED ASSOC, V283, P2304; PEAR R, 1998, NY TIMES        0103, pA8; Reynolds T, 2000, J NATL CANCER I, V92, P681, DOI 10.1093/jnci/92.9.681	8	0	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					442	+		10.1001/jama.284.4.442	http://dx.doi.org/10.1001/jama.284.4.442			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904504				2022-12-28	WOS:000088254200026
J	Payne, D				Payne, D			Ireland's measles outbreak kills two	BRITISH MEDICAL JOURNAL			English	News Item																		Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0	1	3	3	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 22	2000	321	7255					197	197						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903646				2022-12-28	WOS:000088448100017
J	Tepel, M; van der Giet, M; Schwarzfeld, C; Laufer, U; Liermann, D; Zidek, W				Tepel, M; van der Giet, M; Schwarzfeld, C; Laufer, U; Liermann, D; Zidek, W			Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACETYL-L-CYSTEINE; DIABETES-MELLITUS; RANDOMIZED TRIAL; FAILURE; MEDIA; NEPHROTOXICITY; INSUFFICIENCY; NEPHROPATHY; RISK; DOPAMINE	Background: Radiographic contrast agents can cause a reduction in renal function that may be due to reactive oxygen species. Whether the reduction can be prevented by the administration of antioxidants is unknown. Methods: We prospectively studied 83 patients with chronic renal insufficiency (mean [+/-SD] serum creatinine concentration, 2.4+/-1.3 mg per deciliter [216+/- 116 mu mol per liter]) who were undergoing computed tomography with iopromide, a nonionic, low-osmolality contrast agent. Patients were randomly assigned either to receive the antioxidant acetylcysteine (600 mg orally twice daily) and 0.45 percent saline intravenously, before and after administration of the contrast agent, or to receive placebo and saline. Results: Ten of the 83 patients (12 percent) had an increase of at least 0.5 mg per deciliter (44 mu mol per liter) in the serum creatinine concentration 48 hours after administration of the contrast agent: 1 of the 41 patients in the acetylcysteine group (2 percent) and 9 of the 42 patients in the control group (21 percent; P=0.01; relative risk, 0.1; 95 percent confidence interval, 0.02 to 0.9). In the acetylcysteine group, the mean serum creatinine concentration decreased significantly (P<0.001), from 2.5+/-1.3 to 2.1+/-1.3 mg per deciliter (220+/-118 to 186+/-112 mu mol per liter) 48 hours after the administration of the contrast medium, whereas in the control group, the mean serum creatinine concentration increased nonsignificantly (P=0.18), from 2.4+/-1.3 to 2.6+/-1.5 mg per deciliter (212+/-114 to 226+/-133 mu mol per liter) (P<0.001 for the comparison between groups). Conclusions: Prophylactic oral administration of the antioxidant acetylcysteine, along with hydration, prevents the reduction in renal function induced by iopromide, a nonionic, low-osmolality contrast agent, in patients with chronic renal insufficiency. (N Engl J Med 2000;343:180-4.) (C)2000, Massachusetts Medical Society.	Ruhr Univ Bochum, Univ Klin Marienhosp, Med Klin 1, D-44625 Herne, Germany; Ruhr Univ Bochum, Univ Klin Marienhosp, Radiol Klin, D-44625 Herne, Germany	Ruhr University Bochum; St. Marien Hospital; Ruhr University Bochum; St. Marien Hospital	Tepel, M (corresponding author), Ruhr Univ Bochum, Univ Klin Marienhosp, Med Klin 1, Holkeskampring 40, D-44625 Herne, Germany.	martin.tepel@ruhr-uni-bochum.de	Tepel, Martin/GRS-9581-2022	Tepel, Martin/0000-0002-0086-0997				BAKRIS GL, 1990, AM J PHYSIOL, V258, pF115, DOI 10.1152/ajprenal.1990.258.1.F115; Baliga R, 1997, AM J KIDNEY DIS, V29, P465, DOI 10.1016/S0272-6386(97)90212-2; BRADY HR, 1995, LANCET, V346, P1533, DOI 10.1016/S0140-6736(95)92057-9; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; DiMari J, 1997, AM J PHYSIOL-RENAL, V272, pF292, DOI 10.1152/ajprenal.1997.272.3.F292; EISENBERG RL, 1981, AM J ROENTGENOL, V136, P859, DOI 10.2214/ajr.136.5.859; ERLEY CM, 1994, KIDNEY INT, V45, P1425, DOI 10.1038/ki.1994.186; Hans SS, 1998, AM SURGEON, V64, P432; Holt S, 1999, LANCET, V353, P294, DOI 10.1016/S0140-6736(05)74933-3; JONES AL, 1994, GUT, V35, P1290, DOI 10.1136/gut.35.9.1290; Kapoor A, 1996, INT J CARDIOL, V53, P233, DOI 10.1016/0167-5273(95)02547-2; KATHOLI RE, 1993, RADIOLOGY, V186, P183, DOI 10.1148/radiology.186.1.8416561; Khachigian LM, 1997, AM J PATHOL, V151, P1225; Kurnik BRC, 1998, AM J KIDNEY DIS, V31, P674, DOI 10.1053/ajkd.1998.v31.pm9531185; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; PARVEZ Z, 1989, INVEST RADIOL, V24, P697, DOI 10.1097/00004424-198909000-00010; RICH MW, 1990, ARCH INTERN MED, V150, P1237, DOI 10.1001/archinte.150.6.1237; RUDNICK MR, 1995, KIDNEY INT, V47, P254, DOI 10.1038/ki.1995.32; Salom MG, 1998, TRANSPLANTATION, V65, P1315, DOI 10.1097/00007890-199805270-00006; SCHWAB SJ, 1989, NEW ENGL J MED, V320, P149, DOI 10.1056/NEJM198901193200304; SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104; Stevens NA, 1999, J AM COLL CARDIOL, V33, P403; VALE JA, 1995, LANCET, V346, P547, DOI 10.1016/S0140-6736(95)91385-8; WEISBERG LS, 1994, KIDNEY INT, V45, P259, DOI 10.1038/ki.1994.32; YOSHIOKA T, 1992, KIDNEY INT, V41, P1008, DOI 10.1038/ki.1992.153; ZHANG H, 1995, EUR SURG RES, V27, P292, DOI 10.1159/000129412	26	1075	1118	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2000	343	3					180	184		10.1056/NEJM200007203430304	http://dx.doi.org/10.1056/NEJM200007203430304			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335HY	10900277				2022-12-28	WOS:000088239100004
J	Ho, AM; Johnson, MD; Kingsley, DM				Ho, AM; Johnson, MD; Kingsley, DM			Role of the mouse ank gene in control of tissue calcification and arthritis	SCIENCE			English	Article							POSTERIOR LONGITUDINAL LIGAMENT; MURINE PROGRESSIVE ANKYLOSIS; OSTEO-ARTHRITIS; CHROMOSOME 5P; CHONDROCALCINOSIS; PYROPHOSPHATE; ASSOCIATION; DEPOSITION; CRYSTALS; OSTEOARTHRITIS	Mutation at the mouse progressive ankylosis (ank) locus causes a generalized, progressive form of arthritis accompanied by mineral deposition, formation of bony outgrowths, and joint destruction. Here, we show that the ank Locus encodes a multipass transmembrane protein (ANK) that is expressed in joints and other tissues and controls pyrophosphate levels in cultured cells. A highly conserved gene is present in humans and other vertebrates. These results identify ANK-mediated control of pyrophosphate levels as a possible mechanism regulating tissue calcification and susceptibility to arthritis in higher animals.	Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Sch Med, Beckman Ctr B300, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Kingsley, DM (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	kingsley@cmgm.stanford.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER; NIGMS NIH HHS [5T32GM07365] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrew LJ, 1999, AM J HUM GENET, V64, P136, DOI 10.1086/302186; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; CASWELL AM, 1991, CRIT REV CL LAB SCI, V28, P175, DOI 10.3109/10408369109106862; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Concoff A L, 1999, Curr Opin Rheumatol, V11, P436; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; DIEPPE P, 1985, CLIN RHEUM DIS, V11, P367; DOHERTY M, 1982, LANCET, V1, P1207; FELSON DT, 1989, J RHEUMATOL, V16, P1241; FLEISCH H, 1981, METAB BONE DIS RELAT, V3, P279, DOI 10.1016/0221-8747(81)90044-8; FLEISCH H, 1962, NATURE, V195, P911, DOI 10.1038/195911a0; FLEISCH H, 1965, NATURE, V207, P1300, DOI 10.1038/2071300b0; FLEISCH H, 1966, AM J PHYSIOL, V211, P821, DOI 10.1152/ajplegacy.1966.211.3.821; *GENB, AF001533 GENB; *GENB, AF001532 GENB; GIBILISCO PA, 1985, ARTHRITIS RHEUM, V28, P511, DOI 10.1002/art.1780280507; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GUGGINO SE, 1983, AM J PHYSIOL, V244, pF612, DOI 10.1152/ajprenal.1983.244.6.F612; HAKIM FT, 1984, ARTHRITIS RHEUM, V27, P1411, DOI 10.1002/art.1780271212; HAKIM FT, 1986, ARTHRITIS RHEUM, V29, P114, DOI 10.1002/art.1780290115; Helmick C G, 1995, Arthritis Care Res, V8, P203, DOI 10.1002/art.1790080403; HO AF, UNPUB, P42707; HUGHES AE, 1995, HUM MOL GENET, V4, P1225, DOI 10.1093/hmg/4.7.1225; KRUG HE, 1993, ARTHRITIS RHEUM, V36, P1603, DOI 10.1002/art.1780361116; Krug HE, 1997, J RHEUMATOL, V24, P115; LUST G, 1981, SCIENCE, V214, P809, DOI 10.1126/science.6270793; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; MAHOWALD ML, 1989, J RHEUMATOL, V16, P60; Nakamura I, 1999, HUM GENET, V104, P492, DOI 10.1007/s004390050993; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Rojas K, 1999, GENOMICS, V62, P177, DOI 10.1006/geno.1999.5997; ROSENTHAL AK, 1994, J RHEUMATOL, V21, P896; Ryan LM, 1999, RHEUM DIS CLIN N AM, V25, P257, DOI 10.1016/S0889-857X(05)70066-1; SAMPSON HW, 1988, SPINE, V13, P650; Spector TD, 1996, BRIT MED J, V312, P940; Storm EE, 1996, DEVELOPMENT, V122, P3969; SWAN A, 1994, ANN RHEUM DIS, V53, P467, DOI 10.1136/ard.53.7.467; SWEET HO, 1981, J HERED, V72, P87, DOI 10.1093/oxfordjournals.jhered.a109459; TEW WP, 1980, BIOCHEMISTRY-US, V19, P1983, DOI 10.1021/bi00550a039; White D. J., 1996, Journal of Clinical Dentistry, V7, P46; WORDSWORTH P, 1995, BRIT MED BULL, V51, P249, DOI 10.1093/oxfordjournals.bmb.a072959; YELIN E, 1995, ARTHRITIS RHEUM, V38, P1351, DOI 10.1002/art.1780381002	43	486	512	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2000	289	5477					265	270		10.1126/science.289.5477.265	http://dx.doi.org/10.1126/science.289.5477.265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894769				2022-12-28	WOS:000088169400033
J	DeParle, NA				DeParle, NA			Evaluation & management services guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									US Hlth Care Financing Adm, Baltimore, MD 21207 USA		DeParle, NA (corresponding author), US Hlth Care Financing Adm, Baltimore, MD 21207 USA.								0	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2000	283	23					3061	3061		10.1001/jama.283.23.3061	http://dx.doi.org/10.1001/jama.283.23.3061			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PV	10896530				2022-12-28	WOS:000087574900010
J	Egger, M; Pauw, J; Lopatatzidis, A; Medrano, D; Paccaud, F; Smith, GD				Egger, M; Pauw, J; Lopatatzidis, A; Medrano, D; Paccaud, F; Smith, GD			Promotion of condom use in a high-risk setting in Nicaragua: a randomised controlled trial	LANCET			English	Article							SEXUALLY-TRANSMITTED DISEASES; HUMAN-IMMUNODEFICIENCY-VIRUS; BEHAVIORAL INTERVENTIONS; AIDS-PREVENTION; INFECTION; MANAGUA; PEOPLE; WOMEN	Background In Latin America, motels rent rooms for commercial and non-commercial sex. We investigated the impact of providing health-education material and condoms on condom use in Managua, Nicaragua. Methods in a randomised controlled trial, in 19 motels, we gave condoms on request, made them available in rooms, or gave condoms directly to couples, with and without the presence of health-education material in the rooms. In a factorial design we assessed condom use directly by searching the rooms after couples had left. Findings 11 motels were used mainly by sex workers and their clients and eight mainly for non-commercial sex. 6463 couples attended the motels in 24 days. On 3106 (48.0%) occasions, at least one used condom was retrieved. Condom use was more frequent for commercial sex than for non-commercial sex (60.5 vs 20.2%). The presence of health-education material lowered the frequency of condom use for commercial sex (odds ratio 0.89 [95% CI 0.84-0.94]) and had no effect on use for non-commercial sex (1.03 [0.97-1.08]). Condom use increased for commercial [1.31 [1.09-1.75]) and noncommercial sex (1.81 (1.14-2.81) if condoms were available in rooms. Directly handing condoms to couples was similarly effective for commercial sex but less effective for non-commercial sex (1.32 [1.03-1.61] vs 1.52 (1.01-2.38]). Interpretation In Latin America, motels are key locations for promoting the use of condoms. Making condoms available in rooms is the most effective strategy to increase condom use, whereas use of health-education material was ineffective. These findings have important implications for HIV-prevention policies.	Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England; Salud Integrat Social TESIS, Trabajadores Educ, Managua, Nicaragua; Univ Lausanne, Dept Social & Prevent Med, Lausanne, Switzerland	University of Bristol; University of Lausanne	Egger, M (corresponding author), Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England.		paccaud, fred/M-7516-2019; Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Egger, Matthias/0000-0001-7462-5132				Angell M, 2000, NEW ENGL J MED, V342, P967, DOI 10.1056/NEJM200003303421309; Aral SO, 1998, LANCET, V351, P33; CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; Celentano DD, 2000, ARCH INTERN MED, V160, P535, DOI 10.1001/archinte.160.4.535; Celentano DD, 1998, SCIENCE, V280, P1889, DOI 10.1126/science.280.5371.1889; COYLE SL, 1991, EVALUATING AIDS PREV; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; Egger M, 1993, Bull Pan Am Health Organ, V27, P360; GORTER A, 1993, SOC SCI MED, V36, P1645, DOI 10.1016/0277-9536(93)90353-6; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Hart GJ, 1996, INT J STD AIDS, V7, P25, DOI 10.1258/0956462961917744; Herrmann B, 1996, GENITOURIN MED, V72, P20; HOLTGRAVE DR, 1995, PUBLIC HEALTH REP, V110, P134; *J HOPK SCH PUBL H, 1990, COND NOW MOR EV PO H; *JOINT UN PROGR HI, 1998, REP GLOB HIV AIDS EP; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; LOW N, 1993, INT J HEALTH SERV, V23, P685, DOI 10.2190/1P6N-BPDW-M7BM-P2DR; LOW N, 1992, Boletin de la Oficina Sanitaria Panamericana, V112, P319; OAKLEY A, 1995, BRIT MED J, V310, P158, DOI 10.1136/bmj.310.6973.158; OAKLEY A, 1995, AIDS, V9, P479, DOI 10.1097/00002030-199509050-00010; Pauw J, 1996, AIDS, V10, P537, DOI 10.1097/00002030-199605000-00014; Rasbash J., 1995, MLN COMMAND REFERENC; Rice N, 1996, J Health Serv Res Policy, V1, P154; Shain RN, 1999, NEW ENGL J MED, V340, P93, DOI 10.1056/NEJM199901143400203; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3	26	57	59	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2101	2105		10.1016/S0140-6736(00)02376-X	http://dx.doi.org/10.1016/S0140-6736(00)02376-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	325QD	10902623				2022-12-28	WOS:000087687100009
J	White, HD; Simes, RJ; Anderson, NE; Hankey, GJ; Watson, JDG; Hunt, D; Colquhoun, DM; Glasziou, P; MacMahon, S; Kirby, AC; West, MJ; Tonkin, AM				White, HD; Simes, RJ; Anderson, NE; Hankey, GJ; Watson, JDG; Hunt, D; Colquhoun, DM; Glasziou, P; MacMahon, S; Kirby, AC; West, MJ; Tonkin, AM			Pravastatin therapy and the risk of stroke.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AVERAGE CHOLESTEROL LEVELS; CORONARY HEART-DISEASE; CAROTID ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; REDUCTASE INHIBITORS; EVENTS; PREVENTION; ARTERY; TRIALS; PROGRESSION	Background: Several epidemiologic studies have concluded that there is no relation between total cholesterol levels and the risk of stroke. In some studies that classified strokes according to cause, there was an association between increasing cholesterol levels and the risk of ischemic stroke and a possible association between low cholesterol levels and the risk of hemorrhagic stroke. Recent reviews of trials of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors have suggested that these agents may reduce the risk of stroke. Methods: In a double-blind trial (the Long-Term Intervention with Pravastatin in Ischaemic Disease study), we compared the effects of pravastatin on mortality due to coronary heart disease (the primary end point) with the effects of placebo among 9014 patients with a history of myocardial infarction or unstable angina and a total cholesterol level of 155 to 271 mg per deciliter (4.0 to 7.0 mmol per liter). Our goal in the present study was to assess effects on stroke from any cause and nonhemorrhagic stroke, which were secondary end points. Results: There were 419 strokes among 373 patients over a follow-up period of six years. A total of 309 strokes were classified as ischemic, 31 as hemorrhagic, and 79 as of unknown type. Among the patients given placebo, the risk of stroke was 4.5 percent, as compared with 3.7 percent among those given pravastatin (relative reduction in risk, 19 percent; 95 percent confidence interval, 0 to 34 percent; P=0.05). Nonhemorrhagic stroke occurred in 4.4 percent of the patients given placebo, as compared with 3.4 percent of those given pravastatin (reduction in risk, 23 percent; 95 percent confidence interval, 5 to 38 percent; P=0.02). Pravastatin had no effect on hemorrhagic stroke (incidence, 0.2 percent in the placebo group vs. 0.4 percent in the pravastatin group; P=0.28). Conclusions: Pravastatin has a moderate effect in reducing the risk of stroke from any cause and the risk of nonhemorrhagic stroke in patients with previous myocardial infarction or unstable angina. (N Engl J Med 2000;343:317-26.) (C) 2000, Massachusetts Medical Society.	Green Lane Hosp, Dept Cardiol, Auckland 1030, New Zealand; Univ Auckland, Dept Med, Auckland, New Zealand; Univ Sydney, Natl Hlth & Med Res Council, Clin Trials Ctr, Sydney, NSW 2006, Australia; Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; Univ Sydney, Inst Int Hlth Res & Dev, Sydney, NSW 2006, Australia; Royal Perth Hosp, Stroke Unit, Perth, WA, Australia; Royal Melbourne Hosp, Dept Cardiac, Melbourne, Vic, Australia; Univ Queensland, Wesley Med Ctr, Brisbane, Qld, Australia; Univ Queensland, Mayne Med Sch, Dept Social & Prevent Med, Brisbane, Qld, Australia; Univ Queensland, Dept Med, Brisbane, Qld 4000, Australia; Natl Heart Fdn Australia, Melbourne, Vic, Australia	University of Auckland; University of Sydney; University of Sydney; University of Sydney; Royal Perth Hospital; University of Western Australia; Royal Melbourne Hospital; University of Queensland; Wesley Hospital; University of Queensland; University of Queensland	White, HD (corresponding author), Green Lane Hosp, Dept Cardiol, Private Bag 92 189, Auckland 1030, New Zealand.	harveyw@ahsl.co.nz	west, malcolm J/C-9425-2009; Colquhoun, David M/F-9078-2013; Glasziou, Paul/A-7832-2008; Hankey, Graeme J/H-4968-2014	west, malcolm J/0000-0002-7629-5277; Glasziou, Paul/0000-0001-7564-073X; Hankey, Graeme J/0000-0002-6044-7328; Watson, John/0000-0003-0988-2583; MacMahon, Stephen/0000-0003-2064-7699				*AM HEART ASS, 1997, HART STROK FACTS 1 S; ANDERSON TJ, 1995, NEW ENGL J MED, V332, P488, DOI 10.1056/NEJM199502233320802; [Anonymous], 1988, BRIT MED J, V296, P320; BLANKENHORN DH, 1993, CIRCULATION, V88, P20, DOI 10.1161/01.CIR.88.1.20; Blauw GJ, 1997, STROKE, V28, P946, DOI 10.1161/01.STR.28.5.946; Bucher HC, 1998, ANN INTERN MED, V128, P89, DOI 10.7326/0003-4819-128-2-199801150-00002; Carr S, 1996, J VASC SURG, V23, P755, DOI 10.1016/S0741-5214(96)70237-9; CARUZZO C, 1995, ANGIOLOGY, V46, P269, DOI 10.1177/000331979504600401; CHAMBERS BR, 1986, NEW ENGL J MED, V315, P860, DOI 10.1056/NEJM198610023151404; COX DR, 1972, J R STAT SOC B, V34, P187; CROUSE JR, 1995, AM J CARDIOL, V75, P455, DOI 10.1016/S0002-9149(99)80580-3; CROUSE JR, 1992, ANNU REV MED, V43, P301; CROUSE JR, 1995, AM J CARDIOL, V75, P862; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; FINEEDELSTEIN JS, 1994, NEUROLOGY, V44, P1046, DOI 10.1212/WNL.44.6.1046; FURBERG CD, 1994, CIRCULATION, V90, P1679, DOI 10.1161/01.CIR.90.4.1679; HANKEY GJ, 1991, BMJ-BRIT MED J, V302, P499, DOI 10.1136/bmj.302.6775.499; Hebert PR, 1997, JAMA-J AM MED ASSOC, V278, P313, DOI 10.1001/jama.278.4.313; HEBERT PR, 1995, ARCH INTERN MED, V155, P50, DOI 10.1001/archinte.155.1.50; Helgason CM, 1997, CIRCULATION, V96, P701; Hodis HN, 1996, ANN INTERN MED, V124, P548, DOI 10.7326/0003-4819-124-6-199603150-00002; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; JONES EF, 1995, STROKE, V26, P218; LACOSTE L, 1995, CIRCULATION, V92, P3172, DOI 10.1161/01.CIR.92.11.3172; Lee E, 2013, STAT METHODS SURVIVA; *LONG TERM INT PRA, 1995, AM J CARDIOL, V76, P474; MacMahon S, 1998, CIRCULATION, V97, P2479; Mercuri M, 1996, AM J MED, V101, P627, DOI 10.1016/S0002-9343(96)00333-6; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 1998, AM J CARDIOL, V81, P333, DOI 10.1016/S0002-9149(97)00904-1; Plehn JF, 1999, CIRCULATION, V99, P216, DOI 10.1161/01.CIR.99.2.216; Qizilbash N, 1995, LANCET, V346, P1647; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Rodgers A, 1998, LANCET, V352, P1801; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SALONEN R, 1995, CIRCULATION, V92, P1758, DOI 10.1161/01.CIR.92.7.1758; SHARRETT AR, 1994, ARTERIOSCLER THROMB, V14, P1098, DOI 10.1161/01.ATV.14.7.1098; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Taylor TN, 1996, STROKE, V27, P1459, DOI 10.1161/01.STR.27.9.1459; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; TREASURE CB, 1995, NEW ENGL J MED, V332, P481, DOI 10.1056/NEJM199502233320801; Williams JK, 1998, J AM COLL CARDIOL, V31, P684, DOI 10.1016/S0735-1097(97)00537-8	43	245	251	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2000	343	5					317	326		10.1056/NEJM200008033430502	http://dx.doi.org/10.1056/NEJM200008033430502			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340GR	10922421				2022-12-28	WOS:000088525200002
J	Noda, S; Tomoda, K; Yamamoto, N; Chutinan, A				Noda, S; Tomoda, K; Yamamoto, N; Chutinan, A			Full three-dimensional photonic bandgap crystals at near-infrared wavelengths	SCIENCE			English	Article							STRUCTURAL FLUCTUATIONS; WAVE-GUIDES; MU-M; FABRICATION; BENDS; LIGHT	An artificial crystal structure has been fabricated exhibiting a full three-dimensional photonic bandgap effect at optical communication wavelengths. The photonic crystal was constructed by stacking 0.7-micrometer period semiconductor stripes with the accuracy of 30 nanometers by advanced wafer-fusion technique. A bandgap effect of more than 40 decibels (which corresponds to 99.99% reflection) was successfully achieved. The result encourages us to create an ultra-small optical integrated circuit including a three-dimensional photonic crystal waveguide with a sharp bend.	Kyoto Univ, Dept Elect Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan; Minist Int Trade & Ind, Agcy Ind Sci & Technol, Electrotech Lab, Tsukuba, Ibaraki 3058568, Japan	Kyoto University; National Institute of Advanced Industrial Science & Technology (AIST)	Noda, S (corresponding author), Kyoto Univ, Dept Elect Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan.	snoda@kuee.kyoto-u.ac.jp	Yamamoto, Noritsugu/D-5315-2017	Yamamoto, Noritsugu/0000-0003-3701-7319				ArbetEngels V, 1996, NATO ADV SCI I E-APP, V324, P125; Astratov VN, 1995, NUOVO CIMENTO D, V17, P1349, DOI 10.1007/BF02457208; Chutinan A, 1999, J OPT SOC AM B, V16, P240, DOI 10.1364/JOSAB.16.000240; Chutinan A, 1999, J OPT SOC AM B, V16, P1398, DOI 10.1364/JOSAB.16.001398; Chutinan A, 1999, APPL PHYS LETT, V75, P3739, DOI 10.1063/1.125441; Fleming JG, 1999, OPT LETT, V24, P49, DOI 10.1364/OL.24.000049; HO KM, 1994, SOLID STATE COMMUN, V89, P413, DOI 10.1016/0038-1098(94)90202-X; Joannopoulos JD, 1997, NATURE, V386, P143, DOI 10.1038/386143a0; JOHN S, 1991, PHYS TODAY, V44, P32, DOI 10.1063/1.881300; Lin SY, 1998, NATURE, V394, P251, DOI 10.1038/28343; Mekis A, 1996, PHYS REV LETT, V77, P3787, DOI 10.1103/PhysRevLett.77.3787; Noda S, 1999, APPL PHYS LETT, V75, P905, DOI 10.1063/1.124549; YABLONOVITCH E, 1993, J OPT SOC AM B, V10, P283, DOI 10.1364/JOSAB.10.000283; Yamamoto N, 1998, JPN J APPL PHYS 2, V37, pL1052, DOI 10.1143/JJAP.37.L1052; YAMAMOTO N, 1998, P 10 INT C IND PHOSP	15	972	1012	9	306	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2000	289	5479					604	606		10.1126/science.289.5479.604	http://dx.doi.org/10.1126/science.289.5479.604			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915619				2022-12-28	WOS:000088447800048
J	Ruda, MA; Ling, QD; Hohmann, AG; Peng, YB; Tachibana, T				Ruda, MA; Ling, QD; Hohmann, AG; Peng, YB; Tachibana, T			Altered nociceptive neuronal circuits after neonatal peripheral inflammation	SCIENCE			English	Article							SCIATIC-NERVE AFFERENTS; PAIN RESPONSE; DORSAL HORN; ADULT-RAT; SENSITIVITY; TERMINALS; PRETERM; SECTION	Nociceptive neuronal circuits are formed during embryonic and postnatal times when painful stimuli are normally absent or Limited. Today, medical procedures for neonates with health risks can involve tissue injury and pain for which the Long-term effects are unknown. To investigate the impact of neonatal tissue injury and pain on development of nociceptive neuronal circuitry, we used an animal model of persistent hind paw peripheral inflammation, We found that, as adults, these animals exhibited spinal neuronal circuits with increased input and segmental changes in nociceptive primary afferent axons and altered responses to sensory stimulation.	Natl Inst Dent & Craniofacial Res, Cellular Neurosci Sect, Pain & Neurosensory Mechanisms Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ruda, MA (corresponding author), Natl Inst Dent & Craniofacial Res, Cellular Neurosci Sect, Pain & Neurosensory Mechanisms Branch, NIH, Bethesda, MD 20892 USA.			Peng, Yuan B/0000-0002-3124-859X				ABBOTT FV, 1995, PAIN, V60, P91, DOI 10.1016/0304-3959(94)00095-V; ANAND KJS, 1993, PAIN NEONATES, P1; BUCK SH, 1986, PHARMACOL REV, V38, P179; COLEMAN JR, 1990, DEV SENSORY SYSTEMS; CONSTANTINOU J, 1994, NEUROREPORT, V5, P2281, DOI 10.1097/00001756-199411000-00019; CRAIG KD, 1993, PAIN, V52, P287, DOI 10.1016/0304-3959(93)90162-I; Doubell TP, 1997, J COMP NEUROL, V380, P95, DOI 10.1002/(SICI)1096-9861(19970331)380:1<95::AID-CNE7>3.0.CO;2-O; FITZGERALD M, 1995, BRIT J ANAESTH, V75, P177, DOI 10.1093/bja/75.2.177; FITZGERALD M, 1983, NEUROSCI LETT, V43, P149, DOI 10.1016/0304-3940(83)90179-9; GRUNAU RVE, 1994, PAIN, V58, P341, DOI 10.1016/0304-3959(94)90128-7; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; LAMOTTE CC, 1991, J COMP NEUROL, V311, P546, DOI 10.1002/cne.903110409; MESULAM MM, 1978, J HISTOCHEM CYTOCHEM, V26, P106, DOI 10.1177/26.2.24068; SHORTLAND P, 1994, EUR J NEUROSCI, V6, P75, DOI 10.1111/j.1460-9568.1994.tb00249.x; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Taddio A, 1997, LANCET, V349, P599, DOI 10.1016/S0140-6736(96)10316-0	16	282	297	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2000	289	5479					628	630		10.1126/science.289.5479.628	http://dx.doi.org/10.1126/science.289.5479.628			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915627				2022-12-28	WOS:000088447800056
J	Labarrere, CA; Nelson, DR; Cox, CJ; Pitts, D; Kirlin, P; Halbrook, H				Labarrere, CA; Nelson, DR; Cox, CJ; Pitts, D; Kirlin, P; Halbrook, H			Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; PLASMINOGEN-ACTIVATOR INHIBITOR-1; KINASE ISOENZYME-MB; ALLOGRAFT-REJECTION; PROGNOSTIC VALUE; UNSTABLE ANGINA; NONINVASIVE MARKER; T LEVELS; INJURY; PREDICT	Context Previous studies have yielded conflicting data regarding whether a relationship exists between elevated cardiac troponin levels and acute allograft rejection in patients who have received heart transplants, Objective To determine whether cardiac troponin I levels after heart transplantation were associated with a procoagulant microvasculature and long-term allograft outcome. Design Prospective cohort study with a mean (SE) follow-up of 45.1 (2.5) months. Serum troponin I levels were measured 9.9 (0.2) times per patient during the first 12 months after heart transplantation. Setting Heart transplant center in the United States. Patients A total of 110 consecutive patients who received a heart transplant between 1989 and 1997 and survived at least 1 year after transplantation. Main Outcome Measures Histological and immunohistochemical biopsy findings, development of coronary artery disease (CAD), and graft failure in patients with vs without elevated serum cardiac troponin I levels. Results All recipients had elevated troponin I levels during the first month after transplantation. Troponin I levels remained persistently elevated during the first 12 months in 56 patients (51%) and became undetectable in 54 patients (49%). Persistently elevated troponin I levels were associated with increasing fibrin deposits in microvasculature and cardiomyocytes (P<.001). Patients with persistently elevated levels of troponin I had significantly increased risk for subsequent development of CAD (odds ratio [OR], 4.3, 95% confidence interval [CI], 1.8-10.1; P<.001) and graft failure (OR, 3.4; 95% CI, 1.2-9.7; P=.02), and also developed more severe CAD (OR, 4.2; 95% CI, 1.9-9.3; P<.001) and showed more disease progression (OR, 3.7; 95% CI, 1.3-10.4; P=.009). Conclusion In this study, elevated cardiac troponin I levels, which are considered to be a noninvasive surrogate marker of a procoagulant microvasculature, identified a subgroup of patients with high risk for developing CAD and graft failure after cardiac transplantation.	Clarian Hlth, Methodist Res Inst, Indianapolis, IN 46202 USA; Clarian Hlth, Transplant Ctr, Indianapolis, IN 46202 USA; Clarian Hlth, Dept Pathol, Indianapolis, IN 46202 USA; Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA	Indiana University System; Cleveland Clinic Foundation	Labarrere, CA (corresponding author), Clarian Hlth, Methodist Res Inst, 1812 N Capitol Ave, Indianapolis, IN 46202 USA.	Clabarrere@clarian.com		Nelson, David/0000-0002-3240-0725				ADAMS JE, 1994, NEW ENGL J MED, V330, P670, DOI 10.1056/NEJM199403103301003; ADAMS JE, 1993, CIRCULATION, V88, P101, DOI 10.1161/01.CIR.88.1.101; Alexis JD, 1998, J HEART LUNG TRANSPL, V17, P395; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Benza RL, 1998, CIRCULATION, V98, P2248, DOI 10.1161/01.CIR.98.21.2248; Billingham M E, 1990, J Heart Transplant, V9, P587; BODOR GS, 1992, CLIN CHEM, V38, P2203; Costanzo MR, 1998, J HEART LUNG TRANSPL, V17, P744; Dengler TJ, 1998, J AM COLL CARDIOL, V32, P405, DOI 10.1016/S0735-1097(98)00257-5; DONNELLY R, 1993, LANCET, V341, P410, DOI 10.1016/0140-6736(93)92996-7; Faulk WP, 1998, TRANSPLANTATION, V66, P1335, DOI 10.1097/00007890-199811270-00013; Fyfe B, 1996, CIRCULATION, V93, P1133, DOI 10.1161/01.CIR.93.6.1133; Gag SZ, 1996, J AM COLL CARDIOL, V28, P673, DOI 10.1016/0735-1097(96)00201-X; GERHARDT W, 1991, CLIN CHEM, V37, P1405; GRATTAN MT, 1989, JAMA-J AM MED ASSOC, V261, P3561, DOI 10.1001/jama.261.24.3561; Hamm CW, 1997, NEW ENGL J MED, V337, P1648, DOI 10.1056/NEJM199712043372302; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; HAMM CW, 1992, NEW ENGL J MED, V327, P146, DOI 10.1056/NEJM199207163270302; Heeschen C, 1999, LANCET, V354, P1757, DOI 10.1016/S0140-6736(99)10285-X; HOSSEINNIA M, 1993, LANCET, V341, P838, DOI 10.1016/0140-6736(93)90621-M; JOHNSON DE, 1989, J HEART TRANSPLANT, V8, P349; KATUS HA, 1991, CIRCULATION, V83, P902, DOI 10.1161/01.CIR.83.3.902; KATUS HA, 1991, BRIT HEART J, V65, P259; Labarrere CA, 1998, AM J MED, V105, P207, DOI 10.1016/S0002-9343(98)00246-0; Labarrere CA, 1999, CURR OPIN CARDIOL, V14, P133, DOI 10.1097/00001573-199903000-00010; LABARRERE CA, 1994, CIRCULATION, V89, P1599, DOI 10.1161/01.CIR.89.4.1599; LABARRERE CA, 1995, NEW ENGL J MED, V333, P1111, DOI 10.1056/NEJM199510263331704; Labarrere CA, 1997, JAMA-J AM MED ASSOC, V278, P1169, DOI 10.1001/jama.278.14.1169; Lindahl B, 1996, CIRCULATION, V93, P1651, DOI 10.1161/01.CIR.93.9.1651; Lipshultz SE, 1997, CIRCULATION, V96, P2641, DOI 10.1161/01.CIR.96.8.2641; Luscher MS, 1997, CIRCULATION, V96, P2578, DOI 10.1161/01.CIR.96.8.2578; MAIR J, 1993, LANCET, V341, P838, DOI 10.1016/0140-6736(93)90622-N; MILLER LW, 1995, TRANSPLANT REV, V9, P77; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; ONI AA, 1992, TRANSPLANTATION, V53, P1247, DOI 10.1097/00007890-199206000-00015; POBER JS, 1988, AM J PATHOL, V133, P426; RAVKILDE J, 1995, J AM COLL CARDIOL, V25, P574, DOI 10.1016/0735-1097(94)00430-X; RAVKILDE J, 1993, SCAND J CLIN LAB INV, V53, P677, DOI 10.3109/00365519309092571; TOPOL EJ, 1995, CIRCULATION, V92, P2333, DOI 10.1161/01.CIR.92.8.2333; Troponin T, 1991, LANCET, V338, P23; WALPOTH BH, 1995, TRANSPLANT P, V27, P2084; Wang CW, 1996, TRANSPLANTATION, V62, P1938, DOI 10.1097/00007890-199612270-00046; WU AHB, 1995, AM J CARDIOL, V76, P970, DOI 10.1016/S0002-9149(99)80274-4; ZIMMERMANN R, 1993, BRIT HEART J, V69, P395; Zund G, 1997, AM J PHYSIOL-CELL PH, V273, pC1571, DOI 10.1152/ajpcell.1997.273.5.C1571	45	77	80	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					457	464		10.1001/jama.284.4.457	http://dx.doi.org/10.1001/jama.284.4.457			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904509	Bronze			2022-12-28	WOS:000088254200032
J	Stotter, A; Bright, N; Silcocks, PB; Botha, JL				Stotter, A; Bright, N; Silcocks, PB; Botha, JL			Effect of improved data collection on breast cancer incidence and survival: reconciliation of a registry with a clinical database	BRITISH MEDICAL JOURNAL			English	Article									Glenfield Hosp NHS Trust, Leicester LE3 9QP, Leics, England; Weston Pk Hosp NHS Trust, Trent Canc Registry, Sheffield S10 2SJ, S Yorkshire, England	Weston Park Hospital	Stotter, A (corresponding author), Glenfield Hosp NHS Trust, Leicester LE3 9QP, Leics, England.							Coleman MP., 1999, CANC SURVIVAL TRENDS; COX DR, 1972, J R STAT SOC B, V34, P187; Office for National Statistics, 1998, CANC STAT REG CANC D; Quinn MJ, 1998, EUR J CANCER, V34, P2204, DOI 10.1016/S0959-8049(98)00323-2	4	18	18	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 22	2000	321	7255					214	214		10.1136/bmj.321.7255.214	http://dx.doi.org/10.1136/bmj.321.7255.214			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903654	Bronze, Green Published			2022-12-28	WOS:000088448100023
J	Frank, J; Agrawal, RK				Frank, J; Agrawal, RK			A ratchet-like inter-subunit reorganization of the ribosome during translocation	NATURE			English	Article							ESCHERICHIA-COLI RIBOSOME; ELONGATION-FACTOR-G; 70S RIBOSOME; CRYOELECTRON MICROSCOPY; ANGSTROM RESOLUTION; TRANSFER-RNAS; EF-TU; VISUALIZATION; MOVEMENT; PROTEIN	The ribosome is a macromolecular assembly that is responsible for protein biosynthesis following genetic instructions in all organisms. It is composed of two unequal subunits: the smaller subunit binds messenger RNA and the anticodon end of transfer RNAs, and helps to decode the mRNA; and the larger subunit interacts with the amino-acid-carrying end of tRNAs and catalyses the formation of the peptide bonds. After peptide-bond formation, elongation factor G (EF-G) binds to the ribosome, triggering the translocation of peptidyl-tRNA from its aminoacyl site to the peptidyl site, and movement of mRNA by one codon(1). Here we analyse three-dimensional cryo-electron microscopy maps of the Escherichia coli 70S ribosome in various functional states, and show that both EF-G binding and subsequent GTP hydrolysis lead to ratchet-like rotations of the small 30S subunit relative to the large 50S subunit. Furthermore, our finding indicates a two-step mechanism of translocation: first, relative rotation of the subunits and opening of the mRNA channel following binding of GTP to EF-G; and second, advance of the mRNA/(tRNA)(2) complex in the direction of the rotation of the 30S subunit, following GTP hydrolysis.	SUNY Albany, Howard Hughes Med Inst, Albany, NY 12201 USA; SUNY Albany, Wadsworth Ctr, Hlth Res Inc, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA	Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Health Research Inc; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Frank, J (corresponding author), SUNY Albany, Howard Hughes Med Inst, Empire State Plaza,POB 509, Albany, NY 12201 USA.							Agrawal RK, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P53; Agrawal RK, 1996, J BIOL CHEM, V271, P21285, DOI 10.1074/jbc.271.35.21285; Agrawal RK, 1999, INT J BIOCHEM CELL B, V31, P243, DOI 10.1016/S1357-2725(98)00149-6; Agrawal RK, 1996, SCIENCE, V271, P1000, DOI 10.1126/science.271.5251.1000; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; AGRAWAL RK, IN PRESS J CELL BIOL; BRETSCHER MS, 1968, NATURE, V218, P675, DOI 10.1038/218675a0; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Frank J, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P45; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Mueller F, 1997, J MOL BIOL, V271, P566, DOI 10.1006/jmbi.1997.1212; Newcomb LF, 1999, RNA, V5, P849, DOI 10.1017/S1355838299990192; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Porse BT, 1998, J MOL BIOL, V276, P391, DOI 10.1006/jmbi.1997.1541; POWERS T, 1994, TRENDS GENET, V10, P27, DOI 10.1016/0168-9525(94)90016-7; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; SERDYUK I, 1992, BIOCHIMIE, V74, P299, DOI 10.1016/0300-9084(92)90107-P; SPIRIN AS, 1969, COLD SPRING HARB SYM, V34, P197, DOI 10.1101/SQB.1969.034.01.026; SPIRIN AS, 1987, J MOL BIOL, V194, P119, DOI 10.1016/0022-2836(87)90720-0; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Wilson KS, 1998, CELL, V92, P337, DOI 10.1016/S0092-8674(00)80927-7; WOESE C, 1970, NATURE, V226, P817, DOI 10.1038/226817a0	31	648	663	0	46	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					318	322		10.1038/35018597	http://dx.doi.org/10.1038/35018597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917535				2022-12-28	WOS:000088251900053
J	Finlayson, B				Finlayson, B			Learning the hard way	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 15	2000	321	7254					185	185		10.1136/bmj.321.7254.185	http://dx.doi.org/10.1136/bmj.321.7254.185			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336MG	10894710	Green Published			2022-12-28	WOS:000088305700054
J	Dugan, B; Flemings, PB				Dugan, B; Flemings, PB			Overpressure and fluid flow in the New Jersey continental slope: Implications for slope failure and cold seeps	SCIENCE			English	Article							GULF-OF-MEXICO; COMPACTION DISEQUILIBRIUM; COMMUNITIES; SEDIMENTS; PATTERNS; BASIN	Miocene through Pleistocene sediments on the New Jersey continental slope (Ocean Drilling Program Site 1073) are undercompacted (porosity between 40 and 65%) to 640 meters below the sea floor, and this is interpreted to record fluid pressures that reach 95% of the lithostatic stress. A two-dimensional model, where rapid Pleistocene sedimentation loads permeable sandy silt of Miocene age, successfully predicts the observed pressures. The model describes how lateral pressure equilibration in permeable beds produces fluid pressures that approach the lithostatic stress where overburden is thin. This transfer of pressure may cause slope failure and drive cold seeps on passive margins around the world.	Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dugan, B (corresponding author), Penn State Univ, Dept Geosci, 503 Deike Bldg, University Pk, PA 16802 USA.		Flemings, Peter B/B-9676-2008; Dugan, Brandon/A-2651-2011	Dugan, Brandon/0000-0002-2555-6430				Athy LF., 1930, BULLET AM ASS PETROL, V14, P1; AUSTIN JA, 1998, P OCEAN DRILL PROG A, V174; BETHKE CM, 1986, J GEOPHYS RES-SOLID, V91, P6535, DOI 10.1029/JB091iB06p06535; BLUM P, 1996, P OCEAN DRILLING PRO, V150, P377, DOI DOI 10.2973/ODP.PROC.SR.150.028.1996; BREDEHOE.JD, 1968, GEOL SOC AM BULL, V79, P1097, DOI 10.1130/0016-7606(1968)79[1097:OTMOAF]2.0.CO;2; CRAIG RF, 1992, SOIL MECH, P83; DOMENICO PA, 1990, PHYSICAL CHEM HYDROG, P362; Driscoll NW, 2000, GEOLOGY, V28, P407; FERTL WH, 1976, ABNORMAL FORMATION P, pCH9; Gibson R. E., 1958, GEOTECHNIQUE, V8, P171, DOI DOI 10.1680/GEOT.1958.8.4.171; Gordon DS, 1998, BASIN RES, V10, P177, DOI 10.1046/j.1365-2117.1998.00052.x; HAMPSON JC, 1984, I1608 MIS US GEOL SU; HART BS, 1995, GEOLOGY, V23, P45, DOI 10.1130/0091-7613(1995)023<0045:PAPROC>2.3.CO;2; HUBBERT MK, 1959, GEOL SOC AM BULL, V70, P115; JOHNSON D, 1967, ORIGIN SUBMARINE CAN, pCH4; Kooi H, 1997, BASIN RES, V9, P227, DOI 10.1046/j.1365-2117.1997.00042.x; KOPPULA SD, 1982, CAN GEOTECH J, V19, P260, DOI 10.1139/t82-033; LAMBE TW, 1979, SOIL MECH SI VERSION, P321; LI YH, 1974, GEOCHIM COSMOCHIM AC, V38, P703; MacDonald IR, 1996, AAPG MEMOIR, V66, P27; MACDONALD IR, 1990, GEO-MAR LETT, V10, P244, DOI 10.1007/BF02431071; MCGREGOR B, 1982, GEOLOGY, V10, P27, DOI 10.1130/0091-7613(1982)10<27:WSCAMF>2.0.CO;2; MOUNTAIN GS, 1994, P OCEAN DRILL PROG I, V150; NEUZIL CE, 1994, WATER RESOUR RES, V30, P145, DOI 10.1029/93WR02930; Olu K, 1997, DEEP-SEA RES PT I, V44, P811, DOI 10.1016/S0967-0637(96)00123-9; PAULL CK, 1984, SCIENCE, V226, P965, DOI 10.1126/science.226.4677.965; Pratson LF, 1996, GEOL SOC AM BULL, V108, P225, DOI 10.1130/0016-7606(1996)108<0225:AMFTHE>2.3.CO;2; Revil A, 1998, GEOPHYS RES LETT, V25, P389, DOI 10.1029/97GL03775; ROBB JM, 1981, SCIENCE, V211, P935, DOI 10.1126/science.211.4485.935; ROBB JM, 1990, GROUNDWATER GEOMORPH, pCH12; RONA P, 2000, 35 ANN M NE SECT GEO; Rona P. A., 1969, AAPG BULL, V53, P1453; RONA PA, 1967, J GEOPHYS RES, V72, P2107, DOI 10.1029/JZ072i008p02107; RUBEY WW, 1959, GEOL SOC AM BULL, V70, P167, DOI 10.1130/0016-7606(1959)70[167:ROFPIM]2.0.CO;2; SHEPARD FP, 1981, AAPG BULL, V65, P1062; STRACK ODL, 1989, GROUNDWATER MECH, P10; TERZAGHI K, 1943, THEORETICAL SOIL MEC, pCH9	37	218	226	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					288	291		10.1126/science.289.5477.288	http://dx.doi.org/10.1126/science.289.5477.288			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894774				2022-12-28	WOS:000088169400038
J	Feenstra, P				Feenstra, P			Strengths and weaknesses of leprosy-elimination campaigns	LANCET			English	Editorial Material									Royal Trop Inst, Dept Hlth, NL-1092 AD Amsterdam, Netherlands		Feenstra, P (corresponding author), Royal Trop Inst, Dept Hlth, NL-1092 AD Amsterdam, Netherlands.							Croft R, 1999, LEPROSY REV, V70, P428; Croft RP, 2000, LANCET, V355, P1603, DOI 10.1016/S0140-6736(00)02216-9; Dharmshaktu NS, 1999, LEPROSY REV, V70, P430; Patnaik PKB, 1999, LEPROSY REV, V70, P440; Smith WCS, 1999, LEPROSY REV, V70, P498; Sofola O, 1999, LEPROSY REV, V70, P465; van Beers SM, 1999, INT J LEPROSY, V67, P119; vanBeers SM, 1996, FEMS MICROBIOL LETT, V136, P221, DOI 10.1016/0378-1097(95)00505-6; *WHO, 1999, LEPROSY REV, V70, P404; *WHO, 1999, WHOLEP991; *WHO, 1999, LEPROSY REV, V70, P408; World Health Organization, 1998, WEEKLY EPIDEMIOLOGIC, V73, P177	12	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2089	2090		10.1016/S0140-6736(00)02370-9	http://dx.doi.org/10.1016/S0140-6736(00)02370-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902617				2022-12-28	WOS:000087687100003
J	Wood, E; Braitstein, P; Montaner, JSG; Schechter, MT; Tyndall, MW; O'Shaughnessy, MV; Hogg, RS				Wood, E; Braitstein, P; Montaner, JSG; Schechter, MT; Tyndall, MW; O'Shaughnessy, MV; Hogg, RS			Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa	LANCET			English	Article							TO-CHILD TRANSMISSION; COST-EFFECTIVENESS; VERTICAL TRANSMISSION; RANDOMIZED TRIAL; ORAL ZIDOVUDINE; COTE-DIVOIRE; NEVIRAPINE; THERAPY; HIV; PREVENTION	Background Despite growing international pressure to provide HIV-1 treatment to less-developed countries, potential demographic and epidemiological impacts have yet to be characterised. We modelled the future impact of antiretroviral use in South Africa from 2000 to 2005. Methods We produced a population projection model that assumed zero antiretroviral use to estimate the future demographic impacts of the HIV-1 epidemic. We also constructed four antiretroviral-adjusted scenarios to estimate the potential effect of antiretroviral use. We modelled total drug cost, cost per life-year gained, and the proportion of per-person health-care expenditure required to finance antiretroviral treatment in each scenario. Findings With no antiretroviral use between 2000 and 2005, there will be about 276 000 cumulative HIV-1-positive births, 2 302 000 cumulative new AIDS cases, and the life expectancy at birth will be 46.6 years by 2005. By contrast, 110 000 HIV-1-positive births could be prevented by short-course antiretroviral prophylaxis, as well as a decline of up to 1 year of life expectancy. The direct drug costs of universal coverage for this intervention would be US$54 million-less than 0.001% of the per-person health-care expenditure. In comparison, triple-combination treatment for 25% of the HIV-1-positive population could prevent a 3.1-year decline in life expectancy and more than 430 000 incident AIDS cases. The drug costs of this intervention would, however, be more than $19 billion at present prices, and would require 12.5% of the country's per-person healthcare expenditure. Interpretation Although there are barriers to widespread HIV-1 treatment, limited use of antiretrovirals could have an immediate and substantial impact on South Africa's AIDS epidemic.	St Pauls Hosp, British Columbia Excellence HIV AIDS, Vancouver, BC V6Z 1YG, Canada; Univ British Columbia, Dept Hlth Care & Epidemiol, Vancouver, BC V6T 1W5, Canada; Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1W5, Canada; Univ British Columbia, Dept Med, Vancouver, BC V6T 1W5, Canada	St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia; University of British Columbia	Hogg, RS (corresponding author), BC Ctr Excellence HIV AIDS, Div Epidemiol & Publ Hlth, Vancouver, BC V6Z 1Y6, Canada.	bobhogg@hivnet.ubc.ca	Montaner, Julio/K-7621-2012; Hogg, Robert S/B-2783-2012	Hogg, Robert S/0000-0003-3463-5488; Schechter, Martin/0000-0001-6063-2155; Tyndall, Mark/0000-0003-4450-5679				Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Campa AM, 1999, LANCET, V354, P1817, DOI 10.1016/S0140-6736(05)70582-1; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Gallant JE, 2000, JAMA-J AM MED ASSOC, V283, P1329, DOI 10.1001/jama.283.10.1329; Gilson L, 1997, LANCET, V350, P1805, DOI 10.1016/S0140-6736(97)08222-6; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hogg RS, 1998, AIDS, V12, P2203, DOI 10.1097/00002030-199816000-00016; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Hogg RS, 1998, AIDS, V12, P279, DOI 10.1097/00002030-199803000-00005; Hogg RS, 1996, AIDS, V10, P889, DOI 10.1097/00002030-199607000-00012; *IAS, 1999, AIDS, V13, P5; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; Marseille E, 1998, AIDS, V12, P939, DOI 10.1097/00002030-199808000-00017; Marseille E, 1999, LANCET, V354, P1818, DOI 10.1016/S0140-6736(05)70584-5; MCINTYRE JA, 1998, INT C AIDS, V12, P406; Mirochnick M, 1998, J INFECT DIS, V178, P368, DOI 10.1086/515641; Musoke P, 1999, AIDS, V13, P479, DOI 10.1097/00002030-199903110-00006; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Phair JP, 1999, J INFECT DIS, V179, pS384, DOI 10.1086/513839; Pollard RB, 1998, CLIN THER, V20, P1071, DOI 10.1016/S0149-2918(98)80105-7; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; SABA J, 1999, 2 C GLOB STRAT PREV; Soderlund N, 1999, BRIT MED J, V318, P1650, DOI 10.1136/bmj.318.7199.1650; Stover J, 1998, AIDS, V12, pS29; U.S. Bureau of the Census, 1999, WP98 US BUR CENS, P9; *UN SECR, 1999, DEM IMP HIV AIDS REP; *UNAIDS WHO, 1998, GUID MOD ANT TREATM, P40; *US BUR CENS, 1999, POP DIV INT DAT; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9; Wilfert CM, 1999, LANCET, V353, P832, DOI 10.1016/S0140-6736(98)10414-2; Wood E, 2000, AIDS, V14, P1229, DOI 10.1097/00002030-200006160-00021; Wood E, 2000, CAN J PUBLIC HEALTH, V91, P125, DOI 10.1007/BF03404927; *WORLD BANK, 2000, WORLD DEV IND 2000; 2000, SUNDAY TIMES S  0409	37	57	57	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2000	355	9221					2095	2100		10.1016/S0140-6736(00)02375-8	http://dx.doi.org/10.1016/S0140-6736(00)02375-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902622				2022-12-28	WOS:000087687100008
J	Seet, B; Burnham, GM				Seet, B; Burnham, GM			Fatality trends in United Nations peacekeeping operations, 1948-1998	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context The rising number of deaths among United Nations (UN) peacekeeping forces after the Cold War has made some troop-contributing countries hesitant to participate in peacekeeping operations. While the number and scale of missions have increased, no data have demonstrated a parallel increase in risks to peacekeepers. Objective To determine the association of characteristics of UN peacekeeping operations with risks and mortality rates among UN peacekeeping forces in both the Cold War and post-Cold War periods. Design, Setting, and Participants Descriptive analysis of 1559 personnel deaths during 49 UN peacekeeping missions from 1948-1998 based on the casualty database maintained by Department of Peacekeeping Operations, UN Headquarters. Main Outcome Measures Number and percentage of deaths by circumstance, total crude death rate, and crude death rate and relative risk of death by circumstance (hostile acts, unintentional violence, and illness or other causes) and time period (Cold War vs post-Cold War), geographic region, and nature of peacekeeping response; and regression analysis of mission variables (strength, duration, and humanitarian mandate) associated with total number of deaths. Results More deaths have occurred among UN peacekeeping forces in the past decade alone than in the previous 40 years of UN peacekeeping (807 vs 752), but crude death rates did not differ significantly by time period (Cold War vs post-Cold War, 21.8 vs 21.2 deaths per 10 000 person-years; P = .58), level of peacekeeping response, or for geographic regions other than East Europe and Central America, where rates were lower (P < .001 for both regions). Unintentional violence accounted for 41.2% of deaths, followed by hostile acts (36.1%), and illness or other causes (22.7%). Deaths from hostile acts increased after the Cold War (relative risk [RR] 1.51; 95% confidence interval [CI], 1.22-1.88), while rates for deaths caused by unintentional violence decreased (RR, 0.79; 95% CI, 0.67-0.94) but remain high, particularly in the Middle East and Asia (RR, 1.39; 95% CI, 1.15-1.69). Regression analysis showed a significant association between number of deaths and the strength (P < .001) and duration (P < .001) of a peacekeeping mission. Conclusion The increase in number of deaths among UN peacekeeping personnel since 1990 can be attributed to the increased number and scale of missions after the Cold War rather than increased RR of death. Post-Cold War peacekeeping personnel have a higher risk of dying from hostile acts in missions where more force is required. In missions providing or facilitating humanitarian assistance, both the RR of deaths from all causes and deaths from hostile acts are increased.	Johns Hopkins Univ, Sch Hyg & Publ Hlth, Ctr Refugee & Disaster Studies, Baltimore, MD 21205 USA; UN, Dept Peacekeeping Operat, Med Support Unit, New York, NY USA	Johns Hopkins University	Burnham, GM (corresponding author), Johns Hopkins Univ, Sch Hyg & Publ Hlth, Ctr Refugee & Disaster Studies, 615 N Wolfe St, Baltimore, MD 21205 USA.							ANNAN K, 1998, HARD CHOICES MORAL D, P55; ARMENIAN HK, 1986, AM J EPIDEMIOL, V124, P28, DOI 10.1093/oxfordjournals.aje.a114367; BAKER JH, 1994, PARAMETERS, V24, P13; Boutros-Ghali Boutros, 1992, AGENDA PEACE; BRATT D, 1996, INT PEACEKEEPING, V4, P64; BURKLE FM, 1995, PREHOSP DISASTER MED, V10, P55; DENNEHY EJ, 1993, BLUE HELMET COMBAT F; *DEP PEAC OP, 1997, BLUE HELM REV UN PEA; *DEP PUBL INF, 1997, CHART UN; FRAME JD, 1992, AM J TROP MED HYG, V46, P686, DOI 10.4269/ajtmh.1992.46.686; GARFIELD RM, 1991, JAMA-J AM MED ASSOC, V266, P688, DOI 10.1001/jama.266.5.688; GOULDING M, 1996, INT PEACEKEEPING, V3, P1; James Alan, 1994, INT PEACEKEEPING, V1, P44; KATZ LM, 1993, USA TODAY       0201, pA11; LEWIS P, 1988, NY TIMES        1211, pA4; MACKINLAY J, 1996, GUIDE PEACE SUPPORT; McClure Robert L., 1999, US ARMY WAR COLL Q, VXXIX, P96; SCHOUTEN EJ, 1995, BRIT MED J, V311, P1342; Seet B, 1999, MIL MED, V164, P451, DOI 10.1093/milmed/164.7.451; SHEIK M, IN PRESS BMJ; SLIM H, 1999, J HUMANITARIAN ASSIS; Szayna T. S., 1996, INT PEACEKEEPING, V3, P77; *UN DEP PEAC OP, 1998, MULT PEAC LESS REC E; *UN DEP PEAC OP, 1999, MED SUPP MAN UN PEAC; *UN DEP PEAC OP, 2000, UN PEAC OP; URQUHART B, 1988, WASHINGTON POST 1210, pA27; Wentges J Taylor., 1998, INT PEACEKEEPING, V5, P58, DOI [10.1080/13533319808413731., DOI 10.1080/13533319808413731]; 1999, LANCET, V354, P609	28	25	25	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2000	284	5					598	603		10.1001/jama.284.5.598	http://dx.doi.org/10.1001/jama.284.5.598			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	337WG	10918706				2022-12-28	WOS:000088385400029
J	Forsen, T; Eriksson, J; Tuomilehto, J; Reunanen, A; Osmond, C; Barker, D				Forsen, T; Eriksson, J; Tuomilehto, J; Reunanen, A; Osmond, C; Barker, D			The fetal and childhood growth of persons who develop type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; CORONARY HEART-DISEASE; LOW-BIRTH-WEIGHT; INSULIN-RESISTANCE; FAMILY HISTORY; MELLITUS; OBESITY; MEN; PREGNANCY; WOMEN	Background: Type 2 diabetes is associated with low birthweight followed by obesity in adulthood. Persons who develop the disease may therefore have a particular pattern of growth from birth through childhood. Objective: To examine the relation of type 2 diabetes to size at birth and childhood growth. Design: Cohort study. Setting: Helsinki, Finland. Participants: Men (n = 3639) and women (n = 3447) who were born at the Helsinki University Central Hospital between 1924 and 1933, who went to school in Helsinki, and who still lived in Finland in 1971. Detailed birth and school health records were available for all 7086 participants. We identified 471 men and women who developed type 2 diabetes by using the national Social Insurance Institution's register of all persons in Finland who are receiving long-term therapy with medication. Measurements: Incidence of diabetes ascertained from a national register. The main explanatory measurements were size at birth and childhood growth in terms of height, weight, and body mass index. Results: The cumulative incidence of type 2 diabetes was 7.9% (n = 286) in men and 5.4% (n = 185) In women. The incidence increased with decreasing birthweight, birth length, ponderal index (birthweight/length(3)), and placental weight. The odds ratio for type 2 diabetes was 1.38 (95% CI, 1.15 to 1.66; P < 0.001) for each l-kg decrease in birthweight. The mean weights and heights of the children at 7 years of age who later developed type 2 diabetes were about average. Thereafter, their growth in weight and height;was accelerated until 15 years of age. The odds ratio for development of type 2 diabetes was 1.39 (CI, 1.21 to 1.61; P < 0.001) for each standard deviation Increase in weight between 7 and 15 years of age. The odds ratio became 1.83 (CI, 1.37 to 2.45; P < 0.001) in an analysis restricted to persons whose birthweights were below 3000 g. Children of both sexes whose mothers had a high body mass index in pregnancy had more rapid growth during childhood and an increased incidence of type 2 diabetes. Conclusions: These findings are consistent with the hypothesis that type 2 diabetes is programmed In utero in association with low rates of fetal growth. The increased risk for type 2 diabetes associated with small size at birth is further increased by high growth rates after 7 years of age.	Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FIN-00300 Helsinki, Finland; Dept Hlth & Disabil, Helsinki, Finland; Univ Southampton, Southampton Gen Hosp, Southampton, Hants, England	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Southampton	Eriksson, J (corresponding author), Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Mannerheimintie 166, FIN-00300 Helsinki, Finland.			Osmond, Clive/0000-0002-9054-4655				BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Barker DJP, 1998, MOTHERS BABIES HLTH; Bavdekar A, 1999, DIABETES, V48, P2422, DOI 10.2337/diabetes.48.12.2422; Carlsson S, 1999, DIABETES CARE, V22, P1043, DOI 10.2337/diacare.22.7.1043; CARMELLI D, 1994, AM J HUM GENET, V55, P566; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Elbein SC, 1997, J NUTR, V127, pS1891, DOI 10.1093/jn/127.9.1891S; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Fall CHD, 1998, DIABETIC MED, V15, P220, DOI 10.1002/(SICI)1096-9136(199803)15:3<220::AID-DIA544>3.0.CO;2-O; Flanagan DE, 2000, AM J PHYSIOL-ENDOC M, V278, pE700, DOI 10.1152/ajpendo.2000.278.4.E700; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Forsen T, 1997, BRIT MED J, V315, P837, DOI 10.1136/bmj.315.7112.837; GUILLAUME M, 1995, INT J OBESITY, V19, pS5; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hales CN, 1996, BIOCHEM SOC T, V24, P341, DOI 10.1042/bst0240341; KANGAS T, 1995, 58 NAT RES DEV CTR W; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; MCCRABB GJ, 1991, BRIT J NUTR, V65, P157, DOI 10.1079/BJN19910077; Mi J, 2000, ANN INTERN MED, V132, P253, DOI 10.7326/0003-4819-132-4-200002150-00002; MYKKANEN L, 1990, DIABETES CARE, V13, P1099, DOI 10.2337/diacare.13.11.1099; PHILLIPS DIW, 1994, DIABETOLOGIA, V37, P150, DOI 10.1007/s001250050086; PHIPPS K, 1993, DIABETOLOGIA, V36, P225, DOI 10.1007/BF00399954; Poulsen P, 1997, DIABETOLOGIA, V40, P439, DOI 10.1007/s001250050698; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; ROYSTON P, 1991, STAT MED, V10, P675, DOI 10.1002/sim.4780100502; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; TANNER JM, 1989, FOETUS MAN PHYSICAL; TUOMILEHTO J, 1991, INT J EPIDEMIOL, V20, P1010, DOI 10.1093/ije/20.4.1010; Vanhala M, 1998, BRIT MED J, V317, P319, DOI 10.1136/bmj.317.7154.319; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; *WHO STUD GROUP DI, 1985, WHO TECHN REP SER, V727	33	493	509	0	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2000	133	3					176	182		10.7326/0003-4819-133-3-200008010-00008	http://dx.doi.org/10.7326/0003-4819-133-3-200008010-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XW	10906831				2022-12-28	WOS:000088449400002
J	Cunningham, S; Horrocks, E; Hunt, N; Jones, S; Moseley, H; Noar, J; Scully, C				Cunningham, S; Horrocks, E; Hunt, N; Jones, S; Moseley, H; Noar, J; Scully, C			ABC of oral health - Improving occlusion and orofacial aesthetics: orthodontics	BRITISH MEDICAL JOURNAL			English	Review									Univ London, Eastman Dent Inst Oral Hlth Care Sci, London WC1E 7HU, England	University of London; University College London	Cunningham, S (corresponding author), Univ London, Eastman Dent Inst Oral Hlth Care Sci, London WC1E 7HU, England.			Cunningham, Susan/0000-0002-5006-6783				BROOK PH, 1989, EUR J ORTHODONT, V11, P309, DOI 10.1093/oxfordjournals.ejo.a035999; Cunningham S J, 1995, Int J Adult Orthodon Orthognath Surg, V10, P159; Erverdi N, 1999, AM J ORTHOD DENTOFAC, V116, P687, DOI 10.1016/S0889-5406(99)70205-2; Hunt N, 1998, CLIN ORAL SCI, P120; Khurana M, 1999, Br J Orthod, V26, P295; Otuyemi O D, 1995, Aust Orthod J, V14, P21	6	3	5	1	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					288	290		10.1136/bmj.321.7256.288	http://dx.doi.org/10.1136/bmj.321.7256.288			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915138	Green Published			2022-12-28	WOS:000088619800033
J	Ramrakha, S; Caspi, A; Dickson, N; Moffitt, TF; Paul, C				Ramrakha, S; Caspi, A; Dickson, N; Moffitt, TF; Paul, C			Psychiatric disorders and risky sexual behaviour in young adulthood: cross sectional study in birth cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NATIONAL-COMORBIDITY-SURVEY; ADOLESCENT GIRLS; MENTAL-HEALTH; SUBSTANCE USE; PREVALENCE; LIFETIME; DEPRESSION; VALIDITY	Objective To determine if risky sexual intercourse, sexually transmitted diseases, and sexual intercourse at an early age are associated with psychiatric disorder. Design Cross sectional study of a birth cohort at age 21 years with assessments presented by computer (for sexual behaviour) and by trained interviewers (for psychiatric disorder). Setting New Zealand in 1993-4. Participants 992 study members (487 women) from the Dunedin multidisciplinary health and development study. Complete data were available on both measures for 930 study members. Main outcome measures Psychiatric disorders (anxiety, depression eating disorder; substance dependence, antisocial disorder, mania, schizophrenia spectrum) and measures of sexual behaviour. Results Young people diagnosed with substance dependence, schizophrenia spectrum, and antisocial disorders were more likely to engage in risky sexual intercourse, contract sexually transmitted diseases, and have sexual intercourse at an early age (before 16 years). Unexpectedly, so were young people with depressive disorders. Young people with mania were more likely to report risky sexual intercourse and have sexually transmitted diseases. The likelihood of risky behaviour was increased by psychiatric comorbidity. Conclusions There is a clear association between risky sexual behaviour and common psychiatric disorders. Although the temporal relation is uncertain, the results indicate the need to coordinate sexual medicine with mental health services in the treatment of young people.	Univ Otago, Sch Med, Dept Prevent & Social Med, Dunedin Multidisciplinary Hlth & Dev Res Unit, Dunedin, New Zealand; Univ Otago, Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand; Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, London SE5 8AF, England	University of Otago; University of Otago; University of London; King's College London	Ramrakha, S (corresponding author), Univ Otago, Sch Med, Dept Prevent & Social Med, Dunedin Multidisciplinary Hlth & Dev Res Unit, POB 913, Dunedin, New Zealand.	sramrakha@gandalf.otago.ac.nz	caspi, avshalom/D-5294-2011; caspi, avshalom/AAJ-5874-2020; Moffitt, Terrie E/D-5295-2011	caspi, avshalom/0000-0003-0082-4600; caspi, avshalom/0000-0003-0082-4600; Moffitt, Terrie E/0000-0002-8589-6760	NIMH NIH HHS [MH-4507, MH-49414, MH-56344, R01 MH049414] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056344, R29MH049414, R01MH049414] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADCOCK AG, 1991, ADOLESCENCE, V26, P817; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; [Anonymous], 1996, GLOBAL BURDEN DIS CO; BAKER DG, 1991, AM J PSYCHIAT, V148, P528; Bardone AM, 1996, DEV PSYCHOPATHOL, V8, P811, DOI 10.1017/S0954579400007446; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P589; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P749; COOPER ML, 1994, HEALTH PSYCHOL, V13, P251, DOI 10.1037/0278-6133.13.3.251; Dickson N, 1998, BRIT MED J, V316, P29, DOI 10.1136/bmj.316.7124.29; Dickson N, 1996, NEW ZEAL MED J, V109, P308; ELLEY WB, 1972, NEW ZEAL J EDUC STUD, V7, P153; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; *I MED COMM PREV M, 1994, REDUCING MENTAL DISO; Johnson AM, 1994, SEXUAL ATTITUDES LIF; Kendler KS, 1996, ARCH GEN PSYCHIAT, V53, P1022; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; LOWRY R, 1994, AM J PUBLIC HEALTH, V84, P1116, DOI 10.2105/AJPH.84.7.1116; Newman DL, 1996, J CONSULT CLIN PSYCH, V64, P552, DOI 10.1037/0022-006X.64.3.552; Newman DL, 1998, J ABNORM PSYCHOL, V107, P305, DOI 10.1037/0021-843X.107.2.305; Paul C, 2000, J ADOLESCENT HEALTH, V27, P136, DOI 10.1016/S1054-139X(99)00095-6; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Silva P., 1996, CHILD ADULT DUNEDIN; USTUN TB, 1995, ILLNESS GEN HLTH CAR; WHO (World Health Organization), 1998, WORLD HLTH REP 1998	24	194	195	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2000	321	7256					263	266		10.1136/bmj.321.7256.263	http://dx.doi.org/10.1136/bmj.321.7256.263			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	341ZA	10915126	Green Published, Bronze			2022-12-28	WOS:000088619800020
J	Kelley, SP; Wartho, JA				Kelley, SP; Wartho, JA			Rapid kimberlite ascent and the significance of Ar-Ar ages in xenolith phlogopites	SCIENCE			English	Article							ONTONG-JAVA PLATEAU; LASER-PROBE; SUBCONTINENTAL MANTLE; SOLOMON-ISLANDS; ARGON ISOTOPE; ROCKS; PETROGENESIS; KILOMETERS; EVOLUTION; BIOTITES	Kimberlite eruptions bring exotic rock fragments and minerals, including diamonds, from deep within the mantle up to the surface. Such fragments are rapidly absorbed into the kimberlite magma so their appearance at the surface implies rapid transport from depth. High spatial resolution Ar-Ar age data on phlogopite grains in xenoliths from Malaita in the Solomon Islands, southwest Pacific, and Elovy Island in the Kola Peninsula, Russia, indicate transport times of hours to days depending upon the magma temperature. In addition, the data show that the phlogopite grains preserve Ar-Ar ages recorded at high temperature in the mantle, 700 degrees C above the conventional closure temperature.	Open Univ, Dept Earth Sci, Milton Keynes MK7 6AA, Bucks, England	Open University - UK	Kelley, SP (corresponding author), Open Univ, Dept Earth Sci, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.		Kelley, Simon P/C-5489-2012; Wartho, Jo-Anne/B-5169-2016; Kelley, Simon/AAR-7075-2020	Kelley, Simon P/0000-0002-1756-0480; Kelley, Simon/0000-0002-1756-0480				Beard AD, 1996, LITHOS, V39, P93, DOI 10.1016/S0024-4937(96)00020-5; BIRKHOLD AB, 1999, EOS S, V80, pF1103; Canil D, 1999, EARTH PLANET SC LETT, V167, P227, DOI 10.1016/S0012-821X(99)00019-9; Carroll M. R., 1994, NOBLE GAS GEOCHEMIST, P325; Collerson KD, 2000, SCIENCE, V288, P1215, DOI 10.1126/science.288.5469.1215; Dahl PS, 1996, CONTRIB MINERAL PETR, V123, P22, DOI 10.1007/s004100050141; Davis G.L., 1977, CARNEGIE I WASH YR B, V76, P631; DODSON MH, 1973, CONTRIB MINERAL PETR, V40, P259, DOI 10.1007/BF00373790; Drury MR, 1996, GEOPHYS RES LETT, V23, P701, DOI 10.1029/96GL00702; DUNAI TJ, 1995, GEOCHIM COSMOCHIM AC, V59, P2767, DOI 10.1016/0016-7037(95)00172-V; FOLAND KA, 1979, GEOCHIM COSMOCHIM AC, V43, P793, DOI 10.1016/0016-7037(79)90219-9; GILETTI BJ, 1974, CARNEGIE I WASHINGTO, V634, P107; Grove M, 1996, AM MINERAL, V81, P940; HAGGERTY SE, 1990, SCIENCE, V248, P993, DOI 10.1126/science.248.4958.993; KELLEY SP, 1991, EARTH PLANET SC LETT, V107, P634, DOI 10.1016/0012-821X(91)90108-T; KELLEY SP, 1994, GEOCHIM COSMOCHIM AC, V58, P3519, DOI 10.1016/0016-7037(94)90103-1; KEMPTON PD, IN PRESS J PETROL; LOVERING JF, 1964, J GEOPHYS RES, V69, P4895, DOI 10.1029/JZ069i022p04895; Matsumoto T, 1998, GEOCHIM COSMOCHIM AC, V62, P2521, DOI 10.1016/S0016-7037(98)00173-2; NADEAU S, 1993, EARTH PLANET SC LETT, V114, P431, DOI 10.1016/0012-821X(93)90074-J; Neal C.R., 1997, GEOPH MONOG SERIES, V100, P183; NEAL CR, 1985, T GEOL SOC S AFR, V88, P347; Nixon P.H., 1979, MANTLE SAMPLES AM GE, P400; NIXON PH, 1980, MINERAL MAG, V43, P587, DOI 10.1180/minmag.1980.043.329.05; Pearson DG, 1997, GEOL GEOFIZ+, V38, P100; PHILLIPS D, 1989, NATURE, V340, P460, DOI 10.1038/340460a0; PHILLIPS D, 1991, CHEM GEOL, V87, P71, DOI 10.1016/0168-9622(91)90043-V; Pickles CS, 1997, GEOCHIM COSMOCHIM AC, V61, P3809, DOI 10.1016/S0016-7037(97)00289-5; RODDICK JC, 1980, EARTH PLANET SC LETT, V48, P185, DOI 10.1016/0012-821X(80)90181-8; ROSELIEB K, 1999, 10 EUR UN GEOSC M 28, P368; Rumble D, 1998, GEOCHIM COSMOCHIM AC, V62, P3307, DOI 10.1016/S0016-7037(98)00239-7; SAUTTER V, 1991, SCIENCE, V252, P827, DOI 10.1126/science.252.5007.827; Tejada MLG, 1996, J PETROL, V37, P361, DOI 10.1093/petrology/37.2.361	33	157	167	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2000	289	5479					609	611		10.1126/science.289.5479.609	http://dx.doi.org/10.1126/science.289.5479.609			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915621				2022-12-28	WOS:000088447800050
J	Hadigan, C; Corcoran, C; Basgoz, N; Davis, B; Sax, P; Grinspoon, S				Hadigan, C; Corcoran, C; Basgoz, N; Davis, B; Sax, P; Grinspoon, S			Metformin in the treatment of HIV lipodystrophy syndrome - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIRETROVIRAL THERAPY HAART; INSULIN-RESISTANCE; PROTEASE INHIBITORS; GLUCOSE-TOLERANCE; DIABETES-MELLITUS; INFECTED WOMEN; HEART-DISEASE; FAT; HYPERINSULINEMIA; RISK	Context A syndrome of lipodystrophy, characterized by fat redistribution and insulin resistance, has been estimated to affect the majority of human immunodeficiency virus (HIV)-infected individuals who are treated with combination antiretroviral therapy. There are no proven therapies for the metabolic disturbances associated with HIV lipodystrophy syndrome. Objective To determine the safety and efficacy of metformin therapy in HIV-infected patients with fat redistribution and abnormal glucose homeostasis. Design and Setting Randomized, double-blind, placebo-controlled pilot study conducted in a university hospital between December 1998 and January 2000, Patients Twenty-six HIV-infected, nondiabetic patients with fat redistribution and abnormal oral glucose tolerance test (OGTT) results, hyperinsulinemia, or both. Interventions Patients were randomly assigned to receive metformin, 500 mg twice daily (n=14), or identical placebo (n=12), for 3 months. Main Outcome Measures Insulin area under the curve (AUC), calculated 120 minutes following a 75-g OGTT at baseline vs at 3-month follow-up and compared between treatment groups. Results Patients treated with metformin demonstrated significant reductions in mean (SEM) insulin AUC 120 minutes after OGTT (-2930 [912] vs -414 [432] mu IU/mL [-20349 (6334) vs -2875 {3000} pmol/L]; P=.01), weight (-1.3 [0.6] vs 1.1[0.4] kg; P=.005), and diastolic blood pressure (-5 [4] vs 5 [2] mm Hg; P=.009) vs controls, respectively. Metformin therapy was associated with a decrease in visceral abdominal fat (VAT; -1115 [819] vs 1191 [699] mm(2); P=.08) and a proportional reduction in subcutaneous abdominal fat (SAT); the VAT-SAT ratio was unchanged in metformin-treated vs placebo-treated patients. No increase in lactate or liver transaminase levels was observed with metformin treatment. Mild diarrhea was the most common adverse effect of metformin. No patient discontinued therapy because of adverse effects. Conclusions This study suggests that a relatively low dosage of metformin reduces insulin resistance and related cardiovascular risk parameters in HIV-infected patients with lipodystrophy.	Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Combined Program Pediat Gastroenterol & Nutr, Boston, MA USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Infect Dis, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Grinspoon, S (corresponding author), Massachusetts Gen Hosp, Neuroendocrine Unit, Bulfinch 457B, Boston, MA 02114 USA.	sgrinspoon@partners.org			NCRR NIH HHS [M01-RR300088] Funding Source: Medline; NIDDK NIH HHS [T32-DK07703, K23-DK02844] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007703, K23DK002844] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON RL, 1995, AM J EPIDEMIOL, V142, P724, DOI 10.1093/aje/142.7.724; BORKAN GA, 1982, AM J CLIN NUTR, V36, P172, DOI 10.1093/ajcn/36.1.172; Brinkman K, 1999, LANCET, V354, P1112, DOI 10.1016/S0140-6736(99)06102-4; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Carroll DS, 1998, PALLIATIVE MED, V12, P51, DOI 10.1191/026921698666041220; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Dong KL, 1999, J ACQ IMMUN DEF SYND, V21, P107; Gervasoni C, 1999, AIDS, V13, P465, DOI 10.1097/00002030-199903110-00004; Hadigan C, 2000, J CLIN ENDOCR METAB, V85, P35, DOI 10.1210/jc.85.1.35; Hadigan C, 1999, J CLIN ENDOCR METAB, V84, P1932, DOI 10.1210/jc.84.6.1932; Lo JC, 1998, LANCET, V351, P867, DOI 10.1016/S0140-6736(97)11443-X; Miller KD, 1998, LANCET, V351, P871, DOI 10.1016/S0140-6736(97)11518-5; PEIRIS AN, 1989, ANN INTERN MED, V110, P867, DOI 10.7326/0003-4819-110-11-867; PYORALA K, 1985, ACTA MED SCAND, P38; Pyorala M, 1998, CIRCULATION, V98, P398, DOI 10.1161/01.CIR.98.5.398; Roth VR, 1998, CLIN INFECT DIS, V27, P65, DOI 10.1086/514639; Saint-Marc T, 1999, AIDS, V13, P1000, DOI 10.1097/00002030-199905280-00023; Stokes 3rd J, 1989, HYPERTENSION S1, V13, pI13; Velazquez EM, 1997, METABOLISM, V46, P454, DOI 10.1016/S0026-0495(97)90066-4; Vigouroux C, 1999, DIABETES METAB, V25, P225; Walli R, 1998, AIDS, V12, pF167, DOI 10.1097/00002030-199815000-00001; WALLI RK, 1999, 6 C RETR OPP INF JAN; World Health Organization, 1980, WHO TECHN REP SER, V646, P1	26	264	275	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					472	477		10.1001/jama.284.4.472	http://dx.doi.org/10.1001/jama.284.4.472			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904511				2022-12-28	WOS:000088254200034
J	Dahn, RD; Fallon, JF				Dahn, RD; Fallon, JF			Interdigital regulation of digit identity and homeotic transformation by modulated BMP signaling	SCIENCE			English	Article							CHICK LIMB; MESODERM INDUCTION; SONIC HEDGEHOG; CELL-DEATH; PROTEIN; HETERODIMERS	The developmental mechanisms specifying digital identity have attracted 30 years of intense interest, but still remain poorly understood, Here, through experiments on chick foot development, we show digital identity is not a fixed property of digital primordia. Rather, digital identity is specified by the interdigital mesoderm, demonstrating a patterning function for this tissue before its regression. More posterior interdigits specify more posterior digital identities, and each primordium will develop in accordance with the most posterior cues received. Furthermore, inhibition of interdigital bone morphogenetic protein (BMP) signaling can transform digit identity, suggesting a role for BMPs in this process.	Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fallon, JF (corresponding author), Univ Wisconsin, Dept Anat, 1300 Univ Ave, Madison, WI 53706 USA.				NICHD NIH HHS [HD32551, T32HD07477] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032551, T32HD007477] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; Bateson W., 1894, MAT STUDY VARIATION; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; Ganan Y, 1996, DEVELOPMENT, V122, P2349; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Laufer E, 1997, SCIENCE, V278, P305, DOI 10.1126/science.278.5336.305; Macias D, 1997, DEVELOPMENT, V124, P1109; Marigo V, 1996, DEVELOPMENT, V122, P1225; Nishimatsu S, 1998, MECH DEVELOP, V74, P75, DOI 10.1016/S0925-4773(98)00070-7; Pearse RV, 1998, J EXP ZOOL, V282, P677, DOI 10.1002/(SICI)1097-010X(19981215)282:6<677::AID-JEZ4>3.0.CO;2-F; Saunders J.W., 1967, MAJOR PROBLEMS DEV B, P289; Storm EE, 1996, DEVELOPMENT, V122, P3969; Suzuki A, 1997, BIOCHEM BIOPH RES CO, V232, P153, DOI 10.1006/bbrc.1997.6219; Tucker AS, 1998, SCIENCE, V282, P1136, DOI 10.1126/science.282.5391.1136; Yang Y, 1997, DEVELOPMENT, V124, P4393; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262; Zhang ZY, 2000, DEV BIOL, V220, P154, DOI 10.1006/dbio.2000.9637; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738	21	206	212	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					438	441		10.1126/science.289.5478.438	http://dx.doi.org/10.1126/science.289.5478.438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903202				2022-12-28	WOS:000088305500044
J	Imperiale, TF; Wagner, DR; Lin, CY; Larkin, GN; Rogge, JD; Ransohoff, DF				Imperiale, TF; Wagner, DR; Lin, CY; Larkin, GN; Rogge, JD; Ransohoff, DF			Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONIC NEOPLASMS; FLEXIBLE SIGMOIDOSCOPY; RECTOSIGMOID ADENOMAS; AVERAGE-RISK; COLONOSCOPY; CANCER; POLYPS; LESIONS; HISTORY; AGE	Background and Methods: The clinical significance of a distal colorectal polyp is uncertain. We determined the risk of advanced proximal neoplasia, defined as a polyp with villous features, a polyp with high-grade dysplasia, or cancer, among persons with distal hyperplastic or neoplastic polyps as compared with the risk among persons with no distal polyps. We analyzed data from 1994 consecutive asymptomatic adults (age, 50 years or older) who underwent colonoscopic screening for the first time between September 1995 and December 1998 as part of a program sponsored by an employer. The location and histologic features of all polyps were recorded. Colonoscopy to the level of the cecum was completed in 97.0 percent of the patients. Results: Sixty-one patients (3.1 percent) had advanced lesions in the distal colon, including 5 with cancer, and 50 (2.5 percent) had advanced proximal lesions, including 7 with cancer. Twenty-three patients with advanced proximal neoplasms (46 percent) had no distal polyps. The prevalence of advanced proximal neoplasia among patients with no distal polyps was 1.5 percent (23 cases among 1564 persons; 95 percent confidence interval, 0.9 to 2.1 percent). Among patients with distal hyperplastic polyps, those with distal tubular adenomas, and those with advanced distal polyps, the prevalence of advanced proximal neoplasia was 4.0 percent (8 cases among 201 patients), 7.1 percent (12 cases among 168 patients), and 11.5 percent (7 cases among 61 patients), respectively. The relative risk of advanced proximal neoplasia, adjusted for age and sex, was 2.6 for patients with distal hyperplastic polyps, 4.0 for those with distal tubular adenomas, and 6.7 for those with advanced distal polyps, as compared with patients who had no distal polyps. Older age and male sex were associated with an increased risk of advanced proximal neoplasia (relative risk, 1.3 for every five years of age and 3.3 for male sex). Conclusions: Asymptomatic persons 50 years of age or older who have polyps in the distal colon are more likely to have advanced proximal neoplasia than are persons without distal polyps. However, if colonoscopic screening is performed only in persons with distal polyps, about half the cases of advanced proximal neoplasia will not be detected. (N Engl J Med 2000;343:169-74.) (C)2000, Massachusetts Medical Society.	Indiana Univ, Med Ctr, Div Gastroenterol, Dept Med, Indianapolis, IN 46202 USA; Indianapolis Gastroenterol Res Fdn, Indianapolis, IN USA; Richard L Roudebush Vet Affairs Med Ctr, Dept Med, Indianapolis, IN 46202 USA; Eli Lilly & Co, Indianapolis, IN 46285 USA	Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Eli Lilly	Imperiale, TF (corresponding author), Indiana Univ, Med Ctr, Div Gastroenterol, Dept Med, 975 W Walnut St,IB-424, Indianapolis, IN 46202 USA.			Imperiale, Thomas/0000-0001-7586-1073	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002756] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24 DK02756-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; BOND JH, 1994, ANN INTERN MED, V120, P347, DOI 10.7326/0003-4819-120-4-199402150-00032; BRADY PG, 1993, GASTROINTEST ENDOSC, V39, P481, DOI 10.1016/S0016-5107(93)70155-8; Collett JA, 1999, J GASTROEN HEPATOL, V14, P67, DOI 10.1046/j.1440-1746.1999.01804.x; Davidoff F, 1999, ANN INTERN MED, V130, P1019, DOI 10.7326/0003-4819-130-12-199906150-00022; DUKES CE, 1958, BRIT J CANCER, V12, P309, DOI 10.1038/bjc.1958.37; FOUTCH PG, 1991, AM J GASTROENTEROL, V86, P1482; HOSMER DW, 1989, APPL LOGISTIC REGRES; JOHNSON DA, 1990, AM J GASTROENTEROL, V85, P969; KONISHI F, 1982, J CLIN PATHOL, V35, P830, DOI 10.1136/jcp.35.8.830; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Lemmel GT, 1996, GASTROINTEST ENDOSC, V44, P109, DOI 10.1016/S0016-5107(96)70125-6; Levin TR, 1999, JAMA-J AM MED ASSOC, V281, P1611, DOI 10.1001/jama.281.17.1611; Nusko G, 1996, EUR J GASTROEN HEPAT, V8, P351, DOI 10.1097/00042737-199604000-00012; OPELKA FG, 1992, DIS COLON RECTUM, V35, P178, DOI 10.1007/BF02050675; Otori K, 1997, GUT, V40, P660, DOI 10.1136/gut.40.5.660; Papatheodoridis GV, 1996, AM J GASTROENTEROL, V91, P1809; Read TE, 1997, NEW ENGL J MED, V336, P8, DOI 10.1056/NEJM199701023360102; Rex DK, 1999, GASTROINTEST ENDOSC, V49, P727, DOI 10.1016/S0016-5107(99)70290-7; REX DK, 1993, AM J GASTROENTEROL, V88, P825; Rothman K., 1998, MODERN EPIDEMIOLOGY; Schoen RE, 1997, GASTROINTEST ENDOSC, V46, P492, DOI 10.1016/S0016-5107(97)70002-6; Schoen RE, 1998, GASTROENTEROLOGY, V115, P533, DOI 10.1016/S0016-5085(98)70132-5; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; TRIPP MR, 1987, CANCER, V60, P1599, DOI 10.1002/1097-0142(19871001)60:7<1599::AID-CNCR2820600730>3.0.CO;2-I; Wallace MB, 1998, ANN INTERN MED, V129, P273, DOI 10.7326/0003-4819-129-4-199808150-00002; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; Winawer SJ, 1998, GASTROENTEROLOGY, V114, P625; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P1060; ZARCHY TM, 1994, GASTROENTEROLOGY, V106, P1501, DOI 10.1016/0016-5085(94)90403-0	30	783	800	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2000	343	3					169	174		10.1056/NEJM200007203430302	http://dx.doi.org/10.1056/NEJM200007203430302			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335HY	10900275	Bronze			2022-12-28	WOS:000088239100002
J	Scholz, CH				Scholz, CH			A fault in the 'weak San Andreas' theory	NATURE			English	Letter									Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	Scholz, CH (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.							LACHENBRUCH AH, 1980, J GEOPHYS RES, V85, P6185, DOI 10.1029/JB085iB11p06185; Manga M, 1998, GEOLOGY, V26, P799, DOI 10.1130/0091-7613(1998)026<0799:AHTBLT>2.3.CO;2; Scholz CH, 2000, GEOLOGY, V28, P163, DOI 10.1130/0091-7613(2000)28<163:EFASSA>2.0.CO;2; Scholz CH, 1998, NATURE, V391, P37, DOI 10.1038/34097; Townend J, 2000, GEOLOGY, V28, P399, DOI 10.1130/0091-7613(2000)28<399:HFKTCS>2.0.CO;2; Zoback MD, 2000, NATURE, V405, P31, DOI 10.1038/35011181	6	7	7	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					234	234		10.1038/35018740	http://dx.doi.org/10.1038/35018740			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917505				2022-12-28	WOS:000088251900018
J	Sesmilo, G; Biller, BMK; Llevadot, J; Hayden, D; Hanson, G; Rifai, N; Klibanski, A				Sesmilo, G; Biller, BMK; Llevadot, J; Hayden, D; Hanson, G; Rifai, N; Klibanski, A			Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency - A randomized, controlled clinical trial	ANNALS OF INTERNAL MEDICINE			English	Article							C-REACTIVE PROTEIN; CORONARY HEART-DISEASE; AVERAGE CHOLESTEROL LEVELS; PLACEBO-CONTROLLED TRIAL; INTIMA-MEDIA THICKNESS; RECOMBINANT HUMAN GH; NESTED CASE-CONTROL; MYOCARDIAL-INFARCTION; BODY-COMPOSITION; HYPOPITUITARY ADULTS	Background: Growth hormone-deficient adults have increased cardiovascular mortality. Growth hormone replacement may affect cardiovascular risk. Inflammation plays an important role in atherosclerosis, and inflammatory markers are predictive of cardiovascular events. Objective: To investigate the effect of growth hormone replacement on inflammatory and other cardiovascular risk factors. Design: Randomized, single-blind, placebo-controlled trial. Patients: 40 men with adult-onset growth hormone deficiency. Intervention: Growth hormone or placebo given for 18 months at a dose adjusted for normal serum insulin-like growth factor I level. Measurements: Anthropometric, hemoglobin A(1c), and central fat values were assessed every 6 months. Levels of glucose, insulin, insulin-like growth factor I, and lipids were measured at 1, 3, 6, 12, and 18 months. C-reactive protein, serum amyloid polypeptide A, interleukin-6, and lipoprotein(a) levels were determined at baseline and 6 and 18 months. Results: C-reactive protein and interleukin-6 levels decreased in growth hormone recipients compared with placebo recipients (differences between groups, -1.9+/-0.6 mg/L [P=0.0027] and -1.3+/-0.5 ng/L [P=0.013], respectively). Changes in serum amyloid polypeptide A levels between groups did not reach statistical significance (difference between groups, -2.4+/-1.2 mg/L; P = 0.056). Serum cholesterol levels, low-density lipoprotein cholesterol levels, and ratios of total cholesterol to high-density lipoprotein cholesterol decreased in growth hormone recipients in the first 3 months compared with placebo recipients (differences between groups, -0.86 +/- 0.17 mmol/L [-33.2 +/- 6.6 mg/dL] [P < 0.001], -0.63 +/- 0.20 mmol/L [-24.5 +/- 5.9 mg/dL] [P < 0.001], and -0.56 +/- 0.26 [P = 0.040], respectively), but the decrease was not maintained from month 6 to month 18. Lipoprotein(a) levels increased (difference between groups, 22.0 +/- 8.0 mg/L; P = 0.0096). Short-term increases occurred in glucose levels, insulin levels, and insulin-to-glucose ratios (differences between groups, 0.54 +/- 0.16 mmol/L [9.6 +/- 2.8 mg/dL] [P = 0.0018], 37.9 +/- 9.6 pmol/L [P < 0.001], and 6.0 +/- 1.8 [P = 0.0025], respectively), but only the increase in glucose level was maintained over the long term (difference between groups, 0.56 +/- 0.17 mmol/L [10.0 +/- 3.1 mg/dL]; P = 0.0026). Hemoglobin A,, values did not change. Truncal fat-to-total fat ratios decreased (difference between groups, -0.018 +/- 0.007; P = 0.0087), Conclusions: Long-term growth hormone replacement in men reduces levels of inflammatory cardiovascular risk markers, decreases central fat, and increases lipoprotein(a) and glucose levels without affecting lipid levels.	Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Klibanski, A (corresponding author), Massachusetts Gen Hosp, Neuroendocrine Unit, 55 Fruit St,Bulfinch 457B, Boston, MA 02114 USA.				NCRR NIH HHS [RR 1066] Funding Source: Medline; NIDDK NIH HHS [DK08783] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK008783] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Attanasio AF, 1997, J CLIN ENDOCR METAB, V82, P82, DOI 10.1210/jc.82.1.82; AUEMHAMMER CJ, 1995, EUR J ENDOCRINOL, V133, P635; Baum HBA, 1998, J CLIN ENDOCR METAB, V83, P3184, DOI 10.1210/jc.83.9.3184; Baum HBA, 1996, ANN INTERN MED, V125, P883, DOI 10.7326/0003-4819-125-11-199612010-00003; BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; Beshyah SA, 1999, CLIN ENDOCRINOL, V50, P1, DOI 10.1046/j.1365-2265.1999.00682.x; BESHYAH SA, 1995, J CLIN ENDOCR METAB, V80, P356, DOI 10.1210/jc.80.2.356; Biasucci LM, 1996, CIRCULATION, V94, P874, DOI 10.1161/01.CIR.94.5.874; BINNERTS A, 1992, AM J CLIN NUTR, V55, P918, DOI 10.1093/ajcn/55.5.918; Borson-Chazot F, 1999, J CLIN ENDOCR METAB, V84, P1329, DOI 10.1210/jc.84.4.1329; Bozzola M, 1997, ACTA PAEDIATR, V86, P84; Bulow B, 1997, CLIN ENDOCRINOL, V46, P75, DOI 10.1046/j.1365-2265.1997.d01-1749.x; Capaldo B, 1997, J CLIN ENDOCR METAB, V82, P1378, DOI 10.1210/jc.82.5.1378; CarterSu C, 1996, ANNU REV PHYSIOL, V58, P187, DOI 10.1146/annurev.ph.58.030196.001155; CREMER P, 1994, EUR J CLIN INVEST, V24, P444, DOI 10.1111/j.1365-2362.1994.tb02373.x; Cuneo RC, 1998, J CLIN ENDOCR METAB, V83, P107, DOI 10.1210/jc.83.1.107; CUNEO RC, 1993, METABOLISM, V42, P1519, DOI 10.1016/0026-0495(93)90145-E; CUNEO RC, 1992, CLIN ENDOCRINOL, V37, P387, DOI 10.1111/j.1365-2265.1992.tb02347.x; DEBOER H, 1992, J CLIN ENDOCR METAB, V75, P833, DOI 10.1210/jc.75.3.833; EDEN S, 1993, ARTERIOSCLER THROMB, V13, P296, DOI 10.1161/01.ATV.13.2.296; Evans LM, 1999, CLIN ENDOCRINOL, V50, P457; Florkowski CM, 1996, CLIN ENDOCRINOL, V45, P769, DOI 10.1046/j.1365-2265.1996.830895.x; FOWELIN J, 1993, METABOLISM, V42, P1443, DOI 10.1016/0026-0495(93)90197-V; Fyfe AI, 1997, CIRCULATION, V96, P2914, DOI 10.1161/01.CIR.96.9.2914; Geffner M, 1997, ACTA PAEDIATR, V86, P76; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Hadigan C, 1999, J CLIN ENDOCR METAB, V84, P1932, DOI 10.1210/jc.84.6.1932; HANSEN PS, 1995, METABOLISM, V44, P725, DOI 10.1016/0026-0495(95)90184-1; Hwu CM, 1997, J CLIN ENDOCR METAB, V82, P3285, DOI 10.1210/jc.82.10.3285; Ikonomidis I, 1999, CIRCULATION, V100, P793, DOI 10.1161/01.CIR.100.8.793; INOUE L, 1995, ARCH SURG-CHICAGO, V130, P1115; Jarrar D, 1997, ARCH SURG-CHICAGO, V132, P1171; JAUHIAINEN M, 1991, ATHEROSCLEROSIS, V89, P59, DOI 10.1016/0021-9150(91)90007-P; JOHANNSSON G, 1995, ARTERIOSCL THROM VAS, V15, P2142, DOI 10.1161/01.ATV.15.12.2142; JOHANSSON JO, 1995, METABOLISM, V44, P1126, DOI 10.1016/0026-0495(95)90004-7; JORGENSEN JOL, 1989, LANCET, V1, P1221; JORGENSEN JOL, 1994, CLIN ENDOCRINOL, V41, P609, DOI 10.1111/j.1365-2265.1994.tb01826.x; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kratz A, 1998, NEW ENGL J MED, V339, P1063, DOI 10.1056/NEJM199810083391508; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Libby P, 1999, CIRCULATION, V100, P1148, DOI 10.1161/01.CIR.100.11.1148; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Lucidi P, 1998, J CLIN ENDOCR METAB, V83, P353, DOI 10.1210/jc.83.2.353; MARKUSSIS V, 1992, LANCET, V340, P1188, DOI 10.1016/0140-6736(92)92892-J; Nolte W, 1997, EUR J ENDOCRINOL, V137, P459, DOI 10.1530/eje.0.1370459; Pfeifer M, 1999, J CLIN ENDOCR METAB, V84, P453, DOI 10.1210/jc.84.2.453; Renier G, 1996, ENDOCRINOLOGY, V137, P4611, DOI 10.1210/en.137.11.4611; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; RIDKER PM, 1993, JAMA-J AM MED ASSOC, V270, P2195, DOI 10.1001/jama.270.18.2195; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Ridker PM, 1999, ANN INTERN MED, V130, P933, DOI 10.7326/0003-4819-130-11-199906010-00018; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; ROSEN T, 1993, ACTA ENDOCRINOL-COP, V129, P195, DOI 10.1530/acta.0.1290195; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rus HG, 1996, ATHEROSCLEROSIS, V127, P263, DOI 10.1016/S0021-9150(96)05968-0; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605; SCHAEFER EJ, 1994, JAMA-J AM MED ASSOC, V271, P999, DOI 10.1001/jama.271.13.999; Serri O, 1999, J CLIN ENDOCR METAB, V84, P58, DOI 10.1210/jc.84.1.58; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; WEAVER JU, 1995, J CLIN ENDOCR METAB, V80, P153, DOI 10.1210/jc.80.1.153; Webster JM, 1997, ATHEROSCLEROSIS, V133, P115, DOI 10.1016/S0021-9150(97)00110-X; WHITEHEAD HM, 1992, CLIN ENDOCRINOL, V36, P45, DOI 10.1111/j.1365-2265.1992.tb02901.x; WUSTER C, 1991, KLIN WOCHENSCHR, V69, P769, DOI 10.1007/BF01797616	67	218	226	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2000	133	2					111	122		10.7326/0003-4819-133-2-200007180-00010	http://dx.doi.org/10.7326/0003-4819-133-2-200007180-00010			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335RL	10896637				2022-12-28	WOS:000088258500004
J	Arioglu, E; Duncan-Morin, J; Sebring, N; Rother, KI; Gottlieb, N; Lieberman, J; Herion, D; Kleiner, DE; Reynolds, J; Premkumar, A; Sumner, AE; Hoofnagle, J; Reitman, ML; Taylor, SI				Arioglu, E; Duncan-Morin, J; Sebring, N; Rother, KI; Gottlieb, N; Lieberman, J; Herion, D; Kleiner, DE; Reynolds, J; Premkumar, A; Sumner, AE; Hoofnagle, J; Reitman, ML; Taylor, SI			Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes	ANNALS OF INTERNAL MEDICINE			English	Article							CONGENITAL GENERALIZED LIPODYSTROPHY; TYPE-2 DIABETES-MELLITUS; BODY-FAT DISTRIBUTION; ADIPOSE-TISSUE MASS; INSULIN-RESISTANCE; INDIRECT CALORIMETRY; OBESITY; GENE; THIAZOLIDINEDIONES; TRIGLYCERIDE	Background: Troglitazone promotes adipocyte differentiation in vitro and increases insulin sensitivity in vivo. Therefore, troglitazone may have therapeutic benefit in lipoatrophic diabetes. Objective: To determine whether troglitazone ameliorates hyperglycemia and hypertriglyceridemia or increases fat mass in lipoatrophic patients. Design: Open-labeled prospective study. Setting: United States and Canada. Patients: 20 patients with various syndromes associated with lipoatrophy or lipodystrophy. Intervention: 6 months of therapy with troglitazone, 200 to 600 mg/d. Measurements: Levels of hemoglobin A(1c), triglycerides, free fatty acids, and insulin; respiratory quotient; percentage of body fat; liver volume; and regional fat mass. Results: In the 13 patients with diabetes who completed 6 months of troglitazone therapy, hemoglobin A(1c) levels decreased by a mean of 2.8% (95% CI, 1.9% to 3.7%; P < 0.001). In all 19 study patients, fasting triglyceride levels decreased by 2.6 mmol/L (230 mg/dL) (CI, 0.7 to 4.5 mmol/L [62 to 398 mg/dL] P = 0.019) and free fatty acid levels decreased by 325 mu mol/L (CI, 135 to 515 mu mol/L; P = 0.035). The respiratory quotient decreased by a mean of 0.12 (CI, 0.08 to 0.16; P < 0.001), suggesting that troglitazone promoted oxidation of fat. Body fat increased by a mean of 2.4 percentage points (CI, 1.3 to 4.5 percentage points; P = 0.044). Magnetic resonance imaging showed an increase in subcutaneous adipose tissue but not in visceral fat. In one patient, the serum alanine aminotransferase level increased eightfold during the 10th months of troglitazone treatment but normalized 3 months after discontinuation of treatment. Liver biopsy revealed an eosinophilic infiltrate, suggesting hypersensitivity reaction as a cause of hepatotoxicity. Conclusion: Troglitazone therapy improved metabolic control and increased body fat in patients with lipoatrophic diabetes. The substantial benefits of troglitazone must be balanced against the risk for hepatotoxicity, which can occur relatively late in the treatment course.	NIH, Ctr Clin, Bethesda, MD 20892 USA; NIDDKD, Bethesda, MD 20892 USA; NCI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Arioglu, E (corresponding author), NIH, Ctr Clin, Bldg 10,Room 9S213, Bethesda, MD 20892 USA.	bhudson@mail.acponline.org	Reitman, Marc/B-4448-2013; Kleiner, David E/N-2770-2013	Reitman, Marc/0000-0002-0426-9475; Kleiner, David E/0000-0003-3442-4453; Oral, Elif/0000-0002-9171-1144	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK047031, Z01DK047022] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABATE N, 1994, J LIPID RES, V35, P1490; Al-Salman J, 2000, ANN INTERN MED, V132, P121, DOI 10.7326/0003-4819-132-2-200001180-00006; Burant CF, 1997, J CLIN INVEST, V100, P2900, DOI 10.1172/JCI119839; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Chen DL, 1999, J LIPID RES, V40, P1735; DUNNIGAN MG, 1974, Q J MED, V43, P33; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; ELIA M, 1988, AM J CLIN NUTR, V47, P591, DOI 10.1093/ajcn/47.4.591; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fonseca VA, 1998, J CLIN ENDOCR METAB, V83, P3169, DOI 10.1210/jc.83.9.3169; FOSTER DW, 1994, HARRISONS PRINCIPLES, P2131; Freid J, 2000, ANN INTERN MED, V132, P164, DOI 10.7326/0003-4819-132-2-200001180-00015; FULLER NJ, 1992, CLIN PHYSIOL, V12, P253, DOI 10.1111/j.1475-097X.1992.tb00831.x; Garg A, 1999, J CLIN ENDOCR METAB, V84, P3390, DOI 10.1210/jc.84.9.3390; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Ghazzi MN, 1997, DIABETES, V46, P433, DOI 10.2337/diabetes.46.3.433; Gitlin N, 1998, ANN INTERN MED, V129, P36, DOI 10.7326/0003-4819-129-1-199807010-00008; Gonzalez FJ, 1997, BIOCHIMIE, V79, P139, DOI 10.1016/S0300-9084(97)81506-4; Gotto AM, 1998, AM J CARDIOL, V82, p22Q; Harris MI, 1997, DIABETES CARE, V20, P1859, DOI 10.2337/diacare.20.12.1859; Henry RR, 1997, ENDOCRIN METAB CLIN, V26, P553, DOI 10.1016/S0889-8529(05)70267-X; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; JEQUIER E, 1987, BAILLIERE CLIN ENDOC, V1, P911, DOI 10.1016/S0950-351X(87)80011-3; Kreisberg RA, 1998, AM J CARDIOL, V82, p67U, DOI 10.1016/S0002-9149(98)00848-0; LILLIOJA S, 1988, DIABETES METAB REV, V4, P517, DOI 10.1002/dmr.5610040508; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Maggs DG, 1998, ANN INTERN MED, V128, P176, DOI 10.7326/0003-4819-128-3-199802010-00002; Mantzoros C S, 1995, Adv Endocrinol Metab, V6, P193; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Mori Y, 1999, DIABETES CARE, V22, P908, DOI 10.2337/diacare.22.6.908; Okazawa H, 1997, DIABETES, V46, P1904, DOI 10.2337/diab.46.11.1904; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Peters JM, 1998, NAT GENET, V18, P292, DOI 10.1038/ng0398-292; Quecedo E, 1996, PEDIATR DERMATOL, V13, P477, DOI 10.1111/j.1525-1470.1996.tb00728.x; RAVUSSIN E, 1995, METABOLISM, V44, P12, DOI 10.1016/0026-0495(95)90312-7; Ristow M, 1998, NEW ENGL J MED, V339, P953, DOI 10.1056/NEJM199810013391403; Rusk MH, 1998, NEW ENGL J MED, V339, P406; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Schwartz S, 1998, NEW ENGL J MED, V338, P861, DOI 10.1056/NEJM199803263381302; Seip M, 1996, ACTA PAEDIATR, V85, P2, DOI 10.1111/j.1651-2227.1996.tb14262.x; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shibuya A, 1998, DIABETES CARE, V21, P2140, DOI 10.2337/diacare.21.12.2140; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Speckman RA, 2000, AM J HUM GENET, V66, P1192, DOI 10.1086/302836; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Sumner AE, 1997, METABOLISM, V46, P400, DOI 10.1016/S0026-0495(97)90055-X; Taylor Simeon I., 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P419; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vasudeva R, 1997, DIGEST DIS, V15, P357, DOI 10.1159/000171611; Vella A, 1998, ANN INTERN MED, V129, P1080, DOI 10.7326/0003-4819-129-12-199812150-00032; Vigouroux C, 1998, DIABETES, V47, P490, DOI 10.2337/diabetes.47.3.490; WESTSTRATE JA, 1989, AM J CLIN NUTR, V50, P1104, DOI 10.1093/ajcn/50.5.1104; 1999, MED LETT DRUGS THER, V41, P71	54	223	236	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2000	133	4					263	274		10.7326/0003-4819-133-4-200008150-00009	http://dx.doi.org/10.7326/0003-4819-133-4-200008150-00009			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346NG	10929166				2022-12-28	WOS:000088877500003
J	Peto, R; Darby, S; Deo, H; Silcocks, P; Whitley, E; Doll, R				Peto, R; Darby, S; Deo, H; Silcocks, P; Whitley, E; Doll, R			Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies	BRITISH MEDICAL JOURNAL			English	Article							MALE BRITISH DOCTORS; MORTALITY; TOBACCO	Objective and design To relate UK national trends since 1950 in smoking, in smoking cessation, and in lung cancer to the contrasting results from two large case-control studies centred around 1950 and 1990. Setting United Kingdom. Participants Hospital patients under 75 years of age with and without lung cancer in 1950 and 1990, plus, in 1990, a matched sample of the local population: 1465 case-control pairs in the 1950 study, and 982 cases plus 3185 controls in the 1990 study. Main outcome measures Smoking prevalence and lung cancer Results For men in ear-iv middle age in the United Kingdom the prevalence of smoking halved between 1950 and 1990 but the death rate from lung cancer at ages 35-54 fell even more rapidly, indicating some reduction in the risk among continuing smokers. Ln contrast women and older men who were still current smokers in 1990 were more likely than those in 1950 to have been persistent cigarette smokers throughout adult life and so had higher lung cancer rates than current smokers in 1950. The cumulative risk of death from lung cancer by age 75 tin the absence of other causes of death) rose from 6% at 1950 rates to 16% at 1990 rates in male cigarette smokers, and from 1% to 10% in female cigarette smokers. Among both men and women in 1990, however, the farmer smokers had only a fraction of the lung cancer rate of continuing smokers, and this fraction fell steeply with time since stopping. By 1990 cessation had almost halved the number of lung cancers that would have been expected if the former smokers had continued. For men who stopped at ages 60, 50, 40, and 30 the cumulative risks of lung cancer by age 75 were 10%, 6%, 3%, and 2%. Conclusions People who stop smoking, even well into middle age, avoid most of their subsequent risk of lung cancer, and stopping before middle age avoids more than 90% of the risk attributable to tobacco. Mortality in the near future and throughout the first half of the 21st century could be substantially reduced by current smokers giving up the habit. In contrast, the extent to which young people henceforth become persistent smokers will affect mortality rates chiefly in the middle or second half of the 21st century.	Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Epidemiol Studies Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Canc Epidemiol Unit, Oxford OX2 6HE, England; Queens Med Ctr, Trent Inst Hlth Serv Res, Nottingham NG7 2UH, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford; University of Nottingham; University of Bristol	Darby, S (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England.							Darby S, 1998, BRIT J CANCER, V78, P394, DOI 10.1038/bjc.1998.506; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; DOLL R, 1952, BMJ-BRIT MED J, V2, P1271, DOI 10.1136/bmj.2.4797.1271; Doll R, 1998, Stat Methods Med Res, V7, P87, DOI 10.1191/096228098668199908; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; DOLL R, 1980, BRIT MED J, V280, P967, DOI 10.1136/bmj.280.6219.967; DOLL R, 1997, HLTH ADULT BRITAIN 1, V1, P128; LEVIN ML, 1950, JAMA-J AM MED ASSOC, V143, P336, DOI 10.1001/jama.1950.02910390008002; MILLS CA, 1950, CANCER RES, V10, P539; NICOLAIDESBOUMA.A, 1993, INT SMOKING STAT; *OFF NAT STAT, 2000, RES 1998 GEN HOUS SU; *OFF NAT STAT, 1997, MORT STAT GEN 1993 1; Peto R, 1999, NAT MED, V5, P15, DOI 10.1038/4691; Peto R, 1986, IARC Sci Publ, P211; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; PETO R, 2000, GLOBAL HLTH 21 CENTU; PETO R, 1994, MORTALITY TOBACCO DE; SCHREK R, 1950, CANCER RES, V10, P49; *STAT CORP, 1997, STAT STAT SOFTW REL; THUN MJ, 1995, AM J PUBLIC HEALTH, V85, P1223, DOI 10.2105/AJPH.85.9.1223; Wald N, 1988, UK SMOKING STAT; *WHO, MORT STAT UK 1950 19; WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001	25	922	956	1	125	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					323	329		10.1136/bmj.321.7257.323	http://dx.doi.org/10.1136/bmj.321.7257.323			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QH	10926586	Bronze, Green Published			2022-12-28	WOS:000088656300020
J	Morgan, DR; Trimble, M; McVeigh, GE				Morgan, DR; Trimble, M; McVeigh, GE			Atrial fibrillation associated with sumatriptan	BRITISH MEDICAL JOURNAL			English	Letter									Belfast City Hosp, Gen Med Dept, Belfast BT9 7AB, Antrim, North Ireland	Belfast City Hospital	Morgan, DR (corresponding author), Belfast City Hosp, Gen Med Dept, Belfast BT9 7AB, Antrim, North Ireland.							Lewis PJ, 1997, NEUROLOGY, V48, P1542, DOI 10.1212/WNL.48.6.1542; Ottervanger JP, 1997, EUR J CLIN PHARMACOL, V53, P105, DOI 10.1007/s002280050346; VanDenBrink AM, 1998, CIRCULATION, V98, P25, DOI 10.1161/01.CIR.98.1.25; Villalon CM, 1997, BRIT J PHARMACOL, V121, P1187, DOI 10.1038/sj.bjp.0701260	4	10	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					275	275		10.1136/bmj.321.7256.275	http://dx.doi.org/10.1136/bmj.321.7256.275			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915131	Green Published			2022-12-28	WOS:000088619800028
J	Perry, HM; Davis, BR; Price, TR; Applegate, WB; Fields, WS; Guralnik, JM; Kuller, L; Pressel, S; Stamler, J; Probstfield, JL				Perry, HM; Davis, BR; Price, TR; Applegate, WB; Fields, WS; Guralnik, JM; Kuller, L; Pressel, S; Stamler, J; Probstfield, JL		Systolic Hypertension Elderly Prog	Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke - The Systolic Hypertension in the Elderly Program (SHEP)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEMORRHAGE	Context The Systolic Hypertension in the Elderly Program (SHEP) demonstrated that treating isolated systolic hypertension in older patients decreased incidence of total stroke, but whether all types of stroke were reduced was not evaluated. Objective To investigate antihypertensive drug treatment effects on incidence of stroke by type and subtype, timing of strokes, case-fatality rates, stroke residual effects, and relationship of attained systolic blood pressure to stroke incidence. Design The SHEP study, a randomized, double-blind, placebo-controlled trial began March 1, 1985, and had an average follow-up of 4.5 years. Setting and Participants A total of 4736 men and women aged 60 years or older with isolated systolic hypertension at 16 clinical centers in the United States. Interventions Patients were randomly assigned to receive treatment with 12.5 mg/d of chlorthalidone (step 1); either 25 mg/d of atenolol or 0.05 mg/d of reserpine (step 2) could be added (n = 2365); or placebo (n = 2371). Main Outcome Measures Occurrence, type and subtype, and timing of first strokes and stroke fatalities; and change in stroke incidence for participants (whether in active treatment or placebo groups) reaching study-specific systolic blood pressure goal (decrease of at least 20 mm Hg from baseline to below 160 mm Hg) compared with participants not reaching goal. Results A total of 85 and 132 participants in the active treatment and placebo groups, respectively, had ischemic strokes (adjusted relative risk [RR], 0.63; 95% confidence interval [CI], 0.48-0.82); 9 and 19 had hemorrhagic strokes (adjusted RR, 0.46; 95% CI, 0.21-1.02); and 9 and 8 had strokes of unknown type (adjusted RR, 1.05; 95% CI, 0.40-2.73), respectively. Four subtypes of ischemic stroke were observed in active treatment and placebo group participants, respectively, as follows: for lacunar, n=23 and n=43 (adjusted RR, 0.53; 95% CI, 0.32-0.88); for embolic, n=9 and n=16 (adjusted RR, 0.56; 95% CI, 0.25-1.27); for atherosclerotic, n=13 and n=13 (adjusted RR, 0.99; 95% CI, 0.46-2.15); and for unknown subtype, n=40 and n=60 (adjusted RR, 0.64; 95% CI, 0.43-0.96). Treatment effect was observed within 1 year for hemorrhagic strokes but was not seen until the second year for ischemic strokes. Stroke incidence significantly decreased in participants attaining study-specific systolic blood pressure goals. Conclusions In this study, antihypertensive drug treatment reduced the incidence of both hemorrhagic and ischemic (including lacunar) strokes. Reduction in stroke incidence occurred when specific systolic blood pressure goals were attained.	Washington Univ, Dept Med, St Louis, MO 63110 USA; Univ Texas, Hlth Sci Ctr, Sch Publ Hlth, Houston, TX USA; Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; Wake Forest Univ, Dept Med, Winston Salem, NC 27109 USA; NIA, Bethesda, MD 20892 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; Northwestern Univ, Sch Med, Dept Prevent Med, Chicago, IL USA; Univ Washington, Dept Med, Seattle, WA USA	Washington University (WUSTL); University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University System of Maryland; University of Maryland Baltimore; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; University of Washington; University of Washington Seattle	Perry, HM (corresponding author), Washington Univ, Dept Med, Box 8048,660 S Euclid Ave, St Louis, MO 63110 USA.	mperry@imgate.wustl.edu						ANIM JI, 1989, E AFR MED J, V66, P468; [Anonymous], 1991, JAMA, V265, P3255; BAKER AB, 1969, CIRCULATION, V39, P701, DOI 10.1161/01.CIR.39.5.701; BORHANI NO, 1991, HYPERTENSION, V17, P2, DOI 10.1161/01.HYP.17.3_Suppl.II2; COLE FM, 1968, NEUROLOGY, V18, P255, DOI 10.1212/WNL.18.3.255; COX DR, 1972, J R STAT SOC B, V34, P187; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; FISHER CM, 1982, NEUROLOGY, V32, P871, DOI 10.1212/WNL.32.8.871; FOULKES MA, 1988, STROKE, V19, P547, DOI 10.1161/01.STR.19.5.547; FURLAN AJ, 1979, ANN NEUROL, V5, P367, DOI 10.1002/ana.410050410; HOSMER DW, 1989, APPL LOGISTIC REGRES; INZITARI D, 1986, STROKE, V17, P185, DOI 10.1161/01.STR.17.2.185; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; MAHONEY F I, 1965, Md State Med J, V14, P61; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; MOREAU T, 1986, BIOMETRIKA, V73, P513; PROBSTFIELD JL, 1988, J CLIN EPIDEMIOL, V41, P1197; ROSSRUSSELL RW, 1975, LANCET, V2, P1283; Snedecor GW, 1980, STAT METHODS, V7th; SPENCE JD, 1986, STROKE, V17, P808, DOI 10.1161/01.STR.17.5.808; WEILER PG, 1991, HYPERTENSION, V17, P152	21	211	219	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					465	471		10.1001/jama.284.4.465	http://dx.doi.org/10.1001/jama.284.4.465			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904510				2022-12-28	WOS:000088254200033
J	Douglas, C				Douglas, C			Power to the paperwork	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 22	2000	321	7255					249	249						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903672				2022-12-28	WOS:000088448100067
J	Loder, N				Loder, N			UK space strategy slammed as lacking funds and vision	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					222	222		10.1038/35018698	http://dx.doi.org/10.1038/35018698			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917494	Bronze			2022-12-28	WOS:000088251900005
J	Pearson, SD				Pearson, SD			Caring and cost: The challenge for physician advocacy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OREGON HEALTH PLAN; MANAGED CARE; CONTAINMENT; MEDICINE; COMMERCE; JUSTICE	How should physicians respond to the growing tension between care and cost? One option is to reinforce the ideal of doing everything to further the best interests of the individual patient. Others, however, have argued that because health care resources are shared and limited, physicians should consciously participate In rationing by saying "no" to patients' requests for some marginally beneficial services. But even physicians who endorse the idea of rationing wonder whether patient-physician relationships could ever survive a frank admission of rationing at the bedside. This article explores the idea that caring about costs can be brought to the bedside in a way that will sustain trust among patients and the public. By illustrating a hypothetical case and the ensuing conversation between a physician and her patient, a mode of "proportional" patient advocacy is presented in which physicians can remain forceful agents for patient good while acting within a framework that admits to the boundaries of responsible budgets for health care needs.	Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Pilgrim Hlth Care, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University	Pearson, SD (corresponding author), 126 Brookline Ave,Suite 200, Boston, MA 02215 USA.							ABRAMS FR, 1986, JAMA-J AM MED ASSOC, V256, P1784; Angell M, 1993, Kennedy Inst Ethics J, V3, P279; [Anonymous], 1990, NEW MED OLD ETHICS; Bodenheimer T, 1997, NEW ENGL J MED, V337, P651, DOI 10.1056/NEJM199708283370923; DANIELS N, 1986, NEW ENGL J MED, V314, P1380, DOI 10.1056/NEJM198605223142109; Davidoff F, 1998, ANN INTERN MED, V128, P496, DOI 10.7326/0003-4819-128-6-199803150-00012; Davidoff F, 1998, ANN INTERN MED, V128, P572, DOI 10.7326/0003-4819-128-7-199804010-00011; EDDY DM, 1994, JAMA-J AM MED ASSOC, V272, P817, DOI 10.1001/jama.272.10.817; Hall MA, 1998, ANN INTERN MED, V128, P395, DOI 10.7326/0003-4819-128-5-199803010-00009; HIATT HH, 1975, NEW ENGL J MED, V293, P235, DOI 10.1056/NEJM197507312930506; Jacobs L, 1999, J HEALTH POLIT POLIC, V24, P161, DOI 10.1215/03616878-24-1-161; LEVINSKY NG, 1984, NEW ENGL J MED, V311, P1573, DOI 10.1056/NEJM198412133112412; MORREIM EH, 1995, J LAW MED ETHICS, V23, P247, DOI 10.1111/j.1748-720X.1995.tb01361.x; MORREIM EH, 1989, ARCH INTERN MED, V149, P1012, DOI 10.1001/archinte.149.5.1012; Pearson SD, 1998, NEW ENGL J MED, V339, P689, DOI 10.1056/NEJM199809033391009; PELLEGRINO ED, 1988, PATIENTS GOOD RESTOR, P54; PELLEGRINO ED, 1995, DISMEMBERING HIPPOCR, P11; RELMAN AS, 1990, NEW ENGL J MED, V322, P1809, DOI 10.1056/NEJM199006213222510; RELMAN AS, 1986, FOR PROFIT ENTERPRIS, P209; SULMASY DP, 1992, ANN INTERN MED, V116, P920, DOI 10.7326/0003-4819-116-11-920; Ubel PA, 1998, AM J MED, V104, P64, DOI 10.1016/S0002-9343(97)00172-1; UBEL PA, 1995, ARCH INTERN MED, V155, P1837, DOI 10.1001/archinte.155.17.1837; WOOLHANDLER S, 1995, NEW ENGL J MED, V333, P1706, DOI 10.1056/NEJM199512213332510; Woolhandler S, 1999, NEW ENGL J MED, V341, P444, DOI 10.1056/NEJM199908053410611	24	53	54	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2000	133	2					148	153		10.7326/0003-4819-133-2-200007180-00014	http://dx.doi.org/10.7326/0003-4819-133-2-200007180-00014			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335RL	10896641				2022-12-28	WOS:000088258500008
J	Simpson, AJG; Reinach, FC; Arruda, P; Abreu, FA; Acencio, M; Alvarenga, R; Alves, LMC; Araya, JE; Baia, GS; Baptista, CS; Barros, MH; Bonaccorsi, ED; Bordin, S; Bove, JM; Briones, MRS; Bueno, MRP; Camargo, AA; Camargo, LEA; Carraro, DM; Carrer, H; Colauto, NB; Colombo, C; Costa, FF; Costa, MCR; Costa-Neto, CM; Coutinho, LL; Cristofani, M; Dias-Neto, E; Docena, C; El-Dorry, H; Facincani, AP; Ferreira, AJS; Ferreira, VCA; Ferro, JA; Fraga, JS; Franca, SC; Franco, MC; Frohme, M; Furlan, LR; Garnier, M; Goldman, GH; Goldman, MHS; Gomes, SL; Gruber, A; Ho, PL; Hoheisel, JD; Junqueira, ML; Kemper, EL; Kitajima, JP; Krieger, JE; Kuramae, EE; Laigret, F; Lambais, MR; Leite, LCC; Lemos, EGM; Lemos, MVF; Lopes, SA; Lopes, CR; Machado, JA; Machado, MA; Madeira, AMBN; Madeira, HMF; Marino, CL; Marques, MV; Martins, EAL; Martins, EMF; Matsukuma, AY; Menck, CFM; Miracca, EC; Miyaki, CY; Monteiro-Vitorello, CB; Moon, DH; Nagai, MA; Nascimento, ALTO; Netto, LES; Nhani, A; Nobrega, FG; Nunes, LR; Oliveira, MA; de Oliveira, MC; de Oliveira, RC; Palmieri, DA; Paris, A; Peixoto, BR; Pereira, GAG; Pereira, HA; Pesquero, JB; Quaggio, RB; Roberto, PG; Rodrigues, V; Rosa, AJD; de Rosa, VE; de Sa, RG; Santelli, RV; Sawasaki, HE; da Silva, ACR; da Silva, AM; da Silva, FR; Silva, WA; da Silveira, JF; Silvestri, MLZ; Siqueira, WJ; de Souza, AA; de Souza, AP; Terenzi, MF; Truffi, D; Tsai, SM; Tsuhako, MH; Vallada, H; Van Sluys, MA; Verjovski-Almeida, S; Vettore, AL; Zago, MA; Zatz, M; Meidanis, J; Setubal, JC				Simpson, AJG; Reinach, FC; Arruda, P; Abreu, FA; Acencio, M; Alvarenga, R; Alves, LMC; Araya, JE; Baia, GS; Baptista, CS; Barros, MH; Bonaccorsi, ED; Bordin, S; Bove, JM; Briones, MRS; Bueno, MRP; Camargo, AA; Camargo, LEA; Carraro, DM; Carrer, H; Colauto, NB; Colombo, C; Costa, FF; Costa, MCR; Costa-Neto, CM; Coutinho, LL; Cristofani, M; Dias-Neto, E; Docena, C; El-Dorry, H; Facincani, AP; Ferreira, AJS; Ferreira, VCA; Ferro, JA; Fraga, JS; Franca, SC; Franco, MC; Frohme, M; Furlan, LR; Garnier, M; Goldman, GH; Goldman, MHS; Gomes, SL; Gruber, A; Ho, PL; Hoheisel, JD; Junqueira, ML; Kemper, EL; Kitajima, JP; Krieger, JE; Kuramae, EE; Laigret, F; Lambais, MR; Leite, LCC; Lemos, EGM; Lemos, MVF; Lopes, SA; Lopes, CR; Machado, JA; Machado, MA; Madeira, AMBN; Madeira, HMF; Marino, CL; Marques, MV; Martins, EAL; Martins, EMF; Matsukuma, AY; Menck, CFM; Miracca, EC; Miyaki, CY; Monteiro-Vitorello, CB; Moon, DH; Nagai, MA; Nascimento, ALTO; Netto, LES; Nhani, A; Nobrega, FG; Nunes, LR; Oliveira, MA; de Oliveira, MC; de Oliveira, RC; Palmieri, DA; Paris, A; Peixoto, BR; Pereira, GAG; Pereira, HA; Pesquero, JB; Quaggio, RB; Roberto, PG; Rodrigues, V; Rosa, AJD; de Rosa, VE; de Sa, RG; Santelli, RV; Sawasaki, HE; da Silva, ACR; da Silva, AM; da Silva, FR; Silva, WA; da Silveira, JF; Silvestri, MLZ; Siqueira, WJ; de Souza, AA; de Souza, AP; Terenzi, MF; Truffi, D; Tsai, SM; Tsuhako, MH; Vallada, H; Van Sluys, MA; Verjovski-Almeida, S; Vettore, AL; Zago, MA; Zatz, M; Meidanis, J; Setubal, JC		Xylella fastidiosa Consortium Org	The genome sequence of the plant pathogen Xylella fastidiosa	NATURE			English	Article							CITRUS VARIEGATED CHLOROSIS; VIRULENCE FACTORS; SWEET ORANGE; HAEMOPHILUS-INFLUENZAE; DICHELOBACTER-NODOSUS; LIMITED BACTERIUM; ESCHERICHIA-COLI; RTX TOXINS; IDENTIFICATION; SECRETION	Xylella fastidiosa is a fastidious, xylem-limited bacterium that causes a range of economically important plant diseases. Here we report the complete genome sequence of X. fastidiosa clone 9a5c, which causes citrus variegated chlorosis-a serious disease of orange trees. The genome comprises a 52.7% GC-rich 2,679,305-base-pair (bp) circular chromosome and two plasmids of 51,158 bp and 1,285 bp. We can assign putative functions to 47% of the 2,904 predicted coding regions. Efficient metabolic functions are predicted, with sugars as the principal energy and carbon source, supporting existence in the nutrient-poor xylem sap. The mechanisms associated with pathogenicity and virulence involve toxins, antibiotics and ion sequestration systems, as well as bacterium-bacterium and bacterium-host interactions mediated by a range of proteins. Orthologues of some of these proteins have only been identified in animal and human pathogens; their presence in X. fastidiosa indicates that the molecular basis for bacterial pathogenicity is both conserved and independent of host. At least 83 genes are bacteriophage-derived and include virulence-associated genes from other bacteria, providing direct evidence of phage-mediated horizontal gene transfer.	Univ Estadual Campinas, Inst Computacao, BR-13083970 Campinas, SP, Brazil; Inst Ludwig Pesquisa Canc, BR-01509010 Sao Paulo, Brazil; Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil; Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, BR-13083970 Campinas, SP, Brazil; Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Patol, Mol Biol Lab, BR-05508000 Sao Paulo, Brazil; Univ Sao Paulo, Fac Med, Dept Radiol, Disciplina Oncol, BR-01296903 Sao Paulo, Brazil; Univ Estadual Paulista, Fac Ciencias Agr & Vet Jaboticabal, Dept Tecnol, BR-14884900 Jaboticabal, SP, Brazil; Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, BR-04023062 Sao Paulo, Brazil; Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, BR-05508900 Sao Paulo, Brazil; Univ Estadual Campinas, Fac Ciencias Med, Hemoctr, BR-13083970 Campinas, SP, Brazil; INRA, F-33883 Vilenave Dornon, France; Univ Bordeaux 2, Biol Cellulaire & Mol Lab, F-33883 Vilenave Dornon, France; Univ Sao Paulo, Inst Biociencias, Dept Biol, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, BR-13418900 Piracicaba, SP, Brazil; Univ Estadual Paulista, Inst Biociencias, Dept Genet, BR-18618000 Botucatu, SP, Brazil; Inst Agron Campinas, Ctr Genet Biol Mol & Fitoquim, BR-13001970 Campinas, SP, Brazil; Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, BR-14049900 Ribeirao Preto, SP, Brazil; Univ Fed Sao Paulo, Escola Paulista Med, Dept Biofis, BR-04023062 Sao Paulo, Brazil; Inst Agron Campinas, Ctr Citricultura Sylvio Moreira, BR-13490970 Cordeiropolis, SP, Brazil; Inst Biol, Lab Bioquim Fitopatol, BR-04014002 Sao Paulo, Brazil; Inst Biol, Lab Imunol, BR-04014002 Sao Paulo, Brazil; Univ Ribeirao Preto, Dept Biotecnol Plantas Med, BR-14096380 Ribeirao Preto, SP, Brazil; Univ Sao Paulo, Ctr Energia Nucl Agr, BR-13400970 Piracicaba, SP, Brazil; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; Univ Estadual Paulista, Fac Med Vet & Zootecnia, Dept Melhoramento & Nutr, BR-18600000 Botucatu, SP, Brazil; Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Ciencias Farmaceut, BR-14040903 Ribeirao Preto, SP, Brazil; Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Pret, Dept Biol, BR-14040901 Ribeirao Preto, SP, Brazil; Inst Butantan, Ctr Biotecnol, BR-05503900 Sao Paulo, Brazil; Univ Sao Paulo, Fac Med, Inst Coracao, Lab Genet & Cardiol Mol LIM 13, BR-05403000 Sao Paulo, Brazil; Univ Estadual Paulista, Fac Ciencias Agron, Dept Prod Vegetal, BR-18603970 Botucatu, SP, Brazil; Univ Estadual Paulista, Fac Ciencias Agr & Vet Jaboticabal, Dept Biol Aplicada Agropecuaria, BR-14884900 Jaboticabal, SP, Brazil; Hosp Canc AC Camargo, BR-01509010 Sao Paulo, Brazil; Univ Mogi das Cruzes, Nucleo Integrado Biotecnol, BR-08780911 Mogi Das Cruzes, SP, Brazil; Univ Estadual Campinas, Inst Biol, Dept Genet & Evolucao, BR-13083970 Campinas, SP, Brazil; Univ Sao Paulo, Inst Biociencias, Dept Bot, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Parasitol Microbiol & Imunol, BR-14049900 Ribeirao Preto, SP, Brazil; Univ Sao Paulo, Fac Med, Inst Psiquiatria, Dept Psiquiatria, BR-05403010 Sao Paulo, Brazil; Univ Vale Paraiba, Sao Jose dos Campos, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Estadual de Campinas; INRAE; UDICE-French Research Universities; Universite de Bordeaux; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista; Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Ribeirao Preto; Universidade de Sao Paulo; Helmholtz Association; German Cancer Research Center (DKFZ); Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Estadual Paulista; A.C.Camargo Cancer Center; Universidade de Mogi das Cruzes; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade do Vale do Paraiba	Setubal, JC (corresponding author), Univ Estadual Campinas, Inst Computacao, Caixa Postal 6176, BR-13083970 Campinas, SP, Brazil.	setubal@ic.unicamp.br	de Souza, Alessandra Alves/GLR-7357-2022; Camargo, Luis Eduardo A/C-2735-2012; Gomes, Suely Lopes/D-8938-2012; Goldman, Gustavo Henrique/F-1848-2013; Coutinho, Luiz L/C-8455-2012; da Silveira, Jose Franco/F-5390-2012; Lopes Gomes, Suely/HGC-5280-2022; Vallada, Homero/D-1333-2014; Alves, Lucia/D-2270-2012; Simpson, Amelia/HGB-1823-2022; Briones, Marcelo RS/C-5760-2013; Netto, Luis/A-3783-2008; Coutinho, Luiz/P-5233-2019; Lambais, Marcio R/C-1319-2012; Nagai, Maria A/C-6162-2012; Gruber, Arthur/B-4711-2011; Carrer, Helaine/C-3159-2012; LEMOS, ELIANA GM/A-3604-2008; da Silva, Felipe Rodrigues/A-5627-2008; Meidanis, Joao/P-8140-2015; Barros, Mario/Q-6358-2019; Barros, Mario H/B-8118-2012; Madeira, Humberto/C-2212-2008; Leite, Luciana/D-1353-2012; Dias-Neto, Emmanuel/AAE-9147-2020; Lopes, Silvio/L-8100-2016; Dias-Neto, Emmanuel/AAA-6701-2019; Menck, Carlos FM/G-6321-2011; de Oliveira, Mariana Cabral/G-2512-2012; Setubal, Joao Carlos/C-7305-2012; Pereira, Gonçalo A. G./B-7944-2012; Tsai, Siu Mui/C-2793-2012; Palmieri, Darío/C-3613-2012; carraro, dirce/C-9179-2009; Marques, Marilis V/C-3085-2013; Colauto, Nelson/AAG-5416-2019; Papais-Alvarenga, Regina M/A-9385-2012; Cristofani-Yaly, Mariângela/D-2288-2012; Pesquero, Joao/C-1470-2012; Goldman, Maria Helena S./D-1424-2012; Camargo, Anamaria A/E-9388-2012; Ferreira, Ari J S/C-2266-2015; Nhani, Antonio/P-2317-2017; Acencio, Marcio Luis/ABH-1930-2020; Pereira, Alexandre/HHN-1038-2022; Camargo, Luis Eduardo Aranha/Y-9954-2019; Van Sluys, Marie-Anne/A-8483-2012; Zatz, Mayana/M-5338-2015; Dias-Neto, Emmanuel/A-5869-2008; Marino, celso/AAH-2836-2020; Miyaki, Cristina Y/J-2431-2015; Machado, Marcos/G-3582-2012; Bordin, Silvana/G-3147-2012; ZAGO, MARCO A/E-9442-2017; Silva Jr, Wilson Araújo/E-9487-2011; Madeira, AMBN/E-7971-2012; de Macedo Lemos, Eliana Gertrudes/AAA-4225-2020; Costa, Fernando F/D-1566-2012; Costa de Oliveira, Regina/A-4571-2017; Monteiro-Vitorello, Claudia B/F-2436-2012; Kuramae, Eiko Eurya/F-4738-2012; Verjovski-Almeida, Sergio/E-4082-2012; Acencio, Marcio L/D-9264-2012; Ferro, Jesus Aparecido A/C-8251-2013; Lopes, Silvio/X-6733-2019; Krieger, Jose E/C-3117-2011; da Silva, Aline Maria/C-3649-2012; Nunes, Luiz R/M-4804-2013; Arruda, Paulo/H-1440-2011; DE SOUZA, ANETE PEREIRA/B-8663-2012; Siqueira, Walter/ABE-4069-2021; de Oliveira, Marcos A/K-5746-2015; alves, lucia maria carareto/AAH-6555-2020; Vettore, Andre L/J-5168-2012; Ho, Paulo/P-8267-2015; Nascimento, Ana L. T. O./E-8488-2012; Martins, Elizabeth AL/B-7135-2015; De Souza, Alessandra/C-3458-2012; Franca, Suzelei/E-4069-2013; Costa-Neto, Claudio/K-7291-2015; Rosa, Artur/H-7093-2013	de Souza, Alessandra Alves/0000-0003-4589-8355; Camargo, Luis Eduardo A/0000-0002-5650-5695; Gomes, Suely Lopes/0000-0002-3367-9676; Goldman, Gustavo Henrique/0000-0002-2986-350X; Coutinho, Luiz L/0000-0002-7266-8881; Vallada, Homero/0000-0001-5123-8295; Alves, Lucia/0000-0002-9328-2726; Netto, Luis/0000-0002-4250-9177; Coutinho, Luiz/0000-0002-7266-8881; Lambais, Marcio R/0000-0002-7218-3665; Nagai, Maria A/0000-0002-0728-4937; Gruber, Arthur/0000-0001-8093-2278; Carrer, Helaine/0000-0002-9329-1841; LEMOS, ELIANA GM/0000-0002-1119-7748; da Silva, Felipe Rodrigues/0000-0002-3527-6870; Barros, Mario/0000-0003-2977-9815; Madeira, Humberto/0000-0002-0567-8246; Leite, Luciana/0000-0003-0156-1312; Lopes, Silvio/0000-0002-7417-3057; Menck, Carlos FM/0000-0003-1941-0694; de Oliveira, Mariana Cabral/0000-0001-8495-2962; Setubal, Joao Carlos/0000-0001-9174-2816; Tsai, Siu Mui/0000-0002-3733-6312; Palmieri, Darío/0000-0003-0841-6257; carraro, dirce/0000-0001-5667-1418; Colauto, Nelson/0000-0003-4390-8302; Cristofani-Yaly, Mariângela/0000-0003-0283-989X; Pesquero, Joao/0000-0002-4507-632X; Goldman, Maria Helena S./0000-0002-6786-9320; Camargo, Anamaria A/0000-0002-6076-9597; Ferreira, Ari J S/0000-0002-7526-5543; Nhani, Antonio/0000-0002-3096-4009; Acencio, Marcio Luis/0000-0002-8278-240X; Camargo, Luis Eduardo Aranha/0000-0002-5650-5695; Van Sluys, Marie-Anne/0000-0002-6506-2734; Zatz, Mayana/0000-0003-3970-8025; Dias-Neto, Emmanuel/0000-0001-5670-8559; Miyaki, Cristina Y/0000-0002-9708-9202; Machado, Marcos/0000-0001-9780-3990; Bordin, Silvana/0000-0002-0192-8869; Silva Jr, Wilson Araújo/0000-0001-9364-2886; Madeira, AMBN/0000-0002-3917-1849; de Macedo Lemos, Eliana Gertrudes/0000-0002-1119-7748; Costa, Fernando F/0000-0002-4632-572X; Costa de Oliveira, Regina/0000-0002-2446-5510; Monteiro-Vitorello, Claudia B/0000-0002-1238-9354; Kuramae, Eiko Eurya/0000-0001-6701-8668; Verjovski-Almeida, Sergio/0000-0002-6356-2401; Acencio, Marcio L/0000-0002-8278-240X; Ferro, Jesus Aparecido A/0000-0002-3966-1303; Krieger, Jose E/0000-0001-5464-1792; da Silva, Aline Maria/0000-0001-9249-4922; Nunes, Luiz R/0000-0001-9619-269X; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; de Oliveira, Marcos A/0000-0002-1192-7296; Vettore, Andre L/0000-0001-8526-5478; Ho, Paulo/0000-0003-3652-241X; Nascimento, Ana L. T. O./0000-0003-4851-0870; Martins, Elizabeth AL/0000-0002-2333-9379; Franca, Suzelei/0000-0003-4864-430X; Costa-Neto, Claudio/0000-0002-7256-6412; ROBERTO, PATRICIA/0000-0001-8932-4666; Marino, Celso/0000-0003-4524-954X; Briones, Marcelo/0000-0001-8045-2477; colombo, carlos/0000-0003-3269-6068; Rosa, Artur/0000-0002-7015-9207; Marques, Marilis/0000-0003-1542-8221				Alfano JR, 1997, J BACTERIOL, V179, P5655, DOI 10.1128/jb.179.18.5655-5662.1997; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Billington SJ, 1996, FEMS MICROBIOL LETT, V145, P147, DOI 10.1111/j.1574-6968.1996.tb08570.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bridges BA, 1999, CURR BIOL, V9, pR475, DOI 10.1016/S0960-9822(99)80299-1; BRLANSKY RH, 1983, PHYTOPATHOLOGY, V73, P530, DOI 10.1094/Phyto-73-530; Brodbeck BV, 1999, ARCH INSECT BIOCHEM, V42, P37, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;37::AID-ARCH5&gt;3.0.CO;2-9; CHAGAS CM, 1992, J PHYTOPATHOL, V134, P306, DOI 10.1111/j.1439-0434.1992.tb01238.x; CHANG CJ, 1993, CURR MICROBIOL, V27, P137, DOI 10.1007/BF01576010; Cope LD, 1999, J BACTERIOL, V181, P4026, DOI 10.1128/JB.181.13.4026-4034.1999; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FERAT JL, 1993, NATURE, V364, P358, DOI 10.1038/364358a0; Fernandez LA, 2000, FEMS MICROBIOL REV, V24, P21, DOI 10.1111/j.1574-6976.2000.tb00531.x; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HAVARSTEIN LS, 1994, MICROBIOL-SGM, V140, P2383, DOI 10.1099/13500872-140-9-2383; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; HOBEISEL JD, 1993, CELL, V73, P109; KATZ ME, 1992, INFECT IMMUN, V60, P4586, DOI 10.1128/IAI.60.11.4586-4592.1992; KNOOP V, 1994, J MOL BIOL, V242, P389, DOI 10.1006/jmbi.1994.1589; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Li WB, 1999, CURR MICROBIOL, V39, P106, DOI 10.1007/s002849900428; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Merlin C, 1999, PLASMID, V41, P40, DOI 10.1006/plas.1998.1375; Mhlanga-Mutangadura T, 1998, J BACTERIOL, V180, P4693, DOI 10.1128/JB.180.17.4693-4703.1998; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Oresnik IJ, 1999, APPL ENVIRON MICROB, V65, P2833; Paulsen IT, 1998, J MOL BIOL, V277, P573, DOI 10.1006/jmbi.1998.1609; Preston GM, 1998, CURR OPIN MICROBIOL, V1, P589, DOI 10.1016/S1369-5274(98)80094-5; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; RAJU BC, 1986, PLANT DIS, V70, P182, DOI 10.1094/PD-70-182; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Roberto Sergio R., 1996, Fitopatologia Brasileira, V21, P517; ROSSETTI V, 1990, CR ACAD SCI III-VIE, V310, P345; Simpson AJG, 1998, NAT BIOTECHNOL, V16, P795, DOI 10.1038/nbt0998-795; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; StGeme JW, 1996, AM J RESP CRIT CARE, V154, pS192, DOI 10.1164/ajrccm/154.4_Pt_2.S192; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; YE FC, 1994, CURR MICROBIOL, V29, P23, DOI 10.1007/BF01570187; YE FC, 1992, NUCLEIC ACIDS RES, V20, P1559, DOI 10.1093/nar/20.7.1559; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456	50	668	1221	16	243	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					151	157		10.1038/35018003	http://dx.doi.org/10.1038/35018003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910347	Bronze			2022-12-28	WOS:000088221100037
J	Sukhishvili, SA; Chen, Y; Muller, JD; Gratton, E; Schweizer, KS; Granick, S				Sukhishvili, SA; Chen, Y; Muller, JD; Gratton, E; Schweizer, KS; Granick, S			Materials science - Diffusion of a polymer 'pancake'	NATURE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; 2 DIMENSIONS		Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; Univ Illinois, Dept Phys, Fluorescence Dynam Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Sukhishvili, SA (corresponding author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.							Azuma R, 1999, J CHEM PHYS, V111, P8666, DOI 10.1063/1.480206; BERLAND KM, 1995, BIOPHYS J, V68, P694, DOI 10.1016/S0006-3495(95)80230-4; De Gennes P.-G., 1979, SCALING CONCEPTS POL; des Cloizeaux J., 1990, POLYM SOLUTIONS; HUBER K, 1985, MACROMOLECULES, V18, P1461, DOI 10.1021/ma00149a017; KESSEL CR, 1991, LANGMUIR, V7, P532, DOI 10.1021/la00051a020; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; Maier B, 1999, PHYS REV LETT, V82, P1911, DOI 10.1103/PhysRevLett.82.1911; SLATER GW, 1995, PHYS REV LETT, V75, P164, DOI 10.1103/PhysRevLett.75.164; SO PTC, 1995, BIOIMAGING, V3, P1; Yuko K., 1984, POLYM COMMUN, V25, P154	11	157	161	1	71	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					146	146		10.1038/35018166	http://dx.doi.org/10.1038/35018166			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910345	Bronze			2022-12-28	WOS:000088221100035
J	Henney, JE				Henney, JE			New system for monitoring intrapartum fetal oxygen saturation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2000	284	1					33	33		10.1001/jama.284.1.33	http://dx.doi.org/10.1001/jama.284.1.33			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328GX	10905906				2022-12-28	WOS:000087843000004
J	Rigotti, NA; Lee, JE; Wechsler, H				Rigotti, NA; Lee, JE; Wechsler, H			US college students' use of tobacco products - Results of a national survey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BINGE-DRINKING; CIGAR SMOKING; PREVALENCE	Context Adults aged 18 to 24 years, many of whom are in college, represent the youngest legal targets for tobacco industry marketing. Cigarette smoking has been described among college students, but little is known about noncigarette tobacco use by college students or cigar use by adults of any age. Objectives To assess the prevalence of all forms of tobacco use (cigarettes, cigars, pipes, and smokeless tobacco) among US college students and to identify student- and college-level factors associated with use of each product. Design The Harvard College Alcohol Survey, a self-administered survey conducted in 1999. Setting One hundred nineteen nationally representative US 4-year colleges. Subjects A total of 14138 randomly selected students (60% response rate). Main Outcome Measures Self-report of current (in the past 30 days), past-year, and lifetime use of cigarettes, cigars, pipes, smokeless tobacco, and all tobacco products. Results Nearly half (45.7%) of respondents had used a tobacco product in the past year and one third (32.9%) currently used tobacco. Cigarettes accounted for most of the tobacco use (28.5% current prevalence), but cigar use was also substantial (37.1% lifetime prevalence, 23.0% past-year prevalence, and 8.5% current prevalence) and combinations of the 2 were common. Total tobacco use was higher in men than in women (37.9% vs 29.7%; P<.001), despite nearly identical current cigarette smoking rates between the sexes (28.5% for women vs 28.4% for men), because of greater use of cigars (current prevalence, 15.7% vs 3.9%; P<.001) and smokeless tobacco (current prevalence, 8.7% vs 0.4%; P<.001) by men. Tobacco use was significantly higher among white students (P<.001), users of other substances (alcohol and marijuana) (P<.001), and students whose priorities were social rather than educational or athletic (P<.05). Among students who had used both cigars and cigarettes, only 8.9% smoked cigars at an earlier age than they had smoked cigarettes. Conclusion Our study indicates that tobacco use is common among college students and is not limited to cigarettes. College appears to be a time when many students are trying a range of tobacco products and are in danger of developing lifelong nicotine dependence. National efforts to monitor and reduce tobacco use of all types should expand to focus on college students and other young adults.	Massachusetts Gen Hosp, Dept Med, Div Gen Med, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Hlth & Social Behav, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Rigotti, NA (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Gen Med, Tobacco Res & Treatment Ctr, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	nrigotti@partners.org						CARABALLO RS, 1998, ANN M SOC RES NIC TO; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, pSS; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P986; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P229; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P433; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P248; Emmons KM, 1998, AM J PUBLIC HEALTH, V88, P104, DOI 10.2105/AJPH.88.1.104; FRIER ME, 1991, TEENS TELL TRUTH VAL; Gilpin EA, 1999, AM J PREV MED, V16, P195, DOI 10.1016/S0749-3797(98)00092-0; Hatsukami D K, 1999, Nicotine Tob Res, V1, P21, DOI 10.1080/14622299050011131; Healton C, 2000, MMWR Morb Mortal Wkly Rep, V49, P49; Hyland A, 1998, AM J PUBLIC HEALTH, V88, P1086, DOI 10.2105/AJPH.88.7.1086; Jamner MS, 1999, PREV MED, V29, P187, DOI 10.1006/pmed.1999.0521; *NAT CTR ED STAT, 1996, NCES PUBL US DEP ED; U.S. Bureau of the Census, 1997, STAT ABSTR US 1997; *US BUR CENS, 1997, CURR POP REP P20443; *US DEP AGR, 1999, TOB SIT OUTL REP; *US DEP ED, 1997, DIG ED STAT; *US DEP HHS, 1998, NIH PUBL US DEP HHS; US Department of Health and Human Services, 1986, HLTH CONS INV SMOK R; WECHSLER H, 1992, JAMA-J AM MED ASSOC, V267, P2929; WECHSLER H, 1994, JAMA-J AM MED ASSOC, V272, P1672, DOI 10.1001/jama.272.21.1672; Wechsler H, 1998, JAMA-J AM MED ASSOC, V280, P1673, DOI 10.1001/jama.280.19.1673; WECHSLER H, 1995, AM J PUBLIC HEALTH, V85, P921, DOI 10.2105/AJPH.85.7.921; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; [No title captured]; 1999, MMWR MORB MORTAL WKL, V48, P993	27	403	408	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					699	705		10.1001/jama.284.6.699	http://dx.doi.org/10.1001/jama.284.6.699			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	341JM	10927777	Bronze			2022-12-28	WOS:000088587300027
J	Lancaster, T; Stead, L; Silagi, C; Sowden, A				Lancaster, T; Stead, L; Silagi, C; Sowden, A		Cochrane Tobacco Addiction Review	Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library	BRITISH MEDICAL JOURNAL			English	Review							NICOTINE PATCH; CESSATION; TRIAL		Univ Oxford, Inst Hlth Sci, Imperial Canc Res Fund, Gen Practice Res Grp,Dept Primary Hlth Care, Oxford OX3 7LF, England; Monash Med Ctr, Monash Inst Publ Hlth, Clayton, Vic 3168, Australia; Univ York, NHS Ctr Reviews & Disseminat, York YO1 5DD, N Yorkshire, England	University of Oxford; Monash University; University of York - UK	Lancaster, T (corresponding author), Univ Oxford, Inst Hlth Sci, Imperial Canc Res Fund, Gen Practice Res Grp,Dept Primary Hlth Care, Oxford OX3 7LF, England.							Abbot NC, 2000, COCHRANE LIB; Blondal T, 1999, BRIT MED J, V318, P285, DOI 10.1136/bmj.318.7179.285; *GLAX, 1999, ZYB BUPR HYDR SUST R; Gourlay SG, 2000, COCHRANE LIB; Hajek P, 2000, COCHRANE LIB; HOLLIS JF, 1993, ANN INTERN MED, V118, P521, DOI 10.7326/0003-4819-118-7-199304010-00006; Hughes JR, 1999, TOB CONTROL, V8, P323, DOI 10.1136/tc.8.3.323; Hughes JR, 1999, NEW ENGL J MED, V341, P610; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; LANCASTER T, 2000, COCHRANE LIB; McAvoy BR, 1999, BRIT J GEN PRACT, V49, P187; NIAURA R, 1997, ANN BEHAV MED, V19, pS42; PETO R, IN PRESS CRITICAL IS; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Raw M, 1998, THORAX, V53, pS1, DOI 10.1136/thx.53.2008.S1; RICE VH, 2000, COCHRANE LIB; SILAGY C, 2000, COCHRANE LIB; STEAD LF, 2000, COCHRANE LIB; Stead LF, 2000, COCHRANE LIB; USSHER MH, 2000, COCHRANE LIB; WHITE AR, 2000, COCHRANE LIB; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	22	346	362	0	21	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					355	358		10.1136/bmj.321.7257.355	http://dx.doi.org/10.1136/bmj.321.7257.355			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QH	10926597	Green Published			2022-12-28	WOS:000088656300028
J	Matzdorf, R; Fang, Z; Ismail; Zhang, JD; Kimura, T; Tokura, Y; Terakura, K; Plummer, EW				Matzdorf, R; Fang, Z; Ismail; Zhang, JD; Kimura, T; Tokura, Y; Terakura, K; Plummer, EW			Ferromagnetism stabilized by lattice distortion at the surface of the p-wave superconductor Sr2RuO4	SCIENCE			English	Article							EXTENDED VANHOVE SINGULARITY; SPIN FLUCTUATIONS; LAYERED PEROVSKITE; FERMI-SURFACE; RUSR2GDCU2O8; TRIPLET	Ferromagnetic (FM) spin fluctuations are believed to mediate the spin-triplet pairing for the rho-wave superconductivity in Sr2RuO4. Our experiments show that, at the surface, a bulk soft-phonon mode freezes into a static Lattice distortion associated with an in-plane rotation of the RuO6 octahedron. First-principle calculations confirm this structure and predict a FM ground state at the surface. This coupling between structure and magnetism in the environment of broken symmetry at the surface allows a reconsideration of the coupling mechanism in the bulk.	Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Florida Int Univ, Dept Phys, Miami, FL 33199 USA; Joint Res Ctr Atom Technol, Tsukuba, Ibaraki 3050046, Japan; Univ Tokyo, Dept Appl Phys, Tokyo 1130033, Japan	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; State University System of Florida; Florida International University; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Matzdorf, R (corresponding author), Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA.		Kimura, Tsuyoshi/F-8090-2018; Fang, Zhong/D-4132-2009; Tokura, Yoshinori/C-7352-2009	Tokura, Yoshinori/0000-0002-2732-4983				Agterberg DF, 1997, PHYS REV LETT, V78, P3374, DOI 10.1103/PhysRevLett.78.3374; Bernhard C, 1999, PHYS REV B, V59, P14099, DOI 10.1103/PhysRevB.59.14099; Braden M, 1997, PHYSICA C, V273, P248, DOI 10.1016/S0921-4534(96)00637-5; Braden M, 1998, PHYS REV B, V57, P1236, DOI 10.1103/PhysRevB.57.1236; de Boer PK, 1999, PHYS REV B, V59, P9894, DOI 10.1103/PhysRevB.59.9894; Imai T, 1998, PHYS REV LETT, V81, P3006, DOI 10.1103/PhysRevLett.81.3006; Lu DH, 1996, PHYS REV LETT, V76, P4845, DOI 10.1103/PhysRevLett.76.4845; Luke GM, 1998, NATURE, V394, P558, DOI 10.1038/29038; Mackenzie AP, 1996, PHYS REV LETT, V76, P3786, DOI 10.1103/PhysRevLett.76.3786; MAENO Y, 1994, NATURE, V372, P532, DOI 10.1038/372532a0; Mazin II, 1997, PHYS REV LETT, V79, P733, DOI 10.1103/PhysRevLett.79.733; Mazin II, 1999, PHYS REV LETT, V82, P4324, DOI 10.1103/PhysRevLett.82.4324; Mott N.F., 1990, METAL INSULATOR TRAN; Mukuda H, 1999, PHYS REV B, V60, P12279, DOI 10.1103/PhysRevB.60.12279; OGUCHI T, 1995, PHYS REV B, V51, P1385, DOI 10.1103/PhysRevB.51.1385; Pickett WE, 1999, PHYS REV LETT, V83, P3713, DOI 10.1103/PhysRevLett.83.3713; Puchkov AV, 1998, PHYS REV B, V58, P13322, DOI 10.1103/PhysRevB.58.R13322; RICE TM, 1995, J PHYS-CONDENS MAT, V7, pL643, DOI 10.1088/0953-8984/7/47/002; Sidis Y, 1999, PHYS REV LETT, V83, P3320, DOI 10.1103/PhysRevLett.83.3320; Tewordt L, 1999, PHYS REV LETT, V83, P1007, DOI 10.1103/PhysRevLett.83.1007; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Yokoya T, 1996, PHYS REV LETT, V76, P3009, DOI 10.1103/PhysRevLett.76.3009	22	199	199	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					746	748		10.1126/science.289.5480.746	http://dx.doi.org/10.1126/science.289.5480.746			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926529				2022-12-28	WOS:000088581500030
J	Lau, JYW; Sung, JJY; Lee, KKC; Yung, M; Wong, SKH; Wu, JCY; Chan, FKL; Ng, EKW; You, JHS; Lee, CW; Chan, ACW; Chung, SCS				Lau, JYW; Sung, JJY; Lee, KKC; Yung, M; Wong, SKH; Wu, JCY; Chan, FKL; Ng, EKW; You, JHS; Lee, CW; Chan, ACW; Chung, SCS			Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	100th Annual Meeting of the American-Gastroenterological-Association/Digestive Disease Week	MAY 16-19, 1999	ORLANDO, FL	Amer Gastroenterol Assoc			PLACEBO-CONTROLLED MULTICENTER; INTRAGASTRIC PH; RANITIDINE; HEMORRHAGE; INJECTION; COAGULATION; INFUSIONS; THERAPY; TRIALS; PROBE	Background: After endoscopic treatment of bleeding peptic ulcers, bleeding recurs in 15 to 20 percent of patients. Methods: We assessed whether the use of a high dose of a proton-pump inhibitor would reduce the frequency of recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. Patients with actively bleeding ulcers or ulcers with nonbleeding visible vessels were treated with an epinephrine injection followed by thermocoagulation. After hemostasis had been achieved, they were randomly assigned in a double-blind fashion to receive omeprazole (given as a bolus intravenous injection of 80 mg followed by an infusion of 8 mg per hour for 72 hours) or placebo. After the infusion, all patients were given 20 mg of omeprazole orally per day for eight weeks. The primary end point was recurrent bleeding within 30 days after endoscopy. Results: We enrolled 240 patients, 120 in each group. Bleeding recurred within 30 days in 8 patients (6.7 percent) in the omeprazole group, as compared with 27 (22.5 percent) in the placebo group (hazard ratio, 3.9; 95 percent confidence interval, 1.7 to 9.0). Most episodes of recurrent bleeding occurred during the first three days, which made up the infusion period (5 in the omeprazole group and 24 in the placebo group, P<0.001). Three patients in the omeprazole group and nine in the placebo group underwent surgery (P=0.14). Five patients (4.2 percent) in the omeprazole group and 12 (10 percent) in the placebo group died within 30 days after endoscopy (P=0.13). Conclusions: After endoscopic treatment of bleeding peptic ulcers, a high-dose infusion of omeprazole substantially reduces the risk of recurrent bleeding. (N Engl J Med 2000;343:310-6.) (C) 2000, Massachusetts Medical Society.	Chinese Univ Hong Kong, Dept Surg, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Pharm, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chung, SCS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China.	sydneychung@chuk.edu.hk	Wu, Justin/N-6916-2015; Lee, Yeong Yeh/G-2470-2010; Chan, Francis K. L./F-4851-2010; Sung, Joseph J. Y./R-3203-2018; You, Joyce H. S./C-2984-2008; Lau, James Y. W./O-2612-2016; Ng, Enders Kwok-wai/E-8276-2016	Lee, Yeong Yeh/0000-0002-6486-7717; Chan, Francis K. L./0000-0001-7388-2436; Sung, Joseph J. Y./0000-0003-3125-5199; You, Joyce H. S./0000-0002-5763-7403; Lau, James Y. W./0000-0003-0122-4068; Ng, Enders Kwok-wai/0000-0001-7219-5810				Altman D.G., 1991, PRACTICAL STAT MED R; Chung SSC, 1997, BMJ-BRIT MED J, V314, P1307, DOI 10.1136/bmj.314.7090.1307; COLLINS R, 1985, NEW ENGL J MED, V313, P660, DOI 10.1056/NEJM198509123131104; COX DR, 1972, J R STAT SOC B, V34, P187; DANESHMEND TK, 1992, BRIT MED J, V304, P143, DOI 10.1136/bmj.304.6820.143; DeMuckadell OBS, 1997, SCAND J GASTROENTERO, V32, P320, DOI 10.3109/00365529709007679; GREEN FW, 1978, GASTROENTEROLOGY, V74, P38; Hasselgren G, 1997, SCAND J GASTROENTERO, V32, P328, DOI 10.3109/00365529709007680; JOHNSTON JH, 1987, GASTROENTEROLOGY, V92, P1101, DOI 10.1016/S0016-5085(87)91065-1; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Khuroo MS, 1997, NEW ENGL J MED, V336, P1054, DOI 10.1056/NEJM199704103361503; Labenz J, 1997, GUT, V40, P36, DOI 10.1136/gut.40.1.36; LAM SK, 1980, GUT, V21, P324, DOI 10.1136/gut.21.4.324; LANAS A, 1995, J CLIN GASTROENTEROL, V21, P103, DOI 10.1097/00004836-199509000-00008; Lau JYW, 1999, NEW ENGL J MED, V340, P751, DOI 10.1056/NEJM199903113401002; Lau JYW, 1998, ENDOSCOPY, V30, P513, DOI 10.1055/s-2007-1001336; Lin HJ, 1998, ARCH INTERN MED, V158, P54, DOI 10.1001/archinte.158.1.54; MERKI HS, 1994, GASTROENTEROLOGY, V106, P60, DOI 10.1016/S0016-5085(94)94341-9; Netzer P, 1999, AM J GASTROENTEROL, V94, P351; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Rothman K., 1998, MODERN EPIDEMIOLOGY; SWAIN CP, 1986, GASTROENTEROLOGY, V90, P595, DOI 10.1016/0016-5085(86)91113-3; VILLANUEVA C, 1995, ENDOSCOPY, V27, P308, DOI 10.1055/s-2007-1005698; WALT RP, 1992, LANCET, V340, P1058, DOI 10.1016/0140-6736(92)93078-2	24	455	479	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2000	343	5					310	316		10.1056/NEJM200008033430501	http://dx.doi.org/10.1056/NEJM200008033430501			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	340GR	10922420				2022-12-28	WOS:000088525200001
J	Ludwig, J; Cook, PJ				Ludwig, J; Cook, PJ			Homicide and suicide rates associated with implementation of the Brady Handgun Violence Prevention Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRIME; CITY; LAWS	Context In February 1994, the Brady Handgun Violence Prevention Act established a nationwide requirement that licensed firearms dealers observe a waiting period and initiate a background check for handgun sales. The effects of this act have not been analyzed. Objective To determine whether implementation of the Brady Act was associated with reductions in homicide and suicide rates. Design and Setting Analysis of vital statistics data in the United States for 1985 through 1997 from the National Center for Health Statistics. Main Outcome Measures Total and firearm homicide and suicide rates per 100000 adults (greater than or equal to 21 years and greater than or equal to 55 years) and proportion of homicides and suicides resulting from firearms were calculated by state and year. Controlling for population age, race, poverty and income levels, urban residence, and alcohol consumption, the 32 "treatment" states directly affected by the Brady Act requirements were compared with the 18 "control" states and the District of Columbia, which had equivalent legislation already in place. Results Changes in rates of homicide and suicide for treatment and control states were not significantly different, except for firearm suicides among persons aged 55 years or older (-0.92 per 100000; 95% confidence interval [CI], -1.43 to -0.42). This reduction in suicides for persons aged 55 years or older was much stronger in states that had instituted both waiting periods and background checks (-1.03 per 100000; 95% CI, -1.58 to -0.47) than in states that only changed background check requirements (-0.17 per 100000; 95% CI, -1.09 to 0.75), Conclusions Based on the assumption that the greatest reductions in fatal violence would be within states that were required to institute waiting periods and background checks, implementation of the Brady Act appears to have been associated with reductions in the firearm suicide rate for persons aged 55 years or older but not with reductions in homicide rates or overall suicide rates. However, the pattern of implementation of the Brady Act does not permit a reliable analysis of a potential effect of reductions in the flow of guns from treatment-state gun dealers into secondary markets.	Georgetown Univ, Georgetown Publ Policy Inst, Washington, DC 20007 USA; Natl Consortium Violence Res, Washington, DC USA; Duke Univ, Natl Consortium Violence Res, Durham, NC USA; Natl Bur Econ Res, Durham, NC USA	Georgetown University; Duke University; National Bureau of Economic Research	Ludwig, J (corresponding author), Georgetown Univ, Georgetown Publ Policy Inst, 3600 N St NW,Suite 200, Washington, DC 20007 USA.			Cook, Philip/0000-0001-5094-9052				ALLEN L, 1995, EXPERT REPORT L ALLE; Ash P, 1996, JAMA-J AM MED ASSOC, V275, P1754, DOI 10.1001/jama.275.22.1754; BAILEY WC, 1984, CRIMINOLOGY, V22, P531, DOI 10.1111/j.1745-9125.1984.tb00314.x; *BUR JUST STAT, 1999, PRIS JAIL INM MID 19; Cameron C. A., 1998, REGRESSION ANAL COUN; COHEN LE, 1987, AM SOCIOL REV, V52, P170, DOI 10.2307/2095446; Cook P., 1991, CRIME JUSTICE REV RE, P1; Cook P, 1998, CRIME JUSTICE ANN RE, P26; Cook PJ, 1996, LAW CONTEMP PROBL, V59, P91, DOI 10.2307/1192211; Cook PJ, 1995, J CRIM LAW CRIM, V86, P59, DOI 10.2307/1144000; Cook PJ, 2000, GUN VIOLENCE REAL CO; Cook PJ, 1996, GUNS AM RESULTS COMP; Enders W., 1995, APPL ECONOMETRIC TIM; Fagan J, 1998, J CRIM LAW CRIM, V88, P1277, DOI 10.2307/1144257; *GEN ACC OFF, 1996, 9622 GAO; Greene, 2003, ECONOMETRIC ANAL, P1241; Hsiao C., 2003, ANAL PANEL DATA, Vsecond; Kleck G., 1993, J QUANT CRIMINOL, V9, P249, DOI [10.1007/BF01064462, DOI 10.1007/BF01064462]; LAND KC, 1990, AM J SOCIOL, V95, P922, DOI 10.1086/229381; Lott J.R., 1998, MORE GUNS LESS CRIME; Lott JR, 1997, J LEGAL STUD, V26, P1, DOI 10.1086/467988; Ludwig J, 1998, INT REV LAW ECON, V18, P239, DOI 10.1016/S0144-8188(98)00012-X; MANSON DA, 1997, BUREAU JUSTICE STAT, P1; McDowall D, 1995, J CRIM LAW CRIM, V86, P193, DOI 10.2307/1144006; MESSNER SF, 1983, AM J SOCIOL, V88, P997, DOI 10.1086/227767; MOODY C, 2000, RES MAT WEB SITE; Parker RN, 1998, ANNU REV SOCIOL, V24, P291, DOI 10.1146/annurev.soc.24.1.291; RAPHAEL S, 1999, DEINSTITUTIONALIZATI; SAMPSON RJ, 1986, COMMUNITIES CRIME, P271; Sheley J.F., 1993, GUN ACQUISITION POSS; Stevens J A, 1999, MMWR CDC Surveill Summ, V48, P27; *US BUR CENS, 1999, STAT ABSTR US 1999; *US DEP TREAS BUR, 1994, FIR STAT LAWS PUBL O; *US DEP TREAS BUR, 1998, FIR STAT LAWS PUBL O; WEIL DS, 1997, TRAFFIC STOP BRADY A; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wright J.D., 1986, ARMED CONSIDERED DAN; Wright MA, 1999, AM J PUBLIC HEALTH, V89, P88, DOI 10.2105/AJPH.89.1.88; [No title captured]	39	180	181	2	29	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2000	284	5					585	591		10.1001/jama.284.5.585	http://dx.doi.org/10.1001/jama.284.5.585			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	337WG	10918704	Bronze			2022-12-28	WOS:000088385400027
J	Dyer, C				Dyer, C			Gynaecologist struck off the medical register	BRITISH MEDICAL JOURNAL			English	News Item																			0	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					258	258		10.1136/bmj.321.7256.258	http://dx.doi.org/10.1136/bmj.321.7256.258			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915114	Green Published			2022-12-28	WOS:000088619800008
J	McFarlane, M; Bull, SS; Rietmeijer, CA				McFarlane, M; Bull, SS; Rietmeijer, CA			The Internet as a newly emerging risk environment for sexually transmitted diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DETERMINANTS; PATTERNS	Context Transmission of sexually transmitted diseases (STDs) such as human immunodeficiency virus (HIV) infection is associated with unprotected sex among multiple anonymous sex partners. The role of the Internet in risk of STDs is not known. Objective To compare risk of STD transmission for persons who seek sex partners on the Internet with risk for persons not seeking sex partners on the Internet. Design Cross-sectional survey conducted September 1999 through April 2000, Setting and Participants A total of 856 clients of the Denver Public Health HIV Counseling and Testing Site in Colorado. Main Outcome Measures Self-report of logging on to the Internet with the intention of finding sex partners; having sex with partners who were originally contacted via the Internet; number of such partners and use of condoms with them; and time since last sexual contact with Internet partners, linked to HIV risk assessment and test records. Results Of the 856 clients, most were white (77.8%), men (69.2%), heterosexual (65.3%), and aged 20 to 50 years (84.1%), Of those, 135 (15.8%) had sought sex partners on the Internet, and 88 (65.2%) of these reported having sex with a partner initially met via the Internet, Of those with Internet partners, 34 (38.7%) had 4 or more such partners, with 62 (71.2%) of contacts occurring within 6 months prior to the client's HIV test. Internet sex seekers were more likely to be men (P<.001) and homosexual (P<.001) than those not seeking sex via the Internet. Internet sex seekers reported more previous STDs (P=.02); more partners (P<.001); more anal sex (P<.001); and more sexual exposure to men (P<.001), men who have sex with men (P<.001), and partners known to be HIV positive (P<.001) than those not seeking sex via the Internet, Conclusions Seeking sex partners via the Internet was a relatively common practice in this sample of persons seeking HIV testing and counseling (representative of neither Denver nor the overall US population). Clients who seek sex using the Internet appear to be at greater risk for STDs than clients who do not seek sex on the Internet.	Ctr Dis Control & Prevent, Div Sexually Transmitted Dis Prevent, Atlanta, GA USA; Denver Hlth & Hosp Author, Denver Publ Hlth Dept, Denver, CO USA	Centers for Disease Control & Prevention - USA; Denver Health Medical Center	McFarlane, M (corresponding author), 1600 Clifton Rd,MS E-44, Atlanta, GA 30333 USA.	MmcFarlane@cdc.gov			PHS HHS [R18/CCR815954-02] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aral SO, 1999, AM J PUBLIC HEALTH, V89, P825, DOI 10.2105/AJPH.89.6.825; Aral SO, 1999, SEX TRANSM DIS, V26, P262, DOI 10.1097/00007435-199905000-00004; Aral SO, 1999, SOCIAL BEHAV DETERMI, P39; BULL SS, IN PRESS SEX TRANSM; *CDCP, 1998, HIV AIDS EP US 1997; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P773; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P889; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P873; Lamb M, 1998, DEVIANT BEHAV, V19, P121, DOI 10.1080/01639625.1998.9968079; PAGESHAFER KA, 1999, MMWR-MORBID MORTAL W, V48, P45; Richey CM, 1999, SEX TRANSM DIS, V26, P4, DOI 10.1097/00007435-199901000-00002; Rosario M, 1999, AIDS EDUC PREV, V11, P476; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; VALLEROY L, 1998, 12 INT C AIDS JUN 28; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001	15	322	327	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					443	+		10.1001/jama.284.4.443	http://dx.doi.org/10.1001/jama.284.4.443			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904506	Bronze			2022-12-28	WOS:000088254200029
J	Scully, C; Porter, S				Scully, C; Porter, S			ABC of oral health - Swellings and red, white, and pigmented lesions	BRITISH MEDICAL JOURNAL			English	Review							MANAGEMENT; DIAGNOSIS		Univ London, Univ Coll London, Eastman Dent Inst Oral Hlth Care Sci, London WC1E 7HU, England	University of London; University College London	Scully, C (corresponding author), Univ London, Univ Coll London, Eastman Dent Inst Oral Hlth Care Sci, London WC1E 7HU, England.			Porter, Stephen/0000-0002-3328-2759				Lee LA, 1999, J INVEST DERMATOL, V113, P146, DOI 10.1046/j.1523-1747.1999.00651.x; MASHBERG A, 1995, CA-CANCER J CLIN, V45, P328, DOI 10.3322/canjclin.45.6.328; Schoelch ML, 1999, LARYNGOSCOPE, V109, P949, DOI 10.1097/00005537-199906000-00021; Sciubba JJ, 1999, J AM DENT ASSOC, V130, P1445, DOI 10.14219/jada.archive.1999.0055; Scully C, 1998, CRIT REV ORAL BIOL M, V9, P86, DOI 10.1177/10454411980090010501; SCULLY C, 1996, ORAL DIS; SCULLY C, 1996, J EPIDEMIOLOGY BIOST, V1, P3; Triantos D, 1997, CLIN INFECT DIS, V25, P1392, DOI 10.1086/516131	8	23	25	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 22	2000	321	7255					225	228		10.1136/bmj.321.7255.225	http://dx.doi.org/10.1136/bmj.321.7255.225			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903660	Green Published			2022-12-28	WOS:000088448100028
J	McCabe, H				McCabe, H			Jordan chosen to open SESAME	NATURE			English	News Item																		1999, NATURE, V399, P507	1	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					221	221		10.1038/35018693	http://dx.doi.org/10.1038/35018693			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917493	Bronze			2022-12-28	WOS:000088251900004
J	Wilf, P; Labandeira, CC; Kress, WJ; Staines, CL; Windsor, DM; Allen, AL; Johnson, KR				Wilf, P; Labandeira, CC; Kress, WJ; Staines, CL; Windsor, DM; Allen, AL; Johnson, KR			Timing the radiations of leaf beetles: Hispines on gingers from latest Cretaceous to recent	SCIENCE			English	Article							ANGIOSPERM RADIATION; NORTH-AMERICA; EVOLUTION; CHRYSOMELIDAE; COLEOPTERA; HELICONIA; DIVERSITY; GENUS; ASSOCIATIONS; COMMUNITIES	Stereotyped feeding damage attributable solely to rolled-leaf hispine beetles is documented on latest Cretaceous and early Eocene ginger leaves from North Dakota and Wyoming. Hispine beetles (6000 extant species) therefore evolved at least 20 million years earlier than suggested by insect body fossils, and their specialized associations with gingers and ginger relatives are ancient and phylogenetically conservative. The latest Cretaceous presence of these relatively derived members of the hyperdiverse leaf-beetle clade (Chrysomelidae, more than 38,000 species) implies that many of the adaptive radiations that account for the present diversity of leaf beetles occurred during the Late Cretaceous, contemporaneously with the ongoing rapid evolution of their angiosperm hosts.	Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA; Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; Smithsonian Trop Res Inst, Balboa, Panama; Denver Museum Nat Hist, Dept Earth & Space Sci, Denver, CO 80205 USA; Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Maryland; University of Maryland College Park; Smithsonian Institution; Smithsonian Tropical Research Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History	Wilf, P (corresponding author), Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA.	pwilf@umich.edu						ARCHIBALD SB, IN PRESS CAN J ZOOL; ASKEVOLD IS, 1990, CAN J ZOOL, V68, P2135, DOI 10.1139/z90-297; AUERBACH MJ, 1981, ECOL MONOGR, V51, P63, DOI 10.2307/2937307; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; BOROWIEC L, 1987, Polskie Pismo Entomologiczne, V57, P3; Borowiec L., 1995, P541; CALL V B, 1988, American Journal of Botany, V75, P104; Chase M.W., 1995, MONOCOTYLEDONS SYSTE, P109, DOI DOI 10.1016/0378-8741(87)90103-6; Coley PD, 1999, SCIENCE, V284, P2098, DOI 10.1126/science.284.5423.2098; Collinson M. E., 1988, TERTIARY RES, V9, P67; CROWSON RA, 1955, NATURAL CLASSIFICATI; DAVIS JI, 1995, SYST BOT, V20, P503, DOI 10.2307/2419806; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Futuyma DJ, 1996, PHILOS T R SOC B, V351, P1361, DOI 10.1098/rstb.1996.0119; FUTUYMA DJ, 1990, EVOLUTION, V44, P1885, DOI 10.1111/j.1558-5646.1990.tb04298.x; GAGE DA, 1981, BIOCHEM SYST ECOL, V9, P79, DOI 10.1016/0305-1978(81)90063-6; Givnish TJ, 1999, MOL PHYLOGENET EVOL, V12, P360, DOI 10.1006/mpev.1999.0601; Herendeen P.S., 1995, MONOCOTYLEDONS SYSTE, P1; HICKEY LJ, 1978, CAN J BOT, V56, P1136, DOI 10.1139/b78-128; Hickey LJ., 1977, GEOL SOC AM MEM, V150, P1, DOI DOI 10.1130/MEM150-P1; HICKS JF, 1999, GEOL SOC AM ABSTR, V31, P71; Hsiao TH, 1999, ADV CHRYSOMELIDAE BI, V1, P321; HSIAO TH, 1999, ADV CHRYSOMELIDAE BI, V1, P39; JOHNSON KR, 1990, GEOL S AM S, V247, P433; JOHNSON KR, 1996, GEOL SOC AM ABSTR, V29, P432; JOLIVET P, 1989, Bulletin Mensuel de la Societe Linneenne de Lyon, V58, P297; JOLIVET P., 1997, BIOL COLEOPTERES CHR; JOLIVET P, 1995, HOST PLANTS CHRYSOME; Kalshoven L. G. E., 1957, Tijdschrift voor Entomologie Leiden, V100, P5; KNOBLOCH E, 1979, Vestnik Ustredniho Ustavu Geologickeho, V54, P297; Kopf A, 1998, EVOLUTION, V52, P517, DOI 10.1111/j.1558-5646.1998.tb01651.x; KRESS WJ, UNPUB; Kress WJ., 1995, MONOCOTYLEDONS SYSTE, P443; LABANDEIRA CC, 1994, P NATL ACAD SCI USA, V91, P12278, DOI 10.1073/pnas.91.25.12278; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; LIDGARD S, 1988, NATURE, V331, P344, DOI 10.1038/331344a0; Lupia R, 1999, PALEOBIOLOGY, V25, P305, DOI 10.1017/S009483730002131X; Magallon S, 1999, ANN MO BOT GARD, V86, P297, DOI 10.2307/2666180; MANN JS, 1981, J NAT HIST, V15, P727, DOI 10.1080/00222938100770531; MAULIK S, 1931, P ZOOL SOC LOND, P1137; MCCOY ED, 1984, BIOTROPICA, V16, P10, DOI 10.2307/2387887; MCCOY ED, 1985, BIOTROPICA, V17, P326, DOI 10.2307/2388596; MENDONCA VLM, 1991, MEM I OSWALDO CRUZ, V86, P93, DOI 10.1590/S0074-02761991000600023; Meurer-Grimes B, 1997, BOT REV, V63, P356, DOI 10.1007/BF02856597; Meyer H. W., 1997, U CALIF PUBL GEOL SC, V141, P1; Ngo KS, 1998, PHYTOCHEMISTRY, V47, P1117, DOI 10.1016/S0031-9422(97)00606-7; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; POINAR GO, 1999, ADV CHRYSOMELIDAE BI, V1, P1; Poinar GO., 1999, AMBER FOREST; Reid C.A.M., 1995, P559; Ride W.D.L., 1999, INT CODE ZOOLOGICAL; SANTIAGOBLAY JA, 1994, NOVEL ASPECTS BIOL C, P1, DOI DOI 10.1007/978-94-011-1781-4_1; SCHAARSCHMIDT F, 1986, COUR FORSCHINST SENC, V85, P205; Schmitt M., 1985, Zoologische Beitraege, V29, P35; SCHOONHOVEN LM, 1998, INSECT PLANT BIOL; SEIFERT RP, 1979, BIOTROPICA, V11, P51, DOI 10.2307/2388173; STAINES CL, 1996, REV BIOL TROP SPEC P, V3, P1; Stevenson D. W., 1995, MONOCOTYLEDONS SYSTE, P543; STORK NE, 1988, BIOL J LINN SOC, V35, P321, DOI 10.1111/j.1095-8312.1988.tb00474.x; STRONG DR, 1977, BIOTROPICA, V9, P156, DOI 10.2307/2387878; STRONG DR, 1977, ECOLOGY, V58, P573, DOI 10.2307/1939006; STRONG DR, 1982, ECOL ENTOMOL, V7, P217, DOI 10.1111/j.1365-2311.1982.tb00660.x; STRONG DR, 1977, EVOLUTION, V31, P854, DOI 10.1111/j.1558-5646.1977.tb01078.x; STRONG DR, 1982, ECOLOGY, V63, P1039, DOI 10.2307/1937243; STRONG DR, 1984, INSECTS PLANTS; SUZUKI K, 1996, CHRYSOMELIDAE BIOL, V1, P3; Wilf P, 2000, GEOL SOC AM BULL, V112, P292, DOI 10.1130/0016-7606(2000)112<0292:LPEECC>2.3.CO;2; Wilf P, 1999, SCIENCE, V284, P2153, DOI 10.1126/science.284.5423.2153; WINDSOR DM, UNPUB; Wing SL, 1998, ANNU REV EARTH PL SC, V26, P379, DOI 10.1146/annurev.earth.26.1.379	70	121	132	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2000	289	5477					291	294		10.1126/science.289.5477.291	http://dx.doi.org/10.1126/science.289.5477.291			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894775				2022-12-28	WOS:000088169400039
J	Scala, A; Starr, FW; La Nave, E; Sciortino, F; Stanley, HE				Scala, A; Starr, FW; La Nave, E; Sciortino, F; Stanley, HE			Configurational entropy and diffusivity of supercooled water	NATURE			English	Article							LIQUIDS; GLASSES; ENERGY	As a liquid approaches the glass transition, its properties are dominated by local potential minima(1,2) in its energy landscape. The liquid experiences localized vibrations in the basins of attraction surrounding the minima, and rearranges via relatively infrequent inter-basin jumps(3). As a result, the liquid dynamics at low temperature are related to the system's exploration of its own configuration space. The 'thermodynamic approach' to the glass transition considers the reduction in configuration space(4-8) explored as the system cools, and predicts that the configurational entropy(5,9,10) (a measure of the number of local potential energy minima sampled by the liquid) is related to the diffusion constant. Here we report a stringent test of the thermodynamic approach for liquid water (a convenient system to study because of an anomalous pressure dependence in the diffusion constant). We calculate the configurational entropy at points spanning a large region of the temperature-density plane, using a model(11) that reproduces the dynamical anomalies of liquid water. We find that the thermodynamic approach can be used to understand the characteristic dynamic anomalies, and that the diffusive dynamics are governed by the configurational entropy. Our results indicate that the thermodynamic approach might be extended to predict the dynamical behaviour of supercooled liquids in general.	Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; Boston Univ, Ctr Computat Sci, Boston, MA 02215 USA; Boston Univ, Dept Phys, Boston, MA 02215 USA; Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; Univ Roma La Sapienza, Ist Nazl Fis Mat, I-00185 Rome, Italy	Boston University; Boston University; Boston University; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Sapienza University Rome	Scala, A (corresponding author), Natl Inst Stand & Technol, Div Polymers, Gaithersburg, MD 20899 USA.	scala@phys.uniromal.it	Starr, Francis W/C-7703-2012; Scala, Antonio/A-2098-2012; Scala, Antonio/GRS-5823-2022; Sciortino, Francesco/B-4768-2012; Scala, Antonio/H-9153-2019	Starr, Francis W/0000-0002-2895-6595; Scala, Antonio/0000-0002-3414-2686; Scala, Antonio/0000-0002-3414-2686; SCIORTINO, Francesco/0000-0002-2418-2713				ADAM G, 1965, J CHEM PHYS, V43, P139, DOI 10.1063/1.1696442; ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; ANGELL CA, 1976, J CHEM PHYS, V65, P3063, DOI 10.1063/1.433518; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bergman R, 2000, NATURE, V403, P283, DOI 10.1038/35002027; Coluzzi B, 2000, PHYS REV LETT, V84, P306, DOI 10.1103/PhysRevLett.84.306; Debenedetti P. G., 1997, METASTABLE LIQUIDS; Fabbian L, 1999, PHYS REV E, V60, P5768, DOI 10.1103/PhysRevE.60.5768; GOLDSTEIN M, 1969, J CHEM PHYS, V51, P3728, DOI 10.1063/1.1672587; GOTZE W, 1992, REP PROG PHYS, V55, P241, DOI 10.1088/0034-4885/55/3/001; Ito K, 1999, NATURE, V398, P492, DOI 10.1038/19042; KAUZMANN W, 1948, CHEM REV, V43, P219, DOI 10.1021/cr60135a002; Kob W, 1999, J PHYS-CONDENS MAT, V11, pR85, DOI 10.1088/0953-8984/11/10/003; La Nave E, 2000, PHYS REV LETT, V84, P4605, DOI 10.1103/PhysRevLett.84.4605; Mezard M, 1999, J PHYS-CONDENS MAT, V11, pA157, DOI 10.1088/0953-8984/11/10A/011; Mishima O, 2000, PHYS REV LETT, V85, P334, DOI 10.1103/PhysRevLett.85.334; POOLE PH, 1992, NATURE, V360, P324, DOI 10.1038/360324a0; PRESS WH, 1986, NUMERICAL RECIPES AR; PRIELMEIER FX, 1987, PHYS REV LETT, V59, P1128, DOI 10.1103/PhysRevLett.59.1128; Rosenfeld Y, 1998, MOL PHYS, V95, P141, DOI 10.1080/00268979809483145; Sastry S, 1998, NATURE, V393, P554, DOI 10.1038/31146; Schulz M, 1998, PHYS REV B, V57, P11319, DOI 10.1103/PhysRevB.57.11319; Sciortino F, 1999, PHYS REV LETT, V83, P3214, DOI 10.1103/PhysRevLett.83.3214; Smith RS, 1999, NATURE, V398, P788, DOI 10.1038/19725; Speedy RJ, 1999, J PHYS CHEM B, V103, P4060, DOI 10.1021/jp983830w; Starr FW, 1999, PHYS REV E, V60, P6757, DOI 10.1103/PhysRevE.60.6757; STILLINGER FH, 1995, SCIENCE, V267, P1935, DOI 10.1126/science.267.5206.1935; STILLINGER FH, 1988, J CHEM PHYS, V88, P7818, DOI 10.1063/1.454295; Wolfgardt M, 1996, PHYS REV E, V54, P1535, DOI 10.1103/PhysRevE.54.1535	29	309	311	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					166	169		10.1038/35018034	http://dx.doi.org/10.1038/35018034			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910351	Green Submitted			2022-12-28	WOS:000088221100041
J	Doebley, J				Doebley, J			Plant genetics - A tomato gene weighs in	SCIENCE			English	Editorial Material							POLYMORPHISMS; RESOLUTION; LOCUS		Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Doebley, J (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.							Alpert KB, 1996, P NATL ACAD SCI USA, V93, P15503, DOI 10.1073/pnas.93.26.15503; BARTON NH, 1989, ANNU REV GENET, V23, P337, DOI 10.1146/annurev.ge.23.120189.002005; BLAKESLEE AF, 1914, J HERED, V5, P511; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Grandillo S, 1999, THEOR APPL GENET, V99, P978, DOI 10.1007/s001220051405; LAI CG, 1994, SCIENCE, V266, P1697, DOI 10.1126/science.7992053; Lynch M., 1998, GENETICS ANAL QUANTI; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Templeton AR, 1999, ANNU REV ECOL SYST, V30, P23, DOI 10.1146/annurev.ecolsys.30.1.23	9	2	5	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2000	289	5476					71	72		10.1126/science.289.5476.71	http://dx.doi.org/10.1126/science.289.5476.71			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332TW	10928932				2022-12-28	WOS:000088090400031
J	Doyle, LW				Doyle, LW			Effects of perinatal necropsy on counselling	LANCET			English	Editorial Material							AUTOPSY; CARE		Royal Womens Hosp, Dept Obstet & Gynaecol, Carlton, Vic 3053, Australia		Doyle, LW (corresponding author), Royal Womens Hosp, Dept Obstet & Gynaecol, Carlton, Vic 3053, Australia.			Doyle, Lex/0000-0002-7667-7312				Barr P, 1999, J PAEDIATR CHILD H, V35, P185, DOI 10.1046/j.1440-1754.1999.t01-1-00338.x; *CONS COUNC OBST P, 1998, ANN REP YEAR 1997 IN; Faye-Petersen OM, 1999, OBSTET GYNECOL, V94, P915, DOI 10.1016/S0029-7844(99)00468-8; FORREST CG, 1982, BRIT MED J, V285, P1475; HARPER MB, 1994, J REPROD MED, V39, P80; Iwarsson E, 1998, MOL HUM REPROD, V4, P871, DOI 10.1093/molehr/4.9.871; LAKE MF, 1987, AM J OBSTET GYNECOL, V157, P1203, DOI 10.1016/S0002-9378(87)80295-8; LILFORD RJ, 1994, BRIT J OBSTET GYNAEC, V101, P291, DOI 10.1111/j.1471-0528.1994.tb13612.x; RUSHTON DI, 1994, BRIT J HOSP MED, V52, P450	9	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2093	2093		10.1016/S0140-6736(00)02373-4	http://dx.doi.org/10.1016/S0140-6736(00)02373-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902620				2022-12-28	WOS:000087687100006
J	French, N; Nakiyingi, J; Carpenter, LM; Lugada, E; Watera, C; Moi, K; Moore, M; Antvelink, D; Mulder, D; Janoff, EN; Whitworth, J; Gilks, CF				French, N; Nakiyingi, J; Carpenter, LM; Lugada, E; Watera, C; Moi, K; Moore, M; Antvelink, D; Mulder, D; Janoff, EN; Whitworth, J; Gilks, CF			23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; STREPTOCOCCUS-PNEUMONIAE; INFECTED PATIENTS; DISEASE; HIV; BACTEREMIA; POPULATION; EFFICACY; COHORT; RESISTANCE	Background Infection with Streptococcus pneumoniae is a frequent and serious problem for HIV-immunosuppressed adults. Vaccination is recommended in the USA and Europe, but there are no prospective data that show vaccine efficacy. Methods 1392 (937 female) HIV-1-infected adults in Entebbe, Uganda, were enrolled. 697 received 23-valent pneumococcal polysaccharide vaccine and 695 received placebo. The primary endpoint was first event invasive pneumococcal disease. Secondary endpoints included vaccine serogroup-specific invasive disease, all (probable and definite) pneumococcal events, all-cause pneumonia, and death. Findings First invasive events occurred in 25 individuals (24 bacteraemias, one pyomyositis), 15 in the vaccine arm and ten in the placebo arm (hazard ratio [HR] 1.47; 95% CI 0.7-3.3). 22 isolates (88%) were of vaccine-specific serogroups with 15 events in the vaccine arm compared with seven in the placebo arm (HR 2.10; 0.9-5.2). All pneumococcal events had a similar distribution (20 vs 14; HR 1.41: 0.7-2.8) though all-cause pneumonia was significantly more frequent in the vaccine arm (40 vs 21; HR 1.89; 1.1-3.2). Mortality was unaffected by vaccination. Interpretation 23-valent pneumococcal polysaccharide vaccination is ineffective in HIV-1-infected Ugandan adults and probably has little, or no, public health value elsewhere in sub-Saharan Africa. Increased rates of pneumococcal disease in vaccine recipients may necessitate a reappraisal of this intervention in other settings.	Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; MRC, Dept Int Dev, Uganda Virus Res Inst Programme AIDS Uganda, Entebbe, Uganda; AIDS Support Org, Kampala, Uganda; Univ Oxford, Inst Hlth Sci, Dept Publ Hlth, Oxford OX1 2JD, England; Ctr Mucosal & Vaccine Biol, Minneapolis, MN USA	Liverpool School of Tropical Medicine; University of Liverpool; University of Oxford	Gilks, CF (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	gilks@liverpool.ac.uk	French, Neil/A-2994-2012; Gilks, Charles/B-4184-2012	Gilks, Charles/0000-0002-8953-3123; French, Neil/0000-0003-4814-8293	NIAID NIH HHS [AI31373, AI39445] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI031373, R01AI039445, K99AI139445] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 1993, AIDS, V7, P711; AUSTRIAN R, 1976, MT SINAI J MED, V43, P699; Brichacek B, 1996, J INFECT DIS, V174, P1191, DOI 10.1093/infdis/174.6.1191; BRUYN GAW, 1992, CLIN INFECT DIS, V14, P251, DOI 10.1093/clinids/14.1.251; CAIAFFA WT, 1993, AM J EPIDEMIOL, V138, P909, DOI 10.1093/oxfordjournals.aje.a116812; CARSON PJ, 1995, J INFECT DIS, V172, P340, DOI 10.1093/infdis/172.2.340; *CDC, 1989, MMWR-MORBID MORTAL W, V38, P64; FINE MJ, 1994, ARCH INTERN MED, V154, P2666, DOI 10.1001/archinte.1994.00420230051007; Frankel RE, 1996, CLIN INFECT DIS, V23, P577, DOI 10.1093/clinids/23.3.577; French N, 1998, AIDS, V12, P1683, DOI 10.1097/00002030-199813000-00017; GARCIALEONI ME, 1992, ARCH INTERN MED, V152, P1808, DOI 10.1001/archinte.152.9.1808; Gebo KA, 1996, J INFECT DIS, V173, P857, DOI 10.1093/infdis/173.4.857; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; GILKS CF, 1993, J ANTIMICROB CHEMOTH, V31, P119, DOI 10.1093/jac/31.suppl_B.119; Hibbs JR, 1997, CLIN INFECT DIS, V25, P195, DOI 10.1086/514538; JANOFF EN, 1988, J INFECT DIS, V158, P983, DOI 10.1093/infdis/158.5.983; Janoff EN, 1997, J INFECT DIS, V175, P975, DOI 10.1086/514004; Jones N, 1998, AIDS, V12, P2177, DOI 10.1097/00002030-199816000-00013; Koivula I, 1997, AM J MED, V103, P281, DOI 10.1016/S0002-9343(97)00149-6; Medical Informatics Advisory Panel, 1998, MED RES COUNC GUID G, P1; MULDER DW, 1994, AIDS, V8, P87, DOI 10.1097/00002030-199401000-00013; NUNN AJ, 1993, AIDS, V7, P1057, DOI 10.1097/00002030-199308000-00005; Ortqvist A, 1998, LANCET, V351, P399, DOI 10.1016/S0140-6736(97)07358-3; OSTERHOLM MT, 1998, JAMA-J AM MED ASSOC, V260, P1423; Scott JAG, 1998, CLIN INFECT DIS, V27, P1442, DOI 10.1086/515013; SIMBERKOFF MS, 1984, AM REV RESPIR DIS, V130, P1174; SIMBERKOFF MS, 1986, NEW ENGL J MED, V315, P1318, DOI 10.1056/NEJM198611203152104; WORTLEY PM, 1994, AIDS, V8, P941, DOI 10.1097/00002030-199407000-00010; 1992, IMM INF DIS, P167	30	354	364	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2000	355	9221					2106	2111		10.1016/S0140-6736(00)02377-1	http://dx.doi.org/10.1016/S0140-6736(00)02377-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902624				2022-12-28	WOS:000087687100010
J	Symon, B; Marley, J; Martin, J				Symon, B; Marley, J; Martin, J			Treating children with sleep disorders - Early intervention increases sleep times in young babies	BRITISH MEDICAL JOURNAL			English	Letter									Univ Adelaide, Dept Gen Practice, Adelaide, SA 5005, Australia; Adelaide Womens & Childrens Hosp, Adelaide, SA, Australia	University of Adelaide; Womens & Childrens Hospital Australia	Symon, B (corresponding author), Univ Adelaide, Dept Gen Practice, Adelaide, SA 5005, Australia.		Marley, John/F-1239-2010; Wolke, Dieter/C-5372-2008	Wolke, Dieter/0000-0003-0304-268X				ARMSTRONG KL, 1994, MED J AUSTRALIA, V161, P202, DOI 10.5694/j.1326-5377.1994.tb127383.x; Horton R, 1999, BRIT MED J, V319, P865, DOI 10.1136/bmj.319.7214.865; JOHNSON CM, 1991, J DEV BEHAV PEDIATR, V12, P108; Ramchandani P, 2000, BRIT MED J, V320, P209, DOI 10.1136/bmj.320.7229.209	4	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 17	2000	320	7250					1667	1668						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10905835				2022-12-28	WOS:000087734200039
J	Moayyedi, P; Feltbower, R; Brown, J; Mason, S; Mason, J; Nathan, J; Richards, IDG; Dowell, AC; Axon, ATR				Moayyedi, P; Feltbower, R; Brown, J; Mason, S; Mason, J; Nathan, J; Richards, IDG; Dowell, AC; Axon, ATR		Leeds HELP Study Grp	Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial	LANCET			English	Article							GASTROESOPHAGEAL REFLUX DISEASE; PREVENT GASTRIC-CANCER; DUODENAL-ULCER; NONULCER DYSPEPSIA; GASTROINTESTINAL SYMPTOMS; PEPTIC-ULCER; INFECTION; BENEFIT; ERADICATION; PREVALENCE	Background Infection with Helicobacter pylori is the main cause of peptic-ulcer disease. Treatment of this infection might lower the prevalence of dyspepsia in the community and improve quality of life. We investigated this possibility in a double-blind randomised controlled trial. Methods Individuals aged 40-49 years were randomly selected from the lists of 36 primary-care centres. A researcher interviewed participants with a validated dyspepsia questionnaire and the psychological general wellbeing index (PGWB). H pylori status was assessed by the carbon-13-labelled urea breath test. Infected participants were randomly assigned active treatment (omeprazole 20 mg, clarithromycin 250 mg, and tinidazole 500 mg, each twice daily for 7 days) or identical placebo. Participants were followed up at 6 months and 2 years. Findings Of 32 929 individuals invited, 8455 attended and were eligible; 2324 were positive for H pylori and were assigned active treatment (1161) or placebo (1163), 1773 (76%) returned at 2 years. Dyspepsia or symptoms of gastro-oesophageal reflux were reported in 247 (28%) of 880 in the treatment group and 291 (33%) of 871 in the placebo group (absolute-risk reduction 5% [95% CI 1-10]). H pylori treatment had no significant effect on quality of life (mean difference in PGWB score between groups 0.86 [-0.33 to 2.05]), Interpretation Community screening and treatment for H pylori produced only a 5% reduction in dyspepsia. This small benefit had no impact on quality of life.	Univ Leeds, Gen Infirm, Ctr Digest Dis, Leeds LS1 3EX, W Yorkshire, England; Univ Leeds, Paediat Epidemiol Grp, Leeds LS1 3EX, W Yorkshire, England; Univ Leeds, No & Yorkshire Clin Trials & Res Unit, Leeds LS1 3EX, W Yorkshire, England; Univ Leeds, Inst Epidemiol & Hlth Serv Res, Leeds LS1 3EX, W Yorkshire, England; Univ York, Ctr Hlth Econ, York YO1 5DD, N Yorkshire, England; Wellington Sch Med, Dept Gen Practice, Wellington, New Zealand	Leeds General Infirmary; University of Leeds; University of Leeds; University of Leeds; University of Leeds; University of York - UK; University of Otago	Moayyedi, P (corresponding author), Univ Leeds, Gen Infirm, Ctr Digest Dis, Leeds LS1 3EX, W Yorkshire, England.	paulmo@ulth.northg.nhs.uk	Mason, James M/D-9904-2011; Moayyedi, Paul/M-6178-2014	Mason, James M/0000-0001-9210-4082; Moayyedi, Paul/0000-0002-3616-9292; brown, julia/0000-0002-2719-7064				AXON AR, 1991, BRIT MED J, V302, P919, DOI 10.1136/bmj.302.6782.919; Bernersen B, 1996, GUT, V38, P822, DOI 10.1136/gut.38.6.822; DIMENAS E, 1995, SCAND J GASTROENTERO, V30, P1046, DOI 10.3109/00365529509101605; Dupuy H.J., 1984, ASSESSMENT QUALITY L, P170; Forman D, 1996, SCAND J GASTROENTERO, V31, P23, DOI 10.3109/00365529609094746; HOSKING SW, 1994, LANCET, V343, P508, DOI 10.1016/S0140-6736(94)91460-5; KLAUSER AG, 1990, LANCET, V335, P205, DOI 10.1016/0140-6736(90)90287-F; Labenz J, 1997, GUT, V41, P277, DOI 10.1136/gut.41.3.277; Labenz J, 1997, GASTROENTEROLOGY, V112, P1442, DOI 10.1016/S0016-5085(97)70024-6; Mason JM, 1999, INT J TECHNOL ASSESS, V15, P649, DOI 10.1017/S0266462399015445; McColl K, 1998, NEW ENGL J MED, V339, P1869, DOI 10.1056/NEJM199812243392601; Mccoll KEL, 1998, GUT, V42, pA4; Moayyedi P, 1998, ALIMENT PHARM THER, V12, P1257; Moayyedi P, 1998, BRIT MED BULL, V54, P243; Moayyedi P, 1997, EUR J GASTROEN HEPAT, V9, P275, DOI 10.1097/00042737-199703000-00010; Nandurkar S, 1998, ARCH INTERN MED, V158, P1427, DOI 10.1001/archinte.158.13.1427; Parente F, 1996, GUT, V39, P629, DOI 10.1136/gut.39.5.629; Parsonnet J, 1996, LANCET, V348, P150, DOI 10.1016/S0140-6736(96)01501-2; Rosenstock S, 1997, GUT, V41, P169, DOI 10.1136/gut.41.2.169; TALLEY NJ, 1994, GUT, V35, P619, DOI 10.1136/gut.35.5.619; Talley NJ, 1999, NEW ENGL J MED, V341, P1106, DOI 10.1056/NEJM199910073411502; Talley NJ, 1997, GASTROENTEROLOGY, V113, pS67, DOI 10.1016/S0016-5085(97)80016-9; TALLEY NJ, 1998, DIGESTION, V59, P7; VAIRA D, 1994, GUT, V35, P309, DOI 10.1136/gut.35.3.309; Walt B, 1998, LANCET, V351, P887, DOI 10.1016/S0140-6736(05)70303-2	25	143	147	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2000	355	9216					1665	1669		10.1016/S0140-6736(00)02236-4	http://dx.doi.org/10.1016/S0140-6736(00)02236-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905240				2022-12-28	WOS:000086983800007
J	Cox, HS; Williams, JW; de Courten, MP; Chitson, P; Tuomilehto, J; Zimmet, PZ				Cox, HS; Williams, JW; de Courten, MP; Chitson, P; Tuomilehto, J; Zimmet, PZ			Decreasing prevalence of cigarette smoking in the middle income country of Mauritius: questionnaire survey	BRITISH MEDICAL JOURNAL			English	Article							ADULTS; TRENDS	Objectives To describe changes in the prevalence of cigarette smoking in the middle income country of Mauritius from 1987 to 1998, and to relate these changes to legislative and health promotion efforts over the same period Design Questionnaire survey, Setting Mauritius, an island in the Indian Ocean with a population of about 1.2 million (about 70% south Asian, 2% Chinese, and 28% Creole). Participants Data were obtained from 5072 participants in 1987, 6573 in 1992, and 6281 in 1998, Main outcome measures Prevalence of current smoking in 1987, 1992, and 1998, sales of cigarettes in Mauritius, and information on activities for control of tobacco, Results Self reported cigarette smoking has been decreasing in Mauritius since 1987, with the largest decrease between 1987 and 1992, From 1987 to 1998 smoking prevalence decreased by 23% in men and 61% in women. Smoking decreased across all age and ethnic groups and across different levels of income and education Sales of cigarettes also decreased in line with smoking prevalence. Conclusions The introduction of cigarette taxes, a limited health promotion programme, and the absence of massive promotional campaigns by the sole tobacco company on Mauritius have led to a striking and continued decrease in smoking prevalence and cigarette consumption on the island.	Int Diabet Inst, Caulfield 3162, Australia; Natl Publ Hlth Inst, Helsinki, Finland	Finland National Institute for Health & Welfare	Cox, HS (corresponding author), Int Diabet Inst, Caulfield 3162, Australia.		de Courten, Maximilian/B-3300-2012; de Courten, Maximilian P. J./AAH-5104-2020; Zimmet, Paul/O-8486-2019	de Courten, Maximilian/0000-0001-9997-9359; Zimmet, Paul/0000-0003-0627-0776; Williams, Joanne/0000-0002-5633-1592; Cox, Helen/0000-0002-6538-7192	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025446] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-25446] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		*CDCP, 2000, SMOK PREV US AD TOB; *CDCP, 2000, DOM CIG ADV PROM EXP; Dobson AJ, 1998, TOB CONTROL, V7, P14, DOI 10.1136/tc.7.1.14; DOWSE GK, 1990, DIABETES, V39, P390, DOI 10.2337/diabetes.39.3.390; Garfinkel L, 1997, PREV MED, V26, P447, DOI 10.1006/pmed.1997.0191; Hill DJ, 1998, MED J AUSTRALIA, V168, P209, DOI 10.5694/j.1326-5377.1998.tb140132.x; World Bank, 1999, CURB EP GOV EC TOB C; *WORLD BANK, 2000, AFR REG LIV DAT	8	9	9	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					345	349		10.1136/bmj.321.7257.345	http://dx.doi.org/10.1136/bmj.321.7257.345			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QH	10926592	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000088656300025
J	MacDonald, R				MacDonald, R			Plan leaves England "with third division" health service	BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					318	318		10.1136/bmj.321.7257.318	http://dx.doi.org/10.1136/bmj.321.7257.318			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QH	10926575	Green Published			2022-12-28	WOS:000088656300010
J	Collins, S; Myatt, M				Collins, S; Myatt, M			Short-term prognosis in severe adult and adolescent malnutrition during famine - Use of a simple prognostic model based on counting clinical signs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context In the setting of famine, infection is likely to cause mortality among severely malnourished persons. Although clinical signs are likely to be useful prognostic indicators in this setting, use of a clinical assessment model has not been studied. Objective To examine the use of clinical signs in the prediction of short-term mortality in severely malnourished adults and adolescents during famine. Design Retrospective cohort study. Setting Concern Worldwide Adult Therapeutic Feeding Center in Baidoa, Somalia. Patients Data from the clinical records of 383 adult and adolescent inpatients admitted to the center between November 1992 through March 1993 who were aged 15 years or older and had a body mass index (BMI) of 13.5 kg/m(2) or less or any signs of edematous malnutrition. Main Outcome Measures Association of mortality with presence dr absence of 8 clinical signs (edema, hydration, ascites, dysentery, diarrhea, anemia, chest infection, and ability to stand) and BMI at admission, and sensitivity and specificity of models including a count of clinical signs and BMI in the prediction of mortality at the center. Results Ninety-one patients (23.8%) died, with a median time to death of 8 days from admission. Of the 8 clinical signs, severe edema (unadjusted odds ratio [OR], 2.45; 95% confidence interval [CI], 1.41-4.27), apparent dehydration (unadjusted OR, 2.73; 95% CI, 1.60-4.66), and inability to stand (unadjusted OR, 2.96; 95% CI, 1.40-6.26) were independently associated with mortality. The most useful clinical model was that based on the presence of any 1 of these 3 signs, with a sensitivity of 77% and a specificity of 59%. Ability of admission BMI to predict mortality was less than random. Conclusions Models based on clinical signs predicted death better than BMI, Simple counts of clinical signs performed as well as more complex models based on the addition of ORs. Counting relevant clinical signs is an easy and effective prognostic tool in severe adult and adolescent malnutrition during famine; however, it is not sensitive enough for use as a screening tool.	Concern Worldwide, Dublin, Ireland; UCL, Ctr Int Child Hlth, Inst Child Hlth, London, England; UCL, Int Ctr Eye Hlth, Inst Ophthalmol, London, England; Valid Int Ltd, Llanidloes, Wales	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University College London	Collins, S (corresponding author), Oleuffynon, Old Hall, Powys SY18 6PJ, Wales.	steve@validinternational.org						[Anonymous], 1989, ACC SCN STATE OF THE; BAKER JP, 1982, NEW ENGL J MED, V306, P969, DOI 10.1056/NEJM198204223061606; BEATTIE J, 1948, BRIT J NUTR, V2, P47, DOI 10.1079/BJN19480008; BUCHANANSMITH MS, 1999, EVALUATION DANISH HU; Collins S, 1998, AM J CLIN NUTR, V68, P193, DOI 10.1093/ajcn/68.1.193; Collins S, 1996, JAMA-J AM MED ASSOC, V276, P391, DOI 10.1001/jama.276.5.391; COLLINS S, 1995, NAT MED, V1, P810, DOI 10.1038/nm0895-810; Dallal GE, 1988, AM STAT, V42, P272; de Waal A., 1989, FAMINE KILLS DARFUR; DEAN AG, 1990, EPI INFO VERSION 6 W; HABICHT JP, 1980, AM J CLIN NUTR, V33, P531, DOI 10.1093/ajcn/33.3.531; Korcok M, 1981, JAMA, V246, P1878, DOI 10.1001/jama.246.17.1878; LEITER LA, 1982, JAMA-J AM MED ASSOC, V248, P2306, DOI 10.1001/jama.248.18.2306; MCLAREN DS, 1969, AM J CLIN NUTR, V22, P863; MCLAREN DS, 1967, LANCET, V1, P533; *MICR CORP, 1994, MICR EXC COMP PROGR; WATERLOW JC, 1972, BRIT MED J, V3, P566, DOI 10.1136/bmj.3.5826.566; WATERLOW JC, 1993, PROTEIN ENERGY MALNU; 1999, MINIMUM STANDARDS NU, pCH3	19	21	21	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2000	284	5					621	626		10.1001/jama.284.5.621	http://dx.doi.org/10.1001/jama.284.5.621			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	337WG	10918712				2022-12-28	WOS:000088385400035
J	Nakanishi, N; Nakamura, K; Matsuo, Y; Suzuki, K; Tatara, K				Nakanishi, N; Nakamura, K; Matsuo, Y; Suzuki, K; Tatara, K			Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men	ANNALS OF INTERNAL MEDICINE			English	Article							INSULIN-RESISTANCE SYNDROME; OSAKA HEALTH SURVEY; BLOOD-PRESSURE; DIETARY FIBER; MELLITUS; WOMEN; EPIDEMIOLOGY; TOLERANCE; OBESITY; SMOKERS	Background: The contribution of cigarette smoking to development of impaired fasting glucose and type 2 diabetes remains unclear. Objective: To investigate the association of cigarette smoking with development of impaired fasting glucose and type 2 diabetes. Design: Prospective cohort study. Setting: Work site in Osaka, Japan. Participants: 1266 Japanese male office workers 35 to 59 years of age who did not have impaired fasting glucose or type 2 diabetes and were not taking medication for hypertension at study entry. Measurements: Fasting plasma glucose levels were measured at annual health examinations from May 1994 through May 1999. Impaired fasting glucose was defined as a fasting glucose level of at least 6.1 mmol/L (110 mg/dL) but less than 7.0 mmol/L (126 mg/dL). Type 2 diabetes was defined as a fasting glucose level of 7.0 mmol/L or more or current receipt of hypoglycemic medication. Results: 87 and 54 men developed impaired fasting glucose and type 2 diabetes during 5817 and 5937 person-years follow-up, respectively After controlling for potential predictors of diabetes, the relative risk for impaired fasting glucose compared with never-smokers was 1.62 (95% CI, 0.85 to 3.10) for ever-smokers, 1.14 (CI, 0.58 to 2.25) for persons who smoked 1 to 20 cigarettes/d, 1.33 (CI, 0.63 to 2.80) for those who smoked 21 to 30 cigarettes/d, and 2.56 (CI, 1.32 to 4.95) for those who smoked 31 or more cigarettes/d (P for trend for current smokers only = 0.013). The respective multivariate-adjusted relative risks for type 2 diabetes compared with never-smokers were 1.08 (CI, 0.34 to 3.42), 1.88 (CI, 0.71 to 5.00) 3.02 (CI, 1.15 to 7.94), and 4.09 (CI, 1.62 to 10.29) (P for trend for current smokers only < 0.001). The number of pack-years of exposure was also positively related to development of impaired fasting glucose and type 2 diabetes (P for trend = 0.039 and 0.002, respectively). The relative risk for impaired fasting glucose and type 2 diabetes in current smokers versus never-smokers was stronger among men with a body mass index less than 24.2 kg/m(2) than among men with a body mass index of 24.2 kg/m(2) or more, although the absolute risk was greater in more obese men. Conclusion: The number of cigarettes smoked daily and the number of pack-years of exposure seem to be associated with development of impaired fasting glucose and type 2 diabetes in middle-aged Japanese men.	Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka 5650871, Japan; Takenaka Corp, Osaka, Japan; Japan Labor & Welf Assoc, Tokyo, Japan	Osaka University; Takenaka Corporation	Nakanishi, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Social & Environm Med, F2,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.							Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ANDERSON JW, 1987, J AM DIET ASSOC, V87, P1189; ATTVALL S, 1993, J INTERN MED, V233, P327, DOI 10.1111/j.1365-2796.1993.tb00680.x; BARRETTCONNOR E, 1989, EPIDEMIOL REV, V11, P172, DOI 10.1093/oxfordjournals.epirev.a036035; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; COX DR, 1972, J R STAT SOC B, V34, P187; CRYER PE, 1976, NEW ENGL J MED, V295, P573, DOI 10.1056/NEJM197609092951101; ELIASSON B, 1994, ARTERIOSCLER THROMB, V14, P1946, DOI 10.1161/01.ATV.14.12.1946; ELIASSON M, 1995, ATHEROSCLEROSIS, V113, P41, DOI 10.1016/0021-9150(94)05425-I; FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q; FESKENS EJM, 1989, AM J EPIDEMIOL, V130, P1101, DOI 10.1093/oxfordjournals.aje.a115437; Frati AC, 1996, DIABETES CARE, V19, P112, DOI 10.2337/diacare.19.2.112; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hayashi T, 1999, DIABETES CARE, V22, P1683, DOI 10.2337/diacare.22.10.1683; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; *HLTH WELF STAT AS, 1999, KOSEI NO SHIHYO, V46, P98; HUMPHREY LL, 1989, ANN INTERN MED, V111, P788, DOI 10.7326/0003-4819-111-10-788; Kawakami N, 1997, AM J EPIDEMIOL, V145, P103; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; MAYER EJ, 1993, DIABETES CARE, V16, P1459, DOI 10.2337/diacare.16.11.1459; MILLER JCB, 1994, AM J CLIN NUTR, V59, p747S, DOI 10.1093/ajcn/59.3.747S; MORRIS RD, 1989, AM J EPIDEMIOL, V130, P112, DOI 10.1093/oxfordjournals.aje.a115302; NATHAN DM, 1986, DIABETES, V35, P797, DOI 10.2337/diabetes.35.7.797; NILSSON PM, 1995, METABOLISM, V44, P557, DOI 10.1016/0026-0495(95)90110-8; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; PERRY IJ, 1995, BRIT MED J, V310, P560, DOI 10.1136/bmj.310.6979.560; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Ronnemaa T, 1996, DIABETES CARE, V19, P1229, DOI 10.2337/diacare.19.11.1229; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; SANDBERG H, 1973, J PHARMACOL EXP THER, V184, P787; STOLK RP, 1993, EUR J EPIDEMIOL, V9, P134, DOI 10.1007/BF00158782; Uchimoto S, 1999, DIABETIC MED, V16, P951, DOI 10.1046/j.1464-5491.1999.00173.x; WILSON PWF, 1986, AM J MED, V80, P3, DOI 10.1016/0002-9343(86)90532-2	33	107	118	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2000	133	3					183	191		10.7326/0003-4819-133-3-200008010-00009	http://dx.doi.org/10.7326/0003-4819-133-3-200008010-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XW	10906832				2022-12-28	WOS:000088449400003
J	Hruby, RJ				Hruby, RJ			JAMA 100 years ago and osteopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Western Univ Hlth Sci, Pomona, CA 91766 USA	Western University of Health Sciences	Hruby, RJ (corresponding author), Western Univ Hlth Sci, Pomona, CA 91766 USA.							2000, JAMA, V283, P1798	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					442	+		10.1001/jama.284.4.442-a	http://dx.doi.org/10.1001/jama.284.4.442-a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904505				2022-12-28	WOS:000088254200027
J	Phillips, DM				Phillips, DM			JCAHO pain management standards are unveiled	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	387	396	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					428	429		10.1001/jama.284.4.428	http://dx.doi.org/10.1001/jama.284.4.428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904487				2022-12-28	WOS:000088254200005
J	Thomas, DL; Astemborski, J; Rai, RM; Anania, FA; Schaeffer, M; Galai, N; Nolt, K; Nelson, KE; Strathdee, SA; Johnson, L; Laeyendecker, O; Boitnott, J; Wilson, LE; Vlahov, D				Thomas, DL; Astemborski, J; Rai, RM; Anania, FA; Schaeffer, M; Galai, N; Nolt, K; Nelson, KE; Strathdee, SA; Johnson, L; Laeyendecker, O; Boitnott, J; Wilson, LE; Vlahov, D			The natural history of hepatitis C virus infection - Host, viral, and environmental factors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INJECTION-DRUG USERS; NON-B-HEPATITIS; TERM FOLLOW-UP; POLYMERASE-CHAIN-REACTION; CHRONIC ACTIVE HEPATITIS; LONG-TERM; NON-A; POSTTRANSFUSION HEPATITIS; HEPATOCELLULAR-CARCINOMA; RNA LEVELS	Context Hepatitis C virus (HCV) infection may resolve (viral clearance), persist without complications, or cause end-stage liver disease (ESLD), The frequency and determinants of these outcomes are poorly understood. Objective To assess the incidence and determinants of viral clearance and ESLD among persons who acquired HCV infection from injection drug use. Design and Setting Community-based prospective cohort study with enrollment in 1988-1989 and a median follow-up of 8.8 years. Subjects A total of 1667 persons aged 17 years or older with a history of injection drug use and an HCV antibody-positive test result during follow-up. Main outcome Measures Viral clearance was assessed in a subset of 919 patients and defined as failure to detect HCV RNA in at least 2 consecutive samples collected 5 or more months apart. End-stage liver disease was assessed at semiannual visits and by review of medical records and death certificates and defined by the presence of ascites, esophageal varices, or hepatic encephalopathy, or when ESLD was stated as a cause of death. Results Viral clearance was observed in 90 persons who were compared with 722 with persistent viremia, while the viremia of 107 was not resolved. Viral clearance occurred more often in nonblacks (adjusted odds ratio [OR], 5.15; 95% confidence interval [CI], 2.60-10.17) and those not infected with human immunodeficiency virus (HIV) (adjusted OR, 2.19; 95% CI, 1.26-3.47). Forty cases of ESLD were observed throughout follow-up (incidence, 3.1 per 1000 person-years). In a multivariate model, risk of ESLD was higher for persons aged 38 years or older at enrollment (adjusted relative incidence, 3.67; 95% CI, 1.96-6.88) and who reported ingestion of more than 260 g of alcohol per week (adjusted relative incidence, 3.60; 95% CI, 1.73-7.52). Of 210 patients without ESLD randomly selected for biopsy, only 2 had cirrhosis. Conclusions Our results indicate that although HCV infection can be self-limited or associated with ESLD, the majority of adults have persistent viremia without clinically demonstrable liver disease. Further research is needed to explain the less frequent clearance of HCV infection among black persons and to improve utilization of treatment for those infected in the context of injection drug use.	Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Epidemiol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Thomas, DL (corresponding author), 1147 Ross Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.		Strathdee, Steffanie A/B-9042-2009; Laeyendecker, Oliver B/B-9331-2009; Galai, Noya/HII-8086-2022	Laeyendecker, Oliver/0000-0002-6429-4760	NCRR NIH HHS [M01 RR00052] Funding Source: Medline; NIDA NIH HHS [DA04334, DA12568] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA004334, R01DA012568, R01DA004334] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; BARRERA JM, 1995, HEPATOLOGY, V21, P639, DOI 10.1016/0270-9139(95)90511-1; Corrao G, 1998, HEPATOLOGY, V27, P914, DOI 10.1002/hep.510270404; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; De Moliner L, 1998, GUT, V42, P856, DOI 10.1136/gut.42.6.856; DIBISCEGLIE AM, 1991, HEPATOLOGY, V14, P969, DOI 10.1016/0270-9139(91)90113-A; EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602; FARCI P, 1991, NEW ENGL J MED, V325, P98, DOI 10.1056/NEJM199107113250205; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; GRETCH D, 1994, J INFECT DIS, V169, P1219, DOI 10.1093/infdis/169.6.1219; Haydon GH, 1998, GUT, V42, P570, DOI 10.1136/gut.42.4.570; HOOFNAGLE JH, 1981, ANN INTERN MED, V94, P744, DOI 10.7326/0003-4819-94-6-744; HOPF U, 1990, J HEPATOL, V10, P69, DOI 10.1016/0168-8278(90)90075-3; Inglesby TV, 1999, HEPATOLOGY, V29, P590, DOI 10.1002/hep.510290219; Kasahara A, 1998, HEPATOLOGY, V27, P1394, DOI 10.1002/hep.510270529; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; KORETZ RL, 1993, ANN INTERN MED, V119, P110, DOI 10.7326/0003-4819-119-2-199307150-00003; LAU JYN, 1993, LANCET, V341, P1501, DOI 10.1016/0140-6736(93)90635-T; LEVINE OS, 1995, AM J EPIDEMIOL, V142, P331, DOI 10.1093/oxfordjournals.aje.a117639; MATTSON L, 1993, LIVER, V13, P274; Mazzella G, 1996, J HEPATOL, V24, P141, DOI 10.1016/S0168-8278(96)80022-5; MCOMISH F, 1994, J CLIN MICROBIOL, V32, P884, DOI 10.1128/JCM.32.4.884-892.1994; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Negro F, 1999, HEPATOLOGY, V29, P536, DOI 10.1002/hep.510290223; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; OHKAWA K, 1995, J MED VIROL, V46, P258, DOI 10.1002/jmv.1890460316; Ostapowicz G, 1998, HEPATOLOGY, V27, P1730, DOI 10.1002/hep.510270637; Pessione F, 1998, HEPATOLOGY, V27, P1717, DOI 10.1002/hep.510270635; SEEFF LB, 1992, NEW ENGL J MED, V327, P1906, DOI 10.1056/NEJM199212313272703; Seeff LB, 2000, ANN INTERN MED, V132, P105, DOI 10.7326/0003-4819-132-2-200001180-00003; SHEEN IS, 1992, J INFECT DIS, V165, P831, DOI 10.1093/infdis/165.5.831; Thomas DL, 2000, J INFECT DIS, V181, P844, DOI 10.1086/315314; THOMAS DL, 1995, MEDICINE, V74, P212, DOI 10.1097/00005792-199507000-00005; TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202; TREMOLADA F, 1992, J HEPATOL, V16, P273, DOI 10.1016/S0168-8278(05)80657-9; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; Villano SA, 1997, J CLIN MICROBIOL, V35, P3274, DOI 10.1128/JCM.35.12.3274-3277.1997; Vlahov D, 1998, JAMA-J AM MED ASSOC, V279, P35, DOI 10.1001/jama.279.1.35; VLAHOV D, 1991, J DRUG ISSUES, V21, P759, DOI 10.1177/002204269102100406; Vogt M, 1999, NEW ENGL J MED, V341, P866, DOI 10.1056/NEJM199909163411202; *WHO, 1997, WKLY EPIDEMIOL REC, V72, P341	44	838	867	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					450	456		10.1001/jama.284.4.450	http://dx.doi.org/10.1001/jama.284.4.450			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904508	Bronze			2022-12-28	WOS:000088254200031
J	Giessibl, FJ; Hembacher, S; Bielefeldt, H; Mannhart, J				Giessibl, FJ; Hembacher, S; Bielefeldt, H; Mannhart, J			Subatomic features on the silicon (111)-(7x7) surface observed by atomic force microscopy	SCIENCE			English	Article							RECONSTRUCTION; RESOLUTION	The atomic force microscope images surfaces by sensing the forces between a sharp tip and a sample. If the tip-sample interaction is dominated by short-range forces due to the formation of covalent bonds, the image of an individual atom should reflect the angular symmetry of the interaction. Here, we report on a distinct substructure in the images of individual adatoms on silicon (111)(7x7), two crescents with a spherical envelope. The crescents are interpreted as images of two atomic orbitals of the front atom of the tip. Key for the observation of these subatomic features is a force-detection scheme with superior noise performance and enhanced sensitivity to short-range forces.	Univ Augsburg, Inst Phys, Ctr Elect Correlat & Magnetism, D-86135 Augsburg, Germany	University of Augsburg	Giessibl, FJ (corresponding author), Univ Augsburg, Inst Phys, Ctr Elect Correlat & Magnetism, D-86135 Augsburg, Germany.		Giessibl, Franz J/K-8022-2013	Giessibl, Franz J/0000-0002-5585-1326; Mannhart, Jochen/0000-0001-6331-2640				ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; ASHCROFT NW, 1981, SOLID STATE PHYSICS; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BINNIG G, 1983, PHYS REV LETT, V50, P120, DOI 10.1103/PhysRevLett.50.120; BROMMER KD, 1992, PHYS REV LETT, V68, P1355, DOI 10.1103/PhysRevLett.68.1355; Chen C. J., 1993, INTRO SCANNING TUNNE; CHEN CJ, 1991, J VAC SCI TECHNOL A, V9, P44, DOI 10.1116/1.577128; DEMUTH JE, 1988, J MICROSC, V151, P299; Giessibl FJ, 2000, PHYS REV B, V61, P9968, DOI 10.1103/PhysRevB.61.9968; Giessibl FJ, 2000, APPL PHYS LETT, V76, P1470, DOI 10.1063/1.126067; Giessibl FJ, 1997, PHYS REV B, V56, P16010, DOI 10.1103/PhysRevB.56.16010; Giessibl FJ, 1999, APPL SURF SCI, V140, P352, DOI 10.1016/S0169-4332(98)00553-4; GIESSIBL FJ, 1995, SCIENCE, V267, P68, DOI 10.1126/science.267.5194.68; KITAMURA S, 1995, JPN J APPL PHYS 2, V34, pL145, DOI 10.1143/JJAP.34.L145; Lantz MA, 2000, PHYS REV LETT, V84, P2642, DOI 10.1103/PhysRevLett.84.2642; PAULING L, 1957, NATURE CHEM BOND; PEREZ R, 1997, PHYS REV LETT, V78, P10835; STILLINGER FH, 1985, PHYS REV B, V31, P5262, DOI 10.1103/PhysRevB.31.5262; TAKAYANAGI K, 1985, J VAC SCI TECHNOL A, V3, P1502, DOI 10.1116/1.573160; Uchihashi T, 1997, PHYS REV B, V56, P9834, DOI 10.1103/PhysRevB.56.9834	20	286	288	5	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					422	425		10.1126/science.289.5478.422	http://dx.doi.org/10.1126/science.289.5478.422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903196	Green Published			2022-12-28	WOS:000088305500038
J	Pearson, M; Carbone, R; Sebastiani, C; Cioce, M; Fagioli, M; Saito, S; Higashimoto, Y; Appella, E; Minucci, S; Pandolfi, PP; Pelicci, PG				Pearson, M; Carbone, R; Sebastiani, C; Cioce, M; Fagioli, M; Saito, S; Higashimoto, Y; Appella, E; Minucci, S; Pandolfi, PP; Pelicci, PG			PML regulates p53 acetylation and premature senescence induced by oncogenic Ras	NATURE			English	Article							CREB BINDING-PROTEIN; WILD-TYPE P53; PROMYELOCYTIC LEUKEMIA; GENE AMPLIFICATION; DNA-DAMAGE; IN-VITRO; CELLS; MODULATION; GROWTH; TRANSFORMATION	The tumour suppressor p53 induces cellular senescence in response to oncogenic signals(1). p53 activity is modulated by protein stability and post-translational modification, including phosphorylation and acetylation(2). The mechanism of p53 activation by oncogenes remains largely unknown. Here we report that the tumour suppressor PML regulates the p53 response to oncogenic signals. We found that oncogenic pas upregulates PML expression, and overexpression of PML induces senescence in a p53-dependent manner. p53 is acetylated at lysine 382 upon Ras expression, an event that is essential for its biological function. pas induces re-localization of p53 and the CBP acetyltransferase within the PML nuclear bodies and induces the formation of a trimeric p53-PML-CBP complex. Lastly, Ras-induced p53 acetylation, p53-CBP complex stabilization and senescence are lost in PML-/- fibroblasts. Our data establish a link between PML and p53 and indicate that integrity of the PML bodies is required for p53 acetylation and senescence upon oncogene expression.	European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; Univ Perugia, Ist Med Interna & Sci Oncol, I-06100 Perugia, Italy; NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Cornell Univ, Mem Sloan Kettering Canc Ctr, Dept Human Genet, New York, NY 10021 USA; Cornell Univ, Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	IRCCS European Institute of Oncology (IEO); University of Perugia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Pelicci, PG (corresponding author), European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy.	pgpelicci@ieo.it	Sebastiani, Carla/AAB-9817-2022; Pelicci, Pier Giuseppe/AAL-6572-2020; Minucci, Saverio/J-9669-2012; Cioce, Mario/R-9734-2017	Sebastiani, Carla/0000-0003-3927-3279; Cioce, Mario/0000-0001-8129-6664; Higashimoto, Yuichiro/0000-0003-1382-8598	NATIONAL CANCER INSTITUTE [ZIABC005599, Z01BC005599] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; BORROW J, 1990, SCIENCE, V249, P1577, DOI 10.1126/science.2218500; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Doucas V, 1999, P NATL ACAD SCI USA, V96, P2627, DOI 10.1073/pnas.96.6.2627; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fagioli M, 1998, ONCOGENE, V16, P2905, DOI 10.1038/sj.onc.1201811; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Grignani F, 1998, CANCER RES, V58, P14; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HARVEY M, 1993, ONCOGENE, V8, P2457; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; LaMorte VJ, 1998, P NATL ACAD SCI USA, V95, P4991, DOI 10.1073/pnas.95.9.4991; Le XF, 1996, J BIOL CHEM, V271, P130, DOI 10.1074/jbc.271.1.130; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; LIU JH, 1995, J EXP MED, V181, P1965, DOI 10.1084/jem.181.6.1965; Liu L, 1999, MOL CELL BIOL, V19, P1202; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; METZ T, 1995, CELL, V82, P29, DOI 10.1016/0092-8674(95)90049-7; Quignon F, 1998, NAT GENET, V20, P259, DOI 10.1038/3068; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Wang ZG, 1998, SCIENCE, V279, P1547; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367	30	668	694	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					207	210		10.1038/35018127	http://dx.doi.org/10.1038/35018127			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910364				2022-12-28	WOS:000088221100054
J	Henney, JE				Henney, JE			Implant for chronic nausea	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									Commissioner Food & Drugs, Rockville, MD 20857 USA		Henney, JE (corresponding author), Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2000	283	21					2779	2779		10.1001/jama.283.21.2779-b	http://dx.doi.org/10.1001/jama.283.21.2779-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BQ	10896520				2022-12-28	WOS:000087381500007
J	Kaneko, S; Hikida, T; Watanabe, D; Ichinose, H; Nagatsu, T; Kreitman, RJ; Pastan, I; Nakanishi, S				Kaneko, S; Hikida, T; Watanabe, D; Ichinose, H; Nagatsu, T; Kreitman, RJ; Pastan, I; Nakanishi, S			Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function	SCIENCE			English	Article							DOPAMINE-RECEPTORS; STRIATOPALLIDAL NEURONS; GENE-EXPRESSION; MESSENGER-RNAS; MICE LACKING; RAT-BRAIN; D1; DISORDERS; LOCALIZATION; AMPHETAMINE	The physiological role of striatal cholinergic interneurons was investigated with immunotoxin-mediated cell targeting (IMCT). Unilateral cholinergic cell ablation caused an acute abnormal turning behavior. These mice showed gradual recovery but displayed abnormal turning by both excess stimulation and inhibition of dopamine actions. In the acute phase, basal ganglia function was shifted to a hyperactive state by stimulation and suppression of striatonigral and striatopallidal neurons, respectively. D1 and D2 dopamine receptors were then down-regulated, relieving dopamine-predomimant synaptic perturbation but leaving a defect in controlling dopamine responses. The acetylcholine-dopamine interaction is concertedly and adaptively regulated for basal ganglia synaptic integration.	Kyoto Univ, Fac Med, Dept Biol Sci, Kyoto 6068501, Japan; Fujita Hlth Univ, Sch Med, Inst Comprehens Med Sci, Toyoake, Aichi 4701192, Japan; NCI, Mol Biol Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA	Kyoto University; Fujita Health University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nakanishi, S (corresponding author), Kyoto Univ, Fac Med, Dept Biol Sci, Kyoto 6068501, Japan.	snakanis@phy.med.kyoto-u.ac.jp	pastan, ira/P-9319-2019; Hikida, Takatoshi/J-5561-2017; Ichinose, Hiroshi/D-8986-2015	pastan, ira/0000-0002-9223-0270; Hikida, Takatoshi/0000-0002-8653-311X; Ichinose, Hiroshi/0000-0001-6008-6860				Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; BERGER K, 1991, BRAIN RES BULL, V26, P301, DOI 10.1016/0361-9230(91)90242-C; BERNARD V, 1993, EUR J NEUROSCI, V5, P1218, DOI 10.1111/j.1460-9568.1993.tb00976.x; Chesselet MF, 1996, TRENDS NEUROSCI, V19, P417; DI CG, 1994, TRENDS NEUROSCI, V17, P228; FAHN S, 1990, PROG BRAIN RES, V84, P389; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; HALLETT M, 1993, CAN J NEUROL SCI, V20, P177, DOI 10.1017/S0317167100047909; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; KANEKO S, UNPUB; KAWASHIMA K, 1980, J PHARMACOL METHOD, V3, P115, DOI 10.1016/0160-5402(80)90022-4; KOBAYASHI K, 1995, P NATL ACAD SCI USA, V92, P1132, DOI 10.1073/pnas.92.4.1132; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; NISENBAUM LK, 1994, NEUROSCIENCE, V63, P435, DOI 10.1016/0306-4522(94)90541-X; OHISHI H, 1993, NEUROSCIENCE, V53, P1009, DOI 10.1016/0306-4522(93)90485-X; PHELPS PE, 1985, J COMP NEUROL, V238, P286, DOI 10.1002/cne.902380305; PYCOCK CJ, 1980, NEUROSCIENCE, V5, P461, DOI 10.1016/0306-4522(80)90048-2; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; ROBERTSON GS, 1992, NEUROSCIENCE, V49, P285, DOI 10.1016/0306-4522(92)90096-K; SCHULTZ W, 1995, MODELS INFORMATION P, pCH2; Steiner H, 1998, EXP BRAIN RES, V123, P60, DOI 10.1007/s002210050545; SURMEIER DJ, 1993, TRENDS NEUROSCI, V16, P299, DOI 10.1016/0166-2236(93)90103-S; Wang JQ, 1997, BRAIN RES, V748, P62, DOI 10.1016/S0006-8993(96)01244-9; WARNHOFF M, 1984, J CHROMATOGR, V307, P271, DOI 10.1016/S0378-4347(00)84099-2; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; WILSON CJ, 1998, SYNAPTIC ORG BRAIN, pCH9; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4	35	145	152	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2000	289	5479					633	637		10.1126/science.289.5479.633	http://dx.doi.org/10.1126/science.289.5479.633			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915629	Green Submitted			2022-12-28	WOS:000088447800058
J	Schon, JH; Kloc, C; Dodabalapur, A; Batlogg, B				Schon, JH; Kloc, C; Dodabalapur, A; Batlogg, B			RETRACTED: An organic solid state injection laser (Retracted Article. See vol 298, pg 961, 2002)	SCIENCE			English	Article; Retracted Publication							STIMULATED-EMISSION; CONJUGATED POLYMER; CRYSTALS	We report on electrically driven amplified spontaneous emission and Lasing in tetracene single crystals using field-effect electrodes for efficient electron and hole injection. For Laser action, feedback is provided by reflections at the cleaved edges of the crystal resulting in a Fabry-Perot resonator. Increasing the injected current density above a certain threshold value results in the decreasing of the spectral width of the emission from 120 millielectron volts to Less than 1 millielectron volt because of gain narrowing and eventually Laser action. High electron and hole mobilities as well as balanced charge carrier injection Lead to improved exciton generation in these gate-controlled devices. Moreover, the effect of charge-induced absorption is substantially reduced in high-quality single crystals compared with amorphous organic materials.	Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA	Alcatel-Lucent; Lucent Technologies; AT&T	Batlogg, B (corresponding author), Lucent Technol, Bell Labs, 600 Mt Ave, Murray Hill, NJ 07974 USA.	batlogg@lucent.com	Dodabalapur, Ananth/H-3043-2012; Kloc, Christian/A-2255-2011					AVANESJAN OS, 1974, MOL CRYST LIQ CRYST, V29, P165, DOI 10.1080/15421407408083197; AVANESYAN HS, 1975, PHYS STATUS SOLIDI A, V30, P781, DOI 10.1002/pssa.2210300239; AVANESYAN OS, 1973, PHYS STATUS SOLIDI A, V19, pK121; Berggren M, 1997, APPL PHYS LETT, V71, P2230, DOI 10.1063/1.120065; Blom PWM, 1998, IEEE J SEL TOP QUANT, V4, P105, DOI 10.1109/2944.669477; Dodabalapur A, 1998, IEEE J SEL TOP QUANT, V4, P67, DOI 10.1109/2944.669469; Fichou D, 1997, ADV MATER, V9, P1178, DOI 10.1002/adma.19970091512; Frolov SV, 2000, IEEE J QUANTUM ELECT, V36, P2, DOI 10.1109/3.817632; Garnier F, 1998, APPL PHYS LETT, V72, P2087, DOI 10.1063/1.121284; Hide F, 1997, LASER FOCUS WORLD, V33, P151; Jabbour GE, 2000, IEEE J QUANTUM ELECT, V36, P12, DOI 10.1109/3.817633; KALINOWSKI J, 1976, MOL CRYST LIQ CRYST, V33, P247, DOI 10.1080/15421407608084300; Kallinger C, 1998, ADV MATER, V10, P920, DOI 10.1002/(SICI)1521-4095(199808)10:12<920::AID-ADMA920>3.0.CO;2-7; KARL N, 1972, PHYS STATUS SOLIDI A, V13, P651, DOI 10.1002/pssa.2210130237; Kloc C, 1997, J CRYST GROWTH, V182, P416, DOI 10.1016/S0022-0248(97)00370-9; Kolendritskii D. D., 1978, Optics and Spectroscopy, V44, P162; Kozlov VG, 1999, APPL PHYS LETT, V74, P1057, DOI 10.1063/1.123480; Kozlov VG, 2000, IEEE J QUANTUM ELECT, V36, P18, DOI 10.1109/3.817634; LEE TP, 1982, IEEE J QUANTUM ELECT, V18, P1101, DOI 10.1109/JQE.1982.1071656; NELSON RJ, 1981, IEEE J QUANTUM ELECT, V17, P202, DOI 10.1109/JQE.1981.1071067; Schon JH, 2000, SCIENCE, V287, P1022, DOI 10.1126/science.287.5455.1022; SCHON JH, IN PRESS SCIENCE; Tessler N., 1997, Laser und Optoelektronik, V29, P54; Tessler N, 1999, ADV MATER, V11, P363, DOI 10.1002/(SICI)1521-4095(199903)11:5<363::AID-ADMA363>3.0.CO;2-Y; Zenz C, 1997, APPL PHYS LETT, V71, P2566, DOI 10.1063/1.119332	25	248	268	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2000	289	5479					599	601		10.1126/science.289.5479.599	http://dx.doi.org/10.1126/science.289.5479.599			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915617				2022-12-28	WOS:000088447800046
J	Fagerberg, B				Fagerberg, B			beta-blockade for patients with heart failure - Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MYOCARDIAL-INFARCTION		Sahlgrenska Univ Hosp, Gothenburg, Sweden	Sahlgrenska University Hospital	Fagerberg, B (corresponding author), Sahlgrenska Univ Hosp, Gothenburg, Sweden.							CHADDA K, 1986, CIRCULATION, V73, P503, DOI 10.1161/01.CIR.73.3.503; GUNDERSEN T, 1983, BRIT HEART J, V50, P135; Hjalmarson A, 1999, LANCET, V353, P2001; Lechat P, 1999, LANCET, V353, P9	4	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					436	437						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904494				2022-12-28	WOS:000088254200016
J	Bergeron, MG; Ke, DB; Menard, C; Picard, FJ; Gagnon, M; Bernier, M; Ouellette, M; Roy, PH; Marcoux, S; Fraser, WD				Bergeron, MG; Ke, DB; Menard, C; Picard, FJ; Gagnon, M; Bernier, M; Ouellette, M; Roy, PH; Marcoux, S; Fraser, WD			Rapid detection of group B streptococci in pregnant women at delivery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONIZATION; DISEASE; EPIDEMIOLOGY; CULTURES	Background: Group B streptococcal infections are an important cause of neonatal morbidity and mortality. A rapid method for the detection of this organism in pregnant women at the time of delivery is needed to allow early treatment of neonates. Methods: We studied the efficacy of two polymerase-chain-reaction (PCR) assays for routine screening of pregnant women for group B streptococci at the time of delivery. We obtained anal, vaginal, and combined vaginal and anal specimens from 112 pregnant women; in 57 women, specimens were obtained before and after the rupture of the amniotic membranes. The specimens were tested for group B streptococci by culture in a standard selective broth medium, with a conventional PCR assay, and with a new fluorogenic PCR assay. Results: Among the 112 women, the results of the culture of the combined vaginal and anal specimens were positive for group B streptococci in 33 women (29.5 percent). The two PCR assays detected group B streptococcal colonization in specimens from 32 of these 33 women: the one negative PCR result was in a sample obtained after the rupture of membranes. As compared with the culture results, the sensitivity of both PCR assays was 97.0 percent and the negative predictive value was 98.8 percent. Both the specificity and the positive predictive value of the two PCR assays were 100 percent. The length of time required to obtain results was 30 to 45 minutes for the new PCR assay, 100 minutes for the conventional PCR assay, and at least 36 hours for culture. Conclusions: Colonization with group B streptococci can be identified rapidly and reliably by a PCR assay in pregnant women in labor both before and after the rupture of membranes. (N Engl J Med 2000;343:175-9.) (C)2000, Massachusetts Medical Society.	Univ Laval, Infect Dis Res Ctr, Quebec City, PQ, Canada; Univ Laval, Div Microbiol, Quebec City, PQ, Canada; Univ Laval, Dept Biochem & Microbiol, Quebec City, PQ, Canada; Univ Quebec, Ctr Hosp, Grp Rech Epidemiol, Quebec City, PQ, Canada; Univ Laval, Dept Obstet & Gynecol, Clin Trials Unit, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University; University of Quebec; Laval University	Bergeron, MG (corresponding author), Univ Laval, CHU Laval, Infect Dis Res Ctr, 2705 Blvd Laurier, St Foy, PQ G1V 4G2, Canada.		Ouellette, Marc/K-8694-2017	Ouellette, Marc/0000-0002-6743-9646				*ACOG COMM OBST PR, 1996, ACOG COMM OP, V173; [Anonymous], 1977, J Infect Dis, V136, P137; ANTHONY BF, 1978, J INFECT DIS, V137, P524, DOI 10.1093/infdis/137.5.524; BOYER KM, 1983, J INFECT DIS, V148, P802, DOI 10.1093/infdis/148.5.802; Centers for Disease Control and Prevention, 1996, MMWR-MORBID MORTAL W, V45, P679; Glantz JC, 1998, BIRTH-ISS PERINAT C, V25, P45, DOI 10.1046/j.1523-536x.1998.00045.x; Halsey NA, 1997, PEDIATRICS, V99, P489, DOI 10.1542/peds.99.3.489; Ke DB, 2000, CLIN CHEM, V46, P324; Krohn MA, 1999, J INFECT DIS, V179, P1410, DOI 10.1086/314756; KWOK S, 1989, NATURE, V339, P490; Locksmith GJ, 1999, AM J OBSTET GYNECOL, V180, P416, DOI 10.1016/S0002-9378(99)70225-5; ROSS MG, 1986, ESSENTIALS OBSTET GY, P88; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Wittwer CT, 1997, BIOTECHNIQUES, V22, P176, DOI 10.2144/97221pf02; Yancey MK, 1996, OBSTET GYNECOL, V88, P811, DOI 10.1016/0029-7844(96)00320-1; YOW MD, 1980, AM J OBSTET GYNECOL, V137, P34, DOI 10.1016/0002-9378(80)90382-8; 1996, MMWR MORB MORTAL WKL, V45, P1	19	184	216	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2000	343	3					175	179		10.1056/NEJM200007203430303	http://dx.doi.org/10.1056/NEJM200007203430303			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335HY	10900276	Bronze			2022-12-28	WOS:000088239100003
J	Boudvillain, M; de Lencastre, A; Pyle, AM				Boudvillain, M; de Lencastre, A; Pyle, AM			A tertiary interaction that links active-site domains to the 5 ' splice site of a group II intron	NATURE			English	Article							U6 SNRNA; RNA HELIX; RIBOZYME; NUCLEOTIDES; MECHANISM; SELECTION; CONTACTS; PACKING; BINDING; CORE	Group II introns are self-splicing RNAs that are commonly found in the genes of plants, fungi, yeast and bacteria(1,2). Little is known about the tertiary structure of group II introns, which are among the largest natural ribozymes. The most conserved region of the intron is domain 5 (D5), which, together with domain 1 (D1), is required for all reactions catalysed by the intron(3). Despite the importance of D5, its spatial relationship and tertiary contacts to other active-site constituents have remained obscure. Furthermore, D5 has never been placed directly at a site of catalysis by the intron. Here we show that a set of tertiary interactions (lambda-lambda') links catalytically essential regions of D5 and D1, creating the framework for an active-site and anchoring it at the 5' splice site. Highly conserved elements similar to components of the lambda-lambda' interaction are found in the eukaryotic spliceosome.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Pyle, AM (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	amp11@columbia.edu		Boudvillain, Marc/0000-0002-6398-9122; de Lencastre, Alexandre/0000-0002-3951-8515				Abramovitz DL, 1996, SCIENCE, V271, P1410, DOI 10.1126/science.271.5254.1410; Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; CHANFREAU G, 1994, SCIENCE, V266, P1383, DOI 10.1126/science.7973729; CHIN K, 1995, RNA, V1, P391; COSTA M, 1995, EMBO J, V14, P1276, DOI 10.1002/j.1460-2075.1995.tb07111.x; Costa M, 1999, EMBO J, V18, P1025, DOI 10.1093/emboj/18.4.1025; JACQUIER A, 1990, J MOL BIOL, V213, P437, DOI 10.1016/S0022-2836(05)80206-2; JARRELL KA, 1988, MOL CELL BIOL, V8, P2361, DOI 10.1128/MCB.8.6.2361; KANDELSLEWIS S, 1993, SCIENCE, V262, P2035, DOI 10.1126/science.8266100; Konforti BB, 1998, MOL CELL, V1, P433, DOI 10.1016/S1097-2765(00)80043-X; LESSER CF, 1993, SCIENCE, V262, P1982, DOI 10.1126/science.8266093; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Moore M., 1993, RNA WORLD, P303; Ortoleva-Donnelly L, 1998, BIOCHEMISTRY-US, V37, P12933, DOI 10.1021/bi980723j; Ortoleva-Donnelly L, 1998, RNA, V4, P498, DOI 10.1017/S1355838298980086; PEEBLES CL, 1995, P NATL ACAD SCI USA, V92, P4422, DOI 10.1073/pnas.92.10.4422; PLEY HW, 1994, NATURE, V372, P111, DOI 10.1038/372111a0; PYLE AM, 1994, BIOCHEMISTRY-US, V33, P2716, DOI 10.1021/bi00175a047; PYLE AM, 1996, NUCL ACIDS MOL BIOL, V10, P75; Qin PZ, 1998, CURR OPIN STRUC BIOL, V8, P301, DOI 10.1016/S0959-440X(98)80062-6; Strobel SA, 1998, NAT STRUCT BIOL, V5, P60, DOI 10.1038/nsb0198-60; Strobel SA, 1997, P NATL ACAD SCI USA, V94, P2903, DOI 10.1073/pnas.94.7.2903; Szewczak AA, 1998, NAT STRUCT BIOL, V5, P1037, DOI 10.1038/4146; YU YT, 1995, RNA, V1, P46	27	74	75	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					315	318		10.1038/35018589	http://dx.doi.org/10.1038/35018589			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917534				2022-12-28	WOS:000088251900052
J	Eberhard, WG				Eberhard, WG			Spider manipulation by a wasp larva	NATURE			English	Article							NEPHILA-CLAVIPES ARANEAE; TETRAGNATHIDAE; PHYLOGENY		Univ Costa Rica, Smithsonian Trop Res Inst, San Jose, Costa Rica; Univ Costa Rica, Escuela Biol, San Jose, Costa Rica	Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Costa Rica; Universidad Costa Rica	Eberhard, WG (corresponding author), Univ Costa Rica, Smithsonian Trop Res Inst, Ciudad Univ, San Jose, Costa Rica.							Barnard C.J., 1990, PARASITISM HOST BEHA; CODDINGTON JA, 1968, SPIDERS WEBS BEHAV E, P319; EBERHARD WG, 1990, J ARACHNOL, V18, P205; EBERHARD WG, 1982, EVOLUTION, V36, P1067, DOI 10.1111/j.1558-5646.1982.tb05475.x; EBERHARD WG, IN PRESS J HYMEN RES; FINCKE OM, 1990, J ARACHNOL, V18, P321; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Griswold CE, 1998, ZOOL J LINN SOC-LOND, V123, P1; Holmes J. C., 1972, , Behavioural aspects of parasite transmission., P123; JENNI L, 1980, NATURE, V283, P383, DOI 10.1038/283383a0; TILQUIN A, 1942, TOILE GEOMETRIQUE AR; TOFT CA, 1991, PARASITE HOST ASS; WENZEL JW, 1992, ANNU REV ECOL SYST, V23, P361, DOI 10.1146/annurev.es.23.110192.002045; WICKLER WZ, 1976, TIERPSYCHOLOGIE, V42, P200; Witt PN, 1968, SPIDERS WEB	15	115	127	2	67	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					255	256		10.1038/35018636	http://dx.doi.org/10.1038/35018636			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917517				2022-12-28	WOS:000088251900035
J	Schiermeier, Q				Schiermeier, Q			Enhanced advisory role urged for former EU nuclear labs	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					225	225		10.1038/35018711	http://dx.doi.org/10.1038/35018711			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917498	Bronze			2022-12-28	WOS:000088251900011
J	Seiradakis, JH				Seiradakis, JH			Pulsar astronomy - Older than they look	NATURE			English	Editorial Material									Univ Thessaloniki, Dept Phys, Sect Astrophys Astron & Mech, GR-54006 Salonika, Greece	Aristotle University of Thessaloniki	Seiradakis, JH (corresponding author), Univ Thessaloniki, Dept Phys, Sect Astrophys Astron & Mech, GR-54006 Salonika, Greece.							Gaensler BM, 2000, NATURE, V406, P158, DOI 10.1038/35018010; KASPI VM, 1994, ASTROPHYS J, V422, pL83, DOI 10.1086/187218; LYNE AG, 1988, MON NOT R ASTRON SOC, V233, P667, DOI 10.1093/mnras/233.3.667; Lyne AG, 1996, NATURE, V381, P497, DOI 10.1038/381497a0; LYNE AG, 1998, PULSAR ASTRONOMY; MANCHESTER RN, 1991, MON NOT R ASTRON SOC, V253, pP7, DOI 10.1093/mnras/253.1.7P	6	3	3	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					139	140		10.1038/35018198	http://dx.doi.org/10.1038/35018198			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910339				2022-12-28	WOS:000088221100028
J	Hoebe, CJPA; Kool, JL				Hoebe, CJPA; Kool, JL			Control of legionella in drinking-water systems	LANCET			English	Editorial Material							NOSOCOMIAL LEGIONNAIRES-DISEASE; PNEUMOPHILA; CHLORINE; RISK; SURVEILLANCE; EFFICACY; COPPER; OZONE		Municipal Hlth Serv, Dept Infect Dis, NL-6400 AD Heerlen, Netherlands; Natl Inst Publ Hlth & Environm, Dept Infect Dis Epidemiol, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Hoebe, CJPA (corresponding author), Municipal Hlth Serv, Dept Infect Dis, POB 155, NL-6400 AD Heerlen, Netherlands.			Kool, Jacob/0000-0002-9605-2918; Hoebe, Christian/0000-0003-1815-0974				BLACK I, 2000, GUARDIAN        0510; Chen X, 1996, ENVIRON SCI TECHNOL, V30, P2078, DOI 10.1021/es9509184; EDELSTEIN PH, 1982, APPL ENVIRON MICROB, V44, P1330, DOI 10.1128/AEM.44.6.1330-1333.1982; Fiore AE, 1999, INFECT CONT HOSP EP, V20, P412, DOI 10.1086/501642; Hoebe C J, 1999, Ned Tijdschr Geneeskd, V143, P1041; Hoebe CJP, 1998, EUR J CLIN MICROBIOL, V17, P740, DOI 10.1007/s100960050173; Kool JL, 1999, INFECT CONT HOSP EP, V20, P798, DOI 10.1086/501587; Kool JL, 1999, LANCET, V353, P272, DOI 10.1016/S0140-6736(98)06394-6; LANDEEN LK, 1989, APPL ENVIRON MICROB, V55, P3045, DOI 10.1128/AEM.55.12.3045-3050.1989; MARSTON BJ, 1994, ARCH INTERN MED, V154, P2417, DOI 10.1001/archinte.154.21.2417; MURACA P, 1987, APPL ENVIRON MICROB, V53, P447, DOI 10.1128/AEM.53.2.447-453.1987; PICALUAS L, 2000, 4 DEC INT C NOS HEAL, P263; Rohr U, 1999, CLIN INFECT DIS, V29, P1507, DOI 10.1086/313512; Stout JE, 1998, INFECT CONT HOSP EP, V19, P911; *WHO COMM DIS SURV, LEG DIS AUSTR UPD	15	26	27	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2093	2094		10.1016/S0140-6736(00)02374-6	http://dx.doi.org/10.1016/S0140-6736(00)02374-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902621				2022-12-28	WOS:000087687100007
J	Gottlieb, S				Gottlieb, S			Islet cell transplantation more successful than previously thought	BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					321	321						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QH	10926584				2022-12-28	WOS:000088656300018
J	Jenkins, PJ; Sohaib, SA; Akker, S; Phillips, RR; Spillane, K; Wass, JAH; Monson, JP; Grossman, AB; Besser, GM; Reznek, RH				Jenkins, PJ; Sohaib, SA; Akker, S; Phillips, RR; Spillane, K; Wass, JAH; Monson, JP; Grossman, AB; Besser, GM; Reznek, RH			The pathology of median neuropathy in acromegaly	ANNALS OF INTERNAL MEDICINE			English	Article							CARPAL-TUNNEL SYNDROME	Background: Median neuropathy is commonly associated with acromegaly, although its pathology is uncertain. Objective: To study the pathology of median neuropathy in acromegaly by using magnetic resonance imaging (MRI). Design: Case series. Setting: Outpatient clinic and MRI unit. Patients: Nine patients with acromegaly, four of whom had clinical symptoms of neuropathy. Measurements: At presentation and 6 months after treatment, median nerve size, its signal intensity, and the volume of the carpal tunnel contents were measured. Results: At presentation, patients with symptoms of neuropathy had increased nerve size and signal intensity compared with asymptomatic patients, but the two groups did not differ in volume of carpal tunnel contents. These measures improved with treatment of acromegaly in symptomatic patients; asymptomatic patients experienced no change or worsening. Conclusion: The predominant pathology of median neuropathy in acromegaly seems to be increased edema of the median nerve within the carpal tunnel rather than extrinsic compression from increased volume of the carpal tunnel contents.	St Bartholomews Hosp, Dept Endocrinol, London EC1A 7BE, England	University of London; Queen Mary University London	Jenkins, PJ (corresponding author), St Bartholomews Hosp, Dept Endocrinol, W Smithfield, London EC1A 7BE, England.							BAUM H, 1986, ACTA NEUROCHIR, V83, P54, DOI 10.1007/BF01420508; DALINKA MK, 1991, HAND CLIN, V7, P87; DINN JJ, 1970, J CLIN ENDOCR METAB, V31, P140, DOI 10.1210/jcem-31-2-140; Gondring W H, 1966, J Okla State Med Assoc, V59, P274; GOODWILL C J, 1965, Ann Phys Med, V8, P12; HEALY C, 1990, J HAND SURG-BRIT EUR, V15B, P243, DOI 10.1016/0266-7681(90)90131-M; JAMAL GA, 1987, J NEUROL NEUROSUR PS, V50, P886, DOI 10.1136/jnnp.50.7.886; JOHNSTON AW, 1960, BRIT MED J, V1, P1616, DOI 10.1136/bmj.1.5186.1616; Kameyama Shigeki, 1993, Neurologia Medico-Chirurgica, V33, P547, DOI 10.2176/nmc.33.547; LUBOSHITZKY R, 1980, JAMA-J AM MED ASSOC, V244, P1825, DOI 10.1001/jama.244.16.1825; Ma DM, 1983, NERVE CONDUCTION HDB, P362; MELVIN J L, 1968, Archives of Physical Medicine and Rehabilitation, V49, P502; MESGARZADEH M, 1989, RADIOLOGY, V171, P749, DOI 10.1148/radiology.171.3.2541464; MESGARZADEH M, 1989, RADIOLOGY, V171, P743, DOI 10.1148/radiology.171.3.2717746; ODUFFY JD, 1973, ANN INTERN MED, V78, P379, DOI 10.7326/0003-4819-78-3-379; Radack DM, 1997, AM J ROENTGENOL, V169, P1649, DOI 10.2214/ajr.169.6.9393185; ROSENBAUM RB, 1993, CARPAL TUNNEL SYNDRO, P127; SCHILLER F, 1954, NEUROLOGY, V4, P271, DOI 10.1212/WNL.4.4.271; TRAINER PJ, 1995, BARTS ENDOCRINE PROT, P41; Verma A K, 1994, J Indian Med Assoc, V92, P225	20	41	44	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2000	133	3					197	201		10.7326/0003-4819-133-3-200008010-00011	http://dx.doi.org/10.7326/0003-4819-133-3-200008010-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XW	10906834				2022-12-28	WOS:000088449400005
J	Geddes, D; Davies, M; Koyama, H; Hansell, D; Pastorino, U; Pepper, J; Agent, P; Cullinan, P; MacNeill, SJ; Goldstraw, P				Geddes, D; Davies, M; Koyama, H; Hansell, D; Pastorino, U; Pepper, J; Agent, P; Cullinan, P; MacNeill, SJ; Goldstraw, P			Effect of lung-volume-reduction surgery in patients with severe emphysema.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COPD	Background: Although many patients with severe emphysema have undergone lung-volume-reduction surgery, the benefits are uncertain. We conducted a randomized, controlled trial of the surgery in patients with emphysema. Patients with isolated bullae were excluded because such patients are known to improve after bullectomy. Methods: Potentially eligible patients were given intensive medical treatment and completed a smoking-cessation program and a six-week outpatient rehabilitation program before random assignment to surgery or continued medical treatment. After 15 patients had been randomized, the entry criteria were modified to exclude patients with a carbon monoxide gas-transfer value less than 30 percent of the predicted value or a shuttle-walking distance of less than 150 m, because of the deaths of 5 such patients (3 treated surgically and 2 treated medically). Results: Of the 174 subjects who were initially assessed, 24 were randomly assigned to continued medical treatment and 24 to surgery. At base line in both groups, the median forced expiratory volume in one second (FEV1) was 0.75 liter, and the median shuttle-walking distance was 215 m. Five patients in the surgical group (21 percent) and three patients in the medical group (12 percent) died (P=0.43). After six months, the median FEV1) had increased by 70 ml in the surgical group and decreased by 80 ml in the medical group (P=0.02). The median shuttle-walking distance increased by 50 m in the surgical group and decreased by 20 m in the medical group (P=0.02). There were similar changes on a quality-of-life scale and similar changes at 12 months of follow-up. Five of the 19 surviving patients in the surgical group had no benefit from the treatment. Conclusions: In selected patients with severe emphysema, lung-volume-reduction surgery can improve FEV1, walking distance, and quality of life. Whether it reduces mortality is uncertain. (N Engl J Med 2000;343:239-45.) (C) 2000, Massachusetts Medical Society.	Royal Brompton Hosp, Dept Resp Med, London SW3 6LR, England; Royal Brompton Hosp, Dept Radiol, London SW3 6LR, England; Royal Brompton Hosp, Dept Thorac Surg, London SW3 6LR, England	Royal Brompton Hospital; Royal Brompton Hospital; Royal Brompton Hospital	Geddes, D (corresponding author), Royal Brompton Hosp, Dept Resp Med, London SW3 6LR, England.		Pastorino, Ugo/C-2712-2017	Pastorino, Ugo/0000-0001-9974-7902; Agent, Penny/0000-0002-6674-8535				Altman D.G., 1991, PRACTICAL STAT MED R; Argenziano M, 1997, ANN THORAC SURG, V64, P321, DOI 10.1016/S0003-4975(97)00550-X; Cooper JD, 1996, J THORAC CARDIOV SUR, V112, P1319, DOI 10.1016/S0022-5223(96)70147-2; Fein AM, 1996, AM J RESP CRIT CARE, V154, P1151, DOI 10.1164/ajrccm.154.4.8887620; Fessler HE, 1999, AM J RESP CRIT CARE, V159, P1031, DOI 10.1164/ajrccm.159.4.9808060; Kotloff RM, 1996, CHEST, V110, P1399, DOI 10.1378/chest.110.6.1399; Lomas DA, 1997, THORAX, V52, P755, DOI 10.1136/thx.52.9.755; MAHLER DA, 1995, CHEST, V107, P1585, DOI 10.1378/chest.107.6.1585; McKenna RJ, 1996, J THORAC CARDIOV SUR, V111, P317, DOI 10.1016/S0022-5223(96)70440-3; Meyers BF, 1998, ANN THORAC SURG, V66, P331, DOI 10.1016/S0003-4975(98)00499-8; Russi EW, 1999, EUR RESPIR J, V13, P480, DOI 10.1183/09031936.99.13348099; Russi EW, 1997, EUR RESPIR J, V10, P208, DOI 10.1183/09031936.97.10010208; Sciurba FC, 1997, CLIN CHEST MED, V18, P259, DOI 10.1016/S0272-5231(05)70377-4; SINGH SJ, 1992, THORAX, V47, P1019, DOI 10.1136/thx.47.12.1019; Szekely LA, 1997, CHEST, V111, P550, DOI 10.1378/chest.111.3.550; Weinmann GG, 1996, AM J RESP CRIT CARE, V154, P1913, DOI 10.1164/ajrccm.154.6.8970386; Wilkens H, 1999, AM J RESP CRIT CARE, V159, pA926	17	264	271	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2000	343	4					239	245		10.1056/NEJM200007273430402	http://dx.doi.org/10.1056/NEJM200007273430402			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	337QC	10911005				2022-12-28	WOS:000088372300002
J	Soibel, A; Zeldov, E; Rappaport, M; Myasoedov, Y; Tamegai, T; Ooi, S; Konczykowski, M; Geshkenbein, VB				Soibel, A; Zeldov, E; Rappaport, M; Myasoedov, Y; Tamegai, T; Ooi, S; Konczykowski, M; Geshkenbein, VB			Imaging the vortex-lattice melting process in the presence of disorder	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; SINGLE-CRYSTALS; TRANSITION; YBA2CU3O7-DELTA; BI2SR2CACU2O8	General arguments(1) suggest that first-order phase transitions become less sharp in the presence of weak disorder, while extensive disorder can transform them into second-order transitions; but the atomic level details of this process are not clear. The vortex lattice in superconductors provides a unique system in which to study the first-order transition(2-6) on an inter-particle scale, as well as over a wide range of particle densities. Here we use a differential magneto-optical technique to obtain direct experimental visualization of the melting process in a disordered superconductor. The images reveal complex behaviour in nucleation, pattern formation, and solid-liquid interface coarsening and pinning. Although the local melting is found to be first-order, a global rounding of the transition is observed; this results from a disorder-induced broad distribution of local melting temperatures, at scales down to the mesoscopic level. We also resolve local hysteretic supercooling of microscopic liquid domains, a nonequilibrium process that occurs only at selected sites where the disorder-modified melting temperature has a local maximum. By revealing the nucleation process, we are able to experimentally evaluate the solid-liquid surface tension, which we rnd to be extremely small.	Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Serv Phys, IL-76100 Rehovot, Israel; Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; Ecole Polytech, Lab Solides Irradies, CNRS, UMR 7642, F-91128 Palaiseau, France; ETH Honggerberg, CH-8093 Zurich, Switzerland; LD Landau Theoret Phys Inst, Moscow 117940, Russia	Weizmann Institute of Science; Weizmann Institute of Science; University of Tokyo; CEA; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; CNRS - Institute of Physics (INP); Swiss Federal Institutes of Technology Domain; ETH Zurich; Russian Academy of Sciences; Landau Institute for Theoretical Physics	Soibel, A (corresponding author), Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel.		Tamegai, Tsuyoshi/C-6656-2011; Konczykowski, Marcin/AAI-3112-2020; Soibel, Alexander/A-1313-2007; OOI, Shuuichi/H-2781-2011; Zeldov, Eli/K-1546-2012	Zeldov, Eli/0000-0002-8200-4974				BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; DURAN CA, 1992, NATURE, V357, P474, DOI 10.1038/357474a0; IMRY Y, 1979, PHYS REV B, V19, P3580, DOI 10.1103/PhysRevB.19.3580; INDENBOM MV, 1990, PHYSICA C, V166, P486, DOI 10.1016/0921-4534(90)90049-K; Khaykovich B, 1997, PHYS REV B, V56, pR517, DOI 10.1103/PhysRevB.56.R517; KWOK WK, 1992, PHYS REV LETT, V69, P3370, DOI 10.1103/PhysRevLett.69.3370; LANDAU LD, 1993, STAT PHYSICS; Morozov N, 1996, PHYS REV B, V54, pR3784, DOI 10.1103/PhysRevB.54.R3784; NELSON DR, 1988, PHYS REV LETT, V60, P1973, DOI 10.1103/PhysRevLett.60.1973; Oral A, 1997, PHYS REV B, V56, P14295, DOI 10.1103/PhysRevB.56.R14295; SAFAR H, 1992, PHYS REV LETT, V69, P824, DOI 10.1103/PhysRevLett.69.824; WELP U, 1995, NATURE, V376, P44, DOI 10.1038/376044a0; ZELDOV E, 1995, NATURE, V375, P373, DOI 10.1038/375373a0; ZELDOV E, 1994, PHYS REV LETT, V73, P1428, DOI 10.1103/PhysRevLett.73.1428	14	207	207	1	34	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					282	287		10.1038/35018532	http://dx.doi.org/10.1038/35018532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917525				2022-12-28	WOS:000088251900043
J	Crowley, TJ				Crowley, TJ			Causes of climate change over the past 1000 years	SCIENCE			English	Article							SURFACE AIR-TEMPERATURE; GENERAL-CIRCULATION MODEL; SOLAR-CYCLE LENGTH; GLOBAL CLIMATE; PROXY RECORDS; ICE-AGE; NATURAL VARIABILITY; BOREAL FOREST; 6 CENTURIES; OCEAN	Recent reconstructions of Northern Hemisphere temperatures and climate forcing over the past 1000 years allow the warming of the 20th century to be placed within a historical context and various mechanisms of climate change to be tested. Comparisons of observations with simulations from an energy balance climate model indicate that as much as 41 to 64% of preanthropogenic (pre-1850) decadal-scale temperature variations was due to changes in solar irradiance and volcanism. Removal of the forced response from reconstructed temperature time series yields residuals that show similar variability to those of control runs of coupled models, thereby lending support to the models' value as estimates of low-frequency variability in the climate system. Removal of all forcing except greenhouse gases from the similar to 1000-year time series results in a residual with a very large late-20th-century warming that closely agrees with the response predicted from greenhouse gas forcing. The combination of a unique level of temperature increase in the late 20th century and improved constraints on the role of natural variability provides further evidence that the greenhouse effect has already established itself above the level of natural variability in the climate system. A 21st-century global warming projection far exceeds the natural variability of the past 1000 years and is greater than the best estimate of global temperature change for the last interglacial.	Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Crowley, TJ (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	tcrowley@ocean.tamu.edu						Allen MR, 1999, CLIM DYNAM, V15, P419, DOI 10.1007/s003820050291; Bard E, 1997, EARTH PLANET SC LETT, V150, P453, DOI 10.1016/S0012-821X(97)00082-4; Bard E, 2000, TELLUS B, V52, P985, DOI 10.1034/j.1600-0889.2000.d01-7.x; Barnett TP, 1999, B AM METEOROL SOC, V80, P2631, DOI 10.1175/1520-0477(1999)080<2631:DAAORC>2.0.CO;2; Barnett TP, 1996, HOLOCENE, V6, P255, DOI 10.1177/095968369600600301; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; Bergthorsson P., 1969, JOKULL, V19, P94; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Briffa KR, 2000, QUATERNARY SCI REV, V19, P87, DOI 10.1016/S0277-3791(99)00056-6; Briffa KR, 1998, NATURE, V393, P450, DOI 10.1038/30943; Broecker WS, 1999, SCIENCE, V286, P1132, DOI 10.1126/science.286.5442.1132; Brovkin V, 1999, GLOBAL ECOL BIOGEOGR, V8, P509, DOI 10.1046/j.1365-2699.1999.00169.x; COLLINS M, IN PRESS CLIM DYN; Crowley TJ, 1996, GEOPHYS RES LETT, V23, P2199, DOI 10.1029/96GL01982; Crowley TJ, 2000, AMBIO, V29, P51, DOI 10.1579/0044-7447-29.1.51; CROWLEY TJ, 1990, J CLIMATE, V3, P1282, DOI 10.1175/1520-0442(1990)003<1282:ATASGA>2.0.CO;2; Crowley TJ, 1999, GEOPHYS RES LETT, V26, P1901, DOI 10.1029/1999GL900347; Crowley TJ, 1996, GEOPHYS RES LETT, V23, P359, DOI 10.1029/96GL00243; CROWLEY TJ, 1993, GEOPHYS RES LETT, V20, P209, DOI 10.1029/93GL00207; CROWLEY TJ, 1991, J GEOPHYS RES-ATMOS, V96, P9217, DOI 10.1029/91JD00530; CROWLEY TJ, 1993, QUATERNARY SCI REV, V12, P375, DOI 10.1016/S0277-3791(05)80003-4; CROWLEY TJ, UNPUB; Cubasch U, 1997, CLIM DYNAM, V13, P757, DOI 10.1007/s003820050196; CUBASCH U, 1992, CLIM DYNAM, V8, P55, DOI 10.1007/BF00209163; Damon PE, 1999, GEOPHYS RES LETT, V26, P2469, DOI 10.1029/1999GL900578; DANSGAARD W, 1985, GREENLAND ICE CORE G, P71; Delworth TL, 2000, SCIENCE, V287, P2246, DOI 10.1126/science.287.5461.2246; DELWORTH TL, IN PRESS CLIM DYN; DENTON G H, 1973, Quaternary Research (Orlando), V3, P155, DOI 10.1016/0033-5894(73)90040-9; Etheridge DM, 1996, J GEOPHYS RES-ATMOS, V101, P4115, DOI 10.1029/95JD03410; Free M, 1999, J GEOPHYS RES-ATMOS, V104, P19057, DOI 10.1029/1999JD900233; FRIISCHRISTENSEN E, 1991, SCIENCE, V254, P698, DOI 10.1126/science.254.5032.698; GRAYBILL DA, 1993, GLOBAL BIOGEOCHEM CY, V7, P81, DOI 10.1029/92GB02533; HAMMER CU, 1980, NATURE, V288, P230, DOI 10.1038/288230a0; HAMMER CU, 1977, NATURE, V270, P482, DOI 10.1038/270482a0; Haywood JM, 1998, J GEOPHYS RES-ATMOS, V103, P6043, DOI 10.1029/97JD03426; Hegerl GC, 1997, CLIM DYNAM, V13, P613, DOI 10.1007/s003820050186; HEGERL GC, IN PRESS CLIM DYN; HEGERL GC, UNPUB; Houghton J.T., 1992, CLIMATE CHANGE 1992; HOYT DV, 1993, J GEOPHYS RES-SPACE, V98, P18895, DOI 10.1029/93JA01944; Huang SP, 2000, NATURE, V403, P756, DOI 10.1038/35001556; Hyde WT, 1989, J CLIMATE, V2, P864, DOI 10.1175/1520-0442(1989)002<0864:COGAEB>2.0.CO;2; HYDE WT, 1990, J GEOPHYS RES-ATMOS, V95, P18653, DOI 10.1029/JD095iD11p18653; Hyde WT, 2000, J CLIMATE, V13, P1445, DOI 10.1175/1520-0442(2000)013<1445:LOFCSV>2.0.CO;2; Jacoby GC, 1999, QUATERNARY SCI REV, V18, P1365, DOI 10.1016/S0277-3791(98)00112-7; Jacoby GC, 1996, GEOPHYS RES LETT, V23, P2197, DOI 10.1029/96GL01983; Jones PD, 1998, HOLOCENE, V8, P455, DOI 10.1191/095968398667194956; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Kattenberg A, 1995, CLIMATE CHANGE 1995: THE SCIENCE OF CLIMATE CHANGE, P285; KELLY PM, 1992, NATURE, V360, P328, DOI 10.1038/360328a0; Kiehl JT, 2000, J GEOPHYS RES-ATMOS, V105, P1441, DOI 10.1029/1999JD900495; KIM KY, 1994, GEOPHYS RES LETT, V21, P681, DOI 10.1029/94GL00602; LANGWAY CC, 1995, J GEOPHYS RES-ATMOS, V100, P16241, DOI 10.1029/95JD01175; LEAN J, 1995, GEOPHYS RES LETT, V22, P3195, DOI 10.1029/95GL03093; Lean J, 1999, J ATMOS SOL-TERR PHY, V61, P25, DOI 10.1016/S1364-6826(98)00113-8; LEAN J, 1992, GEOPHYS RES LETT, V19, P1591, DOI 10.1029/92GL01578; Lockwood M, 1999, GEOPHYS RES LETT, V26, P2461, DOI 10.1029/1999GL900485; Manabe S, 1996, J CLIMATE, V9, P376, DOI 10.1175/1520-0442(1996)009<0376:LFVOSA>2.0.CO;2; MANABE S, 1993, NATURE, V364, P215, DOI 10.1038/364215a0; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Montoya M, 2000, J CLIMATE, V13, P1057, DOI 10.1175/1520-0442(2000)013<1057:CSFKBW>2.0.CO;2; Montoya M, 1998, PALEOCEANOGRAPHY, V13, P170, DOI 10.1029/97PA02550; Myhre G, 1998, GEOPHYS RES LETT, V25, P2715, DOI 10.1029/98GL01908; North GR, 1998, J CLIMATE, V11, P563, DOI 10.1175/1520-0442(1998)011<0563:DCSITS>2.0.CO;2; OERLEMANS J, 1994, SCIENCE, V264, P243, DOI 10.1126/science.264.5156.243; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251; Penner JE, 1998, CLIM DYNAM, V14, P839, DOI 10.1007/s003820050259; Pielke RA, 1995, J GEOPHYS RES-ATMOS, V100, P25755, DOI 10.1029/95JD02418; PINTO JP, 1989, J GEOPHYS RES-ATMOS, V94, P11165, DOI 10.1029/JD094iD08p11165; RIND D, 1993, QUATERNARY SCI REV, V12, P357, DOI 10.1016/S0277-3791(05)80002-2; ROBOCK A, 1979, SCIENCE, V206, P1402, DOI 10.1126/science.206.4425.1402; Robock A, 1996, CLIMATIC VARIATIONS, P533; Ruddiman W. F., 1984, Quaternary Research, V21, P123, DOI 10.1016/0033-5894(84)90098-X; Santer BD, 1996, NATURE, V382, P39, DOI 10.1038/382039a0; SATO M, 1993, J GEOPHYS RES-ATMOS, V98, P22987, DOI 10.1029/93JD02553; Schimel D, 1995, CLIMATE CHANGE 1995: THE SCIENCE OF CLIMATE CHANGE, P65; SIGURDSSON H, EOS, V63, P601; Simkin T., 1994, VOLCANOES WORLD; Skinner WR, 1999, CLIMATE RES, V12, P39, DOI 10.3354/cr012039; STOTT P, IN PRESS CLIM DYN; Stouffer RJ, 2000, J CLIMATE, V13, P513, DOI 10.1175/1520-0442(2000)013<0513:ACOSAT>2.0.CO;2; STOUFFER RJ, 1994, NATURE, V367, P634, DOI 10.1038/367634a0; STUIVER M, 1993, RADIOCARBON, V35, P1, DOI 10.1017/S0033822200013874; Stuiver M, 1995, QUATERNARY RES, V44, P341, DOI 10.1006/qres.1995.1079; Tett SFB, 1999, NATURE, V399, P569, DOI 10.1038/21164; Voss R, 1998, CLIM DYNAM, V14, P249, DOI 10.1007/s003820050221; WIGLEY TML, 1987, NATURE, V330, P127, DOI 10.1038/330127a0; WIGLEY TML, 1990, NATURE, V344, P324, DOI 10.1038/344324a0; ZIELINSKI GA, 1995, J GEOPHYS RES-ATMOS, V100, P20937, DOI 10.1029/95JD01751	91	1326	1438	28	1125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2000	289	5477					270	277		10.1126/science.289.5477.270	http://dx.doi.org/10.1126/science.289.5477.270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894770				2022-12-28	WOS:000088169400034
J	Pozniak, CD; Radinovic, S; Yang, A; McKeon, F; Kaplan, DR; Miller, FD				Pozniak, CD; Radinovic, S; Yang, A; McKeon, F; Kaplan, DR; Miller, FD			An anti-apoptotic role for the p53 family member, p73, during developmental neuron death	SCIENCE			English	Article							TUMOR-SUPPRESSOR; CELL-DEATH; SURVIVAL; RECEPTORS; PATHWAY; GROWTH; TRKA; P63	p53 plays an essential pro-apoptotic role, a function thought to be shared with its family members p73 and p63. Here, we show that p73 is primarily present in developing neurons as a truncated isoform whose levels are dramatically decreased when sympathetic neurons apoptose after nerve growth factor (NGF) withdrawal. Increased expression of truncated p73 rescues these neurons from apoptosis induced by NCF withdrawal or p53 overexpression. In p73-/- mice, all isoforms of p73 are deleted and the apoptosis of developing sympathetic neurons is greatly enhanced. Thus, truncated p73 is an essential anti-apoptotic protein in neurons, serving to counteract the pro-apoptotic function of p53.	McGill Univ, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal Neurol Inst, Brain Tumor Res Ctr, Montreal, PQ H3A 2B4, Canada; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	McGill University; McGill University; Harvard University; Harvard Medical School	Miller, FD (corresponding author), McGill Univ, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada.							Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; Fagan AM, 1996, J NEUROSCI, V16, P6208; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaelin WG, 1999, ONCOGENE, V18, P7701, DOI 10.1038/sj.onc.1202955; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Mazzoni IE, 1999, J NEUROSCI, V19, P9716; Morrison RS, 1996, J NEUROSCI, V16, P1337; Slack RS, 1996, J CELL BIOL, V135, P1085, DOI 10.1083/jcb.135.4.1085; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang XM, 1998, J NEUROSCI, V18, P8369	17	392	409	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					304	306		10.1126/science.289.5477.304	http://dx.doi.org/10.1126/science.289.5477.304			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894779				2022-12-28	WOS:000088169400043
J	Shonn, MA; McCarroll, R; Murray, AW				Shonn, MA; McCarroll, R; Murray, AW			Requirement of the spindle checkpoint for proper chromosome segregation in budding yeast meiosis	SCIENCE			English	Article							SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; RECOMBINATION; NONDISJUNCTION; ANAPHASE; PROTEIN; KINETOCHORES; SEPARATION; ATTACHMENT; COMPLEX	The spindle checkpoint was characterized in meiosis of budding yeast. In the absence of the checkpoint, the frequency of meiosis I missegregation increased with increasing chromosome Length, reaching 19% for the longest chromosome. Meiosis I nondisjunction in spindle checkpoint mutants could be prevented by delaying the onset of anaphase. In a recombination-defective mutant (spo11 Delta), the checkpoint delays the biochemical events of anaphase I, suggesting that chromosomes that are attached to microtubules but are not under tension can activate the spindle checkpoint. Spindle checkpoint mutants reduce the accuracy of chromosome segregation in meiosis I much more than that in meiosis II, suggesting that checkpoint defects may contribute to Down syndrome.	Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Cereon Genom LLC, Cambridge, MA 02139 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Murray, AW (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.							BIGGINS S, UNPUB; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Cha RS, 2000, GENE DEV, V14, P493; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Galbraith AM, 1997, GENETICS, V146, P481; HAWLEY RS, 1994, HUM MOL GENET, V3, P1521, DOI 10.1093/hmg/3.9.1521; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; KLAPHOLZ S, 1980, GENETICS, V96, P589; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Koehler KE, 1996, NAT GENET, V14, P406, DOI 10.1038/ng1296-406; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MORGAN G, COMMUNICATION; NICKLAS RB, 1974, GENETICS, V78, P205; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Rose MD., 1990, METHODS YEAST GENETI; Ross LO, 1996, P NATL ACAD SCI USA, V93, P4979, DOI 10.1073/pnas.93.10.4979; SHERMAN SL, 1994, HUM MOL GENET, V3, P1529, DOI 10.1093/hmg/3.9.1529; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; SORA S, 1982, GENETICS, V101, P17; STERN BM, UNPUB; STRAIGHT A, UNPUB; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Waters JC, 1996, J CELL SCI, V109, P2823; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601	34	178	183	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					300	303		10.1126/science.289.5477.300	http://dx.doi.org/10.1126/science.289.5477.300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894778				2022-12-28	WOS:000088169400042
J	Seto, KC; Kaufmann, RK; Woodcock, CE				Seto, KC; Kaufmann, RK; Woodcock, CE			Landsat reveals China's farmland reserves, but they're vanishing fast	NATURE			English	Letter									Boston Univ, Dept Geog, Boston, MA 02215 USA	Boston University	Seto, KC (corresponding author), Boston Univ, Dept Geog, 675 Commonwealth Ave,Room 141E, Boston, MA 02215 USA.		Kaufmann, Robert K/I-4962-2017; Woodcock, Curtis/Y-2478-2019; Seto, Karen C./C-2722-2008	Kaufmann, Robert K/0000-0002-5670-7027; Seto, Karen C./0000-0002-4928-2446				BROWN L, 1995, WILL FEED CHINA; Heilig GK, 1997, POPUL DEV REV, V23, P139, DOI 10.2307/2137464; KAUFMANN RK, UNPUB AGR ECOSYSTEMS; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; SETO KC, UNPUB INT J REMOTE S; SMIL V, 1999, CHINA QUART, V158, P414, DOI DOI 10.1017/S030574100000583X; *STAT BUR GANGD, STAT YB GANGD	7	134	146	4	35	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					121	121		10.1038/35018267	http://dx.doi.org/10.1038/35018267			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910328				2022-12-28	WOS:000088221100013
J	Spivak, JL				Spivak, JL			The blood in systemic disorders	LANCET			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; IMMUNOREACTIVE ERYTHROPOIETIN; CHRONIC DISEASE; CHRONIC ANEMIA; MANIFESTATIONS; ABNORMALITIES; ASSOCIATION; MULTICENTER; DEFICIENCY; FEATURES	The high rate of proliferation required of the bone marrow renders it highly susceptible to the influence of external factors. Anaemia is the most common haematological abnormality seen in systemic disorders. In the anaemia of chronic disease, erythropoietin production is reduced and proliferation of erythroid progenitor cells is also impaired; this anaemia can generally be alleviated by correction of the underlying disease process. The status of the endocrine system must always be considered in evaluation of a normocytic, normochromic anaemia. Anaemia in infection can be due to host or parasite factors or to the treatment administered. Anaemia due to malignant disease responds to erythropoietin therapy in many cases; failure to respond is a poor prognostic sign.	Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA	Johns Hopkins University	Spivak, JL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA.							ASHERSON RA, 1989, MEDICINE, V68, P366, DOI 10.1097/00005792-198911000-00004; BARRETTCONNOR E, 1972, AM J MED, V52, P242, DOI 10.1016/0002-9343(72)90073-3; BROWN CH, 1972, BLOOD-J HEMATOL, V39, P650, DOI 10.1182/blood.V39.5.650.650; BUDMAN DR, 1977, ANN INTERN MED, V86, P220, DOI 10.7326/0003-4819-86-2-220; CARMEL R, 1982, ARCH INTERN MED, V142, P1465, DOI 10.1001/archinte.142.8.1465; CARTWRIGHT G. E., 1966, SEMINARS HEMATOL, V3, P351; CASH JM, 1989, AM J MED, V87, P638; Cazzola M, 1998, BLOOD, V91, P2139, DOI 10.1182/blood.V91.6.2139.2139_2139_2145; DALTON RG, 1987, LANCET, V1, P1007; DEMENT SH, 1985, AM J SURG PATHOL, V9, P23, DOI 10.1097/00000478-198501000-00006; DOLL DC, 1983, CANCER TREAT REV, V10, P185, DOI 10.1016/0305-7372(83)90032-4; EICHNER ER, 1973, AM J MED, V54, P621, DOI 10.1016/0002-9343(73)90120-4; ESCHBACH JW, 1989, ANN INTERN MED, V111, P992, DOI 10.7326/0003-4819-111-12-992; FISCHL M, 1990, NEW ENGL J MED, V322, P1488, DOI 10.1056/NEJM199005243222103; HORTON L, 1975, QJM, V177, P101; JELKMANN W, 1992, LIFE SCI, V50, P301, DOI 10.1016/0024-3205(92)90338-P; KLASSEN DK, 1990, AM J MED, V89, P684, DOI 10.1016/0002-9343(90)90190-O; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; LIPKIN GW, 1990, NEPHROL DIAL TRANSPL, V5, P920, DOI 10.1093/ndt/5.11.920; LUDWIG H, 1994, BLOOD, V84, P1056, DOI 10.1182/blood.V84.4.1056.bloodjournal8441056; MEANS RT, 1992, BLOOD, V80, P1639; Moore RD, 1998, J ACQ IMMUN DEF SYND, V19, P29, DOI 10.1097/00042560-199809010-00004; NIGHTINGALE S, 1978, QJM, V185, P35; OSTER W, 1990, J CLIN ONCOL, V8, P956, DOI 10.1200/JCO.1990.8.6.956; PERRIN LH, 1982, SEMIN HEMATOL, V19, P70; PINCUS T, 1990, AM J MED, V89, P161, DOI 10.1016/0002-9343(90)90294-N; Pirayesh A, 1997, J INTERN MED, V242, P425, DOI 10.1046/j.1365-2796.1997.00213.x; POUNDER RE, 1975, GUT, V16, P181, DOI 10.1136/gut.16.3.181; SACK GH, 1977, MEDICINE, V56, P1, DOI 10.1097/00005792-197756010-00001; SAVAGE D, 1986, MEDICINE, V65, P322, DOI 10.1097/00005792-198609000-00005; Schreiber S, 1996, NEW ENGL J MED, V334, P619, DOI 10.1056/NEJM199603073341002; SICILIANO M, 1995, HEPATOLOGY, V22, P1132, DOI 10.1016/0270-9139(95)90620-7; SINGH A, 1993, J CLIN INVEST, V91, P251, DOI 10.1172/JCI116178; SPIVAK JL, 1989, JAMA-J AM MED ASSOC, V261, P3104, DOI 10.1001/jama.261.21.3104; SPIVAK JL, 1991, BLOOD, V77, P1228; SPIVAK JL, 1984, AM J MED, V77, P224, DOI 10.1016/0002-9343(84)90695-8; SPIVAK JL, 1982, ARCH INTERN MED, V142, P2111, DOI 10.1001/archinte.142.12.2111; SPIVAK JL, 1993, SEMIN HEMATOL, V30, P2; SPIVAK JL, 1991, KIDNEY, P1553	39	90	99	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2000	355	9216					1707	1712		10.1016/S0140-6736(00)02249-2	http://dx.doi.org/10.1016/S0140-6736(00)02249-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905258				2022-12-28	WOS:000086983800038
J	Hastings, G; MacFadyen, L				Hastings, G; MacFadyen, L			A day in the life of an advertising man: review of internal documents from the UK tobacco industry's principal advertising agencies	BRITISH MEDICAL JOURNAL			English	Article							CIGARETTE ADVERTISEMENTS; SMOKING; CONSUMPTION; DEMAND		Univ Strathclyde, Ctr Tobacco Control Res, Glasgow G4 0RQ, Lanark, Scotland	University of Strathclyde	Hastings, G (corresponding author), Univ Strathclyde, Ctr Tobacco Control Res, Glasgow G4 0RQ, Lanark, Scotland.		G, G/A-3459-2012					Aitken P., 1986, HLTH ED RES, V1, P203, DOI DOI 10.1093/her/1.3.203; AITKEN PP, 1990, BRIT J ADDICT, V85, P399; AITKEN PP, 1991, BRIT J ADDICT, V86, P383; AITKEN PP, 1985, SOC SCI MED, V21, P785, DOI 10.1016/0277-9536(85)90127-3; AITKEN PP, 1987, BRIT J ADDICT, V82, P615; Arnett JJ, 1998, TOB CONTROL, V7, P129, DOI 10.1136/tc.7.2.129; BARTON J, 1997, SMOKING SECONDARY SC; Charlton A, 1997, LANCET, V350, P1474, DOI 10.1016/S0140-6736(97)26046-0; Charlton A., 1986, HLTH ED J, V45, P75; COX H, 1984, APPL ECON, V16, P569, DOI 10.1080/00036848400000070; *DEP HLTH, 1995, VOL AGR TOB PROD ADV; *EC OP RES DIV, 1992, EFF TOB ADV TOB CONS; FROESE BD, 1996, HLTH CANADA     0515; HASTINGS GB, 1994, BRIT MED J, V309, P933, DOI 10.1136/bmj.309.6959.933; LAUGESEN M, 1991, BRIT J ADDICT, V86, P1343, DOI 10.1111/j.1360-0443.1991.tb01710.x; Ledwith F., 1984, HLTH ED J, V43, P85, DOI DOI 10.1177/001789698404300402; MACFADYEN L, 1999, TACKLING TOBACCO; MCGUINNESS T, 1975, EUR ECON REV, V6, P311, DOI 10.1016/0014-2921(75)90015-X; PERKURINEN M, 1989, BR J ADDICT, V84, P1183; PIEPE AP, 1986, HLTH ED J, V45, P145; Pierce JP, 1998, JAMA-J AM MED ASSOC, V279, P511, DOI 10.1001/jama.279.7.511; Pollay RW, 1996, J MARKETING, V60, P1, DOI 10.2307/1251927; RADFAR M, 1985, EUR ECON REV, V29, P225, DOI 10.1016/0014-2921(85)90053-4; Silverman D., 1995, INTERPRETING QUALITA; WALKER TM, 1998, LIVING BRITAIN RESUL; WITT SF, 1981, SCOT J POLIT ECON, V28, P86, DOI 10.1111/j.1467-9485.1981.tb00076.x	26	40	40	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					366	371		10.1136/bmj.321.7257.366	http://dx.doi.org/10.1136/bmj.321.7257.366			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	342QH	10926601	Green Accepted, Green Published			2022-12-28	WOS:000088656300031
J	Piwowarczyk, L; Moreno, A; Grodin, M				Piwowarczyk, L; Moreno, A; Grodin, M			Health care of torture survivors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLITICAL ACTIVISTS; REFUGEE TRAUMA		Boston Univ, Sch Med, Boston Med Ctr, Div Psychiat, Boston, MA 02118 USA; Boston Univ, Sch Med, Boston Med Ctr, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Boston Med Ctr, Dept Hlth Law, Boston, MA 02118 USA; Boston Univ, Sch Med, Boston Med Ctr, Dept Sociomed Sci, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Boston Med Ctr, Boston, MA 02118 USA; Boston Ctr Refugee Hlth & Human Rights, Boston, MA USA	Boston Medical Center; Boston University; Boston Medical Center; Boston University; Boston Medical Center; Boston University; Boston Medical Center; Boston University; Boston Medical Center; Boston University	Piwowarczyk, L (corresponding author), Boston Univ, Sch Med, Boston Med Ctr, Div Psychiat, 1 Boston Med Ctr Pl,Dowling 7, Boston, MA 02118 USA.			Grodin, Michael/0000-0002-0929-8929; Piwowarczyk, Linda/0000-0002-0791-9605				*AMN INT INT SECR, 2000, AMN INT ANN REP 2000; ANTOLAK K, 1999, CAR TORT SURV C OCT; Baker R., 1992, TORTURE ITS CONSEQUE, P83; Basoglu M, 1996, J ABNORM PSYCHOL, V105, P232, DOI 10.1037//0021-843X.105.2.232; BASOGLU M, 1994, AM J PSYCHIAT, V151, P76; *BRIT MED ASS, 1992, MED BETR PART DOCT H, P33; CULPEPPER L, 1999, J CLIN PSYCHIAT S, V60; DOERRZEGERS O, 1992, PSYCHIATRY, V55, P177; Eisenman DP, 2000, WESTERN J MED, V172, P301, DOI 10.1136/ewjm.172.5.301; FOA EB, IN PRESS EFFECTIVE T; FRIEDMAN MJ, IN PRESS EFFECTIVE T; GUDJONSSON G, 1996, GLIMPSE HELL REPORTS, P36; Holtz TH, 1998, J NERV MENT DIS, V186, P24, DOI 10.1097/00005053-199801000-00005; IACOPINO V, 2000, MANUAL EFFECTIVE INV; Jacobsen L, 1989, Int Nurs Rev, V36, P75; Jaranson JM, 1995, TRANSCULT PSYCHIATRY, V32, P253; KINZIE JD, 1981, AM J PSYCHOTHER, V35, P251, DOI 10.1176/appi.psychotherapy.1981.35.2.251; Mollica RF, 1999, JAMA-J AM MED ASSOC, V282, P433, DOI 10.1001/jama.282.5.433; Mollica RF, 1991, PSYCHOL ASSESSMENT, V3, P2; POPE KS, 1991, PROF PSYCHOL-RES PR, V22, P269, DOI 10.1037/0735-7028.22.4.269; Silove D, 1999, J NERV MENT DIS, V187, P200, DOI 10.1097/00005053-199904000-00002; SUGG NK, 1992, JAMA-J AM MED ASSOC, V267, P3157, DOI 10.1001/jama.267.23.3157; *UN CONV TORTU OTH, 1995, TORTURE, V5, P72; Weinstein HM, 1996, WESTERN J MED, V165, P112	24	37	38	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2000	284	5					539	541		10.1001/jama.284.5.539	http://dx.doi.org/10.1001/jama.284.5.539			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	337WG	10918684				2022-12-28	WOS:000088385400003
J	Trotochaud, AE; Jeong, S; Clark, SE				Trotochaud, AE; Jeong, S; Clark, SE			RETRACTED: CLAVATA3, a multimeric ligand for the CLAVATA1 receptor-kinase (retracted article)	SCIENCE			English	Article; Retracted Publication							PROTEIN PHOSPHATASE; MERISTEM DEVELOPMENT; GENE ENCODES; SHOOT; REGULATOR; DOMAIN	The CLAVATA1 (CLV1) and CLAVATA3 (CLV3) proteins form a potential receptor and ligand pair that regulates the balance between cell proliferation and differentiation at the shoot meristem of Arabidopsis, CLV1 encodes a receptor-kinase, and CLV3 encodes a predicted small, secreted polypeptide. We demonstrate that the CLV3 and CLV1 proteins coimmunoprecipitate in vivo, that yeast cells expressing CLV1 and CLV2 bind to CLV3 from plant extracts, and that binding requires CLV1 kinase activity. CLV3 only associates with the presumed active CLV1 protein complex: in vivo. More than 75% of CLV3 in cauliflower extracts is bound with CLV1, consistent with hypotheses of Ligand sequestration. Soluble CLV3 was found in an approximately 25-kilodalton multimeric complex.	Univ Michigan, Dept Biol, Nat Sci Bldg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Clark, SE (corresponding author), Univ Michigan, Dept Biol, Nat Sci Bldg, Ann Arbor, MI 48109 USA.	clarks@umich.edu						Bevan A, 1998, P NATL ACAD SCI USA, V95, P10384, DOI 10.1073/pnas.95.18.10384; CASANOVA J, 1993, NATURE, V362, P152, DOI 10.1038/362152a0; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; CLARK SE, 1993, DEVELOPMENT, V119, P397; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Franssen HJ, 1998, CURR OPIN PLANT BIOL, V1, P384, DOI 10.1016/S1369-5266(98)80260-4; Grossmann M, 1997, ENDOCR REV, V18, P476, DOI 10.1210/er.18.4.476; Hajnal A, 1997, GENE DEV, V11, P2715, DOI 10.1101/gad.11.20.2715; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Li J, 1999, P NATL ACAD SCI USA, V96, P7821, DOI 10.1073/pnas.96.14.7821; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Pogany JA, 1998, J PLANT RES, V111, P307, DOI 10.1007/BF02512189; Stone JM, 1998, PLANT PHYSIOL, V117, P1217, DOI 10.1104/pp.117.4.1217; STONE JM, 1994, SCIENCE, V266, P793, DOI 10.1126/science.7973632; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; TROTOCHAUD AE, UNPUB; Williams RW, 1997, P NATL ACAD SCI USA, V94, P10467, DOI 10.1073/pnas.94.19.10467	20	146	155	3	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2000	289	5479					613	617		10.1126/science.289.5479.613	http://dx.doi.org/10.1126/science.289.5479.613			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915623				2022-12-28	WOS:000088447800052
J	Wald, NJ; Law, MR; Morris, JK; Zhou, X; Wong, Y; Ward, ME				Wald, NJ; Law, MR; Morris, JK; Zhou, X; Wong, Y; Ward, ME			Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective studs	BRITISH MEDICAL JOURNAL			English	Article							HELICOBACTER-PYLORI; MYOCARDIAL-INFARCTION; RISK FACTOR; ASSOCIATION; CYTOMEGALOVIRUS	Objective To determine whether there is an independent association between infection with Chlamydia pneumoniae and ischaemic heart disease. Design Prospective study using a nested case-control design, Setting Medical centre in London run by BUPA, a private medical organisation. Participants 21 520 professional men aged 35-64 who attended for a medical examination in London between 1975 and 1982. Main outcome measure Death from ischaemic heart disease. Results The distributions of concentrations of IgG and IgA antibodies to C pneumoniae were similar in the 647 men who subsequently died of ischaemic heart disease and in 1294 age matched controls who did not There was no material association with heart disease irrespective of the cut-off point chosen to define seropositivity, At a cut-off point that defines 15% of controls as positive, for example, the odds ratios were 1.26 (95% confidence interval 0.95 to 1.68) for IgG and 1.09 (0.82 to 1.43) for IgA. Conclusions No material association was found between infection with C pneumoniae and ischaemic heart disease. The size and prospective design of the study and the socioeconomic homogeneity of the cohort minimise both random and systematic error.	St Bartholomews & Royal London Sch Med & Dent, Wolfson Inst Prevent Med, BUPA Epidemiol Res Grp, London EC1M 6BQ, England; Southampton Gen Hosp, Mol Microbiol Grp, Southampton SO16 6YD, Hants, England	University of London; Queen Mary University London; University of Southampton	Wald, NJ (corresponding author), St Bartholomews & Royal London Sch Med & Dent, Wolfson Inst Prevent Med, BUPA Epidemiol Res Grp, London EC1M 6BQ, England.		Wald, Nicholas/AAY-2814-2021; Wald, Nicholas/AAY-8924-2021	Morris, Joan/0000-0002-7164-612X				Danesh J, 1999, HEART, V81, P245, DOI 10.1136/hrt.81.3.245; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Haider Agha W., 1999, Journal of the American College of Cardiology, V33, p314A; Jackson LA, 1999, EMERG INFECT DIS, V5, P281, DOI 10.3201/eid0502.990216; Miettinen H, 1996, EUR HEART J, V17, P682; Ossewaarde JM, 1998, EPIDEMIOL INFECT, V120, P93, DOI 10.1017/S0950268897008303; PATEL P, 1995, BRIT MED J, V311, P711, DOI 10.1136/bmj.311.7007.711; Ridker PM, 1999, CIRCULATION, V99, P1161, DOI 10.1161/01.CIR.99.9.1161; SAIKKU P, 1992, ANN INTERN MED, V116, P273, DOI 10.7326/0003-4819-116-4-273; Strachan DP, 1999, BMJ-BRIT MED J, V318, P1035, DOI 10.1136/bmj.318.7190.1035; von Hertzen L, 1999, BRIT MED J, V319, P1575, DOI 10.1136/bmj.319.7224.1575; Wald NJ, 1997, BMJ-BRIT MED J, V315, P1199, DOI 10.1136/bmj.315.7117.1199; Wong YK, 1999, J CLIN PATHOL, V52, P99, DOI 10.1136/jcp.52.2.99	13	69	73	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 22	2000	321	7255					204	207		10.1136/bmj.321.7255.204	http://dx.doi.org/10.1136/bmj.321.7255.204			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903649	Green Published, Bronze			2022-12-28	WOS:000088448100020
J	Cabib, S; Orsini, C; Le Moal, M; Piazza, PV				Cabib, S; Orsini, C; Le Moal, M; Piazza, PV			Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience	SCIENCE			English	Article							INBRED STRAINS; NEURAL BASIS; MICE; DOPAMINE; STRESS; SENSITIZATION; VULNERABILITY; AMPHETAMINE; GENOTYPE; GENETICS	Inbred strains of mice are Largely used to identify the genetic basis of normal and pathological behaviors. This report demonstrates that a moderate period of food shortage, an ecologically common experience, can reverse or abolish strain differences in behavioral responses to the abused psychostimulant amphetamine. The period of food shortage occurred when the animals were mature and was terminated before the administration of amphetamine. Strain differences in behavior appear highly dependent on environmental experiences. Consequently, to identify biological determinants of behavior, an integrated approach considering the interaction between environmental and genetic factors needs to be used.	Univ Bordeaux 2, Inst Francois Magendie, Lab Psychobiol Comportement Adaptat, INSERM,U259, F-33076 Bordeaux, France; Univ Rome La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Sapienza University Rome	Piazza, PV (corresponding author), Univ Bordeaux 2, Inst Francois Magendie, Lab Psychobiol Comportement Adaptat, INSERM,U259, Rue Camille St Saens,Domaine Carreire, F-33076 Bordeaux, France.		LE MOAL, Michel/B-5125-2008; Cabib, Simona/AAB-2378-2019	ORSINI, Cristina/0000-0003-1280-3233; Cabib, Simona/0000-0001-8781-8603				Barrett J E, 1992, NIDA Res Monogr, V124, P161; Cabib S, 1998, NEUROSCIENCE, V84, P193, DOI 10.1016/S0306-4522(97)00468-5; Cabib S, 1996, PSYCHOPHARMACOLOGY, V128, P331, DOI 10.1007/s002130050142; Cabib S, 1996, BRAIN RES, V729, P110, DOI 10.1016/0006-8993(96)00418-0; Cabib S, 1996, PSYCHOPHARMACOLOGY, V125, P92, DOI 10.1007/BF02247398; CABIB S, 1988, BRAIN RES, V441, P153, DOI 10.1016/0006-8993(88)91393-5; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; CRABBE JC, 1994, SCIENCE, V264, P1715, DOI 10.1126/science.8209252; Crabbe JC, 1999, TRENDS NEUROSCI, V22, P173, DOI 10.1016/S0166-2236(99)01393-4; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; FOWELS DC, 1992, ANNU REV PSYCHOL, V43, P303; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Hofstetter JR, 1999, CHRONOBIOL INT, V16, P269, DOI 10.3109/07420529909116857; McBride WJ, 1999, BEHAV BRAIN RES, V101, P129, DOI 10.1016/S0166-4328(99)00022-4; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; Piazza PV, 1996, ANNU REV PHARMACOL, V36, P359, DOI 10.1146/annurev.pa.36.040196.002043; PuglisiAllegra S, 1997, PROG NEUROBIOL, V51, P637, DOI 10.1016/S0301-0082(97)00008-7; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rossi-Arnaud C, 1998, EXP BRAIN RES, V123, P36, DOI 10.1007/s002210050542; Royle SJ, 1999, BRAIN RES, V816, P337, DOI 10.1016/S0006-8993(98)01122-6; SAGHAL ED, 1993, BEHAV NEUROSCIENCE P, V1, pCH2; SHECHTER MD, 1993, NEUROSCI BIO BEHAV R, V17, P21; STEELE PM, 1998, CELL, V79, P958; TATHAM TA, 1992, ANN NY ACAD SCI, V654, P368; van den Bree MBM, 1998, DRUG ALCOHOL DEPEN, V49, P177, DOI 10.1016/S0376-8716(98)00012-X; van den Bree MBM, 1998, DRUG ALCOHOL DEPEN, V52, P231, DOI 10.1016/S0376-8716(98)00101-X; Wehner JM, 1997, NAT GENET, V17, P331, DOI 10.1038/ng1197-331	30	195	196	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					463	465		10.1126/science.289.5478.463	http://dx.doi.org/10.1126/science.289.5478.463			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903209				2022-12-28	WOS:000088305500051
J	Alison, MR; Poulsom, R; Jeffery, R; Dhillon, AP; Quaglia, A; Jacob, J; Novelli, M; Prentice, G; Williamson, J; Wright, NA				Alison, MR; Poulsom, R; Jeffery, R; Dhillon, AP; Quaglia, A; Jacob, J; Novelli, M; Prentice, G; Williamson, J; Wright, NA			Cell differentiation - Hepatocytes from nonhepatic adult stem cells	NATURE			English	Article							PRIMARY BILIARY-CIRRHOSIS; Y-CHROMOSOME; LIVER; TRANSPLANTATION; MICROCHIMERISM		Imperial Coll Sch Med, Dept Histopathol, London W12 0NN, England; Imperial Canc Res Fund, Histopathol Unit, London WC2A 3PX, England; UCL Royal Free & Univ Coll Sch Med, Dept Histopathol, London NW3 2PF, England; UCL Royal Free & Univ Coll Sch Med, Dept Haematol, London NW3 2PF, England; UCL, Dept Histopathol, London WC1E 6JJ, England; Imperial Canc Res Fund, Human Cytogenet Lab, London WC2A 3PX, England	Imperial College London; Cancer Research UK; University of London; University College London; University of London; University College London; University of London; University College London; Cancer Research UK	Alison, MR (corresponding author), Imperial Coll Sch Med, Dept Histopathol, Hammersmith Campus, London W12 0NN, England.	m.alison@ic.ac.uk	Dhillon, Amar P/C-5619-2009; Alison, Malcolm/H-6961-2019; Wright, Nicholas/HHY-7227-2022	Wright, Nicholas/0000-0002-5525-3457				Alison M, 1998, CURR OPIN CELL BIOL, V10, P710, DOI 10.1016/S0955-0674(98)80111-7; Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5; Novelli MR, 1996, SCIENCE, V272, P1187, DOI 10.1126/science.272.5265.1187; Oren R, 1999, HEPATOLOGY, V30, P903, DOI 10.1002/hep.510300418; Overturf K, 1997, AM J PATHOL, V151, P1273; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Rubbia-Brandt L, 1999, HEPATOLOGY, V30, P821, DOI 10.1002/hep.510300322; Tanaka A, 1999, HEPATOLOGY, V30, P833, DOI 10.1002/hep.510300410; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; VANEYKEN P, 1993, LIVER, V13, P113; WOLFE J, 1985, J MOL BIOL, V182, P477, DOI 10.1016/0022-2836(85)90234-7	11	837	936	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					257	257		10.1038/35018642	http://dx.doi.org/10.1038/35018642			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917519	Bronze			2022-12-28	WOS:000088251900037
J	Ansel, KM; Ngo, VN; Hyman, PL; Luther, SA; Forster, R; Sedgwick, JD; Browning, JL; Lipp, M; Cyster, JG				Ansel, KM; Ngo, VN; Hyman, PL; Luther, SA; Forster, R; Sedgwick, JD; Browning, JL; Lipp, M; Cyster, JG			A chemokine-driven positive feedback loop organizes lymphoid follicles	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; FOLLICULAR DENDRITIC CELLS; B-CELL; LYMPHOTOXIN-ALPHA; IMMUNE-RESPONSES; T-CELL; LYMPHOCYTES; EXPRESSION; BETA; RECEPTOR	Lymphoid follicles are B-cell-rich compartments of lymphoid organs that function as sites of B-cell antigen encounter and differentiation. CXC chemokine receptor-5 (CXCR5) is required for B-cell migration to splenic follicles(1), but the requirements for homing to B-cell areas in lymph nodes remain to be defined. Here we show that lymph nodes contain two types of B-cell-rich compartment: follicles containing follicular dendritic cells, and areas lacking such cells. Using gene-targeted mice, we establish that B-lymphocyte chemoattractant (BLC/BCA1)(2,3) and its receptor, CXCR5, are needed for B-cell homing to follicles in lymph nodes as well as in spleen. We also rnd that BLC is required for the development of most lymph nodes and Peyer's patches. In addition to mediating chemoattraction, BLC induces B cells to upregulate membrane lymphotoxin alpha 1 beta 2, a cytokine that promotes follicular dendritic cell development and BLC expression(4,5), establishing a positive feedback loop that is likely to be important in follicle development and homeostasis. In germinal centres the feedback loop is overridden, with B-cell lymphotoxin a1b2 expression being induced by a mechanism independent of BLC.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA; Biogen Inc, Cambridge, MA 02142 USA	University of California System; University of California San Francisco; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Biogen	Cyster, JG (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.		Luther, Sanjiv A/B-4380-2016; Lipp, Martin/G-2235-2010; Luther, Sanjiv/AAP-6525-2020; Förster, Reinhold/D-6770-2011; , Sanjiv/B-4380-2016	Luther, Sanjiv A/0000-0002-8758-957X; Luther, Sanjiv/0000-0002-8758-957X; Ngo, Vu/0000-0002-9501-6990; , Sanjiv/0000-0002-0614-561X; Forster, Reinhold/0000-0001-6190-7923; Browning, Jeffrey/0000-0001-9168-5233				ANDEL KM, 1999, J EXP MED, V190, P1123; Browning JL, 1997, J IMMUNOL, V159, P3288; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Fu YX, 1998, J EXP MED, V187, P1009, DOI 10.1084/jem.187.7.1009; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; GUTMAN GA, 1973, TRANSPLANTATION, V16, P621, DOI 10.1097/00007890-197312000-00014; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; MILLER JJ, 1968, NATURE, V217, P1059, DOI 10.1038/2171059a0; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; POKHOLOK DK, 1995, P NATL ACAD SCI USA, V92, P674, DOI 10.1073/pnas.92.3.674; Tew JG, 1997, IMMUNOL REV, V156, P39, DOI 10.1111/j.1600-065X.1997.tb00957.x; TILNEY NL, 1971, J ANAT, V109, P369; VAJDY M, 1995, J EXP MED, V181, P41, DOI 10.1084/jem.181.1.41; Voigt I, 2000, EUR J IMMUNOL, V30, P560, DOI 10.1002/1521-4141(200002)30:2<560::AID-IMMU560>3.0.CO;2-T; WORM M, 1994, INT IMMUNOL, V6, P1883, DOI 10.1093/intimm/6.12.1883; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643	30	948	987	1	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					309	314		10.1038/35018581	http://dx.doi.org/10.1038/35018581			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917533				2022-12-28	WOS:000088251900051
J	Harvey, JA; Corley, LS; Strand, MR				Harvey, JA; Corley, LS; Strand, MR			Competition induces adaptive shifts in caste ratios of a polyembryonic wasp	NATURE			English	Article							COPIDOSOMA-FLORIDANUM HYMENOPTERA; PSEUDOPLUSIA-INCLUDENS; MICROPLITIS-DEMOLITOR; HARVESTER ANTS; FORMICIDAE; ENCYRTIDAE; ALLOCATION; EVOLUTION; DYNAMICS; COLONIES	An important transition in insect life-history evolution was the shift from a solitary existence to living in groups comprising specialized castes. Caste-forming species produce some individuals that reproduce and others with worker functions that have few or no offspring(1). Morphologically specialized castes are well known in eusocial species like ants and termites(1), but castes have also evolved in less-studied groups like thrips, aphids and polyembryonic wasps(2-5). Because selection acts at both the individual and the colony level, ratios of investment in different castes are predicted to vary with environmental factors like competition and resources(6-8). However, experimental evidence for adaptive shifts in caste ratios is limited(9) owing to the experimental difficulty of manipulating factors thought to influence caste ratios(10-13), and because some species produce behaviourally flexible castes that switch tasks in response to colony needs(14,15). Unlike other caste-forming species, the broods of polyembryonic wasps develop clonally, so that increased production of one caste probably results in decreased production of the other(16). Here we show that the polyembryonic wasp Copidosoma floridanum alters caste ratios in response to interspecific competition. Our results reveal a distinct trade-off by C. floridanum between reproduction and defence, and show experimentally that caste ratios shift in an adaptive manner.	Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Strand, MR (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	mrstrand@facstaff.wisc.edu	Harvey, Jeffrey A/B-7439-2008	Harvey, Jeffrey A/0000-0002-4227-7935; Lavine, Laura/0000-0002-0262-359X				BAEHRECKE EH, 1993, DEV BIOL, V158, P275, DOI 10.1006/dbio.1993.1188; BESHERS SN, 1994, ECOLOGY, V75, P763, DOI 10.2307/1941733; BROWNING HW, 1984, ENVIRON ENTOMOL, V13, P551, DOI 10.1093/ee/13.2.551; CRESPI BJ, 1992, NATURE, V359, P724, DOI 10.1038/359724a0; CRUZ YP, 1981, NATURE, V294, P446, DOI 10.1038/294446a0; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; GORDON DM, 1989, ANIM BEHAV, V38, P194, DOI 10.1016/S0003-3472(89)80082-X; GORDON DM, 1987, ANIM BEHAV, V35, P833, DOI 10.1016/S0003-3472(87)80119-7; Grbic M, 1997, J INSECT PHYSIOL, V43, P553, DOI 10.1016/S0022-1910(97)00004-8; GRBIC M, 1992, NATURE, V360, P254, DOI 10.1038/360254a0; Grbic M, 1998, DEV GENES EVOL, V208, P69, DOI 10.1007/s004270050156; HASEGAWA E, 1993, BEHAV ECOL SOCIOBIOL, V33, P73; Hasegawa E, 1997, AM NAT, V149, P706, DOI 10.1086/286016; HERBERS JM, 1980, EVOLUTION, V34, P575, DOI 10.1111/j.1558-5646.1980.tb04845.x; JOHNSTON AB, 1985, ANN ENTOMOL SOC AM, V78, P8, DOI 10.1093/aesa/78.1.8; ODE PJ, 1995, J ANIM ECOL, V64, P213, DOI 10.2307/5756; Oster G.F., 1978, Monographs in Population Biology, pi; Passera L, 1996, NATURE, V379, P630, DOI 10.1038/379630a0; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Stern DL, 1996, BIOL REV, V71, P27, DOI 10.1111/j.1469-185X.1996.tb00741.x; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335; Strand MR, 1997, J VIROL, V71, P2146, DOI 10.1128/JVI.71.3.2146-2156.1997; STRAND MR, 1990, ENTOMOL EXP APPL, V55, P275, DOI 10.1111/j.1570-7458.1990.tb01372.x; Strand MR, 1997, CURR TOP DEV BIOL, V35, P121, DOI 10.1016/S0070-2153(08)60258-6; STRAND MR, 1989, J INSECT BEHAV, V2, P355, DOI 10.1007/BF01068061; Webb BA, 1998, VIRUSES, P105; WHEELER DE, 1991, AM NAT, V138, P1218, DOI 10.1086/285279; WILSON EO, 1984, BEHAV ECOL SOCIOBIOL, V16, P89, DOI 10.1007/BF00293108	28	81	84	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					183	186		10.1038/35018074	http://dx.doi.org/10.1038/35018074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910357				2022-12-28	WOS:000088221100047
J	Lipkin, HJ				Lipkin, HJ			The structure of matter	NATURE			English	Article									Weizmann Inst Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Lipkin, HJ (corresponding author), Weizmann Inst Sci, IL-76100 Rehovot, Israel.								0	4	4	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					127	127		10.1038/35018174	http://dx.doi.org/10.1038/35018174			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910332				2022-12-28	WOS:000088221100021
J	Money, NP				Money, NP			Genetics - Fungal get-together	NATURE			English	Editorial Material									Miami Univ, Dept Bot, Oxford, OH 45056 USA	Miami University	Money, NP (corresponding author), Miami Univ, Dept Bot, Oxford, OH 45056 USA.							Peabody RB, 2000, FUNGAL GENET BIOL, V29, P72, DOI 10.1006/fgbi.2000.1187; SMITH ML, 1992, NATURE, V356, P428, DOI 10.1038/356428a0	2	4	4	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					751	751		10.1038/35015659	http://dx.doi.org/10.1038/35015659			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10896567	Bronze			2022-12-28	WOS:000087620600032
J	Hovell, MF; Zakarian, JM; Matt, GE; Hofstetter, CR; Bernert, JT; Pirkle, J				Hovell, MF; Zakarian, JM; Matt, GE; Hofstetter, CR; Bernert, JT; Pirkle, J			Effect of counselling mothers on their children's exposure to environmental tobacco smoke: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							PASSIVE SMOKING; ASTHMATIC-CHILDREN; BREAST-MILK; INFANTS; REDUCTION; COTININE; URINE	Objective To test the efficacy of behavioural counselling for smoking mothers in reducing young children's exposure to environmental tobacco smoke, Design Randomised double blind controlled trial, Setting Low income homes in San Diego county, California. Participants 108 ethnically diverse mothers who exposed their children (aged < 4 years) to tobacco smoke in the home. Intervention Mothers were given seven counselling sessions over three months. Main outcome measures Children's reported exposure to environmental tobacco smoke from mothers in the home and from all sources; children's cotinine concentrations in urine. Results Mothers' reports of children's exposure to their smoke in the home declined in the counselled group from 27.30 cigarettes/week at baseline, to 4.47 at three months, to 3.66 at 12 months and in the controls from 24.56, to 12.08, to 8.38. The differences between the groups by time were significant (P = 0.002), Reported exposure to smoke from all sources showed similar declines, with significant differences between groups by time (P = 0.008). At 12 months, the reported exposure in the counselled group was 41.2% that of controls for mothers' smoke (95% confidence interval 34.2% to 48.3%) and was 45.7% (38.4% to 53.0%) that of controls for all sources of smoke. Children's mean urine cotinine concentrations decreased slightly in the counselled group from 10.93 ng/ml at baseline to 10.47 ng/ml at 12 months but increased in the controls from 9.43 ng/ml to 17.47 ng/ml (differences between groups by time P = 0.008). At 12 months the cotinine concentration in the counselled group was 55.6% (48.2% to 63.0%) that of controls. Conclusions Counselling was effective in reducing children's exposure to environmental tobacco smoke. Similar counselling in medical and social services might protect millions of children from environmental tobacco smoke in their homes.	San Diego State Univ, Grad Sch Publ Hlth, Ctr Behav Epidemiol & Community Hlth, San Diego, CA 92182 USA; Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30341 USA	California State University System; San Diego State University; Centers for Disease Control & Prevention - USA	Hovell, MF (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, Ctr Behav Epidemiol & Community Hlth, San Diego, CA 92182 USA.			Matt, Georg/0000-0001-5604-4609	NICHD NIH HHS [R01 HD037749] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037749] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMS EK, 1999, COSTS ENV TOBACCO SM; *CDC, 1997, MMWR-MORBID MORTAL W, V46, P1038; CHARLTON A, 1994, J FAM PRACTICE, V38, P267; Diggle PJ, 1995, J AM STAT ASSOC; EMERSON JA, 1995, J CLIN EPIDEMIOL, V48, P1251, DOI 10.1016/0895-4356(95)00021-U; GREENBERG RA, 1994, J BEHAV MED, V17, P273, DOI 10.1007/BF01857953; HAMMOND SK, 1987, ENVIRON SCI TECHNOL, V21, P494, DOI 10.1021/es00159a012; HOVELL M, 2000, TOBACCO CONTROL S3, V9; HOVELL MF, 1995, CHEST, V107, P1480; HOVELL MF, 1994, CHEST, V106, P440, DOI 10.1378/chest.106.2.440; HOVELL MF, 2000, TOBACCO CONTROL, V9; Jarvis M.J., 1999, CHILDRENS EXPOSURE P; KLONOFFCOHEN HS, 1995, JAMA-J AM MED ASSOC, V273, P795, DOI 10.1001/jama.273.10.795; LEADERER BP, 1991, ENVIRON SCI TECHNOL, V25, P770, DOI 10.1021/es00016a023; Mascola MA, 1998, AM J PUBLIC HEALTH, V88, P893, DOI 10.2105/AJPH.88.6.893; Matt GE, 1999, TOB CONTROL, V8, P282, DOI 10.1136/tc.8.3.282; Matt GE, 2000, HEALTH PSYCHOL, V19, P232, DOI 10.1037//0278-6133.19.3.232; MATTANINI MA, 1996, FINDING SOLUTIONS SO; MURRAY DM, 1987, ADDICT BEHAV, V12, P7, DOI 10.1016/0306-4603(87)90003-7; *NAT HLTH MED RES, 1997, HLTH EFF PASS SMOK; *PHYS SMOK FREE CA, 1999, SMOK CAN HOM ARE CHI; Pirkle JL, 1996, JAMA-J AM MED ASSOC, V275, P1233, DOI 10.1001/jama.275.16.1233; SCHULTEHOBEIN B, 1992, ACTA PAEDIATR, V81, P550, DOI 10.1111/j.1651-2227.1992.tb12293.x; *US DEP HHS, 1993, NIH PUBL; Wahlgren DR, 1997, CHEST, V111, P81, DOI 10.1378/chest.111.1.81; World Health Organization, 1999, INT CONS ENV TOB SMO	26	136	138	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					337	342		10.1136/bmj.321.7257.337	http://dx.doi.org/10.1136/bmj.321.7257.337			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QH	10926589	Green Published, Bronze			2022-12-28	WOS:000088656300023
J	Strayer, C; Oyama, T; Schultz, TF; Raman, R; Somers, DE; Mas, P; Panda, S; Kreps, JA; Kay, SA				Strayer, C; Oyama, T; Schultz, TF; Raman, R; Somers, DE; Mas, P; Panda, S; Kreps, JA; Kay, SA			Cloning of the Arabidopsis clock cone TOC1, an autoregulatory response regulator homolog	SCIENCE			English	Article							CIRCADIAN CLOCK; GENE; PERIOD; PROTEIN; TRANSCRIPTION; PHYTOCHROMES; EXPRESSION; DROSOPHILA; TIMELESS; THALIANA	The toc1 mutation causes shortened circadian rhythms in Light-grown Arabidopsis plants. Here, we report the same toc1 effect in the absence of tight input to the clock. We also show that TOC1 controls photoperiodic flowering response through clock function. The TOC1 gene was isolated and found to encode a nuclear protein containing an atypical response regulator receiver domain and two motifs that suggest a role in transcriptional regulation: a basic motif conserved within the CONSTANS family of transcription factors and an acidic domain. TOC1 is itself circadianly regulated and participates in a feedback Loop to control its own expression.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	Scripps Research Institute; University of Virginia	Kay, SA (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.		Somers, David E/A-9209-2010; Kay, Steve A/F-6025-2011; Panda, Satchidananda/J-6891-2012; Mas, Paloma/B-8215-2016	Kay, Steve A/0000-0002-0402-2878; Mas, Paloma/0000-0002-3780-8041; Schultz, Thomas/0000-0001-9694-9920	NIGMS NIH HHS [GM 56006] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; CRESS WD, 1991, SCIENCE, V251, P87, DOI 10.1126/science.1846049; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; *GENB, AL162973 GENB; *GENB, AC005310 GENB; *GENB, AB019231 GENB; *GENB, AB0256415 GENB; Imamura A, 1999, PLANT CELL PHYSIOL, V40, P733, DOI 10.1093/oxfordjournals.pcp.a029600; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Kaneko M, 1997, J NEUROSCI, V17, P6745; Kreps JA, 1997, PLANT CELL, V9, P297, DOI 10.1105/tpc.9.3.297; Kurup S, 2000, PLANT J, V21, P143, DOI 10.1046/j.1365-313x.2000.00663.x; Makino S, 2000, PLANT CELL PHYSIOL, V41, P791, DOI 10.1093/pcp/41.6.791; Matera AG, 1999, TRENDS CELL BIOL, V9, P302, DOI 10.1016/S0962-8924(99)01606-2; MILLAR AJ, 1995, SCIENCE, V267, P1163, DOI 10.1126/science.7855596; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Putterill J., 1997, PLANT PHYSIOL, V114, P396; Robert LS, 1998, PLANT MOL BIOL, V37, P763, DOI 10.1023/A:1006064514311; ROBSON F, COMMUNICATION; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 1998, DEVELOPMENT, V125, P485; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; STRAYER C, UNPUB; Urao T, 2000, TRENDS PLANT SCI, V5, P67, DOI 10.1016/S1360-1385(99)01542-3; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	29	623	673	7	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					768	771		10.1126/science.289.5480.768	http://dx.doi.org/10.1126/science.289.5480.768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926537				2022-12-28	WOS:000088581500038
J	Greco, RS				Greco, RS			The cardboard box	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2000	284	5					534	534		10.1001/jama.284.5.534	http://dx.doi.org/10.1001/jama.284.5.534			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	337WG	10918681				2022-12-28	WOS:000088385400001
J	Charatan, F				Charatan, F			Executives fly the koop.com	BRITISH MEDICAL JOURNAL			English	News Item																		KOOP CE, 1999, BRIT MED J, V319, P727; KOOP CE, 1999, BRIT MED J, V318, P1644; KOOP CE, 1999, BRIT MED J, V319, P1217	3	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					257	257						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915113				2022-12-28	WOS:000088619800007
J	Chlebowski, RT				Chlebowski, RT			Primary care: Reducing the risk of breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BONE-MINERAL DENSITY; BILATERAL PROPHYLACTIC MASTECTOMY; HEALTHY POSTMENOPAUSAL WOMEN; HORMONE REPLACEMENT THERAPY; SURGICAL-ADJUVANT-BREAST; DIETARY-FAT INTAKE; BOWEL-PROJECT P-1; RANDOMIZED TRIAL; MAMMOGRAPHIC DENSITIES; ENDOMETRIAL CANCER		Univ Calif Los Angeles, Los Angeles Cty Harbor Med Ctr, Res & Educ Inst, Torrance, CA 90502 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Chlebowski, RT (corresponding author), Univ Calif Los Angeles, Los Angeles Cty Harbor Med Ctr, Res & Educ Inst, 1124 W Carson St,Bldg J-3, Torrance, CA 90502 USA.	rchlebow@whi.org			NCI NIH HHS [R01-CA-45504] Funding Source: Medline; NCRR NIH HHS [MO1-RR-00-425] Funding Source: Medline; WHI NIH HHS [N01-WH-4-2120] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA045504] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH042120] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); WHI NIH HHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; [Anonymous], 1996, Lancet, V348, P1189; Armstrong K, 2000, NEW ENGL J MED, V342, P564, DOI 10.1056/NEJM200002243420807; Barrett-Connor E, 1999, PREV MED, V28, P600, DOI 10.1006/pmed.1999.0488; Bernstein L, 1999, J NATL CANCER I, V91, P1654, DOI 10.1093/jnci/91.19.1654; Bilimoria MM, 1996, TAMOXIFEN GUIDE CLIN, P75; BOCCARDO F, 1999, PROG P AM SOC CLIN O, V18, P416; Borgen PI, 1998, ANN SURG ONCOL, V5, P603, DOI 10.1007/BF02303829; Boyd NF, 1997, JNCI-J NATL CANCER I, V89, P488, DOI 10.1093/jnci/89.7.488; Boyd NF, 1999, J NATL CANCER I, V91, P1404, DOI 10.1093/jnci/91.16.1404; Brainard GC, 1999, J PINEAL RES, V26, P65, DOI 10.1111/j.1600-079X.1999.tb00568.x; Bunker JP, 1998, BMJ-BRIT MED J, V317, P1307, DOI 10.1136/bmj.317.7168.1307; Cauley JA, 1996, JAMA-J AM MED ASSOC, V276, P1404, DOI 10.1001/jama.276.17.1404; Cauley JA, 1999, ANN INTERN MED, V130, P270, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00004; Chlebowski RT, 1999, J CLIN ONCOL, V17, P1939, DOI 10.1200/JCO.1999.17.6.1939; CHLEBOWSKI RT, 1993, J CLIN ONCOL, V11, P2072, DOI 10.1200/JCO.1993.11.11.2072; Chlebowski RT, 1999, J CLIN ONCOL, V17, P130, DOI 10.1200/JCO.1999.17.1.130; Clarke M, 1998, LANCET, V351, P1451; Colditz GA, 1998, JNCI-J NATL CANCER I, V90, P814, DOI 10.1093/jnci/90.11.814; Conley B, 2000, J CLIN ONCOL, V18, P275, DOI 10.1200/JCO.2000.18.2.275; CUMMINGS S, 1989, JAMA-J AM MED ASSOC, V282, P2124; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; CUZICK J, 1985, LANCET, V2, P282; Day R, 1999, J CLIN ONCOL, V17, P2659, DOI 10.1200/JCO.1999.17.9.2659; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Eisen A, 2000, J CLIN ONCOL, V18, P1980, DOI 10.1200/JCO.2000.18.9.1980; Eisen A, 1999, NEW ENGL J MED, V340, P137, DOI 10.1056/NEJM199901143400209; Ellis MJ, 1999, J NATL CANCER I, V91, P2067, DOI 10.1093/jnci/91.24.2067; FABIAN CJ, 2000, PROG P AM SOC CLIN O, V19, P290; Fisher B, 1999, LANCET, V353, P1993, DOI 10.1016/S0140-6736(99)05036-9; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; FROST MH, 1999, PROG P AM SOC CLIN O, V18, P2218; Fugere P, 2000, AM J OBSTET GYNECOL, V182, P568, DOI 10.1067/mob.2000.104768; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829; Gail MH, 2000, J NATL CANCER I, V92, P758, DOI 10.1093/jnci/92.9.758; Gradishar W. J., 1997, Breast Cancer Research and Treatment, V46, P53; Grann VR, 2000, CANCER J SCI AM, V6, P13; GRAY R, 1999, BREAST, V8, P225; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; HARTMANN LC, 2000, P AM ASSOC CANC RES, V41, P222; HENDERSON BE, 1988, CANCER RES, V48, P246; Holmes MD, 1999, CANCER, V86, P826, DOI 10.1002/(SICI)1097-0142(19990901)86:5&lt;826::AID-CNCR19&gt;3.0.CO;2-0; Holmes MD, 1999, CANCER, V86, P2707; Hughes KS, 1999, CANCER, V86, P2502, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2502::AID-CNCR7>3.0.CO;2-M; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Hunter DJ, 1996, NEW ENGL J MED, V334, P356, DOI 10.1056/NEJM199602083340603; Ingram D, 1997, LANCET, V350, P990, DOI 10.1016/S0140-6736(97)01339-1; Jordan VC, 1999, BRIT MED J, V319, P331, DOI 10.1136/bmj.319.7206.331; Jordan VC, 1999, ENDOCR REV, V20, P253, DOI 10.1210/edrv.20.3.0368; JORDAN VC, 1998, BREAST CANC RES TREA, V50, P227; Khalkhali I, 1999, J NUCL MED, V40, P1233; Khovidhunkit W, 1999, ANN INTERN MED, V130, P431, DOI 10.7326/0003-4819-130-5-199903020-00015; Labrie F, 1999, J STEROID BIOCHEM, V69, P51, DOI 10.1016/S0960-0760(99)00065-5; LACASSAGNE A., 1936, AMER JOUR CANCER, V27, P217; Laden F, 1998, ANNU REV PUBL HEALTH, V19, P101, DOI 10.1146/annurev.publhealth.19.1.101; LOVE RR, 1988, BREAST CANCER RES TR, V12, P297, DOI 10.1007/BF01811242; MCCASKILLSTEVEN.W, 2000, PROG P AM SOC CLIN O, V19, P70; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; MEIJER WJ, 1992, EUR J OBSTET GYN R B, V47, P59, DOI 10.1016/0028-2243(92)90215-K; Nayfield SG, 1996, J CLIN ONCOL, V14, P1018, DOI 10.1200/JCO.1996.14.3.1018; OCONNOR AM, 1925, J NATL CANC I MONOGR, V25, P67; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Pierce JP, 1997, NUTR CANCER, V28, P282, DOI 10.1080/01635589709514589; Powles T, 1996, J CLIN ONCOL, V14, P78, DOI 10.1200/JCO.1996.14.1.78; Powles T, 1998, LANCET, V352, P98; POWLES TJ, 1989, BREAST CANCER RES TR, V14, P23, DOI 10.1007/BF01805972; PRENTICE R, 1990, J NATL CANCER I, V82, P129, DOI 10.1093/jnci/82.2.129; Pritchard KI, 1998, LANCET, V352, P80, DOI 10.1016/S0140-6736(98)85002-2; PRITCHARD KI, 1999, ASCO ED BOOK     FAL, P202; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; ROSE DP, 1992, CANCER RES, V52, P5386; RUTQUIST LE, 1999, PROG P AM SOC CLIN O, V18, P151; Santen RJ, 1999, ENDOCR-RELAT CANCER, V6, P235, DOI 10.1677/erc.0.0060235; Schairer C, 1997, INT J CANCER, V70, P150, DOI 10.1002/(SICI)1097-0215(19970117)70:2<150::AID-IJC2>3.0.CO;2-W; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; Schrag D, 1997, NEW ENGL J MED, V337, P434; Shushan A, 1996, AM J OBSTET GYNECOL, V174, P141, DOI 10.1016/S0002-9378(96)70386-1; SPICER DV, 1994, J NATL CANCER I, V86, P431, DOI 10.1093/jnci/86.6.431; Struewing J P, 1995, J Natl Cancer Inst Monogr, P33; Suh-Burgmann EJ, 1999, ANN INTERN MED, V131, P127, DOI 10.7326/0003-4819-131-2-199907200-00009; Taylor AL, 1999, J NATL CANCER I, V91, P1792, DOI 10.1093/jnci/91.21.1792; Thune I, 1997, NEW ENGL J MED, V336, P1269, DOI 10.1056/NEJM199705013361801; van Dam FSAM, 1998, J NATL CANCER I, V90, P210, DOI 10.1093/jnci/90.3.210; Veronesi U, 1998, LANCET, V352, P93; Veronesi U, 1999, J NATL CANCER I, V91, P1847, DOI 10.1093/jnci/91.21.1847; Wade C, 1999, J Am Med Womens Assoc (1972), V54, P181; Walsh BW, 1998, JAMA-J AM MED ASSOC, V279, P1445, DOI 10.1001/jama.279.18.1445; Wennberg D E, 1999, Lancet, V353 Suppl 1, pSI9; WILLETT WC, 1987, NEW ENGL J MED, V316, P1174, DOI 10.1056/NEJM198705073161902; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Wu AH, 1999, J NATL CANCER I, V91, P529, DOI 10.1093/jnci/91.6.529; Wynder EL, 1997, JNCI-J NATL CANCER I, V89, P766, DOI 10.1093/jnci/89.11.766	94	39	45	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2000	343	3					191	198		10.1056/NEJM200007203430307	http://dx.doi.org/10.1056/NEJM200007203430307			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335HY	10900280				2022-12-28	WOS:000088239100007
J	Nadis, S				Nadis, S			Industry considers carbon catching	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					224	224		10.1038/35018709	http://dx.doi.org/10.1038/35018709			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917497	Bronze			2022-12-28	WOS:000088251900010
J	Bartels, R; Backus, S; Zeek, E; Misoguti, L; Vdovin, G; Christov, IP; Murnane, MM; Kapteyn, HC				Bartels, R; Backus, S; Zeek, E; Misoguti, L; Vdovin, G; Christov, IP; Murnane, MM; Kapteyn, HC			Shaped-pulse optimization of coherent emission of high-harmonic soft X-rays	NATURE			English	Article							LASER-PULSES; QUANTUM CONTROL; RARE-GASES; GENERATION; DYNAMICS; TRANSITIONS; COMPRESSION	When an intense laser pulse is focused into a gas, the light-atom interaction that occurs as atoms are ionized results in an extremely nonlinear optical process(1-3)-the generation of high harmonics of the driving laser frequency. Harmonics that extend up to orders of about 300 have been reported(4,5), some corresponding to photon energies in excess of 500 eV. Because this technique is simple to implement and generates coherent, laser-like, soft X-ray beams, it is currently being developed for applications in science and technology; these include probing the dynamics in chemical and materials systems(6) and imaging(7). Here we report that by carefully tailoring the shape(8) of intense light pulses, we can control(9,10) the interaction of light with an atom during ionization, improving the efficiency of X-ray generation by an order of magnitude. We demonstrate that it is possible to tune the spectral characteristics of the emitted radiation, and to steer the interaction between different orders of nonlinear processes.	Univ Colorado, Joint Inst Lab Astrophys, Boulder, CO 80309 USA; Univ Colorado, Dept Phys, Boulder, CO 80309 USA; Natl Inst Stand & Technol, Boulder, CO 80309 USA; Delft Univ Technol, NL-2600 GA Delft, Netherlands; Univ Sofia, Dept Phys, BU-1126 Sofia, Bulgaria	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA; Delft University of Technology; Bulgarian Academy of Sciences; University of Sofia	Kapteyn, HC (corresponding author), Univ Colorado, Joint Inst Lab Astrophys, Campus Box 440, Boulder, CO 80309 USA.	kapteyn@jila.colorado.edu	Zeek, Erik/A-6664-2011; Backus, Sterling/C-2506-2008; Kapteyn, Henry C/H-6559-2011; Bartels, Randy/A-1217-2011; Christov, Ivan P/D-4446-2014; Misoguti, Lino/C-2462-2012	Kapteyn, Henry C/0000-0001-8386-6317; Bartels, Randy/0000-0003-0530-0435; Christov, Ivan P/0000-0002-9146-6708; Misoguti, Lino/0000-0001-6624-8453				Altucci C, 2000, J OPT SOC AM B, V17, P34, DOI 10.1364/JOSAB.17.000034; Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; Chang Z, 1998, PHYS REV A, V58, pR30, DOI 10.1103/PhysRevA.58.R30; Chang ZH, 1997, PHYS REV LETT, V79, P2967, DOI 10.1103/PhysRevLett.79.2967; de Boeij WP, 1998, ANNU REV PHYS CHEM, V49, P99, DOI 10.1146/annurev.physchem.49.1.99; DELONG KW, 1994, J OPT SOC AM B, V11, P2206, DOI 10.1364/JOSAB.11.002206; Descamps D, 2000, OPT LETT, V25, P135, DOI 10.1364/OL.25.000135; Ditmire T, 1999, NATURE, V398, P489, DOI 10.1038/19037; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; KULANDER KC, 1993, NATO ADV SCI INST SE, V316, P95, DOI 10.1007/978-1-4615-7963-2_10; LeBlanc SP, 1996, PHYS REV LETT, V77, P5381, DOI 10.1103/PhysRevLett.77.5381; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; LHUILLIER A, 1993, PHYS REV LETT, V70, P774, DOI 10.1103/PhysRevLett.70.774; MACKLIN JJ, 1993, PHYS REV LETT, V70, P766, DOI 10.1103/PhysRevLett.70.766; MCPHERSON A, 1987, J OPT SOC AM B, V4, P595, DOI 10.1364/JOSAB.4.000595; Meshulach D, 1999, PHYS REV A, V60, P1287, DOI 10.1103/PhysRevA.60.1287; Meshulach D, 1998, NATURE, V396, P239, DOI 10.1038/24329; Rettenberger A, 1997, PHYS REV B, V56, P12092, DOI 10.1103/PhysRevB.56.12092; Roos L, 1999, PHYS REV A, V60, P5010, DOI 10.1103/PhysRevA.60.5010; Rundquist A, 1998, SCIENCE, V280, P1412, DOI 10.1126/science.280.5368.1412; Salieres P, 1998, PHYS REV LETT, V81, P5544, DOI 10.1103/PhysRevLett.81.5544; Schoenlein RW, 1996, SCIENCE, V274, P236, DOI 10.1126/science.274.5285.236; Spielmann C, 1997, SCIENCE, V278, P661, DOI 10.1126/science.278.5338.661; WARREN WS, 1993, SCIENCE, V259, P1581, DOI 10.1126/science.259.5101.1581; WEFERS MM, 1995, J OPT SOC AM B, V12, P1343, DOI 10.1364/JOSAB.12.001343; Weinacht TC, 1999, NATURE, V397, P233, DOI 10.1038/16654; Yelin D, 1997, OPT LETT, V22, P1793, DOI 10.1364/OL.22.001793; Zeek E, 2000, OPT LETT, V25, P587, DOI 10.1364/OL.25.000587; Zeek E, 1999, OPT LETT, V24, P493, DOI 10.1364/OL.24.000493; Zhou J, 1996, PHYS REV LETT, V76, P752, DOI 10.1103/PhysRevLett.76.752	30	631	646	4	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					164	166		10.1038/35018029	http://dx.doi.org/10.1038/35018029			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910350	Green Published			2022-12-28	WOS:000088221100040
J	Kupperman, E; An, SZ; Osborne, N; Waldron, S; Stainier, DYR				Kupperman, E; An, SZ; Osborne, N; Waldron, S; Stainier, DYR			A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; SPHINGOSINE 1-PHOSPHATE; CARDIOVASCULAR-SYSTEM; ENDODERM FORMATION; ZEBRAFISH; DROSOPHILA; EXPRESSION; CLONING; GENES; ACID	Coordinated cell migration is essential in many fundamental biological processes including embryonic development, organogenesis, wound healing and the immune response. During organogenesis, groups of cells are directed to specific locations within the embryo. Here we show that the zebrafish miles apart (mil) mutation(1,2) specifically affects the migration of the heart precursors to the midline. We found that mutant cells transplanted into a wild-type embryo migrate normally and that wild-type cells in a mutant embryo fail to migrate, suggesting that mil may be involved in generating an environment permissive for migration. We isolated mil by positional cloning and show that it encodes a member of the lysosphingolipid G-protein-coupled receptor family. We also show that sphingosine-1-phosphate is a ligand for Mil, and that it activates several downstream signalling events that are not activated by the mutant alleles. These data reveal a new role for lysosphingolipids in regulating cell migration during vertebrate development and provide the first molecular clues into the fusion of the bilateral heart primordia during organogenesis of the heart.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.			Stainier, Didier/0000-0002-0382-0026				Alexander J, 1999, DEV BIOL, V215, P343, DOI 10.1006/dbio.1999.9441; ALEXANDER J, 1999, MUTATIONS AFFECTING; An SZ, 2000, J BIOL CHEM, V275, P288, DOI 10.1074/jbc.275.1.288; An SZ, 1997, FEBS LETT, V417, P279, DOI 10.1016/S0014-5793(97)01301-X; An SZ, 1999, MOL PHARMACOL, V55, P787; Chan FY, 1997, BLOOD, V89, P688, DOI 10.1182/blood.V89.2.688; Chen JN, 1996, DEVELOPMENT, V123, P293; Forbes A, 1999, CURR OPIN GENET DEV, V9, P473, DOI 10.1016/S0959-437X(99)80072-0; Goetzl EJ, 1998, FASEB J, V12, P1589, DOI 10.1096/fasebj.12.15.1589; Hla T, 1999, BIOCHEM PHARMACOL, V58, P201; Kikuchi Y, 2000, GENE DEV, V14, P1279; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; MACLENNAN AJ, 1994, MOL CELL NEUROSCI, V5, P201, DOI 10.1006/mcne.1994.1024; Martin CC, 1999, DEV BIOL, V206, P189, DOI 10.1006/dbio.1998.9105; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; OKAZAKI H, 1993, BIOCHEM BIOPH RES CO, V190, P1104, DOI 10.1006/bbrc.1993.1163; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; Scheer A, 2000, MOL PHARMACOL, V57, P219; Schier AF, 1997, DEVELOPMENT, V124, P327; Spiegel S, 1999, J LEUKOCYTE BIOL, V65, P341, DOI 10.1002/jlb.65.3.341; Stainier DYR, 1996, DEVELOPMENT, V123, P285; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; STRAHLE U, 1993, GENE DEV, V7, P1436, DOI 10.1101/gad.7.7b.1436; Yelon D, 2000, DEVELOPMENT, V127, P2573; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0	28	316	320	0	20	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					192	195		10.1038/35018092	http://dx.doi.org/10.1038/35018092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910360				2022-12-28	WOS:000088221100050
J	Henney, JE				Henney, JE			New therapy for macular degeneration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									Commissioners Food & Drugs, Rockville, MD 20857 USA		Henney, JE (corresponding author), Commissioners Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2000	283	21					2779	2779		10.1001/jama.283.21.2779-b	http://dx.doi.org/10.1001/jama.283.21.2779-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BQ	10896520				2022-12-28	WOS:000087381500006
J	Gereda, JE; Leung, DYM; Thatayatikom, A; Streib, JE; Price, MR; Klinnert, MD; Liu, AH				Gereda, JE; Leung, DYM; Thatayatikom, A; Streib, JE; Price, MR; Klinnert, MD; Liu, AH			Relation between house-dust endotoxin exposure, type 1 T cell development, and allergen sensitisation in infants at high risk of asthma	LANCET			English	Article							INTERFERON-GAMMA PRODUCTION; BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; CHILDREN; ATOPY; PREVALENCE; SENSITIZATION; ASSOCIATION; RESPONSES; INTERLEUKIN-4	Background Bacterial endotoxin is known to induce interferon gamma and interleukin 12 production, and therefore has the potential to decrease allergen sensitisation. To find out the role of early chronic endotoxin exposure in the development of allergen sensitisation and asthma, we compared concentrations of endotoxin in house dust with allergen sensitisation in infants at high risk for developing asthma. Methods 61 infants 9-24 months old with at. least three physician-documented episodes of wheezing were studied. Concentrations of house-dust endotoxin and allergens were measured in the infants' homes. Allergen sensitisation was measured by skin-prick testing with a panel of common inhalant and food allergens. In a subset of these infants, proportions of T lymphocytes producing interferon gamma, and interleukins 4, 5, and 13 were calculated by cell-surface and intracellular cytokine staining, with flow cytometry. Findings House-dust endotoxin concentrations ranged from 104 to 10 000 endotoxin units (EU) per mt (geometric mean 912 EU/mL). Concentrations did not vary significantly over a 6-month interval. Ten infants (16%) were sensitised to at least one allergen. The homes of allergen-sensitised infants contained significantly lower concentrations of house-dust endotoxin than those of non-sensitised infants (mean 468 vs 1035 EU/mL, respectively; p=0.01). Increased house-dust endotoxin concentrations correlated with increased proportions of interferon-gamma-producing CD4 T cells (p=0.01). Such concentrations did not correlate with proportions of cells that produced interleukins 4, 5, or 13. Interpretation This study may provide the first direct in-vivo evidence that indoor endotoxin exposure early in life may protect against allergen sensitisation by enhancing type 1 immunity.	Natl Jewish Med & REs Ctr, Dept Behav Sci, Denver, CO 80206 USA; Natl Jewish Med & REs Ctr, Dept Pediat, Div Pediat Allergy & Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Liu, AH (corresponding author), Natl Jewish Med & REs Ctr, Dept Pediat, Div Pediat Allergy & Immunol, Denver, CO 80206 USA.	liua@njc.org	Thatayatikom, Akaluck/AAK-7166-2021		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R18AI041137] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00051] Funding Source: Medline; NHLBI NIH HHS [HL-36577] Funding Source: Medline; NIAID NIH HHS [R18AI41137] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Braun-Fahrlander C, 1999, CLIN EXP ALLERGY, V29, P28, DOI 10.1046/j.1365-2222.1999.00479.x; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; DONHAM K, 1989, BRIT J IND MED, V46, P31; Hamilton RG, 1997, METHODS, V13, P53, DOI 10.1006/meth.1997.0495; Hoekstra MO, 1997, CLIN EXP ALLERGY, V27, P1254; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; LE JM, 1986, J IMMUNOL, V136, P4525; MARTINEZ FD, 1995, J ALLERGY CLIN IMMUN, V96, P652, DOI 10.1016/S0091-6749(95)70264-4; Martinez FD, 1999, J ALLERGY CLIN IMMUN, V103, P355, DOI 10.1016/S0091-6749(99)70456-2; Martinez FD, 1999, LANCET, V354, pS12, DOI 10.1016/S0140-6736(99)90437-3; Matricardi PM, 1998, J ALLERGY CLIN IMMUN, V101, P439, DOI 10.1016/S0091-6749(98)70350-1; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; Milton DK, 1997, AM IND HYG ASSOC J, V58, P861; Munir AKM, 1997, J ALLERGY CLIN IMMUN, V100, P177, DOI 10.1016/S0091-6749(97)70221-5; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; PLATTMILLS TAE, 1995, RELEVANCE INDOOR ALL, P111; PLATTSMILLS TAE, 1992, J ALLERGY CLIN IMMUN, V89, P1046, DOI 10.1016/0091-6749(92)90228-T; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Rizzo MC, 1997, PEDIAT ALLERG IMM-UK, V8, P121; RYLANDER R, 1985, AM REV RESPIR DIS, V131, P209; Sarpong SB, 1996, J ALLERGY CLIN IMMUN, V97, P1393, DOI 10.1016/S0091-6749(96)70209-9; SCHWARTZ J, 1990, AM REV RESPIR DIS, V142, P555, DOI 10.1164/ajrccm/142.3.555; Shaheen SO, 1996, LANCET, V347, P1792, DOI 10.1016/S0140-6736(96)91617-7; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Svanes C, 1999, J ALLERGY CLIN IMMUN, V103, P415, DOI 10.1016/S0091-6749(99)70465-3; TANG MLK, 1995, CLIN EXP ALLERGY, V25, P515, DOI 10.1111/j.1365-2222.1995.tb01088.x; VANASPEREN PP, 1984, J ALLERGY CLIN IMMUN, V73, P381, DOI 10.1016/0091-6749(84)90412-3; VANNIEKERK CH, 1979, CLIN ALLERGY, V9, P319; VONMUTIUS E, 1994, AM J RESP CRIT CARE, V149, P358, DOI 10.1164/ajrccm.149.2.8306030; Wahn U, 1997, J ALLERGY CLIN IMMUN, V99, P763, DOI 10.1016/S0091-6749(97)80009-7; WAITE DA, 1980, CLIN ALLERGY, V10, P71, DOI 10.1111/j.1365-2222.1980.tb02082.x; WEISS KB, 1992, CHEST, V101, pS362, DOI 10.1378/chest.101.6_Supplement.362S; WOODFOLK JA, 1992, ANN ALLERGY, V69, P273	35	511	530	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2000	355	9216					1680	1683		10.1016/S0140-6736(00)02239-X	http://dx.doi.org/10.1016/S0140-6736(00)02239-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905243				2022-12-28	WOS:000086983800010
J	Prebtani, APH; Donat, D; Ezzat, S				Prebtani, APH; Donat, D; Ezzat, S			Worrisome striae in pregnancy	LANCET			English	Article							CUSHINGS-SYNDROME		Univ Toronto, Univ Hlth Network, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Ezzat, S (corresponding author), Univ Toronto, Mt Sinai Hosp, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.							Berwaerts J, 1999, GYNECOL ENDOCRINOL, V13, P175, DOI 10.3109/09513599909167552; BUESCHER MA, 1992, OBSTET GYNECOL, V79, P130; PRICOLO VE, 1990, SURGERY, V108, P1072; SHEELER LR, 1994, ENDOCRIN METAB CLIN, V23, P619, DOI 10.1016/S0889-8529(18)30088-4; Wallace C, 1996, J CLIN ENDOCR METAB, V81, P15, DOI 10.1210/jc.81.1.15	5	25	26	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2000	355	9216					1692	1692		10.1016/S0140-6736(00)02242-X	http://dx.doi.org/10.1016/S0140-6736(00)02242-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905246				2022-12-28	WOS:000086983800013
J	Dobson, R				Dobson, R			Smoking in parents increases meningococcal disease risk	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					319	319						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QH	10926578				2022-12-28	WOS:000088656300012
J	Juel, K				Juel, K			Increased mortality among Danish women: population based register study	BRITISH MEDICAL JOURNAL			English	Article									Natl Inst Publ Hlth, DK-2100 Copenhagen, Denmark		Juel, K (corresponding author), Natl Inst Publ Hlth, DK-2100 Copenhagen, Denmark.		Juel, Knud/C-8916-2013	Juel, Knud/0000-0002-4134-1173				Amos A, 1996, BRIT MED BULL, V52, P74, DOI 10.1093/oxfordjournals.bmb.a011534; HAMTOFT H, 1955, Dan Med Bull, V2, P213; Juel K, 2000, EUR J PUBLIC HEALTH, V10, P93, DOI 10.1093/eurpub/10.2.93; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; World Health Organization, 1997, TOB HLTH GLOB STAT R	5	15	16	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					349	350		10.1136/bmj.321.7257.349	http://dx.doi.org/10.1136/bmj.321.7257.349			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QH	10926593	Green Published, Bronze			2022-12-28	WOS:000088656300026
J	Wang, ZH; Castano, IB; De Las Penas, A; Adams, C; Christman, MF				Wang, ZH; Castano, IB; De Las Penas, A; Adams, C; Christman, MF			Pol kappa: A DNA polymerase required for sister chromatid cohesion	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CHROMOSOME CONDENSATION; TOPOISOMERASE-I; BUDDING YEAST; REPLICATION; PROTEIN; IDENTIFICATION; COMPLEXES; SITES; BETA	Establishment of cohesion between sister chromatids is coupled to replication fork passage through an unknown mechanism. Here we report that TRF4, an evolutionarily conserved gene necessary for chromosome segregation, encodes a DNA polymerase with beta-polymerase-like properties. A double mutant in the redundant homologs, TRF4 and TRF5, is unable to complete S phase, whereas a trf4 single mutant completes a presumably defective S phase that results in a failure of cohesion between the replicated sister chromatids. This suggests that TRFs are a key Link in the coordination between DNA replication and sister chromatid cohesion. Trf4 and Trf5 represent the fourth class of essential nuclear DNA polymerases (designated DNA polymerase kappa) in Saccharomyces cerevisiae and probably in all eukaryotes.	Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia	Christman, MF (corresponding author), Univ Virginia, Dept Microbiol, Box 441,Jordan Hall,1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.		De Las Penas, Alejandro/M-7719-2013	De Las Penas, Alejandro/0000-0002-2933-2856; Castano, Irene/0000-0002-5968-2101				Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Castano IB, 1996, NUCLEIC ACIDS RES, V24, P2404, DOI 10.1093/nar/24.12.2404; Castano IB, 1996, GENE DEV, V10, P2564, DOI 10.1101/gad.10.20.2564; Cha RS, 2000, GENE DEV, V14, P493; DEPAMHILIS ML, 1996, DNA REPLICATION EUKA; GUACCI V, 1994, J CELL BIOL, V125, P517, DOI 10.1083/jcb.125.3.517; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Kornberg A., 1992, DNA REPLICATION; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; RUSCITTI T, 1992, J BIOL CHEM, V267, P16806; SADOFF BU, 1995, GENETICS, V141, P465; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Walowsky C, 1999, J BIOL CHEM, V274, P7302, DOI 10.1074/jbc.274.11.7302; Wang SW, 2000, MOL CELL BIOL, V20, P3234, DOI 10.1128/MCB.20.9.3234-3244.2000; WANG Z, UNPUB; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0	25	163	167	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					774	779		10.1126/science.289.5480.774	http://dx.doi.org/10.1126/science.289.5480.774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926539				2022-12-28	WOS:000088581500040
J	Salama, P; Spiegel, P; Van Dyke, M; Phelps, L; Wilkinson, C				Salama, P; Spiegel, P; Van Dyke, M; Phelps, L; Wilkinson, C			Mental health and nutritional status among the adult Serbian minority in Kosovo	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REFUGEE; QUESTIONNAIRE; POPULATIONS; PENSIONERS; MORTALITY	Context Since the beginning of the North Atlantic Treaty Organization intervention in Kosovo in June 1999, few objective data have been available on relevant health indicators for the Serbian ethnic minority in Kosovo. Objective To determine the prevalence of undernutrition among Serbian adults aged 60 years or older and psychiatric morbidity among the adult Serbian population in Kosovo. Design, Setting, and Participants A systematic random sample survey of 212 households was conducted between September 27 and October 2, 1999, in Pristina, the capital city, and in 10 towns in the rural municipality of Gnjilane in Kosovo. Of the 212 households surveyed, 204 adults aged 15 years or older completed the General Health Questionnaire-28 (GHQ-28) and anthropometric measurements were taken for 98 adults aged 60 years or older and for a comparison group of 51 adults aged 18 to 59 years. Main Outcome Measures Body mass index of less than 18.5 kg/m(2) in older adults; nonspecific psychiatric morbidity among adults; and self-reported use of health care services, access to food rations, and primary sources of prewar and postwar income. Results Undernutrition was found in 11.2% (95% confidence interval [CI], 5.7%-19.2%) of Serbian adults aged 60 years or older compared with 2.0% (95% CI, 0.1% 11.8%) of Serbian adults aged 18 to 59 years. The mean (SE) total score for the GHQ-28 was 13.0 (0.52). In a comparison of the GHQ-28 scores of the Serbian adults with the Kosovar Albanian adults (data from a recent survey), the mean (SE) score adjusted for age and sex was 12.8 (0.52) vs 11.1 (0.58); P=.03, respectively. The GHQ-28 scores were also higher for the Serbians in the subcategories of social dysfunction (2.8 [0.17] vs 2.2 [0.13], P=.008) and severe depression (1.9 [0.15] vs 0.9 [0.09]; P<.001), respectively. Serbian women and persons living alone or in small family units were more prone to psychiatric morbidity. Of the 141 respondents reporting the need for health care services, 83 (57.6%) reported not obtaining such services; 204 of 212 (96.2%) households were on a food distribution list. The majority of prewar income came from government jobs compared with farming and humanitarian aid for postwar income. Conclusions The undernutrition of older Serbian adults in Kosovo should be monitored. The high prevalence of symptoms of social dysfunction and severe depression suggest the need for implementation of mental health programs in the Serbian community.	Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA; Int Rescue Comm, Pristina, Kosovo, Yugoslavia; Action Against Hunger, Pristina, Kosovo, Yugoslavia	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Salama, P (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Natl Ctr Environm Hlth, 4770 Buford Hwy NE,Mailstop F-48, Atlanta, GA 30341 USA.		Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				*ACT AG HUNG, 1999, ANTHR NUTR INF FEED; BASSEY EJ, 1986, ANN HUM BIOL, V13, P499, DOI 10.1080/03014468600008661; BRANCA F, 1996, HLTH NUTR SURVEY INT; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; Coyne JC, 2000, JAMA-J AM MED ASSOC, V283, P55, DOI 10.1001/jama.283.1.55; Furukawa TA, 1999, LANCET, V353, P561, DOI 10.1016/S0140-6736(98)05470-1; GOLDBERG D, 1986, BRIT MED J, V293, P1188, DOI 10.1136/bmj.293.6556.1188; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Karcic AA, 2000, JAMA-J AM MED ASSOC, V283, P55; KOZARICKOVACIC D, 1995, AM J ORTHOPSYCHIAT, V65, P428, DOI 10.1037/h0079656; KWOK T, 1991, J AM GERIATR SOC, V39, P492, DOI 10.1111/j.1532-5415.1991.tb02495.x; LAWRENCE M, 2000, JOINT WFP UNHCR FOOD; MCNABB SJN, 1994, AM J PREV MED, V10, P65, DOI 10.1016/S0749-3797(18)30620-2; Mollica RF, 1997, J AM ACAD CHILD PSY, V36, P1098, DOI 10.1097/00004583-199708000-00017; Mollica RF, 1999, JAMA-J AM MED ASSOC, V282, P433, DOI 10.1001/jama.282.5.433; *PHYS HUM RIGHTS, 1999, WAR CRIM KOS POP BAS; Popkin BM, 1996, AM J PUBLIC HEALTH, V86, P355, DOI 10.2105/AJPH.86.3.355; Rush D, 1996, AM J PUBLIC HEALTH, V86, P361, DOI 10.2105/AJPH.86.3.361; Shetty P. S., 1994, BODY MASS INDEX MEAS; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; TOOLE MJ, 1988, J TROP PEDIATRICS, V34, P218, DOI 10.1093/tropej/34.5.218; Toole MJ, 1997, ANNU REV PUBL HEALTH, V18, P283, DOI 10.1146/annurev.publhealth.18.1.283; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; *UN HIGH COMM REF, 2000, 4 ASS SIT ETHN MIN K; *UN HIGH COMM REF, 1999, 2 ASS SIT ETHN MIN K, P1; *UN HIGH COMM REF, 1999, KOS CRIS UPD; *US STAT DEP, 1999, POSTSCR ALB RETR MIS, P1; WATSON F, 1995, DISASTERS, V19, P216, DOI 10.1111/j.1467-7717.1995.tb00341.x; *WHO, 1995, WHO TECHN REP SER, P439	30	24	24	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2000	284	5					578	584		10.1001/jama.284.5.578	http://dx.doi.org/10.1001/jama.284.5.578			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	337WG	10918703	Bronze			2022-12-28	WOS:000088385400026
J	Lagergren, J; Bergstrom, R; Adami, HO; Nyren, O				Lagergren, J; Bergstrom, R; Adami, HO; Nyren, O			Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma	ANNALS OF INTERNAL MEDICINE			English	Article							GASTROESOPHAGEAL REFLUX; UNITED-STATES; ISOSORBIDE DINITRATE; INCREASING INCIDENCE; GASTRIC-CARCINOMA; RISING INCIDENCE; THEOPHYLLINE; PRESSURE; ACHALASIA; ASTHMA	Background: The incidence of esophageal adenocarcinoma is increasing rapidly. Gastroesophageal reflux is a strong risk factor for this disease. The increase in incidence of esophageal adenocarcinoma coincided with the introduction of medications that promote reflux by relaxing the lower esophageal sphincter (LES), such as nitroglycerin, anticholinergics, beta-adrenergic agonists, aminophyllines, and benzodiazepines. Objective: To test the possible association between use of LES-relaxing medications and risk for adenocarcinoma of the esophagus and gastric cardia. Design: A nationwide population-based case-control study with in-person interviews. Setting: Sweden, 1995 through 1997. Patients: 189 patients with newly diagnosed esophageal adenocarcinoma, 262 with adenocarcinoma of the gastric cardia, and 167 with esophageal squamous-cell carcinoma were compared with 820 population-based controls. Measurements: Estimated incidence rate ratios, calculated by using multivariate logistic regression from case-control data with adjustment for potential confounding. Results: Past use of LES-relaxing drugs was positively associated with risk for esophageal adenocarcinoma. Among daily, long-term users (>5 years) of LES-relaxing drugs, the estimated incidence rate ratio was 3.8 (95% CI, 2.2 to 6.4) compared with persons who had never used these drugs. Drugs of all classes contributed to the increased risk, but the association was particularly strong for anticholinergics. Short-term use of other types of LES-relaxing drugs did not seem to be strongly associated with risk. The association almost disappeared after adjustment for reflux symptoms, indicating that promotion of reflux is the link between use of LES-relaxing drugs and esophageal adenocarcinoma. If 15 490 men in any age group take LES-relaxing drugs daily far 5 years, 1 additional case of adenocarcinoma would be expected (number needed to treat for harm); in men older than 60 years of age, the number needed to treat for harm is 5570. Assuming a causal relation, about 10% of the esophageal adenocarcinomas occurring in the population may be attributable to intake of LES-relaxing drugs. Cardia adenocarcinoma and esophageal squamous-cell carcinoma were not associated with use of LES-relaxing drugs. Conclusions: The widespread use of LES-relaxing drugs may have contributed to the increasing incidence of esophageal adenocarcinoma.	Karolinska Inst, Dept Med Epidemiol, SE-17177 Stockholm, Sweden; Danderyd Hosp, Stockholm, Sweden; Uppsala Univ, Uppsala, Sweden; Harvard Univ, Harvard Ctr Canc Prevent, Boston, MA 02115 USA	Karolinska Institutet; Danderyds Hospital; Uppsala University; Harvard University	Lagergren, J (corresponding author), Karolinska Inst, Dept Med Epidemiol, Box 281, SE-17177 Stockholm, Sweden.	jesper.lagergren@mep.ki.se		Lagergren, Jesper/0000-0002-5143-5448	NCI NIH HHS [R01 CA57947-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057947] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGGESTRUP S, 1991, DIGEST DIS, V9, P360, DOI 10.1159/000171324; Armstrong RW, 1996, INT J EPIDEMIOL, V25, P941, DOI 10.1093/ije/25.5.941; Ayres JG, 1996, EUR RESPIR J, V9, P1073, DOI 10.1183/09031936.96.09051073; BERQUIST WE, 1981, J ALLERGY CLIN IMMUN, V67, P407, DOI 10.1016/0091-6749(81)90087-7; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; CASTELL DO, 1975, ANN INTERN MED, V83, P390, DOI 10.7326/0003-4819-83-3-390; Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; DIMARINO AJ, 1982, DIGEST DIS SCI, V27, P1063, DOI 10.1007/BF01391441; ElSerag HB, 1997, GASTROENTEROLOGY, V113, P755, DOI 10.1016/S0016-5085(97)70168-9; GELFOND M, 1982, GASTROENTEROLOGY, V83, P963; GOYAL RK, 1973, J CLIN INVEST, V52, P337, DOI 10.1172/JCI107189; Hansen S, 1997, INT J CANCER, V71, P340, DOI 10.1002/(SICI)1097-0215(19970502)71:3<340::AID-IJC5>3.0.CO;2-Y; HANSSON LE, 1993, INT J CANCER, V54, P402, DOI 10.1002/ijc.2910540309; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; NELSON LM, 1990, EPIDEMIOL REV, V12, P71, DOI 10.1093/oxfordjournals.epirev.a036063; PERA M, 1993, GASTROENTEROLOGY, V104, P510, DOI 10.1016/0016-5085(93)90420-H; Powell J, 1992, Eur J Cancer Prev, V1, P265, DOI 10.1097/00008469-199204000-00008; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P54; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P150; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P127; RUSHNAK MJ, 1980, AM J GASTROENTEROL, V73, P127; RUZKOWSKI CJ, 1992, ARCH INTERN MED, V152, P783, DOI 10.1001/archinte.152.4.783; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Sontag SJ, 1997, AM J MED, V103, p84S, DOI 10.1016/S0002-9343(97)00330-6; SPECHLER SJ, 1986, NEW ENGL J MED, V315, P362, DOI 10.1056/NEJM198608073150605; Stacher G, 1997, ALIMENT PHARM THERAP, V11, P967, DOI 10.1046/j.1365-2036.1997.00241.x; STEIN MR, 1980, ANN ALLERGY, V45, P238; Vaughan TL, 1998, CANCER EPIDEM BIOMAR, V7, P749; WANG HH, 1994, CANCER CAUSE CONTROL, V5, P573, DOI 10.1007/BF01831386; WEST SL, 1994, PHARMACOEPIDEM DR S, P549; WONG RKH, 1987, J CLIN GASTROENTEROL, V9, P386, DOI 10.1097/00004836-198708000-00006; ZFASS AM, 1970, AM J DIG DIS, V15, P303, DOI 10.1007/BF02239282	33	133	134	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2000	133	3					165	175		10.7326/0003-4819-133-3-200008010-00007	http://dx.doi.org/10.7326/0003-4819-133-3-200008010-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XW	10906830				2022-12-28	WOS:000088449400001
J	Miller, KD; Cameron, M; Wood, LV; Dalakas, MC; Kovacs, JA				Miller, KD; Cameron, M; Wood, LV; Dalakas, MC; Kovacs, JA			Lactic acidosis and hepatic steatosis associated with use of stavudine: Report of four cases	ANNALS OF INTERNAL MEDICINE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; NUCLEOSIDE ANALOG; MITOCHONDRIAL TOXICITY; ZIDOVUDINE THERAPY; HIV-INFECTION; MYOPATHY; THIAMINE; PATIENT; FAILURE; VIRUS	Background: An association between use of zidovudine and didanosine and a rare but life-threatening syndrome of hepatic steatosis, lactic acidosis, and myopathy has been reported. Objective: To describe the syndrome of hepatic steatosis, lactic acidosis, and myopathy in four patients taking stavudine. Design: Case series. Setting: A community hospital in Washington, D.C., and National Institutes of Health Clinical Center, Bethesda, Maryland. Patients: Two men and two women with HIV-1 infection who were taking stavudine presented with lactic acidosis and elevated levels of aminotransferases. All patients required intensive care. Measurements: Levels of lactic acid, alanine aminotransferase, aspartate aminotransferase, amylase, and lipase; computed tomography of the abdomen; liver biopsy (two patients); and muscle biopsy (two patients). Results: Histologic findings consistent with mitochondrial injury confirmed the diagnosis of hepatic or muscle abnormality. Conclusion: Because hepatic steatosis may be life-threatening, physicians should consider it as a possible cause of elevated hepatic aminotransferase levels among patients taking stavudine.	NIAID, Dept Crit Care Med, Warren Grant Magnuson Clin Ctr, NIH,Intramural AIDS Program, Bethesda, MD 20892 USA; NINDS, NIH, Bethesda, MD 20892 USA; Kaiser Permanente Mid Atlantic & W End Med Ctr, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Kaiser Permanente	Miller, KD (corresponding author), NIAID, Dept Crit Care Med, Warren Grant Magnuson Clin Ctr, NIH,Intramural AIDS Program, Bldg 10,Room 8C410, Bethesda, MD 20892 USA.		Kovacs, Joseph/AAU-6105-2021	Kovacs, Joseph/0000-0002-5191-9880				BISSUEL F, 1994, J INTERN MED, V235, P367, DOI 10.1111/j.1365-2796.1994.tb01088.x; Brinkman K, 1998, AIDS, V12, P1735, DOI 10.1097/00002030-199814000-00004; Chariot P, 1999, J HEPATOL, V30, P156, DOI 10.1016/S0168-8278(99)80020-8; CHATTHA G, 1993, ANN INTERN MED, V118, P37, DOI 10.7326/0003-4819-118-1-199301010-00007; CHEN SCA, 1992, PATHOLOGY, V24, P109, DOI 10.3109/00313029209063634; DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602; Fouty B, 1998, LANCET, V352, P291, DOI 10.1016/S0140-6736(05)60266-8; GOPINATH R, 1992, J AM SOC NEPHROL, V3, P1212; JOLLIET P, 1990, LANCET, V335, P1457, DOI 10.1016/0140-6736(90)91481-O; LEBRAS P, 1994, AIDS, V8, P716; Lenzo NP, 1997, AIDS, V11, P1294, DOI 10.1097/00002030-199710001-00003; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702; Mouly S, 1996, AIDS, V10, P931, DOI 10.1097/00002030-199607000-00024; Piscitelli SC, 1996, CLIN INFECT DIS, V23, P685, DOI 10.1093/clinids/23.4.685; Schramm C, 1999, EUR J ANAESTH, V16, P733; Sheth SG, 1997, ANN INTERN MED, V126, P137, DOI 10.7326/0003-4819-126-2-199701150-00008; Stein D. S., 1994, AIDS Clinical Care, V6, P17; Sundar K, 1997, CRIT CARE MED, V25, P1425, DOI 10.1097/00003246-199708000-00034; TSAI CH, 1994, BIOCHEM PHARMACOL, V48, P1477, DOI 10.1016/0006-2952(94)90573-8	20	152	157	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2000	133	3					192	196		10.7326/0003-4819-133-3-200008010-00010	http://dx.doi.org/10.7326/0003-4819-133-3-200008010-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XW	10906833				2022-12-28	WOS:000088449400004
J	Wasserman, SI; Kimball, HR; Duffy, FD				Wasserman, SI; Kimball, HR; Duffy, FD		Task Force Recertification	Recertification in internal medicine: A program of continuous professional development	ANNALS OF INTERNAL MEDICINE			English	Article							CERTIFYING EXAMINATION; PERFORMANCE; CERTIFICATION	In 2000, the American Board of Internal Medicine (ABIM) introduced a second-generation recertification process that builds on the current knowledge-centered program by adding assessments of clinical and communication skills, clinical performance, and medical outcomes. The three-part process, called a program of continuous professional development, includes innovative self-evaluation exercises, documentation of essential knowledge, and confirmation of satisfactory qualifications and professional and community good standing. The program introduces the principles of continuous quality improvement; deemphasizes the summary nature of the traditional secure examination; and is designed to be a more continuous, less saltatory process for maintaining clinical competence. With the continuous professional development program, ABIM believes that it has taken a substantial step toward creating a recertification process that meets its goal of being "valuable, doable, tolerable, and affordable" while maintaining the high standards expected of an accountable profession.	Amer Board Internal Med, Philadelphia, PA 19106 USA; Univ Calif San Diego, San Diego, CA 92103 USA	American Board of Internal Medicine; University of California System; University of California San Diego	Kimball, HR (corresponding author), Amer Board Internal Med, 510 Walnut St,Suite 1700, Philadelphia, PA 19106 USA.							GLASSOCK RJ, 1991, ANN INTERN MED, V114, P59, DOI 10.7326/0003-4819-114-1-59; Gramling A, 1994, Manag Care, V3, P39; LANGDON LO, 1989, J GEN INTERN MED, V4, P557, DOI 10.1007/BF02599561; MAYNARD EP, 1986, ANN INTERN MED, V105, P132, DOI 10.7326/0003-4819-105-1-132_2; NORCINI JJ, 1995, ACAD MED, V70, P512, DOI 10.1097/00001888-199506000-00012; NORCINI JJ, 1985, ANN INTERN MED, V102, P115, DOI 10.7326/0003-4819-102-1-115; NORCINI JJ, 1985, ANN INTERN MED, V102, P385, DOI 10.7326/0003-4819-102-3-385; NORCINI JJ, 1987, J GEN INTERN MED, V2, P330, DOI 10.1007/BF02596169; NORCINI JJ, IN PRESS ACAD MED; RAMSEY PG, 1993, JAMA-J AM MED ASSOC, V269, P1655, DOI 10.1001/jama.269.13.1655; RAMSEY PG, 1989, ANN INTERN MED, V110, P719, DOI 10.7326/0003-4819-110-9-719; RAMSEY PG, 1991, JAMA-J AM MED ASSOC, V266, P1103, DOI 10.1001/jama.266.8.1103; WASSERMAN SI, 1999, REPORT ABIM TASK FOR; Webster G., 1989, FINAL REPORT PATIENT	14	44	44	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2000	133	3					202	208		10.7326/0003-4819-133-3-200008010-00012	http://dx.doi.org/10.7326/0003-4819-133-3-200008010-00012			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XW	10906835				2022-12-28	WOS:000088449400006
J	Blythe, J				Blythe, J			Better screening needed for sickle cell and thalassaemia	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					260	260						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915121				2022-12-28	WOS:000088619800015
J	Roberts, G; Lack, G				Roberts, G; Lack, G			Lesson of the week - Horse allergy in children	BRITISH MEDICAL JOURNAL			English	Review							HOUSE-DUST MITE; ASTHMA; CHILDHOOD; EXPOSURE; DANDER		St Marys Hosp, Imperial Coll Sch Med, Dept Paediat, London W2 1NY, England	Imperial College London	Lack, G (corresponding author), St Marys Hosp, Imperial Coll Sch Med, Dept Paediat, Praed St, London W2 1NY, England.			Lack, Gideon/0000-0001-7350-4021; Roberts, Graham/0000-0003-2252-1248				[Anonymous], 1993, ALLERGY S14, V48, P48; BRUNEKREEF B, 1992, INT J EPIDEMIOL, V21, P338, DOI 10.1093/ije/21.2.338; DAmato G, 1997, J ALLERGY CLIN IMMUN, V99, P577, DOI 10.1016/S0091-6749(97)70088-5; HERXHEIMER H, 1952, INT ARCH ALLER A IMM, V3, P323, DOI 10.1159/000227979; Holgate ST, 1997, LANCET, V350, P5; INGRAM JM, 1995, J ALLERGY CLIN IMMUN, V96, P449, DOI 10.1016/S0091-6749(95)70286-5; LIND P, 1987, J ALLERGY CLIN IMMUN, V80, P541, DOI 10.1016/0091-6749(87)90005-4; SEARS MR, 1989, CLIN EXP ALLERGY, V19, P419, DOI 10.1111/j.1365-2222.1989.tb02408.x; Solomon WR, 1988, ALLERGY PRINCIPLES P; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; vanVelzen E, 1996, THORAX, V51, P582, DOI 10.1136/thx.51.6.582; WARNER JO, 1976, ARCH DIS CHILD, V51, P905, DOI 10.1136/adc.51.12.905	12	28	28	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					286	287		10.1136/bmj.321.7256.286	http://dx.doi.org/10.1136/bmj.321.7256.286			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915137	Bronze, Green Published			2022-12-28	WOS:000088619800032
J	de Waal, FBM				de Waal, FBM			Primates - A natural heritage of conflict resolution	SCIENCE			English	Review							LONG-TAILED MACAQUES; RECONCILIATION BEHAVIOR; SOCIAL RELATIONSHIPS; MACACA-FASCICULARIS; DISPLACEMENT ACTIVITIES; PRESCHOOL-CHILDREN; NONHUMAN-PRIMATES; RHESUS MACAQUES; MONKEYS; CHIMPANZEES	The traditional notion of aggression as an antisocial instinct is being replaced by a framework that considers it a tool of competition and negotiation. When survival depends on mutual assistance, the expression of aggression is constrained by the need to maintain beneficial relationships. Moreover, evolution has produced ways of countering its disruptive consequences. For example, chimpanzees kiss and embrace after fights, and other nonhuman primates engage in similar "reconciliations." Theoretical developments in this field carry implications for human aggression research. From families to high schools, aggressive conflict is subject to the same constraints known of cooperative animal societies. It is only when social relationships are valued that one can expect the full complement of natural checks and balances.	Emory Univ, Yerkes Reg Primate Res Ctr, Ctr Adv Study Human & Ape Evolut, Livings Links, Atlanta, GA 30322 USA; Emory Univ, Dept Psychol, Atlanta, GA 30322 USA	Emory University; Emory University	de Waal, FBM (corresponding author), Emory Univ, Yerkes Reg Primate Res Ctr, Ctr Adv Study Human & Ape Evolut, Livings Links, Atlanta, GA 30322 USA.	dewaal@emory.edu						Ardrey R., 1961, AFRICAN GENESIS; Asquith P.J., 1984, P138; Aureli F, 1997, AGGRESSIVE BEHAV, V23, P315, DOI 10.1002/(SICI)1098-2337(1997)23:5<315::AID-AB2>3.0.CO;2-H; AURELI F, 1992, BEHAV ECOL SOCIOBIOL, V31, P329; AURELI F, 1989, AM J PRIMATOL, V19, P39, DOI 10.1002/ajp.1350190105; AURELI F, 1991, ETHOLOGY, V89, P89; Aureli F., 2000, NATURAL CONFLICT RES; Berkowitz L., 1993, AGGRESSION ITS CAUSE, DOI 3.0.CO;2-9; BERNSTEIN IS, 1993, AM J PRIMATOL, V31, P41, DOI 10.1002/ajp.1350310105; Boehm Christopher, 1994, P211; Butovskaya M.L., 2000, NATURAL CONFLICT RES, P243; Cartmill Matt, 1993, VIEW DEATH MORNING H; CHENEY DL, 1989, BEHAVIOUR, V110, P258, DOI 10.1163/156853989X00501; Coie J., 1993, CURRENT DIRECTIONS P, V2, P89, DOI [10.1111/1467-8721.ep10770946, DOI 10.1111/1467-8721.EP10770946]; CORDS M, 1993, ETHOLOGY, V93, P315; CORDS M, 1992, ANIM BEHAV, V44, P57, DOI 10.1016/S0003-3472(05)80754-7; Cords M, 1998, J PIAGET SY, P193; Cords Marina, 1996, Evolutionary Anthropology, V5, P42, DOI 10.1002/(SICI)1520-6505(1996)5:2<42::AID-EVAN3>3.3.CO;2-R; Cords Marina, 1993, P271; Dart RA, 1925, NATURE, V115, P195, DOI 10.1038/115195a0; De Waal, 1989, PEACEMAKING PRIMATES; De Waal F.B.M., 1993, PRIMATE SOCIAL CONFL, P111; de Waal F. B. M, 1982, CHIMPANZEE POLITICS; De Waal FBM., 1989, COMP SOCIOECOLOGY, P243; De Waal Frans B. M., 1996, P159, DOI 10.1017/CBO9780511752414.014; DEWAAL FBM, 1991, BEHAVIOUR, V118, P297, DOI 10.1163/156853991X00337; DEWAAL FBM, 1993, CHILD DEV, V64, P897, DOI 10.2307/1131225; DEWAAL FBM, 1989, AM J PRIMATOL, V19, P83, DOI 10.1002/ajp.1350190203; DEWAAL FBM, 1988, ETHOLOGY, V78, P129; DEWAAL FBM, 1986, Q REV BIOL, V61, P459, DOI 10.1086/415144; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; DeWaal FBM, 1997, ANN NY ACAD SCI, V807, P317; DEWAAL FBM, 1984, ETHOL SOCIOBIOL, V5, P239, DOI 10.1016/0162-3095(84)90004-9; Dunn J., 1992, CONFLICT CHILD ADOLE, P70; FRY DP, 1988, CHILD DEV, V59, P1008, DOI 10.1111/j.1467-8624.1988.tb03253.x; FRYE DP, 2000, NATURAL CONFLICT RES, P334; Ghiglieri MP, 1999, DARK SIDE MAN TRACIN; Goodall J., 1986, CHIMPANZEES GOMBE PA; Gottman J. M., 1994, WHY MARRIAGES SUCCEE; HARCOURT H, 1992, COALITIONS ALLIANCES; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Hofer H., 2000, NATURAL CONFLICT RES, P232; Johnson DW, 1996, REV EDUC RES, V66, P459, DOI 10.2307/1170651; Johnson R. N., 1972, AGGRESSION MAN ANIMA; JUDGE PG, 1994, FOLIA PRIMATOL, V63, P63, DOI 10.1159/000156792; JUDGE PG, 1991, AM J PRIMATOL, V23, P225, DOI 10.1002/ajp.1350230403; KAGAN S, 1971, DEV PSYCHOL, V5, P32, DOI 10.1037/h0031080; KAPPELER PM, 1992, ETHOLOGY, V92, P51; KILLEN M, 1995, DISCOURSE PROCESS, V19, P329, DOI 10.1080/01638539509544921; KILLEN M, 1995, MORALITY EVERYDAY LI, P52; KUMMER H, 1978, SOC SCI INFORM, V17, P687, DOI 10.1177/053901847801700418; KURLAND JA, 1977, KIN SELECTION JAPANE, V12; LAURSEN B, 1989, MERRILL PALMER QUART, V35, P281; LINDBURG D, 1973, BEHAV REGULATORS BEH, P85; Ljungberg T, 1999, ANIM BEHAV, V58, P1007, DOI 10.1006/anbe.1999.1236; Lorenz Konrad, 1967, AGGRESSION; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; MASON WA, 1964, ADV EXP SOC PSYCHOL, V1, P277, DOI 10.1016/S0065-2601(08)60054-4; MCKENNA JJ, 1978, AM J PHYS ANTHROPOL, V48, P503, DOI 10.1002/ajpa.1330480409; PETIT O, 1994, ANIM BEHAV, V48, P1427, DOI 10.1006/anbe.1994.1378; REN RM, 1991, PRIMATES, V32, P321, DOI 10.1007/BF02382673; ROBARCHEK CA, 1979, ETHOS, V7, P104, DOI 10.1525/eth.1979.7.2.02a00020; SACKIN S, 1984, CHILD DEV, V55, P1098; Samuels A, 2000, NATURAL CONFLICT RES, P229; Schino G, 1996, ANXIETY, V2, P186; Schino G, 1998, BEHAVIOUR, V135, P343, DOI 10.1163/156853998793066302; SEYFARTH RM, 1976, ANIM BEHAV, V24, P917, DOI 10.1016/S0003-3472(76)80022-X; Silk Joan B., 1996, Evolutionary Anthropology, V5, P39, DOI 10.1002/(SICI)1520-6505(1996)5:2<39::AID-EVAN2>3.0.CO;2-R; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Strier KB, 2000, NATURAL CONFLICT RES, P315; Thierry Bernard, 2000, P106; TRIVERS RL, 1974, AM ZOOL, V14, P249; van Lawick-Goodall J., 1968, Animal Behaviour Monographs, V1, P161; VEENEMA HC, 1994, BEHAV PROCESS, V31, P29, DOI 10.1016/0376-6357(94)90035-3; Verbeek P., 2000, NATURAL CONFLICT RES, P34; VERBEEK P, IN PRESS PEACE CONFL; WEAVER AC, 2000, NATURAL CONFLICT RES, P216; Wrangham, 1996, DEMONIC MALES APES E	79	273	281	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2000	289	5479					586	590		10.1126/science.289.5479.586	http://dx.doi.org/10.1126/science.289.5479.586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	338XD	10915614				2022-12-28	WOS:000088447800043
J	Kondo, Y; Takayanagi, K				Kondo, Y; Takayanagi, K			Synthesis and characterization of helical multi-shell gold nanowires	SCIENCE			English	Article							QUANTIZED CONDUCTANCE; CARBON NANOTUBES; SURFACE; CONTACTS	Suspended gold nanowires were made in an ultra-high vacuum. The finest of them was 0.6 nanometer in diameter and 6 nanometers in length. By high-resolution electron microscopy, they were shown to have a multi-shell structure composed of coaxial tubes. Each tube consists of helical atom rows coiled round the wire axis. The difference between the numbers of atom rows in outer and inner shells is seven, resulting in magic shell-closing numbers.	ERATO, Takayanagi Particle Surface Project, Tokyo 1968558, Japan; Tokyo Inst Technol, Midori Ku, Yokohama, Kanagawa 227, Japan	Japan Science & Technology Agency (JST); Tokyo Institute of Technology	Kondo, Y (corresponding author), JEOL Ltd, Japan Electron Opt Lab, Tokyo 1968558, Japan.	kondo@jeol.co.jp		Kondo, Yukihito/0000-0002-5145-1712				AGRAIT N, 1993, PHYS REV B, V47, P12345, DOI 10.1103/PhysRevB.47.12345; CHERNS D, 1979, SURF SCI, V90, P339, DOI 10.1016/0039-6028(79)90348-0; COWLEY JM, 1957, ACTA CRYSTALLOGR, V10, P609, DOI 10.1107/S0365110X57002194; Ebbesen TW, 1996, NATURE, V382, P54, DOI 10.1038/382054a0; Gulseren O, 1998, PHYS REV LETT, V80, P3775, DOI 10.1103/PhysRevLett.80.3775; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Kondo Y, 1997, PHYS REV LETT, V79, P3455, DOI 10.1103/PhysRevLett.79.3455; LANDAUER R, 1957, IBM J RES DEV, V1, P223, DOI 10.1147/rd.13.0223; MINTMIRE JW, 1992, PHYS REV LETT, V68, P631, DOI 10.1103/PhysRevLett.68.631; Niwase K, 1996, PHIL MAG LETT, V74, P167, DOI 10.1080/095008396180326; Ohnishi H, 1998, NATURE, V395, P780, DOI 10.1038/27399; OLESEN L, 1994, PHYS REV LETT, V72, P2251, DOI 10.1103/PhysRevLett.72.2251; PASCUAL JI, 1995, SCIENCE, V267, P1793, DOI 10.1126/science.267.5205.1793; Thess A, 1996, SCIENCE, V273, P483, DOI 10.1126/science.273.5274.483; URBAN J, 1993, Z PHYS D ATOM MOL CL, V28, P247, DOI 10.1007/BF01437891; VANHOVE MA, 1981, SURF SCI, V103, P189, DOI 10.1016/0039-6028(81)90107-2; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139; YAMAZAKI K, 1988, SURF SCI, V199, P595, DOI 10.1016/0039-6028(88)90924-7	19	713	734	4	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2000	289	5479					606	608		10.1126/science.289.5479.606	http://dx.doi.org/10.1126/science.289.5479.606			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915620				2022-12-28	WOS:000088447800049
J	Korzheva, N; Mustaev, A; Kozlov, M; Malhotra, A; Nikiforov, V; Goldfarb, A; Darst, SA				Korzheva, N; Mustaev, A; Kozlov, M; Malhotra, A; Nikiforov, V; Goldfarb, A; Darst, SA			A structural model of transcription elongation	SCIENCE			English	Article							COLI RNA-POLYMERASE; ESCHERICHIA-COLI; BETA-SUBUNIT; FUNCTIONAL TOPOGRAPHY; ANGSTROM RESOLUTION; PROMOTER COMPLEXES; CRYSTAL-STRUCTURE; DNA-REPLICATION; ACTIVE-CENTER; NASCENT RNA	The path of the nucleic acids through a transcription elongation complex was tracked by mapping cross-links between bacterial RNA polymerase (RNAP) and transcript RNA or template DNA onto the x-ray crystal structure. In the resulting model, the downstream duplex DNA is nestled in a trough formed by the beta' subunit and enclosed an top by the beta subunit. In the RNAP channel, the RNA/DNA hybrid extends from the enzyme active site, along a region of the beta subunit harboring rifampicin resistance mutations, to the beta' subunit "rudder. The single-stranded RNA is then extruded through another channel formed by the beta-subunit flap domain. The model provides insight into the functional properties of the transcription complex.	Rockefeller Univ, New York, NY 10021 USA; Publ Hlth Res Inst City New York Inc, New York, NY 10016 USA; Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA; Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia	Rockefeller University; University of Miami; Russian Academy of Sciences	Darst, SA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	darst@rockvax.rockefeller.edu	Kozlov, Maxim/GLN-3047-2022; Malhotra, Arun/A-3916-2008; Malhotra, Arun/Z-5140-2019	Kozlov, Maxim/0000-0002-5994-9099; Malhotra, Arun/0000-0001-6656-7841; Malhotra, Arun/0000-0001-6656-7841	NIGMS NIH HHS [GM30717, GM49242, GM53759] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053759, R01GM030717, R01GM049242] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; Bartlett MS, 1998, J MOL BIOL, V279, P331, DOI 10.1006/jmbi.1998.1779; BORUKHOV S, 1991, J BIOL CHEM, V266, P23921; BORUKHOV S, 1991, J BIOL CHEM, V266, P23932; CHAMBERLIN MJ, 1993, HARVEY LECT, V88, P1; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; CHENG SWC, 1991, SCIENCE, V254, P1205, DOI 10.1126/science.1835546; Darst SA, 1998, COLD SPRING HARB SYM, V63, P269, DOI 10.1101/sqb.1998.63.269; DARST SA, UNPUB; DAUBE SS, 1992, SCIENCE, V258, P1320, DOI 10.1126/science.1280856; DORVAL BC, 1991, J MOL BIOL, V221, P837, DOI 10.1016/0022-2836(91)80179-X; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EPSHTEIN V, UNPUB; Gelles J, 1998, CELL, V93, P13, DOI 10.1016/S0092-8674(00)81140-X; GRACHEV MA, 1989, EUR J BIOCHEM, V180, P577, DOI 10.1111/j.1432-1033.1989.tb14684.x; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; JOKERST RS, 1989, MOL GEN GENET, V215, P266, DOI 10.1007/BF00339727; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KEANA JFW, 1990, J ORG CHEM, V55, P3640, DOI 10.1021/jo00298a048; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KIRKEGAARD K, 1983, P NATL ACAD SCI-BIOL, V80, P2544, DOI 10.1073/pnas.80.9.2544; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1998, P NATL ACAD SCI USA, V95, P14699, DOI 10.1073/pnas.95.25.14699; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Korzheva N, 1998, COLD SPRING HARB SYM, V63, P337, DOI 10.1101/sqb.1998.63.337; LYNN SP, 1988, J BIOL CHEM, V263, P472; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; MCCLURE WR, 1978, J BIOL CHEM, V253, P8949; MECSAS J, 1991, J MOL BIOL, V220, P585, DOI 10.1016/0022-2836(91)90102-C; MONFORTE JA, 1990, BIOCHEMISTRY-US, V29, P7882, DOI 10.1021/bi00486a015; Mooney RA, 1998, J BACTERIOL, V180, P3265, DOI 10.1128/JB.180.13.3265-3275.1998; Mustaev A, 1997, P NATL ACAD SCI USA, V94, P6641, DOI 10.1073/pnas.94.13.6641; Nudler E, 1998, SCIENCE, V281, P424, DOI 10.1126/science.281.5375.424; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; Polyakov A, 1998, J MOL BIOL, V281, P465, DOI 10.1006/jmbi.1998.1958; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; REES WA, 1993, SCIENCE, V260, P1646, DOI 10.1126/science.8503010; RICHARDSON JP, 1975, J MOL BIOL, V98, P565, DOI 10.1016/S0022-2836(75)80087-8; SEVERINOV K, 1994, J BIOL CHEM, V269, P14254; SEVERINOV K, 1995, P NATL ACAD SCI USA, V92, P4591, DOI 10.1073/pnas.92.10.4591; SEVERINOV K, 1994, MOL GEN GENET, V244, P120, DOI 10.1007/BF00283512; Severinov K, 1996, J BIOL CHEM, V271, P27969, DOI 10.1074/jbc.271.44.27969; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; SWEETSER D, 1987, P NATL ACAD SCI USA, V84, P1192, DOI 10.1073/pnas.84.5.1192; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Wang DG, 1997, J BIOL CHEM, V272, P5989, DOI 10.1074/jbc.272.9.5989; WILSON KS, 1995, P NATL ACAD SCI USA, V92, P8793, DOI 10.1073/pnas.92.19.8793; YAGER TD, 1987, ESCHERICHIA COLI SAL, P1241; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; ZAYCHIKOV E, 1995, P NATL ACAD SCI USA, V92, P1739, DOI 10.1073/pnas.92.5.1739; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	56	328	340	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2000	289	5479					619	625		10.1126/science.289.5479.619	http://dx.doi.org/10.1126/science.289.5479.619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915625				2022-12-28	WOS:000088447800054
J	Duncan, J; Seitz, RJ; Kolodny, J; Bor, D; Herzog, H; Ahmed, A; Newell, FN; Emslie, H				Duncan, J; Seitz, RJ; Kolodny, J; Bor, D; Herzog, H; Ahmed, A; Newell, FN; Emslie, H			A neural basis for general intelligence	SCIENCE			English	Article							FRONTAL-LOBE; PET; ACTIVATION; ATTENTION; BEHAVIOR; HUMANS; MODELS; FMRI	Universal positive correlations between different cognitive tests motivate the concept of "general intelligence" or Spearman's g. Here the neural basis for g is investigated by means of positron emission tomography. Spatial, verbal, and perceptuo-motor tasks with high-g involvement are compared with matched Low-g control tasks. In contrast to the common view that g reflects a broad sample of major cognitive functions, high-g tasks do not show diffuse recruitment of multiple brain regions. Instead they are associated with selective recruitment of lateral frontal cortex in one or both hemispheres. Despite very different task content in the three high-g-low-g contrasts, Lateral frontal recruitment is markedly similar in each case, Many previous experiments have shown these same frontal regions to be recruited by a broad range of different cognitive demands. The results suggest that "general intelligence" derives from a specific frontal system important in the control of diverse forms of behavior.	MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England; Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany; Forschungszentrum Julich, Res Ctr, Inst Med, D-52407 Julich, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich	Duncan, J (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 2EF, England.	john.duncan@mrc-cbu.cam.ac.uk	Newell, Fiona/AIE-2422-2022	Newell, Fiona/0000-0002-7363-2346; Duncan, John/0000-0002-9695-2764; Bor, Daniel/0000-0002-0741-8157				[Anonymous], 1998, G FACTOR; BRETT M, 1999, NEUROIMAGE, V9, pS56; Cattell RB, 1973, MEASURING INTELLIGEN; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; DUNCAN J, 1990, ERGONOMICS, V33, P1265, DOI 10.1080/00140139008925331; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; DUNCAN J, IN PRESS TRENDS NEUR; Ekstrom R.B., 1976, ETS KIT FACTOR REFER; Engle Randall W., 1999, MODELS WORKING MEMOR, P102; Esposito G, 1999, BRAIN, V122, P963, DOI 10.1093/brain/122.5.963; Heim AW., 1970, AH4 GROUP TEST GEN I; HERZOG H, 1994, EUR J NUCL MED, V21, P138; Herzog H, 1996, J CEREBR BLOOD F MET, V16, P645, DOI 10.1097/00004647-199607000-00015; HUMPHREYS LG, 1981, INTELLIGENCE LEARNIN, P87, DOI DOI 10.1007/978-1-4684-1083-9_7; Mackintosh Nicholas J., 2011, IQ HUMAN INTELLIGENC; MARSHALEK B, 1983, INTELLIGENCE, V7, P107, DOI 10.1016/0160-2896(83)90023-5; Petrides M, 1994, HDB NEUROPSYCHOLOGY, V9, P59; Prabhakaran V, 1997, COGNITIVE PSYCHOL, V33, P43, DOI 10.1006/cogp.1997.0659; Raven JC, 1988, MANUAL RAVENS PROGR; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Thomson GH, 1916, BRIT J PSYCHOL, V8, P271, DOI 10.1111/j.2044-8295.1916.tb00133.x; THURSTONE LL, 1940, VECTORS MIND; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Worsley KJ, 1997, NEUROIMAGE, V6, P305, DOI 10.1006/nimg.1997.0294; WOTHKE W, 1991, AFHRLTR9067	28	672	690	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					457	460		10.1126/science.289.5478.457	http://dx.doi.org/10.1126/science.289.5478.457			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	336ME	10903207	Green Published			2022-12-28	WOS:000088305500049
J	Diebel, CE; Proksch, R; Green, CR; Neilson, P; Walker, MM				Diebel, CE; Proksch, R; Green, CR; Neilson, P; Walker, MM			Magnetite defines a vertebrate magnetoreceptor	NATURE			English	Article							FORCE MICROSCOPY; BIOGENIC MAGNETITE; ONCORHYNCHUS-NERKA; SOCKEYE SALMON; HOMING PIGEONS; SENSITIVITY; ANIMALS	The key behavioural, physiological and anatomical components of a magnetite-based magnetic sense have been demonstrated in rainbow trout (Oncorhynchus mykiss)(1). Candidate receptor cells located within a discrete sub-layer of the olfactory lamellae contained iron-rich crystals that were similar in size and shape to magnetite crystals extracted from salmon(1,2). Here we show that these crystals, which mapped to individual receptors using confocal and atomic force microscopy, are magnetic, as they are uniquely associated with dipoles detected by magnetic force microscopy. Analysis of their magnetic properties identifies the crystals as single-domain magnetite. In addition, three-dimensional reconstruction of the candidate receptors using confocal and atomic force microscopy imaging confirm that several magnetic crystals are arranged in a chain of about 1 mm within the receptor, and that the receptor is a multi-lobed single cell. These results are consistent with a magnetite-based detection mechanism(2,3), as 1-mu m chains of single-domain magnetite crystals are highly suitable for the behavioural and physiological responses to magnetic intensity previously reported in the trout.	Univ Auckland, Sch Biol Sci, Expt Biol Res Grp, Auckland, New Zealand; Digital Instruments, Magnet Lab, Goleta, CA 93117 USA; Univ Auckland, Sch Med, Dept Anat Radiol, Auckland, New Zealand	University of Auckland; University of Auckland	Diebel, CE (corresponding author), Auckland Museum, Private Bag 92018, Auckland, New Zealand.		Green, Colin R/B-5663-2012	Green, Colin R/0000-0003-3459-6298; Walker, Michael/0000-0001-9631-9128				BABCOCK K, 1995, MATER RES SOC SYMP P, V355, P311; DIAZRICCI JC, 1992, J GEOPHYS RES, V97, P17039; Dunin-Borkowski RE, 1998, SCIENCE, V282, P1868, DOI 10.1126/science.282.5395.1868; GOULD JL, 1984, ANNU REV PHYSIOL, V46, P585, DOI 10.1146/annurev.ph.46.030184.003101; GOULD JL, 1978, SCIENCE, V201, P1026, DOI 10.1126/science.201.4360.1026; Kirschvink J. L., 1983, BIOMAGNETISM, P501; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; KIRSCHVINK JL, 1985, MAGNETITE BIOMINERAL, P243; Liou SH, 1998, J MAGN MAGN MATER, V190, P130, DOI 10.1016/S0304-8853(98)00284-4; LOHMANN KJ, 1984, J EXP BIOL, V113, P29; MANN S, 1988, J EXP BIOL, V140, P35; PROKSCH R, 1995, J APPL PHYS, V78, P3303, DOI 10.1063/1.360022; PROKSCH RB, 1995, APPL PHYS LETT, V66, P2582, DOI 10.1063/1.113508; SEMM P, 1990, BRAIN RES BULL, V25, P735, DOI 10.1016/0361-9230(90)90051-Z; Walker MM, 1999, J THEOR BIOL, V197, P271, DOI 10.1006/jtbi.1998.0875; WALKER MM, 1988, J EXP BIOL, V140, P51; WALKER MM, 1984, J COMP PHYSIOL, V155, P673, DOI 10.1007/BF00610853; WALKER MM, 1989, J EXP BIOL, V145, P489; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Walker MM, 1998, J THEOR BIOL, V192, P341, DOI 10.1006/jtbi.1998.0653; Wiltschko R., 1995, TIEROSYCHOL; Wittborn J, 1999, NANOSTRUCT MATER, V12, P1149, DOI 10.1016/S0965-9773(99)00316-5; YORKE ED, 1981, J THEOR BIOL, V89, P533, DOI 10.1016/0022-5193(81)90367-2; YORKE ED, 1979, J THEOR BIOL, V77, P101, DOI 10.1016/0022-5193(79)90140-1	24	177	191	3	61	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					299	302		10.1038/35018561	http://dx.doi.org/10.1038/35018561			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917530				2022-12-28	WOS:000088251900048
J	Graether, SP; Kuiper, MJ; Gagne, SM; Walker, VK; Jia, ZC; Sykes, BD; Davies, PL				Graether, SP; Kuiper, MJ; Gagne, SM; Walker, VK; Jia, ZC; Sykes, BD; Davies, PL			beta-helix structure and ice-binding properties of a hyperactive antifreeze protein from an insect	NATURE			English	Article							WINTER FLOUNDER; HYSTERESIS; ADSORPTION; MECHANISM; PROGRAM	Insect antifreeze proteins (AFP) are considerably more active at inhibiting ice crystal growth than AFP from fish or plants. Several insect AFPs, also known as thermal hysteresis proteins, have been cloned(1-3) and expressed(1,2). Their maximum activity is 3-4 times that of fish AFPs(1) and they are 10-100 times more effective at micromolar concentrations. Here we report the solution structure of spruce budworm (Choristoneura fumiferana) AFP and characterize its ice-binding properties. The 9-kDa AFP is a beta-helix with a triangular cross-section and rectangular sides that form stacked parallel beta-sheets; a fold which is distinct from the three known fish AFP structures. The ice-binding side contains 9 of the 14 surface-accessible threonines organized in a regular array of TXT motifs that match the ice lattice on both prism and basal planes. In support of this model, ice crystal morphology and ice-etching experiments are consistent with AFP binding to both of these planes and thus may explain the greater activity of the spruce budworm antifreeze.	Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	Queens University - Canada; Queens University - Canada; University of Alberta	Davies, PL (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	daviesp@post.queensu.ca	Graether, Steffen P./AFU-0892-2022; Graether, Steffen P./AAR-8849-2021	Graether, Steffen P./0000-0002-2356-3936; Graether, Steffen P./0000-0002-2356-3936				Beaman TW, 1998, BIOCHEMISTRY-US, V37, P6689, DOI 10.1021/bi980106v; BRUNGER AT, 1992, X PLOR MANUAL VERSIO; Chao HM, 1997, BIOCHEMISTRY-US, V36, P14652, DOI 10.1021/bi970817d; CHOU KC, 1992, J MOL BIOL, V223, P509, DOI 10.1016/0022-2836(92)90666-8; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng GJ, 1997, FEBS LETT, V402, P17, DOI 10.1016/S0014-5793(96)01466-4; Duman JG, 1998, J COMP PHYSIOL B, V168, P225, DOI 10.1007/s003600050140; Gauthier SY, 1998, EUR J BIOCHEM, V258, P445, DOI 10.1046/j.1432-1327.1998.2580445.x; Graether SP, 1999, J BIOL CHEM, V274, P11842, DOI 10.1074/jbc.274.17.11842; Graham LA, 1997, NATURE, V388, P727, DOI 10.1038/41908; Haymet ADJ, 1998, FEBS LETT, V430, P301, DOI 10.1016/S0014-5793(98)00652-8; Jia ZC, 1996, NATURE, V384, P285, DOI 10.1038/384285a0; Kisker C, 1996, EMBO J, V15, P2323, DOI 10.1002/j.1460-2075.1996.tb00588.x; KNIGHT CA, 1993, BIOPHYS J, V64, P252, DOI 10.1016/S0006-3495(93)81361-4; KNIGHT CA, 1991, BIOPHYS J, V59, P409, DOI 10.1016/S0006-3495(91)82234-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUSZEWSKI J, 1995, J MAGN RESON SER B, V106, P92, DOI 10.1006/jmrb.1995.1017; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; Sonnichsen FD, 1996, STRUCTURE, V4, P1325, DOI 10.1016/S0969-2126(96)00140-2; *TRIP SOFTW, 1998, SYBYL MOL MOD PACK V; Tyshenko MG, 1997, NAT BIOTECHNOL, V15, P887, DOI 10.1038/nbt0997-887; WEN DY, 1992, BIOPHYS J, V63, P1659, DOI 10.1016/S0006-3495(92)81750-2; Zhang W, 1998, J BIOL CHEM, V273, P34806, DOI 10.1074/jbc.273.52.34806; [No title captured]	27	363	416	7	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					325	328		10.1038/35018610	http://dx.doi.org/10.1038/35018610			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917537				2022-12-28	WOS:000088251900055
J	Okamoto, H; Yonemori, F; Wakitani, K; Minowa, T; Maeda, K; Shinkai, H				Okamoto, H; Yonemori, F; Wakitani, K; Minowa, T; Maeda, K; Shinkai, H			A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits	NATURE			English	Article							HIGH-DENSITY-LIPOPROTEINS; LIPID-TRANSFER PROTEIN; CORONARY HEART-DISEASE; PLASMA; HDL; DEFICIENCY; TRANSPORT; MUTATION; GENE	Cholesteryl ester transfer protein (CETP) is a plasma protein that mediates the exchange of cholesteryl ester in high-density lipoprotein (HDL) for triglyceride in very low density lipoprotein (VLDL)(1,2). This process decreases the level of antiatherogenic HDL cholesterol and increases pro-atherogenic VLDL and low density lipoprotein (LDL) cholesterol, so CETP is potentially atherogenic(3-9). On the other hand, CETP could also be anti-atherogenic(10-14), because it participates in reverse cholesterol transport (transfer of cholesterol from peripheral cells through the plasma to the liver)(15). Because the role of CETP in atherosclerosis remains unclear, we have attempted to develop a potent and specific CETP inhibitor. Here we describe CETP inhibitors that form a disulphide bond with CETP, and present one such inhibitor (JTT-705) that increases HDL cholesterol, decreases non-HDL cholesterol and inhibits the progression of atherosclerosis in rabbits. Our findings indicate that CETP may be atherogenic in vivo and that JTT-705 may be a potential antiatherogenic drug.	JT Inc, Cent Pharmaceut Res Inst, Biol Pharmacol Res Labs, Osaka 5691125, Japan; JT Inc, Cent Pharmaceut Res Inst, Chem Res Labs, Osaka 5691125, Japan; JT Inc, Cent Pharmaceut Res Inst, Pharmaceut Frontier Res Labs, Kanazawa Ku, Kanagawa 2360004, Japan		Okamoto, H (corresponding author), JT Inc, Cent Pharmaceut Res Inst, Biol Pharmacol Res Labs, 1-1 Murasaki Cho, Osaka 5691125, Japan.							BHATNAGAR D, 1993, ATHEROSCLEROSIS, V98, P25, DOI 10.1016/0021-9150(93)90220-O; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; Bruce C, 1998, ANNU REV NUTR, V18, P297, DOI 10.1146/annurev.nutr.18.1.297; Chiba H, 1997, J LIPID RES, V38, P1204; Connolly DT, 1996, BIOCHEM BIOPH RES CO, V223, P42, DOI 10.1006/bbrc.1996.0843; Fielding CJ, 1996, J CLIN INVEST, V97, P2687, DOI 10.1172/JCI118719; FIELDING CJ, 1995, J LIPID RES, V36, P211; Foger B, 1999, J BIOL CHEM, V274, P36912, DOI 10.1074/jbc.274.52.36912; FOGER B, 1995, J MOL MED, V73, P369; FRANK D, 1996, ARTERIOSCL THROM VAS, V16, P1454; GERDES LU, 1992, CLIN CHIM ACTA, V205, P1, DOI 10.1016/0009-8981(92)90348-T; HAYEK T, 1995, J CLIN INVEST, V96, P2071, DOI 10.1172/JCI118255; Herrera VLM, 1999, NAT MED, V5, P1383, DOI 10.1038/70956; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAGROST L, 1994, BBA-LIPID LIPID MET, V1215, P209, DOI 10.1016/0005-2760(94)90047-7; MACKNESS MI, 1995, ATHEROSCLEROSIS, V115, P243, DOI 10.1016/0021-9150(94)05524-M; MAROTTI KR, 1993, NATURE, V364, P73, DOI 10.1038/364073a0; MORTON RE, 1983, J BIOL CHEM, V258, P1751; Oram JF, 1996, J LIPID RES, V37, P2473; QUINET E, 1991, J CLIN INVEST, V87, P1559, DOI 10.1172/JCI115169; Suc I, 1997, ARTERIOSCL THROM VAS, V17, P2158, DOI 10.1161/01.ATV.17.10.2158; Sugano M, 1998, J BIOL CHEM, V273, P5033, DOI 10.1074/jbc.273.9.5033; TALL AR, 1993, J LIPID RES, V34, P1255; Tollefson J H, 1986, Methods Enzymol, V129, P797; WHITLOCK ME, 1989, J CLIN INVEST, V84, P129, DOI 10.1172/JCI114132; WILSON PWF, 1988, ARTERIOSCLEROSIS, V8, P737, DOI 10.1161/01.ATV.8.6.737; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751	28	443	470	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					203	207		10.1038/35018119	http://dx.doi.org/10.1038/35018119			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910363				2022-12-28	WOS:000088221100053
J	Kennedy, RL				Kennedy, RL			Commentary: Time for improved diagnosis and management of patients presenting with acute chest pain	BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; ADMISSION; EMERGENCY		Sunderland Royal Hosp, Dept Med, Sunderland SR4 7TP, England	Sunderland Royal Hospital	Kennedy, RL (corresponding author), Sunderland Royal Hosp, Dept Med, Sunderland SR4 7TP, England.							BAKKER AJ, 1993, LANCET, V342, P1220, DOI 10.1016/0140-6736(93)92192-V; FINEBERG HV, 1984, NEW ENGL J MED, V310, P1301, DOI 10.1056/NEJM198405173102006; GIBLER WB, 1995, ANN EMERG MED, V25, P1, DOI 10.1016/S0196-0644(95)70347-0; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; Heeschen C, 1999, LANCET, V354, P1757, DOI 10.1016/S0140-6736(99)10285-X; Kennedy RL, 1997, COMPUT METH PROG BIO, V52, P93, DOI 10.1016/S0169-2607(96)01782-8; KENNEDY RL, 1995, BR HEART J S3, V73, pA107	7	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1704	1705						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10917697				2022-12-28	WOS:000087926400023
J	Thorvaldsen, JL; Bartolomei, MS				Thorvaldsen, JL; Bartolomei, MS			Molecular biology - Mothers setting boundaries	SCIENCE			English	Editorial Material							MOUSE H19 GENE; CONTROL ELEMENT; PROTEIN CTCF; DOMAIN; IGF2; EXPRESSION; UPSTREAM; DELETION; ASSAY		Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Thorvaldsen, JL (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.							Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; FILLPPOVA GN, 1996, MOL CELL BIOL, V16, P2802; Frevel MAE, 1999, TRENDS GENET, V15, P216, DOI 10.1016/S0168-9525(99)01752-7; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hark AT, 1998, HUM MOL GENET, V7, P1979, DOI 10.1093/hmg/7.12.1979; Kanduri C, 2000, CURR BIOL, V10, P449, DOI 10.1016/S0960-9822(00)00442-5; Kellum R, 1998, CURR BIOL, V8, pR521, DOI 10.1016/S0960-9822(07)00337-5; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; Khosla S, 1999, MOL CELL BIOL, V19, P2556; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Stadnick MP, 1999, DEV GENES EVOL, V209, P239, DOI 10.1007/s004270050248; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Webber AL, 1998, NATURE, V391, P711, DOI 10.1038/35655	18	19	19	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2145	2146		10.1126/science.288.5474.2145	http://dx.doi.org/10.1126/science.288.5474.2145			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10896590				2022-12-28	WOS:000087782900028
J	Sees, KL; Delucchi, KL; Masson, C; Rosen, A; Clark, HW; Robillard, H; Banys, P; Hall, SM				Sees, KL; Delucchi, KL; Masson, C; Rosen, A; Clark, HW; Robillard, H; Banys, P; Hall, SM			Methadone maintenance for opioid dependence - Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sees, KL (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							[Anonymous], 1998, JAMA, V280, P1936; DAUNNO T, 1992, JAMA-J AM MED ASSOC, V267, P253, DOI 10.1001/jama.267.2.253	2	4	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					694	695						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341JM	10927773				2022-12-28	WOS:000088587300023
J	Biener, L; Harris, JE; Hamilton, W				Biener, L; Harris, JE; Hamilton, W			Impact of the Massachusetts tobacco control programme: population based trend analysis	BRITISH MEDICAL JOURNAL			English	Article								Objective To assess the impact of the Massachusetts tobacco control programme, which, since its start in January 1993, has spent ol er $200m-"the highest per capita expenditure for tobacco control in the world"-funded by an extra tax of 25 cents per pack of cigarettes. Design Population based trend analysis with comparison group. Subjects Adult residents of Massachusetts and other US states excluding California. Main outcome measures Per capita consumption of cigarettes as measured by states' sales tax records; prevalence of smoking in adults as measured by several population-based telephone surveys. Results From 1988 to 1992, decline in per capita consumption of cigarettes in Massachusetts (15%) was similar to that in the comparison states (14%), corresponding to an annual decline of 3-4% for both groups. During 1992-3, consumption continued to decline by 4% in the comparison states but dropped 12% in Massachusetts in response to the tax increase. From 1993 onward, consumption in Massachusetts showed a consistent annual decline of more than 4%, whereas in the comparison states it levelled off, decreasing by less than 1% a year. From 1992, the prevalence of adult smoking in Massachusetts has declined annually by 0.43% (95% confidence interval 0.21% to 0.66%) compared with an increase of 0.03% (-0.06%, to 0.12%) in the comparison states (P < 0.001). Conclusions These findings show that a strongly implemented, comprehensive tobacco control programme can significantly reduce tobacco use.	Univ Massachusetts, Survey Res Ctr, Boston, MA 02125 USA; MIT, Dept Econ, Cambridge, MA 02138 USA; ABT Associates Inc, Cambridge, MA 02138 USA	University of Massachusetts System; University of Massachusetts Boston; Massachusetts Institute of Technology (MIT); ABT Associates	Biener, L (corresponding author), Univ Massachusetts, Survey Res Ctr, 100 Morrissey Blvd, Boston, MA 02125 USA.			Biener, Lois/0000-0002-4130-8138				*ABT ASS, 1998, IND EV MASS TOB CONT; BAL DG, 1990, JAMA-J AM MED ASSOC, V264, P1570, DOI 10.1001/jama.264.12.1570; Biener L, 1998, AM J PUBLIC HEALTH, V88, P1389, DOI 10.2105/AJPH.88.9.1389; BIENER L, 1999, 1998 MASS AD TOB SUR; BIENER L, 1994, TECHNICAL REPORT 199; *CAMP TOB FREE KID, 2000, STAT TOB SETTL TOLL; CDC, 1994, MMWR-MORBID MORTAL W, V43, P342; *CENTR INT AG, 2000, WORLD FACTB 1999; CHALOUPKA FJ, 1995, 5012 NAT BUR EC RES; FARRELLY M, 1999, IMPACT TOBACCO CONTR; GILPIN EA, 1994, AM J PUBLIC HEALTH, V84, P1576, DOI 10.2105/AJPH.84.10.1576; *NCI, 1994, NIH PUB; PIERCE JP, 2000, AM J PUBLIC HEALTH, V90, P893; Prabhat J, 1999, CURBING EPIDEMIC GOV; *SECR STAT HLTH SE, 2000, SMOK KILLS WHIT PAP; Siegel M, 2000, AM J PUBLIC HEALTH, V90, P380, DOI 10.2105/AJPH.90.3.380; Siegel M, 2000, AM J PUBLIC HEALTH, V90, P372, DOI 10.2105/AJPH.90.3.372; *TOB I, 1996, TAX BURD TOB HIST CO; *WHO, 1999, WORLD HLTH REP 1999, P65	19	106	107	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					351	354		10.1136/bmj.321.7257.351	http://dx.doi.org/10.1136/bmj.321.7257.351			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	342QH	10926595	Bronze, Green Published			2022-12-28	WOS:000088656300027
J	Jarvis, MJ; Goddard, E; Higgins, V; Feyerabend, C; Bryant, A; Cook, DG				Jarvis, MJ; Goddard, E; Higgins, V; Feyerabend, C; Bryant, A; Cook, DG			Children's exposure to passive smoking in England since the 1980s: cotinine evidence from population surveys	BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; DETERMINANTS; HOME	Objective To determine whether children's exposure to passive smoking has changed since the late 1980s. Design Cross sectional surveys of nationally representative samples of secondary; school children carried out between 1988 and 1998 by Office for National Statistics. Setting England. Subjects Secondary school children aged 11-15. Main outcome measures Salivary cotinine concentrations in non-smoking children. Results Cotinine concentrations in all non-smoking children almost halved between 1988 and 1998, from a geometric mean of 0.96 (95% confidence interval 0.83 to 1.11) ng/ml in 1988 to 0.52 (0.43 to 0.62) ng/ml in 1998, This reduction was largely due to reductions in exposure in children from non-smoking households and to decreases in the percentage of parents who smoked. Children living with mothers or fathers who smoked experienced little reduction in exposure. Conclusions Exposure to passive smoking among children in England has approximately halved since the late 1980s. This reduction is partly explained by the fall in the percentage of both mothers and fathers who smoke and is also likely to reflect reductions of smoking in public places. However, there is only limited evidence that children from smoking households have experienced a reduction in exposure through parents' avoidance of smoking in their presence.	UCL, Dept Epidemiol & Publ Hlth, Imperial Canc Res Fund, Hlth Behav Unit, London WC1E 6BT, England; Off Natl Stat, London SW1V 2QQ, England; New Cross Hosp, Med Toxicol Unit, London SE14 5ER, England; Univ London St Georges Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England	Cancer Research UK; University of London; University College London; New Cross Hospital; St Georges University London	Jarvis, MJ (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Imperial Canc Res Fund, Hlth Behav Unit, Mortimer St, London WC1E 6BT, England.	martin.jarvis@ucl.ac.uk	Jarvis, Martin J/B-1034-2008	Jarvis, Martin J/0000-0001-9238-8038; Cook, Derek/0000-0002-9723-5759				BOLLING K, 1994, SMOKING SECONDARY SC; Borland R, 1999, TOB CONTROL, V8, P266, DOI 10.1136/tc.8.3.266; Cook DG, 1999, THORAX, V54, P357, DOI 10.1136/thx.54.4.357; DIAMOND A, 1995, SMOKING SECONDARY SC; ERIKSEN W, 1995, SCAND J PRIM HEALTH, V13, P275, DOI 10.3109/02813439508996775; FEYERABEND C, 1990, J PHARM PHARMACOL, V42, P450, DOI 10.1111/j.2042-7158.1990.tb06592.x; GODDARD E, 1989, SMOKING SECONDARY SC; Goddard E., 1999, SMOKING DRINKING DRU, V1; JAAKKOLA N, 1994, SCAND J SOC MED, V22, P107, DOI 10.1177/140349489402200205; Jarvis L., 1997, SMOKING SECONDARY SC; JARVIS MJ, 1992, AM J PUBLIC HEALTH, V82, P1225, DOI 10.2105/AJPH.82.9.1225; JARVIS MJ, 1991, INT J EPIDEMIOL, V20, P26; LADER D, 1991, SMOKING SECONDARY SC; MCNEILL AD, 1987, BRIT J ADDICT, V82, P1355; THOMAS M, 1993, SMOKING SECONDARY SC; Thomas M, 1998, LIVING BRITAIN RESUL; *US CDCP, 1997, MMWR-MORBID MORTAL W, V46, P1038	17	106	110	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					343	345		10.1136/bmj.321.7257.343	http://dx.doi.org/10.1136/bmj.321.7257.343			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QH	10926591	Green Published, Bronze			2022-12-28	WOS:000088656300024
J	Kato, T; Gornitzka, H; Baceiredo, A; Schoeller, WW; Bertrand, G				Kato, T; Gornitzka, H; Baceiredo, A; Schoeller, WW; Bertrand, G			A cyclic carbanionic valence isomer of a carbocation: Diphosphino analogs of diaminocarbocations	SCIENCE			English	Article							CARBENIUM IONS; CHEMISTRY; CATIONS	Diaminocarbocations (or amidinium salts) feature a three-center 4 pi electron system with an open planar structure. Their 2 pi electron three-membered cyclic valence isomers, in which the carbon atom bears a negative charge, are predicted to be about 541 kilojoules per mate higher in energy than the open form. This isomer has not been identified yet. In contrast, the attempted synthesis of a diphosphorus analog of amidinium salts Leads to the cyclic carbanionic form. There is no precedent for such a transformation of a carbocationic center into a carbanionic center, but with the help of heavier main-group elements, numerous examples can be imagined. This approach will enable the preparation of many unknown structural moieties that are difficult or even impossible to access in the corresponding carbon and nitrogen series.	Univ Toulouse 3, Lab Heterochim Fondamentale & Appl, F-31062 Toulouse 04, France; Univ Bielefeld, Fak Chem, D-33615 Bielefeld, Germany	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Bielefeld	Bertrand, G (corresponding author), Univ Toulouse 3, Lab Heterochim Fondamentale & Appl, 118 Route Narbonne, F-31062 Toulouse 04, France.		Schoeller, Wolfgang W/A-5755-2011					BADER RWF, 1994, ATOMS MOL; BECKE AD, 1990, J CHEM PHYS, V92, P5397, DOI 10.1063/1.458517; Canac Y, 1998, SCIENCE, V279, P2080, DOI 10.1126/science.279.5359.2080; COWLEY AH, 1978, J AM CHEM SOC, V100, P7784, DOI 10.1021/ja00492a087; Frisch M. J., 1998, GAUSSIAN 98; Goller A, 1996, J ORG CHEM, V61, P5840, DOI 10.1021/jo960387h; Grutzmacher H, 1997, COORDIN CHEM REV, V163, P287, DOI 10.1016/S0010-8545(97)00043-X; Guerret O, 1997, ACCOUNTS CHEM RES, V30, P486, DOI 10.1021/ar970061a; IGAU A, 1989, J AM CHEM SOC, V111, P6853, DOI 10.1021/ja00199a062; IGAU A, 1989, ANGEW CHEM INT EDIT, V28, P621, DOI 10.1002/anie.198906211; MATHEY F, 1990, CHEM REV, V90, P997, DOI 10.1021/cr00104a004; Minkin V. J., 1994, AROMATICITY ANTIAROM; OLAH GA, 1995, ANGEW CHEM INT EDIT, V34, P1393, DOI 10.1002/anie.199513931; OLAH GA, 1972, J AM CHEM SOC, V94, P808, DOI 10.1021/ja00758a020; OLAH GA, 1993, ANGEW CHEM INT EDIT, V32, P767, DOI 10.1002/anie.199307673; OLAH GA, 1976, CARBONIUM IONS; SAUNDERS M, 1991, CHEM REV, V91, P375, DOI 10.1021/cr00003a005; Schoeller WW, 1998, INORG CHEM, V37, P3183, DOI 10.1021/ic9701524; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Voelter, 1990, CARBON 13 NMR SPECTR; Vogel P., 1985, CARBOCATION CHEM; Volkmann R.A., 1991, COMPREHENSIVE ORGANI, V1, P355	22	26	26	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					754	756		10.1126/science.289.5480.754	http://dx.doi.org/10.1126/science.289.5480.754			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926532				2022-12-28	WOS:000088581500033
J	Sridhar, M				Sridhar, M			What is the future for training overseas graduates?	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					307	307		10.1136/bmj.321.7256.307	http://dx.doi.org/10.1136/bmj.321.7256.307			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915148	Green Published			2022-12-28	WOS:000088619800058
J	Sparrer, HE; Santoso, A; Szoka, FC; Weissman, JS				Sparrer, HE; Santoso, A; Szoka, FC; Weissman, JS			Evidence for the prion hypothesis: Induction of the yeast [PSI+] factor by in vitro-converted Sup35 protein	SCIENCE			English	Article							DE-NOVO APPEARANCE; SACCHAROMYCES-CEREVISIAE; DISEASE; PROPAGATION; GENE; DETERMINANT; TERMINATION; HSP104; PSI(+)	Starting with purified, bacterially produced protein, we have created a [PSI+]-inducing agent based on an altered (prion) conformation of the yeast Sup35 protein. After converting Sup35p to its prion conformation in vitro, we introduced it into the cytoplasm of living yeast using a liposome transformation protocol. Introduction of substoichiometric quantities of converted Sup35p greatly increased the rate of appearance of the well-characterized epigenetic factor [PSI+], which results from self-propagating aggregates of cellular Sup35p. Thus, as predicted by the prion hypothesis, proteins can act as infectious agents by causing self-propagating conformational changes.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.		FRECHET, Jean M/P-1497-2016	Weissman, Jonathan/0000-0003-2445-670X				Bates GP, 1998, BIOCHEM SOC T, V26, P471, DOI 10.1042/bst0260471; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; BOLTON DC, 1991, J GEN VIROL, V72, P2905, DOI 10.1099/0022-1317-72-12-2905; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1998, P NATL ACAD SCI USA, V95, P2400, DOI 10.1073/pnas.95.5.2400; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; DIDICHENKO SA, 1991, EUR J BIOCHEM, V198, P705, DOI 10.1111/j.1432-1033.1991.tb16070.x; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Kaneko K, 2000, J MOL BIOL, V295, P997, DOI 10.1006/jmbi.1999.3386; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; MICHELITSCH MD, UNPUB; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; SPARRER HE, UNPUB; STANSFIELD I, 1992, MOL MICROBIOL, V6, P3469, DOI 10.1111/j.1365-2958.1992.tb01782.x; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; SZOKA F, 1981, P NATL ACAD SCI-BIOL, V78, P1685, DOI 10.1073/pnas.78.3.1685; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; TUITE MF, 1981, GENETICS, V98, P691; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170	38	131	138	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2000	289	5479					595	599		10.1126/science.289.5479.595	http://dx.doi.org/10.1126/science.289.5479.595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915616				2022-12-28	WOS:000088447800045
J	Caruana, L; Petrie, MC; Davie, AP; McMurray, JJV				Caruana, L; Petrie, MC; Davie, AP; McMurray, JJV			Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study	BRITISH MEDICAL JOURNAL			English	Article							PREVALENCE; DYSFUNCTION; POPULATION; CARE	Objectives To characterise the clinical features of patients with suspected heart failure but preserved left ventricular systolic function to determine if they have other potential causes for their symptoms rather than being diagnosed with "diastolic heart failure." Design Prospective descriptive study. Setting Outpatient based direct access echocardiography service. Participants 159 consecutive patients with suspected heart failure referred by general practitioners. Main outcome measures Symptoms (including shortness of breath, ankle oedema, and paroxysmal nocturnal dyspnoea) and history of coronary heart disease and chronic pulmonary disease. Transthoracic echocardiography, body mass index, pulmonary function tests, and electrocardiography. Results 109 of 159 participants had suspected heart failure in the absence of left ventricular systolic dysfunction, valvular heart disease, or atrial fibrillation. Of these 109, 40 were either obese or very obese, 54 had a reduction in forced expiratory volume in 1 second to less than or equal to 70%, and 97 had a peak expiratory flow rate less than or equal to 70% of normal. Thirty one patients had a history of angina, 12 had had a myocardial infarction, and seven had undergone a coronary artery bypass graft. Only seven patients lacked a recognised explanation for their symptoms. Conclusions For most patients with a diagnosis of heart failure but preserved left ventricular systolic function there is an alternative explanation for their symptoms-for example, obesity, lung disease, and myocardial ischaemia-and the diagnosis of diastolic heart failure is rarely needed These alternative diagnoses should be rigorously sought and managed accordingly.	Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G11 6NT, Lanark, Scotland	University of Glasgow	McMurray, JJV (corresponding author), Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G11 6NT, Lanark, Scotland.		mcmurray, John/B-2467-2013	mcmurray, John/0000-0002-6317-3975				ANDERSSON B, 1995, CHEST, V107, P680, DOI 10.1378/chest.107.3.680; CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585; Caruana L, 1999, EUR HEART J, V20, P393; CHOY AMJ, 1994, BRIT HEART J, V72, P16; Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5; Davie AP, 1997, EUR HEART J, V18, P981; Diller PM, 1999, ARCH FAM MED, V8, P414, DOI 10.1001/archfami.8.5.414; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; MIYITAKE K, 1984, AM J CARDIOL, V53, P586; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; REMES J, 1991, EUR HEART J, V12, P315, DOI 10.1093/oxfordjournals.eurheartj.a059896; SCHILLER NB, 1979, CIRCULATION, V60, P547, DOI 10.1161/01.CIR.60.3.547; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; Williams DG, 1997, TRANSPORT Q, V51, P9	16	236	249	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 22	2000	321	7255					215	218		10.1136/bmj.321.7255.215	http://dx.doi.org/10.1136/bmj.321.7255.215			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903655	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000088448100024
J	Jin, YG; Wang, Y; Wang, W; Shang, QH; Cao, CQ; Erwin, DH				Jin, YG; Wang, Y; Wang, W; Shang, QH; Cao, CQ; Erwin, DH			Pattern of marine mass extinction near the Permian-Triassic boundary in South China	SCIENCE			English	Article							TETHYS; RANGE	The Meishan section across the Permian-Triassic boundary in South China is the most thoroughly investigated in the world. A statistical analysis of the occurrences of 162 genera and 333 species confirms a sudden extinction event at 251.4 million years ago, coincident with a dramatic depletion of delta(13)C(carbonate) and an increase in microspherules.	Acad Sinica, Nanjing Inst Geol & Palaeontol, Nanjing 210008, Peoples R China; Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA	Chinese Academy of Sciences; Smithsonian Institution; Smithsonian National Museum of Natural History	Jin, YG (corresponding author), Acad Sinica, Nanjing Inst Geol & Palaeontol, Nanjing 210008, Peoples R China.		Wang, Wen/AAP-9873-2020; Wang, Wei/B-5617-2019; Erwin, Douglas H/A-9668-2009	Erwin, Douglas/0000-0003-2518-5614				Asaro F., 1982, GEOL SOC AM SPEC PAP, V190, P517; BAUD A, 1989, GEOL RUNDSCH, V78, P649, DOI 10.1007/BF01776196; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; CAMPBELL IH, 1992, SCIENCE, V258, P1760, DOI 10.1126/science.258.5089.1760; Cao C. Q., 1998, PALAEOWORLD, V9, P147; CAO CQ, 1999, THESIS NANJING I GEO; DHONDT S, COMMUNICATION; ERWIN DH, 1993, GRAT PALEOZOIC CRISI; Gao Zhengang, 1987, GEOLOGICAL REV, V33, P203; HAO WC, 1994, J GEOSCI OSAKA CITY, V39, P19; He J.W., 1987, J STRATIGR, V11, P194; Marshall CR, 1996, SCIENCE, V274, P1360, DOI 10.1126/science.274.5291.1360; MARSHALL CR, 1994, PALEOBIOLOGY, V20, P459, DOI 10.1017/S0094837300012938; MELDAHL KH, 1990, GEOLOGY, V18, P890, DOI 10.1130/0091-7613(1990)018<0890:SSAATS>2.3.CO;2; OUYANG S, 1990, REV PALAEOBOT PALYNO, V66, P65, DOI DOI 10.1016/0034-6667(90)90029-I; RENNE PR, 1995, SCIENCE, V269, P1413, DOI 10.1126/science.269.5229.1413; RETALLACK GJ, 1995, SCIENCE, V267, P77, DOI 10.1126/science.267.5194.77; Schultz, 1982, GEOLOGICAL SOC AM SP, V190, P291, DOI DOI 10.1130/SPE190-P291; SHENG J-Z, 1984, Journal of the Faculty of Science Hokkaido University Series IV Geology and Mineralogy, V21, P133; SPRINGER MS, 1990, PALEOBIOLOGY, V16, P512, DOI 10.1017/S0094837300010228; TONG J., 1993, PERMO TRIASSIC EVENT, P90; Visscher H, 1996, P NATL ACAD SCI USA, V93, P2155, DOI 10.1073/pnas.93.5.2155; WIGNALL PB, 1993, PALAEOGEOGR PALAEOCL, V102, P215, DOI 10.1016/0031-0182(93)90068-T; YAN Z, 1989, PALAEOWORLD, V1, P113; YIN HF, 1992, PERMOTRIASSIC EVENTS; Zhang K., 1996, PALAEOZOIC MESOZOIC; ZHAO JK, 1981, B NANJING I GEOL PAL, V1, P95	27	534	662	9	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					432	436		10.1126/science.289.5478.432	http://dx.doi.org/10.1126/science.289.5478.432			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903200				2022-12-28	WOS:000088305500042
J	Liou, YC; Tocilj, A; Davies, PL; Jia, ZC				Liou, YC; Tocilj, A; Davies, PL; Jia, ZC			Mimicry of ice structure by surface hydroxyls and water of a beta-helix antifreeze protein	NATURE			English	Article							BEETLE DENDROIDES CANADENSIS; CRYSTAL-STRUCTURE; BINDING; COMPLEX; LARVAE; ATOM	Insect antifreeze proteins (AFP) are much more effective than fish AFPs at depressing solution freezing points by ice-growth inhibition(1,2). AFP from the beetle Tenebrio molitor is a small protein (8.4 kDa) composed of tandem 12-residue repeats(3) (TCTxSxxCxxAx). Here we report its 1.4-Angstrom resolution crystal structure, showing that this repetitive sequence translates into an exceptionally regular beta-helix. Not only are the 12-amino-acid loops almost identical in the backbone, but also the conserved side chains are positioned in essentially identical orientations, making this AFP perhaps the most regular protein structure yet observed. The protein has almost no hydrophobic core but is stabilized by numerous disulphide and hydrogen bonds. On the conserved side of the protein, threonine-cysteine-threonine motifs are arrayed to form a flat beta-sheet, the putative ice-binding surface. The threonine side chains have exactly the same rotameric conformation and the spacing between OH groups is a near-perfect match to the ice lattice. Together with tightly bound co-planar external water, three ranks of oxygen atoms form a two-dimensional array, mimicking an ice section.	Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Davies, PL (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	daviesp@post.queensu.ca						Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN LQ, 1991, P NATL ACAD SCI USA, V88, P4240, DOI 10.1073/pnas.88.10.4240; Davies PL, 1997, CURR OPIN STRUC BIOL, V7, P828, DOI 10.1016/S0959-440X(97)80154-6; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Duman JG, 1998, J COMP PHYSIOL B, V168, P225, DOI 10.1007/s003600050140; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Graham LA, 1997, NATURE, V388, P727, DOI 10.1038/41908; Jenkins J, 1998, J STRUCT BIOL, V122, P236, DOI 10.1006/jsbi.1998.3985; Jia ZC, 1996, NATURE, V384, P285, DOI 10.1038/384285a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KNIGHT CA, 1993, BIOPHYS J, V64, P252, DOI 10.1016/S0006-3495(93)81361-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li N, 1998, BIOCHEMISTRY-US, V37, P6343, DOI 10.1021/bi972853i; Lieu YC, 2000, PROTEIN EXPRES PURIF, V19, P148, DOI 10.1006/prep.2000.1219; Liou YC, 1999, BIOCHEMISTRY-US, V38, P11415, DOI 10.1021/bi990613s; Liou YC, 2000, ACTA CRYSTALLOGR D, V56, P354, DOI 10.1107/S0907444999016844; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Petersen TN, 1997, STRUCTURE, V5, P533, DOI 10.1016/S0969-2126(97)00209-8; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Tyshenko MG, 1997, NAT BIOTECHNOL, V15, P887, DOI 10.1038/nbt0997-887; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994	26	371	407	6	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					322	324		10.1038/35018604	http://dx.doi.org/10.1038/35018604			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917536				2022-12-28	WOS:000088251900054
J	MacLeod, K				MacLeod, K			The Oort crowd	NATURE			English	Article																			0	0	0	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					129	129		10.1038/35018177	http://dx.doi.org/10.1038/35018177			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910333	Bronze			2022-12-28	WOS:000088221100022
J	Elton, C; Lewis, M; Jourdan, MH				Elton, C; Lewis, M; Jourdan, MH			Unusual site of hydatid disease	LANCET			English	Article									Guys Hosp, Dept Surg, London SE1, England	Guy's & St Thomas' NHS Foundation Trust	Elton, C (corresponding author), 7 Rathgar Close, London N3 1UA, England.							Angulo JC, 1998, J UROLOGY, V159, P76, DOI 10.1016/S0022-5347(01)64016-3; Gossios KJ, 1997, EUR RADIOL, V7, P1303, DOI 10.1007/s003300050293; KALOVIDOURIS A, 1994, ABDOM IMAGING, V19, P489, DOI 10.1007/BF00198247; Karavias DD, 1996, WORLD J SURG, V20, P337, DOI 10.1007/s002689900054; WAY LW, 1991, CURRENT SURG DIAGNOS, P717	5	12	13	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2132	2132		10.1016/S0140-6736(00)02381-3	http://dx.doi.org/10.1016/S0140-6736(00)02381-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902628				2022-12-28	WOS:000087687100014
J	Gunsilius, E; Duba, HC; Petzer, AL; Kahler, CM; Grunewald, K; Stockhammer, G; Gabl, C; Dirnhofer, S; Clausen, J; Gastl, G				Gunsilius, E; Duba, HC; Petzer, AL; Kahler, CM; Grunewald, K; Stockhammer, G; Gabl, C; Dirnhofer, S; Clausen, J; Gastl, G			Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells	LANCET			English	Article							CHRONIC MYELOID-LEUKEMIA; IN-SITU HYBRIDIZATION; BLOOD; ANGIOGENESIS; FLUORESCENCE; VASCULOGENESIS; COMMON; TUMORS; FISH; CML	Background Vascular endothelial cells lost from the blood-vessel endothelium through necrosis or apoptosis must be replaced. We investigated in a leukaemia model whether bone-marrow-derived endothelial cells contribute to this maintenance angiogenesis. Methods We studied six patients with chronic myelogenous leukaemia (CML) carrying the BCR/ABL fusion gene in their bone-marrow-derived cells. We screened endothelial cells generated in vitro from bone-marrow-derived progenitor cells and vascular endothelium in myocardial tissue for the BCR/ABL fusion gene by in-situ hybridisation. For detection of donor-type endothelial cells after transplantation of haemopoietic stem cells, recipient tissue was stained with monoclonal antibodies against donor-type HLA antigens, Findings We identified the BCR/ABL fusion gene in variable proportions (0-56%) of endothelial cells generated in vitro. Endothelial cells expressing the fusion gene were found in the vascular endothelium of a patient. In a recipient of an allogeneic stem-cell transplant, normal donor-type endothelial cells were detected in the Vascular endothelium. Interpretation These findings suggest that CML is not solely a haematological disease but originates from a bone-marrow-derived haemangioblastic precursor cell that can give rise to both blood cells and endothelial cells. Moreover, normal bone-marrow-derived endothelial cells can contribute to the maintenance of the blood vascular endothelium. The integration of bone-marrow-derived endothelial cells into the vascular endothelium provides a rationale for developing vascular targeting strategies in vasculopathies, inflammatory diseases, and cancer.	Univ Innsbruck, Div Haematol & Oncol, A-6020 Innsbruck, Austria; Univ Innsbruck, Inst Med Biol & Human Genet, A-6020 Innsbruck, Austria; Univ Innsbruck, Div Gen Internal Med, A-6020 Innsbruck, Austria; Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; Univ Innsbruck, Dept Pathol, A-6020 Innsbruck, Austria	University of Innsbruck; University of Innsbruck; University of Innsbruck; University of Innsbruck; University of Innsbruck	Gunsilius, E (corresponding author), Univ Innsbruck Hosp, Div Haematol & Oncol, Anichstr 35, A-6020 Innsbruck, Austria.	eberhard.gunsilius@uibk.ac.at	Gunsilius, Eberhard/AAI-9333-2021	Gunsilius, Eberhard/0000-0003-1327-2921				Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Choi K, 1998, DEVELOPMENT, V125, P725; Dobler M, 1999, INT J ONCOL, V14, P571; Duba HC, 1999, INT J ONCOL, V14, P145; Eibl B, 1997, GENE CHROMOSOME CANC, V20, P215, DOI 10.1002/(SICI)1098-2264(199711)20:3<215::AID-GCC1>3.0.CO;2-5; FIALKOW PJ, 1977, AM J MED, V63, P125, DOI 10.1016/0002-9343(77)90124-3; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; His W, 1900, ABHANDL KS GES WISS, V22, P171; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; HSU SM, 1981, AM J CLIN PATHOL, V75, P816, DOI 10.1093/ajcp/75.6.816; LANSDORP PM, 1993, J EXP MED, V178, P787, DOI 10.1084/jem.178.3.787; Muhlmann J, 1998, GENE CHROMOSOME CANC, V21, P90, DOI 10.1002/(SICI)1098-2264(199802)21:2<90::AID-GCC3>3.0.CO;2-2; NOWELL PC, 1960, SCIENCE, V132, P1497; Petzer AL, 1996, BLOOD, V88, P2162, DOI 10.1182/blood.V88.6.2162.bloodjournal8862162; RISAU W, 1988, DEVELOPMENT, V102, P471; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367	20	254	273	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2000	355	9216					1688	1691		10.1016/S0140-6736(00)02241-8	http://dx.doi.org/10.1016/S0140-6736(00)02241-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905245				2022-12-28	WOS:000086983800012
J	Prasad, AS; Fitzgerald, JT; Bao, B; Beck, FWJ; Chandrasekar, PH				Prasad, AS; Fitzgerald, JT; Bao, B; Beck, FWJ; Chandrasekar, PH			Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate - A randomized, double-blind, placebo-controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							RESPIRATORY-TRACT INFECTIONS; GLUCONATE LOZENGES; CLINICAL-TRIAL; RHINOVIRUSES; ANTAGONISTS; IMMUNITY; FAILURE; SALTS	Background: Adults and children in the United States get two to six colds per year. Evidence that zinc is effective therapy for colds is inconsistent. Objective: To test the efficacy of zinc acetate lozenges in reducing the duration of symptoms of the common cold. Design: Randomized, double-blind, placebo-controlled trial. Setting: Detroit Medical Center, Detroit, Michigan. Patients: 50 ambulatory volunteers recruited within 24 hours of developing symptoms of the common cold. Intervention: Participants took one lozenge containing 12.8 mg of zinc acetate or placebo every 2 to 3 hours while awake as long as they had cold symptoms. Measurements: Subjective symptom scores for sore throat, nasal discharge, nasal congestion, sneezing, cough, scratchy throat, hoarseness, muscle ache, fever, and headache were recorded daily for 12 days. Plasma zinc and proinflammatory cytokine levels were measured on day 1 and after participants were well. Results: Forty-eight participants completed the study (25 in the zinc group and 23 in the placebo group). Compared with the placebo group, the zinc group had shorter mean overall duration of cold symptoms (4.5 vs. 8.1 days), cough (3.1 [95% CI, 2.1 to 4.1] vs. 6.3 [CI, 4.9 to 7.7] days), and nasal discharge (4.1 [CI, 3.3 to 4.9] vs. 5.8 [CI, 4.3 to 7.3] days) and decreased total severity scores for all symptoms (P < 0.002, test for treatment x time interaction). Mean changes in soluble interleukin-1 receptor antagonist level differed nonsignificantly between the zinc group and the placebo group (difference between changes, -89.4 pg/mL [CI, -243.6 to -64.8 pg/mL]). Conclusion: Administration of zinc lozenges was associated with reduced duration and severity of cold symptoms, especially cough. Improvement in clinical symptoms with zinc treatment may be related to a decrease in proinflammatory cytokine levels; however, in this study, the observed differences between changes in cytokine levels in zinc and placebo recipients were not significant.	Wayne State Univ, Sch Med, Detroit, MI USA; Univ Michigan, Sch Med, Ann Arbor, MI USA	Wayne State University; University of Michigan System; University of Michigan	Prasad, AS (corresponding author), Wayne State Univ, Div Hematol Oncol, Univ Hlth Ctr 5 C, Dept Med, 4201 St Antoine, Detroit, MI 48201 USA.							ALNAKIB W, 1987, J ANTIMICROB CHEMOTH, V20, P893, DOI 10.1093/jac/20.6.893; AREND WP, 1991, J CLIN INVEST, V88, P1445, DOI 10.1172/JCI115453; Beck FWJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE1002, DOI 10.1152/ajpendo.1997.272.6.E1002; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; BUI LM, 1994, P SOC EXP BIOL MED, V206, P438, DOI 10.3181/00379727-206-43784; Catania A, 1997, J GERONTOL A-BIOL, V52, pB93, DOI 10.1093/gerona/52A.2.B93; CATANIA A, 1994, ANN NY ACAD SCI, V741, P149; COUCH RB, 1984, J INFECT DIS, V150, P167, DOI 10.1093/infdis/150.2.167; Davidoff F, 1998, ANN INTERN MED, V128, P75, DOI 10.7326/0003-4819-128-1-199801010-00028; Dingle JH., 1964, STUDY 25000 ILLNESSE; DOUGLAS RM, 1987, ANTIMICROB AGENTS CH, V31, P1263, DOI 10.1128/AAC.31.8.1263; EBY GA, 1984, ANTIMICROB AGENTS CH, V25, P20, DOI 10.1128/AAC.25.1.20; Eby George A., 1995, Journal of Pharmacy Technology, V11, P110; Farr BM, 1997, ANN INTERN MED, V126, P738, DOI 10.7326/0003-4819-126-9-199705010-00013; FARR BM, 1987, ANTIMICROB AGENTS CH, V31, P1183, DOI 10.1128/AAC.31.8.1183; FUCHS D, 1988, IMMUNOL TODAY, V9, P150, DOI 10.1016/0167-5699(88)91203-0; GEIST FC, 1987, ANTIMICROB AGENTS CH, V31, P622, DOI 10.1128/AAC.31.4.622; GODFREY JC, 1992, J INT MED RES, V20, P234, DOI 10.1177/030006059202000305; GWALTNEY JM, 1966, NEW ENGL J MED, V275, P1261, DOI 10.1056/NEJM196612082752301; HACHT B, 1987, INORG CHIM A-BIOINOR, V136, P165, DOI 10.1016/S0020-1693(00)81149-4; Jackson JL, 1997, ARCH INTERN MED, V157, P2373, DOI 10.1001/archinte.157.20.2373; KOCH AE, 1995, J INVEST MED, V43, P28; KORANT BD, 1976, J VIROL, V18, P298, DOI 10.1128/JVI.18.1.298-306.1976; Macknin ML, 1998, JAMA-J AM MED ASSOC, V279, P1962, DOI 10.1001/jama.279.24.1962; MOFFAT AS, 1993, SCIENCE, V260, P910, DOI 10.1126/science.8493525; Mossad SB, 1996, ANN INTERN MED, V125, P81, DOI 10.7326/0003-4819-125-2-199607150-00001; NOAH TL, 1995, J INFECT DIS, V171, P584, DOI 10.1093/infdis/171.3.584; Novick SG, 1996, MED HYPOTHESES, V46, P295, DOI 10.1016/S0306-9877(96)90259-5; Petrus EJ, 1998, CURR THER RES CLIN E, V59, P595, DOI 10.1016/S0011-393X(98)85058-3; Pitkaranta A, 1998, INFECT MED, V15, P50; PRASAD AS, 1993, BIOCH ZINC, P259; SMITH DS, 1989, ANTIMICROB AGENTS CH, V33, P646, DOI 10.1128/AAC.33.5.646; Stockl J, 1999, J CLIN INVEST, V104, P957, DOI 10.1172/JCI7255; Turner RB, 1999, JAMA-J AM MED ASSOC, V281, P1797, DOI 10.1001/jama.281.19.1797; WAHL SM, 1989, J CELL BIOCHEM, V40, P193, DOI 10.1002/jcb.240400208; WEISMANN K, 1990, DAN MED BULL, V37, P279	36	154	160	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2000	133	4					245	252		10.7326/0003-4819-133-4-200008150-00006	http://dx.doi.org/10.7326/0003-4819-133-4-200008150-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346NG	10929163				2022-12-28	WOS:000088877500001
J	Suissa, S; Ernst, P; Benayoun, S; Baltzan, M; Cai, B				Suissa, S; Ernst, P; Benayoun, S; Baltzan, M; Cai, B			Low-dose inhaled corticosteroids and the prevention of death from asthma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEW-ZEALAND; PRESCRIBED FENOTEROL; BETA-AGONISTS; MORTALITY; RISK; GLUCOCORTICOIDS	Background: Although inhaled corticosteroids are effective for the treatment of asthma, it is uncertain whether their use can prevent death from asthma. Methods: We used the Saskatchewan Health data bases to form a population-based cohort of all subjects from 5 through 44 years of age who were using antiasthma drugs during the period from 1975 through 1991. We followed subjects until the end of 1997, their 55th birthday, death, emigration, or termination of health insurance coverage, whichever came first. We conducted a nested case-control study in which subjects who died of asthma were matched with controls within the cohort according to the length of follow-up at the time of death of the case patient (the index date), the date of study entry, and the severity of asthma. We calculated rate ratios after adjustment for the subject's age and sex; the number of prescriptions of theophylline, nebulized and oral (beta)-adrenergic agonists, and oral corticosteroids in the year before the index date; the number of canisters of inhaled (beta)-adrenergic agonists used in the year before the index date; and the number of hospitalizations for asthma in the two years before the index date. Results: The cohort consisted of 30,569 subjects. Of the 562 deaths, 77 were classified as due to asthma. We matched the 66 subjects who died of asthma for whom there were complete data with 2681 controls. Fifty-three percent of the case patients and 46 percent of the control patients had used inhaled corticosteroids in the previous year, most commonly low-dose beclomethasone. The mean number of canisters was 1.18 for the patients who died and 1.57 for the controls. On the basis of a continuous dose-response analysis, we calculated that the rate of death from asthma decreased by 21 percent with each additional canister of inhaled corticosteroids used in the previous year (adjusted rate ratio, 0.79; 95 percent confidence interval, 0.65 to 0.97). The rate of death from asthma during the first three months after discontinuation of inhaled corticosteroids was higher than the rate among patients who continued to use the drugs. Conclusions: The regular use of low-dose inhaled corticosteroids is associated with a decreased risk of death from asthma. (N Engl J Med 2000;343:332-6.) (C) 2000, Massachusetts Medical Society.	McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; McGill Univ, Dept Med, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Div Resp Med, Montreal, PQ, Canada	McGill University; Royal Victoria Hospital; McGill University; McGill University; McGill University	Suissa, S (corresponding author), McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Clin Epidemiol, 687 Pine Ave W,Ross 4-29, Montreal, PQ H3A 1A1, Canada.							ARRIGHI HM, 1995, ANN ALLERG ASTHMA IM, V74, P321; Barnes PJ, 1998, J ALLERGY CLIN IMMUN, V101, pS427, DOI 10.1016/S0091-6749(98)70154-X; Blais L, 1998, THORAX, V53, P1025, DOI 10.1136/thx.53.12.1025; Blais L, 1998, AM J RESP CRIT CARE, V158, P126, DOI 10.1164/ajrccm.158.1.9707107; CRANE J, 1989, LANCET, V1, P917; Cumming RG, 1997, NEW ENGL J MED, V337, P8, DOI 10.1056/NEJM199707033370102; DEVOY MAB, 1995, CHEST, V108, P1768, DOI 10.1378/chest.108.6.1768-a; Donahue JG, 1997, JAMA-J AM MED ASSOC, V277, P887, DOI 10.1001/jama.277.11.887; ERNST P, 1992, EUR RESPIR J, V5, P773; ERNST P, 1992, JAMA-J AM MED ASSOC, V268, P3462, DOI 10.1001/jama.268.24.3462; Garbe E, 1997, JAMA-J AM MED ASSOC, V277, P722, DOI 10.1001/jama.277.9.722; Garbe E, 1998, JAMA-J AM MED ASSOC, V280, P539, DOI 10.1001/jama.280.6.539; GARBE S, 1998, JAMA-J AM MED ASSOC, V280, P1830; GARRETT J, 1995, THORAX, V50, P303, DOI 10.1136/thx.50.3.303; GRAINGER J, 1991, THORAX, V46, P105, DOI 10.1136/thx.46.2.105; Lipworth BJ, 1999, ARCH INTERN MED, V159, P941, DOI 10.1001/archinte.159.9.941; PEARCE N, 1990, THORAX, V45, P170, DOI 10.1136/thx.45.3.170; REA HH, 1986, THORAX, V41, P833, DOI 10.1136/thx.41.11.833; Sears MR, 1997, LANCET, V350, P1; Simons FER, 1998, J ALLERGY CLIN IMMUN, V102, pS77, DOI 10.1016/S0091-6749(98)70035-1; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; Strand LM, 1994, PHARMACOEPIDEM DR S, P217; Suissa S, 1997, J CLIN EPIDEMIOL, V50, P1079, DOI 10.1016/S0895-4356(97)00158-3; SUISSA S, 1994, AM J RESP CRIT CARE, V149, P604, DOI 10.1164/ajrccm.149.3.8118625	24	768	799	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2000	343	5					332	336		10.1056/NEJM200008033430504	http://dx.doi.org/10.1056/NEJM200008033430504			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340GR	10922423				2022-12-28	WOS:000088525200004
J	Ferriman, A				Ferriman, A			UK licence for cisapride suspended	BRITISH MEDICAL JOURNAL			English	News Item																			0	22	22	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					259	259		10.1136/bmj.321.7256.259	http://dx.doi.org/10.1136/bmj.321.7256.259			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915117	Green Published			2022-12-28	WOS:000088619800010
J	Josefson, D				Josefson, D			US judge approves distribution of marijuana	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					261	261						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915124				2022-12-28	WOS:000088619800017
J	Shapiro, AMJ; Lakey, JRT; Ryan, EA; Korbutt, GS; Toth, E; Warnock, GL; Kneteman, NM; Rajotte, RV				Shapiro, AMJ; Lakey, JRT; Ryan, EA; Korbutt, GS; Toth, E; Warnock, GL; Kneteman, NM; Rajotte, RV			Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL-TRANSPLANTATION; GRAFT-SURVIVAL; HUMAN-PANCREAS; RAPAMYCIN; ALLOGRAFT; CYCLOSPORINE; TACROLIMUS; SIROLIMUS; THERAPY; BLOOD	Background: Registry data on patients with type 1 diabetes mellitus who undergo pancreatic islet transplantation indicate that only 8 percent are free of the need for insulin therapy at one year. Methods: Seven consecutive patients with type 1 diabetes and a history of severe hypoglycemia and metabolic instability underwent islet transplantation in conjunction with a glucocorticoid-free immunosuppressive regimen consisting of sirolimus, tacrolimus, and daclizumab. Islets were isolated by ductal perfusion with cold, purified collagenase, digested and purified in xenoprotein-free medium, and transplanted immediately by means of a percutaneous transhepatic portal embolization. Results: All seven patients quickly attained sustained insulin independence after transplantation of a mean (+/-SD) islet mass of 11,547+/-1604 islet equivalents per kilogram of body weight (median follow-up, 11.9 months; range, 4.4 to 14.9). All recipients required islets from two donor pancreases, and one required a third transplant from two donors to achieve sustained insulin independence. The mean glycosylated hemoglobin values were normal after transplantation in all recipients. The mean amplitude of glycemic excursions (a measure of fluctuations in blood glucose concentrations) was significantly decreased after the attainment of insulin independence (from 198+/-32 mg per deciliter [11.1+/-1.8 mmol per liter] before transplantation to 119+/-37 mg per deciliter [6.7+/-2.1 mmol per liter] after the first transplantation and 51+/-30 mg per deciliter [2.8+/-1.7 mmol per liter] after the attainment of insulin independence; P<0.001). There were no further episodes of hypoglycemic coma. Complications were minor, and there were no significant increases in lipid concentrations during follow-up. Conclusions: Our observations in patients with type 1 diabetes indicate that islet transplantation can result in insulin independence with excellent metabolic control when glucocorticoid-free immunosuppression is combined with the infusion of an adequate islet mass. (N Engl J Med 2000;343:230-8.) (C) 2000, Massachusetts Medical Society.	Univ Alberta, Surg Med Res Inst, Edmonton, AB, Canada; Univ Alberta, Dept Surg, Edmonton, AB, Canada; Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Shapiro, AMJ (corresponding author), Univ Alberta Hosp, Mackenzie Hlth Sci Ctr, Dept Surg 2D4 37, 8440 112 St, Edmonton, AB T6G 2B7, Canada.	amjs@powersurfr.com						[Anonymous], 1997, DIABETES, V46, P271, DOI 10.2337/diab.46.2.271; Bartlett ST, 1996, ANN SURG, V224, P440, DOI 10.1097/00000658-199610000-00003; Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Brandhorst H, 1998, CELL TRANSPLANT, V7, P489, DOI 10.1016/S0963-6897(98)00028-1; BRENDEL M, 1999, INT ISLER TRANSPLANT, V1, P20; Bretzel RG, 1999, J MOL MED, V77, P140, DOI 10.1007/s001090050322; Chen H, 1998, TRANSPLANT P, V30, P2579, DOI 10.1016/S0041-1345(98)00736-2; Darenkov IA, 1997, TRANSPLANTATION, V64, P848, DOI 10.1097/00007890-199709270-00010; Drachenberg CB, 1999, TRANSPLANTATION, V68, P396, DOI 10.1097/00007890-199908150-00012; Gavin JR, 1997, DIABETES CARE, V20, P1183; Groth CG, 1999, TRANSPLANTATION, V67, P1036, DOI 10.1097/00007890-199904150-00017; Halloran PF, 1999, TRANSPLANT P, V31, P769, DOI 10.1016/S0041-1345(98)01759-X; HERING BJ, 1999, GRAFT, V2, P12; Kahan BD, 1998, TRANSPLANTATION, V66, P1040, DOI 10.1097/00007890-199810270-00013; KAHAN BD, 1992, J AM SOC NEPHROL, V2, pS222; KAUFMAN DB, 1994, DIABETES, V43, P778, DOI 10.2337/diabetes.43.6.778; Kenyon NS, 1998, DIABETES METAB REV, V14, P303, DOI 10.1002/(SICI)1099-0895(199812)14:4<303::AID-DMR243>3.0.CO;2-E; Kneteman NM, 1996, TRANSPLANTATION, V61, P1206, DOI 10.1097/00007890-199604270-00015; Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649; Lakey JRT, 1996, TRANSPLANTATION, V61, P1047, DOI 10.1097/00007890-199604150-00010; Lakey JRT, 1999, CELL TRANSPLANT, V8, P285, DOI 10.1177/096368979900800309; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Linetsky E, 1997, DIABETES, V46, P1120, DOI 10.2337/diabetes.46.7.1120; McAlister VC, 2000, LANCET, V355, P376, DOI 10.1016/S0140-6736(99)03882-9; NUMAZAKI K, 1990, In Vivo (Attiki), V4, P49; PAK CY, 1988, LANCET, V2, P1; RICORDI C, 1989, DIABETES, V38, P140, DOI 10.2337/diab.38.1.S140; RICORDI C, 1990, ACTA DIABETOL LAT, V27, P185, DOI 10.1007/BF02581331; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; SEHGAL SN, 1975, J ANTIBIOT, V28, P727, DOI 10.7164/antibiotics.28.727; SERVICE FJ, 1970, DIABETES, V19, P644, DOI 10.2337/diab.19.9.644; Shapiro AMJ, 1998, TRANSPLANT P, V30, P647, DOI 10.1016/S0041-1345(97)01445-0; SHAPIRO AMJ, 1995, TRANSPLANTATION, V59, P1060, DOI 10.1097/00007890-199504150-00027; Vargas F, 1998, TRANSPLANTATION, V65, P722, DOI 10.1097/00007890-199803150-00020; Verge CF, 1998, DIABETES, V47, P1857, DOI 10.2337/diabetes.47.12.1857; Vincenti F, 1998, NEW ENGL J MED, V338, P161, DOI 10.1056/NEJM199801153380304; Vu MD, 1997, TRANSPLANTATION, V64, P1853, DOI 10.1097/00007890-199712270-00039; Weinand S, 1999, J MOL MED, V77, P121, DOI 10.1007/s001090050317; YAKIMETS WJ, 1993, TRANSPLANTATION, V56, P1293, DOI 10.1097/00007890-199312000-00001; ZENG YJ, 1993, SURGERY, V113, P98	40	3837	4201	4	294	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2000	343	4					230	238		10.1056/NEJM200007273430401	http://dx.doi.org/10.1056/NEJM200007273430401			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	337QC	10911004				2022-12-28	WOS:000088372300001
J	Berger, A				Berger, A			Science commentary: Echocardiography	BRITISH MEDICAL JOURNAL			English	Editorial Material																		CHEESEMAN MG, 1998, HEART, V80, P1	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 22	2000	321	7255					218	219		10.1136/bmj.321.7255.218	http://dx.doi.org/10.1136/bmj.321.7255.218			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903656	Green Published			2022-12-28	WOS:000088448100025
J	Asmerom, Y; Cheng, H; Thomas, R; Hirschmann, M; Edwards, RL				Asmerom, Y; Cheng, H; Thomas, R; Hirschmann, M; Edwards, RL			Melting of the Earth's lithospheric mantle inferred from protactinum-thorium-uranium isotopic data	NATURE			English	Article							IONIZATION MASS-SPECTROMETRY; BENEATH MIDOCEAN RIDGES; COLORADO PLATEAU; SERIES DISEQUILIBRIUM; VOLCANIC-ROCKS; BASALTS; TH; CLINOPYROXENE; PERIDOTITE; GARNET	The processes responsible for the generation of partial melt in the Earth's lithospheric mantle and the movement of this melt to the Earth's surface remain enigmatic, owing to the perceived difficulties in generating large-degree partial melts at depth and in transporting small-degree melts through a static lithosphere(1). Here we present a method of placing constraints on melting in the lithospheric mantle using Pa-231-U-235 data obtained from continental basalts in the southwestern United States and Mexico. Combined with Th-230-U-238 data(2,3), the Pa-231-U-235 data allow us to constrain the source mineralogy and thus the depth of melting of these basalts. Our analysis indicates that it is possible to transport small melt fractions-of the order of 0.1%-through the lithosphere, as might result from the coalescence of melt by compaction(4) owing to melting-induced deformation(5). The large observed Pa-231 excesses require that the timescale of melt generation and transport within the lithosphere is small compared to the half-life of Pa-231 (similar to 32.7 kyr). The Pa-231-Th-230 data also constrain the thorium and uranium distribution coefficients for clinopyroxene in the source regions of these basalts to be within 2% of one another, indicating that in this setting Th-230 excesses are not expected during melting at depths shallower than 85 km.	Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA	University of New Mexico; University of Minnesota System; University of Minnesota Twin Cities	Asmerom, Y (corresponding author), Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA.		CHENG, HAI/H-3413-2017; Hirschmann, marc m/B-9455-2016; Edwards, R. Lawrence/I-3124-2014	CHENG, HAI/0000-0002-5305-9458; Hirschmann, marc m/0000-0003-1213-6645; Edwards, R. Lawrence/0000-0002-7027-5881				ALIBERT C, 1994, J GEOPHYS RES-SOL EA, V99, P21605, DOI 10.1029/94JB01555; Asmerom Y, 1999, EARTH PLANET SC LETT, V166, P163, DOI 10.1016/S0012-821X(99)00008-4; ASMEROM Y, 1995, EARTH PLANET SC LETT, V134, P1, DOI 10.1016/0012-821X(95)00109-P; BEATTIE P, 1993, NATURE, V363, P63, DOI 10.1038/363063a0; Bourdon B, 1998, EARTH PLANET SC LETT, V164, P119, DOI 10.1016/S0012-821X(98)00227-1; Edwards RL, 1997, SCIENCE, V276, P782, DOI 10.1126/science.276.5313.782; GOLDSTEIN SJ, 1993, EARTH PLANET SC LETT, V115, P151, DOI 10.1016/0012-821X(93)90219-Y; Hirschmann MM, 1996, CONTRIB MINERAL PETR, V124, P185, DOI 10.1007/s004100050184; Kohlstedt DL, 1996, ANNU REV EARTH PL SC, V24, P41, DOI 10.1146/annurev.earth.24.1.41; LATOURRETTE TZ, 1992, EARTH PLANET SC LETT, V110, P227, DOI 10.1016/0012-821X(92)90050-6; LATOURRETTE TZ, 1993, SCIENCE, V261, P739, DOI 10.1126/science.261.5122.739; LEEMAN WP, 1993, SCIENCE, V262, P1550, DOI 10.1126/science.262.5139.1550; Lundstrom CC, 1998, EARTH PLANET SC LETT, V157, P167, DOI 10.1016/S0012-821X(98)00039-9; LUNDSTROM CC, 1994, EARTH PLANET SC LETT, V128, P407, DOI 10.1016/0012-821X(94)90159-7; LYNCH DJ, 1993, LITHOS, V29, P295, DOI 10.1016/0024-4937(93)90023-6; MCKENZIE D, 1984, J PETROL, V25, P713, DOI 10.1093/petrology/25.3.713; MCKENZIE D, 1985, EARTH PLANET SC LETT, V74, P81, DOI 10.1016/0012-821X(85)90168-2; MENZIES MA, 1991, J GEOPHYS RES-SOLID, V96, P13645, DOI 10.1029/91JB00556; NAVON O, 1987, J GEOL, V95, P285, DOI 10.1086/629131; PERRY FV, 1987, J GEOPHYS RES-SOLID, V92, P9193, DOI 10.1029/JB092iB09p09193; Pickett DA, 1997, EARTH PLANET SC LETT, V148, P259, DOI 10.1016/S0012-821X(97)00037-X; PICKETT DA, 1994, ANAL CHEM, V66, P1044, DOI 10.1021/ac00079a020; Riter JCA, 1996, GEOLOGY, V24, P267, DOI 10.1130/0091-7613(1996)024<0267:XCOTTH>2.3.CO;2; Robinson JAC, 1998, EARTH PLANET SC LETT, V164, P277, DOI 10.1016/S0012-821X(98)00213-1; Salters VJM, 1999, EARTH PLANET SC LETT, V166, P15, DOI 10.1016/S0012-821X(98)00271-4; SPIEGELMAN M, 1993, EARTH PLANET SC LETT, V118, P1, DOI 10.1016/0012-821X(93)90155-3; THOMPSON GA, 1979, TECTONOPHYSICS, V61, P149, DOI 10.1016/0040-1951(79)90296-8; WILLIAMS RW, 1989, GEOCHIM COSMOCHIM AC, V53, P1607; Wood BJ, 1999, GEOCHIM COSMOCHIM AC, V63, P1613, DOI 10.1016/S0016-7037(98)00302-0	29	32	32	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					293	296		10.1038/35018550	http://dx.doi.org/10.1038/35018550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917528				2022-12-28	WOS:000088251900046
J	Sondermann, P; Huber, R; Oosthuizen, V; Jacob, U				Sondermann, P; Huber, R; Oosthuizen, V; Jacob, U			The 3.2-angstrom crystal structure of the human IgG1 Fc fragment-Fc gamma RIII complex	NATURE			English	Article							CYANOGEN-BROMIDE FRAGMENTS; BINDING-SITE; EPSILON-RI; EFFECTOR FUNCTIONS; RECEPTOR IIB; AMINO-ACID; HUMAN IGE; IMMUNOGLOBULIN; ANTIBODIES; REGION	The immune response depends on the binding of opsonized antigens to cellular Fc receptors and the subsequent initiation of various cellular effector functions of the immune system. Here we describe the crystal structures of a soluble Fc gamma receptor (sFc gamma RIII, CD16), an Fc fragment from human IgG1 (hFc1) and their complex. In the 1:1 complex the receptor binds to the two halves of the Fc fragment in contact with residues of the C gamma 2 domains and the hinge region. Upon complex formation the angle between the two sFcgRIII domains increases significantly and the Fc fragment opens asymmetrically. The high degree of amino acid conservation between sFC gamma RIII and other Fc receptors, and similarly between hFc1 and related immunoglobulins, suggest similar structures and modes of association. Thus the described structure is a model for immune complex recognition and helps to explain the vastly differing affinities of other Fc gamma R-IgG complexes and the Fc epsilon RI alpha-IgE complex.	Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany; Univ Port Elizabeth, Dept Biochem & Microbiol, ZA-6000 Port Elizabeth, South Africa	Max Planck Society; Nelson Mandela University	Sondermann, P (corresponding author), Max Planck Inst Biochem, Abt Strukturforsch, Klopferspitz 18A, D-82152 Martinsried, Germany.	sonderma@biochem.mpg.de						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; CHAPPEL MS, 1991, P NATL ACAD SCI USA, V88, P9036, DOI 10.1073/pnas.88.20.9036; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cook JPD, 1997, BIOCHEMISTRY-US, V36, P15579, DOI 10.1021/bi9713005; Curnow RT, 1997, CANCER IMMUNOL IMMUN, V45, P210, DOI 10.1007/s002620050435; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DIAMOND B, 1985, J IMMUNOL, V134, P1080; DUNCAN AR, 1988, NATURE, V332, P563, DOI 10.1038/332563a0; Edberg JC, 1997, J IMMUNOL, V159, P3849; Galon J, 1997, Int Rev Immunol, V16, P87, DOI 10.3109/08830189709045704; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; GERGELY J, 1990, FASEB J, V4, P3275, DOI 10.1096/fasebj.4.15.2253843; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; GHIRLANDO R, 1995, BIOCHEMISTRY-US, V34, P13320, DOI 10.1021/bi00041a007; GREENWOOD J, 1993, EUR J IMMUNOL, V23, P1098, DOI 10.1002/eji.1830230518; Henry AJ, 1997, BIOCHEMISTRY-US, V36, P15568, DOI 10.1021/bi971299+; HUBER R, 1976, NATURE, V264, P415, DOI 10.1038/264415a0; HULETT MD, 1995, J BIOL CHEM, V270, P21188, DOI 10.1074/jbc.270.36.21188; Hulett MD, 1999, J BIOL CHEM, V274, P13345, DOI 10.1074/jbc.274.19.13345; Hulett MD, 1998, MOL IMMUNOL, V35, P989, DOI 10.1016/S0161-5890(98)00069-8; Isakov N, 1997, IMMUNOL RES, V16, P85, DOI 10.1007/BF02786325; ISHIZAKA T, 1978, J IMMUNOL, V120, P800; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Kato K, 2000, J MOL BIOL, V295, P213, DOI 10.1006/jmbi.1999.3351; Keown MB, 1998, BIOCHEMISTRY-US, V37, P8863, DOI 10.1021/bi972354h; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LUND J, 1992, MOL IMMUNOL, V29, P53, DOI 10.1016/0161-5890(92)90156-R; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; METZGER H, 1992, J IMMUNOL, V149, P1477; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Reddy MP, 2000, J IMMUNOL, V164, P1925, DOI 10.4049/jimmunol.164.4.1925; RUTISHAUSER U, 1970, BIOCHEMISTRY-US, V9, P3171, DOI 10.1021/bi00818a009; SARMAY G, 1992, MOL IMMUNOL, V29, P633, DOI 10.1016/0161-5890(92)90200-H; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; Sondermann P, 1999, BIOL CHEM, V380, P717, DOI 10.1515/BC.1999.090; Sondermann P, 1999, BIOCHEMISTRY-US, V38, P8469, DOI 10.1021/bi982889q; Sondermann P, 1999, EMBO J, V18, P1095, DOI 10.1093/emboj/18.5.1095; SUTTON BJ, 1993, NATURE, V366, P421, DOI 10.1038/366421a0; Tamm A, 1997, Int Rev Immunol, V16, P57, DOI 10.3109/08830189709045703; TAX WJM, 1983, NATURE, V304, P445, DOI 10.1038/304445a0; WARMERDAM PAM, 1991, J IMMUNOL, V147, P1338; Woodle ES, 1999, TRANSPLANTATION, V68, P608, DOI 10.1097/00007890-199909150-00003; WOOF JM, 1986, MOL IMMUNOL, V23, P319, DOI 10.1016/0161-5890(86)90059-3	48	578	742	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					267	273		10.1038/35018508	http://dx.doi.org/10.1038/35018508			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917521				2022-12-28	WOS:000088251900039
J	Ross, R; Dagnone, D; Jones, PJH; Smith, H; Paddags, A; Hudson, R; Janssen, I				Ross, R; Dagnone, D; Jones, PJH; Smith, H; Paddags, A; Hudson, R; Janssen, I			Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							VISCERAL ADIPOSE-TISSUE; ISCHEMIC-HEART-DISEASE; BODY-MASS INDEX; INSULIN SENSITIVITY; PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; CARDIOVASCULAR-DISEASE; GLUCOSE-METABOLISM; FAT DISTRIBUTION; BLOOD-PRESSURE	Background: The independent effects of diet- or exercise-induced weight loss on the reduction of obesity and related comorbid conditions are not known. The effects of exercise without weight loss on fat distribution and other risk factors are also unclear. Objective: To determine the effects of equivalent diet- or exercise-induced weight loss and exercise without weight loss on subcutaneous fat, visceral fat, skeletal muscle mass, and insulin sensitivity in obese men. Design: Randomized, controlled trial. Setting: University research center. Participants: 52 obese men (mean body mass index [+/-SD], 31.3 +/- 2.0 kg/m(2)) with a mean waist circumference of 110.1 +/- 5.8 cm, Intervention: Participants were randomly assigned to one of four study groups (diet-induced weight loss, exercise-induced weight loss, exercise without weight loss, and control) and were observed for 3 months. Measurements: Change in total, subcutaneous, and visceral fat; skeletal muscle mass; cardiovascular fitness; glucose tolerance and insulin sensitivity. Results: Body weight decreased by 7.5 kg (8%) in both weight loss groups and did not change in the exercise without weight loss and control groups. Compared with controls, cardiovascular fitness (peak oxygen uptake) in the exercise groups improved by approximately 16% (P < 0.01). Although total fat decreased in both weight loss groups (P < 0.001), the average reduction was 1.3 kg (95% CI, 0.3 to 2.3 kg) greater in the exercise-induced weight loss group than in the diet-induced weight loss group (P = 0.03). Similar reductions in abdominal subcutaneous, visceral, and visceral fat-to-subcutaneous fat ratios were observed in the weight loss groups (P < 0.001), Abdominal and visceral fat also decreased in the exercise without weight loss group (P = 0.001). Plasma glucose and insulin values (fasting and oral glucose challenge) did not change in the treatment groups compared with controls (P = 0.10 for all comparisons). Average improvement in glucose disposal was similar in the diet-induced weight loss group (5.6 mg/kg skeletal muscle per minute) and in the exercise-induced weight loss group (7.2 mg/kg skeletal muscle per minute) (P > 0.2). However, these values were significantly greater than those in the control and exercise without weight loss groups (P < 0.001). Conclusions: Weight loss induced by increased daily physical activity without caloric restriction substantially reduces obesity (particularly abdominal obesity) and insulin resistance in men. Exercise without weight loss reduces abdominal fat and prevents further weight gain.	Queens Univ, Sch Phys & Hlth Educ, Kingston, ON K7L 3N6, Canada; McGill Univ, Montreal, PQ, Canada	Queens University - Canada; McGill University	Ross, R (corresponding author), Queens Univ, Sch Phys & Hlth Educ, Kingston, ON K7L 3N6, Canada.	rossr@post.queensu.ca	Janssen, Ian/B-7700-2009	Janssen, Ian/0000-0003-2159-3012; Jones, Peter/0000-0001-5887-2846				ALLISON DB, 1995, DIABETES CARE, V18, P245, DOI 10.2337/diacare.18.2.245; [Anonymous], 1996, JAMA, V276, P241; BALLOR DL, 1994, INT J OBESITY, V18, P35; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320; Dengel DR, 1996, J APPL PHYSIOL, V81, P318, DOI 10.1152/jappl.1996.81.1.318; Despres Jean-Pierre, 1993, Nutrition Research Reviews, V6, P137, DOI 10.1079/NRR19930010; DESPRES JP, 1995, INT J OBESITY, V19, pS76; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; DYER AR, 1989, J HUM HYPERTENS, V3, P299; Fried S K, 1993, Obes Res, V1, P443; GARROW JS, 1995, EUR J CLIN NUTR, V49, P1; Goodpaster BH, 1999, DIABETES, V48, P839, DOI 10.2337/diabetes.48.4.839; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Harris JA., 1919, BIOMETRIC STUDY BASA; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Henriksson J, 1995, J Cardiovasc Risk, V2, P303, DOI 10.1097/00043798-199508000-00004; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; JONES PJH, 1993, J APPL PHYSIOL, V75, P1790, DOI 10.1152/jappl.1993.75.4.1790; KAHN HA, 1971, J CHRON DIS, V23, P617, DOI 10.1016/0021-9681(71)90158-5; KAYMAN S, 1990, AM J CLIN NUTR, V52, P800, DOI 10.1093/ajcn/52.5.800; Kelley D.E., 1995, DIABETES REV, V3, P366; KING AC, 1991, SPORTS MED, V11, P331, DOI 10.2165/00007256-199111050-00004; Lamarche B, 1998, JAMA-J AM MED ASSOC, V279, P1955, DOI 10.1001/jama.279.24.1955; LARSSON B, 1981, INT J OBESITY, V5, P97; Mayer-Davis EJ, 1998, JAMA-J AM MED ASSOC, V279, P669, DOI 10.1001/jama.279.9.669; Meek SE, 1999, DIABETES, V48, P10, DOI 10.2337/diabetes.48.1.10; MIKINES KJ, 1988, AM J PHYSIOL, V254, pE248, DOI 10.1152/ajpendo.1988.254.3.E248; Miller WC, 1997, INT J OBESITY, V21, P941, DOI 10.1038/sj.ijo.0800499; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; MOTT DM, 1986, METABOLISM, V35, P160, DOI 10.1016/0026-0495(86)90118-6; Mourier A, 1997, DIABETES CARE, V20, P385, DOI 10.2337/diacare.20.3.385; Niskanen L, 1996, INT J OBESITY, V20, P154; NOLAN JJ, 1994, NEW ENGL J MED, V331, P1188, DOI 10.1056/NEJM199411033311803; OLEFSKY J, 1975, METABOLISM, V24, P495, DOI 10.1016/0026-0495(75)90074-8; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Perseghin G, 1996, NEW ENGL J MED, V335, P1357, DOI 10.1056/NEJM199610313351804; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Rexrode KM, 1997, JAMA-J AM MED ASSOC, V277, P1539, DOI 10.1001/jama.277.19.1539; Rice B, 1999, DIABETES CARE, V22, P684, DOI 10.2337/diacare.22.5.684; Ross R, 1996, J APPL PHYSIOL, V81, P2445, DOI 10.1152/jappl.1996.81.6.2445; Ross R, 1997, SPORTS MED, V24, P55, DOI 10.2165/00007256-199724010-00005; Ross R, 1996, DIABETES CARE, V19, P1404, DOI 10.2337/diacare.19.12.1404; SCHULZ LO, 1994, AM J CLIN NUTR, V60, P676, DOI 10.1093/ajcn/60.5.676; SEGAL KR, 1991, J APPL PHYSIOL, V71, P2402, DOI 10.1152/jappl.1991.71.6.2402; Snyder WS, 1975, REPORT TASK GROUP RE; STAMLER R, 1978, JAMA-J AM MED ASSOC, V240, P1607, DOI 10.1001/jama.240.15.1607; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; WIDEN EIM, 1992, DIABETES, V41, P354, DOI 10.2337/diabetes.41.3.354; Williams MJ, 1996, INT J OBESITY, V20, P613; WILLIAMSON DF, 1992, AM J PUBLIC HEALTH, V82, P1251, DOI 10.2105/AJPH.82.9.1251; World Health Organization, 1997, OB PREV MAN GLOB EP	54	938	961	1	134	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2000	133	2					92	103		10.7326/0003-4819-133-2-200007180-00008	http://dx.doi.org/10.7326/0003-4819-133-2-200007180-00008			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335RL	10896648				2022-12-28	WOS:000088258500002
J	David, P; Bjorksten, T; Fowler, K; Pomiankowski, A				David, P; Bjorksten, T; Fowler, K; Pomiankowski, A			Condition-dependent signalling of genetic variation in stalk-eyes flies	NATURE			English	Article							SECONDARY SEXUAL CHARACTER; EVOLUTION; SELECTION; TRAITS; PREFERENCES; ORNAMENTS	Handicap models of sexual selection predict that male sexual ornaments have strong condition-dependent expression and this allows females to evaluate male genetic quality(1-5). A number of previous experiments have demonstrated heightened condition-dependence of sexual ornaments in response to environmental stress(6-9). Here we show that genetic variation underlies the response to environmental stress (variable food quality) of a sexual ornament (male eye span) in the stalk-eyed fly Cyrtodiopsis dalmanni. Some male genotypes develop large eye span under all conditions, whereas other genotypes progressively reduce eye span as conditions deteriorate. Several non-sexual traits (female eye span, male and female wing length) also show genetic variation in condition-dependent expression, but their genetic response is entirely explained by scaling with body size. In contrast, the male sexual ornament still reveals genetic variation in the response to environmental stress after accounting for differences in body size. These results strongly support the hypothesis that female mate choice yields genetic benefits for offspring.	UCL, Dept Biol, Galton Lab, London NW1 2HE, England; CNRS, CEFE, F-34293 Montpellier 05, France; Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	University of London; University College London; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Colorado State University	Pomiankowski, A (corresponding author), UCL, Dept Biol, Galton Lab, 4 Stephenson Way, London NW1 2HE, England.	ucbhpom@ucl.ac.uk	Pomiankowski, Andrew/X-3888-2019	Pomiankowski, Andrew/0000-0002-5171-8755				ANDERSSON M, 1986, EVOLUTION, V40, P804, DOI 10.1111/j.1558-5646.1986.tb00540.x; BURKHARDT D, 1988, J COMP PHYSIOL A, V162, P649, DOI 10.1007/BF01342640; Falconer DS, 1996, INTRO QUANTITATIVE G; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; GUSTAFSSON L, 1995, NATURE, V375, P311, DOI 10.1038/375311a0; HILL GE, 1992, AUK, V109, P1; Hunt J, 1997, BEHAV ECOL SOCIOBIOL, V41, P109, DOI 10.1007/s002650050370; IWASA Y, 1994, EVOLUTION, V48, P853, DOI 10.1111/j.1558-5646.1994.tb01367.x; Lynch M., 1998, GENETICS ANAL QUANTI; POMIANKOWSKI A, 1987, PROC R SOC SER B-BIO, V231, P123, DOI 10.1098/rspb.1987.0038; Qvarnstrom A, 1999, EVOLUTION, V53, P1564, DOI 10.1111/j.1558-5646.1999.tb05419.x; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Wilkinson GS, 1999, P ROY SOC B-BIOL SCI, V266, P1685, DOI 10.1098/rspb.1999.0832; WILKINSON GS, 1994, P ROY SOC B-BIOL SCI, V255, P1, DOI 10.1098/rspb.1994.0001; [No title captured]	17	243	244	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					186	188		10.1038/35018079	http://dx.doi.org/10.1038/35018079			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910358				2022-12-28	WOS:000088221100048
J	Peifer, M				Peifer, M			Cell biology - Travel bulletin - Traffic jams cause tumors	SCIENCE			English	Editorial Material							SUPPRESSOR PROTEIN; EPITHELIAL-CELLS; SHAPE CHANGE; DROSOPHILA; MEMBRANE; TOMOSYN; COMPLEX; FORMS		Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Peifer, M (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	pfeifer@unc.edu	Peifer, Mark/A-1152-2010	Peifer, Mark/0000-0003-1412-3987				Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; GATEFF E, 1974, ROUX ARCH DEV BIOL, V176, P23, DOI 10.1007/BF00577830; Goode S, 1997, GENE DEV, V11, P2532, DOI 10.1101/gad.11.19.2532; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Kagami M, 1998, GENETICS, V149, P1717; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Manfruelli P, 1996, DEVELOPMENT, V122, P2283; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361; STRAND D, 1994, J CELL BIOL, V127, P1345, DOI 10.1083/jcb.127.5.1345; WATSON KL, 1994, J CELL SCI, P19; WOOD D, 1969, P C WELDING DISSIMIL, V1, P134	15	15	15	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2000	289	5476					67	+		10.1126/science.289.5476.67	http://dx.doi.org/10.1126/science.289.5476.67			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332TW	10928931				2022-12-28	WOS:000088090400029
J	Zhang, PC; Shao, GF; Zhao, G; Le Master, DC; Parker, GR; Dunning, JB; Li, QL				Zhang, PC; Shao, GF; Zhao, G; Le Master, DC; Parker, GR; Dunning, JB; Li, QL			Ecology - China's forest policy for the 21st century	SCIENCE			English	Article									Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; State Forestry Adm, Ctr Nat Forest Conservat & Management, Beijing 100714, Peoples R China; S Carolina Dept Hlth & Environm Control, Columbia, SC 29201 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Shao, GF (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	gshao@fnr.purdue.edu	Shao, Guofan/F-1276-2010					LI W, 1993, CHINAS BIODIVERSITY, P168; LIU J, 1996, MACRO INVENTORY CHIN, P353; LIU S, 1963, CHINESE FORESTRY, V10, P8; MINISTRY OF FORESTRY, 1997, CHIN FOR YB; QU G, 1999, ENV PROTECTION KNOWL, P354; Richardson SD, 1990, FOREST FORESTRY CHIN; Shao G, 1998, NAT AREA J, V18, P358; SHAW N, 1914, CHINESE FOREST TREES; WANG T, 1991, HDB ABT AGENT BIOL T, P330; ZHANG P, 1999, INTRO NATURAL FOREST, P388; Zhang PeiChang, 1999, Scientia Silvae Sinicae, V35, P124	11	402	462	21	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2000	288	5474					2135	2136		10.1126/science.288.5474.2135	http://dx.doi.org/10.1126/science.288.5474.2135			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10896587				2022-12-28	WOS:000087782900021
J	Saleem, A; Yap, J; Osman, S; Brady, F; Suttle, B; Lucas, SV; Jones, T; Price, PM; Aboagye, EO				Saleem, A; Yap, J; Osman, S; Brady, F; Suttle, B; Lucas, SV; Jones, T; Price, PM; Aboagye, EO			Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action	LANCET			English	Article							POSITRON EMISSION TOMOGRAPHY; DIHYDROPYRIMIDINE DEHYDROGENASE; 5-ETHYNYLURACIL 776C85; RAT HEPATOCYTES; CANCER-PATIENTS; BETA-ALANINE; 5-FLUOROURACIL; ALPHA; PLASMA; METABOLITES	Background Fluorouracil is widely used for chemotherapy of gastrointestinal cancer; but response rates are poor. Eniluracil is being developed as an inactivator of dihydropyrimidine dehydrogenase, the enzyme that brings about first-pass degradation of fluorouracil. We studied the mechanism of action of eniluracil by measuring with positron emission tomography (PET) the effect of eniluracil on tumour and normal-tissue pharmacokinetics of fluorine-18-labelled fluorouracil. Methods Six patients with advanced gastrointestinal cancers were studied. PET scanning was done after injection of oxygen-15-labelled water to assess tissue blood flow, followed by 1 mg/m(2) F-18-fluorouracil. We compared the pharmacokinetics of F-18-fluorouracil when the patients had not received eniluracil, during a 4-day course of oral eniluracil, and during a 28-day course of oral fluorouracil plus eniluracil. Findings In eniluracil-naive patients, F-18-fluorouracil localised more strongly (mean 0.0234% [SE 0.0019] of injected activity per mL tissue at 11 min) in liver than in tumours (0.0032% [0.0004]). There was substantial inhibition, after eniluracil administration, of radiotracer uptake and retention in normal liver (mean area under the time versus radioactivity curve 0.927 [SE 0.086] vs 1.857 [0.169] m(2) mL(-1) s) and kidneys (1.096 [0.048] vs 5.043 [0.915] m(2) mL(-1) s). There was also an increase in plasma uracil and unmetabolised F-18-fluorouracil and an increase in the radiotracer half-life in tumours (2.3 h to >4.0 h). Interpretation Two events strongly suggested increased exposure of F-18-fluorouracil and its anabolites in the tumours, consistent with the inactivation of dihydropyrimidine dehydrogenase: a selective decrease in radiotracer exposure in normal liver and kidneys compared with tumours; and an increase in radiotracer half-life in tumours.	Hammersmith Hosp, Imperial Coll Sch Med, Dept Canc Med, Canc Res Campaign PET Oncol Grp, London W12 0NN, England; Hammersmith Hosp, MRC, Cyclotron Unit, London W12 0NN, England; Glaxo Wellcome Inc, Res & Dev, Res Triangle Pk, NC 27709 USA	Imperial College London; Imperial College London; GlaxoSmithKline	Price, PM (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Dept Canc Med, Canc Res Campaign PET Oncol Grp, London W12 0NN, England.	p.price@ic.ac.uk		Yap, Jeffrey/0000-0001-5306-2860; ABOAGYE, Eric/0000-0003-2276-6771				Adams ER, 1999, CANCER RES, V59, P122; Ahmed FY, 1999, J CLIN ONCOL, V17, P2439, DOI 10.1200/JCO.1999.17.8.2439; Amin J. M., 1997, Pharmaceutical Research (New York), V14, pS267; Baker SD, 2000, J CLIN ONCOL, V18, P915, DOI 10.1200/JCO.2000.18.4.915; Baker SD, 1996, J CLIN ONCOL, V14, P3085, DOI 10.1200/JCO.1996.14.12.3085; Brix G, 1998, RADIOLOGY, V209, P259, DOI 10.1148/radiology.209.1.9769841; BROWN G, 1999, J LABELLED COMPD RAD, V42, P533; DAVIS ST, 1994, BIOCHEM PHARMACOL, V48, P233, DOI 10.1016/0006-2952(94)90092-2; DIASIO RB, 1988, J CLIN INVEST, V81, P47, DOI 10.1172/JCI113308; ETIENNE MC, 1995, J CLIN ONCOL, V13, P1663, DOI 10.1200/JCO.1995.13.7.1663; FRAILE RJ, 1980, CANCER RES, V40, P2223; Harte RJA, 1999, J CLIN ONCOL, V17, P1580, DOI 10.1200/JCO.1999.17.5.1580; HEGGIE GD, 1987, CANCER RES, V47, P2203; Jessen H, 1996, BBA-BIOMEMBRANES, V1282, P225, DOI 10.1016/0005-2736(96)00060-0; Kissel J, 1997, CANCER RES, V57, P3415; Levy E, 1998, J CLIN ONCOL, V16, P3537, DOI 10.1200/JCO.1998.16.11.3537; Liu MP, 1999, AM J PHYSIOL-GASTR L, V276, pG206, DOI 10.1152/ajpgi.1999.276.1.G206; MALETMARTINO MC, 1988, DRUG METAB DISPOS, V16, P78; NAGUIB FNM, 1985, CANCER RES, V45, P5405; PETIT E, 1988, CANCER RES, V48, P1676; PIEDBOIS P, 1992, J CLIN ONCOL, V10, P896; PINEDO HM, 1988, J CLIN ONCOL, V6, P1653, DOI 10.1200/JCO.1988.6.10.1653; SOMMADOSSI JP, 1982, J BIOL CHEM, V257, P8171; SPECTOR T, 1993, BIOCHEM PHARMACOL, V46, P2243, DOI 10.1016/0006-2952(93)90615-4; SWEENY DJ, 1988, DRUG METAB DISPOS, V16, P892; WILSON CBJH, 1992, CANCER RES, V52, P1592; WOLF W, 1987, MAGN RESON IMAGING, V5, P165, DOI 10.1016/0730-725X(87)90016-6	27	70	74	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2000	355	9221					2125	2131		10.1016/S0140-6736(00)02380-1	http://dx.doi.org/10.1016/S0140-6736(00)02380-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902627				2022-12-28	WOS:000087687100013
J	Banfield, JF; Welch, SA; Zhang, HZ; Ebert, TT; Penn, RL				Banfield, JF; Welch, SA; Zhang, HZ; Ebert, TT; Penn, RL			Aggregation-based crystal growth and microstructure development in natural iron oxyhydroxide biomineralization products	SCIENCE			English	Article							PHASE-STABILITY; NANOCRYSTALLINE TITANIA; ORIENTED ATTACHMENT; FERRIHYDRITE; HYDROLYSIS; FEROXYHITE; MECHANISM; HEMATITE; INSIGHTS; MODEL	Crystals are generally considered to grow by attachment of ions to inorganic surfaces or organic templates. High-resolution transmission electron microscopy of biomineralization products of iron-oxidizing bacteria revealed an alternative coarsening mechanism in which adjacent 2- to 3-nanometer particles aggregate and rotate so their structures adopt parallel orientations in three dimensions. Crystal growth is accomplished by eliminating water molecules at interfaces and forming iron-oxygen bonds. Self-assembly occurs at multiple sites, Leading to a coarser, polycrystalline material. Point defects (from surface-adsorbed impurities), dislocations, and slabs of structurally distinct material are created as a consequence of this growth mechanism and can dramatically impact subsequent reactivity.	Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA; Divers Scuba, Madison, WI 53705 USA; Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA	University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University	Banfield, JF (corresponding author), Univ Wisconsin, Dept Geol & Geophys, 1215 W Dayton St, Madison, WI 53706 USA.			Banfield, Jill/0000-0001-8203-8771; Welch, Susan/0000-0002-2890-0065				BAILEY JK, 1993, J COLLOID INTERF SCI, V157, P1, DOI 10.1006/jcis.1993.1150; DRITS VA, 1993, CLAY MINER, V28, P185, DOI 10.1180/claymin.1993.028.2.02; DRITS VA, 1993, CLAY MINER, V28, P209, DOI 10.1180/claymin.1993.028.2.03; Emerson D, 1997, APPL ENVIRON MICROB, V63, P4784, DOI 10.1128/AEM.63.12.4784-4792.1997; Gribb AA, 1997, AM MINERAL, V82, P717, DOI 10.2138/am-1997-7-809; LANGMUIR D, 1971, AM J SCI, V271, P147, DOI 10.2475/ajs.271.2.147; MANCEAU A, 1993, CLAY MINER, V28, P165, DOI 10.1180/claymin.1993.028.2.01; McHale JM, 1997, SCIENCE, V277, P788, DOI 10.1126/science.277.5327.788; Onuma K, 1998, CHEM MATER, V10, P3346, DOI 10.1021/cm980062c; Penn RL, 1999, AM MINERAL, V84, P871, DOI 10.2138/am-1999-5-621; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Penn RL, 1999, GEOCHIM COSMOCHIM AC, V63, P1549, DOI 10.1016/S0016-7037(99)00037-X; Penn RL, 1998, AM MINERAL, V83, P1077; Privman V, 1999, J COLLOID INTERF SCI, V213, P36, DOI 10.1006/jcis.1999.6106; Pykhteev OY, 1999, RUSS J APPL CHEM+, V72, P9; Schwertmann U, 1999, J COLLOID INTERF SCI, V209, P215, DOI 10.1006/jcis.1998.5899; Zhang HZ, 1998, J MATER CHEM, V8, P2073, DOI 10.1039/a802619j; Zhu HL, 1996, PHIL MAG LETT, V73, P27, DOI 10.1080/095008396181073	18	1516	1567	20	894	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					751	754		10.1126/science.289.5480.751	http://dx.doi.org/10.1126/science.289.5480.751			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926531				2022-12-28	WOS:000088581500032
J	Schmitz, O; Katayama, M; Williams, SB; Kondo, T; Golden, SS				Schmitz, O; Katayama, M; Williams, SB; Kondo, T; Golden, SS			CikA, a bacteriophytochrome that resets the cyanobacterial circadian clock	SCIENCE			English	Article							GENE-EXPRESSION; PHYTOCHROME; SYSTEM; TRANSCRIPTION; ARABIDOPSIS; PROKARYOTES; SEQUENCES	The circadian oscillator of the cyanobacterium Synechococcus elongatus, Like those in eukaryotes, is entrained by environmental cues. Inactivation of the gene cikA (circadian input kinase) shortens the circadian period of gene expression rhythms in S. elongatus by approximately 2 hours, changes the phasing of a subset of rhythms, and nearly abolishes resetting of phase by a pulse of darkness. The CikA protein sequence reveals that it is a divergent bacterio-phytochrome with characteristic histidine protein kinase motifs and a cryptic response regulator motif. CikA is Likely a key component of a pathway that provides environmental input to the circadian oscillator in S. elongatus.	Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Texas A&M University System; Texas A&M University College Station; Nagoya University	Golden, SS (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037040] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM37040] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson CR, 2000, METHOD ENZYMOL, V305, P527; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; *GENB, AF258464 GENB; *GENB, X53695; Golden S. S., 1994, MOL BIOL CYANOBACTER, P693; GOLDEN SS, 1989, J BACTERIOL, V171, P4707, DOI 10.1128/jb.171.9.4707-4713.1989; Golden SS, 1998, CURR OPIN MICROBIOL, V1, P669, DOI 10.1016/S1369-5274(98)80113-6; HERSHEY HP, 1985, NUCLEIC ACIDS RES, V13, P8543, DOI 10.1093/nar/13.23.8543; Hughes O, 1999, PLANT PHYSIOL, V121, P1059; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Katayama M, 1999, J BACTERIOL, V181, P3516, DOI 10.1128/JB.181.11.3516-3524.1999; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; KONDO T, 1994, SCIENCE, V266, P1233, DOI 10.1126/science.7973706; LI LM, 1992, J BIOL CHEM, V267, P19204; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; OUYANG Y, 1998, THESIS VANDERBILT U; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; RIPPKA M, 1992, CATALOGUE STRAINS; ROIPPKA R, 1983, ANN MICROBIOL PARIS, V134, P21; SCHMITZ O, UNPUB; Smith RF, 1996, GENOME RES, V6, P454, DOI 10.1101/gr.6.5.454; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Stock J.B., 1995, 2 COMPONENT SIGNAL T, P25; Tsinoremas NF, 1996, EMBO J, V15, P2488, DOI 10.1002/j.1460-2075.1996.tb00606.x; VOLZ K, 1995, 2 COMPONENT SIGNAL T, P25; WILMOTTE AMR, 1984, J GEN MICROBIOL, V130, P2737; Wu S., UNPUB; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	33	200	220	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					765	768		10.1126/science.289.5480.765	http://dx.doi.org/10.1126/science.289.5480.765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926536				2022-12-28	WOS:000088581500037
J	Shin, JS; Gao, ZM; Abraham, SN				Shin, JS; Gao, ZM; Abraham, SN			Involvement of cellular caveolae in bacterial entry into mast cells	SCIENCE			English	Article							FACTOR-ALPHA RESPONSE; MEMBRANE; SEQUESTRATION; PURIFICATION; MICRODOMAINS; TRANSPORT; MOLECULES; PROTEINS; COMPLEX	Caveolae are subcellular structures implicated in the import and transcytosis of macromolecules and in transmembrane signaling. To date, evidence for the existence of caveolae in hematopoietic cells has been ambiguous. Caveolae were detected in the microvilli and intracellular vesicles of cultured mouse bone marrow-derived mast cells (BMMCs). CD48, a receptor for FimH-expressing (type 1 fimbriated) Escherichia coli, was specifically Localized to plasmalemmal caveolae in BMMCs, The involvement of caveolae in bacterial entry into BMMCs was indicated because caveolae-disrupting and -usurping agents specifically blocked E, coli entry, and markers of caveolae were actively recruited to sites of bacterial entry. The formation of bacteria-encapsulating caveolar chambers in BMMCs represents a distinct mechanism of microbial entry into phagocytes.	Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA	Duke University; Duke University	Shin, JS (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	abrah006@mc.duke.edu			NCI NIH HHS [CA 14236] Funding Source: Medline; NIAID NIH HHS [AI 35678] Funding Source: Medline; NIDDK NIH HHS [DK 50814] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050814, R37DK050814] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAHAM SN, 1988, NATURE, V336, P682, DOI 10.1038/336682a0; ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Arock M, 1998, INFECT IMMUN, V66, P6030, DOI 10.1128/IAI.66.12.6030-6034.1998; Baorto DM, 1997, NATURE, V389, P636, DOI 10.1038/39376; CHANG WJ, 1994, J CELL BIOL, V126, P127, DOI 10.1083/jcb.126.1.127; CONRAD PA, 1995, J CELL BIOL, V131, P1421, DOI 10.1083/jcb.131.6.1421; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; FRA AM, 1994, J BIOL CHEM, V269, P30745; GAO Z, UNPUB; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Malaviya R, 1999, P NATL ACAD SCI USA, V96, P8110, DOI 10.1073/pnas.96.14.8110; MAYOR S, 1994, SCIENCE, V264, P1948, DOI 10.1126/science.7516582; MICHAEL PL, 1995, MOL MEMBR BIOL, V12, P121; MONTESANO R, 1982, NATURE, V296, P651, DOI 10.1038/296651a0; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Schlegel A, 1998, CELL SIGNAL, V10, P457, DOI 10.1016/S0898-6568(98)00007-2; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P89, DOI 10.1016/S0962-8924(00)88956-4; TAKASHI O, 1998, J BIOL CHEM, V273, P5419; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026	26	265	275	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2000	289	5480					785	788		10.1126/science.289.5480.785	http://dx.doi.org/10.1126/science.289.5480.785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926542				2022-12-28	WOS:000088581500043
J	Heller, G; Misselwitz, B; Schmidt, S				Heller, G; Misselwitz, B; Schmidt, S			Early neonatal mortality asphyxia related deaths, and timing of low risk births in Hesse, Germany, 1990-8: observational study	BRITISH MEDICAL JOURNAL			English	Article							INTRAPARTUM		Univ Marburg, Sch Med, Med Ctr Methodol & Hlth Res, Inst Med Sociol & Social Med, D-35033 Marburg, Germany; Univ Marburg, Ctr Gynaecol & Obstet, Dept Obstet, D-35032 Marburg, Germany; Inst Qual Assurance Hesse, D-65760 Eschborn, Germany	Philipps University Marburg; Philipps University Marburg	Heller, G (corresponding author), Univ Marburg, Sch Med, Med Ctr Methodol & Hlth Res, Inst Med Sociol & Social Med, D-35033 Marburg, Germany.							Chalmers JWT, 1998, BRIT MED J, V317, P539; HOFACKER G, 1999, STAAT WIRTSCHAFT HES, V11, P326; KUNZEL W, 1994, EUR J OBSTET GYN R B, V54, P13, DOI 10.1016/0028-2243(94)90075-2; Stewart JH, 1998, BRIT MED J, V316, P657, DOI 10.1136/bmj.316.7132.657	4	60	63	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					274	275		10.1136/bmj.321.7256.274	http://dx.doi.org/10.1136/bmj.321.7256.274			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915130	Bronze, Green Published			2022-12-28	WOS:000088619800026
J	Josefson, D				Josefson, D			Women doctors earn $63 000 less than male counterparts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ness RB, 2000, ANN INTERN MED, V133, P104, DOI 10.7326/0003-4819-133-2-200007180-00009	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2000	321	7256					258	258						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915115				2022-12-28	WOS:000088619800009
J	Kunnas, TA; Laippala, P; Penttila, A; Lehtimaki, T; Karhunen, PK				Kunnas, TA; Laippala, P; Penttila, A; Lehtimaki, T; Karhunen, PK			Association of polymorphism of human a oestrogen receptor gene with coronary artery disease in men: a necropsy study	BRITISH MEDICAL JOURNAL			English	Article									Univ Tampere, Tampere Univ Hosp, Sch Med, Dept Forens Med, FIN-33014 Tampere, Finland; Univ Tampere, Sch Publ Hlth, FIN-33014 Tampere, Finland; Univ Helsinki, Dept Forens Med, FIN-00014 Helsinki, Finland; Univ Tampere, Dept Clin Chem, Lab Atherosclerosis Genet, FIN-33014 Tampere, Finland	Tampere University; Tampere University Hospital; Tampere University; University of Helsinki; Tampere University	Kunnas, TA (corresponding author), Univ Tampere, Tampere Univ Hosp, Sch Med, Dept Forens Med, FIN-33014 Tampere, Finland.		Lehtimäki, Terho/AAD-1094-2022	Lehtimäki, Terho/0000-0002-2555-4427; Kunnas, Tarja/0000-0002-9647-642X				Kunnas TA, 1999, HUM HERED, V49, P142, DOI 10.1159/000022862; LOSORDO DW, 1994, CIRCULATION, V89, P1501, DOI 10.1161/01.CIR.89.4.1501; Matsubara Y, 1997, ARTERIOSCL THROM VAS, V17, P3006, DOI 10.1161/01.ATV.17.11.3006; Mikkelsson J, 1999, ARTERIOSCL THROM VAS, V19, P2573, DOI 10.1161/01.ATV.19.10.2573; SANO M, 1995, BIOCHEM BIOPH RES CO, V217, P378, DOI 10.1006/bbrc.1995.2787	5	71	74	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					273	274		10.1136/bmj.321.7256.273	http://dx.doi.org/10.1136/bmj.321.7256.273			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915129	Bronze, Green Published			2022-12-28	WOS:000088619800025
J	Sturges, WT; Wallington, TJ; Hurley, MD; Shine, KP; Sihra, K; Engel, A; Oram, DE; Penkett, SA; Mulvaney, R; Brenninkmeijer, CAM				Sturges, WT; Wallington, TJ; Hurley, MD; Shine, KP; Sihra, K; Engel, A; Oram, DE; Penkett, SA; Mulvaney, R; Brenninkmeijer, CAM			A potent greenhouse gas identified in the atmosphere: SF5CF3	SCIENCE			English	Article							LIFETIMES; CLIMATE; TRENDS; SF6	We detected a compound previously unreported in the atmosphere, trifluoromethyl sulfur pentafluoride (SF5CF3). Measurements of its infrared absorption cross section show SF5CF3 to have a radiative forcing of 0.57 watt per square meter per parts per billion. This is the largest radiative forcing, on a per molecule basis, of any gas found in the atmosphere to date. Antarctic firn measurements show it to have grown from near zero in the late 1960s to about 0.12 part per trillion in 1999. It is presently growing by about 0.008 part per trillion per year, or 6% per year. Stratospheric profiles of SF5CF3 suggest that it is long-Lived in the atmosphere (on the order of 1000 years).	Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; Ford Motor Co, Dearborn, MI 48121 USA; Univ Reading, Dept Meteorol, Reading RG6 6BB, Berks, England; Univ Frankfurt, Inst Meteorol & Geophys, D-60325 Frankfurt, Germany; British Antarctic Survey, NERC, Cambridge CB3 0ET, England; Max Planck Inst Chem, Div Atmospher Chem, D-55060 Mainz, Germany	University of East Anglia; Ford Motor Company; University of Reading; Goethe University Frankfurt; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Max Planck Society	Sturges, WT (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England.		Brenninkmeijer, Carl/B-6860-2013; Mulvaney, Robert/K-3929-2012; Shine, Keith P/D-9093-2012; Engel, Andreas/E-3100-2014	Mulvaney, Robert/0000-0002-5372-8148; Shine, Keith P/0000-0003-2672-9978; Engel, Andreas/0000-0003-0557-3935				Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; Christidis N, 1997, J GEOPHYS RES-ATMOS, V102, P19597, DOI 10.1029/97JD01137; DUDHIA A, 1997, POMAOXFGS0003 ESA U; Engel A, 1997, J ATMOS CHEM, V27, P107, DOI 10.1023/A:1005781919448; Fabre A, 2000, GEOPHYS RES LETT, V27, P557, DOI 10.1029/1999GL010780; Fraser PJ, 1999, J GEOPHYS RES-ATMOS, V104, P15985, DOI 10.1029/1999JD900113; Freckleton RS, 1998, Q J ROY METEOR SOC, V124, P2099, DOI 10.1002/qj.49712455014; FULLER EN, 1966, IND ENG CHEM, V58, P19, DOI 10.1021/ie50677a007; GOODWIN JWL, 1999, UK EMISSIONS AIR POL; MAISS M, 1994, GEOPHYS RES LETT, V21, P569, DOI 10.1029/94GL00179; Maiss M, 1998, ENVIRON SCI TECHNOL, V32, P3077, DOI 10.1021/es9802807; PINNOCK S, 1995, J GEOPHYS RES-ATMOS, V100, P23227, DOI 10.1029/95JD02323; RAVISHANKARA AR, 1993, SCIENCE, V259, P194, DOI 10.1126/science.259.5092.194; SCHWANDER J, 1993, J GEOPHYS RES-ATMOS, V98, P2831, DOI 10.1029/92JD02383; Strunk M, 2000, GEOPHYS RES LETT, V27, P341, DOI 10.1029/1999GL011044; Volk CM, 1997, J GEOPHYS RES-ATMOS, V102, P25543, DOI 10.1029/97JD02215; *WORLD MET ORG, 1998, 44 WORLD MET ORG	17	130	136	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2000	289	5479					611	613		10.1126/science.289.5479.611	http://dx.doi.org/10.1126/science.289.5479.611			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915622				2022-12-28	WOS:000088447800051
J	Massad, LS				Massad, LS			Missed connections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		GREGG J, 1994, SOC SCI MED, V39, P519, DOI 10.1016/0277-9536(94)90094-9; Jennings K M, 1997, Oncol Nurs Forum, V24, P827; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; LACEY L, 1993, CANCER, V72, P1078, DOI 10.1002/1097-0142(19930801)72:3+<1078::AID-CNCR2820721323>3.0.CO;2-7	4	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					409	410		10.1001/jama.284.4.409	http://dx.doi.org/10.1001/jama.284.4.409			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904482				2022-12-28	WOS:000088254200001
J	Ibanescu, M; Fink, Y; Fan, S; Thomas, EL; Joannopoulos, JD				Ibanescu, M; Fink, Y; Fan, S; Thomas, EL; Joannopoulos, JD			An all-dielectric coaxial waveguide	SCIENCE			English	Article							GUIDANCE; LIGHT; AIR	An all-dielectric coaxial waveguide that can overcome problems of polarization rotation and pulse broadening in the transmission of optical Light is presented here. It consists of a coaxial waveguiding region with a Low index of refraction, bounded by two cylindrical, dielectric, multilayer, omnidirectional reflecting mirrors. The waveguide can be designed to support a single mode whose properties are very similar to the unique transverse electromagnetic mode of a traditional metallic coaxial cable. The new mode has radial symmetry and a point of zero dispersion. Moreover, because the Light is not confined by total internal reflection, the waveguide can guide Light around very sharp corners.	MIT, Ctr Mat Sci & Engn, Cambridge, MA 02139 USA; MIT, Dept Phys, Cambridge, MA 02139 USA; MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ibanescu, M (corresponding author), MIT, Ctr Mat Sci & Engn, Cambridge, MA 02139 USA.		Joannopoulos, John D/E-6401-2013; Fan, Shanhui/B-4659-2012	Thomas, Edwin/0000-0001-5911-6524				Cregan RF, 1999, SCIENCE, V285, P1537, DOI 10.1126/science.285.5433.1537; Cronin N. J., 1995, MICROWAVE OPTICAL WA; Fink Y, 1998, SCIENCE, V282, P1679, DOI 10.1126/science.282.5394.1679; Fink Y, 1999, J LIGHTWAVE TECHNOL, V17, P2039, DOI 10.1109/50.802992; Knight JC, 1998, SCIENCE, V282, P1476, DOI 10.1126/science.282.5393.1476; MATSUURA Y, 1997, J OPT SOC AM, V14, P6; Meade RD, 1997, PHYS REV B, V55, P15942, DOI 10.1103/PhysRevB.55.15942; MILLER SE, 1979, OPTICAL FIBER TELECO; MIYAGI M, 1983, APPL PHYS LETT, V43, P430, DOI 10.1063/1.94377; Saleh B.E.A., 2007, FUNDAMENTALS PHOTONI, V2nd; TRANTER CJ, 1969, BESSEL FUNCTIONS SOM; WALDRON RA, 1969, THEORY GUIDED ELECTR; Yariv A., 1997, OPTICAL ELECT MODERN; YEH P, 1978, J OPT SOC AM, V68, P1196, DOI 10.1364/JOSA.68.001196	14	269	300	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					415	419		10.1126/science.289.5478.415	http://dx.doi.org/10.1126/science.289.5478.415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903194				2022-12-28	WOS:000088305500036
J	Thomas, R; Akins, T; Csatho, B; Fahnestock, M; Gogineni, P; Kim, C; Sonntag, J				Thomas, R; Akins, T; Csatho, B; Fahnestock, M; Gogineni, P; Kim, C; Sonntag, J			Mass balance of the Greenland ice sheet at high elevations	SCIENCE			English	Article								Comparison of ice discharge from higher elevation areas of the entire Greenland Ice Sheet with total snow accumulation gives estimates of ice thickening rates over the past few decades. On average, the region has been in balance, but with thickening of 21 centimeters per year in the southwest and thinning of 30 centimeters per year in the southeast. The north of the ice sheet shows Less variability, with average thickening of 2 centimeters per year in the northeast and thinning of about 5 centimeters per year in the northwest. These results agree well with those from repeated altimeter surveys, except in the extreme south, where we find substantially higher rates of both thickening and thinning.	EG&G Serv, Wallops Flight Facil, Wallops Island, VA 23337 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA; Univ Maryland, ESSIC, College Pk, MD 20742 USA; Univ Kansas, Radar Syst & Remote Sensing Lab, Lawrence, KS 66045 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University System of Ohio; Ohio State University; University System of Maryland; University of Maryland College Park; University of Kansas	Thomas, R (corresponding author), EG&G Serv, Wallops Flight Facil, Bldg N-159, Wallops Island, VA 23337 USA.		Kim, Changjoo/B-9362-2008; Fahnestock, Mark/N-2678-2013					ABDALATI W, 1998, ARCTIC RES US, V12, P38; [Anonymous], COMMUNICATION; Davis CH, 1998, SCIENCE, V279, P2086, DOI 10.1126/science.279.5359.2086; Gogineni S, 1998, J GLACIOL, V44, P659, DOI 10.3189/S0022143000002161; HUYBRECHTS P, 1994, GLOBAL PLANET CHANGE, V9, P39, DOI 10.1016/0921-8181(94)90006-X; HUYBRECTHS P, 1996, ANN GLACIOL, V10, P226; Krabill W, 2000, SCIENCE, V289, P428, DOI 10.1126/science.289.5478.428; Krabill W, 1999, SCIENCE, V283, P1522, DOI 10.1126/science.283.5407.1522; MCCONNELL J, 2000, MILL C EARTH PLAN SO; OHMURA A, 1991, J GLACIOL, V37, P140; Thomas RH, 1998, J GLACIOL, V44, P653, DOI 10.3189/S002214300000215X	11	70	73	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					426	428		10.1126/science.289.5478.426	http://dx.doi.org/10.1126/science.289.5478.426			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903197	Green Submitted			2022-12-28	WOS:000088305500039
J	Xu, GY; Aeppli, G; Bisher, ME; Broholm, C; DiTusa, JF; Frost, CD; Ito, T; Oka, K; Paul, RL; Takagi, H; Treacy, MMJ				Xu, GY; Aeppli, G; Bisher, ME; Broholm, C; DiTusa, JF; Frost, CD; Ito, T; Oka, K; Paul, RL; Takagi, H; Treacy, MMJ			Holes in a quantum spin liquid	SCIENCE			English	Article							TRANSITION-METAL OXIDE; HALDANE-GAP; HEISENBERG CHAIN; FLUCTUATIONS; DYNAMICS; Y2BANIO5; ANTIFERROMAGNETS; SYSTEMS; STATES	Magnetic neutron scattering provides evidence for nucleation of antiferromagnetic droplets around impurities in a doped nickel oxide-based quantum magnet. The undoped parent compound contains a spin Liquid with a cooperative singlet ground state and a gap in the magnetic excitation spectrum. Calcium doping creates excitations below the gap with an incommensurate structure factor. We show that weakly interacting antiferromagnetic droplets with a central phase shift of pi and a size controlled by the correlation Length of the quantum Liquid can account for the data. The experiment provides a quantitative impression of the magnetic polarization cloud associated with holes in a doped transition metal oxide.	Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; NEC Res Inst, Princeton, NJ 08540 USA; Natl Inst Stand & Technol, Ctr Neutron Res, Gaithersburg, MD 20899 USA; Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA; Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England; Electrotech Lab, Tsukuba, Ibaraki 305, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Tokyo 1138656, Japan	Johns Hopkins University; NEC Corporation; National Institute of Standards & Technology (NIST) - USA; Louisiana State University System; Louisiana State University; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Broholm, C (corresponding author), Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA.		Broholm, Collin Leslie/E-8228-2011; TAKAGI, HIDENORI/Q-1041-2019; Oka, Kunihiko/L-6888-2018; Takagi, Hidenori/B-2935-2010; Ito, Toshimitsu/K-8543-2012; Xu, Guangyong/A-8707-2010	Broholm, Collin Leslie/0000-0002-1569-9892; TAKAGI, HIDENORI/0000-0001-5700-3761; Oka, Kunihiko/0000-0002-0159-124X; Ito, Toshimitsu/0000-0003-2094-2807; Xu, Guangyong/0000-0003-1441-8275				AHARONY A, 1988, PHYS REV LETT, V60, P1330, DOI 10.1103/PhysRevLett.60.1330; CHEN CH, 1993, PHYS REV LETT, V71, P2461, DOI 10.1103/PhysRevLett.71.2461; CHEONG SW, 1991, PHYS REV LETT, V67, P1791, DOI 10.1103/PhysRevLett.67.1791; Dagotto E, 1996, PHYS REV LETT, V76, P1731, DOI 10.1103/PhysRevLett.76.1731; DARRIET J, 1993, SOLID STATE COMMUN, V86, P409, DOI 10.1016/0038-1098(93)90455-V; DITUSA JF, 1994, PHYSICA B, V194, P181, DOI 10.1016/0921-4526(94)90420-0; DITUSA JF, 1994, PHYS REV LETT, V73, P1857, DOI 10.1103/PhysRevLett.73.1857; EMERY VJ, 1988, PHYS REV B, V38, P4547, DOI 10.1103/PhysRevB.38.4547; FUJIMOTO S, 1995, PHYS REV B, V52, P6189, DOI 10.1103/PhysRevB.52.6189; HALDANE FDM, 1983, PHYS LETT A, V93, P464, DOI 10.1016/0375-9601(83)90631-X; HAYDEN SM, 1992, PHYS REV LETT, V68, P1061, DOI 10.1103/PhysRevLett.68.1061; Hyman RA, 1996, PHYS REV LETT, V76, P839, DOI 10.1103/PhysRevLett.76.839; KENNEDY T, 1990, J PHYS-CONDENS MAT, V2, P5737, DOI 10.1088/0953-8984/2/26/010; KOJIMA K, 1995, PHYS REV LETT, V74, P3471, DOI 10.1103/PhysRevLett.74.3471; Lee SH, 1997, PHYS REV LETT, V79, P2514, DOI 10.1103/PhysRevLett.79.2514; LU ZY, 1995, PHYS REV LETT, V74, P4297, DOI 10.1103/PhysRevLett.74.4297; Mook HA, 1998, NATURE, V395, P580, DOI 10.1038/26931; PENC K, 1995, PHYS REV B, V52, pR715, DOI 10.1103/PhysRevB.52.R715; Sakaguchi T, 1996, J PHYS SOC JPN, V65, P3025, DOI 10.1143/JPSJ.65.3025; SORENSEN ES, 1995, PHYS REV B, V51, P16115, DOI 10.1103/PhysRevB.51.16115; TRANQUADA JM, 1994, PHYS REV LETT, V73, P1003, DOI 10.1103/PhysRevLett.73.1003; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; WHITE SR, 1993, PHYS REV B, V48, P3844, DOI 10.1103/PhysRevB.48.3844; Xu GY, 1996, PHYS REV B, V54, pR6827, DOI 10.1103/PhysRevB.54.R6827	25	62	63	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					419	422		10.1126/science.289.5478.419	http://dx.doi.org/10.1126/science.289.5478.419			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903195	Green Submitted			2022-12-28	WOS:000088305500037
J	Sidebottom, C; Buckley, S; Pudney, P; Twigg, S; Jarman, C; Holt, C; Telford, J; McArthur, A; Worrall, D; Hubbard, R; Lillford, P				Sidebottom, C; Buckley, S; Pudney, P; Twigg, S; Jarman, C; Holt, C; Telford, J; McArthur, A; Worrall, D; Hubbard, R; Lillford, P			Phytochemistry - Heat-stable antifreeze protein from grass	NATURE			English	Article							ICE; RECRYSTALLIZATION; MECHANISM		Unilever Res, Colworth House, Sharnbrook MK44 1LQ, Beds, England; Univ York, Dept Biol, Plant Lab, York YO1 5YW, N Yorkshire, England	Unilever; University of York - UK	Sidebottom, C (corresponding author), Unilever Res, Colworth House, Sharnbrook MK44 1LQ, Beds, England.	Chris.Sidebottom@unilever.com	pudney, paul/R-6733-2019	Worrall, Dawn/0000-0002-9062-7987				ARRONDO JLR, 1988, BIOCHIM BIOPHYS ACTA, V952, P261, DOI 10.1016/0167-4838(88)90125-2; Duman John G., 1993, Advances in Low-Temperature Biology, V2, P131; FEENEY RE, 1993, FOOD TECHNOL-CHICAGO, V47, P82; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Graham LA, 1997, NATURE, V388, P727, DOI 10.1038/41908; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; Hall DG, 1999, LANGMUIR, V15, P1905, DOI 10.1021/la980657m; KNIGHT CA, 1984, NATURE, V308, P295, DOI 10.1038/308295a0; KNIGHT CA, 1991, BIOPHYS J, V59, P409, DOI 10.1016/S0006-3495(91)82234-2; Li N, 1998, J EXP BIOL, V201, P2243; Li N, 1998, ARCH BIOCHEM BIOPHYS, V360, P25, DOI 10.1006/abbi.1998.0930; Thomashow M. F., 1990, Advances in Genetics, V28, P99; Worrall D, 1998, SCIENCE, V282, P115, DOI 10.1126/science.282.5386.115	13	207	243	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					256	256		10.1038/35018639	http://dx.doi.org/10.1038/35018639			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917518				2022-12-28	WOS:000088251900036
J	Bao, HM; Thiemens, MH; Farquhar, J; Campbell, DA; Lee, CCW; Heine, K; Loope, DB				Bao, HM; Thiemens, MH; Farquhar, J; Campbell, DA; Lee, CCW; Heine, K; Loope, DB			Anomalous O-17 compositions in massive sulphate deposits on the Earth	NATURE			English	Article							ISOTOPE; OXYGEN; ATMOSPHERE; DELTA-O-17; PALEOSOLS; OZONE	The variation of delta(18)O that results from nearly all physical, biological and chemical processes on the Earth is approximately twice as large as the variation of delta(17)O. This so-called 'mass-dependent' fractionation is well documented in terrestrial minerals(1,2). Evidence for 'mass- independent' fractionation (Delta(17)O = delta(17)O-0.52 delta(18)O), where deviation from this tight relationship occurs, has so far been found only in meteoritic material and a few terrestrial atmospheric substances(3). In the rock record it is thought that oxygen isotopes have followed a mass-dependent relationship for at least the past 3.7 billion years (ref. 4), and no exception to this has been encountered for terrestrial solids(5). Here, however, we report oxygen-isotope values of two massive sulphate mineral deposits, which formed in surface environments on the Earth but show large isotopic anomalies (Delta(17)O up to 4.6 parts per thousand). These massive sulphate deposits are gypcretes from the central Namib Desert and the sulphate-bearing Miocene volcanic ash-beds in North America. The source of this isotope anomaly might be related to sulphur oxidation reactions in the atmosphere and therefore enable tracing of such oxidation. These findings also support the possibility of a chemical origin of variable isotope anomalies on other planets, such as Mars(6).	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Regensburg, Inst Geog, D-93053 Regensburg, Germany; Univ Nebraska, Dept Geosci, Lincoln, NE 68588 USA	University of California System; University of California San Diego; University of Regensburg; University of Nebraska System; University of Nebraska Lincoln	Bao, HM (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Mail Code 0356, La Jolla, CA 92093 USA.	hbao@chem.ucsd.edu	Bao, Huiming/C-1069-2012					ARMSTRONG RL, 1991, J GEOPHYS RES-SOLID, V96, P13201, DOI 10.1029/91JB00412; BAO H, IN PRESS ANAL CHEM; Berner RA, 2000, SCIENCE, V287, P1630, DOI 10.1126/science.287.5458.1630; BHATTACHARYA SK, 1989, Z NATURFORSCH A, V44, P435; CERLING TE, 1991, AM J SCI, V291, P377, DOI 10.2475/ajs.291.4.377; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; Clayton RN, 1996, GEOCHIM COSMOCHIM AC, V60, P1999, DOI 10.1016/0016-7037(96)00074-9; CLAYTON RN, 1983, EARTH PLANET SC LETT, V62, P1, DOI 10.1016/0012-821X(83)90066-3; Eckardt FD, 1999, SEDIMENT GEOL, V123, P255, DOI 10.1016/S0037-0738(98)00137-7; Farquhar J, 2000, J GEOPHYS RES-PLANET, V105, P11991, DOI 10.1029/1999JE001194; Farquhar J, 1998, SCIENCE, V280, P1580, DOI 10.1126/science.280.5369.1580; FORREST J, 1977, ANAL CHEM, V49, P1579, DOI 10.1021/ac50019a030; Gamsjager H., 1983, ADV INORG BIOINORG, V2, P317; Johnston JC, 1997, J GEOPHYS RES-ATMOS, V102, P25395, DOI 10.1029/97JD02075; KARLSSON KR, 1992, SCIENCE, V255, P1409, DOI 10.1126/science.11537889; KRANKOWSKY D, 1995, GEOPHYS RES LETT, V22, P1713, DOI 10.1029/95GL01436; Lee C. W., 1998, AM GEOPHYS UNION, V79, pF91; LEE CW, 1997, AM GEOPHYSICAL UNION, V78, pF111; MATSUHISA Y, 1978, GEOCHIM COSMOCHIM AC, V42, P173, DOI 10.1016/0016-7037(78)90130-8; MAUERSBERGER K, 1987, GEOPHYS RES LETT, V14, P80, DOI 10.1029/GL014i001p00080; NICKNISH J.M., 1962, BASAL MIOCENE ASH WH, V46, P685; ROBERT F, 1992, EARTH PLANET SC LETT, V108, P1, DOI 10.1016/0012-821X(92)90055-Z; ROSE WI, 1980, AM J SCI, V280, P671, DOI 10.2475/ajs.280.8.671; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; Savarino J, 1999, ATMOS ENVIRON, V33, P3683, DOI 10.1016/S1352-2310(99)00122-3; SIESSER WG, 1980, SCIENCE, V208, P283, DOI 10.1126/science.208.4441.283; SWISHER CC, 1982, THESIS U NEBRASKA; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341	28	87	93	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					176	178		10.1038/35018052	http://dx.doi.org/10.1038/35018052			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910354				2022-12-28	WOS:000088221100044
J	von Dassow, G; Meir, E; Munro, EM; Odell, GM				von Dassow, G; Meir, E; Munro, EM; Odell, GM			The segment polarity network is a robust developmental module	NATURE			English	Article							CUBITUS-INTERRUPTUS PROTEIN; FUSHI-TARAZU; EMBRYONIC EXPRESSION; GENE-EXPRESSION; DROSOPHILA; PATTERN; CONSERVATION; EVOLUTION; TARGET; CELLS	All insects possess homologous segments, but segment specification differs radically among insect orders. In Drosophila, maternal morphogens control the patterned activation of gap genes, which encode transcriptional regulators that shape the patterned expression of pair-rule genes. This patterning cascade takes place before cellularization. Pair-rule gene products subsequently 'imprint' segment polarity genes with reiterated patterns, thus defining the primordial segments. This mechanism must be greatly modified in insect groups in which many segments emerge only after cellularization(1). In beetles,and parasitic wasps, for instance, pair-rule homologues are expressed in patterns consistent with roles during segmentation, but these patterns emerge within cellular fields(2-4). In contrast, although in locusts pair-rule homologues may not control segmentation(5,6), some segment polarity genes and their interactions are conserved(3,7-10). Perhaps segmentation is modular, with each module autonomously expressing a characteristic intrinsic behaviour in response to transient stimuli. If so, evolution could rearrange inputs to modules without changing their intrinsic behaviours. Here we suggest, using computer simulations, that the Drosophila segment polarity genes constitute such a module, and that this module is resistant to variations in the kinetic constants that govern its behaviour.	Univ Washington, Dept Zool, Box 351800, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	von Dassow, G (corresponding author), Univ Washington, Dept Zool, Box 351800, Seattle, WA 98195 USA.	dassow@u.washington.edu		Meir, Eli/0000-0002-1874-1750				AKAM M, 1987, DEVELOPMENT, V101, P1; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; ARIAS AM, 1988, DEVELOPMENT, V103, P157; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BROWN SJ, 1994, DEV GENET, V15, P7, DOI 10.1002/dvg.1020150103; BROWN SJ, 1994, P NATL ACAD SCI USA, V91, P12922, DOI 10.1073/pnas.91.26.12922; Brown SJ, 1997, MECH DEVELOP, V61, P165, DOI 10.1016/S0925-4773(96)00642-9; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; DAWES R, 1994, DEVELOPMENT, V120, P1561; DINARDO S, 1994, CURR OPIN GENET DEV, V4, P529, DOI 10.1016/0959-437X(94)90068-E; DINARDO S, 1988, NATURE, V332, P604, DOI 10.1038/332604a0; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; Grbic M, 1996, DEVELOPMENT, V122, P795; HEEMSKERK J, 1991, NATURE, V352, P404, DOI 10.1038/352404a0; HOOPER JE, 1994, NATURE, V372, P461, DOI 10.1038/372461a0; INGHAM PW, 1988, NATURE, V331, P73, DOI 10.1038/331073a0; Kauffman S.A., 1993, ORIGINS ORDER; Morton-Firth CJ, 1999, J MOL BIOL, V286, P1059, DOI 10.1006/jmbi.1999.2535; NAGY LM, 1994, NATURE, V367, P460, DOI 10.1038/367460a0; Oppenheimer DI, 1999, CURR BIOL, V9, P1288, DOI 10.1016/S0960-9822(00)80050-0; PATEL NH, 1994, DEVELOPMENT, P201; PATEL NH, 1989, DEVELOPMENT, V107, P201; PATEL NH, 1992, NATURE, V357, P339, DOI 10.1038/357339a0; Sanchez L, 1997, J THEOR BIOL, V189, P377, DOI 10.1006/jtbi.1997.0523; SCHWARTZ C, 1995, DEVELOPMENT, V121, P1625; Slack JMW, 1983, EGG EMBRYO DETERMINA; TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635; VINCENT JP, 1994, CELL, V77, P909, DOI 10.1016/0092-8674(94)90139-2; VonOhlen T, 1997, P NATL ACAD SCI USA, V94, P2404, DOI 10.1073/pnas.94.6.2404	30	821	854	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					188	192		10.1038/35018085	http://dx.doi.org/10.1038/35018085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910359				2022-12-28	WOS:000088221100049
J	Senior, K				Senior, K			Abnormal neurokinin B concentrations may cause pre-eclampsia	LANCET			English	News Item																		Page NM, 2000, NATURE, V405, P797, DOI 10.1038/35015579	1	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2140	2140		10.1016/S0140-6736(05)72769-0	http://dx.doi.org/10.1016/S0140-6736(05)72769-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902635				2022-12-28	WOS:000087687100022
J	Kruger, DH; Schneck, P; Gelderblom, HR				Kruger, DH; Schneck, P; Gelderblom, HR			Helmut Ruska and the visualisation of viruses	LANCET			English	Article							ELECTRON-MICROSCOPY		Humboldt Univ, Charite Med Sch, Dept Virol, D-10098 Berlin, Germany; Robert Koch Inst, D-13353 Berlin, Germany; Humboldt Univ, Charite Med Sch, Dept Med Hist, D-10098 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kruger, DH (corresponding author), Humboldt Univ, Charite Med Sch, Dept Virol, D-10098 Berlin, Germany.	detlev.kruger@charite.de						Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/bf02956173, DOI 10.1007/BF02956173, 10.1007/ BF02956173]; Beijerinck M. W., 1898, VERSL GEWONE VERGAD, V7, P229; Biel SS, 1999, J CLIN VIROL, V13, P105, DOI 10.1016/S1386-6532(99)00027-X; BRUCHE E, 1940, NATURWISSENSCHAFTEN, V28, P113; Cairns J., 1966, PHAGE ORIGINS MOL BI; d'Herelle F, 1917, CR HEBD ACAD SCI, V165, P373; Frosch P., 1898, ZTBL BAKT PARASITKDE, V23, P371; HAWKES PW, 1985, ADV ELECT ELECT PH S, V16, P589; Hooke R., 1665, MICROGRAPHIA; Kausche GA, 1939, NATURWISSENSCHAFTEN, V27, P292, DOI 10.1007/BF01493353; Koch R., 1912, GESAMMELTE WERKE R K; Leeuwenhoek A.V, 1695, ARCANA NATURAE DETEC; Marton L, 1934, NATURE, V133, P911, DOI 10.1038/133911b0; MURPHY FA, 1995, ARCH VIROL S, V10; Rudenberg R, 1943, J APPL PHYS, V14, P434, DOI 10.1063/1.1715011; RUSKA E, 1986, J ULTRA MOL STRUCT R, V95, P3, DOI 10.1016/0889-1605(86)90025-X; Ruska E., 1980, EARLY DEV ELECT LENS; Ruska H, 1939, NATURWISSENSCHAFTEN, V27, P287, DOI 10.1007/BF01493352; Ruska H., 1943, ARCH GES VIRUSFORSCH, V2, P480, DOI 10.1007/BF01244584; Ruska H, 1940, NATURWISSENSCHAFTEN, V28, P45, DOI DOI 10.1007/BF01486931; RUSKA H, 1942, KLIN WOCHENSCHR, V22, P703; Ruska H., 1940, ARCH GES VIRUSFORSCH, V1, P155; Twort FW, 1915, LANCET, V2, P1241, DOI 10.1016/s0140-6736(01)20383-3; VANZUYLEN J, 1981, J MICROSC-OXFORD, V121, P309, DOI 10.1111/j.1365-2818.1981.tb01227.x; von Ardenne M, 1940, NATURWISSENSCHAFTEN, V28, P113, DOI 10.1007/BF01481089; von Borries B., 1938, KLIN WOCHENSCHR, V17, P921, DOI [10.1007/BF01775798, DOI 10.1007/BF01775798]; Waterson A. P., 1978, INTRO HIST VIROLOGY; WOLPERS C, 1991, ADV ELECTRON EL PHYS, V81, P211; Zaitlin M, 1999, ASM NEWS, V65, P675	29	46	47	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2000	355	9216					1713	1717		10.1016/S0140-6736(00)02250-9	http://dx.doi.org/10.1016/S0140-6736(00)02250-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905259				2022-12-28	WOS:000086983800039
J	Walker, RW; McLarty, DG; Kitange, HM; Whiting, D; Masuki, G; Mtasiwa, DM; Machibya, H; Unwin, N; Alberti, KGMM				Walker, RW; McLarty, DG; Kitange, HM; Whiting, D; Masuki, G; Mtasiwa, DM; Machibya, H; Unwin, N; Alberti, KGMM		Adult Morbitiy Mortality Project	Stroke mortality in urban and rural Tanzania	LANCET			English	Article							CORONARY HEART-DISEASE; SUB-SAHARAN AFRICA; BLOOD-PRESSURE; VERBAL AUTOPSIES; BLACK-PEOPLE; RISK-FACTORS; HYPERTENSION; CHILDHOOD; ZIMBABWE; DEATHS	Background Most data for stroke mortality in sub-Saharan Africa are hospital based. We aimed to establish the contribution of cerebrovascular disease to all-cause mortality and cerebrovascular disease mortality rates in adults aged 15 years or more in one urban and two rural areas of Tanzania. Methods Regular censuses of the three surveillance populations consisting of 307 820 people (125 932 aged below 15 years and 181 888 aged 15 or more) were undertaken with prospective monitoring of all deaths arising in these populations between June 1, 1992 and May 31, 1995. Verbal autopsies were completed with relatives or carers of the deceased to assess. when possible. the cause of death. Findings During the 3-year observation period 11 975 deaths were recorded in the three surveillance areas, of which 7629 (64%) were in adults aged 15 years or more (4088 [54%] of these in men and 3541 [46%] in women). In the adults, 421 (5.5%) of the deaths were attributed to cerebrovascular disease, 225 (53%) of these in men and 196 (47%) in women. The yearly age-adjusted rates per 100 000 in the 15-64 year age group for the three project areas (urban, fairly prosperous rural, and poor rural, respectively) were 65 (95% CI 39-90), 44 (31-56), and 35 (22-48) for men. and 88 (48-128), 33 (22-43), and 27 (16-38) for women, as compared with the England and Wales (1993) rates of 10.8 (10.0-11.6) for men and 8.6 (7.9-9.3) for women. Interpretation We postulate that the high rates in Tanzania were due to untreated hypertension. Our study assessed mortality over a single time period and therefore it is not posible to comment on trends with time. However, ageing of the population is likely to lead to a very large increase in mortality from stroke in the future.	N Tyneside Gen Hosp, Dept Med, N Shields NE29 8NH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Sch Med, Dept Diabet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Minist Hlth, Dar Es Salaam, Tanzania; Adult Morbid & Moratl Project, Dar Es Salaam, Tanzania; Univ Newcastle Upon Tyne, Sch Med, Dept Epidemiol & Publ Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Walker, RW (corresponding author), N Tyneside Gen Hosp, Dept Med, Rake Lane, N Shields NE29 8NH, Tyne & Wear, England.			Unwin, Nigel/0000-0002-1368-1648; Whiting, David/0000-0001-9827-2896; Walker, Richard/0000-0003-3155-122X				ABEBE M, 1990, ETHIOPIAN MED J, V28, P53; Anker M, 1997, INT J EPIDEMIOL, V26, P1090, DOI 10.1093/ije/26.5.1090; BAMFORD J, 1986, BRIT MED J, V292, P1369, DOI 10.1136/bmj.292.6532.1369; BERTRAND E, 1995, E AFR MED J, V72, P37; BONITA R, 1984, AM J EPIDEMIOL, V120, P236, DOI 10.1093/oxfordjournals.aje.a113885; CELANI MG, 1994, BRIT MED J, V308, P1674, DOI 10.1136/bmj.308.6945.1674; CHANDRAMOHAN D, 1994, INT J EPIDEMIOL, V23, P213, DOI 10.1093/ije/23.2.213; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Cooper RS, 1998, BMJ-BRIT MED J, V316, P614, DOI 10.1136/bmj.316.7131.614; DENNIS MS, 1986, BRIT MED J, V293, P134, DOI 10.1136/bmj.293.6539.134; DENNIS MS, 1993, STROKE, V24, P796, DOI 10.1161/01.STR.24.6.796; Edwards R, 2000, J HYPERTENS, V18, P145, DOI 10.1097/00004872-200018020-00003; JOUBERT J, 1991, S AFR MED J, V80, P567; Kitange HM, 1996, BRIT MED J, V312, P216, DOI 10.1136/bmj.312.7025.216; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MATENGA J, 1986, BRIT MED J, V292, P1649, DOI 10.1136/bmj.292.6536.1649; MENSAH GA, 1994, J HUM HYPERTENS, V8, P799; Ministry of Health and AMMP team, 1997, POL IMPL AD MORB MOR; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; NISSINEN A, 1988, World Health Statistics Quarterly, V41, P141; *OFF NAT STAT, 1996, MORT STAT CAUS REV R; Osuntokun BO, 1994, HYPERTENS RES, V17, pS1; POULTER NR, 1990, BMJ-BRIT MED J, V300, P967, DOI 10.1136/bmj.300.6730.967; ROSMAN KD, 1986, STROKE, V17, P667, DOI 10.1161/01.STR.17.4.667; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; SWAI ABM, 1993, INT J EPIDEMIOL, V22, P651, DOI 10.1093/ije/22.4.651; WALKER R, 1994, T ROY SOC TROP MED H, V88, P609, DOI 10.1016/0035-9203(94)90193-7	27	153	156	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2000	355	9216					1684	1687		10.1016/S0140-6736(00)02240-6	http://dx.doi.org/10.1016/S0140-6736(00)02240-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905244				2022-12-28	WOS:000086983800011
J	Kaukonen, J; Juselius, JK; Tiranti, V; Kyttala, A; Zeviani, M; Comi, GP; Keranen, S; Peltonen, L; Suomalainen, A				Kaukonen, J; Juselius, JK; Tiranti, V; Kyttala, A; Zeviani, M; Comi, GP; Keranen, S; Peltonen, L; Suomalainen, A			Role of adenine nucleotide translocator 1 in mtDNA maintenance	SCIENCE			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL-DNA DELETIONS; MULTIPLE DELETIONS; GENETIC FEATURES; ADP/ATP CARRIER; MUSCLE; YEAST; EXPRESSION; MUTATIONS; DISORDER	Autosomal dominant progressive external ophthalmoplegia is a rare human disease that shows a Mendelian inheritance pattern, but is characterized by Large-scale mitochondrial DNA (mtDNA) deletions. We have identified two heterozygous missense mutations in the nuclear gene encoding the heart/skeletal muscle isoform of the adenine nucleotide translocator (ANT1) in five families and one sporadic patient. The familiar mutation substitutes a proline for a highly conserved alanine at position 114 in the ANT1 protein. The analogous mutation in yeast caused a respiratory defect. These results indicate that ANT has a role in mtDNA maintenance and that a mitochondrial disease can be caused by a dominant mechanism.	Natl Publ Hlth Inst, Dept Human Mol Genet, SF-00300 Helsinki, Finland; VTT Biotechnol, Espoo, Finland; Natl Neurol Inst C Besta, Dept Neurol Res, Div Biochem & Genet, Milan, Italy; Univ Milan, Osped Maggiore Policlin, Ist Ricovero & Cura Carattere Sci, Ist Clin Neurol,Ctr Dino Ferrari, Milan, Italy; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	Finland National Institute for Health & Welfare; VTT Technical Research Center Finland; IRCCS Istituto Neurologico Besta; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Suomalainen, A (corresponding author), Natl Publ Hlth Inst, Dept Human Mol Genet, Mannerheimintie 166, SF-00300 Helsinki, Finland.		Comi, Giacomo P/K-5702-2016; Tiranti, Valeria/AFN-5783-2022; Tiranti, Valeria/J-8233-2016; Zeviani, Massimo/AAU-2632-2021; Zeviani, Massimo/K-2891-2014	Comi, Giacomo P/0000-0002-1383-5248; Tiranti, Valeria/0000-0002-3584-7338; Tiranti, Valeria/0000-0002-3584-7338; Zeviani, Massimo/0000-0002-9067-5508; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195	Telethon [1180] Funding Source: Medline	Telethon(Fondazione Telethon)		BAKKER HD, 1993, J INHERIT METAB DIS, V16, P548, DOI 10.1007/BF00711678; Bauer MKA, 1999, J CELL BIOL, V147, P1493, DOI 10.1083/jcb.147.7.1493; BODENSTEINLANG J, 1989, FEBS LETT, V258, P22, DOI 10.1016/0014-5793(89)81606-0; Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329; Brustovetsky N, 1996, BIOCHEMISTRY-US, V35, P8483, DOI 10.1021/bi960833v; Carrozzo R, 1999, J NEUROL SCI, V170, P24, DOI 10.1016/S0022-510X(99)00193-8; Doerner A, 1997, FEBS LETT, V414, P258, DOI 10.1016/S0014-5793(97)01000-4; DRGON T, 1992, FEBS LETT, V304, P277, DOI 10.1016/0014-5793(92)80637-V; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721; JUSELILUS J, UNPUB; Kaukonen J, 1999, AM J HUM GENET, V65, P256, DOI 10.1086/302445; Kaukonen JA, 1996, AM J HUM GENET, V58, P763; Klingenberg M, 1976, ENZYMES BIOLOGICAL M, V3, P383; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Melberg A, 1996, MUSCLE NERVE, V19, P751; MORAES CT, 1991, AM J HUM GENET, V48, P492; Muller V, 1996, BIOCHEMISTRY-US, V35, P16132, DOI 10.1021/bi960667r; NELSON DR, 1993, J MOL BIOL, V230, P1159, DOI 10.1006/jmbi.1993.1233; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; Suomalainen A, 1997, ANN MED, V29, P235, DOI 10.3109/07853899708999341; Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; SUOMALAINEN A, UNPUB; SYVANEN AC, 1994, CLIN CHIM ACTA, V226, P225, DOI 10.1016/0009-8981(94)90217-8; TIRANTI V, UNPUB; Toikkanen J, 1996, YEAST, V12, P425, DOI 10.1002/(SICI)1097-0061(199604)12:5<425::AID-YEA924>3.3.CO;2-2; VIOLA AM, 1995, CURR GENET, V27, P229, DOI 10.1007/BF00326153; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896; YOUNG P, 1994, BIOCHEM BIOPH RES CO, V203, P46, DOI 10.1006/bbrc.1994.2146; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	37	465	476	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					782	785		10.1126/science.289.5480.782	http://dx.doi.org/10.1126/science.289.5480.782			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926541				2022-12-28	WOS:000088581500042
J	Annas, GJ				Annas, GJ			Ulysses and the fate of frozen embryos - Reproduction, research, or destruction?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							POLITICS							Annas, George/0000-0001-5836-7831				Annas G J, 1986, Law Med Health Care, V14, P138; Annas GJ, 1999, NAT MED, V5, P1339, DOI 10.1038/70900; Annas GJ, 1996, NEW ENGL J MED, V334, P1329, DOI 10.1056/NEJM199605163342012; Annas GJ, 1998, NEW ENGL J MED, V339, P935, DOI 10.1056/NEJM199809243391325; CHAPMAN A, 1999, STEM CELL RES APPL M, pR9; Coleman CH, 1999, MINN LAW REV, V84, P55; Garrison M, 2000, HARVARD LAW REV, V113, P835, DOI 10.2307/1342435; HOMER T, 1996, ODYSSEY; *NAT BIOETH ADV CO, 1999, ETH ISS HUM STEM CEL, V1; Oghoetuoma JO, 2000, LANCET, V355, P1336, DOI 10.1016/S0140-6736(00)02122-X; Shuster E, 1997, NEW ENGL J MED, V337, P1436, DOI 10.1056/NEJM199711133372006; 1994, INFERNO DANTE NEW VE, P90	12	13	13	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2000	343	5					373	376		10.1056/NEJM200008033430519	http://dx.doi.org/10.1056/NEJM200008033430519			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340GR	10922428	Green Published			2022-12-28	WOS:000088525200028
J	Davidson, RJ; Putnam, KM; Larson, CL				Davidson, RJ; Putnam, KM; Larson, CL			Dysfunction in the neural circuitry of emotion regulation - A possible prelude to violence	SCIENCE			English	Review							POSITRON-EMISSION-TOMOGRAPHY; FLUID 5-HYDROXYINDOLEACETIC ACID; HUMAN AMYGDALA ACTIVATION; MEDIAL PREFRONTAL CORTEX; CEREBROSPINAL-FLUID; GLUCOSE-METABOLISM; FACIAL EXPRESSIONS; SEROTONERGIC RESPONSIVITY; TRYPTOPHAN DEPLETION; PERSONALITY-DISORDER	Emotion is normally regulated in the human brain by a complex circuit consisting of the orbital frontal cortex, amygdala, anterior cingulate cortex, and several other interconnected regions. There are both genetic and environmental contributions to the structure and function of this circuitry. We posit that impulsive aggression and violence arise as a consequence of faulty emotion regulation. Indeed, the prefrontal cortex receives a major serotonergic projection, which is dysfunctional in individuals who show impulsive violence. Individuals vulnerable to faulty regulation of negative emotion are at risk for violence and aggression. Research on the neural circuitry of emotion regulation suggests new avenues of intervention for such at-risk populations.	Univ Wisconsin, Lab Affect Neurosci, Madison, WI 53706 USA; Univ Wisconsin, WM Keck Lab Funct Brain Imaging & Behav, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Davidson, RJ (corresponding author), Univ Wisconsin, Lab Affect Neurosci, Madison, WI 53706 USA.	rjdavids@facstaff.wisc.edu	anand, amit/A-7222-2009	Davidson, Richard/0000-0002-8506-4964	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH043454, R01MH040747, R01MH043454, P50MH052354] Funding Source: NIH RePORTER; NIMH NIH HHS [P50-MH52354, MH43454, MH40747] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abercrombie HC, 1996, PSYCHOPHYSIOLOGY, V33, pS17; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; [Anonymous], 2000, SER AFFECTIVE SCI; Barratt ES, 1999, PSYCHIAT RES, V86, P163, DOI 10.1016/S0165-1781(99)00024-4; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Berkowitz L., 1999, HDB COGNITION EMOTIO, P411; BERKOWITZ L, IN PRESS HDB AFFECTI; Biver F, 1996, NEUROSCI LETT, V204, P25, DOI 10.1016/0304-3940(96)12307-7; Bjork JM, 1999, PSYCHOPHARMACOLOGY, V142, P24, DOI 10.1007/s002130050858; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; CHAMBERLAIN B, 1987, PHARMACOL BIOCHEM BE, V28, P503, DOI 10.1016/0091-3057(87)90513-2; CLEARE AJ, 1995, PSYCHOPHARMACOLOGY, V118, P72, DOI 10.1007/BF02245252; COCCARO EF, 1989, BRIT J PSYCHIAT, V155, P52, DOI 10.1192/S0007125000291769; Coccaro EF, 1997, ARCH GEN PSYCHIAT, V54, P1081; Davidson R.J., 2000, SER AFFECTIVE SCI, P106; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; DAVIDSON RJ, IN PRESS PSYCHOL B; Davidson RJ, 2000, HDB PSYCHOPHYSIOLOGY, P27; DAVIS M, 1992, P255; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; Dewey M. M., 1989, STRUCTURE HUMAN BRAI; Dougherty DD, 1999, BIOL PSYCHIAT, V46, P466, DOI 10.1016/S0006-3223(99)00063-3; Gewirtz JC, 1997, BEHAV NEUROSCI, V111, P712, DOI 10.1037/0735-7044.111.4.712; Globisch J, 1999, PSYCHOPHYSIOLOGY, V36, P66, DOI 10.1017/S0048577299970634; GOYER PF, 1994, NEUROPSYCHOPHARMACOL, V10, P21, DOI 10.1038/npp.1994.3; Higley JD, 1996, BIOL PSYCHIAT, V40, P1067, DOI 10.1016/S0006-3223(95)00675-3; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Irwin W, 1996, NEUROREPORT, V7, P1765, DOI 10.1097/00001756-199607290-00014; JACKSON DC, IN PRESS PSYCHOPHYSI; JACKSON DJC, UNPUB; KAPLAN JR, 1994, PSYCHOSOM MED, V56, P479, DOI 10.1097/00006842-199411000-00001; Kimbrell TA, 1999, BIOL PSYCHIAT, V46, P454, DOI 10.1016/S0006-3223(99)00103-1; KRUESI MJP, 1992, ARCH GEN PSYCHIAT, V49, P429; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Larson CL, 2000, PSYCHOPHYSIOLOGY, V37, P92, DOI 10.1017/S0048577200981344; LINNOILA M, 1983, LIFE SCI, V33, P2609, DOI 10.1016/0024-3205(83)90344-2; LINNOILA M, 1989, PSYCHOPHARMACOL BULL, V25, P404; Mann JJ, 1996, J CEREBR BLOOD F MET, V16, P418, DOI 10.1097/00004647-199605000-00008; Mann JJ, 1998, NAT MED, V4, P25, DOI 10.1038/nm0198-025; Manuck SB, 1999, BIOL PSYCHIAT, V45, P603, DOI 10.1016/S0006-3223(98)00375-8; Manuck SB, 1998, NEUROPSYCHOPHARMACOL, V19, P287, DOI 10.1038/sj.npp.1395199; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; MOSS HB, 1990, BIOL PSYCHIAT, V28, P325, DOI 10.1016/0006-3223(90)90660-T; NIELSEN DA, 1994, ARCH GEN PSYCHIAT, V51, P34; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Raine A, 1997, AM J PSYCHIAT, V154, P1265; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; RAINE A, 1994, BIOL PSYCHIAT, V36, P365, DOI 10.1016/0006-3223(94)91211-4; Raine A, 1997, BIOL PSYCHIAT, V42, P495, DOI 10.1016/S0006-3223(96)00362-9; Raine A, 1998, BEHAV SCI LAW, V16, P319, DOI 10.1002/(SICI)1099-0798(199822)16:3<319::AID-BSL311>3.0.CO;2-G; ROLLS ET, 1999, BRAIN EMOTION; ROY A, 1988, PSYCHIAT RES, V24, P187, DOI 10.1016/0165-1781(88)90061-3; SCHAEFER SM, IN PRESS NEUROSCI AB; Siever LJ, 1999, NEUROPSYCHOPHARMACOL, V20, P413, DOI 10.1016/S0893-133X(98)00111-0; Soloff PH, 2000, BIOL PSYCHIAT, V47, P540, DOI 10.1016/S0006-3223(99)00202-4; Sutton SK, 1997, PSYCHOPHYSIOLOGY, V34, P217, DOI 10.1111/j.1469-8986.1997.tb02135.x; VIRKKUNEN M, 1987, ARCH GEN PSYCHIAT, V44, P241; VIRKKUNEN M, 1994, ARCH GEN PSYCHIAT, V51, P20; VIRKKUNEN M, 1989, ARCH GEN PSYCHIAT, V46, P600; Volavka J, 1999, J CLIN PSYCHIAT, V60, P43; Volkow ND, 1995, PSYCHIAT RES-NEUROIM, V61, P243, DOI 10.1016/0925-4927(95)02671-J; VRANA SR, 1988, J ABNORM PSYCHOL, V97, P487, DOI 10.1037/0021-843X.97.4.487; Whalen PJ, 1998, J NEUROSCI, V18, P411; Woermann FG, 2000, J NEUROL NEUROSUR PS, V68, P162, DOI 10.1136/jnnp.68.2.162; WURTMAN RJ, 1980, PHARMACOL REV, V32, P315; [No title captured]	74	1296	1353	6	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2000	289	5479					591	594		10.1126/science.289.5479.591	http://dx.doi.org/10.1126/science.289.5479.591			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	338XD	10915615				2022-12-28	WOS:000088447800044
J	Klausner, JD; Wolf, W; Fischer-Ponce, L; Zolt, I; Katz, MH				Klausner, JD; Wolf, W; Fischer-Ponce, L; Zolt, I; Katz, MH			Tracing a syphilis outbreak through cyberspace	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELIMINATION	Context A recent outbreak of syphilis among users of an Internet chat room challenged traditional methods of partner notification and community education because locating information on sexual partners was limited to screen names and privacy concerns precluded identifying sexual partners through the Internet service provider. Objectives To determine the association of Internet use and acquisition of syphilis and to describe innovative methods of partner notification in cyberspace. Design, Setting, and Patients Outbreak investigation conducted at the San Francisco (Calif) Department of Public Health (SFDPH) in June-August 1999 of 7 cases of early syphilis among gay men linked to an online chat room; case-control study of 6 gay men with syphilis reported to SFDPH in July-August 1999 (cases) and 32 gay men without syphilis who presented to a city clinic in April-July 1999 (controls), Main Outcome Measures Association of syphilis infection with Internet use, Internet use among cases vs controls, and partner notification methods and partner evaluation indexes. Results During the outbreak, cases were significantly more likely than controls to have met their sexual partners through use of the Internet (67% vs 19%; odds ratio, 8.7; P=.03). We notified and confirmed testing for 42% of named partners; the mean number of sexual partners medically evaluated per index case was 5.9, Conclusions In this study, meeting sexual partners through the Internet was associated with acquisition of syphilis among gay men. Public health efforts must continually adapt disease control procedures to new venues, carefully weighing the rights to privacy vs the need to protect public health.	San Francisco Dept Publ Hlth, STD Serv, San Francisco, CA 94103 USA; Univ Calif San Francisco, Dept Med, Div AIDS & Oncol, San Francisco, CA USA; Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA USA	San Francisco Department of Public Health; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA	Klausner, JD (corresponding author), San Francisco Dept Publ Hlth, STD Serv, 1360 Mission St,Suite 401, San Francisco, CA 94103 USA.	jeff_klausner@dph.sf.ca.us						Cates W, 1996, SEX TRANSM DIS, V23, P68, DOI 10.1097/00007435-199601000-00013; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P45; *DEP PUBL HLTH, 1999, FACT SHEET; DOUGHERTY WJ, 1962, J MED SOC NEW JERSEY, V59, P564; Ekstrand ML, 1999, AIDS, V13, P1525, DOI 10.1097/00002030-199908200-00013; LELCHUK I, 1999, SAN FRANCISCO E 0826, pA1; MOORE MB, 1963, PUBLIC HEALTH REP, V78, P966, DOI 10.2307/4591989; NIEVES E, 1999, NY TIMES        0825, pA1; Richards E. P., 1999, SEXUALLY TRANSMITTED, P1441; ROTHENBERG RB, 1984, SEXUALLY TRANSMITTED, P970; *SAN FRANC DEP PUB, 2000, SAN FRANC MONTHL STD; *SAN FRANC DEP PUB, 1999, SAN FRANC SEX TRANSM; St Louis ME, 1998, SCIENCE, V281, P353, DOI 10.1126/science.281.5375.353; Williams LA, 1999, AM J PUBLIC HEALTH, V89, P1093, DOI 10.2105/AJPH.89.7.1093	14	228	231	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					447	+		10.1001/jama.284.4.447	http://dx.doi.org/10.1001/jama.284.4.447			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904507				2022-12-28	WOS:000088254200030
J	Summerfield, D				Summerfield, D			Conflict and health - War and mental health: a brief overview	BRITISH MEDICAL JOURNAL			English	Article							POSTTRAUMATIC-STRESS-DISORDER; POLITICAL VIOLENCE; ASIAN REFUGEES; LONG-TERM; CHILDREN; TRAUMA; TORTURE; RESPONSES; SURVIVORS; ATROCITY		Univ London St Georges Hosp, Sch Med, Dept Psychiat, London SW17 0RE, England	St Georges University London	Summerfield, D (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Psychiat, London SW17 0RE, England.							BASOGLU M, 1994, JAMA-J AM MED ASSOC, V272, P357, DOI 10.1001/jama.272.5.357; Berry J., 1992, CROSS CULTURAL PSYCH, P378; BRACKEN PJ, 1995, SOC SCI MED, V40, P1073, DOI 10.1016/0277-9536(94)00181-R; British Medical Association, 1992, MED BETR PART DOCT H; DAWES A, 1990, INT J PSYCHOL, V25, P13, DOI 10.1080/00207599008246811; EISENBRUCH M, 1991, SOC SCI MED, V33, P673, DOI 10.1016/0277-9536(91)90021-4; FARIAS PJ, 1991, CULT MED PSYCHIAT, V15, P167, DOI 10.1007/BF00119043; Freud A, 1943, WAR CHILDREN; Gorst-Unsworth C, 1998, BRIT J PSYCHIAT, V172, P90, DOI 10.1192/bjp.172.1.90; Hume F, 1994, Med War, V10, P4, DOI 10.1080/07488009408409136; LIN EHB, 1985, AM J PUBLIC HEALTH, V75, P1080, DOI 10.2105/AJPH.75.9.1080; LOUGHREY G, 1997, PSYCHOL TRAUMA DEV A, P156; LYKES MB, 1994, SOC SCI MED, V38, P543, DOI 10.1016/0277-9536(94)90250-X; McFarlane A. C., 1995, TRAUMA CULTURAL SOCI, P31; MCIVOR RJ, 1995, BRIT J PSYCHIAT, V166, P705, DOI 10.1192/bjp.166.6.705; MOLLICA RF, 1992, TORTURE ITS CONSEQUE, P253; PUNAMAKI RL, 1990, BRIT J SOC PSYCHOL, V29, P67, DOI 10.1111/j.2044-8309.1990.tb00887.x; RAPHAEL B, 1995, BRIT MED J, V310, P1479, DOI 10.1136/bmj.310.6993.1479; REYNOLDS P, 1990, AFRICA, V60, P1, DOI 10.2307/1160425; Richards P., 1998, RETHINKING TRAUMA WA; RICHMAN N, 1993, J CHILD PSYCHOL PSYC, V34, P1286, DOI 10.1111/j.1469-7610.1993.tb02092.x; SIVARD R, 1989, WORLD MILITARY SOCIA; SUMMERFIELD D, 1995, BRIT MED J, V311, P495, DOI 10.1136/bmj.311.7003.495; SUMMERFIELD D, 1993, J NERV MENT DIS, V181, P522, DOI 10.1097/00005053-199308000-00012; Summerfield D, 1996, J NERV MENT DIS, V184, P375, DOI 10.1097/00005053-199606000-00008; Summerfield D, 1999, SOC SCI MED, V48, P1449, DOI 10.1016/S0277-9536(98)00450-X; The Arms Project Human Rights Watch and Physicians for Human Rights, 1993, LANDM DEADL LEG	27	139	147	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 22	2000	321	7255					232	235		10.1136/bmj.321.7255.232	http://dx.doi.org/10.1136/bmj.321.7255.232			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	338XG	10903662	Green Published			2022-12-28	WOS:000088448100030
J	Mullan, F				Mullan, F			The case for more US medical students	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hlth Affairs, Bethesda, MD 20814 USA		Mullan, F (corresponding author), Hlth Affairs, Bethesda, MD 20814 USA.							*AM ASS COLL OST M, 1998, 1998 ANN STAT REP, P8; *ASS AM MED COLL, 1999, AAMC DAT BOOK, P9; COLLINS KS, 1999, US MINORITY HLTH CHA, P139; *COUNC GRAD MED ED, 1998, 12 DEP HLTH HUM SERV; *COUNC GRAD MED ED, 1999, 14 COGME; *COUNC GRAD MED ED, 1996, 8 COGME DEP HLTH HUM; DECKELBAUM R, 1999, CU DIRECTORS UPDATE, V1, P1; FODERARO LW, 1999, NY TIMES        0401, pA1; *GRAD MED ED NAT A, 1980, DHHS PUBL; MCGINN PR, 1999, AM MED NEWS     0426, P14; MCGINN PR, 1999, AM MED NEWS     0426, P12; MCGINN PR, 1999, AM MED NEWS     0426, P11; Miller RS, 1999, JAMA-J AM MED ASSOC, V282, P855, DOI 10.1001/jama.282.9.855; Miller RS, 1998, JAMA-J AM MED ASSOC, V280, P777, DOI 10.1001/jama.280.9.777; MITKA M, 1997, AM MED NEWS     0120, P1; *PEW HLTH PROF COM, 1994, ACH PHYS WORKF MIX 5	16	32	32	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2000	343	3					213	217		10.1056/NEJM200007203430312	http://dx.doi.org/10.1056/NEJM200007203430312			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335HY	10900285				2022-12-28	WOS:000088239100012
J	Sluder, G; McCollum, D				Sluder, G; McCollum, D			Molecular biology - The mad ways of meiosis	SCIENCE			English	Editorial Material							CHECKPOINT; MUTATIONS		Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Sluder, G (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA.							Basu J, 1999, J CELL BIOL, V146, P13, DOI 10.1083/jcb.146.1.13; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Hassold T, 1996, ENVIRON MOL MUTAGEN, V28, P167; Kitagawa R, 1999, NAT CELL BIOL, V1, P514, DOI 10.1038/70309; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300	6	11	11	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					254	255		10.1126/science.289.5477.254	http://dx.doi.org/10.1126/science.289.5477.254			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10917849				2022-12-28	WOS:000088169400029
J	Norman, C				Norman, C			HIV and Africa's future	SCIENCE			English	Editorial Material																			0	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2149	2149		10.1126/science.288.5474.2149	http://dx.doi.org/10.1126/science.288.5474.2149			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10896591				2022-12-28	WOS:000087782900030
J	Cumings, J; Zettl, A				Cumings, J; Zettl, A			Low-friction nanoscale linear bearing realized from multiwall carbon nanotubes	SCIENCE			English	Article							FORCE MICROSCOPY	We demonstrate the controlled and reversible telescopic extension of multiwall carbon nanotubes, thus realizing ultralow-friction nanoscale linear bearings and constant-force nanosprings. Measurements performed in situ on individual custom-engineered nanotubes inside a high-resolution transmission electron microscope demonstrated the anticipated van der Waals energy-based retraction force and enabled us to place quantitative limits on the static and dynamic interwall frictional forces between nested nanotubes. Repeated extension and retraction of telescoping nanotube segments revealed no wear or fatigue on the atomic scale. Hence, these nanotubes may constitute near perfect, wear-free surfaces.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zettl, A (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	azettl@physics.berkeley.edu	Cumings, John/A-3595-2012; Zettl, Alex K/O-4925-2016	Zettl, Alex K/0000-0001-6330-136X				Benedict LX, 1998, CHEM PHYS LETT, V286, P490, DOI 10.1016/S0009-2614(97)01466-8; Carpick RW, 1997, APPL PHYS LETT, V70, P1548, DOI 10.1063/1.118639; Crespi VH, 1999, AIP CONF PROC, V486, P364; CUMINGS J, IN PRESS NATURE; Enachescu M, 1998, PHYS REV LETT, V81, P1877, DOI 10.1103/PhysRevLett.81.1877; IIJIMA S, 1992, PHYS REV LETT, V69, P3100, DOI 10.1103/PhysRevLett.69.3100; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; KOLMOGOROV A, 2000, B AM PHYS SOC, V45, P254; Persson BNJ, 1999, SURF SCI REP, V33, P85; Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513; TRIMMER WS, 1997, MICROMECHANICS MEMS; Wagner HD, 1998, APPL PHYS LETT, V72, P188, DOI 10.1063/1.120680; Yu MF, 2000, SCIENCE, V287, P637, DOI 10.1126/science.287.5453.637	13	1157	1204	12	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2000	289	5479					602	604		10.1126/science.289.5479.602	http://dx.doi.org/10.1126/science.289.5479.602			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915618				2022-12-28	WOS:000088447800047
J	Colucci, WS; Elkayam, U; Horton, DP; Abraham, WT; Bourge, RC; Johnson, AD; Wagoner, LE; Givertz, MM; Liang, CS; Neibaur, M; Haught, WH				Colucci, WS; Elkayam, U; Horton, DP; Abraham, WT; Bourge, RC; Johnson, AD; Wagoner, LE; Givertz, MM; Liang, CS; Neibaur, M; Haught, WH		Nesiritide Study Grp	Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; INFUSION; TRIAL	Background: Intravenous infusion of nesiritide, a brain (B-type) natriuretic peptide, has beneficial hemodynamic effects in patients with decompensated congestive heart failure. We investigated the clinical use of nesiritide in such patients. Methods: Patients hospitalized because of symptomatic congestive heart failure were enrolled in either an efficacy trial or a comparative trial. In the efficacy trial, which required the placement of a Swan-Ganz catheter, 127 patients with a pulmonary-capillary wedge pressure of 18 mm Hg or higher and a cardiac index of 2.7 liters per minute per square meter of body-surface area or less were randomly assigned to double-blind treatment with placebo or nesiritide (infused at a rate of 0.015 or 0.030 mu g per kilogram of body weight per minute) for six hours. In the comparative trial, which did not require hemodynamic monitoring, 305 patients were randomly assigned to open-label therapy with standard agents or nesiritide for up to seven days. Results: In the efficacy trial, at six hours, nesiritide infusion at rates of 0.015 and 0.030 mu g per kilogram per minute decreased pulmonary-capillary wedge pressure by 6.0 and 9.6 mm Hg, respectively (as compared with an increase of 2.0 mm Hg with placebo, P<0.001), resulted in improvements in global clinical status in 60 percent and 67 percent of the patients (as compared with 14 percent of those receiving placebo, P<0.001), reduced dyspnea in 57 percent and 53 percent of the patients (as compared with 12 percent of those receiving placebo, P<0.001), and reduced fatigue in 32 percent and 38 percent of the patients (as compared with 5 percent of those receiving placebo, P<0.001). In the comparative trial, the improvements in global clinical status, dyspnea, and fatigue were sustained with nesiritide therapy for up to seven days and were similar to those observed with standard intravenous therapy for heart failure. The most common side effect was dose-related hypotension, which was usually asymptomatic. Conclusions: In patients hospitalized with decompensated congestive heart failure, nesiritide improves hemodynamic function and clinical status. Intravenous nesiritide is useful for the short-term treatment of decompensated congestive heart failure. (N Engl J Med 2000;343:246-53.) (C) 2000, Massachusetts Medical Society.	Univ So Calif, Sch Med, Los Angeles, CA USA; Scios, Dept Clin Res, Sunnyvale, CA USA; Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA; Univ Alabama, Birmingham, AL USA; Scripps Clin & Res Fdn, La Jolla, CA 92037 USA; Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Jacksonville Heart Ctr, Jacksonville, FL USA; Jacksonville Ctr Res, Jacksonville, FL USA; Albert Einstein Coll Med, Bronx, NY 10467 USA	University of Southern California; Scios; University System of Ohio; University of Cincinnati; University of Alabama System; University of Alabama Birmingham; Scripps Research Institute; University of Rochester; Yeshiva University; Albert Einstein College of Medicine	Colucci, WS (corresponding author), Boston Univ, Med Ctr, Sect Cardiovasc Med, 88 E Newton St, Boston, MA 02118 USA.			Colucci, Wilson/0000-0002-0576-9420; Liang, Chang-seng/0000-0002-0328-0277				Abraham W T, 1998, J Card Fail, V4, P37, DOI 10.1016/S1071-9164(98)90506-1; ANDERSON JL, 1986, AM HEART J, V111, P466, DOI 10.1016/0002-8703(86)90050-5; BRAUNWALD E, 1997, HEART DIS TXB CARDIO, V1, P445; Colucci WS, 1996, CIRCULATION, V94, P2800, DOI 10.1161/01.CIR.94.11.2800; HOLMES SJ, 1993, J CLIN ENDOCR METAB, V76, P91, DOI 10.1210/jc.76.1.91; Marcus LS, 1996, CIRCULATION, V94, P3184, DOI 10.1161/01.CIR.94.12.3184; Mills RM, 1999, J AM COLL CARDIOL, V34, P155, DOI 10.1016/S0735-1097(99)00184-9; PACKER M, 1987, NEW ENGL J MED, V317, P799, DOI 10.1056/NEJM198709243171304; STEVENSON LW, 1996, CARDIOVASCULAR THERA, P199; TISDALE JE, 1995, PROG CARDIOVASC DIS, V38, P167, DOI 10.1016/S0033-0620(05)80005-2; WEI CM, 1993, CIRCULATION, V88, P1004, DOI 10.1161/01.CIR.88.3.1004	11	650	727	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2000	343	4					246	253		10.1056/NEJM200007273430403	http://dx.doi.org/10.1056/NEJM200007273430403			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	337QC	10911006				2022-12-28	WOS:000088372300003
J	Mayor, S				Mayor, S			Lung cancer trial has problems in recruitment	BRITISH MEDICAL JOURNAL			English	News Item																		2000, THORAX, V55, P463	1	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 22	2000	321	7255					195	195						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903640				2022-12-28	WOS:000088448100011
J	Price, C				Price, C			Evidence for a link between global lightning activity and upper tropospheric water vapour	NATURE			English	Article							CLIMATE-CHANGE; SCHUMANN RESONANCE; TEMPERATURE; CIRCUIT; DATASET; CIRRUS	Tropospheric water vapour is a key element of the Earth's climate, which has direct effects as a greenhouse gas, as well as indirect effects through interaction with clouds, aerosols and tropospheric chemistry. Small changes in upper-tropospheric water vapour have a much larger impact on the greenhouse effect than small changes in water vapour in the lower atmosphere(1), but whether this impact is a positive or negative feedback remains uncertain(2-6). The main challenge in addressing this question is the difficulty in monitoring upper-tropospheric water vapour globally over long timescales. Here I show that upper-tropospheric water-vapour variability and global lightning activity are closely linked, suggesting that upper-tropospheric water-vapour changes can be inferred from records of global lightning activity, readily obtained from observations at a single location on the Earth's surface. This correlation reflects the fact that continental deep-convective thunderstorms transport large amounts of water vapour into the upper troposphere and thereby dominate the variations of global upper-tropospheric water vapour while producing most of the lightning on Earth. As global lightning induces Schumann resonances, an electromagnetic phenomenon in the atmosphere that can be observed easily at low cost, monitoring of these resonances might provide a convenient method for tracking upper-tropospheric water-vapour variability and hence contribute to a better understanding of the processes affecting climate change.	Tel Aviv Univ, Dept Geophys & Planetary Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University	Price, C (corresponding author), Tel Aviv Univ, Dept Geophys & Planetary Sci, Levanon Rd, IL-69978 Tel Aviv, Israel.	cprice@flash.tau.ac.il	Price, Colin/K-5117-2017					Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; Christian HJ, 1998, Q J ROY METEOR SOC, V124, P1771, DOI 10.1002/qj.49712454919; DELGENIO AD, 1994, GEOPHYS RES LETT, V21, P2701, DOI 10.1029/94GL02658; Fraser-Smith A.C., 1991, ENV SPACE ELECTROMAG, P191; Heckman SJ, 1998, J GEOPHYS RES-ATMOS, V103, P31775, DOI 10.1029/98JD02648; HOUZE RA, 1989, Q J ROY METEOR SOC, V115, P425, DOI 10.1002/qj.49711548702; Hu H, 1998, GEOPHYS RES LETT, V25, P3151, DOI 10.1029/98GL02252; Jensen EJ, 1999, GEOPHYS RES LETT, V26, P2347, DOI 10.1029/1999GL900266; KENT GS, 1995, J CLIMATE, V8, P2577, DOI 10.1175/1520-0442(1995)008<2577:STRVIT>2.0.CO;2; Lerner J., 1984, CLIMATE PROCESSES CL, V29, P130, DOI 10.1029/GM029p0130; LINDZEN RS, 1990, B AM METEOROL SOC, V71, P288, DOI 10.1175/1520-0477(1990)071<0288:SCCGW>2.0.CO;2; Markson R, 1999, ATMOS RES, V51, P309, DOI 10.1016/S0169-8095(99)00015-0; Newell RE, 1996, J GEOPHYS RES-ATMOS, V101, P1961, DOI 10.1029/95JD02275; OLTMANS SJ, 1995, NATURE, V374, P146, DOI 10.1038/374146a0; PRICE C, 1993, GEOPHYS RES LETT, V20, P1363, DOI 10.1029/93GL01774; PRICE C, 1994, J GEOPHYS RES-ATMOS, V99, P10823, DOI 10.1029/94JD00019; Randel DL, 1996, B AM METEOROL SOC, V77, P1233, DOI 10.1175/1520-0477(1996)077<1233:ANGWVD>2.0.CO;2; Read WG, 1995, B AM METEOROL SOC, V76, P2381, DOI 10.1175/1520-0477(1995)076<2381:UTWVFM>2.0.CO;2; Reeve N, 1999, Q J ROY METEOR SOC, V125, P893, DOI 10.1002/qj.49712555507; Rind D, 1998, SCIENCE, V281, P1152, DOI 10.1126/science.281.5380.1152; RIND D, 1991, NATURE, V349, P500, DOI 10.1038/349500a0; SCHUMANN WO, 1952, Z NATURFORSCH A, V7, P149, DOI 10.1515/zna-1952-0202; SODEN BJ, 1995, J CLIMATE, V8, P2333, DOI 10.1175/1520-0442(1995)008<2333:ASAODC>2.0.CO;2; SUN DZ, 1993, J ATMOS SCI, V50, P1643, DOI 10.1175/1520-0469(1993)050<1643:DOTTWV>2.0.CO;2; Sun DZ, 1996, J CLIMATE, V9, P665, DOI 10.1175/1520-0442(1996)009<0665:ACOMAO>2.0.CO;2; Susskind J, 1997, B AM METEOROL SOC, V78, P1449, DOI 10.1175/1520-0477(1997)078<1449:COTTPP>2.0.CO;2; TAKAHASHI T, 1990, GEOPHYS RES LETT, V17, P2381, DOI 10.1029/GL017i013p02381; WILLIAMS ER, 1992, SCIENCE, V256, P1184, DOI 10.1126/science.256.5060.1184; WILLIAMS ER, 1992, J ATMOS SCI, V49, P1386, DOI 10.1175/1520-0469(1992)049<1386:ARAESO>2.0.CO;2; WILLIAMS ER, 1994, MON WEATHER REV, V122, P1917, DOI 10.1175/1520-0493(1994)122<1917:GCRTSV>2.0.CO;2	30	95	98	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					290	293		10.1038/35018543	http://dx.doi.org/10.1038/35018543			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917527				2022-12-28	WOS:000088251900045
J	Song, YQ; Ryu, SG; Sen, PN				Song, YQ; Ryu, SG; Sen, PN			Determining multiple length scales in rocks	NATURE			English	Article							POROUS-MEDIA; SUSCEPTIBILITY DIFFERENCES; DIFFUSION; NMR; DIFFRACTION; FLUIDS	Carbonate reservoirs in the Middle East are believed to contain about half of the world's oil(1). The processes of sedimentation and diagenesis produce in carbonate rocks microporous grains and a wide range of pore sizes, resulting in a complex spatial distribution of pores and pore connectivity(2). This heterogeneity makes it difficult to determine by conventional techniques the characteristic pore-length scales, which control fluid transport properties. Here we present a bulk-measurement technique that is non-destructive and capable of extracting multiple length scales from carbonate rocks. The technique uses nuclear magnetic resonance to exploit the spatially varying magnetic field inside the pore space itself-a 'fingerprint' of the pore structure. We found three primary length scales (1-100 mu m) in the Middle-East carbonate rocks and determined that the pores are well connected and spatially mixed. Such information is critical for reliably estimating the amount of capillary-bound water in the rock, which is important for efficient oil production. This method might also be used to complement other techniques(3-5) for the study of shaly sand reservoirs and compartmentalization in cells and tissues.	Schlumberger Doll Res Ctr, Ridgefield, CT 06877 USA	Schlumberger	Song, YQ (corresponding author), Schlumberger Doll Res Ctr, Old Quarry Rd, Ridgefield, CT 06877 USA.			Song, Yiqiao/0000-0002-3416-4279				*A AND CAMBR EN RE, 1997, WORLD OIL TRENDS; BARRALL GA, 1992, SCIENCE, V255, P714, DOI 10.1126/science.255.5045.714; Borgia GC, 1996, MAGN RESON IMAGING, V14, P731, DOI 10.1016/S0730-725X(96)00157-9; BROWNSTEIN KR, 1979, PHYS REV A, V19, P2446, DOI 10.1103/PhysRevA.19.2446; Callaghan, 1993, PRINCIPLES NUCL MAGN; CALLAGHAN PT, 1991, NATURE, V351, P467, DOI 10.1038/351467a0; CORY DG, 1990, MAGNET RESON MED, V14, P435, DOI 10.1002/mrm.1910140303; COTTS RM, 1991, NATURE, V351, P443, DOI 10.1038/351443a0; HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580; HALPERIN WP, 1989, MOL DYNAMICS RESTRIC, pCH3; Hurlimann MD, 1998, J MAGN RESON, V131, P232, DOI 10.1006/jmre.1998.1364; KENYON WE, 1992, NUCL GEOPHYS, V6, P153; KLEINBERG RL, 1996, ENCY NUCL MAGNETIC R, V8, P4969; LATOUR LL, 1993, J MAGN RESON SER A, V101, P342, DOI 10.1006/jmra.1993.1056; Snaar JEM, 1997, MAGN RESON IMAGING, V15, P983, DOI 10.1016/S0730-725X(97)00036-2; TORREY HC, 1956, PHYS REV, V104, P563, DOI 10.1103/PhysRev.104.563; Tucker M.E., 1991, SEDIMENTARY PETROLOG; WEISSKOFF RM, 1994, MAGNET RESON MED, V31, P601, DOI 10.1002/mrm.1910310605; WONG PZ, 1999, METHODS PHYSICS PORO	19	193	203	4	61	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					178	181		10.1038/35018057	http://dx.doi.org/10.1038/35018057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910355				2022-12-28	WOS:000088221100045
J	Henney, JE				Henney, JE			New first-line therapy for colorectal cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2000	284	1					33	33		10.1001/jama.284.1.33	http://dx.doi.org/10.1001/jama.284.1.33			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328GX	10905906				2022-12-28	WOS:000087843000003
J	Haber, D				Haber, D			BRCA1: an emerging role in the cellular response to DNA damage	LANCET			English	Editorial Material							MEIOTIC CELLS; BREAST-CANCER; PHOSPHORYLATION; MUTATIONS; REPAIR; GENES; CYCLE; ATM		Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	Haber, D (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.							Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Chehab NH, 2000, GENE DEV, V14, P278; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Phillips KA, 1999, J CLIN ONCOL, V17, P3653, DOI 10.1200/JCO.1999.17.11.3653; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Venkitaraman AR, 1999, SCIENCE, V286, P1100, DOI 10.1126/science.286.5442.1100; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743	17	6	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2090	2091		10.1016/S0140-6736(00)02371-0	http://dx.doi.org/10.1016/S0140-6736(00)02371-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902618				2022-12-28	WOS:000087687100004
J	Poulter, NR				Poulter, NR			Risk of fatal pulmonary embolism with oral contraceptives	LANCET			English	Editorial Material									Imperial Coll Sch Med, Dept Clin Pharmacol & Therapeut, Cardiovasc Studies Unit, London W2 1PG, England	Imperial College London	Poulter, NR (corresponding author), Imperial Coll Sch Med, Dept Clin Pharmacol & Therapeut, Cardiovasc Studies Unit, London W2 1PG, England.							Bloemenkamp KWM, 1999, ARCH INTERN MED, V159, P65, DOI 10.1001/archinte.159.1.65; INMAN WHW, 1968, BRIT MED J, V2, P193, DOI 10.1136/bmj.2.5599.193; JORDAN WM, 1961, LANCET, V2, P1146, DOI DOI 10.1016/S0140-6736(61)91061-3; Thorogood M., 1993, PHARMACOEPIDEMIOL DR, V2, P3; Walker AM, 1998, CONTRACEPTION, V57, P169, DOI 10.1016/S0010-7824(98)00014-6; *WHO SCI GROUP CAR, 1998, WHO TECH REP SER, V877; 2000, DRUG THER B, V38, P1	7	7	7	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2088	2088		10.1016/S0140-6736(00)02369-2	http://dx.doi.org/10.1016/S0140-6736(00)02369-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902616				2022-12-28	WOS:000087687100002
J	Sears, MR				Sears, MR			Short-acting inhaled beta-agonists: to be taken regularly or as needed?	LANCET			English	Editorial Material							AIRWAY RESPONSIVENESS; ASTHMA; ALBUTEROL; ALLERGEN; SALBUTAMOL; EXACERBATIONS; SEVERITY		McGill Univ, Dept Med, Hamilton, ON L8N 4A6, Canada; St Josephs Hosp, Firestone Reg Chest & Allergy Unit, Hamilton, ON L8N 4A6, Canada	McGill University; McMaster University; McGill University; McMaster University	Sears, MR (corresponding author), McGill Univ, Dept Med, Hamilton, ON L8N 4A6, Canada.							BEASLEY R, 1994, CLIN EXP ALLERGY, V24, P660, DOI 10.1111/j.1365-2222.1994.tb00970.x; Bhagat R, 1996, J ALLERGY CLIN IMMUN, V97, P47, DOI 10.1016/S0091-6749(96)70282-8; COCKCROFT DW, 1995, J ALLERGY CLIN IMMUN, V96, P44, DOI 10.1016/S0091-6749(95)70031-5; COCKCROFT DW, 1993, LANCET, V342, P833, DOI 10.1016/0140-6736(93)92695-P; Drazen JM, 1996, NEW ENGL J MED, V335, P841, DOI 10.1056/NEJM199609193351202; Ellman MS, 1997, CHEST, V112, P582, DOI 10.1378/chest.112.3.582; Gauvreau GM, 1997, AM J RESP CRIT CARE, V156, P1738, DOI 10.1164/ajrccm.156.6.96-08042; Inman MD, 1996, AM J RESP CRIT CARE, V153, P65, DOI 10.1164/ajrccm.153.1.8542164; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; RICHTER B, IN PRESS J INTERN ME; SEARS MR, 1986, BRIT MED J, V293, P1342, DOI 10.1136/bmj.293.6558.1342; SEARS MR, 1994, DRUG SAFETY, V11, P259, DOI 10.2165/00002018-199411040-00005; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; SEARS MR, 1996, CAN RESPIR J, V3, P261; SHEPHERD GL, 1981, BRIT J DIS CHEST, V75, P215, DOI 10.1016/0007-0971(81)90057-7; SPEIZER FE, 1968, BRIT MED J, V1, P335, DOI 10.1136/bmj.1.5588.335; Taylor DR, 1998, THORAX, V53, P744, DOI 10.1136/thx.53.9.744; TAYLOR DR, 1994, THORAX, V49, P190, DOI 10.1136/thx.49.2.190; TAYLOR DR, 1993, THORAX, V48, P134, DOI 10.1136/thx.48.2.134; WILSON JD, 1981, LANCET, V1, P1235	20	12	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2000	355	9216					1658	1659		10.1016/S0140-6736(00)02231-5	http://dx.doi.org/10.1016/S0140-6736(00)02231-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905235				2022-12-28	WOS:000086983800002
J	Baker, F; Ainsworth, SR; Dye, JT; Crammer, C; Thun, MJ; Hoffmann, D; Repace, JL; Henningfield, JE; Slade, J; Pinney, J; Shanks, T; Burns, DM; Connolly, GN; Shopland, DR				Baker, F; Ainsworth, SR; Dye, JT; Crammer, C; Thun, MJ; Hoffmann, D; Repace, JL; Henningfield, JE; Slade, J; Pinney, J; Shanks, T; Burns, DM; Connolly, GN; Shopland, DR			Health risks associated with cigar smoking	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CANCER; DISEASE; MEN	This article summarizes principal findings from a conference convened by the American Cancer Society in June 1998 to examine the health risks of cigar smoking. State-of-the-science reports were presented and 120 attendees (representing government and private agencies, academia, health educators, and tobacco control experts) participated in panels and summary development discussions, The following conclusions were reached by consensus: (1) rates of cigar smoking am rising among both adults and adolescents; (2) smoking cigars instead of cigarettes does not reduce the risk of nicotine addiction; (3) as the number of cigars smoked and the amount of smoke inhaled increases, the risk of death related to cigar smoking approaches that of cigarette smoking; (4) cigar smoke contains higher concentrations of toxic and carcinogenic compounds than cigarettes and is a major source of fine-particle and carbon monoxide indoor air pollution; and (5) cigar smoking is known to cause cancers of the lung and upper aerodigestive tract.	Amer Canc Soc, Behav Res Ctr, Atlanta, GA 30329 USA; Amer Hlth Fdn, Valhalla, NY 10595 USA; Repace Associates Inc, Bowie, MD USA; NCI, Smoking & Tobacco Control Program, Bethesda, MD 20892 USA; Piney Associates Inc, Bethesda, MD USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08903 USA; Univ Calif San Diego, Tobacco Control Policies Project, San Diego, CA 92103 USA; Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; Massachusetts Dept Publ Hlth, Boston, MA USA	American Cancer Society; American Health Foundation; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California San Diego; University of California System; University of California San Diego; Massachusetts Department of Public Health	Baker, F (corresponding author), Amer Canc Soc, Behav Res Ctr, 1599 Clifton Rd NE, Atlanta, GA 30329 USA.	fbaker@cancer.org		Repace, james/0000-0002-7104-900X				ALTMAN DG, 1998, HDB HLTH BEHAV CHANG, P305; BAKER F, 1998, AM CANC SOC CIG SMOK; Boffetta P, 1999, JNCI-J NATL CANCER I, V91, P697, DOI 10.1093/jnci/91.8.697; *CDCP, 1996, CDCP CDC PUBL; *CDCP, 1997, JAMA-J AM MED ASSOC, V278, P17; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P229; CRONINGER AB, 1958, CANCER RES, V18, P1263; Gilpin EA, 1999, AM J PREV MED, V16, P195, DOI 10.1016/S0749-3797(98)00092-0; Green CR, 1996, RECENT ADV TOBACCO S, V22, P131; HAMILTON K, 1997, NEWSWEEK        0721, P54; Henningfield J E, 1999, Nicotine Tob Res, V1, P163, DOI 10.1080/14622299050011271; HOFFMANN D, 1998, C P INV PAP SEPT 20; HOMBURGER F, 1963, J NATL CANCER I, V31, P1445; Iribarren C, 1999, NEW ENGL J MED, V340, P1773, DOI 10.1056/NEJM199906103402301; Jacobs EJ, 1999, ARCH INTERN MED, V159, P2413, DOI 10.1001/archinte.159.20.2413; KENSLER CJ, 1962, TOBACCO HEALTH, P5; Klepeis NE, 1999, J EXPO ANAL ENV EPID, V9, P622, DOI 10.1038/sj.jea.7500065; LEVIN ML, 1950, JAMA-J AM MED ASSOC, V143, P336, DOI 10.1001/jama.1950.02910390008002; *NCI, 2000, NCI NIH PUBL; Pierce JP., 1998, TOBACCO CONTROL CALI; STRECHER VJ, 1995, J BEHAV MED, V18, P45, DOI 10.1007/BF01857704; TRILLIN C, 1996, TIME            0715, P18; *US DEP HHS, 1999, YOUTH US CIG PATT US; *US DEP HHS, 1986, US DEP HHS NIH PUBL; *US DEP HHS, 1979, US DEP HHS PUBL PHS; *US DEP HHS, 1999, SUMM FIND 1998 NAT H; *US SURG GEN, 1983, HLTH CONS SMOK CARD; *USDA, 1998, USDA COMM EC DIV EC; Wald NJ, 1997, BMJ-BRIT MED J, V314, P1860, DOI 10.1136/bmj.314.7098.1860; WEINSTEIN ND, 1987, J BEHAV MED, V10, P481, DOI 10.1007/BF00846146; WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001; ZARIDZE D, 1986, P INT M ORG INT AG R	32	158	160	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					735	740		10.1001/jama.284.6.735	http://dx.doi.org/10.1001/jama.284.6.735			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341JM	10927783				2022-12-28	WOS:000088587300033
J	Berger, A				Berger, A			Vaccination in utero may cut vertical transmission	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					320	320		10.1136/bmj.321.7257.320	http://dx.doi.org/10.1136/bmj.321.7257.320			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QH	10926580	Green Published			2022-12-28	WOS:000088656300014
J	Farquhar, J; Bao, HM; Thiemens, M				Farquhar, J; Bao, HM; Thiemens, M			Atmospheric influence of Earth's earliest sulfur cycle	SCIENCE			English	Article							ISOTOPE EVIDENCE; SOUTH-AFRICA; CARBON; SULFATE; ABUNDANCES; BARBERTON; EVOLUTION; PYRITE; OCEANS; OXYGEN	Mass-independent isotopic signatures for delta(33), delta(34) and delta(36)S from sulfide and sulfate in Precambrian rocks indicate that a change occurred in the sulfur cycle between 2090 and 2450 million years ago (Ma), Before 2450 Ma, the cycle was influenced by gas-phase atmospheric reactions. These atmospheric reactions also played a role in determining the oxidation state of sulfur, implying that atmospheric oxygen partial pressures were Low and that the roles of oxidative weathering and of microbial oxidation and reduction of sulfur were minimal. Atmospheric fractionation processes should be considered in the use of sulfur isotopes to study the onset and consequences of microbial fractionation processes in Earth's early history.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Farquhar, J (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.		Bao, Huiming/C-1069-2012					BAINSSAHOTA SK, 1989, J CHEM PHYS, V90, P6099, DOI 10.1063/1.456375; BAO H, IN PRESS NATURE; BERNER RA, 1983, GEOCHIM COSMOCHIM AC, V47, P855, DOI 10.1016/0016-7037(83)90151-5; Brimblecombe P, 1989, EVOLUTION GLOBAL BIO, P77; CAMERON EM, 1982, NATURE, V296, P145, DOI 10.1038/296145a0; CANUTO VM, 1983, NATURE, V305, P281, DOI 10.1038/305281a0; Farquhar J, 2000, J GEOPHYS RES-PLANET, V105, P11991, DOI 10.1029/1999JE001194; Farquhar J, 2000, NATURE, V404, P50, DOI 10.1038/35003517; GOODWIN AM, 1976, ECON GEOL, V71, P870, DOI 10.2113/gsecongeo.71.5.870; HULSTON JR, 1965, J GEOPHYS RES, V70, P3475, DOI 10.1029/JZ070i014p03475; Kakegawa T, 1999, PRECAMBRIAN RES, V96, P209, DOI 10.1016/S0301-9268(99)00006-6; KASTING JF, 1990, ORIGINS LIFE EVOL B, V20, P199, DOI 10.1007/BF01808105; KASTING JF, 1985, J GEOPHYS RES-ATMOS, V90, P10497, DOI 10.1029/JD090iD06p10497; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; Lambert I.B., 1992, EARLY ORGANIC EVOLUT, P408; Lee C. W., 1998, AM GEOPHYS UNION, V79, pF91; MOORE TB, 1992, PROTEROZOIC BIOSPHER, P605; OHMOTO H, 1993, SCIENCE, V262, P555, DOI 10.1126/science.11539502; OHMOTO H, 1987, NATURE, V328, P244, DOI 10.1038/328244a0; Okabe H., 1978, PHOTOCHEMISTRY SMALL; Paytan A, 1998, SCIENCE, V282, P1459, DOI 10.1126/science.282.5393.1459; Sagan C, 1997, SCIENCE, V276, P1217, DOI 10.1126/science.276.5316.1217; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; WALKER JCG, 1985, PRECAMBRIAN RES, V28, P205, DOI 10.1016/0301-9268(85)90031-2; Weston RE, 1999, CHEM REV, V99, P2115, DOI 10.1021/cr9800154; YORK D, 1969, EARTH PLANET SC LETT, V5, P320; ZAHNLE KJ, 1982, REV GEOPHYS, V20, P280, DOI 10.1029/RG020i002p00280; Zmolek P, 1999, J PHYS CHEM A, V103, P2477, DOI 10.1021/jp9907140; [No title captured]	29	1239	1298	16	481	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					756	758		10.1126/science.289.5480.756	http://dx.doi.org/10.1126/science.289.5480.756			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926533				2022-12-28	WOS:000088581500034
J	Moreno, A; Grodin, MA				Moreno, A; Grodin, MA			The not-so-silent marks of torture	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURVIVORS; HEALTH		Boston Univ, Sch Med, Boston Med Ctr,Hlth Law Dept, Boston Ctr Refugee Hlth & Human Rights, Boston, MA 02118 USA; Boston Univ, Sch Med, Boston Med Ctr,Sect Gen Internal Med, Boston Ctr Refugee Hlth & Human Rights, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Boston Med Ctr, Boston, MA 02118 USA	Boston Medical Center; Boston University; Boston Medical Center; Boston University; Boston Medical Center; Boston University	Moreno, A (corresponding author), Boston Univ, Sch Med, Boston Med Ctr,Hlth Law Dept, Boston Ctr Refugee Hlth & Human Rights, 715 Albany St,Talbot Bldg,T3W, Boston, MA 02118 USA.			Grodin, Michael/0000-0002-0929-8929				AUDET AM, 1995, ANN INTERN MED, V122, P607, DOI 10.7326/0003-4819-122-8-199504150-00009; Brenner, 1996, Health Hum Rights, V2, P129, DOI 10.2307/4065239; COUPLAND RM, 1993, JAMA-J AM MED ASSOC, V270, P624, DOI 10.1001/jama.270.5.624; EISENMAN D, 1999, 8 INT S TORT NEW DEL, P2; Forrest D, 1995, FORENSIC SCI INT, V76, P77, DOI 10.1016/0379-0738(95)10800-9; GOLDFELD AE, 1988, JAMA-J AM MED ASSOC, V259, P2725, DOI 10.1001/jama.259.18.2725; Iacopino V, 1996, JAMA-J AM MED ASSOC, V276, P396, DOI 10.1001/jama.276.5.396; KANTEMIR E, 1994, JAMA-J AM MED ASSOC, V272, P400, DOI 10.1001/jama.272.5.400; Mollica RF, 1999, JAMA-J AM MED ASSOC, V282, P433, DOI 10.1001/jama.282.5.433; PETERSEN HD, 1992, FORENSIC SCI INT, V53, P97, DOI 10.1016/0379-0738(92)90137-L; PETERSEN HD, 1995, FORENSIC SCI INT, V75, P45, DOI 10.1016/0379-0738(95)01766-C; RAFUSE J, 1993, CAN MED ASSOC J, V148, P282; RANDALL G, 1991, SERVING SURVIVORS TO, P55; RASMUSSEN OV, 1990, DAN MED BULL, V37, P1; Sonis J, 1996, JAMA-J AM MED ASSOC, V276, P1676, DOI 10.1001/jama.276.20.1676; *US DEP HHS, 2000, ADM CHILDR FAM FACT; *US DEP HHS, 2000, 1997 REP C; *US DEP JUST IMM N, 2000, 1997 STAT YB IMM NAT; Weinstein HM, 1996, WESTERN J MED, V165, P112	19	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2000	284	5					538	538		10.1001/jama.284.5.538	http://dx.doi.org/10.1001/jama.284.5.538			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	337WG	10918683				2022-12-28	WOS:000088385400002
J	Guo, HT; Karberg, M; Long, M; Jones, JP; Sullenger, B; Lambowitz, AM				Guo, HT; Karberg, M; Long, M; Jones, JP; Sullenger, B; Lambowitz, AM			Group II introns designed to insert into therapeutically relevant DNA target sites in human cells	SCIENCE			English	Article							PRIMED REVERSE TRANSCRIPTION; T7 RNA-POLYMERASE; HIV-1 INFECTION; CLONED GENES; MOBILITY; TERMINATION; CORECEPTOR; EXPRESSION	Mobile group II intron RNAs insert directly into DNA target sites and are then reverse-transcribed into genomic DNA by the associated intron-encoded protein. Target site recognition involves modifiable base-pairing interactions between the intron RNA and a >14-nucleotide region of the DNA target site, as well as fixed interactions between the protein and flanking regions. Here, we developed a highly efficient Escherichia coli genetic assay to determine detailed target site recognition rules for the Lactococcus lactis group II intron LL.LtrB and to select introns that insert into desired target sites. Using human immunodeficiency virus-type 1 (HIV-1) proviral DNA and the human CCR5 gene as examples, we show that group II introns can be retargeted to insert efficiently into virtually any target DNA and that the retargeted introns retain activity in human cells. This work provides the practical basis for potential applications of targeted group II introns in genetic engineering, functional genomics, and gene therapy.	Univ Texas, Sch Biol Sci, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Univ Texas, Sch Biol Sci, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas, Sch Biol Sci, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; Duke Univ, Med Ctr, Dept Surg, Ctr Genet & Cellular Therapies, Durham, NC 27710 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Duke University	Lambowitz, AM (corresponding author), Univ Texas, Sch Biol Sci, Inst Mol & Cellular Biol, Austin, TX 78712 USA.				NIAID NIH HHS [AI40981] Funding Source: Medline; NIGMS NIH HHS [GM37949] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI040981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037949] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bieniasz PD, 1997, EMBO J, V16, P2599, DOI 10.1093/emboj/16.10.2599; Cousineau B, 1998, CELL, V94, P451, DOI 10.1016/S0092-8674(00)81586-X; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DEMINOFF SJ, 1995, GENETICS, V141, P1263; Eskes R, 1997, CELL, V88, P865, DOI 10.1016/S0092-8674(00)81932-7; Guo HT, 1997, EMBO J, V16, P6835, DOI 10.1093/emboj/16.22.6835; Hartvig L, 1996, EMBO J, V15, P4767, DOI 10.1002/j.1460-2075.1996.tb00854.x; KARBERG M, UNPUB; Lambowitz AM., 1999, GROUP GROUP 2 RIBOZY, P451; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Matsuura M, 1997, GENE DEV, V11, P2910, DOI 10.1101/gad.11.21.2910; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Mills DA, 1997, J BACTERIOL, V179, P6107, DOI 10.1128/jb.179.19.6107-6111.1997; Mohr G, 2000, GENE DEV, V14, P559; MOHR G, UNPUB; OROSZ A, 1991, EUR J BIOCHEM, V201, P653, DOI 10.1111/j.1432-1033.1991.tb16326.x; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Saldanha R, 1999, BIOCHEMISTRY-US, V38, P9069, DOI 10.1021/bi982799l; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Wank H, 1999, MOL CELL, V4, P239, DOI 10.1016/S1097-2765(00)80371-8; Yang J, 1998, J MOL BIOL, V282, P505, DOI 10.1006/jmbi.1998.2029; Yang J, 1996, NATURE, V381, P332, DOI 10.1038/381332a0; ZIMMERLY S, 1995, CELL, V83, P529, DOI 10.1016/0092-8674(95)90092-6; ZIMMERLY S, 1995, CELL, V82, P545, DOI 10.1016/0092-8674(95)90027-6	25	151	178	2	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					452	457		10.1126/science.289.5478.452	http://dx.doi.org/10.1126/science.289.5478.452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903206				2022-12-28	WOS:000088305500048
J	Nuth, JA; Hill, HGM; Kletetschka, G				Nuth, JA; Hill, HGM; Kletetschka, G			Determining the ages of comets from the fraction of crystalline dust	NATURE			English	Article							SOLAR NEBULA; SILICATE GRAINS; BETA-PICTORIS; DISK	The timescale for the accretion of bodies in the disk surrounding a young star depends upon a number of assumptions, but there are few observational constraints. In our own Solar System, measurements of meteoritic components can provide information about the inner regions of the nebula, but not the outer parts. Observations of the evolution of more massive protostellar systems (Herbig A(e)/B-e stars) imply that significant changes occur in the physical properties of their dust with time(1). The simplest explanation is that thermal annealing of the original, amorphous grains in the hot inner nebula slowly increases the fractional abundance of crystalline material over time. Crystalline dust is then transported outward, where it is incorporated into comets that serve as a longterm reservoir for dust disks, such as that surrounding Beta Pictoris. Here we show that when applied to our own Solar System, this process can explain observed variations in both the volatile and dusty components of comets, while also providing a natural indicator of a comet's mean formation age. Studies of comets with different dust contents can therefore be used to investigate the timescales of the early Solar System.	NASA, Goddard Space Flight Ctr, Astrochem Branch, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Nuth, JA (corresponding author), NASA, Goddard Space Flight Ctr, Astrochem Branch, Code 691, Greenbelt, MD 20771 USA.	uljan@lepvax.gsfc.nasa.gov	Nuth, Joseph/E-7085-2012; Kletetschka, Gunther/C-9996-2011; Kletetschka, Gunther/AAA-2008-2021	Kletetschka, Gunther/0000-0002-0645-9037; Kletetschka, Gunther/0000-0002-0645-9037				AHearn MF, 1995, ICARUS, V118, P223, DOI 10.1006/icar.1995.1190; Brown G. N.  Jr., 1980, Advances in Cryogenic Engineering. Vol.25. Proceedings of the 1979 Cryogenic Engineering Conference, P662; CAMPINS H, 1989, ASTROPHYS J, V341, P1059, DOI 10.1086/167563; DRAINE BT, 1984, ASTROPHYS J, V285, P89, DOI 10.1086/162480; FEGLEY B, 1993, NATO ADV SCI INST SE, V416, P75; Gerakines PA, 1999, ASTROPHYS J, V522, P357, DOI 10.1086/307611; Grady C. A., 2000, PROTOSTARS PLANETS, P613; Hallenbeck SL, 2000, ASTROPHYS J, V535, P247, DOI 10.1086/308810; HALLENBECK SL, ICARUS; HANNER MS, 1994, ASTROPHYS J, V425, P274, DOI 10.1086/173984; Hanner MS, 1999, SPACE SCI REV, V90, P99, DOI 10.1023/A:1005285711945; KNACKE RF, 1993, ASTROPHYS J, V418, P440, DOI 10.1086/173405; LIDE DR, 1994, CRC HDB CHEM PHYSICS, P66; Mumma M. J., 1993, PROTOSTARS PLANETS, P1177; Prinn R.G.P., 1989, ORIGIN EVOLUTION PLA, P78; PRINN RG, 1990, ASTROPHYS J, V348, P725, DOI 10.1086/168281; RYAN EV, 1991, ASTRON J, V101, P694, DOI 10.1086/115716; SMITH BA, 1984, SCIENCE, V226, P1421, DOI 10.1126/science.226.4681.1421; STEVENSON DJ, 1990, ASTROPHYS J, V348, P730, DOI 10.1086/168282; Weidenschilling SJ, 1997, ICARUS, V127, P290, DOI 10.1006/icar.1997.5712; Woolum DS, 1999, METEORIT PLANET SCI, V34, P897, DOI 10.1111/j.1945-5100.1999.tb01408.x	21	69	69	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					275	276		10.1038/35018516	http://dx.doi.org/10.1038/35018516			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917522				2022-12-28	WOS:000088251900040
J	Ness, RB; Ukoli, F; Hunt, S; Kiely, SC; McNeil, MA; Richardson, V; Weissbach, N; Belle, SH				Ness, RB; Ukoli, F; Hunt, S; Kiely, SC; McNeil, MA; Richardson, V; Weissbach, N; Belle, SH			Salary equity among male and female internists in Pennsylvania	ANNALS OF INTERNAL MEDICINE			English	Article							ACADEMIC MEDICINE; SEX-DIFFERENCES; WOMEN; PHYSICIANS; MEN; ADVANCEMENT; PATTERNS; INCOMES; FACULTY; RANK	Background: Women constitute an increasing proportion of physicians in the United States. Historically, inequities have existed between male and female physicians in professional advancement, but evidence has suggested that disparities in salary are resolving. Objective: To examine the current state of salary equity among male and female internists. Design: Population-based survey mailed to all Board-certified female internists and a matched group of male internists who had graduated from medical school 10 to 30 years ago and were currently practicing. Setting: Pennsylvania. Participants: 232 male and 213 female internists for whom data were complete. Measurements: Respondents answered questions about demographic characteristics, training, practice type and setting, status within the practice, family life, and salary. Results: Women were more likely to be involved in the least lucrative practice arrangements. They were more likely to be in low-paying specialties, to not be a partner in the practice, and to be salaried employees; they also spent fewer hours per week seeing patients. Even after adjustment for these differences, hourly earnings were significantly higher (14%) among men than among their female colleagues. Men's earnings significantly exceeded women's earnings among physicians with no academic affiliation, those in high-earning specialties, and those in general internal medicine. Conclusions: Significant salary differentials exist between male and female internists overall and in various medical practice settings.	Univ Pittsburgh, Grad Sch Publ Hlth, Med Ctr, Vet Affairs Med Ctr, Pittsburgh, PA 15261 USA; St Francis Med Ctr, Pittsburgh, PA USA; St Vincents Hlth Ctr, Erie, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ness, RB (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Med Ctr, Vet Affairs Med Ctr, 130 DeSoto St,517 Parran Hall, Pittsburgh, PA 15261 USA.	repro@vms.cis.pitt.edu						*AM COLL PHYS AM S, FALL 1998 REPORT BOA; American Medical Association, 1999, PHYS CHAR DISTR US; ARMITAGE P, 1971, STAT METHODS MED RES, P33; Baker LC, 1996, NEW ENGL J MED, V334, P960, DOI 10.1056/NEJM199604113341506; Bickel J, 1995, WOMEN US ACAD MED ST; BOBULA JD, 1980, J MED EDUC, V55, P826; CARR P, 1992, J GEN INTERN MED, V7, P418, DOI 10.1007/BF02599159; CARR PL, 1993, ANN INTERN MED, V119, P908, DOI 10.7326/0003-4819-119-9-199311010-00008; *COUNC GRAD MED ED, 1995, DRSA P DM 95 1; DIAL TH, 1994, AM J PSYCHIAT, V151, P96; DIAL TH, 1989, ACAD MED, V64, P198, DOI 10.1097/00001888-198904000-00007; Fried LP, 1996, JAMA-J AM MED ASSOC, V276, P898, DOI 10.1001/jama.276.11.898; Kaplan SH, 1996, NEW ENGL J MED, V335, P1282, DOI 10.1056/NEJM199610243351706; LANGWELL KM, 1982, J HUM RESOUR, V17, P261, DOI 10.2307/145472; NICKERSON KG, 1990, JAMA-J AM MED ASSOC, V264, P1813, DOI 10.1001/jama.264.14.1813; OGLE KS, 1986, J FAM PRACTICE, V23, P357; OHSFELDT RL, 1986, J HEALTH ECON, V5, P335, DOI 10.1016/0167-6296(86)90008-1; TESCH BJ, 1995, JAMA-J AM MED ASSOC, V273, P1022, DOI 10.1001/jama.273.13.1022; VALINA V, 1998, WHY SO SLOW ADV WOME; WALLIS LA, 1981, JAMA-J AM MED ASSOC, V246, P2350, DOI 10.1001/jama.246.20.2350; WILKINSON CJ, 1986, ANESTHESIOLOGY, V64, P496, DOI 10.1097/00000542-198604000-00014	21	63	63	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2000	133	2					104	110		10.7326/0003-4819-133-2-200007180-00009	http://dx.doi.org/10.7326/0003-4819-133-2-200007180-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335RL	10896636				2022-12-28	WOS:000088258500003
J	Saito, I; Folsom, AR; Brancati, FL; Duncan, BB; Chambless, LE; McGovern, PG				Saito, I; Folsom, AR; Brancati, FL; Duncan, BB; Chambless, LE; McGovern, PG			Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: The Atherosclerosis Risk in Communities (ARIC) Study	ANNALS OF INTERNAL MEDICINE			English	Article							HIGH-DENSITY-LIPOPROTEIN; IMPROVED LIPOLYTIC EFFICIENCY; FACTOR INTERVENTION TRIAL; VON-WILLEBRAND-FACTOR; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; ENZYMATIC DETERMINATION; ALBUMIN EXCRETION; GLYCEMIC CONTROL; PLASMA-LEVELS	Background: Major risk factors explain much of the excess risk for coronary heart disease produced by diabetes, but nontraditional factors may also relate to incident coronary heart disease. Objective: To examine the association of traditional and nontraditional risk factors with incidence of coronary heart disease in adults with diabetes. Design: Prospective cohort study, Setting: The Atherosclerosis Risk in Communities (ARIC) Study. Participants: 1676 middle-aged persons who had diabetes but no history of prevalent coronary heart disease. Measurements: Multiple risk factors were recorded at baseline. Follow-up was from 1987 through 1995, Results: 186 participants developed incident coronary heart disease events during follow-up. As expected, the incidence of coronary heart disease in participants with diabetes was associated positively with traditional risk factors (hypertension, smoking, total cholesterol level, and low high-density lipoprotein [HDL] cholesterol level). After adjustment for sex, age, ethnicity, and ARIC field center, incident coronary heart disease was also significantly associated with waist-to-hip ratio; levels of HDL3 cholesterol, apo-lipoproteins A-1 and B, albumin, fibrinogen, and von Willebrand factor; factor VIII activity; and leukocyte count. However, after adjustment for traditional risk factors for coronary heart disease, only levels of albumin, fibrinogen, and von Willebrand factor; factor VIII activity; and leukocyte count remained independently associated with coronary heart disease (P < 0.03). The relative risks associated with the highest compared with lowest groupings of albumin, fibrinogen, factor VIII, and von Willebrand factor values and leukocyte count were 0.64 (95% CI, 0.44 to 0.92), 1.75 (CI, 1.12 to 2.73), 1.58 (CI, 1.02 to 2.42), 1.71 (Cl, 1.11 to 2.63), and 1.90 (Cl, 1.16 to 3.13), respectively. Adjustment for diabetes treatment status attenuated these associations somewhat Conclusions: Levels of albumin, fibrinogen, and von Willebrand factor; factor VIII activity; and leukocyte count were predictors of coronary heart disease among persons with diabetes. These associations may reflect 1) the underlying inflammatory reaction or microvascular injury related to atherosclerosis and a tendency toward thrombosis or 2) common antecedents for both diabetes and coronary heart disease.	Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55454 USA; Oita Med Univ, Oita, Japan; Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil; Univ N Carolina, Chapel Hill, NC USA	University of Minnesota System; University of Minnesota Twin Cities; Oita University; Johns Hopkins University; Johns Hopkins Medicine; Universidade Federal do Rio Grande do Sul; University of North Carolina; University of North Carolina Chapel Hill	Folsom, AR (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Suite 300,1300 S 2nd St, Minneapolis, MN 55454 USA.	folsom@epi.umn.edu	Duncan, Bruce B/L-4140-2016	Duncan, Bruce B/0000-0002-7491-2630	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055018, N01HC055016, N01HC055015] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-55018, N01-HC-55015, N01-HC-55016] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAIRA C, 1995, DIABETES CARE, V18, P1113, DOI 10.2337/diacare.18.8.1113; [Anonymous], 1999, Diabetologia, V42, P647; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Borch-Johnsen K, 1999, LANCET, V354, P617; Bruno G, 1996, ANN INTERN MED, V125, P653, DOI 10.7326/0003-4819-125-8-199610150-00005; CERIELLO A, 1994, THROMB HAEMOSTASIS, V71, P593; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; CONLAN MG, 1993, THROMB HAEMOSTASIS, V70, P380; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DEFEO P, 1993, DIABETES, V42, P995, DOI 10.2337/diabetes.42.7.995; Destefano Frank, 1993, Ethnicity and Disease, V3, P145; DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2; Duncan BB, 1999, DIABETES CARE, V22, P767, DOI 10.2337/diacare.22.5.767; ECKFELDT JH, 1994, ARCH PATHOL LAB MED, V118, P496; FACCHINI F, 1992, J INTERN MED, V232, P267, DOI 10.1111/j.1365-2796.1992.tb00582.x; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; Folsom AR, 1997, DIABETES CARE, V20, P935, DOI 10.2337/diacare.20.6.935; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GAUBATZ JW, 1990, J LIPID RES, V31, P603; Gavin JR, 1997, DIABETES CARE, V20, P1183; GETZ GS, 1993, ARTERIOSCLER THROMB, V13, P459, DOI 10.1161/01.ATV.13.3.459; GINDLER EM, 1971, CLIN CHEM, V17, P662; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Haffner SM, 1997, AM J MED, V103, P152, DOI 10.1016/S0002-9343(97)00027-2; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; JARRETT RJ, 1988, DIABETOLOGIA, V31, P737, DOI 10.1007/BF00274775; JuhanVague I, 1996, ANN MED, V28, P371, DOI 10.3109/07853899608999095; KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8; KANNEL WB, 1990, AM HEART J, V120, P672, DOI 10.1016/0002-8703(90)90026-T; Kessler L, 1998, DIABETES METAB, V24, P327; LAAKSO M, 1993, CIRCULATION, V88, P1421, DOI 10.1161/01.CIR.88.4.1421; Lehto S, 1997, DIABETES, V46, P1354, DOI 10.2337/diabetes.46.8.1354; Liao FZ, 1998, AM HEART J, V136, P480, DOI 10.1016/S0002-8703(98)70224-8; MACIEJKO JJ, 1982, CLIN CHEM, V28, P199; Mattock MB, 1998, DIABETES, V47, P1786, DOI 10.2337/diabetes.47.11.1786; Missov RM, 1996, DIABETES CARE, V19, P157, DOI 10.2337/diacare.19.2.157; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; NAGELE U, 1984, J CLIN CHEM CLIN BIO, V22, P165; NISKANEN LK, 1995, DIABETES CARE, V18, P1557, DOI 10.2337/diacare.18.12.1557; PATSCH W, 1989, CLIN CHEM, V35, P265; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; Prineas R., 1982, MINNESOTA CODE MANUA; RAUTAHARJU PM, 1981, CIRCULATION, V64, P249, DOI 10.1161/01.CIR.64.2.249; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; SCHONFELD G, 1974, J CLIN INVEST, V54, P236, DOI 10.1172/JCI107758; SCHONFELD G, 1974, J CLIN INVEST, V53, P1458, DOI 10.1172/JCI107694; Schreiner PJ, 1996, ARTERIOSCL THROM VAS, V16, P471, DOI 10.1161/01.ATV.16.3.471; SIEDEL J, 1983, CLIN CHEM, V29, P1075; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Standl E, 1996, DIABETOLOGIA, V39, P1540, DOI 10.1007/s001250050612; STEHOUWER CDA, 1992, LANCET, V340, P319, DOI 10.1016/0140-6736(92)91401-S; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; TUMER R, 1997, LANCET, V350, P1288; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UK Prospective Diabet Study Grp, 1998, DIABETES CARE, V21, P1271; UUSITUPA MIJ, 1990, CIRCULATION, V82, P27, DOI 10.1161/01.CIR.82.1.27; Vaccaro O, 1998, INT J EPIDEMIOL, V27, P636, DOI 10.1093/ije/27.4.636; Vilbergsson S, 1998, J INTERN MED, V244, P309, DOI 10.1046/j.1365-2796.1998.00368.x; WARNICK GR, 1982, CLIN CHEM, V28, P1574; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Yudkin JS, 1996, DIABETOLOGIA, V39, P1407, DOI 10.1007/s001250050592	67	179	189	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2000	133	2					81	91		10.7326/0003-4819-133-2-200007180-00007	http://dx.doi.org/10.7326/0003-4819-133-2-200007180-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335RL	10896647				2022-12-28	WOS:000088258500001
J	Morrison, RS; Kinoshita, Y				Morrison, RS; Kinoshita, Y			Development - p73 - Guilt by association?	SCIENCE			English	Editorial Material							P53; APOPTOSIS; DEATH; GENE; IDENTIFICATION; PROTEIN; CELLS		Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Morrison, RS (corresponding author), Univ Washington, Sch Med, Dept Neurol Surg, Box 356470, Seattle, WA 98195 USA.							Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; De Laurenzi V, 1999, CELL DEATH DIFFER, V6, P389, DOI 10.1038/sj.cdd.4400521; Ding HF, 1998, J BIOL CHEM, V273, P28378, DOI 10.1074/jbc.273.43.28378; Gottlieb E, 1998, EMBO J, V17, P3587, DOI 10.1093/emboj/17.13.3587; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Mazzoni IE, 1999, J NEUROSCI, V19, P9716; MIYASHITA T, 1994, CANCER RES, V54, P3131; MORRISON RS, IN PRESS CELL DEATH; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Roperch JP, 1998, NAT MED, V4, P835, DOI 10.1038/nm0798-835; Slack RS, 1996, J CELL BIOL, V135, P1085, DOI 10.1083/jcb.135.4.1085; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	14	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					257	258		10.1126/science.289.5477.257	http://dx.doi.org/10.1126/science.289.5477.257			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10917851				2022-12-28	WOS:000088169400031
J	Stuart, HR				Stuart, HR			Dispersive multiplexing in multimode optical fiber	SCIENCE			English	Article								Recently developed ideas in the field of wireless communications suggest that the presence of scattering can be used to enhance, rather than degrade, the total information capacity of a transmission system. This concept is applied to data transmission over multimode optical fiber, and the result is an optical multiplexing that can increase the capacity of such fiber. Experimental results demonstrate the feasibility of this approach. The technique may play an important role in future high-bandwidth local area networking applications.	Bell Labs, Lucent Technol, Holmdel, NJ 07733 USA	Alcatel-Lucent; Lucent Technologies; AT&T	Stuart, HR (corresponding author), Bell Labs, Lucent Technol, 101 Crawford Corner Rd, Holmdel, NJ 07733 USA.							Aronson LB, 1998, IEEE PHOTONIC TECH L, V10, P1489, DOI 10.1109/68.720304; DUBOIS F, 1994, OPT LETT, V19, P433, DOI 10.1364/OL.19.000433; Foschini G. J., 1998, Wireless Personal Communications, V6, P311, DOI 10.1023/A:1008889222784; Foschini G. J., 1996, Bell Labs Technical Journal, V1, P41, DOI 10.1002/bltj.2015; Garito AF, 1998, SCIENCE, V281, P962, DOI 10.1126/science.281.5379.962; Golden GD, 1999, ELECTRON LETT, V35, P14, DOI 10.1049/el:19990058; Jakes W. C., 1974, MICROWAVE MOBILE COM, P133; Moustakas AL, 2000, SCIENCE, V287, P287, DOI 10.1126/science.287.5451.287; Raddatz L, 1998, J LIGHTWAVE TECHNOL, V16, P324, DOI 10.1109/50.661357; Raddatz L, 1999, IEEE PHOTONIC TECH L, V11, P266, DOI 10.1109/68.740725; SCHWARTZ M, 1990, INFORMATION TRANSMIS; Woodward TK, 1999, IEEE PHOTONIC TECH L, V11, P382, DOI 10.1109/68.748243	12	225	243	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					281	283		10.1126/science.289.5477.281	http://dx.doi.org/10.1126/science.289.5477.281			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894772				2022-12-28	WOS:000088169400036
J	Hallett, M				Hallett, M			Transcranial magnetic stimulation and the human brain	NATURE			English	Article							MOTOR CORTEX EXCITABILITY; VISUAL-CORTEX; PARKINSONS-DISEASE; CORTICAL OUTPUTS; CEREBRAL-CORTEX; READING HAND; REORGANIZATION; DEPRESSION; MODULATION; ORGANIZATION	Transcranial magnetic stimulation (TMS) is rapidly developing as a powerful, non-invasive tool for studying the human brain. A pulsed magnetic field creates current flow in the brain and can temporarily excite or inhibit specific areas. TMS of motor cortex can produce a muscle twitch or block movement; TMS of occipital cortex can produce visual phosphenes or scotomas. TMS can also alter the functioning of the brain beyond the time of stimulation, offering potential for therapy.	NINDS, Human Motor Control Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Hallett, M (corresponding author), NINDS, Human Motor Control Sect, NIH, Bldg 10,Room 5N226,10 Ctr Dr,MSC 1428, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002669, ZIANS002669] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMASSIAN VE, 1989, ELECTROEN CLIN NEURO, V74, P458, DOI 10.1016/0168-5597(89)90036-1; BARKER AT, 1985, LANCET, V1, P1106; BECKERS G, 1995, BRAIN, V118, P49, DOI 10.1093/brain/118.1.49; BRUNHOLZL C, 1994, ARCH NEUROL-CHICAGO, V51, P245, DOI 10.1001/archneur.1994.00540150039013; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Corthout E, 1999, NEUROPSYCHOLOGIA, V37, P137; DAY BL, 1989, BRAIN, V112, P649, DOI 10.1093/brain/112.3.649; Di Lazzaro V, 1998, ELECTROMYOGR MOTOR C, V109, P397, DOI 10.1016/S0924-980X(98)00038-1; Epstein CM, 1996, NEUROLOGY, V47, P1590, DOI 10.1212/WNL.47.6.1590; GEORGE MS, 1995, NEUROREPORT, V6, P1853, DOI 10.1097/00001756-199510020-00008; Gerloff C, 1997, BRAIN, V120, P1587, DOI 10.1093/brain/120.9.1587; Ghabra MB, 1999, NEUROLOGY, V52, P768, DOI 10.1212/WNL.52.4.768; Hallett M, 1998, ARCH NEUROL-CHICAGO, V55, P601, DOI 10.1001/archneur.55.5.601; Hallett M, 1999, EEG CL N SU, P183; HALLETT M, 1993, SPASTICITY MECH MANA, P67; KEW JJM, 1994, J NEUROPHYSIOL, V72, P2517, DOI 10.1152/jn.1994.72.5.2517; Klein E, 1999, ARCH GEN PSYCHIAT, V56, P315, DOI 10.1001/archpsyc.56.4.315; Liepert J, 1995, ELECTROMYOGR MOTOR C, V97, P382, DOI 10.1016/0924-980X(95)00194-P; MANO Y, 1995, ANN NEUROL, V38, P15, DOI 10.1002/ana.410380106; MERTON PA, 1980, NATURE, V285, P227, DOI 10.1038/285227a0; PascualLeone A, 1995, ANN NEUROL, V38, P910, DOI 10.1002/ana.410380611; PASCUALLEONE A, 1991, NEUROLOGY, V41, P697, DOI 10.1212/WNL.41.5.697; PASCUALLEONE A, 1993, ANN NEUROL, V34, P33, DOI 10.1002/ana.410340108; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; PASCUALLEONE A, 1994, NEUROLOGY, V44, P892, DOI 10.1212/WNL.44.5.892; Paus T, 1997, J NEUROSCI, V17, P3178; REUTENS DC, 1993, ANN NEUROL, V34, P351, DOI 10.1002/ana.410340308; RIDDING MC, 1995, J NEUROL NEUROSUR PS, V59, P493, DOI 10.1136/jnnp.59.5.493; Rijntjes M, 1997, ANN NEUROL, V41, P621, DOI 10.1002/ana.410410511; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; SANES JN, 1990, EXP BRAIN RES, V79, P479; Siebner HR, 1999, NEUROREPORT, V10, P589, DOI 10.1097/00001756-199902250-00027; Siebner HR, 1999, NEUROLOGY, V52, P529, DOI 10.1212/WNL.52.3.529; Triggs WJ, 1999, BIOL PSYCHIAT, V45, P1440, DOI 10.1016/S0006-3223(99)00031-1; Valzania F, 1999, CLIN NEUROPHYSIOL, V110, P152, DOI 10.1016/S0013-4694(98)00115-1; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306	41	1035	1090	4	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					147	150		10.1038/35018000	http://dx.doi.org/10.1038/35018000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910346				2022-12-28	WOS:000088221100036
J	Finestone, HM				Finestone, HM			Safe feeding methods in stroke patients	LANCET			English	Editorial Material							MALNUTRITION		London Hlth Sci Ctr, Dept Phys Med & Rehabil, London, ON N6A 5A5, Canada	London Health Sciences Centre	Finestone, HM (corresponding author), London Hlth Sci Ctr, Dept Phys Med & Rehabil, Univ Campus, London, ON N6A 5A5, Canada.							APTAKER RL, 1994, ARCH PHYS MED REHAB, V75, P80; AXELSSON K, 1989, J AM DIET ASSOC, V89, P1092; Buelow J M, 1990, Rehabil Nurs, V15, P260; Davalos A, 1996, STROKE, V27, P1028, DOI 10.1161/01.STR.27.6.1028; FINEGOLD SM, 1991, REV INFECT DIS, V13, pS737; FINESTONE HM, 1995, ARCH PHYS MED REHAB, V76, P310, DOI 10.1016/S0003-9993(95)80655-5; FINESTONE HM, 1996, ARCH PHYS MED REHAB, V77, P430; GORDON C, 1987, BRIT MED J, V295, P411, DOI 10.1136/bmj.295.6595.411; HICKS ME, 1990, AM J ROENTGENOL, V154, P725, DOI 10.2214/ajr.154.4.2107665; LAZARUS BA, 1990, ARCH PHYS MED REHAB, V71, P46; Nakajoh K, 2000, J INTERN MED, V247, P39, DOI 10.1046/j.1365-2796.2000.00565.x; Smithard DG, 1998, AGE AGEING, V27, P99, DOI 10.1093/ageing/27.2.99; WEINBERG AD, 1995, JAMA-J AM MED ASSOC, V274, P1552, DOI 10.1001/jama.274.19.1552	13	20	21	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2000	355	9216					1662	1663		10.1016/S0140-6736(00)02234-0	http://dx.doi.org/10.1016/S0140-6736(00)02234-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905238				2022-12-28	WOS:000086983800005
J	Cardozo, BL; Vergara, A; Agani, F; Gotway, CA				Cardozo, BL; Vergara, A; Agani, F; Gotway, CA			Mental health, social functioning, and attitudes of Kosovar Albanians following the War in Kosovo	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PRIMARY-CARE; REFUGEES; QUESTIONNAIRE; SYMPTOMS; TRAUMA; SURVIVORS; EXPERIENCE; DISABILITY; HOLOCAUST	Context The 1998-1999 war in Kosovo had a direct impact on large numbers of civilians. The mental health consequences of the conflict are not known. Objectives To establish the prevalence of psychiatric morbidity associated with the war in Kosovo, to assess social functioning, and to identify vulnerable populations among ethnic Albanians in Kosovo. Design, Setting, and Participants Cross-sectional cluster sample survey conducted from August to October 1999 among 1358 Kosovar Albanians aged 15 years or older in 558 randomly selected households across Kosovo. Main Outcome Measures Nonspecific psychiatric morbidity, posttraumatic stress disorder (PTSD) symptoms, and social functioning using the General Health Questionnaire 28 (GHQ-28), Harvard Trauma Questionnaire, and the Medical Outcomes Study Short-Form 20 (MOS-20), respectively; feelings of hatred and a desire for revenge among persons surveyed as addressed by additional questions. Results Of the respondents, 17.1% (95% confidence interval [CI], 13.2%-21.0%) reported symptoms that met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for PTSD; total mean score on the GHQ-28 was 11.1 (95% CI, 9.9-12.4). Respondents reported a high prevalence of traumatic events. There was a significant linear decrease in mental health status and social functioning with increasing amount of traumatic events (P less than or equal to.02 for all 3 survey tools). Populations at increased risk for psychiatric morbidity as measured by GHQ-28 scores were those aged 65 years or older (P=.006), those with previous psychiatric illnesses or chronic health conditions (P<.001 for both), and those who had been internally displaced (P=.009). Populations at risk for poorer social functioning were living in rural areas (P=.001), were unemployed (P=.046) or had a chronic illness (P=.01). Respondents scored highest on the physical functioning and role functioning subscales of the MOS-20 and lowest On the mental health and social functioning subscales. Eighty-nine percent of men and 90% of women reported having strong feelings of hatred toward Serbs. Fifty-one percent of men and 43% of women reported strong feelings of revenge; 44% of men and 33% of women stated that they would act on these feelings. Conclusions Mental health problems and impaired social functioning related to the recent war are important issues that need to be addressed to return the Kosovo region to a stable and productive environment.	Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Int Emergency & Refugee Hlth Branch, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div Quarantine, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Natl Ctr Environm Hlth Environm Hazards & Hlth Ef, Atlanta, GA 30341 USA; Inst Mental Hlth & Recovery, Pristina, Kosovo, Yugoslavia	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Cardozo, BL (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Int Emergency & Refugee Hlth Branch, 4770 Buford Hwy NE,Mailstop F-48, Atlanta, GA 30341 USA.	bhc8@cdc.gov						CARLSON EB, 1993, AM J ORTHOPSYCHIAT, V63, P223, DOI 10.1037/h0079422; *CDCP, 1994, EP INF VERS 6 4; de Jong K, 1999, LANCET, V353, P1616, DOI 10.1016/S0140-6736(99)00084-7; Furukawa TA, 1999, LANCET, V353, P561, DOI 10.1016/S0140-6736(98)05470-1; GOLDBERG D, 1986, BRIT MED J, V293, P1188, DOI 10.1136/bmj.293.6556.1188; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Goldberg DP, 1998, PSYCHOL MED, V28, P915, DOI 10.1017/S0033291798006874; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; Kaplan HI, 1995, COMPREHENSIVE TXB PS; KUCH K, 1992, AM J PSYCHIAT, V149, P337; MARSELLA AJ, 1994, AMIDST PERIL PAIN ME; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; Mollica RF, 1998, BRIT J PSYCHIAT, V173, P482, DOI 10.1192/bjp.173.6.482; Mollica RF, 1999, JAMA-J AM MED ASSOC, V282, P433, DOI 10.1001/jama.282.5.433; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; SARTORIUS N, 1993, ARCH GEN PSYCHIAT, V50, P819; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; *UN HIGH COMM REF, 1999, KOS CRIS UPD; *US INT DEV AG, 2000, KOS CRIS FACT SHEET; VonKorff M, 1996, J CLIN EPIDEMIOL, V49, P297, DOI 10.1016/0895-4356(95)00512-9; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WARE JE, 1994, SF36 PHYSICAL MENTAL; WARE JE, 1997, SF36 HLTH SURVEY MAN; Weine SM, 1998, AM J PSYCHIAT, V155, P562, DOI 10.1176/ajp.155.4.562; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; YEHUDA R, 1995, AM J PSYCHIAT, V152, P1815	30	215	218	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2000	284	5					569	577		10.1001/jama.284.5.569	http://dx.doi.org/10.1001/jama.284.5.569			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	337WG	10918702	Bronze			2022-12-28	WOS:000088385400025
J	Starfield, B				Starfield, B			Is US health really the best in the world?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA	Johns Hopkins University	Starfield, B (corresponding author), Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway,Room 452, Baltimore, MD 21205 USA.	bstarfie@jhsph.edu	Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213				ANDERSON G, 1999, HLTH SPENDING ACCESS; Donohoe MT, 1998, ARCH INTERN MED, V158, P1596, DOI 10.1001/archinte.158.15.1596; Evans R, 1999, MILBANK Q, V77, P393, DOI 10.1111/1468-0009.00141; Guyer B, 1999, PEDIATRICS, V104, P1229, DOI 10.1542/peds.104.6.1229; Harrold LR, 1999, J GEN INTERN MED, V14, P499, DOI 10.1046/j.1525-1497.1999.08168.x; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; KUNST A, 1997, CROSS NATL COMP SOCI; LAW M, 1999, BRIT MED J, V313, P1471; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LEAPE LL, 1992, ANNU REV PUBL HEALTH, V13, P363, DOI 10.1146/annurev.pu.13.050192.002051; MOLD JW, 1986, NEW ENGL J MED, V314, P512, DOI 10.1056/NEJM198602203140809; Phillips DP, 1998, LANCET, V351, P643, DOI 10.1016/S0140-6736(98)24009-8; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Shi LY, 1999, J FAM PRACTICE, V48, P275; Starfield B, 2000, ANNU REV PUBL HEALTH, V21, P569, DOI 10.1146/annurev.publhealth.21.1.569; Starfield B, 1998, PRIMARY CARE BALANCI; Weingart SN, 2000, BRIT MED J, V320, P774, DOI 10.1136/bmj.320.7237.774; Wilkinson R., 1996, UNHEALTHY SOC AFFLIC	18	327	334	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					483	+		10.1001/jama.284.4.483	http://dx.doi.org/10.1001/jama.284.4.483			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	335QB	10904513				2022-12-28	WOS:000088254200036
J	Danesh, J; Whincup, P; Walker, M; Lennon, L; Thomson, A; Appleby, P; Gallimore, JR; Pepys, MB				Danesh, J; Whincup, P; Walker, M; Lennon, L; Thomson, A; Appleby, P; Gallimore, JR; Pepys, MB			Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Article							C-REACTIVE PROTEIN; SERUM AMYLOID-A; ACUTE-PHASE PROTEINS; MIDDLE-AGED MEN; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ENZYME-IMMUNOASSAY; LEUKOCYTE COUNT; RISK FACTOR; EVENTS	Objective To assess associations between baseline values of four different circulating markers of inflammation and future risk of coronary heart disease, potential triggers of systemic inflammation (such as persistent infection), and other markers of inflammation. Design Nested case-control comparisons in a prospective, population based cohort. Setting General practices in 18 towns in Britain. Participants 506 men who died from coronary heart disease or had a non-fatal myocardial infarction and 1025 men who remained free of such disease until 1996 selected from 5661 men aged 40-59 years who provided blood samples in 1978-1980. Main outcome measures Plasma concentrations of C reactive protein, serum amyloid A protein, and serum albumin and leucocyte count Information on fatal and non-fatal coronary heart disease was obtained from medical records and death certificates. Results Compared with men in the bottom third of baseline measurements of C reactive protein, men in the top third had an odds ratio for coronary heart disease of 2.13 (95% confidence interval 1.38 to 3.28) after age, town, smoking, vascular risk factors, and indicators of socioeconomic status were adjusted for. Similar adjusted odds ratios were 1.65 (1.07 to 2.55) for serum amyloid A protein; 1.12 (0.71 to 1.77) for leucocyte count; and 0.67 (0.43 to 1.04) for albumin. No strong associations were observed of these factors with Helicobacter pylori seropositivity, Chlamydia pneumoniae IgG titres, or plasma total homocysteine concentrations. Baseline values of the acute phase reactants were significantly associated with one another (P < 0.0001), although the association between low serum albumin concentration and leucocyte count was weaker (P = 0.08). Conclusion In the context of results from other relevant studies these findings suggest that some inflammatory processes, unrelated to the chronic infections studied here, are likely to be involved in coronary heart disease.	Univ Oxford, Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Univ Oxford, Radcliffe Infirm, Epidemiol Studies Unit, Oxford OX2 6HE, England; St George Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England; UCL Royal Free & Univ Coll Med Sch, Dept Med, London NW3 2PF, England; UCL Royal Free & Univ Coll Med Sch, Dept Populat Sci & Primary Care, London NW3 2PF, England; Imperial Canc Res Fund, Epidemiol Unit, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford; St Georges University London; University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School; University of Oxford	Danesh, J (corresponding author), Univ Oxford, Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England.		Lennon, Lucy/ABB-9433-2020; Lennon, Lucy/AFT-1973-2022	Lennon, Lucy/0000-0002-1738-1351; Whincup, Peter/0000-0002-5589-4107				Agewall S, 1998, J HYPERTENS, V16, P537, DOI 10.1097/00004872-199816040-00016; Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; CERMAK J, 1993, BLOOD, V82, P513, DOI 10.1182/blood.V82.2.513.513; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; Danesh J, 1999, JAMA-J AM MED ASSOC, V282, P2169, DOI 10.1001/jama.282.22.2169; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DEBEER FC, 1982, J EXP MED, V156, P230, DOI 10.1084/jem.156.1.230; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96; LOWE GDO, 1999, BLOOD COAGUL FIBRI S, V10, pS92; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; PHILLIPS A, 1989, LANCET, V2, P1434; PHILLIPS AN, 1992, AM J EPIDEMIOL, V136, P59, DOI 10.1093/oxfordjournals.aje.a116421; Poole S, 1998, J IMMUNOL METHODS, V214, P1, DOI 10.1016/S0022-1759(98)00057-X; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Roivainen M, 2000, CIRCULATION, V101, P252, DOI 10.1161/01.CIR.101.3.252; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SHAPER AG, 1981, BRIT MED J, V283, P179, DOI 10.1136/bmj.283.6285.179; Toss H, 1997, CIRCULATION, V96, P4204; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; WILKINS J, 1994, CLIN CHEM, V40, P1284; Wilkins J, 1998, CLIN CHEM, V44, P1358; Witherell H, 1999, GASTROENTEROLOGY, V116, pA355; Wong YK, 1999, J CLIN PATHOL, V52, P99, DOI 10.1136/jcp.52.2.99; Zhang YX, 1999, ATHEROSCLEROSIS, V145, P375, DOI 10.1016/S0021-9150(99)00105-7	34	1264	1335	0	48	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2000	321	7255					199	204		10.1136/bmj.321.7255.199	http://dx.doi.org/10.1136/bmj.321.7255.199			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903648	Green Published			2022-12-28	WOS:000088448100019
J	Danesh, J; Whincup, P; Walker, M; Lennon, L; Thomson, A; Appleby, P; Wong, YK; Bernardes-Silva, M; Ward, M				Danesh, J; Whincup, P; Walker, M; Lennon, L; Thomson, A; Appleby, P; Wong, YK; Bernardes-Silva, M; Ward, M			Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis	BRITISH MEDICAL JOURNAL			English	Article							MYOCARDIAL-INFARCTION; HELICOBACTER-PYLORI; SEROLOGICAL EVIDENCE; RISK FACTOR; INFECTION; ATHEROSCLEROSIS; CYTOMEGALOVIRUS; ROXITHROMYCIN; AZITHROMYCIN; ASSOCIATION	Objective To examine the association between coronary heart disease and serum markers of chronic Chlamydia pneumoniae infection. Design "Nested" case-control analysis in a prospective cohort study and an updated meta-analysis of previous relevant studies. Setting General practices in 18 towns in Britain. Participants Of the 5661 men aged 40-59 who provided blood samples during 1978-80, 496 men who died from coronary heart disease or had non-fatal myocardial infarction and 989 men who had not developed coronary heart disease by 1996 were included. Main outcome measures IgG serum antibodies to C pneumoniae in baseline samples; details of fatal and non-fatal coronary heart disease from medical records and death certificates. Results 200 (40%) of the 496 men with coronary heart disease were in the top third of C pneumoniae titres compared with 329 (33%) of the 989 controls. The corresponding odds ratio for coronary heart disease was 1.66 (95% confidence interval 1.25 to 2.21), which fell to 1.22 (0.82 to 1.82) after adjustment for smoking and indicators of socioeconomic status. No strong associations were observed between C pneumoniae IgG titres and blood lipid concentrations, blood pressure, or plasma homocysteine concentration. In aggregate, the present study and 14 other prospective studies of C pneumoniae IgG titres included 3169 cases, yielding a combined odds ratio of 1.15 (0.97 to 1.36), with no significant heterogeneity among the separate studies (chi(2) = 10.5, df = 14; P > 0.1). Conclusion This study, together with a meta-analysis of previous prospective studies, reliably excludes the existence of any strong association between C pneumoniae IgG titres and incident corollary heart disease. Further studies are required, however, to confirm or refute any modest association that may exist, particularly at younger ages.	Univ Oxford, Clin Trial Serv Unit, Oxford OX2 6HE, England; Univ Oxford, Epidemiol Studies Unit, Oxford OX2 6HE, England; St George Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England; UCL Royal Free & UCL Med Sch, Dept Populat Sci & Primary Care, London NW3 2PF, England; Imperial Canc Res Fund, Epidemiol Unit, Oxford OX2 6HE, England; Univ Southampton, Dept Cardiol, Southampton SO16 6YD, Hants, England; Univ Southampton, Dept Mol Microbiol, Southampton SO16 6YD, Hants, England	University of Oxford; University of Oxford; St Georges University London; University of London; University College London; University of Oxford; University of Southampton; University of Southampton	Danesh, J (corresponding author), Univ Oxford, Clin Trial Serv Unit, Oxford OX2 6HE, England.		Lennon, Lucy/AFT-1973-2022; Lennon, Lucy/ABB-9433-2020	Lennon, Lucy/0000-0002-1738-1351; Whincup, Peter/0000-0002-5589-4107				Anderson JL, 1999, CIRCULATION, V99, P1540, DOI 10.1161/01.CIR.99.12.1540; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Danesh J, 1999, BRIT MED J, V319, P1157, DOI 10.1136/bmj.319.7218.1157; Danesh J, 1998, Expert Opin Investig Drugs, V7, P691, DOI 10.1517/13543784.7.5.691; Glader CA, 2000, EUR HEART J, V21, P639, DOI 10.1053/euhj.1999.1755; Gupta S, 1997, CIRCULATION, V96, P404; Gurfinkel E, 1999, EUR HEART J, V20, P121, DOI 10.1053/euhj.1998.1283; Gurfinkel E, 1997, LANCET, V350, P404, DOI 10.1016/S0140-6736(97)07201-2; Haider Agha W., 1999, Journal of the American College of Cardiology, V33, p314A; Miettinen H, 1996, EUR HEART J, V17, P682; Nieto FJ, 1999, AM J EPIDEMIOL, V150, P149, DOI 10.1093/oxfordjournals.aje.a009974; Ossewaarde JM, 1998, EPIDEMIOL INFECT, V120, P93, DOI 10.1017/S0950268897008303; Ridker PM, 1999, ANN INTERN MED, V131, P573, DOI 10.7326/0003-4819-131-8-199910190-00004; Ridker PM, 1999, CIRCULATION, V99, P1161, DOI 10.1161/01.CIR.99.9.1161; Roivainen M, 2000, CIRCULATION, V101, P252, DOI 10.1161/01.CIR.101.3.252; SAIKKU P, 1992, ANN INTERN MED, V116, P273, DOI 10.7326/0003-4819-116-4-273; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; SISCOVIK DS, 1997, CIRCULATION S1, V97, P814; Strachan DP, 1999, BMJ-BRIT MED J, V318, P1035, DOI 10.1136/bmj.318.7190.1035; TAVENDALE R, 1999, EUR HEART J SUPPL, V20, P450; VONHERTZEN L, 1999, BRIT MED J, P1575; Wald NJ, 2000, BRIT MED J, V321, P204, DOI 10.1136/bmj.321.7255.204; Whincup P, 2000, CIRCULATION, V101, P1647; Wong YK, 1999, HEART, V81, P232, DOI 10.1136/hrt.81.3.232; Wong YK, 1999, J CLIN PATHOL, V52, P99, DOI 10.1136/jcp.52.2.99	25	237	244	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 22	2000	321	7255					208	212		10.1136/bmj.321.7255.208	http://dx.doi.org/10.1136/bmj.321.7255.208			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903653	Bronze, Green Published			2022-12-28	WOS:000088448100021
J	Allan, BB; Moyer, BD; Balch, WE				Allan, BB; Moyer, BD; Balch, WE			Rab1 recruitment of p115 into a cis-SNARE complex: Programming budding COPII vesicles for fusion	SCIENCE			English	Article							NUCLEOTIDE DISSOCIATION INHIBITOR; ENDOCYTIC MEMBRANE-FUSION; ENDOPLASMIC-RETICULUM; GOLGI TRANSPORT; VESICULAR TRANSPORT; T-SNARE; PROTEIN-TRANSPORT; CARRIER VESICLES; REQUIRES USO1P; IN-VITRO	The guanosine triphosphatase Rab1 regulates the transport of newly synthesized proteins from the endoplasmic reticulum to the Golgi apparatus through interaction with effector molecules, but the molecular mechanisms by which this occurs are unknown. Here, the tethering factor p115 was shown to be a Rab1 effector that binds directly to activated Rab1. Rab1 recruited p115 to coat protein complex II (COPII) vesicles during budding from the endoplasmic reticulum, where it interacted with a select set of COPII vesicle-associated SNAREs (soluble N-ethylmateimide-sensitive factor attachment protein receptors) to form a cis-SNARE complex that promotes targeting to the Golgi apparatus. We propose that Rab1-regulated assembly of functional effector-SNARE complexes defines a conserved molecular mechanism to coordinate recognition between subcellular compartments.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Balch, WE (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NATIONAL CANCER INSTITUTE [P01CA058689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042336, R01GM033301] Funding Source: NIH RePORTER; NCI NIH HHS [CA58689] Funding Source: Medline; NIGMS NIH HHS [GM42336, GM 33301] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN BW, UNPUB; Alvarez C, 1999, J CELL BIOL, V147, P1205, DOI 10.1083/jcb.147.6.1205; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097; BECKERS CJM, 1987, CELL, V50, P523, DOI 10.1016/0092-8674(87)90025-0; Burd CG, 1997, MOL BIOL CELL, V8, P1089, DOI 10.1091/mbc.8.6.1089; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Dascher C, 1996, J BIOL CHEM, V271, P15866, DOI 10.1074/jbc.271.27.15866; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; DAVIDSON HW, 1993, J BIOL CHEM, V268, P4216; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Grote E, 1999, MOL BIOL CELL, V10, P4149, DOI 10.1091/mbc.10.12.4149; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; Hui N, 1997, MOL BIOL CELL, V8, P1777, DOI 10.1091/mbc.8.9.1777; Kito M, 1996, BIOCHEM BIOPH RES CO, V220, P653, DOI 10.1006/bbrc.1996.0459; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; LIAN JP, 1994, NATURE, V372, P698, DOI 10.1038/372698a0; Lowe M, 1998, BBA-MOL CELL RES, V1404, P53, DOI 10.1016/S0167-4889(98)00046-9; Lupashin VV, 1997, SCIENCE, V276, P1255, DOI 10.1126/science.276.5316.1255; Martinez O, 1998, BBA-MOL CELL RES, V1404, P101, DOI 10.1016/S0167-4889(98)00050-0; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Nelson DS, 1998, J CELL BIOL, V143, P319, DOI 10.1083/jcb.143.2.319; NEWMAN AP, 1992, EMBO J, V11, P3609, DOI 10.1002/j.1460-2075.1992.tb05445.x; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; PETER F, 1994, J CELL BIOL, V126, P1393, DOI 10.1083/jcb.126.6.1393; Peterson MR, 1999, CURR BIOL, V9, P159, DOI 10.1016/S0960-9822(99)80071-2; PIND SN, 1994, J CELL BIOL, V125, P239, DOI 10.1083/jcb.125.2.239; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; REXACH MF, 1994, J CELL BIOL, V126, P1133, DOI 10.1083/jcb.126.5.1133; Rowe T, 1996, J CELL BIOL, V135, P895, DOI 10.1083/jcb.135.4.895; Rowe T, 1998, SCIENCE, V279, P696, DOI 10.1126/science.279.5351.696; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Sapperstein SK, 1996, J CELL BIOL, V132, P755, DOI 10.1083/jcb.132.5.755; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Schimmoller F, 1998, J BIOL CHEM, V273, P22161, DOI 10.1074/jbc.273.35.22161; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589; Stahl B, 1996, EMBO J, V15, P1799, DOI 10.1002/j.1460-2075.1996.tb00529.x; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Tall GG, 1999, MOL BIOL CELL, V10, P1873, DOI 10.1091/mbc.10.6.1873; Tisdale EJ, 1996, J BIOL CHEM, V271, P29372, DOI 10.1074/jbc.271.46.29372; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Turner MD, 1997, J BIOL CHEM, V272, P13479, DOI 10.1074/jbc.272.21.13479; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941; VONMOLLARD GF, 1994, TRENDS BIOCHEM SCI, V19, P164, DOI 10.1016/0968-0004(94)90278-X; Walter DM, 1998, J BIOL CHEM, V273, P29565, DOI 10.1074/jbc.273.45.29565; WATERS MG, 1992, J CELL BIOL, V118, P1015, DOI 10.1083/jcb.118.5.1015; Wu SK, 1998, J BIOL CHEM, V273, P26931, DOI 10.1074/jbc.273.41.26931	60	365	374	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					444	448		10.1126/science.289.5478.444	http://dx.doi.org/10.1126/science.289.5478.444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903204				2022-12-28	WOS:000088305500046
J	Dubrovinsky, LS; Dubrovinskaia, NA; Saxena, SK; Annersten, H; Halenius, E; Harryson, H; Tutti, F; Rekhi, S; Le Bihan, T				Dubrovinsky, LS; Dubrovinskaia, NA; Saxena, SK; Annersten, H; Halenius, E; Harryson, H; Tutti, F; Rekhi, S; Le Bihan, T			Stability of ferropericlase in the lower mantle	SCIENCE			English	Article							HIGH-PRESSURE; FEO; TEMPERATURE; COLLAPSE; EQUATION; WUSTITE; STATE; MGO; GPA	We have heated ferropericlases (Mg0.60Fe0.40)O and (Mg0.50Fe0.50)O to temperatures of 1000 kelvin at pressures of 86 gigapascals, simulating the stability of the solid solution at physical conditions relevant to Earth's lower mantle. The in situ x-ray study of the externally heated samples in a Mao-Bell-type diamond anvil cell shows that ferropericlase may dissociate into magnesium-rich and iron-rich oxide components. The result is important because the decomposition of ferropericlase into Lighter and heavier phases will cause dynamic effects that could lead to mantle heterogeneity.	Uppsala Univ, Inst Earth Sci, S-75236 Uppsala, Sweden; European Synchrotron Radiat Facil, F-38043 Grenoble, France	Uppsala University; European Synchrotron Radiation Facility (ESRF)	Dubrovinsky, LS (corresponding author), Uppsala Univ, Inst Earth Sci, S-75236 Uppsala, Sweden.		Dubrovinskaia, Natalia/A-8013-2015; LE BIHAN, Tristan/I-5063-2013	Dubrovinskaia, Natalia/0000-0002-8256-5675; Dubrovinsky, Leonid/0000-0002-3717-7585				Cohen RE, 1997, SCIENCE, V275, P654, DOI 10.1126/science.275.5300.654; Cohen RE, 1998, REV HIGH PRESS SCI T, V7, P160, DOI [10.4131/jshpreview.7.160, DOI 10.4131/JSHPREVIEW.7.160]; DUFFY TS, 1995, PHYS REV LETT, V74, P1371, DOI 10.1103/PhysRevLett.74.1371; Fang Z, 1998, PHYS REV LETT, V81, P1027, DOI 10.1103/PhysRevLett.81.1027; FEI Y, 1996, GEOCHEM SOC SPEC PUB, V243; FEI YW, 1994, SCIENCE, V266, P1678, DOI 10.1126/science.266.5191.1678; Fei YW, 1999, AM MINERAL, V84, P272; FEI YW, 1992, PHYS CHEM MINER, V18, P416; HALENIUS E, 1996, GEOCHEM SOC SPEC PUB, V5, P255; ISAAK DG, 1990, J GEOPHYS RES-SOLID, V95, P7055, DOI 10.1029/JB095iB05p07055; LARSON AC, 1994, MSH805 GSAS LANSCE, P86; Mao HK, 1997, SCIENCE, V278, P2098, DOI 10.1126/science.278.5346.2098; Mazin II, 1998, AM MINERAL, V83, P451; MCCAMMON CA, 1983, GEOPHYS J ROY ASTR S, V72, P577, DOI 10.1111/j.1365-246X.1983.tb02821.x; Pasternak MP, 1997, PHYS REV LETT, V79, P5046, DOI 10.1103/PhysRevLett.79.5046; RICHET P, 1989, J GEOPHYS RES-SOLID, V94, P3037, DOI 10.1029/JB094iB03p03037; Rosenhauer M., 1976, CARNEGIE I YB, V75, P513; Saxena SK, 2000, MINER PETROL, V69, P1, DOI 10.1007/s007100050016; Shu JF, 1998, NEUES JB MINER ABH, V172, P309; Stolen S, 1996, AM MINERAL, V81, P973	20	61	63	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					430	432		10.1126/science.289.5478.430	http://dx.doi.org/10.1126/science.289.5478.430			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903199				2022-12-28	WOS:000088305500041
J	Clarke, G; Collins, RA; Leavitt, BR; Andrews, DF; Hayden, MR; Lumsden, CJ; McInnes, RR				Clarke, G; Collins, RA; Leavitt, BR; Andrews, DF; Hayden, MR; Lumsden, CJ; McInnes, RR			A one-hit model of cell death in inherited neuronal degenerations	NATURE			English	Article							RETINITIS-PIGMENTOSA; RETINAL DEGENERATION; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; MUTANT MOUSE; LIGHT; NEURODEGENERATION; NUCLEAR; ROD; RAT	In genetic disorders associated with premature neuronal death, symptoms may not appear for years or decades. This delay in clinical onset is often assumed to reflect the occurrence of age-dependent cumulative damage(1-6). For example, it has been suggested that oxidative stress disrupts metabolism in neurological degenerative disorders by the cumulative damage of essential macromolecules(1,4,7). A prediction of the cumulative damage hypothesis is that the probability of cell death will increase over time. Here we show in contrast that the kinetics of neuronal death in 12 models of photoreceptor degeneration, hippocampal neurons undergoing excitotoxic cell deaths, a mouse model of cerebellar degeneration(9) and Parkinson's(10) and Huntington's diseases are all exponential and better explained by mathematical models in which the risk of cell death remains constant or decreases exponentially with age. These kinetics argue against the cumulative damage hypothesis; instead, the time of death of any neuron is random. Our findings are most simply accommodated by a 'one-hit' biochemical model in which mutation imposes a mutant steady state on the neuron and a single event randomly initiates cell death. This model appears to be common to many forms of neurodegeneration and has implications for therapeutic strategies.	Hosp Sick Children, Res Inst, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Res Inst, Genet Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Pediat, Toronto, ON M5S 1A8, Canada; Univ Toronto, Inst Med Sci, Dept Med, Toronto, ON M5S 1A8, Canada; Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; Univ Toronto, Dept Stat, Toronto, ON M5S 3G3, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of British Columbia; University of Toronto	McInnes, RR (corresponding author), Hosp Sick Children, Res Inst, Program Dev Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Hayden, Michael R/D-8581-2011; Leavitt, Blair R/G-1934-2012	Hayden, Michael R/0000-0001-5159-1419; leavitt, Blair/0000-0002-4532-766X				Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; BERSON EL, 1985, AM J OPHTHALMOL, V99, P240, DOI 10.1016/0002-9394(85)90351-4; Birch DG, 1999, OPHTHALMOLOGY, V106, P258, DOI 10.1016/S0161-6420(99)90064-7; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Cassarino DS, 1999, BRAIN RES REV, V29, P1, DOI 10.1016/S0165-0173(98)00046-0; Clarke G, 2000, NAT GENET, V25, P67, DOI 10.1038/75621; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Cummings JL, 1998, NEUROLOGY, V51, pS2, DOI 10.1212/WNL.51.1_Suppl_1.S2; DUBINSKY JM, 1995, NEUROPHARMACOLOGY, V34, P701, DOI 10.1016/0028-3908(95)00041-4; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; ERICKSON PA, 1983, INVEST OPHTH VIS SCI, V24, P927; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; Kremer B, 1999, NEUROLOGY, V53, P1000, DOI 10.1212/WNL.53.5.1000; LAVAIL MM, 1993, J COMP NEUROL, V333, P168, DOI 10.1002/cne.903330204; LAVAIL MM, 1982, J COMP NEUROL, V212, P217, DOI 10.1002/cne.902120302; Li ZY, 1995, DEGENERATIVE DISEASES OF THE RETINA, P1; MASSOF RW, 1990, CLIN VISION SCI, V5, P1; Parshall C. J., 1991, Progress in Veterinary & Comparative Ophthalmology, V1, P187; Ratkowsky D., 1983, NONLINEAR REGRESSION; SANYAL S, 1981, EXP EYE RES, V33, P213, DOI 10.1016/S0014-4835(81)80070-X; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; SCHMIDT SY, 1985, INVEST OPHTH VIS SCI, V26, P679; Seigel G M, 1997, Mol Vis, V3, P14; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Travis GH, 1998, AM J HUM GENET, V62, P503, DOI 10.1086/301772; Triarhou LC, 1998, BRAIN RES BULL, V47, P219, DOI 10.1016/S0361-9230(98)00076-8; WEN R, 1995, J NEUROSCI, V15, P7377	28	242	250	1	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					195	199		10.1038/35018098	http://dx.doi.org/10.1038/35018098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910361				2022-12-28	WOS:000088221100051
J	Schwartlander, B; Garnett, G; Walker, N; Anderson, R				Schwartlander, B; Garnett, G; Walker, N; Anderson, R			AIDS special report - AIDS in a new millennium	SCIENCE			English	Editorial Material							TRANSMISSION; RESISTANT		UNAIDS, CH-1211 Geneva 27, Switzerland; Univ Oxford, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 3PS, England	UNAIDS; University of Oxford	Schwartlander, B (corresponding author), UNAIDS, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.		Garnett, Geoffrey P/A-9312-2008					Anderson R.M., 1999, SEX TRANSM DIS, V3rd, P25; ANDERSON RM, 1988, NATURE, V332, P228, DOI 10.1038/332228a0; AsiimweOkiror G, 1997, AIDS, V11, P1757, DOI 10.1097/00002030-199714000-00013; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P151; Dodds JP, 2000, BRIT MED J, V320, P1510, DOI 10.1136/bmj.320.7248.1510; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; KITSIRIPORNCHAI S, 1998, 12 WORLD AIDS C GEN; *MIN HLTH STD AIDS, 1999, HIV AIDS SURV REP; Page-Shafer KA, 1999, JAMA-J AM MED ASSOC, V281, P696; Piot P, 2000, SCIENCE, V288, P2176, DOI 10.1126/science.288.5474.2176; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; UNAIDS, 2000, REP GLOB HIV AIDS EP; *UNAIDS BEST PRACT, 2000, EV 100 PERCENT CONDO; *US CENS BUR, 2000, WORLD POP PROF 2000; Wodak A, 1995, B NEW YORK ACAD MED, V72, P339; *WPRO WHO, 1999, STI AIDS SIT PEOPL R; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6; 1999, REPORT AIDS PREVENTI	19	26	26	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2000	289	5476					64	67		10.1126/science.289.5476.64	http://dx.doi.org/10.1126/science.289.5476.64			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332TW	10928930				2022-12-28	WOS:000088090400028
J	Golstein, P				Golstein, P			Signal transduction - FasL binds preassembled Fas	SCIENCE			English	Editorial Material							SELF-ASSOCIATION; RECEPTOR; APOPTOSIS; DOMAINS; DEATH		CNRS Marseille Luminy, INSERM, Ctr Immunol, F-13288 Marseille 9, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Golstein, P (corresponding author), CNRS Marseille Luminy, INSERM, Ctr Immunol, Case 906, F-13288 Marseille 9, France.		Golstein, Pierre/A-4954-2014	Golstein, Pierre/0000-0003-1750-3483				BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; Hueber AO, 2000, NAT CELL BIOL, V2, pE23, DOI 10.1038/35000092; ITOH N, 1993, J BIOL CHEM, V268, P10932; Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543; LENARDO MJ, COMMUNICATION; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Orlinick JR, 1997, J BIOL CHEM, V272, P32221, DOI 10.1074/jbc.272.51.32221; Papoff G, 1999, J BIOL CHEM, V274, P38241, DOI 10.1074/jbc.274.53.38241; PETER ME, 1995, CELL DEATH DIFFER, V2, P163; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; SLEGEL RM, 2000, SCIENCE, V288, P2354; Starling GC, 1998, BIOCHEMISTRY-US, V37, P3723, DOI 10.1021/bi972959d	15	37	42	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 30	2000	288	5475					2328	2329		10.1126/science.288.5475.2328	http://dx.doi.org/10.1126/science.288.5475.2328			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329NP	10917832				2022-12-28	WOS:000087913400027
J	Roizman, B				Roizman, B			Microbiology - Redefining virology	SCIENCE			English	Editorial Material							BINDING PROTEIN U(S)11		Univ Chicago, Marjorie B Kovler Viral Oncol Labs, Chicago, IL 60637 USA	University of Chicago	Roizman, B (corresponding author), Univ Chicago, Marjorie B Kovler Viral Oncol Labs, 910 E 58th St, Chicago, IL 60637 USA.							Bresnahan WA, 2000, SCIENCE, V288, P2373, DOI 10.1126/science.288.5475.2373; LWOFF A, 1962, COLD SPRING HARB SYM, V27, P51, DOI 10.1101/SQB.1962.027.001.008; ROFFMAN E, 1990, J VIROL, V64, P6308, DOI 10.1128/JVI.64.12.6308-6313.1990; Roizman B., 1974, COMPREHENSIVE VIROLO, P229, DOI DOI 10.1007/978-1-4684-2703-5_4; ROLLER RJ, 1992, J VIROL, V66, P3624, DOI 10.1128/JVI.66.6.3624-3632.1992; Roller RJ, 1996, J VIROL, V70, P2842, DOI 10.1128/JVI.70.5.2842-2851.1996	6	5	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 30	2000	288	5475					2327	2328		10.1126/science.288.5475.2327	http://dx.doi.org/10.1126/science.288.5475.2327			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329NP	10917831				2022-12-28	WOS:000087913400026
J	Cuttini, M; Nadai, M; Kaminski, M; Hansen, G; de Leeuw, R; Lenoir, S; Persson, J; Rebagliato, M; Reid, M; de Vonderweid, U; Lenard, HG; Orzalesi, M; Saracci, R				Cuttini, M; Nadai, M; Kaminski, M; Hansen, G; de Leeuw, R; Lenoir, S; Persson, J; Rebagliato, M; Reid, M; de Vonderweid, U; Lenard, HG; Orzalesi, M; Saracci, R		EURONIC Study Grp	End-of-life decisions in neonatal intensive care: physicians' self-reported practices in seven European countries	LANCET			English	Article							ETHICAL DECISIONS; INFANTS; UNIT; SUPPORT; DEATH; NETHERLANDS; DILEMMAS; NURSERY	Background The ethical issue of foregoing life-sustaining treatment for newborn infants at high risk of death or severe disability is extensively debated, but there is little information on how physicians in different countries actually confront this issue to reach end-of-life decisions. The EURONIC project aimed to investigate practices as reported by physicians themselves. Methods The study recruited a large, representative sample of 122 neonatal intensive-care units (NICUs) by census tin Luxembourg, the Netherlands, and Sweden) or stratified random sampling (in France, Germany, the UK, Italy, and Spain) with an overall response rate of 86%. Physicians' practices of end-of-life decision-making were investigated through an anonymous, self-administered questionnaire. 1235 completed questionnaires were returned (response rate 89%). Findings In all countries, most physicians reported having been involved at least once in setting limits to intensive care because of incurable conditions (61-96%); smaller proportions reported such involvement because of a baby's poor neurological prognosis (46-90%). Practices such as continuation of current treatment without intensification and withholding of emergency manoeuvres were widespread, but withdrawal of mechanical ventilation was reported by variable proportions (28-90%). Only in France (73%) and the Netherlands (47%) was the administration of drugs with the aim of ending life reported with substantial frequency. Age, length of professional experience, and the importance of religion in the physician's life affected the likelihood of reporting of non-treatment decisions. Interpretation A vast majority of neonatologists in European NICUs have been involved in end-of-life limitation of treatments, but type of decision-making varies among countries, Cultur-related and other country-specific factors are more relevant than characteristics of individual physicians or units in explaining such variability.	Burlo Garofolo Childrens Hosp, Epidemiol Unit, I-34137 Trieste, Italy; Burlo Garofolo Childrens Hosp, Neonatal Intens Care Unit, I-34137 Trieste, Italy; INSERM, U149, Epidemiol Unit Womens & Childrens Hlth, Villejuif, France; Univ Halle Wittenberg, Dept Pediat, Halle, Germany; Univ Amsterdam, Dept Neonatol, Amsterdam, Netherlands; Fac Med Toulouse, INSERM, CJF 8908, Unit Res Reprod, F-31073 Toulouse, France; Ctr Med Technol Assessment, Linkoping, Sweden; Miguel Hernandez Univ, Dept Publ Hlth, Alicante, Spain; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8QQ, Lanark, Scotland; Univ Dusseldorf, Dept Pediat, D-4000 Dusseldorf, Germany; Bambino Gesu Childrens Hosp, Neonatal Intens Care Unit, Rome, Italy; Natl Res Council, IFC, Div Epidemiol, Pisa, Italy	IRCCS Burlo Garofolo; IRCCS Burlo Garofolo; Institut National de la Sante et de la Recherche Medicale (Inserm); Martin Luther University Halle Wittenberg; University of Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); Universidad Miguel Hernandez de Elche; University of Glasgow; Heinrich Heine University Dusseldorf; IRCCS Bambino Gesu; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Cuttini, M (corresponding author), Burlo Garofolo Childrens Hosp, Epidemiol Unit, Via Istria 65-1, I-34137 Trieste, Italy.		Cuttini, Marina/AAI-1987-2019; Rebagliato, Marisa/L-6116-2018	Cuttini, Marina/0000-0002-3284-6874; Rebagliato, Marisa/0000-0001-5825-0190				Avery GB, 1998, SEMIN PERINATOL, V22, P216, DOI 10.1016/S0146-0005(98)80037-2; Cuttini M, 1999, ARCH DIS CHILD-FETAL, V81, pF84, DOI 10.1136/fn.81.2.F84; Cuttini M, 1997, PAEDIATR PERINAT EP, V11, P461, DOI 10.1046/j.1365-3016.1997.d01-29.x; DEHAN M, 1993, M S-MED SCI, V9, P260, DOI 10.4267/10608/2907; deLeeuw R, 1996, J PEDIATR-US, V129, P661, DOI 10.1016/S0022-3476(96)70146-4; DUFF RS, 1973, NEW ENGL J MED, V289, P890, DOI 10.1056/NEJM197310252891705; Garel M, 1997, ARCH PEDIATRIE, V4, P662, DOI 10.1016/S0929-693X(97)83370-2; Guillemin J, 1986, MIXED BLESSINGS INTE; KELLY NP, 1994, J PAEDIATR CHILD H, V30, P419, DOI 10.1111/j.1440-1754.1994.tb00692.x; Lemeshow S, 1998, AM J EPIDEMIOL, V148, P298; LEVIN BW, 1990, SOC SCI MED, V30, P901, DOI 10.1016/0277-9536(90)90218-H; Mason JK, 1996, LANCET, V347, P810, DOI 10.1016/S0140-6736(96)90875-2; McHaffie HE, 1999, J MED ETHICS, V25, P440, DOI 10.1136/jme.25.6.440; MCHAFFIE HE, 1996, LIFE DEATH DECISIONS; MULLER JH, 1992, SOC SCI MED, V34, P885, DOI 10.1016/0277-9536(92)90257-Q; Nederlandse Vereniging voor Kindergeneeskunde, 1992, DOEN LAT GRENZ MED H; Partridge JC, 1997, PEDIATRICS, V99, P76, DOI 10.1542/peds.99.1.76; Payer L., 1988, MED CULTURE VARIETIE; RAGATZ SC, 1983, CLIN PEDIATR, V22, P729, DOI 10.1177/000992288302201101; Rennie JM, 1996, ARCH DIS CHILD-FETAL, V74, pF214, DOI 10.1136/fn.74.3.F214; RHODEN NK, 1986, HASTINGS CENT REP, V16, P34, DOI 10.2307/3563115; *ROYAL COLL PAED C, 1997, WITHH WITHDR LIF SAV; RYAN CA, 1993, J PEDIATR-US, V123, P534, DOI 10.1016/S0022-3476(05)80946-1; Stevenson DK, 1998, SEMIN PERINATOL, V22, P198, DOI 10.1016/S0146-0005(98)80035-9; vanderHeide A, 1997, LANCET, V350, P251, DOI 10.1016/S0140-6736(97)02315-5; Wall SN, 1997, PEDIATRICS, V99, P64, DOI 10.1542/peds.99.1.64; WHITELAW A, 1986, LANCET, V2, P328; YOUNG EWD, 1990, AM J DIS CHILD, V144, P549, DOI 10.1001/archpedi.1990.02150290043023; YOUNG EWD, 1984, MONOGRAPH WORLD REHA, V25; 1999, CORRIERE SERA   0316; 2000, LANCET, V355, P79	31	270	273	0	30	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2112	2118		10.1016/S0140-6736(00)02378-3	http://dx.doi.org/10.1016/S0140-6736(00)02378-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	325QD	10902625				2022-12-28	WOS:000087687100011
J	Crosby, MH				Crosby, MH			Religious challenge by shareholder actions: changing the behaviour of tobacco companies and their allies	BRITISH MEDICAL JOURNAL			English	Article									Interfaith Ctr Corp Responsibil, Tobacco Program, New York, NY 10115 USA		Crosby, MH (corresponding author), Interfaith Ctr Corp Responsibil, Milwaukee, WI 53233 USA.							BALU R, 1988, WALL STREET J   0408, pB1; *BIBLE, CORINITHIANS, V6; BLUM A, 1985, NEW YORK STATE J MED, V85, P445; Blum A., 1992, TOB CONTROL, V1, P134, DOI [10.1136/tc.1.2.134, DOI 10.1136/TC.1.2.134]; CROSBY MH, 1998, NATL CATHOLIC R 1218, P24; DIFRANZA JR, 1995, J FAM PRACTICE, V40, P385; *IRRC, 1997, IRRC INV TOB REP; WILDEY MB, 1995, TOB CONTROL, V4, P355; 1994, CATECHISM CATHOLIC C, P551	9	7	7	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					375	377		10.1136/bmj.321.7257.375	http://dx.doi.org/10.1136/bmj.321.7257.375			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QH	10926603	Green Published			2022-12-28	WOS:000088656300033
J	Francey, N; Chapman, S				Francey, N; Chapman, S			"Operation Berkshire": the international tobacco companies' conspiracy	BRITISH MEDICAL JOURNAL			English	Article									VicHlth Ctr Tobacco Control, Carlton, Vic 3053, Australia; Wentworth Chambers, Sydney, NSW 2000, Australia		Chapman, S (corresponding author), Univ Sydney, Dept Publ Hlth & Community Med, Sydney, NSW 2006, Australia.		Chapman, Simon/D-4114-2009					BENTLEY, 1978, COMMUNICATION   0601; *BRIT AM TOB, 2000, 3 BRIT AM TOB; *BRIT AM TOPP, 1980, APPR AIM BEC STRONG; *CDCP, 2000, TOB IND DOC; COLBY FG, 1977, M WORK PART MED RES; COVINGTON MW, 1981, REPORT PUBLI POSITIO; CULLMAN H, 1976, COMMUNICATION   1203; DOYLE J, 1979, COMMUNICATION   0712; FALKIEWICZ AW, 1987, COMMUNICATION   0720; FERNANDES E, 2000, FOCUS NO SAFE CIGARE; GAISCH H, 2000, COMMUNICATION   0812; GARRETT RA, 2000, COMMUNICATION   0216; *ICOSI TASK FORC, 1978, 4 WORLD C SMOK HLTH; *INT COMM SMOK ISS, 1979, JOINT M NAT ASS ZUR; *INT COMM SMOK ISS, 1978, PROV JOB DESCR SECR; LOCKHART GHS, 2000, COMMUNICATION   0215; *MJL GFT BRIT AM T, 1980, POSS POS SMOK HLTH D; OSDENE TS, 2000, ROPER STUDYPROPOSAL; 1977, 2 ICOSI M BRILL LAUS; 1977, 1 INT COMM SMOK ISS; 1977, POSITION PAPER; DRAFT PRESS STATEMEN	22	56	56	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					371	374		10.1136/bmj.321.7257.371	http://dx.doi.org/10.1136/bmj.321.7257.371			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QH	10926602	Green Published			2022-12-28	WOS:000088656300032
J	Jha, P; Chaloupka, FJ				Jha, P; Chaloupka, FJ			The economics of global tobacco control	BRITISH MEDICAL JOURNAL			English	Review							SMOKING		WHO, Econ Advisory Serv, CH-1211 Geneva 27, Switzerland; Univ Illinois, Chicago, IL USA	World Health Organization; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Jha, P (corresponding author), WHO, Econ Advisory Serv, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.			Jha, Prabhat/0000-0001-7067-8341				[Anonymous], TOBACCO CONTROL DEV; Chaloupka FJ, 2000, TOBACCO CONTROL DEVE, P237; *CHIN AC PREV MED, 1997, SMOK CHIN 1996 NAT P; Gupta P C, 1996, Tob Control, V5, P114, DOI 10.1136/tc.5.2.114; Jha P., 2000, TOBACCO CONTROL DEV; Jha P., 1999, CURBING EPIDEMIC GOV; JOOSSENS L, 1995, BRIT MED J, V310, P1393, DOI 10.1136/bmj.310.6991.1393; Kenkel Donald, 2000, THBACCO CONTROL DEVE, P177; ORPHANIDES A, 1995, J POLIT ECON, V103, P739, DOI 10.1086/262001; PETO R, IN PRESS GLOBAL HLTH; Ranson K, 2000, TOBACCO CONTROL DEV, P427; Raw M, 1999, BMJ-BRIT MED J, V318, P182, DOI 10.1136/bmj.318.7177.182; SAFFER H, IN PRESS J HLTH EC; Siegel M, 1999, PREV MED, V29, P334, DOI 10.1006/pmed.1999.0551; SWEANOR DT, 1994, SMUGGLING TOBACCO PR; Taylor AL, 2000, TOBACCO CONTROL DEV, P343; TOWNSEND J, 1993, ADDICTION, V88, P43; *US DEP HHS, 1994, PREV TOB US YOUNG PE; *US DEP HHS, 1989, DHHS PUBL; VANDERMERWE R, 1998, EC TOBACCO CONTROL O, P199; Warner KE, 1997, JAMA-J AM MED ASSOC, V278, P1087, DOI 10.1001/jama.278.13.1087; Warner KE, 1995, TOB CONTROL, V4, P380; Weinstein ND, 1998, ANN BEHAV MED, V20, P135, DOI 10.1007/BF02884459; *WHO, 1999, MAK DIFF WORLD HLTH; Yurekli AA, 2000, HEALTH ECON, V9, P159, DOI 10.1002/(SICI)1099-1050(200003)9:2<159::AID-HEC499>3.0.CO;2-T; 1997, ECONOMIST       1220, P59; [No title captured]	27	173	174	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					358	361		10.1136/bmj.321.7257.358	http://dx.doi.org/10.1136/bmj.321.7257.358			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	342QH	10926598	Green Published			2022-12-28	WOS:000088656300029
J	Lieberman, DA; Weiss, DG; Bond, JH; Ahnen, DJ; Garewal, H; Chejfec, G; Harford, WV; Provenzale, D; Sontag, S; Schnell, T; Campbell, DR; Durbin, TE; Nelson, DB; Ewing, SL; Triadafilopoulos, G; Ramirez, FC; Lee, JG; Collins, JF; Fennerty, B; Johnston, TK; Corless, CT; McQuaid, KR; Sampliner, RE; Morales, TG; Fass, R; Smith, R; Maheshwari, Y				Lieberman, DA; Weiss, DG; Bond, JH; Ahnen, DJ; Garewal, H; Chejfec, G; Harford, WV; Provenzale, D; Sontag, S; Schnell, T; Campbell, DR; Durbin, TE; Nelson, DB; Ewing, SL; Triadafilopoulos, G; Ramirez, FC; Lee, JG; Collins, JF; Fennerty, B; Johnston, TK; Corless, CT; McQuaid, KR; Sampliner, RE; Morales, TG; Fass, R; Smith, R; Maheshwari, Y		Veterans Affairs Cooperative Study	Use of colonoscopy to screen asymptomatic adults for colorectal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FLEXIBLE SIGMOIDOSCOPY; COLONIC NEOPLASIA; FAMILY HISTORY; RISK; ADENOMAS; PREVENTION; MORTALITY; RELATIVES	Background and Methods: The role of colonoscopy in screening for colorectal cancer is uncertain. At 13 Veterans Affairs medical centers, we performed colonoscopy to determine the prevalence and location of advanced colonic neoplasms and the risk of advanced proximal neoplasia in asymptomatic patients (age range, 50 to 75 years) with or without distal neoplasia. Advanced colonic neoplasia was defined as an adenoma that was 10 mm or more in diameter, a villous adenoma, an adenoma with high-grade dysplasia, or invasive cancer. In patients with more than one neoplastic lesion, classification was based on the most advanced lesion. Results: Of 17,732 patients screened for enrollment, 3196 were enrolled; 3121 of the enrolled patients (97.7 percent) underwent complete examination of the colon. The mean age of the patients was 62.9 years, and 96.8 percent were men. Colonoscopic examination showed one or more neoplastic lesions in 37.5 percent of the patients, an adenoma with a diameter of at least 10 mm or a villous adenoma in 7.9 percent, an adenoma with high-grade dysplasia in 1.6 percent, and invasive cancer in 1.0 percent. Of the 1765 patients with no polyps in the portion of the colon that was distal to the splenic flexure, 48 (2.7 percent) had advanced proximal neoplasms. Patients with large adenomas (greater/equal 10 mm) or small adenomas (<10 mm) in the distal colon were more likely to have advanced proximal neoplasia than were patients with no distal adenomas (odds ratios, 3.4 [95 percent confidence interval, 1.8 to 6.5] and 2.6 [95 percent confidence interval, 1.7 to 4.1], respectively). However, 52 percent of the 128 patients with advanced proximal neoplasia had no distal adenomas. Conclusions: Colonoscopic screening can detect advanced colonic neoplasms in asymptomatic adults. Many of these neoplasms would not be detected with sigmoidoscopy. (N Engl J Med 2000; 343: 162-8.) (C)2000, Massachusetts Medical Society.	Oregon Hlth Sci Univ, Vet Affairs Med Ctr, Div Gastroenterol, Portland, OR 97207 USA; Vet Affairs Med Ctr, Perry Point, MD USA; Vet Affairs Med Ctr, Minneapolis, MN USA; Vet Affairs Med Ctr, Denver, CO USA; Vet Affairs Med Ctr, Tucson, AZ USA; Vet Affairs Med Ctr, Hines, IL USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Southern Arizona Veterans Affairs Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Lieberman, DA (corresponding author), Oregon Hlth Sci Univ, Vet Affairs Med Ctr, Div Gastroenterol, P3-GI,OB 1034, Portland, OR 97207 USA.							ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; FOUTCH PG, 1991, DIGEST DIS SCI, V36, P924, DOI 10.1007/BF01297142; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; GROSSMAN S, 1989, GASTROENTEROLOGY, V96, P299, DOI 10.1016/0016-5085(89)91551-5; HOSMER DW, 1989, APPL LOGISTIC REGRES; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Levin TR, 1999, JAMA-J AM MED ASSOC, V281, P1611, DOI 10.1001/jama.281.17.1611; LIEBERMAN DA, 1991, AM J GASTROENTEROL, V86, P946; MANDEL JS, 1993, NEW ENGL J MED, V329, P672; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; Pariente A, 1998, GASTROENTEROLOGY, V115, P7, DOI 10.1016/S0016-5085(98)70358-0; RANSOHOFF DF, 1994, NIH PUBL, P204; Read TE, 1997, NEW ENGL J MED, V336, P8, DOI 10.1056/NEJM199701023360102; Rex DK, 1997, GASTROENTEROLOGY, V112, P17, DOI 10.1016/S0016-5085(97)70213-0; REX DK, 1993, AM J GASTROENTEROL, V88, P825; Schoen RE, 1998, GASTROENTEROLOGY, V115, P533, DOI 10.1016/S0016-5085(98)70132-5; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; STJOHN DJB, 1993, ANN INTERN MED, V118, P785, DOI 10.7326/0003-4819-118-10-199305150-00005; *US PREV SERV TASK, 1996, PREV SERV TASK FORC, P89; Wallace MB, 1998, ANN INTERN MED, V129, P273, DOI 10.7326/0003-4819-129-4-199808150-00002; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; Winawer SJ, 1998, GASTROENTEROLOGY, V114, P625; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P1060; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; ZARCHY TM, 1994, GASTROENTEROLOGY, V106, P1501, DOI 10.1016/0016-5085(94)90403-0	26	1384	1431	1	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2000	343	3					162	168		10.1056/NEJM200007203430301	http://dx.doi.org/10.1056/NEJM200007203430301			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335HY	10900274				2022-12-28	WOS:000088239100001
J	Marangos, J				Marangos, J			Faster than a speeding photon	NATURE			English	Editorial Material							PROPAGATION		Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2BZ, England	Imperial College London	Marangos, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Prince Consort Rd, London SW7 2BZ, England.							Balcou P, 1997, PHYS REV LETT, V78, P851, DOI 10.1103/PhysRevLett.78.851; CHIAO RY, 1993, PHYS REV A, V48, P34; CHU S, 1982, PHYS REV LETT, V48, P738, DOI 10.1103/PhysRevLett.48.738; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; Mugnai D, 2000, PHYS REV LETT, V84, P4830, DOI 10.1103/PhysRevLett.84.4830; STEINBERG AM, 1994, PHYS REV A, V49, P2071, DOI 10.1103/PhysRevA.49.2071; STEINBERG AM, 1993, PHYS REV LETT, V71, P708, DOI 10.1103/PhysRevLett.71.708; Wang LJ, 2000, NATURE, V406, P277, DOI 10.1038/35018520	8	28	30	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					243	244		10.1038/35018657	http://dx.doi.org/10.1038/35018657			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917509				2022-12-28	WOS:000088251900027
J	Taga, A; Nordstrom, L; James, P; Johansson, B; Eriksson, O				Taga, A; Nordstrom, L; James, P; Johansson, B; Eriksson, O			Non-collinear states in magnetic sensors	NATURE			English	Article							MAGNETORESISTANCE; EXCHANGE	Certain materials have an electrical conductivity that is extremely sensitive to an applied magnetic field; this phenomenon, termed 'giant magnetoresistance'(1-3), can be used in sensor applications. Typically, such a device comprises several ferromagnetic layers, separated by non-magnetic spacer layer(s)-a so-called 'super-lattice' geometry(1-3). In the absence of a magnetic field, the ferromagnetic layers may be magnetized in opposite directions by interlayer exchange coupling, while an applied external magnetic field causes the magnetization directions to become parallel. Because the resistivity depends on the magnetization direction, an applied field that changes the magnetic configuration may be detected simply by measuring the change in resistance. In order to detect weak fields, the energy difference between different magnetization directions should be small; this is usually achieved by using many non-magnetic atomic spacer layers. Here we show, using first-principles theory, that materials combinations such as Fe/V/Co multilayers can produce a non-collinear magnetic state in which the magnetization direction between Fe and Co layers differs by about 90 degrees. This state is energetically almost degenerate with the collinear magnetic states, even though the number of non-magnetic vanadium spacer layers is quite small.	Univ Uppsala, Dept Phys, Condensed Matter Theory Grp, S-75121 Uppsala, Sweden	Uppsala University	Johansson, B (corresponding author), Univ Uppsala, Dept Phys, Condensed Matter Theory Grp, Box 530, S-75121 Uppsala, Sweden.		Eriksson, Olle/E-3265-2014	Eriksson, Olle/0000-0001-5111-1374				Aharoni A., 1996, INTRO THEORY FERROMA; BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472; BINASCH G, 1989, PHYS REV B, V39, P4828, DOI 10.1103/PhysRevB.39.4828; BRUNO P, 1995, PHYS REV B, V52, P411, DOI 10.1103/PhysRevB.52.411; PARKIN SSP, 1990, PHYS REV LETT, V64, P2304, DOI 10.1103/PhysRevLett.64.2304	5	25	25	1	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					280	282		10.1038/35018528	http://dx.doi.org/10.1038/35018528			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917524				2022-12-28	WOS:000088251900042
J	Gow, NAR; Brown, AJP; Odds, FC				Gow, NAR; Brown, AJP; Odds, FC			Microbiology - Candida's arranged marriage	SCIENCE			English	Editorial Material							GENETIC-ANALYSIS; ALBICANS; MUTANTS		Univ Aberdeen, Dept Mol & Cell Biol, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Gow, NAR (corresponding author), Univ Aberdeen, Dept Mol & Cell Biol, Aberdeen AB25 2ZD, Scotland.		Brown, Alistair J.P./B-6627-2014; GOW, Neil/AAS-5323-2021	GOW, Neil/0000-0002-2776-5850				BARTON RC, 1992, MOL MICROBIOL, V6, P171, DOI 10.1111/j.1365-2958.1992.tb01998.x; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; MACKAY V, 1974, GENETICS, V76, P273; Magee BB, 2000, SCIENCE, V289, P310, DOI 10.1126/science.289.5477.310; Odds FC, 2000, TRENDS MICROBIOL, V8, P4, DOI 10.1016/S0966-842X(99)01655-8; OLAIYA AF, 1980, J BACTERIOL, V141, P1284, DOI 10.1128/JB.141.3.1284-1290.1980; SUZUKI T, 1982, J BACTERIOL, V152, P893; Tibayrenc M, 1997, TRENDS MICROBIOL, V5, P253, DOI 10.1016/S0966-842X(97)01068-8; VANDERWA.JP, 1970, MYCOPATH MYCOL APPL, V40, P231; WHELAN WL, 1985, J BACTERIOL, V161, P1131, DOI 10.1128/JB.161.3.1131-1136.1985; WHELAN WL, 1981, J BACTERIOL, V145, P896, DOI 10.1128/JB.145.2.896-903.1981	13	7	11	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					256	257		10.1126/science.289.5477.256	http://dx.doi.org/10.1126/science.289.5477.256			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10917850				2022-12-28	WOS:000088169400030
J	Hull, CM; Raisner, RM; Johnson, AD				Hull, CM; Raisner, RM; Johnson, AD			Evidence for mating of the "asexual" yeast Candida albicans in a mammalian host	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; GENETICS; HOMOLOG; BIOLOGY; FUNGI	Since its classification nearly 80 years ago, the human pathogen Candida albicans has been designated as an asexual yeast. In this report, we describe the construction of C. albicans strains that were subtly altered at the mating-type-like (MTL) locus, a cluster of genes that resembles the mating-type Loci of other fungi. These derivatives were capable of mating after inoculation into a mammalian host. C. albicans is a diploid organism, but most of the mating products isolated from a mouse host were tetrasomic for the two chromosomes that could be rigorously monitored and, overall, exhibited substantially higher than 2n DNA content. These observations demonstrated that C, albicans can recombine sexually.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037049] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM37049] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Casselton LA, 1998, MICROBIOL MOL BIOL R, V62, P55, DOI 10.1128/MMBR.62.1.55-70.1998; Diener AC, 1996, GENETICS, V143, P769; Graser Y, 1996, P NATL ACAD SCI USA, V93, P12473, DOI 10.1073/pnas.93.22.12473; HERSKOWITZ I, 1992, MOL CELLULAR BIOL YE, V2, P583; Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271; HULL CM, UNPUB; JOHNSON AD, 1995, CURR OPIN GENET DEV, V5, P552, DOI 10.1016/0959-437X(95)80022-0; Kronstad JW, 1997, ANNU REV GENET, V31, P245, DOI 10.1146/annurev.genet.31.1.245; Leberer E, 1996, P NATL ACAD SCI USA, V93, P13217, DOI 10.1073/pnas.93.23.13217; Odds FC., 1988, CANDIDA CANDIDOSIS; Raymond M, 1998, MOL MICROBIOL, V27, P587, DOI 10.1046/j.1365-2958.1998.00704.x; SADHU C, 1992, MOL CELL BIOL, V12, P1977, DOI 10.1128/MCB.12.5.1977; Taylor JW, 1999, CLIN MICROBIOL REV, V12, P126, DOI 10.1128/CMR.12.1.126; Tibayrenc M, 1997, TRENDS MICROBIOL, V5, P253, DOI 10.1016/S0966-842X(97)01068-8; Turgeon BG, 1998, ANNU REV PHYTOPATHOL, V36, P115, DOI 10.1146/annurev.phyto.36.1.115; Vilgalys R, 1997, TRENDS MICROBIOL, V5, P254, DOI 10.1016/S0966-842X(97)01076-7	16	361	391	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					307	310		10.1126/science.289.5477.307	http://dx.doi.org/10.1126/science.289.5477.307			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894780				2022-12-28	WOS:000088169400044
J	Gunther, T; Chen, ZF; Kim, JS; Priemel, M; Rueger, JM; Amling, M; Moseley, JM; Martin, TJ; Anderson, DJ; Karsenty, G				Gunther, T; Chen, ZF; Kim, JS; Priemel, M; Rueger, JM; Amling, M; Moseley, JM; Martin, TJ; Anderson, DJ; Karsenty, G			Genetic ablation of parathyroid glands reveals another source of parathyroid hormone	NATURE			English	Article							MESSENGER-RIBONUCLEIC-ACID; BLOMSTRAND CHONDRODYSPLASIA; CELLS; DROSOPHILA; EXPRESSION; RECEPTOR; HYPERCALCEMIA; CALCIUM; PROTEIN; SWITCH	The parathyroid glands are the only known source of circulating parathyroid hormone (PTH), which initiates an endocrine cascade that regulates serum calcium concentration(1). Glial cells missing2 (Gcm2), a mouse homologue of Drosophila Gcm, is the only transcription factor whose expression is restricted to the parathyroid glands(2-5). Here we show that Gcm2-deficient mice lack parathyroid glands and exhibit a biological hypoparathyroidism, identifying Gcm2 as a master regulatory gene of parathyroid gland development. Unlike PTH receptor-deficient mice, however, Gcm2-deficient mice are viable and fertile, and have only a mildly abnormal bone phenotype. Despite their lack of parathyroid glands, Gcm2-deficient mice have PTH serum levels identical to those of wild-type mice, as do parathyroidectomized wild-type animals. Expression and ablation studies identified the thymus, where Gcm1, another Gcm homologue, is expressed, as the additional, downregulatable source of PTH. Thus, Gcm2 deletion uncovers an auxiliary mechanism for the regulation of calcium homeostasis in the absence of parathyroid glands. We propose that this backup mechanism may be a general feature of endocrine regulation.	Baylor Coll Med, Program Dev Biol, Dept Mol & Human Genet, Houston, TX 77030 USA; Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Hamburg, Dept Trauma Surg, D-20246 Hamburg, Germany; St Vincents Inst Med Res, Melbourne, Vic 3065, Australia	Baylor College of Medicine; Washington University (WUSTL); California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; University of Hamburg; St. Vincent's Institute of Medical Research	Karsenty, G (corresponding author), Baylor Coll Med, Program Dev Biol, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.			Gunther, Thomas/0000-0003-3903-9490				Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; AMIEL C, 1976, J CLIN INVEST, V57, P256, DOI 10.1172/JCI108276; BRONNER F, 1964, MINERAL METABOLISM D, P342; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; COWIE AT, 1945, NATURE, V156, P19; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Dusso AS, 1998, AM J KIDNEY DIS, V32, pS13, DOI 10.1053/ajkd.1998.v32.pm9808140; Emanuel RL, 1996, MOL ENDOCRINOL, V10, P555, DOI 10.1210/me.10.5.555; FRASER RA, 1990, ENDOCRINOLOGY, V127, P2517, DOI 10.1210/endo-127-5-2517; GRILL V, 1991, J CLIN ENDOCR METAB, V73, P1309, DOI 10.1210/jcem-73-6-1309; Hammett FS, 1927, J BIOL CHEM, V72, P505; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Jaffe R. B., 1991, REPROD ENDOCRINOLOGY, P389; Jobert AS, 1998, J CLIN INVEST, V102, P34, DOI 10.1172/JCI2918; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; KALU DN, 1970, LANCET, V1, P1363; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; KOVACS CS, 1998, 80 M END SOC, P91; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Loshkajian A, 1997, AM J MED GENET, V71, P283, DOI 10.1002/(SICI)1096-8628(19970822)71:3<283::AID-AJMG7>3.0.CO;2-V; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; NAVEHMANY T, 1989, ENDOCRINOLOGY, V125, P275, DOI 10.1210/endo-125-1-275; NEUBUSER A, 1995, DEV BIOL, V170, P701, DOI 10.1006/dbio.1995.1248; Potts J. T., 1998, METABOLIC BONE DIS C, P52; Selye H, 1932, ENDOCRINOLOGY, V16, P547, DOI 10.1210/endo-16-5-547; SILVER J, 1985, P NATL ACAD SCI USA, V82, P4270, DOI 10.1073/pnas.82.12.4270; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618	28	270	286	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					199	203		10.1038/35018111	http://dx.doi.org/10.1038/35018111			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910362				2022-12-28	WOS:000088221100052
J	Huxley, A; Rodiere, P; Paul, DM; van Dijk, N; Cubitt, R; Flouquet, J				Huxley, A; Rodiere, P; Paul, DM; van Dijk, N; Cubitt, R; Flouquet, J			Realignment of the flux-line lattice by a change in the symmetry of superconductivity in UPt3	NATURE			English	Article							VORTEX LATTICE; NEUTRON-DIFFRACTION; UNCONVENTIONAL SUPERCONDUCTOR; PHASE-DIAGRAM; ORDER; PENETRATION; TRANSITIONS; STATE	In 1957, Abrikosov(1) described how quanta of magnetic flux enter the interior of a bulk type II superconductor. It was subsequently predicted that, in an isotropic superconductor, the repulsive forces between the flux lines would cause them to order in two dimensions, forming a hexagonal lattice(2). Flux-line lattices with different geometry can also be found in conventional (type II) superconductors(3); however, the ideal hexagonal lattice structure should always occur when the magnetic field is applied along a hexagonal crystal direction(4). Here we report measurements of the orientation of the flux-line lattice in the heavy-fermion superconductor(5) UPt3, for this special case. As the temperature is increased, the hexagonal lattice, which is initially aligned along the crystal symmetry directions, realigns itself with the anisotropic superconducting gap. The superconductivity in UPt3 is unusual (even compared to unconventional oxide superconductors(6)) because the superconducting gap has a lower rotational symmetry than the crystal structure. This special feature enables our data to demonstrate clearly the link between the microscopic symmetry of the superconductivity and the mesoscopic physics of the flux-line lattice. Moreover, our observations provide a stringent test of the theoretical description of the unconventional superconductivity in UPt3.	CEA, Dept Rech Fondamentale Mat Condensee, SPSMS, F-38054 Grenoble 9, France; Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; Delft Univ Technol, NL-2629 JB Delft, Netherlands; Inst Max Von Laue Paul Langevin, F-38042 Grenoble 9, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Warwick; Delft University of Technology; Institut Laue-Langevin (ILL)	Huxley, A (corresponding author), CEA, Dept Rech Fondamentale Mat Condensee, SPSMS, F-38054 Grenoble 9, France.		cubitt, robert/B-9408-2008	cubitt, robert/0000-0003-1778-3307				Abrikosov AA., 1957, ZH EKSP TEOR FIZ+, V32, P1442, DOI DOI 10.1103/PHYSREV.133.A1226; ADENWALLA S, 1990, PHYS REV LETT, V65, P2298, DOI 10.1103/PhysRevLett.65.2298; Brandt EH, 1997, PHYS REV LETT, V78, P2208, DOI 10.1103/PhysRevLett.78.2208; BRISON JP, 1994, J LOW TEMP PHYS, V95, P145, DOI 10.1007/BF00754931; BROHOLM C, 1990, PHYS REV LETT, V65, P2062, DOI 10.1103/PhysRevLett.65.2062; CLEM JR, 1975, J LOW TEMP PHYS, V18, P427, DOI 10.1007/BF00116134; ELLMAN B, 1996, PHYS REV B, V54, P9403; Eskildsen MR, 1998, NATURE, V393, P242, DOI 10.1038/30447; GORKOV LP, 1987, SOV SCI REV A, V9, P1; Heffner R. H., 1996, Comments on Condensed Matter Physics, V17, P361; Joynt R, 1997, PHYS REV LETT, V78, P3189, DOI 10.1103/PhysRevLett.78.3189; KLEIMAN RN, 1992, PHYS REV LETT, V69, P3120, DOI 10.1103/PhysRevLett.69.3120; KLEINER WH, 1964, PHYS REV A-GEN PHYS, V133, P1226; Kogan VG, 1997, PHYS REV B, V55, pR8693, DOI 10.1103/PhysRevB.55.R8693; Kogan VG, 1996, PHYS REV B, V54, P12386, DOI 10.1103/PhysRevB.54.12386; Kycia JB, 1998, PHYS REV B, V58, pR603, DOI 10.1103/PhysRevB.58.R603; LEGGETT AJ, 1999, ELECT CENTENARY VOLU, P148; LONDON E, 1950, SUPERFLUIDS; Luk'yanchuk I. A., 1995, Superconductivity Review, V1, P207; PARK KA, 1995, PHYS REV LETT, V74, P4734, DOI 10.1103/PhysRevLett.74.4734; Paul DM, 1998, PHYS REV LETT, V80, P1517, DOI 10.1103/PhysRevLett.80.1517; Riseman TM, 1998, NATURE, V396, P242, DOI 10.1038/24335; SAULS JA, 1994, ADV PHYS, V43, P113, DOI 10.1080/00018739400101475; TAILLEFER L, 1988, PHYS REV LETT, V60, P1570, DOI 10.1103/PhysRevLett.60.1570; TAKANAKA K, 1973, PROG THEOR PHYS, V50, P365, DOI 10.1143/PTP.50.365; TOKUYASU TA, 1990, PHYS REV B, V41, P8891, DOI 10.1103/PhysRevB.41.8891; Yaouanc A, 1998, J PHYS-CONDENS MAT, V10, P9791, DOI 10.1088/0953-8984/10/43/023; YARON U, 1994, PHYS REV LETT, V73, P2748, DOI 10.1103/PhysRevLett.73.2748; Yaron U, 1997, PHYS REV LETT, V78, P3185, DOI 10.1103/PhysRevLett.78.3185	32	66	66	1	21	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					160	164		10.1038/35018020	http://dx.doi.org/10.1038/35018020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910349				2022-12-28	WOS:000088221100039
J	Li, S; Ting, NSY; Zheng, L; Chen, PL; Ziv, Y; Shiloh, Y; Lee, EYHP; Lee, WH				Li, S; Ting, NSY; Zheng, L; Chen, PL; Ziv, Y; Shiloh, Y; Lee, EYHP; Lee, WH			Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response	NATURE			English	Article							PROTEIN-KINASE; BREAST-CANCER; CELL-CYCLE; ATM; PHOSPHORYLATION; P53; EXPRESSION; BINDING; PATHWAY; GADD45	BRCA1 encodes a familial breast cancer suppressor that has a critical role in cellular responses to DNA damage(1,2). Mouse cells deficient for Brca1 show genetic instability, defective G2-M checkpoint control and reduced homologous recombination(3,4). BRCA1 also directly interacts with proteins of the DNA repair machinery(5) and regulates expression of both the p21 and GADD45 genes(6-8). However, it remains unclear how DNA damage signals are transmitted to modulate the repair function of BRCA1. Here we show that the BRCA1-associated protein CtIP(9-12) becomes hyperphosphorylated and dissociated from BRCA1 upon ionizing radiation. This phosphorylation event requires the protein kinase (ATM) that is mutated in the disease ataxia telangiectasia(13). ATM phosphorylates CtIP at serine residues 664 and 745, and mutation of these sites to alanine abrogates the dissociation of BRCA1 from CtIP, resulting in persistent repression of BRCA1-dependent induction of GADD45 upon ionizing radiation. We conclude that ATM, by phosphorylating CtIP upon ionizing radiation, may modulate BRCA1-mediated regulation of the DNA damage-response GADD45 gene, thus providing a potential link between ATM deficiency and breast cancer.	Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA; Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel	University of Texas System; University of Texas Health San Antonio; Tel Aviv University; Sackler Faculty of Medicine	Lee, WH (corresponding author), Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA.	leew@uthscsa.edu	LI, SHANG/HII-4989-2022	LI, SHANG/0000-0002-6226-3362				Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; CHENG CY, 1985, INT J ANDROL, V8, P1, DOI 10.1111/j.1365-2605.1985.tb00812.x; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Lavin M, 1998, BRIT MED J, V317, P486; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Swift M, 1999, BRIT MED J, V318, P400, DOI 10.1136/bmj.318.7180.400; Welcsh PL, 2000, TRENDS GENET, V16, P69, DOI 10.1016/S0168-9525(99)01930-7; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	25	257	268	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					210	215		10.1038/35018134	http://dx.doi.org/10.1038/35018134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910365				2022-12-28	WOS:000088221100055
J	Harrington, M; Carpenter, CCJ				Harrington, M; Carpenter, CCJ			Hit HIV-1 hard, but only when necessary	LANCET			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS INFECTION; PNEUMOCYSTIS-CARINII PNEUMONIA; CD4 CELL COUNTS; CUBIC MILLIMETER; CONTROLLED TRIAL; IN-VIVO; DISCONTINUATION; INDIVIDUALS; RESPONSES	Randomised, controlled trial data show that combination antiretroviral therapy for HIV-1 infection benefits people with CD4-cell counts less than 350 cells/mu L. Based on currently known risks and benefits, we believe that if CD4-cell counts and viral load are monitored carefully, and highly active antiretroviral therapy (HAART) is started commonly when the CD4-cell count drops below 350 cells/mu L, then clinically relevant immune-system damage and progression to AIDS and death can be greatly delayed or prevented. This approach is dictated by three features of HIV-1 infection that are not typical of infectious diseases: no available regimen can eradicate HIV-1; all currently effective regimens may cause undesirable, sometimes life-threatening, toxic effects; and, unless regimens are strictly adhered to, multidrug resistance can develop, limiting future treatment options. If therapy is started too early, cumulative side-effects of the drugs used and the development of multidrug resistance may outweigh the net benefits of the lengthening of life. If therapy is started too late, increases in disease progression and mortality outweigh the risk of adverse events. A patients' activist (MH) and a clinician (CCJC) discuss data that justify this balanced approach and the feasibility of randomised controlled trials to provide clearer answers about when to start treatment.	Treatment Act Grp, New York, NY 10001 USA; Brown Univ, Miriam Hosp, Sch Med, Providence, RI USA	Brown University; Lifespan Health Rhode Island; Miriam Hospital	Harrington, M (corresponding author), Treatment Act Grp, 350 7th Ave,Suite 1603, New York, NY 10001 USA.	markharrington@aol.com						[Anonymous], 1999, MMWR Recomm Rep, V48, P1; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; CARR A, 1998, 5 C RETR OPP INF CHI; CHUN TW, 2000, 7 C RETR OPP INF SAN; Cohen OJ, 2000, J CLIN INVEST, V105, P709, DOI 10.1172/JCI9590; Cooper DA, 1998, NEW ENGL J MED, V339, P1319, DOI 10.1056/NEJM199810293391810; CURRIER JS, 1999, 39 INT C ANT AG CHEM; DEEKS SG, 2000, 7 C RETR OPP INF SAN; DELFRAISSY JF, 1999, PRISE CHARGE THERAPE; *DEP HHS HJ KAIS F, 2000, GUID US ANT AG HIV I; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Gallant JE, 2000, JAMA-J AM MED ASSOC, V283, P1329, DOI 10.1001/jama.283.10.1329; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hammer SM, 1996, NEW ENGL J MED, V335, P1081, DOI 10.1056/NEJM199610103351501; Ho DD, 1997, J CLIN INVEST, V99, P2565, DOI 10.1172/JCI119443; Junghans C, 1999, AIDS, V13, P2547, DOI 10.1097/00002030-199912240-00008; Komanduri KV, 1998, NAT MED, V4, P953, DOI 10.1038/nm0898-953; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; MEIBOHM A, 2000, 7 C RETR OPP INF SAN; *NAT PROGR STD AID, 1999, REC ANT THER HIV INF; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paterson D., 1999, 6 C RETR OPP INF CHI; PHAIR J, 1990, NEW ENGL J MED, V322, P161, DOI 10.1056/NEJM199001183220304; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; POZNIAK A, 1999, BRIT HIV ASS BHIVA G; Rizzardi GP, 2000, J CLIN INVEST, V105, P777, DOI 10.1172/JCI9079; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rouzine IM, 1999, P NATL ACAD SCI USA, V96, P10758, DOI 10.1073/pnas.96.19.10758; Safrin S, 1999, AIDS, V13, P2493, DOI 10.1097/00002030-199912240-00002; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Weverling GJ, 1999, LANCET, V353, P1293, DOI 10.1016/S0140-6736(99)03287-0; Whitcup SM, 1999, JAMA-J AM MED ASSOC, V282, P1633, DOI 10.1001/jama.282.17.1633; Zhang ZQ, 1998, P NATL ACAD SCI USA, V95, P1154, DOI 10.1073/pnas.95.3.1154	36	85	87	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2000	355	9221					2147	2152		10.1016/S0140-6736(00)02388-6	http://dx.doi.org/10.1016/S0140-6736(00)02388-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902643				2022-12-28	WOS:000087687100039
J	Clark, PI; Natanblut, SL; Schmitt, CL; Wolters, C; Iachan, R				Clark, PI; Natanblut, SL; Schmitt, CL; Wolters, C; Iachan, R			Factors associated with tobacco sales to minors - Lessons learned from the FDA compliance checks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							YOUTH ACCESS; CIGARETTE SALES; UNDERAGE YOUTH; AVAILABILITY; COMMUNITIES; LAWS; AGE	Context. Tobacco products continue to be widely accessible to miners. Between 1997 and 1999, the US Food and Drug Administration (FDA) conducted more than 150000 tobacco sales age-restriction compliance checks. Data obtained from these checks provide important guidance for curbing illegal sales. Objective To determine which elements of the compliance checks were most highly associated with illegal sales and thereby inform best practices for conducting efficient compliance check programs. Design and Setting Cross-sectional analysis of FDA compliance checks in 110062 unique establishments in 36 US states and the District of Columbia. Main Outcome Measure Illegal sales of tobacco to miners at compliance checks; association of illegal sales with variables such as age and sex of the minor. Results The rate of illegal sales for all first compliance checks in unique stores was 26.6%. Clerk failure to request proof of age was strongly associated with illegal sales (uncorrected sales rate, 10.5% compared with 89.5% sales when proof was not requested; multivariate-adjusted odds ratio [OR], 0.03; 95% confidence interval [CI], 0.03-0.04). Other factors associated with increased illegal sales were employment of older miners to make the purchase attempt (adjusted ORs for 16- and 17-year-old miners compared with 15-year-olds were 1.52 [95% CI, 1.46-1.63] and 2.43 [95% CI, 2.31-2.59], respectively), attempt to purchase smokeless tobacco (adjusted OR, 2.16 [95% CI, 1.90-2.45] vs cigarette purchase attempts), and performing checks at or after 5 PM (adjusted OR, 1.28 [95% CI, 1.21-1.35] vs before 5 PM). Female sex of clerk and minor, Saturday checks, type of store (convenience store selling gas, gas station, drugstore, supermarket and general merchandise), and rural store locations also were associated with increased illegal sales. Conclusions This analysis found that a request for age verification strongly predicted compliance with the law. The results suggest several ways in which the process of compliance checks might be optimized.	Battelle Mem Inst, Ctr Publ Hlth Res & Evaluat, Baltimore, MD 21209 USA; US FDA, Off Tobacco Programs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA); FDA Center for Tobacco Products (CTP)	Clark, PI (corresponding author), Battelle Mem Inst, Ctr Publ Hlth Res & Evaluat, 6115 Falls Rd,Suite 200, Baltimore, MD 21209 USA.							ALTMAN DG, 1989, JAMA-J AM MED ASSOC, V261, P80, DOI 10.1001/jama.261.1.80; Arday DR, 1997, PREV MED, V26, P8, DOI 10.1006/pmed.1996.9984; BOYLE RG, 1995, HEALTH VAL, V19, P10; Cismoski J, 1993, Wis Med J, V92, P626; DiFranza JR, 1996, AM J PUBLIC HEALTH, V86, P221, DOI 10.2105/AJPH.86.2.221; DiFranza JR, 1999, TOB CONTROL, V8, P152, DOI 10.1136/tc.8.2.152; DiFranza JR, 1999, PREV MED, V29, P321, DOI 10.1006/pmed.1999.0553; DIFRANZA JR, 1987, JAMA-J AM MED ASSOC, V257, P3387, DOI 10.1001/jama.257.24.3387; DiFranza JR, 1999, AM J PUBLIC HEALTH, V89, P1106, DOI 10.2105/AJPH.89.7.1106; *FDA, 1996, FED REGISTER, V61, P44369; FORSTER J L, 1989, Health Education Research, V4, P45, DOI 10.1093/her/4.1.45; FORSTER JL, 1992, PREV MED, V21, P320, DOI 10.1016/0091-7435(92)90031-C; Forster JL, 1998, ANNU REV PUBL HEALTH, V19, P203, DOI 10.1146/annurev.publhealth.19.1.203; Gratias EJ, 1999, J ADOLESCENT HEALTH, V25, P276, DOI 10.1016/S1054-139X(99)00019-1; HOPPOCK KC, 1990, J FAM PRACTICE, V30, P174; Jason LA, 1996, EVAL HEALTH PROF, V19, P3, DOI 10.1177/016327879601900101; JOHNSTON L, 2000, CIGARETTE SMOKING AM; JOHNSTON L, 1994, NATL SURVEY RESULTS, V1; Keay K.D., 1993, TOB CONTROL, V2, P145, DOI [10.1136/tc.2.2.145, DOI 10.1136/TC.2.2.145]; LANDRINE H, 1994, PREV MED, V23, P322, DOI 10.1006/pmed.1994.1045; LANGEMANN HA, 1996, ENV HLTH REV, V40, P6; MYLLYLUOMA J, 1996, COMMUNITY CONTEXT ST; *NAT ASS CONV STOR, 1997, PREV TOB SAL MIN; O'Grady B, 1999, TOB CONTROL, V8, P301, DOI 10.1136/tc.8.3.301; O'Grady W, 2000, CAN J CRIMINOL, V42, P1; Radecki Thomas E., 1993, TOB CONTROL, V2, P300, DOI DOI 10.1136/TC.2.4.300; Rigotti NA, 1997, NEW ENGL J MED, V337, P1044, DOI 10.1056/NEJM199710093371505; SANSONFISHER RW, 1992, AUST J PUBLIC HEALTH, V16, P354; *US DEP HHS, 1994, PREV TOB US YOUNG PE; 1996, MMWR MORB MORTAL WKL, V45, P1095; 1990, MMWR MORB MORTAL WKL, V39, P794; 1995, MMWR MORB MORTAL WKL, V44, P839; 1996, MMWR MORB MORTAL WKL, V45, P1079	33	52	53	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					729	734		10.1001/jama.284.6.729	http://dx.doi.org/10.1001/jama.284.6.729			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	341JM	10927782	Bronze			2022-12-28	WOS:000088587300032
J	Wu, JF; Sunda, W; Boyle, EA; Karl, DM				Wu, JF; Sunda, W; Boyle, EA; Karl, DM			Phosphate depletion in the western North Atlantic Ocean	SCIENCE			English	Article							PACIFIC-OCEAN; NITROGEN-FIXATION; FERTILIZATION EXPERIMENT; DISSOLVED PHOSPHORUS; NUTRIENT; IRON; DENITRIFICATION; PHYTOPLANKTON; TRICHODESMIUM; RATIOS	Surface waters of the subtropical Sargasso Sea contain dissolved inorganic phosphate (DIP) concentrations of 0.2 to 1.0 nanomolar, which are sufficiently Low to result in phosphorus control of primary production. The DIP concentrations in this area (which receives high inputs of iron-rich dust from arid regions of North Africa) are one to two orders of magnitude lower than surface Levels in the North Pacific (where eolian iron inputs are much Lower and water column denitrification is much more substantial). These data indicate a severe relative phosphorus depletion in the Atlantic. We hypothesize that nitrogen versus phosphorus Limitation of primary production in the present-day ocean may be closely linked to iron supply through control of dinitrogen (N-2) fixation, an iron-intensive metabolic process. Although the oceanic phosphorus inventory may set the upper Limit for the total amount of organic matter produced in the ocean over geological time scales, at any instant in geological time, oceanic primary production may fall below this Limit because of a persistent insufficient iron supply. By controlling N-2 fixation, iron may control not only nitrogen versus phosphorus Limitation but also carbon fixation and export stoichiometry and hence biological sequestration of atmospheric carbon dioxide.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; NOAA, Beaufort Lab, Beaufort, NC 28516 USA; Univ Hawaii, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA	Massachusetts Institute of Technology (MIT); National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System	Wu, JF (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.		Karl, David/AFP-3837-2022; Wu, Jingfeng/B-1301-2012	Wu, Jingfeng/0000-0003-0156-1507; Karl, David/0000-0002-6660-6721				Abell J, 2000, J MAR RES, V58, P203, DOI 10.1357/002224000321511142; ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; ARMSTRONG FA, 1967, DEEP-SEA RES, V14, P381, DOI 10.1016/0011-7471(67)90082-4; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; BARBER RT, 1992, ENVIR SCI R, V43, P89; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; Broecker W.S., 1982, TRACERS SEA; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; BRULAND K, COMMUNICATION; Bruland K. W., 1983, Trace Metals in Sea Water. Proceedings of the NATO Advanced Research Institute, P395; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CARPENTER EJ, 1991, SCIENCE, V254, P1356, DOI 10.1126/science.254.5036.1356; CLINE JD, 1972, LIMNOL OCEANOGR, V17, P885, DOI 10.4319/lo.1972.17.6.0885; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; CODISPOTI LA, 1976, LIMNOL OCEANOGR, V21, P379, DOI 10.4319/lo.1976.21.3.0379; CODISPOTI LA, 1995, NATURE, V376, P724, DOI 10.1038/376724a0; CODISPOTI LA, 1985, MAR CHEM, V16, P277, DOI 10.1016/0304-4203(85)90051-9; CODISPOTI LA, 1989, LIFE SCI R, V44, P377; DITULLIO GR, 1993, LIMNOL OCEANOGR, V38, P495, DOI 10.4319/lo.1993.38.3.0495; Duce RA, 1991, GLOBAL BIOGEOCHEM CY, V5, P193, DOI 10.1029/91GB01778; DUCE RA, 1991, LIMNOL OCEANOGR, V36, P1715, DOI 10.4319/lo.1991.36.8.1715; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; Evans JC, 1997, LIMNOL OCEANOGR, V42, P461, DOI 10.4319/lo.1997.42.3.0461; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FANNING KA, 1992, J GEOPHYS RES-OCEANS, V97, P5693, DOI 10.1029/92JC00007; GALLOWAY JN, 1995, GLOBAL BIOGEOCHEM CY, V9, P235, DOI 10.1029/95GB00158; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; JACKSON GA, 1985, DEEP-SEA RES, V32, P223, DOI 10.1016/0198-0149(85)90030-5; JOHNSON DL, 1971, ENVIRON SCI TECHNOL, V5, P411, DOI 10.1021/es60052a005; Jones DR, 1996, DEEP-SEA RES PT I, V43, P1567, DOI 10.1016/S0967-0637(96)00079-9; KARI DM, 1992, MARINE PELAGIC CYANO, P219; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; KARL DM, 1992, LIMNOL OCEANOGR, V37, P105, DOI 10.4319/lo.1992.37.1.0105; Karl DM, 1997, MAR CHEM, V56, P77, DOI 10.1016/S0304-4203(96)00081-3; LIBES SM, 1999, INTRO MARINE BIOGEOC, V400, P525; Lipschultz F, 1996, BIOGEOCHEMISTRY, V35, P261, DOI 10.1007/BF02179830; LONGHURST AR, 1991, LIMNOL OCEANOGR, V36, P1507, DOI 10.4319/lo.1991.36.8.1507; MCELROY MB, 1983, NATURE, V302, P328, DOI 10.1038/302328a0; Michaels AF, 1996, BIOGEOCHEMISTRY, V35, P181, DOI 10.1007/BF02179827; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Prospero JM, 1996, BIOGEOCHEMISTRY, V35, P27, DOI 10.1007/BF02179824; RAVEN JA, 1988, NEW PHYTOL, V109, P279, DOI 10.1111/j.1469-8137.1988.tb04196.x; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; RHEE GY, 1973, J PHYCOL, V9, P495, DOI 10.1111/j.1529-8817.1973.tb04126.x; RUETER JG, 1992, NATO ADV SCI I C-MAT, V362, P289; RUETER JG, 1988, J PHYCOL, V24, P249; SCHINDLER DW, 1976, SCIENCE, V193, P251; SMITH SV, 1984, LIMNOL OCEANOGR, V29, P1149, DOI 10.4319/lo.1984.29.6.1149; SMITH SV, 1986, LIMNOL OCEANOGR, V31, P161, DOI 10.4319/lo.1986.31.1.0161; STOCKNER JG, 1988, LIMNOL OCEANOGR, V33, P1348, DOI 10.4319/lo.1988.33.6.1348; STRICKLAND J. D. H., 1972, PRACTICAL HDB SEAWAT; SUNDA WG, 1992, LIMNOL OCEANOGR, V37, P25, DOI 10.4319/lo.1992.37.1.0025; THOMAS WH, 1969, J FISH RES BOARD CAN, V26, P1133, DOI 10.1139/f69-104; THOMAS WILLIAM H., 1966, DEEP SEA RES OCEANOGR ABSTR, V13, P1109, DOI 10.1016/0011-7471(66)90702-9; Thomson-Bulldis A, 1998, LIMNOL OCEANOGR, V43, P1565, DOI 10.4319/lo.1998.43.7.1565; Toggweiler JR, 1999, NATURE, V400, P511, DOI 10.1038/22892; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Villareal T.A., 1989, BIOL OCEANOGR, V6, P327, DOI [10.1080/01965581.1988.10749535, DOI 10.1080/01965581.1988.10749535]; WURTSBAUGH WA, 1983, CAN J FISH AQUAT SCI, V40, P1419, DOI 10.1139/f83-164	62	588	615	7	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2000	289	5480					759	762		10.1126/science.289.5480.759	http://dx.doi.org/10.1126/science.289.5480.759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926534				2022-12-28	WOS:000088581500035
J	Leibowitz, HM				Leibowitz, HM			Primary care: The red eye.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							EPIDEMIC KERATOCONJUNCTIVITIS; OPHTHALMIC CHLORAMPHENICOL; GENERAL-PRACTICE; TEAR FILM; CONJUNCTIVITIS		Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA	Boston University	Leibowitz, HM (corresponding author), Boston Univ, Sch Med, Dept Ophthalmol, 715 Albany St,Suite L907, Boston, MA 02118 USA.							ALBERT DM, 1994, PRINCIPLES PRACTICE, V4, P2828; DART JKG, 1986, BRIT MED J, V293, P1477, DOI 10.1136/bmj.293.6560.1477; DAWSON CR, 1998, CORNEAL DISORDERS CL, P644; Donahue SP, 1996, DRUGS, V52, P526, DOI 10.2165/00003495-199652040-00006; DOONA M, 1995, BRIT MED J, V310, P1217, DOI 10.1136/bmj.310.6989.1217; FOSTER CS, 1984, OPHTHALMOLOGY, V91, P1253; FRAUNFELDER FT, 1982, AM J OPHTHALMOL, V93, P356, DOI 10.1016/0002-9394(82)90540-2; FRAUNFELDER FT, 1993, AM J OPHTHALMOL, V115, P812, DOI 10.1016/S0002-9394(14)73653-0; FRIEDLAENDER MH, 1993, SURV OPHTHALMOL, V38, P105, DOI 10.1016/0039-6257(93)90035-6; GIGLIOTTI F, 1984, J PEDIATR-US, V104, P623; HAIMOVICI R, 1989, AM J OPHTHALMOL, V107, P511, DOI 10.1016/0002-9394(89)90495-9; KLINE AH, 1964, JAMA-J AM MED ASSOC, V188, P178; KULSHRESTHA M, 1998, PRESCRIBER, V8, P35; LEIBOWITZ H M, 1991, American Journal of Ophthalmology, V112, p29S; LEIBOWITZ HM, 1976, ARCH OPHTHALMOL-CHIC, V94, P1752, DOI 10.1001/archopht.1976.03910040526011; LOWE RF, 1970, BRIT J OPHTHALMOL, V54, P161, DOI 10.1136/bjo.54.3.161; Manners T, 1997, BRIT MED J, V315, P816; Mathers WD, 1998, ADV EXP MED BIOL, V438, P349; Mathers WD, 1997, CORNEA, V16, P162; MCCORMICK A, 1995, MORBIDITY STAT GEN P; McCulley JP, 1998, ADV EXP MED BIOL, V438, P319; MCDONNELL PJ, 1988, BRIT J OPHTHALMOL, V72, P733, DOI 10.1136/bjo.72.10.733; Miller I M, 1992, Eur J Ophthalmol, V2, P58; NAUHEIM RC, 1990, OPHTHALMOLOGY, V97, P1450; *PRESCR PRIC AUT, 1998, EL PACT DAT KENS CHE; RITCH R, 1989, GLAUCOMAS, V2, P841; ROBA LA, 1993, INVEST OPHTH VIS SCI, V34, P848; SCHACHTER J, 1989, NEW ENGL J MED, V320, P802, DOI 10.1056/NEJM198903233201210; SHAPIRO MB, 1997, CORNEA, P438; SHINE WE, 1996, CORNEA, V15, P320; Soparkar CNS, 1997, ARCH OPHTHALMOL-CHIC, V115, P34, DOI 10.1001/archopht.1997.01100150036004; SOUKIASIAN SH, 1997, CORNEA, P759; TOMLINSON A, 1973, BRIT J OPHTHALMOL, V57, P475, DOI 10.1136/bjo.57.7.475; WARD JB, 1993, CORNEA, V12, P216, DOI 10.1097/00003226-199305000-00006; WEYMAN J, 1965, Br Dent J, V118, P289; WILSON A, 1987, J ROY COLL GEN PRACT, V37, P62	36	113	118	3	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2000	343	5					345	351		10.1056/NEJM200008033430507	http://dx.doi.org/10.1056/NEJM200008033430507			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340GR	10922425				2022-12-28	WOS:000088525200007
J	McGarry, RC				McGarry, RC			Lung cancer presenting as an ankle metastasis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Nebraska, Med Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	McGarry, RC (corresponding author), Univ Nebraska, Med Ctr, 600 S 42nd St, Omaha, NE 68198 USA.								0	11	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2000	343	4					268	268		10.1056/NEJM200007273430406	http://dx.doi.org/10.1056/NEJM200007273430406			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	337QC	10911009				2022-12-28	WOS:000088372300006
J	Aynsley-Green, A; Barker, M; Burr, S; Macfarlane, A; Morgan, J; Sibert, J; Turner, T; Viner, R; Waterston, T; Hall, D				Aynsley-Green, A; Barker, M; Burr, S; Macfarlane, A; Morgan, J; Sibert, J; Turner, T; Viner, R; Waterston, T; Hall, D			Who is speaking for children and adolescents and for their health at the policy level?	BRITISH MEDICAL JOURNAL			English	Article									Great Ormond St Hosp Sick Children, London WC1N 1EH, England; UCL, Inst Child Hlth, London WC1N 1EH, England; Camden & Islington Hlth Author, London NW1 2LJ, England; Royal Coll Nursing UK, London W1M 0AB, England; Univ Oxford, Publ Hlth resource Unit, Inst Hlth Sci, Oxford OX1 3PT, England; Univ Wales Coll Cardiff, Coll Med, Llandough Hosp, Cardiff CF64 2XX, S Glam, Wales; Natl Childrens Bur, London EC1V 7QR, England; Royal Coll Paediat & Child Hlth, London W1N 6DE, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of Oxford; Cardiff University	Aynsley-Green, A (corresponding author), Great Ormond St Hosp Sick Children, London WC1N 1EH, England.	a.aynsley-green@ich.ucl.ac.uk	Viner, Russell M/A-1441-2009	Viner, Russell M/0000-0003-3047-2247				Audit Commission, 1993, CHILDR 1 STUD HOSP S; Berman S, 1998, PEDIATRICS, V102, P632, DOI 10.1542/peds.102.3.632; *BRIT MED ASS, 1999, GROW BRIT; *DEP HLTH, 1996, IMPR HLTH MOTH CHILD; *HC HLTH COMM, 1997, 2 3 4 5 REP SESS 199; *NSPCC CHILDR SOC, 2000, IMPR CHILDR HLTH SUR; Viner R, 1998, YOUTH MATTERS EVIDEN	7	42	42	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 22	2000	321	7255					229	232		10.1136/bmj.321.7255.229	http://dx.doi.org/10.1136/bmj.321.7255.229			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903661	Green Published			2022-12-28	WOS:000088448100029
J	Josefson, D				Josefson, D			Interleukin 2 increases CD4 T cell counts in people with HIV	BRITISH MEDICAL JOURNAL			English	News Item																		Davey RT, 2000, JAMA-J AM MED ASSOC, V284, P183, DOI 10.1001/jama.284.2.183	1	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 22	2000	321	7255					196	196						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903642				2022-12-28	WOS:000088448100013
J	Maynard, SJ; Scott, GO; Riddell, JW; Adgey, AAJ				Maynard, SJ; Scott, GO; Riddell, JW; Adgey, AAJ			Regular review - Management of acute coronary syndromes	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CARDIAC TROPONIN-T; UNSTABLE ANGINA; STRATIFICATION		Royal Victoria Hosp, Reg Med Cardiol Ctr, Belfast BT12 6BA, Antrim, North Ireland		Adgey, AAJ (corresponding author), Royal Victoria Hosp, Reg Med Cardiol Ctr, Belfast BT12 6BA, Antrim, North Ireland.							Alexander JH, 1999, AM J CARDIOL, V83, P1147, DOI 10.1016/S0002-9149(99)00049-1; Armstrong PW, 1998, CIRCULATION, V98, P1860, DOI 10.1161/01.CIR.98.18.1860; Bazzino O, 1998, NEW ENGL J MED, V338, P1498; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Bhatt DL, 1998, CIRCULATION, V98, P17; CHAITMAN BR, 1997, HEART DIS TXB CARDIO, P153; COLLINSON J, 1990, EUR HEART J, V20, P281; Collinson PO, 1998, EUR HEART J, V19, pN16; de Sa EL, 1998, J AM COLL CARDIOL, V31, p79A; GERSH BJ, 1997, HEART DIS TXB CARDIO, P1289; Hahn SS, 1998, J AM COLL CARDIOL, V31, p229A, DOI 10.1016/S0735-1097(97)84701-8; Hamm CW, 1997, NEW ENGL J MED, V337, P1648, DOI 10.1056/NEJM199712043372302; HAMM CW, 1992, NEW ENGL J MED, V327, P146, DOI 10.1056/NEJM199207163270302; Heeschen C, 1999, CIRCULATION, V100, P1509, DOI 10.1161/01.CIR.100.14.1509; Heeschen C, 1999, LANCET, V354, P1757, DOI 10.1016/S0140-6736(99)10285-X; Luscher MS, 1997, CIRCULATION, V96, P2578, DOI 10.1161/01.CIR.96.8.2578; Ottani F, 1999, AM HEART J, V137, P284, DOI 10.1053/hj.1999.v137.92779; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; Simoons ML, 1997, LANCET, V349, P1429; Theroux P., 1998, European Heart Journal, V19, P50; Topol E, 1998, NEW ENGL J MED, V339, P436; Wallentin L, 1999, LANCET, V354, P708	22	13	15	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2000	321	7255					220	223		10.1136/bmj.321.7255.220	http://dx.doi.org/10.1136/bmj.321.7255.220			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903658	Green Published			2022-12-28	WOS:000088448100026
J	Ferrandiz, C; Liljegren, SJ; Yanofsky, MF				Ferrandiz, C; Liljegren, SJ; Yanofsky, MF			Negative regulation of the SHATTERPROOF genes by FRUITFULL during Arabidopsis fruit development	SCIENCE			English	Article							MADS-BOX GENE; TRANSCRIPTION	The terminal step of fruit development in Arabidopsis involves valve separation from the replum, allowing seed dispersal. This process requires the activities of the SHATTERPROOF MADS-box genes, which promote dehiscence zone differentiation at the valve/replum boundary. Here we show that the FRUITFULL MADS-box gene, which is necessary for fruit valve differentiation, is a negative regulator of SHATTERPROOF expression and that constitutive expression of FRUITFULL is sufficient to prevent formation of the dehiscence zone. Our studies suggest that ectopic expression of FRUITFULL may directly allow the control of pod shatter in oilseed crops such as canola.	Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Yanofsky, MF (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.		Ferrandiz, Cristina/E-6280-2015	Ferrandiz, Cristina/0000-0002-2460-1068				BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Flanagan CA, 1996, PLANT J, V10, P343, DOI 10.1046/j.1365-313X.1996.10020343.x; Gu Q, 1998, DEVELOPMENT, V125, P1509; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; MANDEL MA, 1995, PLANT CELL, V7, P1763, DOI 10.1105/tpc.7.11.1763; SAVIDGE B, 1995, PLANT CELL, V7, P721, DOI 10.1105/tpc.7.6.721; Spence J, 1996, J MICROSC-OXFORD, V181, P195, DOI 10.1046/j.1365-2818.1996.111391.x; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797	9	335	383	6	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					436	438		10.1126/science.289.5478.436	http://dx.doi.org/10.1126/science.289.5478.436			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903201				2022-12-28	WOS:000088305500043
J	Magee, BB; Magee, PT				Magee, BB; Magee, PT			Induction of mating in Candida albicans by construction of MTLa and MTL alpha strains	SCIENCE			English	Article							GENE; IDENTIFICATION; DISRUPTION; OPAQUE; WHITE	Although the diploid fungus Candida albicans, a human pathogen, has been thought to have no sexual cycle. it normally possesses mating-type-like orthologs (Mn) of both of the Saccharomyces cerevisiae mating-type genes (MAT) a and alpha. When strains containing only MTLa or MTL alpha were constructed by the Loss of one homolog of chromosome 5, the site of the MTL Loci, MTLa and MTL alpha strains mated, but like mating types did not. Evidence for mating included formation of stable prototrophs from strains with complementing auxotrophic markers; these contained both MTL alleles and molecular markers from both parents and were tetraploid in DNA content and mononucleate.	Univ Minnesota, Dept Genet Cell Biol & Dev, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Magee, PT (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 1445 Gortner Ave, St Paul, MN 55108 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016567, R01AI046351, R01AI035109] Funding Source: NIH RePORTER; NIAID NIH HHS [AI16567, AI46351, AI35109] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHU WS, 1993, J BACTERIOL, V175, P6637, DOI 10.1128/jb.175.20.6637-6651.1993; DIEN BS, 1994, METHOD CELL BIOL, V42, P457; FONZI WA, 1993, GENETICS, V134, P717; Forche A, 1999, FUNGAL GENET BIOL, V28, P107, DOI 10.1006/fgbi.1999.1164; Girishkumar H, 1999, POSTGRAD MED J, V75, P151, DOI 10.1136/pgmj.75.881.151; Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; KAKAR SN, 1982, J BACTERIOL, V151, P1247, DOI 10.1128/JB.151.3.1247-1252.1982; Magee BB, 1997, MICROBIOL-UK, V143, P289, DOI 10.1099/00221287-143-2-289; MAGEE PT, 1992, J CLIN MICROBIOL, V30, P2674, DOI 10.1128/JCM.30.10.2674-2679.1992; MAGEE PT, 1983, MICROBIOLOGY 1983, P230; Natarajan A, 1999, METAB ENG, V1, P320, DOI 10.1006/mben.1999.0125; Negredo A, 1997, MICROBIOL-UK, V143, P297, DOI 10.1099/00221287-143-2-297; PUJOL C, 1993, P NATL ACAD SCI USA, V90, P9456, DOI 10.1073/pnas.90.20.9456; SCHERER S, 1990, MICROBIOL REV, V54, P226, DOI 10.1128/MMBR.54.3.226-241.1990; SLUTSKY B, 1987, J BACTERIOL, V169, P189, DOI 10.1128/JB.169.1.189-197.1987; SOLL DR, 1992, CLIN MICROBIOL REV, V5, P183, DOI 10.1128/CMR.5.2.183-203.1992; SUZUKI T, 1989, J GEN MICROBIOL, V135, P425; THRASHBINGHAM C, 1992, CURR GENET, V22, P93, DOI 10.1007/BF00351467; WICKES BL, 1991, INFECT IMMUN, V59, P1762, DOI 10.1128/IAI.59.5.1762-1771.1991; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999	21	348	375	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					310	313		10.1126/science.289.5477.310	http://dx.doi.org/10.1126/science.289.5477.310			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894781				2022-12-28	WOS:000088169400045
J	Ryan, JV; Berry, AD; Anderson, ML; Long, JW; Stroud, RM; Cepak, VM; Browning, VM; Rolison, DR; Merzbacher, CI				Ryan, JV; Berry, AD; Anderson, ML; Long, JW; Stroud, RM; Cepak, VM; Browning, VM; Rolison, DR; Merzbacher, CI			Electronic connection to the interior of a mesoporous insulator with nanowires of crystalline RuO2	NATURE			English	Article							CHEMICAL-VAPOR-DEPOSITION; RUTHENIUM DIOXIDE; AEROGELS; ELECTROCHEMISTRY; OXIDES; FILMS	Highly porous materials such as mesoporous oxides are of technological interest(1) for catalytic, sensing and remediation applications: the mesopores (of size 2-50 nm) permit ingress by molecules and guests that are physically excluded from microporous materials. Connecting the interior of porous materials with a nanoscale or 'molecular' wire would allow the direct electronic control (and monitoring) of chemical reactions and the creation of nanostructures for high-density electronic materials(2). The challenge is to create an electronic pathway (that is a wire) within a mesoporous platform without greatly occluding its free volume and reactive surface area(3). Here we report the synthesis of an electronically conductive mesoporous composite-by the cryogenic decomposition of RuO4-on the nanoscale network of a partially densified silica aerogel. The composite consists of a three-dimensional web of interconnected (similar to 4-nm in diameter) crystallites of RuO2, supported conformally on the nanoscopic silica network. The resulting monolithic (RuO(2)parallel to SiO2) composite retains the free volume of the aerogel and exhibits pure electronic conductivity. In addition to acting as a wired mesoporous platform, the RuO2-wired silica aerogel behaves as a porous catalytic electrode for the oxidation of chloride to molecular chlorine.	USN, Res Lab, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Rolison, DR (corresponding author), USN, Res Lab, 4555 Overlook Ave SW, Washington, DC 20375 USA.	rolison@nrl.navy.mil	Stroud, Rhonda M/S-4584-2018; Stroud, Rhonda M./C-5503-2008; Ryan, Joseph/ABG-6820-2020; Stroud, Rhonda/GQZ-0151-2022	Stroud, Rhonda M/0000-0001-5242-8015; Stroud, Rhonda M./0000-0001-5242-8015; Ryan, Joseph/0000-0002-2549-660X; Stroud, Rhonda/0000-0001-5242-8015				ANDERSON ML, IN PRESS ADV ENG MAT; Ardizzone S, 1996, ADV COLLOID INTERFAC, V64, P173, DOI 10.1016/0001-8686(95)00286-3; ARDIZZONE S, 1982, J ELECTROCHEM SOC, V129, P1689, DOI 10.1149/1.2124251; BRINKER CJ, 1989, SOL GEL SCI PHYSICS, P503; Ciesla U, 1999, MICROPOR MESOPOR MAT, V27, P131, DOI 10.1016/S1387-1811(98)00249-2; CROSS J, 1989, J PHYS-PARIS, V50, pC4185; GAYLARDE P, 1968, SCIENCE, V161, P1157, DOI 10.1126/science.161.3846.1157; Hulteen JC, 1997, J MATER CHEM, V7, P1075, DOI 10.1039/a700027h; HUNT AJ, 1995, J NON-CRYST SOLIDS, V185, P227, DOI 10.1016/0022-3093(95)00017-8; Husing N, 1998, ANGEW CHEM INT EDIT, V37, P23, DOI 10.1002/(SICI)1521-3773(19980202)37:1/2<22::AID-ANIE22>3.0.CO;2-I; KREIDER KG, 1991, MATER RES SOC SYMP P, V234, P205, DOI 10.1557/PROC-234-205; LEE DG, 1992, J ORG CHEM, V57, P3276, DOI 10.1021/jo00038a009; MAR SY, 1995, APPL SURF SCI, V90, P497, DOI 10.1016/0169-4332(95)00177-8; Merzbacher CI, 1999, NANOSTRUCT MATER, V12, P551, DOI 10.1016/S0965-9773(99)00181-6; Merzbacher CI, 1998, J NON-CRYST SOLIDS, V225, P234, DOI 10.1016/S0022-3093(98)00044-1; Morris CA, 1999, SCIENCE, V284, P622, DOI 10.1126/science.284.5414.622; Rosenblum SS, 1997, PHYS REV B, V56, P529, DOI 10.1103/PhysRevB.56.529; Sankar J, 1999, J MATER CHEM, V9, P2439, DOI 10.1039/a902470k; Sasaki M, 1998, MICROPOR MESOPOR MAT, V21, P597, DOI 10.1016/S1387-1811(98)00116-4; TRASATTI S, 1991, ELECTROCHIM ACTA, V36, P225, DOI 10.1016/0013-4686(91)85244-2; Trasatti S., 1994, PLATIN MET REV, V38, P46; TRASATTI S, 1981, ELECTRODES CONDUCT B, pCH10; Yamamichi S, 1997, IEEE T ELECTRON DEV, V44, P1076, DOI 10.1109/16.595934; YUAN Z, 1993, CHEM MATER, V5, P908, DOI 10.1021/cm00031a004; Zhang ZB, 1999, CHEM MATER, V11, P1659, DOI 10.1021/cm9811545	25	135	140	6	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					169	172		10.1038/35018040	http://dx.doi.org/10.1038/35018040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910352				2022-12-28	WOS:000088221100042
J	Green, AR				Green, AR			Haemangioblast origin of chronic myeloid leukaemia?	LANCET			English	Editorial Material							ENDOTHELIAL-CELLS; HEMATOPOIETIC-CELLS		Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England; Addenbrookes Hosp, Cambridge CB2 2XY, England	University of Cambridge; Addenbrooke's Hospital; University of Cambridge	Green, AR (corresponding author), Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England.			Green, Anthony/0000-0002-9795-0218				Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Choi K, 1998, DEVELOPMENT, V125, P725; Eichmann A, 1998, DEVELOPMENT, V125, P743; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; Ziegler BL, 1999, SCIENCE, V285, P1553, DOI 10.1126/science.285.5433.1553	12	7	7	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2000	355	9216					1659	1660		10.1016/S0140-6736(00)02232-7	http://dx.doi.org/10.1016/S0140-6736(00)02232-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905236				2022-12-28	WOS:000086983800003
J	Bauer, UE; Johnson, TM; Hopkins, RS; Brooks, RG				Bauer, UE; Johnson, TM; Hopkins, RS; Brooks, RG			Changes in youth cigarette use and intentions following implementation of a tobacco control program - Findings from the Florida Youth Tobacco Survey, 1998-2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Many states are developing tobacco use prevention and reduction programs, and current data on tobacco use behaviors and how these change over time in response to program activities are needed for program design, implementation, and evaluation. Objectives To assess changes in youth cigarette use and intentions following implementation of the Florida Pilot Program on Tobacco Control, Design, Setting, and Participants Self-administered survey conducted prior to program implementation (1998), and 1 and 2 years (1999, 2000) later among a sample of Florida public middle school and high school students who were classified as never users, experimenters, current users, and former users of cigarettes based on survey responses. Main Outcome Measures Changes in cigarette use status, intentions, and behaviors among students over a 2-year period. Results Surveys were completed by 22 540, 20978, and 23 745 students attending 255, 242, and 243 Florida public middle and high schools in 1998, 1999 and 2000, respectively. Response rates for the 3 survey years ranged from 80% to 82% and 72% to 82% for the middle school and high school surveys, respectively. After 2 years, current cigarette use dropped from 18.5% to 11.1% (P<.001) among middle school students and from 27.4% to 22.6% (P=.01) among high school students. Prevalence of never use increased from 56.4% to 69.3% (P<.001) and from 31.9% to 43.1% (P=.001) among middle school and high school students, respectively. Prevalence of experimenting decreased among middle school and high school students from 21.4% to 16.2% (P<.001) and from 32.8% to 28.2% (P<.001), respectively. Among never users, the percentage of committed nonsmokers increased from 67.4% to 76.9% (P<.001) and from 73.7% to 79.3% (P<.001) among middle school and high school students, respectively. Among experimenters, the percentage of students who said they will not smoke again increased from 30.4% to 42.0% (P<.001) in middle school and from 44.4% to 51.0% (P<.001) in high school. Conclusions Progress toward reduction of youth tobacco use was observed in each of the 2 years of Florida's Pilot Program on Tobacco Control. Our results suggest that a comprehensive statewide program can be effective in preventing and reducing youth tobacco use.	Florida Dept Hlth, HSDE, Tallahassee, FL 32399 USA	Florida Department of Health	Bauer, UE (corresponding author), Florida Dept Hlth, HSDE, 4052 Bald Cypress Way,Bin A-12, Tallahassee, FL 32399 USA.							BAUER U, 1999, 3 FLOR DEP HLTH, V2; BAUER U, 1999, HIGHLIGHTS PILOT PRO; BAUER U, 1999, MMWR-MORBID MORTAL W, V48, P248; BAUER U, 1999, 1 FLOR DEP HLTH S, V2; BAUER U, 2000, 1 FLOR DEP HLTH, V3; Bauer UE, 2000, AM J EPIDEMIOL, V151, P921; *BUR EP, 1999, HLTH EC IMP TOB UC F; *CDCP, 1999, BEST PRACT COMPR TOB; Centers for Disease Control and Prevention, 1994, PREV TOB US YOUNG PE; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1217; Connolly G, 1998, CANCER, V83, P2722, DOI 10.1002/(SICI)1097-0142(19981215)83:12A+<2722::AID-CNCR12>3.0.CO;2-O; *FL DEP HLTH, 2000, ONL TOB ED RES; *FL PIL PROGR TOB, 1998, FORM STRAT PLAN, P20; GREEN LW, 1990, ANNU REV PUBL HEALTH, V11, P319; *IND EV CONS, 1998, IND EV CAL TOB PREV; JOHNSTON L, 2000, CIGARETTE SMOKING AM; KELDER G, 1999, MULTISTATE MASTER SE; LEFEBVRE RC, 1988, HEALTH EDUC QUART, V15, P299; MARCUS SE, 1993, PUBLIC HEALTH REP, V108, P20; *MS STAT DEP HLTH, 1999, MISS 1999 YOUTH TOB; *NAT CTR HLTH STAT, 1996, HEALTH PEOPL 2000 RE; *SAS I INC, 1989, SAS LANG PROC VERS 6; Shah BV, 1997, SUDAAN USERS MANUAL; Sly D.F., 1999, FLORIDA ANTITOBACCO; TACKETT N, 1999, RESULTS 1999 FYTS PR; *U MIAM RES EV COO, 1999, YOUTH TOB US PREV FL; ZEVALLOS J, 2000, C EP INT SERV CDC AP	27	139	141	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					723	728		10.1001/jama.284.6.723	http://dx.doi.org/10.1001/jama.284.6.723			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341JM	10927781	Bronze			2022-12-28	WOS:000088587300031
J	Lam, TH; Ho, LM; Hedley, AJ; Adab, P; Fielding, R; McGhee, SM; Aharonson-Daniel, L				Lam, TH; Ho, LM; Hedley, AJ; Adab, P; Fielding, R; McGhee, SM; Aharonson-Daniel, L			Environmental tobacco smoke exposure among police officers in Hong Kong	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY SYMPTOMS; PASSIVE SMOKING; NONSMOKING WOMEN; LUNG-FUNCTION; ADULTS	Context Few epidemiological studies have examined the relationship between chronic respiratory symptoms and exposure to environmental tobacco smoke (ETS) at work in adults, and none have shown clear dose-response relationships. Objective To examine the respiratory effects of ETS exposure at home and at work among never-smoking adults. Design, Setting, and Participants Cross-sectional, self-administered questionnaire survey conducted in December 1995 and January 1996 among 4468 male and 728 female police officers in Hong Kong who were never-smokers. Main Outcome Measures Respiratory symptoms and physician consultation in the previous 14 days for such symptoms by presence and amount of ETS exposure at work. Results Eighty percent of both men and women reported ETS exposure at work, Significant odds ratios (ORs) for respiratory symptoms were found among men with ETS exposure at work (for any respiratory symptoms, difference in absolute rate, 20.4%; OR, 2.33; 95% confidence interval [CI], 1.97-2.75; attributable risk, 57%) and physician consultation (difference in absolute rate, 4.5%; OR, 1.30; 95% CI, 1.05-1.61; attributable risk, 23%). Trends were similar among women for any respiratory symptoms (difference in absolute rate, 15.4%; OR, 1.63; 95% CI, 1.04-2.56; attributable risk, 39%) and for physician consultation (difference In absolute rates, 2.8%; OR, 1.45; 95% CI, 0.87-2.41; attributable risk, 31%), Positive dose-response relationships with number of coworkers smoking nearby and amount of ETS exposure in the work place were found. Conclusions This study provides further evidence of the serious health hazards associated with ETS exposure at work, The findings support a ban on smoking in the workplace to protect all workers in both developed and developing countries.	Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Behav Sci Unit, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Lam, TH (corresponding author), Univ Hong Kong, Dept Community Med, Patrick Manson Bldg S Wing,7 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.		Hedley, Anthony/C-4305-2009; Fielding, Richard/C-4268-2009; Adab, Peymane/ABC-9651-2021; McGhee, Sarah/C-4367-2009; Aharonson-Daniel, Limor/F-1998-2012; Hedley, Anthony J/A-9113-2013; McGhee, Sarah M/A-6460-2013; Lam, Tai Hing/C-4317-2009	Adab, Peymane/0000-0001-9087-3945; Aharonson-Daniel, Limor/0000-0003-4585-6892; McGhee, Sarah M/0000-0003-1025-5915; ho, lm/0000-0002-2709-927X; Lam, Tai Hing/0000-0002-2033-9971				*CENS STAT DEP, 1991, 7 CENS STAT DEP; *CENS STAT DEP, 1996, 15 CENS STAT DEP; CUMMINGS KM, 1990, ARCH ENVIRON HEALTH, V45, P74, DOI 10.1080/00039896.1990.9935929; Davis RM, 1998, JAMA-J AM MED ASSOC, V280, P1947, DOI 10.1001/jama.280.22.1947; *DEP HLTH, 2000, REP SCI COMM TOB HLT; EISNER MD, 1998, JAMA-J AM MED ASSOC, V280, P1947; FLOREY CD, 1982, WHO EUROPEAN SERIES, V12; HO SY, 1998, AS PAC 5 C TOB HLTH; HOLE DJ, 1989, BRIT MED J, V299, P423, DOI 10.1136/bmj.299.6696.423; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Jaakkola MS, 1996, J CLIN EPIDEMIOL, V49, P581, DOI 10.1016/0895-4356(96)00004-2; KAUFFMANN F, 1989, INT J EPIDEMIOL, V18, P334, DOI 10.1093/ije/18.2.334; LEUENBERGER P, 1994, AM J RESP CRIT CARE, V150, P1222, DOI 10.1164/ajrccm.150.5.7952544; *NCI, 2000, US DEP HHS PHS SMOK, V10; NG TP, 1993, J EPIDEMIOL COMMUN H, V47, P454, DOI 10.1136/jech.47.6.454; *OCC SAF HLTH ADM, 1999, OCC SAF HLTH ADM US, V59; *OFF TOB RED PROGR, 2000, RESTR WORKPL SMOK; [Office of Research and Development Office of Health Environmental Assessment United States Environmental Protection Agency], 1992, RESP HLTH EFF PASS S; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; POPE CA, 1993, ENVIRON HEALTH PERSP, V101, P314, DOI 10.2307/3431441; RIBOLI E, 1990, CANCER CAUSE CONTROL, V1, P243, DOI 10.1007/BF00117476; SCHWARTZ J, 1990, AM REV RESPIR DIS, V141, P62, DOI 10.1164/ajrccm/141.1.62; *STATA CORP, 1996, STATA STAT SOFTW COM; TREDANIEL J, 1994, EUR RESPIR J, V7, P173, DOI 10.1183/09031936.94.07010173; WHITE JR, 1991, CHEST, V100, P39, DOI 10.1378/chest.100.1.39; YANG GH, 1998, SMOKING HLTH CHINA 1, P44	26	31	31	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					756	763		10.1001/jama.284.6.756	http://dx.doi.org/10.1001/jama.284.6.756			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341JM	10927788				2022-12-28	WOS:000088587300038
J	Zhou, JQ; Monson, EK; Teng, SC; Schulz, VP; Zakian, VA				Zhou, JQ; Monson, EK; Teng, SC; Schulz, VP; Zakian, VA			Pif1p helicase, a catalytic inhibitor of telomerase in yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA HELICASE; S-PHASE; ELONGATION	Mutations in the yeast Saccharomyces cerevisiae PIF1 gene, which encodes a 5'-to-3/ DNA helicase, cause telomere Lengthening and a Large increase in the formation rate of new telomeres. Here, we show that Pif1p acts by inhibiting telomerase rather than telomere-telomere recombination, and this inhibition requires the helicase activity of Pif1p, Overexpression of enzymatically active Pif1p causes telomere shortening. Thus, Pif1p is a catalytic inhibitor of telomerase-mediated telomere Lengthening, Because Pif1p is associated with telomeric DNA in vivo, its effects on telomeres are Likely direct. Pif1p-like helicases are found in diverse organisms, including humans. We propose that Pif1p-mediated inhibition of telomerase promotes genetic stability by suppressing telomerase-mediated healing of double-strand breaks.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Zakian, VA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.			Schulz, Vincent/0000-0001-6333-4284; TENG, SHU-CHUN/0000-0002-6492-2560	NIGMS NIH HHS [GM26938] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026938, R01GM026938] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chakraverty RK, 1999, BIOESSAYS, V21, P286; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HARTWELL LH, 1985, GENETICS, V110, P381; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; KRAMER KM, 1993, GENE DEV, V7, P2345, DOI 10.1101/gad.7.12a.2345; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; LIN JJ, 1995, CELL, V81, P1127, DOI 10.1016/S0092-8674(05)80017-0; Martin AD, 2000, MOL CELL BIOL, V20, P786, DOI 10.1128/MCB.20.3.786-796.2000; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; RUNGE KW, 1989, MOL CELL BIOL, V9, P1488, DOI 10.1128/MCB.9.4.1488; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Shiratori A, 1999, YEAST, V15, P219, DOI 10.1002/(SICI)1097-0061(199902)15:3<219::AID-YEA349>3.3.CO;2-V; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Teng SC, 1999, MOL CELL BIOL, V19, P8083; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WELLINGER RJ, 1993, MOL CELL BIOL, V13, P4057, DOI 10.1128/MCB.13.7.4057; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Zhou J.-S., UNPUB	24	191	198	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					771	774		10.1126/science.289.5480.771	http://dx.doi.org/10.1126/science.289.5480.771			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926538				2022-12-28	WOS:000088581500039
J	Medzhitov, R; Janeway, CJ				Medzhitov, R; Janeway, CJ			Advances in immunology: Innate immunity.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TOLL-LIKE RECEPTOR-4; LPS BINDING-PROTEIN; DROSOPHILA TOLL; LIPOPOLYSACCHARIDE LPS; ADAPTIVE IMMUNITY; RECOGNITION; GENE; TLR4; SYSTEM; MICE		Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	Yale University	Janeway, CJ (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	ruslan@yale.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI44220-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Epstein J, 1996, CURR OPIN IMMUNOL, V8, P29, DOI 10.1016/S0952-7915(96)80101-4; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Fraser IP, 1998, SEMIN IMMUNOL, V10, P363, DOI 10.1006/smim.1998.0141; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoshino K, 1999, J IMMUNOL, V162, P3749; Imler JL, 2000, CURR OPIN MICROBIOL, V3, P16, DOI 10.1016/S1369-5274(99)00045-4; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kuhns DB, 1997, J IMMUNOL, V158, P3959; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; QUERSHI ST, 1999, J EXP MED, V189, pA1518; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thomas CA, 2000, J EXP MED, V191, P147, DOI 10.1084/jem.191.1.147; WRIGHT SD, 1989, J EXP MED, V170, P1231, DOI 10.1084/jem.170.4.1231; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	29	1520	1620	5	139	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2000	343	5					338	344		10.1056/NEJM200008033430506	http://dx.doi.org/10.1056/NEJM200008033430506			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340GR	10922424				2022-12-28	WOS:000088525200006
J	Roach, K; Stern, S; Altkom, D; Cifu, A; Levinson, W				Roach, K; Stern, S; Altkom, D; Cifu, A; Levinson, W			Update in general internal medicine	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED TRIAL; ERADICATING HELICOBACTER-PYLORI; NONULCER DYSPEPSIA; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; CLINICAL-TRIAL; INFLUENZA; OSTEOPOROSIS; THERAPY; PLACEBO		Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago	Levinson, W (corresponding author), Univ Chicago, Pritzker Sch Med, 5841 S Maryland Ave,MC 6098, Chicago, IL 60637 USA.	wendy@medicine.bsd.uchicago.edu	anand, amit/A-7222-2009					Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Blum AL, 1998, NEW ENGL J MED, V339, P1875, DOI 10.1056/NEJM199812243392602; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Greenberg PD, 1999, ARCH INTERN MED, V159, P2283, DOI 10.1001/archinte.159.19.2283; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Katzan IL, 2000, JAMA-J AM MED ASSOC, V283, P1151, DOI 10.1001/jama.283.9.1151; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kutinsky I, 1999, ARCH INTERN MED, V159, P1569, DOI 10.1001/archinte.159.14.1569; Kwatkowski TG, 1999, NEW ENGL J MED, V340, P1781; Langman MJ, 1999, JAMA-J AM MED ASSOC, V282, P1929, DOI 10.1001/jama.282.20.1929; Lindsay R, 1999, J CLIN ENDOCR METAB, V84, P3076, DOI 10.1210/jc.84.9.3076; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; McColl K, 1998, NEW ENGL J MED, V339, P1869, DOI 10.1056/NEJM199812243392601; Monto AS, 1999, JAMA-J AM MED ASSOC, V282, P31, DOI 10.1001/jama.282.1.31; Monto AS, 1999, J INFECT DIS, V180, P254, DOI 10.1086/314904; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Quinn DA, 1999, AM J RESP CRIT CARE, V159, P1445, DOI 10.1164/ajrccm.159.5.9808094; Recker RR, 1999, ANN INTERN MED, V130, P897, DOI 10.7326/0003-4819-130-11-199906010-00005; Rowe BH, 1999, JAMA-J AM MED ASSOC, V281, P2119, DOI 10.1001/jama.281.22.2119; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; Simon LS, 1999, JAMA-J AM MED ASSOC, V282, P1921, DOI 10.1001/jama.282.20.1921; Talley NJ, 1999, BMJ-BRIT MED J, V318, P833, DOI 10.1136/bmj.318.7187.833; Talley NJ, 1999, NEW ENGL J MED, V341, P1106, DOI 10.1056/NEJM199910073411502; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Yusuf S, 2000, NEW ENGL J MED, V342, P145	29	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2000	133	3					209	217		10.7326/0003-4819-133-3-200008010-00013	http://dx.doi.org/10.7326/0003-4819-133-3-200008010-00013			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XW	10906836				2022-12-28	WOS:000088449400007
J	Payne, D				Payne, D			Irish blood service sues its former medical consultant	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					261	261						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915123				2022-12-28	WOS:000088619800018
J	Reid, DHS				Reid, DHS			The forgotten children	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 22	2000	321	7255					249	249		10.1136/bmj.321.7255.249	http://dx.doi.org/10.1136/bmj.321.7255.249			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903671	Green Published			2022-12-28	WOS:000088448100066
J	Wittenburg, N; Eimer, S; Lakowski, B; Rohrig, S; Rudolph, C; Baumeister, R				Wittenburg, N; Eimer, S; Lakowski, B; Rohrig, S; Rudolph, C; Baumeister, R			Presenilin is required for proper morphology and function of neurons in C-elegans	NATURE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; LIM HOMEOBOX GENE; ALZHEIMERS-DISEASE; SENSORY NEURONS; NERVOUS-SYSTEM; NOTCH; EXPRESSION; PATHWAY; LOCALIZATION; THERMOTAXIS	Mutations in the human presenilin genes cause the most frequent and aggressive forms of familial Alzheimer's disease (FAD)(1). Here we show that in addition to its role in cell fate decisions in nonneuronal tissues(2-4), presenilin activity is required in terminally differentiated neurons in vivo. Mutations in the Caenorhabditis elegans presenilin genes sel-12 and hop-1 result in a defect in the temperature memory of the animals. This defect is caused by the loss of presenilin function in two cholinergic interneurons that display neurite morphology defects in presenilin mutants. The morphology and function of the affected neurons in sel-12 mutant animals can be restored by expressing sel-12 only in these cells. The wild-type human presenilin PS1, but not the FAD mutant PS1 A246E, can also rescue these morphological defects. As lin-12 mutant animals display similar morphological and functional defects to presenilin mutants, we suggest that presenilins mediate their activity in postmitotic neurons by facilitating Notch signalling. These data indicate cell-autonomous and evolutionarily conserved control of neural morphology and function by presenilins.	Univ Munich, Genzentrum, D-81377 Munich, Germany; EleGene Gmbh, D-82152 Martinsried, Germany	University of Munich	Baumeister, R (corresponding author), Univ Munich, Genzentrum, Feodor Lynen Str 25, D-81377 Munich, Germany.	bmeister@lmb.uni-muenchen.de						Baumeister R, 1997, Genes Funct, V1, P149; Berezovska O, 1999, MOL BRAIN RES, V69, P273, DOI 10.1016/S0169-328X(99)00119-9; Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8; BRENNER S, 1974, GENETICS, V77, P71; Cook DG, 1996, P NATL ACAD SCI USA, V93, P9223, DOI 10.1073/pnas.93.17.9223; Franklin JL, 1999, CURR BIOL, V9, P1448, DOI 10.1016/S0960-9822(00)80114-1; GINIGER E, 1993, DEVELOPMENT, V117, P431; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hobert O, 1998, J NEUROSCI, V18, P2084; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; MADURO M, 1995, GENETICS, V141, P977; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Peckol EL, 1999, DEVELOPMENT, V126, P1891; Pedersen WA, 1997, J BIOL CHEM, V272, P22397, DOI 10.1074/jbc.272.36.22397; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Westlund B, 1999, P NATL ACAD SCI USA, V96, P2497, DOI 10.1073/pnas.96.5.2497; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	30	79	89	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					306	309		10.1038/35018575	http://dx.doi.org/10.1038/35018575			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917532				2022-12-28	WOS:000088251900050
J	Engler, HS; Spencer, KC; Gilbert, LE				Engler, HS; Spencer, KC; Gilbert, LE			Insect metabolism - Preventing cyanide release from leaves	NATURE			English	Article							LEPIDOPTERA; GLUCOSIDES; PLANTS		Univ Texas, Sch Biol Sci, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Engler, HS (corresponding author), Univ Texas, Sch Biol Sci, Sect Integrat Biol, Austin, TX 78712 USA.							ADSERSEN A, 1993, PHYTOCHEMISTRY, V33, P365, DOI 10.1016/0031-9422(93)85519-W; CHAMBERLAIN P, 1981, CYANIDE BIOL, P184; CONN EE, 1981, CYANIDE BIOL, P335; GILBERT LE, 1982, SCI AM, V247, P110, DOI 10.1038/scientificamerican0882-110; JAROSZEWSKI JW, 1987, TETRAHEDRON, V43, P2349, DOI 10.1016/S0040-4020(01)86821-6; Jones DA, 1998, PHYTOCHEMISTRY, V47, P155, DOI 10.1016/S0031-9422(97)00425-1; NAHRSTEDT A, 1983, COMP BIOCHEM PHYS B, V75, P65, DOI 10.1016/0305-0491(83)90041-X; RAUBENHEIMER D, 1989, J CHEM ECOL, V15, P2177, DOI 10.1007/BF01014108; Seigler D., 1993, METHODS PLANT BIOCH, VVolume 8, P51; Spencer K.C., 1988, P167	10	81	83	0	37	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					144	145		10.1038/35018159	http://dx.doi.org/10.1038/35018159			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910343				2022-12-28	WOS:000088221100033
J	Wiersma, D				Wiersma, D			Laser physics - The smallest random laser	NATURE			English	Editorial Material							SCATTERING		European Lab Non Linear Spect, I-50125 Florence, Italy; Ist Nazl Fis Mat, I-50125 Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR)	Wiersma, D (corresponding author), European Lab Non Linear Spect, Largo E Fermi 2, I-50125 Florence, Italy.		wiersma, diederik/ABG-6454-2021	wiersma, diederik/0000-0001-8150-7425				Cao H, 2000, PHYS REV LETT, V84, P5584, DOI 10.1103/PhysRevLett.84.5584; Cao H, 2000, APPL PHYS LETT, V76, P2997, DOI 10.1063/1.126557; GOUEDARD C, 1993, J OPT SOC AM B, V10, P2358, DOI 10.1364/JOSAB.10.002358; John S, 1996, PHYS REV A, V54, P3642, DOI 10.1103/PhysRevA.54.3642; LAWANDY NM, 1994, NATURE, V368, P436, DOI 10.1038/368436a0; LETOKHOV VS, 1968, SOV PHYS JETP-USSR, V26, P835; Sheng P., 1995, INTRO WAVE SCATTERIN, Vsecond; Wiersma DS, 1996, PHYS REV E, V54, P4256, DOI 10.1103/PhysRevE.54.4256; WOLFLE P, 1998, SPRINGER TRACTS MODE, V144	9	265	276	3	106	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					132	+		10.1038/35018184	http://dx.doi.org/10.1038/35018184			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910335				2022-12-28	WOS:000088221100024
J	Ferriman, A				Ferriman, A			$1bn drug deal creates debt for "tomorrow's AIDS orphans"	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					260	260						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915120				2022-12-28	WOS:000088619800014
J	Pieterman, RM; van Putten, JWG; Meuzelaar, JJ; Mooyaart, EL; Vaalburg, W; Koeter, GH; Fidler, V; Pruim, J; Groen, HJM				Pieterman, RM; van Putten, JWG; Meuzelaar, JJ; Mooyaart, EL; Vaalburg, W; Koeter, GH; Fidler, V; Pruim, J; Groen, HJM			Preoperative staging of non-small-cell lung cancer with positron-emission tomography.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	35th Annual Meeting of the American-Society-of-Clinical-Oncology	MAY 15-18, 1999	ATLANTA, GEORGIA	Amer Soc Clin Oncol			FDG-PET SCAN; FUSION IMAGES; METASTASES; CT; FLUORINE-18-FLUORODEOXYGLUCOSE; INVIVO	Background: Determining the stage of non-small-cell lung cancer often requires multiple preoperative tests and invasive procedures. Whole-body positron-emission tomography (PET) may simplify and improve the evaluation of patients with this tumor. Methods: We prospectively compared the ability of a standard approach to staging (computed tomography [CT], ultrasonography, bone scanning, and, when indicated, needle biopsies) and one involving PET to detect metastases in mediastinal lymph nodes and at distant sites in 102 patients with resectable non-small-cell lung cancer. The presence of mediastinal metastatic disease was confirmed histopathologically. Distant metastases that were detected by PET were further evaluated by standard imaging tests and biopsies. Patients were followed postoperatively for six months by standard methods to detect occult metastases. Logistic-regression analysis was used to evaluate the ability of PET and CT to identify malignant mediastinal lymph nodes. Results: The sensitivity and specificity of PET for the detection of mediastinal metastases were 91 percent (95 percent confidence interval, 81 to 100 percent) and 86 percent (95 percent confidence interval, 78 to 94 percent), respectively. The corresponding values for CT were 75 percent (95 percent confidence interval, 60 to 90 percent) and 66 percent (95 percent confidence interval, 55 to 77 percent). When the results of PET and CT were adjusted for each other, only PET results were positively correlated with the histopathological findings in mediastinal lymph nodes (P<0.001). PET identified distant metastases that had not been found by standard methods in 11 of 102 patients. The sensitivity and specificity of PET for the detection of both mediastinal and distant metastatic disease were 95 percent (95 percent confidence interval, 88 to 100 percent) and 83 percent (95 percent confidence interval, 74 to 92 percent), respectively. The use of PET for clinical staging resulted in a different stage from the one determined by standard methods in 62 patients: the stage was lowered in 20 and raised in 42. Conclusions: PET improves the rate of detection of local and distant metastases in patients with non-small-cell lung cancer. (N Engl J Med 2000;343:254-61.) (C) 2000, Massachusetts Medical Society.	Univ Groningen Hosp, Dept Pulm Dis, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Dept Thorac Surg, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Dept Radiol, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Dept Biostat & Epidemiol, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Positron Emiss Tomog Ctr, NL-9700 RB Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Groen, HJM (corresponding author), Univ Groningen Hosp, Dept Pulm Dis, Hanzepl 1, NL-9700 RB Groningen, Netherlands.		Groen, Harry/AAP-2242-2021	Groen, Harry J.M./0000-0002-2978-5265				Ahuja V, 1998, CANCER, V83, P918, DOI 10.1002/(SICI)1097-0142(19980901)83:5<918::AID-CNCR17>3.0.CO;2-Y; Brown RS, 1999, J NUCL MED, V40, P556; Bury T, 1998, EUR J NUCL MED, V25, P1244, DOI 10.1007/s002590050291; CHIN R, 1995, AM J RESP CRIT CARE, V152, P2090, DOI 10.1164/ajrccm.152.6.8520780; DAHLBOM M, 1992, J NUCL MED, V33, P1191; DEWAN NA, 1993, CHEST, V104, P997, DOI 10.1378/chest.104.4.997; HAMACHER K, 1986, J NUCL MED, V27, P235; Imran MB, 1998, J NUCL MED, V39, P1219; KUBOTA R, 1992, J NUCL MED, V33, P1972; LEWIS PJ, 1994, J NUCL MED, V35, P1647; Lonneux M, 1999, EUR J NUCL MED, V26, P591, DOI 10.1007/s002590050426; Medema J., 1999, Journal of Labelled Compounds and Radiopharmaceuticals, V42, pS853; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Mountain CF, 1997, CHEST, V111, P1718, DOI 10.1378/chest.111.6.1718; NOLOP KB, 1987, CANCER, V60, P2682, DOI 10.1002/1097-0142(19871201)60:11<2682::AID-CNCR2820601118>3.0.CO;2-H; Sazon DAD, 1996, AM J RESP CRIT CARE, V153, P417, DOI 10.1164/ajrccm.153.1.8542152; Steinert HC, 1997, RADIOLOGY, V202, P441, DOI 10.1148/radiology.202.2.9015071; Valk PE, 1995, ANN THORAC SURG, V60, P1573, DOI 10.1016/0003-4975(95)00752-0; Vansteenkiste JF, 1998, J CLIN ONCOL, V16, P2142, DOI 10.1200/JCO.1998.16.6.2142; Vansteenkiste JF, 1999, J CLIN ONCOL, V17, P3201, DOI 10.1200/JCO.1999.17.10.3201; Vansteenkiste JF, 1998, EUR J NUCL MED, V25, P1495, DOI 10.1007/s002590050327; WAHL RL, 1994, RADIOLOGY, V191, P371, DOI 10.1148/radiology.191.2.8153308; Weder W, 1998, ANN THORAC SURG, V66, P886, DOI 10.1016/S0003-4975(98)00675-4	23	858	894	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2000	343	4					254	261		10.1056/NEJM200007273430404	http://dx.doi.org/10.1056/NEJM200007273430404			8	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	337QC	10911007	Bronze			2022-12-28	WOS:000088372300004
J	McKoy, G; Protonotarios, N; Crosby, A; Tsatsopoulou, A; Anastasakis, A; Coonar, A; Norman, M; Baboonian, C; Jeffery, S; McKenna, WJ				McKoy, G; Protonotarios, N; Crosby, A; Tsatsopoulou, A; Anastasakis, A; Coonar, A; Norman, M; Baboonian, C; Jeffery, S; McKenna, WJ			Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease)	LANCET			English	Article							DILATED CARDIOMYOPATHY; STRUCTURAL PROTEINS; MISSENSE MUTATIONS; EMBRYONIC HEART; LONG ARM; GENE; DYSPLASIA; MAPS; LOCUS; LOCALIZATION	Background Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an autosomal dominant heart muscle disorder that causes arrhythmia, heart failure, and sudden death. Previously we mapped the genetic locus for the triad of autosomal recessive ARVC, palmoplantar keratoderma, and woolly hair (Naxos disease) to chromosome 17q21, in which the gene for plakoglobin is encoded, This protein is a key component of desmosomes and adherens junctions, and is important for the tight adhesion of many cell types, including those in the heart and skin. Methods We studied 19 individuals with Naxos disease, as well as unaffected family members and unrelated individuals from the neighbouring Greek islands of Naxos and Miles. Gene sequence was determined by reverse transcriptase PCR from RNA isolated from the skin of an affected individual and mutations in other cases were confirmed by restriction-enzyme analysis. Findings A homozygous 2 base pair deletion in the plakoglobin gene was identified only in the 19 affected individuals. This deletion caused a frameshift and premature termination of the protein, which was shown by western blot analysis. 29 clinically unaffected family members were heterozygous for the mutation; 20 unrelated individuals from Naxos and 43 autosomal dominant ARVC probands were homozygous for the normal allele. Interpretation The finding of a deletion in plakoglobin in ARVC suggests that the proteins involved in, cell-cell adhesion play an important part in maintaining myocyte integrity, acid when junctions are disrupted, cell death, and fibrofatty replacement occur. Therefore, the discovery of a mutation in a protein with functions in maintaining cell junction integrity has important implications for other dominant forms of ARVC, related cardiomyopathies, and other cutaneous diseases.	Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England; Univ London St Georges Hosp, Sch Med, Dept Med Genet, London SW17 0RE, England; Yannis Protonotarios Med Ctr Naxos, Naxos 84300, Greece; Univ Athens, Dept Cardiol, Hippokrat Hosp 114, Athens 11527, Greece	St Georges University London; St Georges University London; National & Kapodistrian University of Athens	McKenna, WJ (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, Cranmer Terrace, London SW17 0RE, England.		McKenna, William J/C-3243-2008; Crosby, Andrew H/E-2218-2015	McKenna, William J/0000-0001-7994-2460; Crosby, Andrew H/0000-0003-3667-9054				ABERLE H, 1995, P NATL ACAD SCI USA, V92, P6384, DOI 10.1073/pnas.92.14.6384; Ahmad F, 1998, CIRCULATION, V98, P2791, DOI 10.1161/01.CIR.98.25.2791; Bierkamp C, 1996, DEV BIOL, V180, P780, DOI 10.1006/dbio.1996.0346; Carvajal-Huerta L, 1998, J AM ACAD DERMATOL, V39, P418, DOI 10.1016/S0190-9622(98)70317-2; Coonar AS, 1998, CIRCULATION, V97, P2049, DOI 10.1161/01.CIR.97.20.2049; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Fontaine G, 1998, CIRCULATION, V97, P1532, DOI 10.1161/01.CIR.97.16.1532; GUIRAUDON CM, 1989, EUR HEART J, V10, P95, DOI 10.1093/eurheartj/10.suppl_D.95; Haftek M, 1996, J INVEST DERMATOL, V106, P498, DOI 10.1111/1523-1747.ep12343791; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; Hertig CM, 1996, J CELL SCI, V109, P11; Jongbloed RJE, 1999, HUM MUTAT, V13, P301, DOI 10.1002/(SICI)1098-1004(1999)13:4<301::AID-HUMU7>3.3.CO;2-M; KAPPRELL HP, 1987, EUR J BIOCHEM, V166, P505, DOI 10.1111/j.1432-1033.1987.tb13543.x; Koch PJ, 1998, J CELL SCI, V111, P2529; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; North AJ, 1999, J CELL SCI, V112, P4325; Palka HL, 1997, J CELL SCI, V110, P2359; PROTONOTARIOS N, 1986, BRIT HEART J, V56, P321; PROTONOTARIOS N, 1997, ARRHYTHMOGENIC RIGHT, P454; RAMPAZZO A, 1995, HUM MOL GENET, V4, P2151, DOI 10.1093/hmg/4.11.2151; Rampazzo A, 1997, GENOMICS, V45, P259, DOI 10.1006/geno.1997.4927; RAMPAZZO A, 1994, HUM MOL GENET, V3, P959, DOI 10.1093/hmg/3.6.959; Rao B H, 1996, Indian Heart J, V48, P161; RONCALI L, 1989, EUR HEART J, V10, P97, DOI 10.1093/eurheartj/10.suppl_D.97; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; Schnittler HJ, 1997, AM J PHYSIOL-HEART C, V273, pH2396, DOI 10.1152/ajpheart.1997.273.5.H2396; Severini GM, 1996, GENOMICS, V31, P193, DOI 10.1006/geno.1996.0031; Troyanovsky RB, 1996, J CELL SCI, V109, P3069; ZIMMER HG, 1994, BASIC RES CARDIOL, V89, P101	31	739	763	0	17	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2119	2124		10.1016/S0140-6736(00)02379-5	http://dx.doi.org/10.1016/S0140-6736(00)02379-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902626				2022-12-28	WOS:000087687100012
J	Christen, WG; Glynn, RJ; Ajani, UA; Schaumberg, DA; Buring, JE; Hennekens, CH; Manson, JE				Christen, WG; Glynn, RJ; Ajani, UA; Schaumberg, DA; Buring, JE; Hennekens, CH; Manson, JE			Smoking cessation and risk of age-related cataract in men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CIGARETTE-SMOKING; LENS OPACITIES; VITAMIN-C; ALCOHOL; PLASMA; EYE	Context Although cigarette smoking has been shown to be a risk factor for age-related cataract, data are inconclusive on the risk of cataract in individuals who quit smoking. Objective To examine the association between smoking cessation and incidence of age-related cataract. Design Prospective cohort study conducted from 1982 through 1997, with an average follow-up of 13.6 years. Setting and Participants A total of 20907 US male physicians participating in the Physicians' Health Study I who did not have a diagnosis of age-related cataract at baseline and had reported their level of smoking at baseline. Main Outcome Measures Incident age-related cataract defined as self-report confirmed by medical record review, diagnosed after study randomization and responsible for vision loss to 20/30 or worse, and surgical extraction of incident age-related cataract, in relation to smoking status and years since quitting smoking. Results At baseline, 11% were current smokers, 39% were past smokers, and 50% were never smokers. Average reported cumulative dose of smoking at baseline was approximately 2-fold greater in current than in past smokers (35.8 vs 20.5 pack-years). Two thousand seventy-four incident cases of age-related cataract and 1193 cataract extractions were confirmed during follow-up. Compared with current smokers, multivariate relative risks (RRs) of cataract in past smokers who quit smoking fewer than 10 years, 10 to fewer than 20 years, and 20 or more years before the study were 0.79 (95% confidence interval [CI], 0.64-0.98), 0.73 (95% CI, 0.61-0.88), and 0.74 (95% CI, 0.63-0.87), respectively, after adjustment for other risk factors for cataract and age at smoking inception. The RR for never smelters was 0.64 (95% CI, 0.54-0.76). The reduced risk in past smokers was principally due to a lower total cumulative dose (RR of cataract for increase of 10 pack-years of smoking, 1.07; 95% CI, 1.04-1.10). A benefit of stopping smoking independent of cumulative dose was suggested in some analyses. Results for cataract extraction were similar. Conclusion These prospective data indicate that while some smoking-related damage to the lens may be reversible, smoking cessation reduces the risk of cataract primarily by limiting total dose-related damage to the lens.	Harvard Univ, Sch Med, Div Prevent Med, Boston, MA USA; Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Univ Miami, Sch Med, Dept Med, Miami, FL USA; Univ Miami, Sch Med, Dept Epidemiol, Miami, FL USA; Univ Miami, Sch Med, Dept Publ Hlth, Miami, FL USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Miami; University of Miami; University of Miami	Christen, WG (corresponding author), 900 Commonwealth Ave E, Boston, MA 02215 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER; NCI NIH HHS [CA 34944] Funding Source: Medline; NHLBI NIH HHS [HL 34595, HL 26490] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BUNCE GE, 1990, ANNU REV NUTR, V10, P233, DOI 10.1146/annurev.nu.10.070190.001313; CHOW CK, 1986, J AM COLL NUTR, V5, P305; CHRISTEN WG, 1992, JAMA-J AM MED ASSOC, V268, P989; Christen WG, 1996, JAMA-J AM MED ASSOC, V276, P1147, DOI 10.1001/jama.276.14.1147; CLAYTON RM, 1982, T OPHTHAL SOC UK, V102, P331; FLAYE DE, 1989, EYE, V3, P379, DOI 10.1038/eye.1989.56; HANKINSON SE, 1992, JAMA-J AM MED ASSOC, V268, P994, DOI 10.1001/jama.268.8.994; HARDING JJ, 1988, BRIT J OPHTHALMOL, V72, P809, DOI 10.1136/bjo.72.11.809; Hiller R, 1997, ARCH OPHTHALMOL-CHIC, V115, P1113, DOI 10.1001/archopht.1997.01100160283003; JACQUES PF, 1988, ARCH OPHTHALMOL-CHIC, V106, P337, DOI 10.1001/archopht.1988.01060130363022; KLEIN BEK, 1985, OPHTHALMOLOGY, V92, P1191; KLEIN BEK, 1993, AM J PREV MED, V9, P27, DOI 10.1016/S0749-3797(18)30763-3; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244, DOI 10.1001/archopht.1991.01080020090051; MOHAN M, 1989, ARCH OPHTHALMOL-CHIC, V107, P670, DOI 10.1001/archopht.1989.01070010688028; *NAT ADV EYE COUNC, 1998, NAT ADV EYE COUNC NI; Paik DC, 2000, EXP EYE RES, V70, P73, DOI 10.1006/exer.1999.0761; RAMAKRISHNAN S, 1995, BRIT J OPHTHALMOL, V79, P202, DOI 10.1136/bjo.79.3.202; STRYKER WS, 1988, AM J EPIDEMIOL, V127, P283, DOI 10.1093/oxfordjournals.aje.a114804; TAYLOR A, 1987, FREE RADICAL BIO MED, V3, P371, DOI 10.1016/0891-5849(87)90015-3; *US DEP HHS, 1990, DHHS PUBL CDC; WEST S, 1989, ARCH OPHTHALMOL-CHIC, V107, P1166, DOI 10.1001/archopht.1989.01070020232031; WEST S, 1995, ARCH OPHTHALMOL-CHIC, V113, P1377, DOI 10.1001/archopht.1995.01100110037022	22	54	55	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					713	716		10.1001/jama.284.6.713	http://dx.doi.org/10.1001/jama.284.6.713			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341JM	10927779	Bronze			2022-12-28	WOS:000088587300029
J	Hartman, EE; Parker, RA				Hartman, EE; Parker, RA			A 36-year-old woman with endometriosis, pelvic pain, and infertility, 1 year later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																		Adamson GD, 1999, JAMA-J AM MED ASSOC, V282, P2347, DOI 10.1001/jama.282.24.2347	1	0	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					749	749		10.1001/jama.284.6.749	http://dx.doi.org/10.1001/jama.284.6.749			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341JM	10927785				2022-12-28	WOS:000088587300035
J	Thun, MJ; Apicella, LF; Henley, SJ				Thun, MJ; Apicella, LF; Henley, SJ			Smoking vs other risk factors as the cause of smoking-attributable deaths - Confounding in the courtroom	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CIGARETTE-SMOKING; EDUCATIONAL STATUS; UNITED-STATES; MORTALITY; SMOKERS; NUTRIENT; CANCER; FOOD	Context The surgeon general estimates that more than 400000 deaths are attributable to smoking annually in the United States. The tobacco industry has criticized the surgeon general's estimates because they do not control for the lower educational and socioeconomic status of modern-day smokers. Objective To determine whether controlling for education, occupation, race, alcohol consumption, and various dietary factors, in addition to age and sex, substantially alters the relative and attributable risk estimates associated with tobacco smoking. Design, Setting, and Participants Nationwide American Cancer Society prospective cohort study of 974150 US adults aged 30 years or older, enrolled in 1982 and followed up through 1988. (The same study is used for the surgeon general and Centers for Disease Control and Prevention [CDC] estimates of smoking-attributable deaths in the United States.) Main Outcome Measures Death from each of the chronic diseases considered in the CDC's estimate of smoking-attributable mortality (cancers of the lung, oropharynx, larynx, esophagus, pancreas, kidney, bladder, and cervix; ischemic heart disease, arterial disease, and other heart conditions; stroke; chronic obstructive pulmonary disease; and other respiratory conditions). Estimates adjusted for multiple covariates were compared with those adjusted for age only among current and former vs never smokers. Results Adjusting for multiple covariates slightly decreased the relative and attributable risk estimates for current smoking in both men and women, but slightly increased the estimates for former smoking in women. Multivariate adjustment decreased the overall estimate of deaths attributable to smoking in the United States by approximately 1%, from 401 109 to 396 741 per year. Conclusions Our study suggests that federal estimates of deaths caused by smoking are not substantially altered by adjustment for behavioral and demographic factors associated with smoking beyond the current adjustment for age and sex.	Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA	American Cancer Society	Thun, MJ (corresponding author), Amer Canc Soc, Dept Epidemiol & Surveillance Res, 1599 Clifton Rd NE, Atlanta, GA 30329 USA.	mthun@cancer.org	Henley, Jane/A-4698-2010	Henley, S Jane/0000-0002-2420-306X				CADE JE, 1991, J EPIDEMIOL COMMUN H, V45, P270, DOI 10.1136/jech.45.4.270; *CDCP, 1996, SMOK ATTR MORT MORB; *CDCP, 1992, CDCP DHHS PUBL NAT C; Cohen J, 1996, SCIENCE, V272, P488, DOI 10.1126/science.272.5261.488; COX DR, 1972, J R STAT SOC B, V34, P187; DOLL R, 1956, BRIT MED J, V2, P1071, DOI 10.1136/bmj.2.5001.1071; DOLL R, 1980, BRIT MED J, V280, P967, DOI 10.1136/bmj.280.6219.967; ESCOBEDO LG, 1990, JAMA-J AM MED ASSOC, V264, P1550, DOI 10.1001/jama.264.12.1550; FRIEDMAN GD, 1979, NEW ENGL J MED, V300, P213, DOI 10.1056/NEJM197902013000501; Garfinkel L, 1985, Natl Cancer Inst Monogr, V67, P49; HAMMOND E, 1966, EPIDEMIOLOGICAL APPR, V127, P204; HAMMOND E C, 1958, J Am Med Assoc, V166, P1159; KAHN HAROLD A., 1966, NAT CANCER INST MONOGR, V19, P1; Kawachi I, 1997, NATL CANCER I MONOGR, V8, P531; Kleinbaum DG, 1996, SURVIVAL ANAL SELF L; LACROIX AZ, 1991, NEW ENGL J MED, V324, P1619, DOI 10.1056/NEJM199106063242303; Last J., 1988, DICT EPIDEMIOLOGY; LEVY R, 1998, REGULATION, V21, P24; MALARCHER AM, IN PRESS AM J EPIDEM; MIDGETTE AS, 1993, AM J EPIDEMIOL, V137, P521, DOI 10.1093/oxfordjournals.aje.a116705; *NAT CTR CHRON DIS, 1989, RED HLTH CONS SMOK 2; *NAT CTR HLTH STAT, 1996, HLTH US 1995; STERLING TD, 1993, AM J EPIDEMIOL, V138, P128, DOI 10.1093/oxfordjournals.aje.a116835; SUBAR AF, 1993, ANN NY ACAD SCI, V686, P310, DOI 10.1111/j.1749-6632.1993.tb39193.x; SUBAR AF, 1990, AM J PUBLIC HEALTH, V80, P1323, DOI 10.2105/AJPH.80.11.1323; THUN MJ, 1995, AM J PUBLIC HEALTH, V85, P1223, DOI 10.2105/AJPH.85.9.1223; THUN MJ, 1992, JNCI-J NATL CANCER I, V84, P1491, DOI 10.1093/jnci/84.19.1491; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; Thun MJ, 1997, NATL CANCER I MONOGR, P305; WAGENKNECHT LE, 1990, PREV MED, V19, P158, DOI 10.1016/0091-7435(90)90017-E; WEINKAM JJ, 1992, AM J EPIDEMIOL, V136, P722, DOI 10.1093/oxfordjournals.aje.a116551; World Health Organization, 1977, INT CLASS DIS; Zhu BP, 1996, AM J PUBLIC HEALTH, V86, P1582, DOI 10.2105/AJPH.86.11.1582; Zondervan KT, 1996, INT J EPIDEMIOL, V25, P70, DOI 10.1093/ije/25.1.70; 1995, WEBSTERS 2 NEW COLL, P237; 1990, VITAL STAT US 1990, V2, P312; 1993, MMWR MORB MORTAL WKL, V42, P645; 1997, MMWR MORB MORTAL WKL, V46, P444	38	223	240	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					706	712		10.1001/jama.284.6.706	http://dx.doi.org/10.1001/jama.284.6.706			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341JM	10927778	Bronze			2022-12-28	WOS:000088587300028
J	Donnelly, GB; Randlett, D				Donnelly, GB; Randlett, D			Methemoglobinemia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Mem Sloan Kettering Canc Ctr, New York, NY 10003 USA	Memorial Sloan Kettering Cancer Center	Donnelly, GB (corresponding author), Mem Sloan Kettering Canc Ctr, New York, NY 10003 USA.								0	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2000	343	5					337	337		10.1056/NEJM200008033430505	http://dx.doi.org/10.1056/NEJM200008033430505			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340GR	10928887				2022-12-28	WOS:000088525200005
J	Gottlieb, S				Gottlieb, S			Lumpectomy as good as mastectomy for tumours up to 5 cm	BRITISH MEDICAL JOURNAL			English	News Item																		van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					261	261		10.1136/bmj.321.7256.261	http://dx.doi.org/10.1136/bmj.321.7256.261			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915122	Green Published			2022-12-28	WOS:000088619800016
J	Lopez-Coviella, I; Berse, B; Krauss, R; Thies, RS; Blusztajn, JK				Lopez-Coviella, I; Berse, B; Krauss, R; Thies, RS; Blusztajn, JK			Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9	SCIENCE			English	Article							BONE MORPHOGENETIC PROTEINS; NEURAL CREST CULTURES; SPINAL-CORD; DOPAMINERGIC-NEURONS; SIGNALING PATHWAYS; ADRENERGIC CELLS; BASAL FOREBRAIN; GROWTH-FACTOR; EXPRESSION; DIFFERENTIATION	Bone morphogenetic proteins (BMPs) have multiple functions in the developing nervous system. A member of this family, BMP-9, was found to be highly expressed in the embryonic mouse septum and spinal cord, indicating a possible role in regulating the cholinergic phenotype. In cultured neurons, BMP-9 directly induced the expression of the cholinergic gene locus encoding choline acetyltransferase and the vesicular acetylcholine transporter and up-regulated acetylcholine synthesis. The effect was reversed upon withdrawal of BMP-9. Intracerebroventricular injection of BMP-9 increased acetylcholine levels in vivo. Although certain other BMPs also up-regulated the cholinergic phenotype in vitro, they were less effective than BMP-9. These data indicate that BMP-9 is a differentiating factor for cholinergic central nervous system neurons.	Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; Genet Inst, Cambridge, MA 02140 USA	Boston University; Boston University	Blusztajn, JK (corresponding author), Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA.			/0000-0001-8438-3122; Berse, Brygida/0000-0002-0735-2792	NATIONAL INSTITUTE ON AGING [P01AG009525] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG09525] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson DJ, 1997, COLD SPRING HARB SYM, V62, P493; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Berse B, 1999, BIOCHEM J, V342, P301, DOI 10.1042/0264-6021:3420301; BERSE B, 1995, J BIOL CHEM, V270, P22101, DOI 10.1074/jbc.270.38.22101; Ericson J, 1998, DEVELOPMENT, V125, P1005; FANN MJ, 1994, J NEUROCHEM, V63, P2074; Galter D, 1999, EUR J NEUROSCI, V11, P2444, DOI 10.1046/j.1460-9568.1999.00667.x; Greenwood AL, 1999, DEVELOPMENT, V126, P3545; Hattori A, 1999, J NEUROCHEM, V72, P2264, DOI 10.1046/j.1471-4159.1999.0722264.x; Helm GA, 2000, J NEUROSURG, V92, P191, DOI 10.3171/spi.2000.92.2.0191; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Jordan J, 1997, EUR J NEUROSCI, V9, P1699, DOI 10.1111/j.1460-9568.1997.tb01527.x; Kalyani AJ, 1998, J NEUROSCI, V18, P7856; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Li WW, 2000, DEV NEUROSCI-BASEL, V22, P68, DOI 10.1159/000017428; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Lo LC, 1998, DEVELOPMENT, V125, P609; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Ploemacher RE, 1999, LEUKEMIA, V13, P428, DOI 10.1038/sj.leu.2401363; Reiriz J, 1999, J NEUROBIOL, V38, P161, DOI 10.1002/(SICI)1097-4695(19990205)38:2<161::AID-NEU1>3.3.CO;2-V; Reissmann E, 1996, DEVELOPMENT, V122, P2079; SCHAMBRA UB, 1989, J COMP NEUROL, V288, P101, DOI 10.1002/cne.902880109; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; Soderstrom S, 1996, CELL TISSUE RES, V286, P269, DOI 10.1007/s004410050697; SOFRONIEW MV, 1990, SCIENCE, V247, P338, DOI 10.1126/science.1688664; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Streit A, 1999, MECH DEVELOP, V82, P51, DOI 10.1016/S0925-4773(99)00013-1; SWEENEY JE, 1989, NEUROSCIENCE, V31, P413, DOI 10.1016/0306-4522(89)90384-9; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Varley JE, 1998, DEV BIOL, V196, P107, DOI 10.1006/dbio.1998.8853; Varley JE, 1996, EXP NEUROL, V140, P84, DOI 10.1006/exnr.1996.0118; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	38	184	215	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					313	316		10.1126/science.289.5477.313	http://dx.doi.org/10.1126/science.289.5477.313			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894782				2022-12-28	WOS:000088169400046
J	Larison, JR; Likens, GE; Fitzpatrick, JW; Crock, JG				Larison, JR; Likens, GE; Fitzpatrick, JW; Crock, JG			Cadmium toxicity among wildlife in the Colorado Rocky Mountains	NATURE			English	Article							REPRODUCTION; ALUMINUM; CALCIUM; MERCURY; BIRDS; LEAD	Cadmium is known to be both extremely toxic and ubiquitous in natural environments. It occurs in almost all soils, surface waters and plants(1-3), and it is readily mobilized by human activities such as mining(4). As a result, cadmium has been named as a potential health threat to wildlife species(5); however, because it exists most commonly in the environment as a trace constituent, reported incidences of cadmium toxicity are rare. Here we have measured trace metals in the food web and tissues of white-tailed ptarmigan (Lagopus leucurus) in Colorado. Our results suggest that cadmium toxicity may be more common among natural populations of vertebrates than has been appreciated to date and that cadmium toxicity may often go undetected or unrecognized. In addition, our research shows that ingestion of even trace quantities of cadmium can influence not only the physiology and health of individual organisms, but also the demographics and the distribution of species.	Cornell Univ, Sect Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; Inst Ecosyst Studies, Millbrook, NY 12545 USA; Cornell Lab Ornithol, Ithaca, NY 14850 USA; US Geol Survey, Denver Fed Ctr, Lakewood, CO 80225 USA	Cornell University; Cary Institute of Ecosystem Studies; Cornell University; United States Department of the Interior; United States Geological Survey	Larison, JR (corresponding author), Oregon State Univ, 138 Strand Hall, Corvallis, OR 97331 USA.	larisonj@ucs.orst.edu						ANDO M, 1978, TOXICOL APPL PHARM, V46, P625, DOI 10.1016/0041-008X(78)90308-3; ARMSTRONG DM, 1987, ROCKY MOUNTAIN MAMMA; Bonnell JA, 1955, BRIT J IND MED, V12, P181; BRAUN CE, 1976, 38 COL DIV WILDL SPE; BRAUN CE, 1993, BIRDS N AM, V68; Braun CE, 1969, THESIS COLORADO STAT; BURBANK WS, 1968, GEOLOGY ORE DEPOSITS, V1, P715; CHANG LW, 1980, CADMIUM ENV, P784; CHURCH SE, 1997, 97151 US GEOL SURV; Crock J.G., 1999, REV EC GEOLOGY A, P265; CROCK JG, 1999, 9933 US GEOL SURV; Foulkes E. C., 1986, CADMIUM, P75; Friberg L., 1986, HDB TOXICOLOGY METAL, P130; Furness Robert W., 1996, P389; GOERING PL, 1986, CADMIUM HDB EXPT PHA, P189; GRAVELAND J, 1994, NATURE, V368, P446, DOI 10.1038/368446a0; HAMILTON DL, 1978, ENVIRON RES, V15, P175, DOI 10.1016/0013-9351(78)90094-4; KIDO T, 1988, ARCH ENVIRON HEALTH, V43, P213, DOI 10.1080/00039896.1988.9934935; NICHOLSON JK, 1983, J ZOOL, V200, P99, DOI 10.1111/j.1469-7998.1983.tb06111.x; NOGAWA K, 1980, CADMIUM ENV, P1; PAGE AL, 1987, LEAD MERCURY CADMIUM, P33; PETERSON AP, 1979, CHEM BIOCH BIOL CADM, P45; Quick H. F., 1947, Condor Berkeley, V49, P233, DOI 10.2307/1364181; RICHARDSON ME, 1974, J NUTR, V104, P323, DOI 10.1093/jn/104.3.323; SCHEUHAMMER AM, 1987, ENVIRON POLLUT, V46, P263, DOI 10.1016/0269-7491(87)90173-4; Scheuhammer AM, 1996, ENVIRON POLLUT, V94, P337, DOI 10.1016/S0269-7491(96)00084-X; SHACKLETTE HT, 1972, GEOLOGICAL SURVEY G, V1314; SIMKISS K, 1961, BIOL REV, V36, P321, DOI 10.1111/j.1469-185X.1961.tb01292.x; WARREN E.R., 1942, MAMMALS COLORADO THE; Wiebe KL, 1998, IBIS, V140, P14, DOI 10.1111/j.1474-919X.1998.tb04536.x	30	182	193	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					181	183		10.1038/35018068	http://dx.doi.org/10.1038/35018068			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910356				2022-12-28	WOS:000088221100046
J	Henney, JE				Henney, JE			Web site for clinical investigators	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									Commissioner Food & Drugs, Rockville, MD 20857 USA		Henney, JE (corresponding author), Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2000	283	21					2779	2779		10.1001/jama.283.21.2779-b	http://dx.doi.org/10.1001/jama.283.21.2779-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BQ	10896520				2022-12-28	WOS:000087381500005
J	Dennis, SM; Sharp, SJ; Vickers, MR; Frost, CD; Crompton, GK; Barnes, PJ; Lee, TH				Dennis, SM; Sharp, SJ; Vickers, MR; Frost, CD; Crompton, GK; Barnes, PJ; Lee, TH		Natl Asthma Task Force; MRC Gen Practice Res Framework	Regular inhaled salbutamol and asthma control: the TRUST randomised trial	LANCET			English	Article							BETA-AGONISTS; RESPONSIVENESS; EXACERBATIONS; TERBUTALINE; BUDESONIDE; MORTALITY; DEATH	Background Previous work has suggested that the long-term regular use of inhaled beta(2)-agonist bronchodilators might lead to a deterioration in asthma control. The aim of TRUST (The Regular Use of Salbutamol Trial) was to study the effects of regular use of inhaled salbutamol, the most widely prescribed bronchodilator in the UK, on the control of asthma, Methods A randomised, double-blind, placebo-controlled trial was undertaken in 983 patients with asthma being treated at least twice a week with short-acting beta(2)-agonist, alone or in combination with inhaled steroids (2 mg or less) daily. Patients were aged 18 years and over and were recruited from 115 general practices in the UK. 90% (881) of the patients used inhaled corticosteroid therapy, and all patients continued to use their usual inhaled beta(2)-agonist for symptomatic relief. Patients were randomised to receive 400 mu g salbutamol or matched placebo via a Diskhaler four times per day for 12 months. The primary outcome measure was rate of exacerbations of asthma, with criteria based on data from diary cards completed daily by each patient, treatment with additional corticosteroids, or both. Findings There were no differences in the annual rate, timing, or duration of exacerbations between the two groups. The mean morning peak expiratory flow was similar for the two groups. The mean evening peak expiratory flow (p<0.001) and the diurnal variation (p<0.001) were greater, and the use of rescue bronchodilator was less (p<0.001), in the group receiving regular salbutamol. Interpretation There was no evidence that regular use of inhaled salbutamol 400 mu g four times daily for a year increased the exacerbation rate of asthma in the population studied.	Guys Hosp, Guys Kings & St Thomas Sch Med, Dept Resp Med & Allergy, London SE1 9RT, England; Univ London Queen Mary & Westfield Coll, St Bartholomews & Royal London Sch Med & Dent, MRC, Epidemiol & Med Care Unit, London E1 4NS, England; Univ London London Sch Hyg & Trop Med, Med Stat Unit, London WC1E 7HT, England; Western Gen Hosp, Resp Med Unit, Edinburgh EH4 2XU, Midlothian, Scotland; London Sch Hyg & Trop Med, Natl Heart & Lung Inst, Dept Thorac Med, London WC1, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; Queen Mary University London; University of London; London School of Hygiene & Tropical Medicine; University of Edinburgh; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Lee, TH (corresponding author), Guys Hosp, Guys Kings & St Thomas Sch Med, Dept Resp Med & Allergy, London SE1 9RT, England.		Lee, Tak/AAA-9526-2020	Lee, Tak/0000-0002-7554-4059; Dennis, Sarah/0000-0003-2685-9246; Barnes, Peter/0000-0002-5122-4018				CHAPMAN KR, 1994, LANCET, V343, P1379, DOI 10.1016/S0140-6736(94)92520-8; COCKCROFT DW, 1993, LANCET, V342, P833, DOI 10.1016/0140-6736(93)92695-P; CRANE J, 1989, LANCET, V1, P917; DENNIS SM, IN PRESS NHS EXECUTI; Drazen JM, 1996, NEW ENGL J MED, V335, P841, DOI 10.1056/NEJM199609193351202; *GLOB STRAT ASTHM, 1995, NHLIBI WHO WORKSH RE; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; INMAN WHW, 1969, LANCET, V2, P279; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; KRAAN J, 1987, J ALLERGY CLIN IMMUN, V79, P653; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; PEARCE N, 1990, THORAX, V45, P170, DOI 10.1136/thx.45.3.170; SEARS MR, 1994, DRUG SAFETY, V11, P259, DOI 10.2165/00002018-199411040-00005; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; SPEIZER FE, 1968, BRIT MED J, V1, P335, DOI 10.1136/bmj.1.5588.335; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; STOLLEY PD, 1972, AM REV RESPIR DIS, V105, P883; SUISSA S, 1994, AM J RESP CRIT CARE, V149, P604, DOI 10.1164/ajrccm.149.3.8118625; TAYLOR DR, 1993, THORAX, V48, P134, DOI 10.1136/thx.48.2.134; VANSCHAYCK CP, 1991, BRIT MED J, V303, P1426, DOI 10.1136/bmj.303.6815.1426; VANSCHAYCK CP, 1993, THORAX, V48, P470, DOI 10.1136/thx.48.5.470; VATHENEN AS, 1988, LANCET, V1, P554; Wilding P, 1997, BRIT MED J, V314, P1441, DOI 10.1136/bmj.314.7092.1441; YARBROUGH J, 1985, ANN ALLERGY, V55, P25; [No title captured], DOI DOI 10.1136/THX.52.2008.S1]	26	70	72	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2000	355	9216					1675	1679		10.1016/S0140-6736(00)02238-8	http://dx.doi.org/10.1016/S0140-6736(00)02238-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905242				2022-12-28	WOS:000086983800009
J	Arthur, HM; Daniels, C; McKelvie, R; Hirsh, J; Rush, B				Arthur, HM; Daniels, C; McKelvie, R; Hirsh, J; Rush, B			Effect of a preoperative intervention on preoperative and postoperative outcomes in low-risk patients awaiting elective coronary artery bypass graft surgery - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							REVASCULARIZATION	Background: In publicly funded health care systems, a waiting period for such services as coronary artery bypass graft surgery (CABG) is common. The possibility of using the waiting period to improve patient outcomes should be investigated. Objective: To examine the effect of a multidimensional preoperative intervention on presurgery and postsurgery outcomes in low-risk patients awaiting elective CABG. Design: Randomized, controlled trial. Setting: A regional cardiovascular surgery center in a tertiary care hospital, southwestern Ontario, Canada. Patients: 249 patients on a waiting list for elective CABG whose surgeries were scheduled for a minimum of 10 weeks from the time of study recruitment. Intervention: During the waiting period, the treatment group received exercise training twice per week, education and reinforcement, and monthly nurse-initiated telephone calls. After surgery, participation in a cardiac rehabilitation program was offered to all patients. Measurements: Postoperative length of stay was the primary outcome, secondary outcomes were exercise performance, general health-related quality of life, social support, anxiety, and utilization of health care services. Results: Length of stay differed significantly between groups. Patients who received the preoperative intervention spent 1 less day [95% CI, 0.0 to 1.0 day] in the hospital overall (P = 0.002) acid less time in the intensive care unit (median, 2.1 hours [CI, -1.2 to 16 hours]; P = 0.001). During the waiting period, patients in the intervention group had a better quality of life than controls. Improved quality of life continued up to 6 months after surgery. Mortality rates did not differ. Conclusion: The waiting period for elective procedures, such as CABG, may be used to enhance in-hospital and early-phase recovery, improving patients' functional abilities and quality of life while reducing their hospital stay.	McMaster Univ, Fac Hlth Sci, Hamilton, ON L8N 3Z5, Canada; Hamilton Hlth Sci Corp, Hamilton, ON, Canada	McMaster University; McMaster University	Arthur, HM (corresponding author), McMaster Univ, Fac Hlth Sci, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	arthurh@fhs.mcmaster.ca						BECKERMAN A, 1995, HEART LUNG, V24, P213, DOI 10.1016/S0147-9563(05)80039-1; Bengtson A, 1996, HEART, V75, P257, DOI 10.1136/hrt.75.3.257; Browne G, WORKING PAPER SERIES, V92-12; *CARD CAR NETW ONT, 1999, CCN CONS PAN CARD SU, P1; CARRIER M, 1993, CAN MED ASSOC J, V149, P1117; Cohen S., 1985, SOCIAL SUPPORT THEOR, P73, DOI [10.1007/978-94-009-5115-0_5, DOI 10.1007/978-94-009-5115-0_5]; Deedwania Prakash C., 1996, Cardiology Clinics, V14, P229; DENOLLET J, 1993, J CONSULT CLIN PSYCH, V61, P686; JENKINS CD, 1983, ARCH INTERN MED, V143, P2107, DOI 10.1001/archinte.143.11.2107; Krantz David S., 1996, Cardiology Clinics, V14, P271; LLEWELLYNTHOMAS HA, 1992, MED DECIS MAKING, V12, P115, DOI 10.1177/0272989X9201200204; MULGAN R, 1990, NEW ZEAL MED J, V103, P371; NAYLOR CD, 1990, LANCET, V335, P1070, DOI 10.1016/0140-6736(90)92640-4; Norman G., 2014, BIOSTATISTICS BARE E, V4; PIEPER B, 1985, HEART LUNG, V14, P40; Spielberger C. D., 1970, SELF EVALUATION QUES; *SPSS INC, 1997, SPSS STAT PACK; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WEBBER GC, 1990, MED CARE, V28, P1089, DOI 10.1097/00005650-199011000-00009	20	279	292	1	52	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2000	133	4					253	262		10.7326/0003-4819-133-4-200008150-00007	http://dx.doi.org/10.7326/0003-4819-133-4-200008150-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346NG	10929164				2022-12-28	WOS:000088877500002
J	Sickafus, KE; Minervini, L; Grimes, RW; Valdez, JA; Ishimaru, M; Li, F; McClellan, KJ; Hartmann, T				Sickafus, KE; Minervini, L; Grimes, RW; Valdez, JA; Ishimaru, M; Li, F; McClellan, KJ; Hartmann, T			Radiation tolerance of complex oxides	SCIENCE			English	Article							DAMAGE; PLUTONIUM; PHASE	The radiation performance of a variety of complex oxides is predicted on the basis of a material's propensity to accommodate lattice point defects. The calculations indicate that a particular class of oxides possessing the fluorite crystal structure should accept radiation-induced defects into their Lattices far more readily than a structurally similar class of oxides based on the pyrochlore crystal structure. Preliminary radiation damage experiments substantiate the prediction that fluorites are inherently more radiation resistant than pyrochlores, These results may permit the chemical durability and radiation tolerance of potential hosts for actinides and radioactive wastes to be tailored.	Univ Calif Los Alamos Natl Lab, Div Mat Sci & Technol, Los Alamos, NM 87545 USA; Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England; Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	United States Department of Energy (DOE); Los Alamos National Laboratory; Imperial College London; Osaka University	Sickafus, KE (corresponding author), Univ Calif Los Alamos Natl Lab, Div Mat Sci & Technol, MS-G755, Los Alamos, NM 87545 USA.							Bevan D. J. M., 1979, Handbook on the Physics and Chemistry of Rare-earths, Vol.3. Non-metallic Compounds 1, P401, DOI 10.1016/S0168-1273(79)03011-7; BORN M, 1923, ATOMTHEORIE FESTEN Z; CLINARD FW, 1984, NUCL INSTRUM METH B, V1, P581, DOI 10.1016/0168-583X(84)90127-7; CLINARD FW, 1982, J NUCL MATER, V108, P655, DOI 10.1016/0022-3115(82)90538-4; Ewing R. C., 1995, Progress in Nuclear Energy, V29, P63, DOI 10.1016/0149-1970(94)00016-Y; EWING RC, 1995, J MATER RES, V10, P243, DOI 10.1557/JMR.1995.0243; HOBBS LW, 1980, J PHYSIQUE, V41, P232; *INT COMM DIFR DAT, 1974, POWD DIFFR FIL; LESLIE M, 1982, DISCITM31T UK SCI EN; Levin E. M., 1964, PHASE DIAGRAMS CERAM; LUMPKIN GR, 1994, RADIOCHIM ACTA, V66-7, P469; Matzke H, 1997, J NUCL MATER, V247, P108, DOI 10.1016/S0022-3115(97)00081-0; MINERVINI L, IN PRESS J AM CERAM; PARKER CA, 1985, J NUCL MATER, V133, P741, DOI 10.1016/0022-3115(85)90248-X; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sickafus KE, 1999, J NUCL MATER, V274, P66, DOI 10.1016/S0022-3115(99)00041-0; SICKAFUS KE, 1995, J NUCL MATER, V219, P128, DOI 10.1016/0022-3115(94)00386-6; SLEIGHT AW, 1969, INORG CHEM, V8, P1807, DOI 10.1021/ic50078a060; SUBRAMANIAN MA, 1983, PROG SOLID STATE CH, V15, P55, DOI 10.1016/0079-6786(83)90001-8; Wang SX, 1999, J MATER RES, V14, P4470, DOI 10.1557/JMR.1999.0606; Wang SX, 1999, NUCL INSTRUM METH B, V148, P704, DOI 10.1016/S0168-583X(98)00847-7; WEBER WJ, 1983, RADIAT EFF DEFECT S, V77, P295, DOI 10.1080/00337578308228193; Zacate MO, 2000, SOLID STATE IONICS, V128, P243, DOI 10.1016/S0167-2738(99)00348-3	23	778	795	4	239	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					748	751		10.1126/science.289.5480.748	http://dx.doi.org/10.1126/science.289.5480.748			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926530				2022-12-28	WOS:000088581500031
J	Chen, YQ; Cann, MJ; Litvin, TN; Iourgenko, V; Sinclair, ML; Levin, LR; Buck, J				Chen, YQ; Cann, MJ; Litvin, TN; Iourgenko, V; Sinclair, ML; Levin, LR; Buck, J			Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor	SCIENCE			English	Article							SPIRULINA-PLATENSIS; SPERM; PURIFICATION; CYAC	Spermatozoa undergo a poorly understood activation process induced by bicarbonate and mediated by cyclic adenosine 3',5'-monophosphate (cAMP). It has been assumed that bicarbonate mediates its effects through changes in intracellular pH or membrane potential; however, we demonstrate here that bicarbonate directly stimulates mammalian soluble adenylyl cyclase (sAC) activity in vivo and in vitro in a pH-independent manner. sAC is most similar to adenylyl cyclases from cyanobacteria, and bicarbonate regulation of cyclase activity is conserved in these early forms of life. sAC is also expressed in other bicarbonate-responsive tissues, which suggests that bicarbonate regulation of cAMP signaling plays a fundamental role in many biological systems.	Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA	Cornell University	Cann, MJ (corresponding author), Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Pharmacol, 1300 York Ave, New York, NY 10021 USA.		Cann, Martin/G-2864-2012	Cann, Martin/0000-0001-6305-8769; Levin, Lonny/0000-0002-5204-6356				BRAUN T, 1975, P NATL ACAD SCI USA, V72, P1097, DOI 10.1073/pnas.72.3.1097; BRAUN T, 1991, METHOD ENZYMOL, V195, P130; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; CANN MJ, UNPUB; CANN MJ, COMMUNICATION; FORTE LR, 1983, MOL PHARMACOL, V24, P42; GARTY NB, 1987, FEBS LETT, V218, P148, DOI 10.1016/0014-5793(87)81036-0; Johnson LR, 1998, ESSENTIAL MED PHYSL; Kasahara M, 1999, J BIOL CHEM, V274, P15167, DOI 10.1074/jbc.274.21.15167; Kasahara M, 1997, PLANT CELL PHYSIOL, V38, P828, DOI 10.1093/oxfordjournals.pcp.a029241; LEVIN LR, 1995, J BIOL CHEM, V270, P7573, DOI 10.1074/jbc.270.13.7573; LEVINE N, 1971, J PHYSIOL-LONDON, V213, P557, DOI 10.1113/jphysiol.1971.sp009400; MITTAG TW, 1993, AM J PHYSIOL, V264, pF1060, DOI 10.1152/ajprenal.1993.264.6.F1060; OHMORI K, 1992, PLANT CELL PHYSIOL, V33, P21; Ohno S, 1997, J MOL EVOL, V44, pS23, DOI 10.1007/PL00000055; OKAMURA N, 1991, J BIOL CHEM, V266, P17754; Pitts RF, 1974, PHYSL KIDNEY BODY FL, V3rd; Scholich K, 1997, P NATL ACAD SCI USA, V94, P2915, DOI 10.1073/pnas.94.7.2915; Sinclair ML, 2000, MOL REPROD DEV, V56, P6, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;6::AID-MRD2&gt;3.0.CO;2-M; Visconti PE, 1998, J ANDROL, V19, P242	20	658	686	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2000	289	5479					625	628		10.1126/science.289.5479.625	http://dx.doi.org/10.1126/science.289.5479.625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915626				2022-12-28	WOS:000088447800055
J	Barnes, PJ				Barnes, PJ			Medical progress: Chronic obstructive pulmonary disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NECROSIS-FACTOR-ALPHA; POSITIVE-PRESSURE VENTILATION; BRONCHOALVEOLAR LAVAGE FLUID; RANDOMIZED CONTROLLED TRIAL; ACUTE RESPIRATORY-FAILURE; VOLUME-REDUCTION SURGERY; EXHALED NITRIC-OXIDE; TERM OXYGEN-THERAPY; CHRONIC-BRONCHITIS; LUNG-FUNCTION		Natl Heart & Lung Inst, Dept Thorac Med, Imperial Coll Sch Med, London SW3 6LY, England	Imperial College London	Barnes, PJ (corresponding author), Natl Heart & Lung Inst, Dept Thorac Med, Imperial Coll Sch Med, Dovehouse St, London SW3 6LY, England.	p.j.barnes@ic.ac.uk		Barnes, Peter/0000-0002-5122-4018				Agusti AGN, 1999, EUR RESPIR J, V14, P523, DOI 10.1034/j.1399-3003.1999.14c08.x; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Antonelli M, 1998, NEW ENGL J MED, V339, P429, DOI 10.1056/NEJM199808133390703; Barbe F, 1996, EUR RESPIR J, V9, P1240, DOI 10.1183/09031936.96.09061240; Barnes PJ, 2000, CHEST, V117, P10; Barnes PJ, 1999, AM J RESP CRIT CARE, V160, pS72, DOI 10.1164/ajrccm.160.supplement_1.17; Barnes PJ, 1999, THORAX, V54, P245, DOI 10.1136/thx.54.3.245; Barnes PJ, 1998, THORAX, V53, P137, DOI 10.1136/thx.53.2.137; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bernard S, 1998, AM J RESP CRIT CARE, V158, P629, DOI 10.1164/ajrccm.158.2.9711023; Betsuyaku T, 1999, AM J RESP CRIT CARE, V159, P1985, DOI 10.1164/ajrccm.159.6.9809043; Bhowmik A, 2000, THORAX, V55, P114, DOI 10.1136/thorax.55.2.114; Boyd G, 1997, EUR RESPIR J, V10, P1696; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Cawston TE, 1996, PHARMACOL THERAPEUT, V70, P163, DOI 10.1016/0163-7258(96)00015-0; *CDCP, 1996, DHHS PUBL; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; Chaouat A, 1999, EUR RESPIR J, V14, P1002, DOI 10.1183/09031936.99.14510029; Cooper JD, 1996, J THORAC CARDIOV SUR, V112, P1319, DOI 10.1016/S0022-5223(96)70147-2; Criner GJ, 1999, AM J RESP CRIT CARE, V160, P2018, DOI 10.1164/ajrccm.160.6.9902117; Culpitt SV, 1999, AM J RESP CRIT CARE, V160, P1635, DOI 10.1164/ajrccm.160.5.9811058; Davies L, 1999, LANCET, V354, P456, DOI 10.1016/S0140-6736(98)11326-0; deGodoy I, 1996, AM J RESP CRIT CARE, V153, P633, DOI 10.1164/ajrccm.153.2.8564110; Dekhuijzen PNR, 1996, AM J RESP CRIT CARE, V154, P813, DOI 10.1164/ajrccm.154.3.8810624; Dennis RJ, 1996, CHEST, V109, P115, DOI 10.1378/chest.109.1.115; Di Stefano A, 1998, AM J RESP CRIT CARE, V158, P1277, DOI 10.1164/ajrccm.158.4.9802078; DIFRANCIA M, 1994, AM J RESP CRIT CARE, V150, P1453, DOI 10.1164/ajrccm.150.5.7952575; Disse B, 1999, LIFE SCI, V64, P457, DOI 10.1016/S0024-3205(98)00588-8; Donaldson GC, 1999, EUR RESPIR J, V13, P844, DOI 10.1034/j.1399-3003.1999.13d25.x; Dowling RB, 1998, EUR RESPIR J, V11, P86, DOI 10.1183/09031936.98.11010086; Doyle R L, 1998, Adv Intern Med, V43, P233; Espada R, 1999, CHEST, V116, P1750; Feldman M, 1998, TRANSPLANT P, V30, P4126, DOI 10.1016/S0041-1345(98)01365-7; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Finlay GA, 1997, AM J RESP CRIT CARE, V156, P240, DOI 10.1164/ajrccm.156.1.9612018; Geddes D, 2000, NEW ENGL J MED, V343, P239, DOI 10.1056/NEJM200007273430402; Gorecka D, 1997, THORAX, V52, P674, DOI 10.1136/thx.52.8.674; Gottlieb DJ, 1996, AM J RESP CRIT CARE, V154, P1290, DOI 10.1164/ajrccm.154.5.8912738; Griffiths TL, 2000, LANCET, V355, P362, DOI 10.1016/S0140-6736(99)07042-7; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Higham MA, 2000, EUR RESPIR J, V15, P281, DOI 10.1034/j.1399-3003.2000.15b10.x; Hill AT, 1999, AM J RESP CRIT CARE, V160, P893, DOI 10.1164/ajrccm.160.3.9901091; Hospers JJ, 1999, AM J RESP CRIT CARE, V160, P1869, DOI 10.1164/ajrccm.160.6.9811041; Huang SL, 1997, AM J RESP CRIT CARE, V156, P1436, DOI 10.1164/ajrccm.156.5.9609138; Ingenito EP, 1998, NEW ENGL J MED, V338, P1181, DOI 10.1056/NEJM199804233381703; Jeffery PK, 1998, THORAX, V53, P129, DOI 10.1136/thx.53.2.129; JONES DJM, 1995, AM J RESP CRIT CARE, V152, P538; Jones SE, 1998, THORAX, V53, P495, DOI 10.1136/thx.53.6.495; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Keatings VM, 1997, AM J RESP CRIT CARE, V155, P542, DOI 10.1164/ajrccm.155.2.9032192; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Keicho N, 1999, AM J PHYSIOL-LUNG C, V277, pL523, DOI 10.1152/ajplung.1999.277.3.L523; Lacasse Y, 1996, LANCET, V348, P1115, DOI 10.1016/S0140-6736(96)04201-8; Liu AN, 1999, AM J RESP CELL MOL, V20, P849, DOI 10.1165/ajrcmb.20.5.3585; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Luisetti M, 1996, EUR RESPIR J, V9, P1482, DOI 10.1183/09031936.96.09071482; Maesen BLP, 1999, EUR RESPIR J, V13, P1103, DOI 10.1034/j.1399-3003.1999.13e27.x; Mahadeva R, 1998, THORAX, V53, P501, DOI 10.1136/thx.53.6.501; Mahler DA, 1999, CHEST, V115, P957, DOI 10.1378/chest.115.4.957; Maltais F, 1999, EUR RESPIR J, V13, P850, DOI 10.1034/j.1399-3003.1999.13d26.x; MATSUSE T, 1992, AM REV RESPIR DIS, V146, P177, DOI 10.1164/ajrccm/146.1.177; Maziak W, 1998, AM J RESP CRIT CARE, V157, P998, DOI 10.1164/ajrccm.157.3.97-05009; Meagher LC, 1996, J IMMUNOL, V156, P4422; Montuschi P, 1999, AM J RESP CRIT CARE, V159, pA798; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Nightingale JA, 2000, AM J RESP CRIT CARE, V161, P479, DOI 10.1164/ajrccm.161.2.9905031; Noguera A, 1998, AM J RESP CRIT CARE, V158, P1664, DOI 10.1164/ajrccm.158.5.9712092; O'Donnell DE, 1998, AM J RESP CRIT CARE, V158, P1557, DOI 10.1164/ajrccm.158.5.9804004; Ohnishi K, 1998, LAB INVEST, V78, P1077; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Paggiaro PL, 1998, LANCET, V351, P773, DOI 10.1016/S0140-6736(97)03471-5; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Pesci A, 1998, EUR RESPIR J, V12, P380, DOI 10.1183/09031936.98.12020380; Pratico D, 1998, AM J RESP CRIT CARE, V158, P1709, DOI 10.1164/ajrccm.158.6.9709066; Rahman I, 1996, AM J RESP CRIT CARE, V154, P1055, DOI 10.1164/ajrccm.154.4.8887607; Rennard SI, 1996, CHEST, V110, P62, DOI 10.1378/chest.110.1.62; Repine JE, 1997, AM J RESP CRIT CARE, V156, P341, DOI 10.1164/ajrccm.156.2.9611013; Rutgers SR, 2000, THORAX, V55, P12, DOI 10.1136/thorax.55.1.12; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; SAETTA M, 1994, AM J RESP CRIT CARE, V150, P1646, DOI 10.1164/ajrccm.150.6.7952628; SAINT S, 1995, JAMA-J AM MED ASSOC, V273, P957, DOI 10.1001/jama.273.12.957; Sandford AJ, 1997, EUR RESPIR J, V10, P1380, DOI 10.1183/09031936.97.10061380; Schols AMWJ, 1999, AM J RESP CRIT CARE, V160, P1220, DOI 10.1164/ajrccm.160.4.9811033; Schols AMWJ, 1998, AM J RESP CRIT CARE, V157, P1791, DOI 10.1164/ajrccm.157.6.9705017; Schols AMWJ, 1996, THORAX, V51, P819, DOI 10.1136/thx.51.8.819; SCHOLS AMWJ, 1995, AM J RESP CRIT CARE, V152, P1268, DOI 10.1164/ajrccm.152.4.7551381; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Seemungal TAR, 1999, THORAX, V54, pA70; Shapiro SD, 1999, AM J RESP CELL MOL, V20, P1100, DOI 10.1165/ajrcmb.20.6.f151; SILAGY C, 1994, LANCET, V343, P139, DOI 10.1016/S0140-6736(94)90933-4; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; Smith CAD, 1997, LANCET, V350, P630, DOI 10.1016/S0140-6736(96)08061-0; SOMMERHOFF CP, 1990, J CLIN INVEST, V85, P682, DOI 10.1172/JCI114492; Stockley RA, 1999, AM J RESP CRIT CARE, V160, pS49, DOI 10.1164/ajrccm.160.supplement_1.13; STRACHAN DP, 1994, INT J EPIDEMIOL, V23, P1060, DOI 10.1093/ije/23.5.1060; STRUMPF DA, 1991, AM REV RESPIR DIS, V144, P1234, DOI 10.1164/ajrccm/144.6.1234; TARPY SP, 1995, NEW ENGL J MED, V333, P710, DOI 10.1056/NEJM199509143331107; Tashkin DP, 1996, AM J RESP CRIT CARE, V153, P1802, DOI 10.1164/ajrccm.153.6.8665038; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Torphy TJ, 1999, PULM PHARMACOL THER, V12, P131, DOI 10.1006/pupt.1999.0181; TURATO G, 1995, AM J RESP CRIT CARE, V152, P1262, DOI 10.1164/ajrccm.152.4.7551380; Vestbo J, 1996, AM J RESP CRIT CARE, V153, P1530, DOI 10.1164/ajrccm.153.5.8630597; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095; Witko-Sarsat V, 1999, AM J RESP CELL MOL, V20, P729, DOI 10.1165/ajrcmb.20.4.3371; YOSHIOKA A, 1995, AM J RESP CRIT CARE, V152, P2127, DOI 10.1164/ajrccm.152.6.8520785	106	966	1056	3	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2000	343	4					269	280		10.1056/NEJM200007273430407	http://dx.doi.org/10.1056/NEJM200007273430407			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	337QC	10911010				2022-12-28	WOS:000088372300007
J	Krabill, W; Abdalati, W; Frederick, E; Manizade, S; Martin, C; Sonntag, J; Swift, R; Thomas, R; Wright, W; Yungel, J				Krabill, W; Abdalati, W; Frederick, E; Manizade, S; Martin, C; Sonntag, J; Swift, R; Thomas, R; Wright, W; Yungel, J			Greenland ice sheet: High-elevation balance and peripheral thinning	SCIENCE			English	Article								Aircraft Laser-altimeter surveys over northern Greenland in 1994 and 1999 have been coupled with previously reported data from southern Greenland to analyze the recent mass-balance of the Greenland Ice Sheet. Above 2000 meters elevation, the ice sheet is in balance on average but has some regions of local thickening or thinning. Thinning predominates at Lower elevations, with rates exceeding 1 meter per year close to the coast. Interpolation of our results between flight lines indicates a net loss of about 51 cubic kilometers of ice per year from the entire ice sheet, sufficient to raise sea Level by 0.13 millimeter per year-approximately 7% of the observed rise.	NASA, Lab Hydrospher Proc, Goddard Space Flight Ctr, Wallops Island, VA 23337 USA; EG&G Serv, Wallops Flight Facil, Wallops Island, VA 23337 USA; NASA, Lab Hydrospher Proc, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Krabill, W (corresponding author), NASA, Lab Hydrospher Proc, Goddard Space Flight Ctr, Bldg N-159, Wallops Island, VA 23337 USA.							BRAITHWAITE RJ, 1995, J GLACIOL, V41, P153, DOI 10.3189/S0022143000017846; Bromwich DH, 1999, J GEOPHYS RES-ATMOS, V104, P22103, DOI 10.1029/1999JD900373; Davis CH, 1998, SCIENCE, V279, P2086, DOI 10.1126/science.279.5359.2086; ELSCHEID JK, 1995, J APPL METEOROL, V34, P2787; HERRON MM, 1981, NATURE, V293, P389, DOI 10.1038/293389a0; Krabill W, 1999, SCIENCE, V283, P1522, DOI 10.1126/science.283.5407.1522; KRABILL WB, 1995, INT J REMOTE SENS, V16, P1211, DOI 10.1080/01431169508954472; McConnell JR, 2000, J GEOPHYS RES-ATMOS, V105, P4039, DOI 10.1029/1999JD901049; PEDERSEN L, COMMUNICATION; Thomas R, 2000, SCIENCE, V289, P426, DOI 10.1126/science.289.5478.426; WAHR J, COMMUNICATION; Weidick A, 1991, RAPP GRONLANDS GEOL, V152, P73; [No title captured]	13	291	298	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					428	430		10.1126/science.289.5478.428	http://dx.doi.org/10.1126/science.289.5478.428			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903198	Green Submitted			2022-12-28	WOS:000088305500040
J	Johnsen, A; Andersen, V; Sunding, C; Lifjeld, JT				Johnsen, A; Andersen, V; Sunding, C; Lifjeld, JT			Female bluethroats enhance offspring immunocompetence through extra-pair copulations	NATURE			English	Article							LUSCINIA S. SVECICA; ZEBRA FINCH; PATERNITY; BIRDS; FERTILIZATIONS; SURVIVAL	Female birds frequently copulate with extra-pair males(1,2), but the adaptive value of this behaviour is poorly understood(2). Some studies have suggested that 'good genes' may be involved, where females seek to have their eggs fertilized by high-quality males without receiving any material benefits from them(3,4). Nevertheless, it remains to be shown that a genetic benefit is passed on to offspring(5,6). Here we report that nestling bluethroats, Luscinia svecica, sired by extra-pair males had a higher T-cell-mediated immune response than their maternal half-siblings raised in the same nest. The difference could not be attributed to nestling body mass, sex or hatching order, but may be an effect of paternal genotype. Extra-pair young were also more immunocompetent than their paternal half-sibs raised in the genetic father's own nest, which indicates an additional effect of maternal genotype. Our results are consistent with the idea that females engage in extra-pair copulations to obtain compatible viability genes, rather than 'good genes' per se.	Univ Oslo, Zool Museum, N-0562 Oslo, Norway	University of Oslo	Lifjeld, JT (corresponding author), Univ Wisconsin, Dept Biol Sci, Lapham Hall,POB 413, Milwaukee, WI 53201 USA.	j.t.lifjeld@toyen.uio.no	Lifjeld, Jan T/B-1978-2008	Lifjeld, Jan T/0000-0002-9172-9985; Johnsen, Arild/0000-0003-4864-6284				Andersson Malte, 1994; Anthonisen K, 1997, AUK, V114, P553; Birkhead T.R., 1998, P579, DOI 10.1016/B978-012100543-6/50039-8; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P385, DOI 10.1098/rspb.1999.0649; Brinkhof MWG, 1999, P ROY SOC B-BIOL SCI, V266, P2315, DOI 10.1098/rspb.1999.0925; Christe P, 1998, OIKOS, V83, P175, DOI 10.2307/3546559; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; JAMIESON A, 1994, ANIM GENET, V25, P37, DOI 10.1111/j.1365-2052.1994.tb00401.x; JEFFREYS AJ, 1992, FORENSIC SCI INT, V56, P65, DOI 10.1016/0379-0738(92)90148-P; Johnsen A, 1998, BEHAV ECOL SOCIOBIOL, V43, P401, DOI 10.1007/s002650050507; Johnsen A, 1998, P ROY SOC B-BIOL SCI, V265, P1313, DOI 10.1098/rspb.1998.0435; Kempenaers B, 1996, ANIM BEHAV, V51, P1165, DOI 10.1006/anbe.1996.0118; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; MCCORKLE F, 1980, POULTRY SCI, V59, P616, DOI 10.3382/ps.0590616; PETRIE M, 1994, NATURE, V371, P598, DOI 10.1038/371598a0; Saino N, 1997, J ANIM ECOL, V66, P827, DOI 10.2307/5998; Sheldon BC, 1997, P ROY SOC B-BIOL SCI, V264, P297, DOI 10.1098/rspb.1997.0042; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381	22	172	174	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					296	299		10.1038/35018556	http://dx.doi.org/10.1038/35018556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917529				2022-12-28	WOS:000088251900047
J	Soden, BJ				Soden, BJ			Atmospheric physics - Enlightening water vapour	NATURE			English	Editorial Material									Princeton Univ, NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University	Soden, BJ (corresponding author), Princeton Univ, NOAA, Geophys Fluid Dynam Lab, Box 308, Princeton, NJ 08542 USA.		Soden, Brian/ABC-3659-2021					LINDZEN RS, 1990, B AM METEOROL SOC, V71, P288, DOI 10.1175/1520-0477(1990)071<0288:SCCGW>2.0.CO;2; Price C, 2000, NATURE, V406, P290, DOI 10.1038/35018543; Rind D, 1998, SCIENCE, V281, P1152, DOI 10.1126/science.281.5380.1152	3	11	12	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					247	248		10.1038/35018666	http://dx.doi.org/10.1038/35018666			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917512				2022-12-28	WOS:000088251900030
J	Jailwala, J; Imperiale, TF; Kroenke, K				Jailwala, J; Imperiale, TF; Kroenke, K			Pharmacologic treatment of the irritable bowel syndrome: A systematic review of randomized, controlled trials	ANNALS OF INTERNAL MEDICINE			English	Review							QUALITY-OF-LIFE; LONG-TERM TREATMENT; DOUBLE-BLIND TRIAL; FUNCTIONAL GASTROINTESTINAL DISORDERS; ORAL SODIUM CROMOGLYCATE; WHEAT BRAN; CIMETROPIUM BROMIDE; PEPPERMINT-OIL; UNITED-STATES; LEUPROLIDE ACETATE	Purpose: To evaluate the efficacy of pharmacologic agents for the irritable bowel syndrome. Data Sources: Electronic literature search of MEDLINE (1966 to 1999), EMBASE (1980 to 1999), PsycINFO (1967 to 1999), and the Cochrane controlled trials registry and a manual search of references from bibliographies of identified articles. Study Selection: Randomized, double-blind, placebo-controlled, parallel, or crossover trials of a pharmacologic intervention for adult patients that reported outcomes of improvement in global or irritable bower-specific symptoms. Data Extraction: Qualitative and quantitative data reported on study groups, interventions, treatment outcomes, and trial methodologic characteristics. Data Synthesis: 70 studies met the inclusion criteria. The most common medication classes were smooth-muscle relaxants (16 trials), bulking agents (13 trials), prokinetic agents (6 trials), psychotropic agents (7 trials), and loperamide (4 trials). The strongest evidence for efficacy was shown for smooth-muscle relaxants in patients with abdominal pain as the predominant symptom. Loperamide seems to reduce diarrhea but does not relieve abdominal pain. Although psychotropic agents were shown to produce global improvement, the evidence is based on a small number of studies of suboptimal quality. Psychotropic drugs, 5-hydroxytryptamine (5-HT)-receptor antagonists, peppermint oil, and Chinese herbal medicine require further study. Conclusions: Smooth-muscle relaxants are beneficial when abdominal pain is the predominant symptom. In contrast, the efficacy of bulking agents has not been established. Loperamide is effective for diarrhea. Evidence for use of psychotropic agents is inconclusive; more high-quality trials of longer duration are needed. Evidence for the efficacy of 5-HT-receptor antagonists seems favorable, although more studies are needed.	Richard L Roudebush Vet Affairs Med Ctr, Hlth Serv Res & Policy, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Imperiale, TF (corresponding author), Richard L Roudebush Vet Affairs Med Ctr, Hlth Serv Res & Policy, Route 11-H,1481 W 10th St, Indianapolis, IN 46202 USA.		anand, amit/A-7222-2009	Imperiale, Thomas/0000-0001-7586-1073; Kroenke, Kurt/0000-0002-0114-4669	NIDDK NIH HHS [1 K24 DK 02756-01] Funding Source: Medline; BHP HRSA HHS [T32 PE15001] Funding Source: Medline; DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [T32PE015001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002756] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); BHP HRSA HHS; DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARFFMANN S, 1985, SCAND J GASTROENTERO, V20, P295, DOI 10.3109/00365528509091653; ARTHURS Y, 1983, IRISH MED J, V76, P253; Awad R., 1995, Acta Gastroenterologica Latinoamericana, V25, P137; BALDI F, 1991, ITAL J GASTROENTEROL, V23, P60; Battaglia G, 1998, ALIMENT PHARM THERAP, V12, P1003; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bensoussan A, 1998, JAMA-J AM MED ASSOC, V280, P1585, DOI 10.1001/jama.280.18.1585; BOLIN TD, 1980, GUT, V21, P848, DOI 10.1136/gut.21.10.848; CAMILLERI M, 1992, ANN INTERN MED, V116, P1001, DOI 10.7326/0003-4819-116-12-1001; Camilleri M, 1999, ALIMENT PHARM THERAP, V13, P1149; CANN PA, 1983, GUT, V24, P1135, DOI 10.1136/gut.24.12.1135; CANN PA, 1994, ANN NY ACAD SCI, V713, P449, DOI 10.1111/j.1749-6632.1994.tb44123.x; CANN PA, 1984, DIGEST DIS SCI, V29, P239, DOI 10.1007/BF01296258; CANN PA, 1987, SCAND J GASTROENTERO, V22, P67, DOI 10.3109/00365528709091002; CENTONZE V, 1988, AM J GASTROENTEROL, V83, P1262; Chadda V S, 1983, J Assoc Physicians India, V31, P425; CHALMERS TC, 1981, CONTROL CLIN TRIALS, V2, P31, DOI 10.1016/0197-2456(81)90056-8; CONNELL AM, 1965, BRIT MED J, V2, P848, DOI 10.1136/bmj.2.5466.848; COOK DJ, 1995, J CLIN EPIDEMIOL, V48, P167, DOI 10.1016/0895-4356(94)00172-M; Cook DJ, 1997, ANN INTERN MED, V126, P376, DOI 10.7326/0003-4819-126-5-199703010-00006; COOK IJ, 1990, GASTROENTEROLOGY, V98, P66, DOI 10.1016/0016-5085(90)91292-E; DAPOIGNY M, 1995, DIGEST DIS SCI, V40, P2244, DOI 10.1007/BF02209014; DOBRILLA G, 1990, GUT, V31, P355, DOI 10.1136/gut.31.3.355; DOTEVALL G, 1974, BRIT MED J, V4, P16, DOI 10.1136/bmj.4.5935.16; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; DROSSMAN DA, 1995, DIGEST DIS SCI, V40, P986, DOI 10.1007/BF02064187; DROSSMAN DA, 1992, ANN INTERN MED, V116, P1009, DOI 10.7326/0003-4819-116-12-1009; Drossman DA, 1997, GASTROENTEROLOGY, V112, P2120, DOI 10.1053/gast.1997.v112.agast972120; Efskind PS, 1996, SCAND J GASTROENTERO, V31, P463, DOI 10.3109/00365529609006766; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; EVERHART JE, 1991, GASTROENTEROLOGY, V100, P998, DOI 10.1016/0016-5085(91)90275-P; Farup PG, 1998, SCAND J GASTROENTERO, V33, P128; FIELDING JF, 1982, DIGESTION, V23, P125, DOI 10.1159/000198701; FIELDING JF, 1981, DIGESTION, V22, P155, DOI 10.1159/000198627; FOWLIE S, 1992, J PSYCHOSOM RES, V36, P175, DOI 10.1016/0022-3999(92)90026-X; FRIEDMAN LM, 1996, FUNDAMENTALS CLIN TR; Gade J, 1989, Scand J Prim Health Care, V7, P23, DOI 10.3109/02813438909103666; GHIDINI O, 1986, CURR THER RES CLIN E, V39, P541; GILVARRY J, 1989, IRISH J MED SCI, V158, P262, DOI 10.1007/BF02943704; Golechha A C, 1982, J Assoc Physicians India, V30, P353; GORARD DA, 1995, DIGEST DIS SCI, V40, P86, DOI 10.1007/BF02063948; GORARD DA, 1994, ALIMENT PHARM THER, V8, P159; GREENBAUM DS, 1987, DIGEST DIS SCI, V32, P257, DOI 10.1007/BF01297051; GREENBAUM DS, 1973, NEW ENGL J MED, V288, P13, DOI 10.1056/NEJM197301042880103; GUSLANDI M, 1981, CLIN TRIALS J, V18, P138; GUYATT GH, 1993, JAMA-J AM MED ASSOC, V270, P2598, DOI 10.1001/jama.270.21.2598; Hahn BA, 1997, ALIMENT PHARM THERAP, V11, P547, DOI 10.1046/j.1365-2036.1997.00168.x; Hahn BA, 1997, ALIMENT PHARM THERAP, V11, P553, DOI 10.1046/j.1365-2036.1997.00160.x; Halpern GM, 1996, AM J GASTROENTEROL, V91, P1579; HAYNES RB, 1994, J AM MED INFORM ASSN, V1, P447, DOI 10.1136/jamia.1994.95153434; HOVDENAK N, 1987, SCAND J GASTROENTERO, V22, P81, DOI 10.3109/00365528709091004; JALIHAL A, 1990, J GASTROEN HEPATOL, V5, P507, DOI 10.1111/j.1440-1746.1990.tb01432.x; KAISCH AM, 1959, AM J DIG DIS, V4, P229; KLEIN KB, 1988, GASTROENTEROLOGY, V95, P232, DOI 10.1016/0016-5085(88)90319-8; KRUIS W, 1986, DIGESTION, V34, P196, DOI 10.1159/000199329; LANCASTERSMITH MJ, 1982, ACTA PSYCHIAT SCAND, V66, P33, DOI 10.1111/j.1600-0447.1982.tb00912.x; LAVO B, 1987, SCAND J GASTROENTERO, V22, P77, DOI 10.3109/00365528709091003; LAWSON MJ, 1988, J GASTROEN HEPATOL, V3, P235, DOI 10.1111/j.1440-1746.1988.tb00244.x; Light R.J., 1984, SUMMING SCI REV RES; LISKER R, 1989, AM J GASTROENTEROL, V84, P756; Liu JH, 1997, J GASTROENTEROL, V32, P765, DOI 10.1007/BF02936952; LONGSTRETH GF, 1981, ANN INTERN MED, V95, P53, DOI 10.7326/0003-4819-95-1-53; LUCEY MR, 1987, GUT, V28, P221, DOI 10.1136/gut.28.2.221; LUNARDI C, 1991, CLIN EXP ALLERGY, V21, P569, DOI 10.1111/j.1365-2222.1991.tb00848.x; LYNN RB, 1993, NEW ENGL J MED, V329, P1940, DOI 10.1056/NEJM199312233292608; MATHIAS JR, 1994, DIGEST DIS SCI, V39, P1163, DOI 10.1007/BF02093779; Mathias JR, 1998, DIGEST DIS SCI, V43, P1347, DOI 10.1023/A:1018888631286; Maxton DG, 1996, ALIMENT PHARM THERAP, V10, P595, DOI 10.1046/j.1365-2036.1996.30172000.x; MAXTON DG, 1991, J PHARM MED, V1, P219; MILO R, 1980, CURR MED RES OPIN, V6, P577, DOI 10.1185/03007998009109491; MITCHELL CM, 1987, GASTROENTEROLOGY, V92, P1282, DOI 10.1016/S0016-5085(87)91099-7; MORTENSEN PB, 1987, SCAND J GASTROENTERO, V22, P185, DOI 10.3109/00365528708991878; MOSHAL MG, 1979, J INT MED RES, V7, P231, DOI 10.1177/030006057900700311; MYREN J, 1984, SCAND J GASTROENTERO, V19, P835, DOI 10.1080/00365521.1984.12005817; NASH P, 1986, BRIT J CLIN PRACT, V40, P292; NEWCOMER AD, 1983, AM J CLIN NUTR, V38, P257, DOI 10.1093/ajcn/38.2.257; Nigam P, 1984, J Assoc Physicians India, V32, P1041; OWENS DM, 1995, ANN INTERN MED, V122, P107, DOI 10.7326/0003-4819-122-2-199501150-00005; PAGE JG, 1981, J CLIN GASTROENTEROL, V3, P153, DOI 10.1097/00004836-198106000-00009; Patrick DL, 1998, DIGEST DIS SCI, V43, P400, DOI 10.1023/A:1018831127942; PEREZMATEO M, 1986, INT J CLIN PHARM RES, V6, P425; PIAI G, 1987, CURR THER RES CLIN E, V41, P967; PIAI G, 1979, GASTROENTEROLOGY, V77, P500; Pittler MH, 1998, AM J GASTROENTEROL, V93, P1131, DOI 10.1111/j.1572-0241.1998.00343.x; POYNARD T, 1994, ALIMENT PHARM THERAP, V8, P499; PRIOR A, 1987, GUT, V28, P1510, DOI 10.1136/gut.28.11.1510; PRIOR A, 1988, Alimentary Pharmacology and Therapeutics, V2, P535; Rajagopalan M, 1998, J GASTROEN HEPATOL, V13, P738, DOI 10.1111/j.1440-1746.1998.tb00723.x; RITCHIE JA, 1979, BRIT MED J, V1, P376, DOI 10.1136/bmj.1.6160.376; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, P187; SANDLER RS, 1990, GASTROENTEROLOGY, V99, P409, DOI 10.1016/0016-5085(90)91023-Y; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schutze K, 1997, ALIMENT PHARM THER, V11, P387, DOI 10.1046/j.1365-2036.1997.133311000.x; SLAVIN RE, 1995, J CLIN EPIDEMIOL, V48, P9, DOI 10.1016/0895-4356(94)00097-A; Snedecor GW, 1980, STAT METHODS, V7th; SNOOK J, 1994, ALIMENT PHARM THERAP, V8, P511; SOLTOFT J, 1976, LANCET, V1, P270; STEADMAN CJ, 1992, MAYO CLIN PROC, V67, P732, DOI 10.1016/S0025-6196(12)60797-6; STEINHART MJ, 1981, INT J PSYCHIAT MED, V11, P45, DOI 10.2190/WFHG-GR7T-79D6-UQVD; Talley N, 1993, GASTROENTEROL INT, V6, P189; TALLEY NJ, 1995, AM J EPIDEMIOL, V142, P76, DOI 10.1093/oxfordjournals.aje.a117548; TALLEY NJ, 1995, GASTROENTEROLOGY, V109, P1736, DOI 10.1016/0016-5085(95)90738-6; Talley NJ, 1996, AM J GASTROENTEROL, V91, P277; TASMANJONES C, 1973, NEW ZEAL MED J, V77, P232; TOSKES PP, 1993, ALIMENT PHARM THERAP, V7, P87; VANOUTRYVE M, 1991, J CLIN GASTROENTEROL, V13, P49; Whitehead WE, 1996, DIGEST DIS SCI, V41, P2248, DOI 10.1007/BF02071408; YADAV S K, 1989, Indian Journal of Medical Research Section B, V90, P496; 1996, PRACTITIONER, V217, P276	109	266	297	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2000	133	2					136	147		10.7326/0003-4819-133-2-200007180-00013	http://dx.doi.org/10.7326/0003-4819-133-2-200007180-00013			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335RL	10896640				2022-12-28	WOS:000088258500007
J	Kotz, RI; Windhager, R; Dominkus, M; Robioneck, B; Muller-Daniels, H				Kotz, RI; Windhager, R; Dominkus, M; Robioneck, B; Muller-Daniels, H			A self-extending paediatric leg implant - This device spares the need for surgical intervention by simulating natural limb growth.	NATURE			English	Article									Univ Vienna, Dept Orthopaed, A-1090 Vienna, Austria; Graz Univ, Dept Orthopaed, A-8036 Graz, Austria; Stryker Howmed Osteon, D-24232 Schonkirchen, Germany	University of Vienna; University of Graz	Kotz, RI (corresponding author), Univ Vienna, Dept Orthopaed, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.			Windhager, Reinhard/0000-0002-6321-1804				Bien, 1995, MED ORTHOPADISCHE TE, V115, P152; CHAO EYS, 1983, TUMOR PROSTHESES BON, P335; ECKARDT JJ, 1991, LIMB SALVAGE MAJOR R, P585; KOTZ R, 1986, ORTHOPEDICS, V9, P1639; KOTZ R, 1991, MAJOR RECONSTRUCTION, P591; LEWIS MM, 1987, LIMB SALVAGE MUSCULO, P606; MITTERMEYER F, UNPUB CLIN ORTHOPED; Scales JT, 1987, LIMB SALVAGE MUSCULO, P52; SCHILLER C, 1995, J BONE JOINT SURG BR, V77B, P608, DOI 10.1302/0301-620X.77B4.7615607	9	20	22	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					143	144		10.1038/35018155	http://dx.doi.org/10.1038/35018155			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910342				2022-12-28	WOS:000088221100032
J	Henney, JE				Henney, JE			Joint meeting of advisory committees	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2000	284	1					33	33		10.1001/jama.284.1.33	http://dx.doi.org/10.1001/jama.284.1.33			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328GX	10905906				2022-12-28	WOS:000087843000005
J	Abrams, P; Lowry, SK; Wein, AJ; Bump, R; Denis, L; Kalache, A; Kawabe, K; Melchior, H; Richard, F; Thuroff, J; Tsechkovski, MS				Abrams, P; Lowry, SK; Wein, AJ; Bump, R; Denis, L; Kalache, A; Kawabe, K; Melchior, H; Richard, F; Thuroff, J; Tsechkovski, MS		Sci Comm First Int Consultation In	Assessment and treatment of urinary incontinence	LANCET			English	Article								The first International Consultation on Incontinence was held under the auspices of WHO in 1998. The multidisciplinary consultation covered anatomy, physiology, pathology, and the investigation and management of incontinent individuals. Because incontinence is a prevalent global disease, the consultation was mindful of the need to make its recommendations applicable in all health-care systems. The management recommendations are presented as nine algorithms divided into basic management (five) and specialised management (four), for men, women, children, the frail elderly, and individuals with neurogenic incontinence separately. The basic algorithms are intended for all healthcare professionals working with incontinent individuals and are applied worldwide. The specalised algorithms are presented on The Lancet website.	Southmead Gen Hosp, Bristol Urol Inst, Bristol BS10 5NB, Avon, England	Southmead Hospital	Abrams, P (corresponding author), Southmead Gen Hosp, Bristol Urol Inst, Bristol BS10 5NB, Avon, England.		Thueroff, Joachim/AAF-7652-2020	Thueroff, Joachim/0000-0002-9189-2387				Abrams P, 1999, INCONTINENCE 1 INT C; Abrams P., 1990, INT UROGYNECOL J, V1, P45, DOI [10.1007/BF00373608, DOI 10.1007/BF00373608]; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; FANTL JA, 1996, AHCPR PUBLICATION	5	62	64	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2153	2158						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902644				2022-12-28	WOS:000087687100040
J	Kozlowski, LT; O'Connor, RJ				Kozlowski, LT; O'Connor, RJ			Official cigarette tar tests are misleading: use a two-stage, compensating test	LANCET			English	Editorial Material							CARBON-MONOXIDE EXPOSURE; LOW-YIELD CIGARETTES; SAFER SMOKING; NICOTINE; TOBACCO; SMOKERS; BRANDS		Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kozlowski, LT (corresponding author), Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA.		O'Connor, Richard/A-6961-2009					Bates C, 1999, TOB CONTROL, V8, P225, DOI 10.1136/tc.8.2.225; BENOWITZ NL, 1986, JAMA-J AM MED ASSOC, V256, P241; BENOWITZ NL, 1983, NEW ENGL J MED, V309, P139, DOI 10.1056/NEJM198307213090303; Djordjevic MV, 2000, JNCI-J NATL CANCER I, V92, P106, DOI 10.1093/jnci/92.2.106; *FED TRAD COMM, 1999, TAR NIC CARB MON SMO; *FED TRAD COMM, 1997, P944509 FTC; FROST C, 1995, THORAX, V50, P1038, DOI 10.1136/thx.50.10.1038; Glantz S.A., 1996, CIGARETTE PAPERS; HENNINGFIELD JE, 1994, JAMA-J AM MED ASSOC, V272, P312, DOI 10.1001/jama.272.4.312; HERNING RI, 1981, BRIT MED J, V283, P187, DOI 10.1136/bmj.283.6285.187; Kozlowski LT, 1998, TOB CONTROL, V7, P369, DOI 10.1136/tc.7.4.369; Kozlowski LT, 2000, AM J PREV MED, V18, P339, DOI 10.1016/S0749-3797(00)00125-2; Kozlowski LT, 1998, AM J PREV MED, V15, P9, DOI 10.1016/S0749-3797(98)00004-X; KOZLOWSKI LT, 1983, NIDA RES MONOGRAPH, V48; PEELER CE, 1996, NCI SMOKING TOBACCO, V7, P1; RICKERT WS, 1983, PREV MED, V12, P682, DOI 10.1016/0091-7435(83)90226-8; *ROYAL COLL PHYS, 2000, NIC ADD BRIT REP TOB; RUSSELL MAH, 1976, BRIT MED J, V1, P1430, DOI 10.1136/bmj.1.6023.1430; RUSSELL MAH, 1974, LANCET, V1, P254; SAMET JM, 1996, NCI SMOKING TOBACCO, V7, P77; Sweeney CT, 1999, PHARMACOL BIOCHEM BE, V63, P167, DOI 10.1016/S0091-3057(98)00250-0; TOWNSEND DE, 1996, NCI SMOKING TOBACCO, V7, pCH13; WARNER KE, 1992, AM J PUBLIC HEALTH, V82, P17, DOI 10.2105/AJPH.82.1.17	23	33	38	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2159	2161		10.1016/S0140-6736(00)02390-4	http://dx.doi.org/10.1016/S0140-6736(00)02390-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902645				2022-12-28	WOS:000087687100041
J	Keenan, SP				Keenan, SP			Measuring level of sedation in the intensive care unit - Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Royal Columbian Hosp, New Westminster, BC, Canada		Keenan, SP (corresponding author), Royal Columbian Hosp, New Westminster, BC, Canada.		Ramsay, Michael/A-7743-2009; Ramsay, Michael/AAX-8362-2021	Ramsay, Michael/0000-0002-6775-1306; 				De Jonghe B, 2000, INTENS CARE MED, V26, P275, DOI 10.1007/s001340051150; Ostermann ME, 2000, JAMA-J AM MED ASSOC, V283, P1451, DOI 10.1001/jama.283.11.1451	2	31	33	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					441	+		10.1001/jama.284.4.441	http://dx.doi.org/10.1001/jama.284.4.441			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904503				2022-12-28	WOS:000088254200025
J	Ramsay, MAE				Ramsay, MAE			Measuring level of sedation in the intensive care unit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Baylor Univ, Med Ctr, Dallas, TX 75246 USA	Baylor University; Baylor University Medical Center	Ramsay, MAE (corresponding author), Baylor Univ, Med Ctr, Dallas, TX 75246 USA.		Ramsay, Michael/A-7743-2009; Ramsay, Michael/AAX-8362-2021	Ramsay, Michael/0000-0002-6775-1306; 				Joint Commission on Accreditation of Healthcare Organizations, 2000, COMPR ACCR MAN HOSP; Ostermann ME, 2000, JAMA-J AM MED ASSOC, V283, P1451, DOI 10.1001/jama.283.11.1451; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; RHONEY DH, 1998, CRIT CARE MED, V26, pA24	4	31	33	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					441	441		10.1001/jama.284.4.441	http://dx.doi.org/10.1001/jama.284.4.441			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904503				2022-12-28	WOS:000088254200024
J	Schriefer, ME; Dennis, DT; Gubler, DJ; Hayes, EB; Johnson, BJB; Chu, MC				Schriefer, ME; Dennis, DT; Gubler, DJ; Hayes, EB; Johnson, BJB; Chu, MC			Serologic testing for lyme disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							BORRELIA-BURGDORFERI; IMMUNE-COMPLEXES		Ctr Dis Control & Prevent, Ft Collins, CO 80522 USA	Centers for Disease Control & Prevention - USA	Schriefer, ME (corresponding author), Ctr Dis Control & Prevent, Ft Collins, CO 80522 USA.							Centers for Disease Control and Prevention (CDC), 1995, MMWR MORB MORTAL WKL, V44, P590; SCHUTZER SE, 1990, LANCET, V335, P312, DOI 10.1016/0140-6736(90)90606-6; Schutzer SE, 1999, JAMA-J AM MED ASSOC, V282, P1942, DOI 10.1001/jama.282.20.1942	3	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					695	696		10.1001/jama.284.6.695	http://dx.doi.org/10.1001/jama.284.6.695			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341JM	10927775				2022-12-28	WOS:000088587300024
J	Javitt, JC				Javitt, JC			How often should patients with diabetes be screened for retinopathy?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							HEALTH		Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Javitt, JC (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.		Javitt, Jonathan/AAJ-5574-2021	Javitt, Jonathan/0000-0003-2371-1609; Hofer, Timothy/0000-0003-0434-8787				BASS EB, 1997, OPHTHALMIC EPIDEMIOL, V4, P89; Eastman RC, 1997, DIABETES CARE, V20, P725, DOI 10.2337/diacare.20.5.725; JAVITT JC, 1994, DIABETES CARE, V17, P909, DOI 10.2337/diacare.17.8.909; TORRANCE GW, 1982, OPER RES, V30, P1043, DOI 10.1287/opre.30.6.1043; Torrance GW, 1987, METHODS EC EVALUATIO; Vijan S, 2000, JAMA-J AM MED ASSOC, V283, P889, DOI 10.1001/jama.283.7.889	6	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					437	438		10.1001/jama.284.4.437	http://dx.doi.org/10.1001/jama.284.4.437			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904495				2022-12-28	WOS:000088254200017
J	Brown, L				Brown, L			On earth as it is in hell	WESTERN JOURNAL OF MEDICINE			English	News Item																			0	0	0	0	1	B M J PUBLISHING INC	SAN FRANCISCO	221 MAIN ST, PO BOX 7690, SAN FRANCISCO, CA 94120-7690 USA	0093-0415			WESTERN J MED	West. J. Med.	SEP	2000	173	3					158	159		10.1136/ewjm.173.3.158	http://dx.doi.org/10.1136/ewjm.173.3.158			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349CN	10894708	Green Published			2022-12-28	WOS:000089026400009
